
<html lang="en"     class="pb-page"  data-request-id="e1b7b5b5-158f-4aa7-b26b-702b32508dce"  
><head data-pb-dropzone="head"><meta name="pbContext" content=";requestedJournal:journal:jmcmar;issue:issue:10.1021/jmcmar.2018.61.issue-22;journal:journal:jmcmar;page:string:Article/Chapter View;ctype:string:Journal Content;wgroup:string:ACHS website Group;website:website:acspubs;article:article:10.1021/acs.jmedchem.8b00639;pageGroup:string:Publication Pages;subPage:string:Full Text"/></meta>




        <link rel="schema.DC" href="http://purl.org/DC/elements/1.0/" /></link><meta name="citation_journal_title" content="Journal of Medicinal Chemistry" /></meta><meta name="dc.Title" content="Discovery, Synthesis, and Evaluation of Oxynitidine Derivatives as Dual Inhibitors of DNA Topoisomerase IB (TOP1) and Tyrosyl-DNA Phosphodiesterase 1 (TDP1), and Potential Antitumor Agents" /></meta><meta name="dc.Creator" content="Xiao-Ru  Zhang" /></meta><meta name="dc.Creator" content="Hao-Wen  Wang" /></meta><meta name="dc.Creator" content="Wen-Lin  Tang" /></meta><meta name="dc.Creator" content="Yu  Zhang" /></meta><meta name="dc.Creator" content="Hui  Yang" /></meta><meta name="dc.Creator" content="De-Xuan  Hu" /></meta><meta name="dc.Creator" content="Azhar  Ravji" /></meta><meta name="dc.Creator" content="Christophe  Marchand" /></meta><meta name="dc.Creator" content="Evgeny  Kiselev" /></meta><meta name="dc.Creator" content="Kwabena  Ofori-Atta" /></meta><meta name="dc.Creator" content="Keli  Agama" /></meta><meta name="dc.Creator" content="Yves  Pommier" /></meta><meta name="dc.Creator" content="Lin-Kun  An" /></meta><meta name="dc.Description" content="Tyrosyl–DNA phosphodiesterase 1 (TDP1) is a recently discovered enzyme repairing DNA lesions resulting from stalled topoisomerase IB (TOP1)–DNA covalent complex. Inhibiting TDP1 in conjunction with..." /></meta><meta name="Description" content="Tyrosyl–DNA phosphodiesterase 1 (TDP1) is a recently discovered enzyme repairing DNA lesions resulting from stalled topoisomerase IB (TOP1)–DNA covalent complex. Inhibiting TDP1 in conjunction with..." /></meta><meta name="dc.Publisher" content="American Chemical Society" /></meta><meta name="dc.Date" scheme="WTN8601" content="October 18, 2018" /></meta><meta name="dc.Type" content="research-article" /></meta><meta name="dc.Format" content="text/HTML" /></meta><meta name="dc.Identifier" scheme="doi" content="10.1021/acs.jmedchem.8b00639" /></meta><meta name="dc.Language" content="en" /></meta><meta name="dc.Coverage" content="world" /></meta><meta name="dc.Rights" content="Copyright © 2018 American Chemical Society" /></meta>
        
        

        
            <link rel="meta" type="application/atom+xml" href="https://doi.org/10.1021%2Facs.jmedchem.8b00639" /></link>
            <link rel="meta" type="application/rdf+json" href="https://doi.org/10.1021%2Facs.jmedchem.8b00639" /></link>
            <link rel="meta" type="application/unixref+xml" href="https://doi.org/10.1021%2Facs.jmedchem.8b00639" /></link>
        
    
    

<title>Discovery, Synthesis, and Evaluation of Oxynitidine Derivatives as Dual Inhibitors of DNA Topoisomerase IB (TOP1) and Tyrosyl-DNA Phosphodiesterase 1 (TDP1), and Potential Antitumor Agents | Journal of Medicinal Chemistry</title>












<meta charset="UTF-8">




<meta name="robots" content="noarchive"/></meta>
<meta name="pb-robots-disabled">









        <meta property="og:url" content="https://pubs.acs.org/doi/full/10.1021/acs.jmedchem.8b00639" /></meta><meta property="og:title" content="Discovery, Synthesis, and Evaluation of Oxynitidine Derivatives as Dual Inhibitors of DNA Topoisomerase IB (TOP1) and Tyrosyl-DNA Phosphodiesterase 1 (TDP1), and Potential Antitumor Agents" /></meta><meta property="og:image" content="https://pubs.acs.org/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-22/acs.jmedchem.8b00639/20181119/images/large/jm-2018-00639p_0016.jpeg" /></meta><meta property="og:description" content="Tyrosyl–DNA phosphodiesterase 1 (TDP1) is a recently discovered enzyme repairing DNA lesions resulting from stalled topoisomerase IB (TOP1)–DNA covalent complex. Inhibiting TDP1 in conjunction with TOP1 inhibitors can boost the action of the latter. Herein, we report the discovery of the natural product oxynitidine scaffold as a novel chemotype for the development of TOP1 and TDP1 inhibitors. Three kinds of analogues, benzophenanthridinone, dihydrobenzophenanthridine, and benzophenanthridine derivatives, were synthesized and evaluated for both TOP1 and TDP1 inhibition and cytotoxicity. Analogue 19a showed high TOP1 inhibition (+++) and induced the formation of cellular TOP1cc and DNA damage, resulting in cancer cells apoptosis at nanomolar concentration range. In vivo studies indicated that 19a exhibits antitumor efficiency in HCT116 xenograft model. 41a exhibited additional TDP1 inhibition with IC50 value of 7 μM and synergistic effect with camptothecin in MCF-7 cells. This work will facilitate future efforts for the discovery of natural product-based TOP1 and TDP1 inhibitors." /></meta><meta property="og:type" content="Article" /></meta><meta property="og:site_name" content="ACS Publications" /></meta><meta name="twitter:card" content="summary_large_image" /></meta><meta name="twitter:site" content="@ACSPublications" /></meta>
    


    <meta name="viewport" content="width=device-width,initial-scale=1,maximum-scale=10, user-scalable=0"/></meta>















    

    <meta name="dc.identifier" content="10.1021/acs.jmedchem.8b00639"/></meta>



<meta name="format-detection" content="telephone=no">













<link rel="stylesheet" type="text/css" href="/wro/kfa7~product.css">


    <link rel="stylesheet" href="/products/achs/releasedAssets/fonts/achs-fonts/font-roboto/font-roboto.css"/></link><link rel="stylesheet" href="/products/achs/releasedAssets/css/build-f32cfd249ff7cb4cf9c7.css"/></link><link rel="stylesheet" href="/products/achs/releasedAssets/fonts/achs-fonts/font-lato/font-lato.css"/></link>




<meta http-equiv="X-UA-Compatible" content="IE=edge">
<meta http-equiv="content-type" content="text/html; charset=UTF-8">
<link rel="stylesheet" type="text/css" href="/pb-assets/styles/achs-1625058702970.css">
<link rel="stylesheet" type="text/css" href="/pb-assets/styles/acs-1622125181777.css">
<script type="text/javascript" src="/templates/jsp/js/jquery-3.1.1.min.js"></script>
<script type="text/javascript" src="/pb-assets/javascript/eloqua-1619549134767.js"></script>
<script async="" type="text/javascript" src="https://www.googletagservices.com/tag/js/gpt.js" rel="preconnect"></script>

<script defer src="https://static.cloudflareinsights.com/beacon.min.js" data-cf-beacon='{"rayId":"5200035e6e4d5180","startTime":1570117212010}'></script>






    








    
        
            <script type="text/javascript">
                (function (i, s, o, g, r, a, m) {
                    i['GoogleAnalyticsObject'] = r;
                    i[r] = i[r] || function () {
                        (i[r].q = i[r].q || []).push(arguments)
                    }, i[r].l = 1 * new Date();
                    a = s.createElement(o), m = s.getElementsByTagName(o)[0];
                    a.async = 1;
                    a.src = g;
                    m.parentNode.insertBefore(a, m)
                })(window, document, 'script', '//www.google-analytics.com/analytics.js', 'ga');
                ga('create', 'UA-7663985-4'
                    
                    
                    , 'auto'
                    
                    );
                
                
                ga('send', 'pageview');
            </script>
            
        
    















    
    
            
                
                

                <link rel="canonical" href="https://pubs.acs.org/doi/10.1021/acs.jmedchem.8b00639">
            
        




























    
    

    
    
    
    
    <script src="//unpkg.com/@theidentityselector/thiss-ds"></script>

    <script type="text/javascript">

        var SeamlessAccessService = {
            spUrl: "/action/ssostart",
            returnURL: window.location.href,
            my_context: 'seamlessaccess.org',
            timeout: 5000,

            getWAYFLessUrl: function (entityId) {
                return this.spUrl + "?idp=" + encodeURIComponent(entityId)
                    + "&redirectUri=" + encodeURIComponent(this.returnURL);
            },
            retrieveEntity: function (ms) {
                var self = this;
                var persistService = new thiss.PersistenceService('https://service.seamlessaccess.org/ps/');

                if(ms == undefined || ms === ''){
                    ms = this.timeout;
                }

                return new Promise(function (resolve, reject) {
                    persistService.entities(self.my_context)
                        .then(function (res) {
                            // get the results
                            var results = res.data;
                            return resolve(results);
                        }, function (err) {
                            // failed
                            reject('retrieve entity error: ' + err);
                        });
                        // Set up the timeout
                        setTimeout(function() {
                            reject('Promise timed out ' + ms + ' ms');
                        }, ms);
                });
            },
            updateEntity: function (entitydata) {
                var self = this;
                var persistService =  new thiss.PersistenceService('https://service.seamlessaccess.org/ps/');

                var jsonObj = {};
                try {
                    //try to parse it, if it is a json string
                    jsonObj = JSON.parse(entitydata.val());
                } catch (e) {
                    jsonObj = entitydata;
                }
                return new Promise(function (resolve, reject) {
                    persistService.update(self.my_context, jsonObj)
                        .then(function (res) {
                            // Process the results
                            var ssoInstitutions = res.data;
                            return resolve(ssoInstitutions);
                        }, function (err) {
                            // failed
                            console.log('failed to update the local storage duo to: ' + err);
                            reject(err);
                        });
                })
            },
            removeEntity: function (entityId) {
                var self = this;
                var persistService =  new thiss.PersistenceService('https://service.seamlessaccess.org/ps/');

                return new Promise(function (resolve) {
                    persistService.remove(self.my_context, entityId)
                        .then(function (res) {
                            return resolve(res);
                        }, function (err) {
                            // failed
                            console.log('failed to remove from local storage duo to: ' + err);
                        });
                })
            },
            getAccessibleEntityStatus: function (doi, entityId) {
                return new Promise(function (resolve) {
                    $.ajax({
                        type: 'POST',
                        url: '/action/seamlessAccess',
                        accept: {
                            text: "application/json"
                        },
                        data: {doi: doi, entityid: entityId}

                    }).done(function (status) {
                        return resolve(status);
                    });
                });
            },
            getEntitiesWithAllInfo: function (doi) {
                let self = this,
                    arrayOfPromises = [];
                return new Promise(function (resolve, reject) {
                    self.retrieveEntity().then(function (res) {
                        let allSsoInstitutions = res;
                        for (i = 0; i < allSsoInstitutions.length; i++) {
                            let ssoInstitution = allSsoInstitutions[i];
                            arrayOfPromises.push(new Promise(function (resolve) {
                                self.getAccessibleEntityStatus(doi, ssoInstitution.entity.entityID)
                                    .then(function (entityStatus) {
                                        resolve({
                                            entityID: ssoInstitution.entity.entityID,
                                            entityTitle: ssoInstitution.entity.title,
                                            entityStatusObj: entityStatus,
                                            entitySsoUrl: self.getWAYFLessUrl(ssoInstitution.entity.entityID)
                                        });
                                    }, function (err) {
                                        console.log('failed to get the entity status: ' + err);
                                    });
                            }));
                        }
                        Promise.all(arrayOfPromises)
                            .then(function (finalResponse) {
                                resolve(finalResponse);
                            });

                    }).catch(function (err) {
                        reject(err);
                    })
                });
            }
        };

        window.addEventListener('load', function () {
            document.querySelectorAll(".sso-institution").forEach(function (institution) {
                var entityId = institution.getAttribute('data-entityid');
                var entityName = institution.getAttribute('data-name');
                var entitydata = {
                    entityID: entityId,
                    title: entityName
                };
                institution.addEventListener("click", function (e) {
                    e.preventDefault();
                    var self = this;
                    SeamlessAccessService.updateEntity(entitydata).then(function (res) {
                        console.log(res);
                        window.location.href = self.href;
                    }).catch(function (err){
                        window.location.href = self.href;
                    });
                });
            });
        });

    </script>




























    






    <meta name="google-site-verification" content="uBHpu2M2kL7VihPCSRXWyBSxooDf7L_BGgfHA3cjSfY" /></meta>


<link rel="prefetch" href="https://tpc.googlesyndication.com/safeframe/1-0-29/html/container.html"></head>
<body class="pb-ui">


























<script type="text/javascript">

    if(false) {
        document.getElementById("skipNavigationLink").onclick =function skipElement () {
            var element = document.getElementById('');
            if(element == null || element == undefined) {
                element = document.getElementsByClassName('').item(0);
            }
            element.setAttribute('tabindex','0');
            element.focus();

        }

    }

</script>











    <div id="pb-page-content" data-ng-non-bindable>
        <div data-pb-dropzone="main" data-pb-dropzone-name="Main">










        <div data-widget-def="UX3HTMLWidget" data-widget-id="ed6ae788-7707-48f4-b02c-3187c75e10db" class="hide">
        



        
        

        </div>
    




        
        




        
        



        <div class="pb-ad">
            <script type="text/javascript">
	var dartInstitutionType = 'none';
	var dartMember = 'false';
</script>
        </div>
    





        
        <script type="text/javascript">
$(document).ready(function() {
	setTimeout(function() {
		// var journalTitle = 'medicinal_chemistry';
		var taxonomyKeywords = $('.article_header-taxonomy');
		var articleKeyword = $('meta[name="keywords"]');
		var articleTitle = $('meta[name="dc.Title"]');
		var articleDescription = $('meta[name="dc.Description"]');
		var abstractKeyword = $('p.articleBody_abstractText:contains("Keywords: ")');
		var searchTerms = [];

		if (taxonomyKeywords.length > 0) {
			$(taxonomyKeywords).children(".rlist--inline").children("li").each(function() {
				searchTerms.push($(this).text());
			});
		}
		else if (articleKeyword.length > 0) { 
			searchTerms = searchTerms.concat(articleKeyword.prop('content').split(', '));
		}
		else if (abstractKeyword.length > 0) {
			searchTerms = searchTerms.concat(abstractKeyword.text().split("Keywords: ")[1].split('; '));
		}
		else if (articleDescription.length > 0) {
			$(articleDescription).each(function() {
				articleDescriptionKeywords = $(this).prop('content');
				articleDescriptionKeywords = articleDescriptionKeywords.replace(/.,/g,"");
				articleDescriptionKeywords = articleDescriptionKeywords.replace(/\s{2,}/g," ");
				searchTerms = searchTerms.concat(articleDescriptionKeywords.split(' '));
			});
		}

		if (articleTitle.length > 0) {
			searchTerms = searchTerms.concat(articleTitle.prop('content').split(' '));
		}

		googletag.cmd.push(function() {
			var mappingLeader = googletag.sizeMapping().
			addSize([320, 400], [320, 50]).
			addSize([320, 700], [320, 50]).
			addSize([750, 200], [728, 90]). 
			addSize([980, 690], [728, 90]).
			addSize([1024, 768], [728, 90]).
			build();
			//leaderboard
			googletag.defineSlot('/8868/journal/medicinal_chemistry/article', [728, 90], 'dfp-journal-article-leaderboard').defineSizeMapping(mappingLeader).setTargeting('location', 'leaderboard1').setTargeting('Keyword', searchTerms).addService(googletag.pubads());
			//recommend
			googletag.defineSlot("/8868/journal/medicinal_chemistry/article", [1, 1], "dfp-journal-article-recommend").setTargeting("ntvPlacement", ["1100167"]).setTargeting("location", "recommend").setTargeting('Keyword', searchTerms).addService(googletag.pubads());
			//googletag.pubads().enableSingleRequest();
			googletag.pubads().collapseEmptyDivs();
			googletag.pubads().setTargeting('inst',dartInstitutionType).setTargeting('memb',dartMember);
			googletag.pubads().addEventListener("slotRenderEnded", function(event) {
				if((event.isEmpty === false) && (event.slot.getSlotElementId() != "dfp-journal-article-recommend")) {
					$("#" + event.slot.getSlotElementId()).parents(".advertisement").slideDown();
				}
			});
			googletag.enableServices();
		});
	}, 1000);
});
</script>





        
        <script src="https://common.ccdc.cam.ac.uk/ccdc-widget/1.0.0.76/Widget.min.js"></script>




        
        <header class="header header_article_inactive">



        
        <div class="header_topbar hidden-sm hidden-xs">



        
        <div class="container"><div class="row"><div class="col-lg-3 col-md-4 col-sm-5 header_topbar_left">









        <div data-widget-def="UX3HTMLWidget" data-widget-id="0be92cec-36a8-4b4d-9a08-a28c790ce306" class="header_mainmenu">
        



        
        <ul>
	<li>
		<a href="http://www.acs.org">ACS</a>
	</li>
	<li class="header_mainmenu_current">
		<a href="/">ACS Publications</a>
	</li>
	<li>
		<a href="https://cen.acs.org">C&EN</a>
	</li>
	<li>
		<a href="https://www.cas.org">CAS</a>
	</li>
</ul>

        </div>
    
</div><div class="col-lg-9 col-md-8 col-sm-7 header_topbar_right">



        
        <div class="institution"><span class="institution-info-wrapper"><span class="institution__intro">Access provided by</span><span class="institution__name">Hong Kong University of Science and Technology Library</span></span></div>




        
        <div class="user-login-bar"><input type="hidden" name="statusEndpoint" value="https://sso.acs.org/idp/status" class="statusEndpoint"/></input><input type="hidden" name="clientID" value="atypon-lives" class="clientID"/></input><input type="hidden" name="heartBeatReloadInterval" value="1740000" class="heartBeatReloadInterval"/></input><input type="hidden" name="logoutUrl" value="https://pubs.acs.org/action/doLogout?logoutRedirectUrl=https%3A%2F%2Fsso.acs.org%2Fidp%2Fglogout%3Fappid%3Datypon-live%26returnURL%3Dhttps%253A%252F%252Fpubs.acs.org%252F" class="logoutUrl"/></input><img src="https://sso.acs.org/idp/heartbeat?appid=atypon-lives&amp;max_auth_age=2592000" alt="Blank image" class="ssoHeartBeatImg"/></img><span class="user-login-bar__value"><a href="https://pubs.acs.org/action/ssoRequestForLoginPage" class="user-login-bar__Login">Log In</a></span><input type="hidden" name="isUserLoggedIn" value="false" class="user-login-bar_is-loggedin"/></input><input type="hidden" name="isPaired" value="false" class="pair-device-is-paired"/></input><input type="hidden" name="isStronglyAuthenticated" value="false" class="isStronglyAuthenticated"/></input></div>
</div></div></div>
</div>




        
        <div class="header_content">



        
        <div class="container"><div class="row"><div class="header_content_main">



        
        <div class="header_content_row">



        
        <div class="header_content_left pull-left">



        
        <a href="/" title="ACS Publications. Most Trusted. Most Cited. Most Read"><img id="" alt="ACS Publications. Most Trusted. Most Cited. Most Read" src="/pb-assets/ux3/pubs-logo-481x82-1523435513963.png"/></img></a>




        
        <div class="pj-badge"></div><a href="/journal/jmcmar" title="journal logo" class="header_article-logo"><img src="/na101/home/literatum/publisher/achs/journals/covergifs/jmcmar/title.png" alt="Journal Logo"></a><div class="header_article-separator"></div>
</div><div class="header_content_center">



        
        <div class="header_contnav">
    <div class="header_contnav-row">
         <a href="#" title="Previous" class="header_contnav-pre">
                <i class="icon-angle-left"></i>
        </a>
       <div class="header_contnav-title">
            <span>
                <a href="#" title=""></a>
            </span>
        </div>
         <a href="#" title="Next" class="header_contnav-next">
                <i class="icon-angle-right"></i>
            </a>
    </div>
</div>
</div><div class="header_content_right pull-right">



        
        <div class="header_qv-link"><a href="#" title="Quick View" data-slide-target=".article_qv-xs-container" class="w-slide__btn slide-active icon-quickview">Quick View</a></div>




        
        <div class="header_article-share">



        
        <script type="text/javascript" async="async" src="//s7.addthis.com/js/300/addthis_widget.js#pubid=xa-4faab26f2cff13a7"></script><div class="share"><div class="share_button"><span class="share__label">Share</span><a href="#" data-db-target-for="527d28d6-3414-4cb2-9560-99e677e62c0d" data-db-switch="icon-close_thin" aria-label="share button" class="share__ctrl"><i aria-hidden="true" class="icon-Icon_Share"></i></a></div><div class="pb-dropzone" data-pb-dropzone="ShareDropzone1" title="ShareDropzone1"></div><div class="pb-dropzone" data-pb-dropzone="ShareDropzone2" title="ShareDropzone2"></div><div data-db-target-of="527d28d6-3414-4cb2-9560-99e677e62c0d" id="527d28d6-3414-4cb2-9560-99e677e62c0d_Pop" class="share__block dropBlock__holder fixed"><div class="pb-dropzone" data-pb-dropzone="shareBlock" title="shareBlock"></div><span class="sr-only">Share on</span><ul class="rlist w-slide--list addthis addthis_toolbox addthis_default_style addthis_32x32_style"><li><a role="link" class="addthis_button_facebook"><i aria-hidden="true" class="at-icon-wrapper icon-facebook"></i>Facebook</a></li><li><a role="link" class="addthis_button_twitter"><i aria-hidden="true" class="at-icon-wrapper icon-twitter"></i>Twitter</a></li><li><a role="link" class="addthis_button_wechat"><i aria-hidden="true" class="at-icon-wrapper icon-wechat"></i>WeChat</a></li><li><a role="link" class="addthis_button_linkedin"><i aria-hidden="true" class="at-icon-wrapper icon-linkedin"></i>Linked In</a></li><li><a role="link" class="addthis_button_reddit"><i aria-hidden="true" class="at-icon-wrapper icon-reddit"></i>Reddit</a></li><li><a role="link" class="addthis_button_email"><i aria-hidden="true" class="at-icon-wrapper icon-envelope-o"></i>Email</a></li></ul></div></div>
</div>




        
        <div class="header_article-separator"></div>




        
        <div class="quick-search"><a href="#" aria-label="quick search" class="quick-search_icon icon-search"></a><div class="quick-search_content"><form action="/action/checkIsValidDoi" name="defaultQuickSearch" method="get" title="Quick Search" autocomplete="off" class="quick-search_default"><input type="search" name="AllField" placeholder="Search text, DOI, authors, etc." aria-label="Search text, DOI, authors, etc." data-auto-complete-max-words="7" data-auto-complete-max-chars="32" data-contributors-conf="3" data-topics-conf="3" data-publication-titles-conf="3" data-history-items-conf="3" value="" required="true" class="quick-search_all-field autocomplete"/></input><button type="submit" title="Search" class="icon-search"></button><div role="radiogroup" aria-labelledby="journal filter" class="quick-search_journal-filter"><label for="thisJournalRadio" tabindex="0" aria-checked="true" role="radio" class="radio--primary"><input id="thisJournalRadio" type="radio" value="jmcmar" name="SeriesKey" checked="checked" class="all-content"/></input><span>J. Med. Chem.</span></label><label for="allPubRadio" tabindex="0" aria-checked="false" role="radio" class="radio--primary"><input id="allPubRadio" type="radio" value="" name="SeriesKey" class="all-content"/></input><span>All Publications/Website</span></label></div></form><p>OR SEARCH CITATIONS</p><form action="/action/quickLink" name="citationQuickSearch" method="get" title="Quick Search" class="quick-search_citation"><input type="hidden" name="quickLink" value="true"/></input><select name="quickLinkJournal" class="quick-search_journals-select"><option value="jmcmar">Journal of Medicinal Chemistry</option><option value="achre4">Accounts of Chemical Research</option><option value="amrcda">Accounts of Materials Research</option><option value="aastgj">ACS Agricultural Science & Technology</option><option value="aabmcb">ACS Applied Bio Materials</option><option value="aaembp">ACS Applied Electronic Materials</option><option value="aaemcq">ACS Applied Energy Materials</option><option value="aamick">ACS Applied Materials & Interfaces</option><option value="aanmf6">ACS Applied Nano Materials</option><option value="aapmcd">ACS Applied Polymer Materials</option><option value="abmcb8">ACS Bio & Med Chem Au</option><option value="abseba">ACS Biomaterials Science & Engineering</option><option value="accacs">ACS Catalysis</option><option value="acscii">ACS Central Science</option><option value="acbcct">ACS Chemical Biology</option><option value="achsc5">ACS Chemical Health & Safety</option><option value="acncdm">ACS Chemical Neuroscience</option><option value="acsccc">ACS Combinatorial Science</option><option value="aesccq">ACS Earth and Space Chemistry</option><option value="aelccp">ACS Energy Letters</option><option value="aeacb3">ACS Engineering Au</option><option value="aeacc4">ACS Environmental Au</option><option value="aeecco">ACS ES&T Engineering</option><option value="aewcaa">ACS ES&T Water</option><option value="afsthl">ACS Food Science & Technology</option><option value="aidcbc">ACS Infectious Diseases</option><option value="amlccd">ACS Macro Letters</option><option value="amacgu">ACS Materials Au</option><option value="amlcef">ACS Materials Letters</option><option value="amachv">ACS Measurement Science Au</option><option value="amclct">ACS Medicinal Chemistry Letters</option><option value="ancac3">ACS Nano</option><option value="anaccx">ACS Nanoscience Au</option><option value="acsodf">ACS Omega</option><option value="aoiab5">ACS Organic & Inorganic Au</option><option value="aptsfn">ACS Pharmacology & Translational Science</option><option value="apchd5">ACS Photonics</option><option value="apcach">ACS Physical Chemistry Au</option><option value="apaccd">ACS Polymers Au</option><option value="ascefj">ACS Sensors</option><option value="ascecg">ACS Sustainable Chemistry & Engineering</option><option value="asbcd6">ACS Synthetic Biology</option><option value="ancham">Analytical Chemistry</option><option value="bichaw">Biochemistry</option><option value="bcches">Bioconjugate Chemistry</option><option value="bomaf6">Biomacromolecules</option><option value="bipret">Biotechnology Progress</option><option value="cgeabj">C&EN Global Enterprise</option><option value="cenear">Chemical & Engineering News Archive</option><option value="chlseg">Chemical Health & Safety</option><option value="chlseg0">Chemical Health & Safety</option><option value="crtoec">Chemical Research in Toxicology</option><option value="chreay">Chemical Reviews</option><option value="cmatex">Chemistry of Materials</option><option value="cgdefu">Crystal Growth & Design</option><option value="enfuem">Energy & Fuels</option><option value="esthag">Environmental Science & Technology</option><option value="estlcu">Environmental Science & Technology Letters</option><option value="iepra6.2">I&EC Product Research and Development</option><option value="iechad">Industrial & Engineering Chemistry</option><option value="iecac0">Industrial & Engineering Chemistry Analytical Edition</option><option value="iecjc0">Industrial & Engineering Chemistry Chemical & Engineering Data Series</option><option value="iecfa7">Industrial & Engineering Chemistry Fundamentals</option><option value="iepdaw">Industrial & Engineering Chemistry Process Design and Development</option><option value="iepra6">Industrial & Engineering Chemistry Product Research and Development</option><option value="iecred">Industrial & Engineering Chemistry Research</option><option value="iecnav">Industrial and Engineering Chemistry, News Edition</option><option value="inocaj">Inorganic Chemistry</option><option value="jaaucr">JACS Au</option><option value="jacsat">Journal of the American Chemical Society</option><option value="jafcau">Journal of Agricultural and Food Chemistry</option><option value="jceaax">Journal of Chemical & Engineering Data</option><option value="jci001">Journal of Chemical Documentation</option><option value="jceda8">Journal of Chemical Education</option><option value="jchsc2">Journal of Chemical Health & Safety</option><option value="jchsc20">Journal of Chemical Health & Safety</option><option value="jcics1">Journal of Chemical Information and Computer Sciences</option><option value="jcisd8">Journal of Chemical Information and Modeling</option><option value="jctcce">Journal of Chemical Theory and Computation</option><option value="jcchff">Journal of Combinatorial Chemistry</option><option value="iechad.1">Journal of Industrial & Engineering Chemistry</option><option value="jmcmar.1">Journal of Medicinal and Pharmaceutical Chemistry</option><option value="jnprdf">Journal of Natural Products</option><option value="joceah">The Journal of Organic Chemistry</option><option value="jpchax">The Journal of Physical Chemistry</option><option value="jpchax.2">The Journal of Physical Chemistry</option><option value="jpcafh">The Journal of Physical Chemistry A</option><option value="jpcbfk">The Journal of Physical Chemistry B</option><option value="jpccck">The Journal of Physical Chemistry C</option><option value="jpclcd">The Journal of Physical Chemistry Letters</option><option value="jprobs">Journal of Proteome Research</option><option value="jamsef">Journal of the American Society for Mass Spectrometry</option><option value="jamsef1">Journal of the American Society for Mass Spectrometry</option><option value="jamsef0">Journal of the American Society for Mass Spectrometry</option><option value="langd5">Langmuir</option><option value="mamobx">Macromolecules</option><option value="mpohbp">Molecular Pharmaceutics</option><option value="nalefd">Nano Letters</option><option value="neaca9">News Edition, American Chemical Society</option><option value="orlef7">Organic Letters</option><option value="oprdfk">Organic Process Research & Development</option><option value="orgnd7">Organometallics</option><option value="iepra6.1">Product R&D</option><option value="scimts">SciMeetings</option><option value="jpchax.1">The Journal of Physical and Colloid Chemistry</option></select><input type="search" inputmode="numeric" pattern="[0-9]*" name="quickLinkVolume" autoComplete="false" placeholder="Vol" required="required" class="quick-search_volume-input"/></input><input type="search" inputmode="numeric" pattern="[0-9]*" name="quickLinkPage" autoComplete="false" placeholder="Page" required="required" class="quick-search_page-input"/></input><button type="submit" title="Search" class="icon-search"></button></form></div></div>




        
        <div class="header_my-activity">



        
        <a href="#"><i class="icon-id-badge" aria-hidden=”true”></i><span>My Activity</span></a>
<div class="header_my-activity-content">
    <div class="header_my-activity-single">
        <i aria-hidden="true" aria-label="close" class="icon-close"></i>
        <div class="" data-name="recentlyViewedDropzone">



        
        <div class="show-recently"><div class="show-recently-header">Recently Viewed</div><h6 class="show-recently-empty">You have not visited any articles yet, Please visit some articles to see contents here. </h6></div>
</div>
    </div>
</div>
</div>




        
        <div class="header_publications">



        
        <a href="#" class="pubModal_button"><i class="icon-book" aria-hidden=”true”></i><span>Publications</span></a>

</div>




        
        <div class="header_burger-menu">



        
        <a href="#?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuIcon&amp;utm_campaign=Pubs_Refere" class="header_burger-menu_button" title="menu button" aria-label="menu button"><i class="icon-navicon"></i><i
        class="icon-close"></i></a>
<div class="header_burger-menu_content">
    <ul class="hidden-lg">
        <li><a href="#" class="pubModal_button"><i class="icon-book" aria-hidden=”true”></i><span>publications</span></a></li>
        <li class="myActivityMobile"><a href="#" class="openTabletActivity"><i class="icon-id-badge" aria-hidden=”true”></i><span>my Activity</span></a>
            <ul>
                <li><a href="javascript:void(0)" class="recentlyViewed--open">Recently Viewed</a></li>
            </ul>
        </li>
    </ul>
    <ul>
        <li><a href="#">user resources</a>
            <ul>
                <li><a href="/page/remoteaccess"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Access Options');">Access Options</a></li>
                <li><a href="https://publish.acs.org/publish/"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Authors & Reviewers');">Authors &
                        Reviewers</a></li>
                <li><a href="http://www.acs.org/content/acs/en/membership-and-networks/acs/benefits/professional/publications-benefits.html"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'ACS Members');">ACS Members</a></li>
                <li><a href="https://preferences.acspubs.org/journals"
                        onclick="ga('send', 'event', 'Home_MainMenu', 'Click', 'eAlert');">eAlerts</a></li>
                <li><a href="/page/follow.html?widget=follow-pane-mobile"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'RSS & Mobile');">RSS & Mobile</a></li>
            </ul>
        </li>
		<li><a href="#">for organizations</a>
			<ul>
			    <li><a href="https://solutions.acs.org/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Products & Services');">Products & Services</a></li>
				<li><a href="https://solutions.acs.org/access-options/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Get Access');">Get Access</a></li>
				<li><a href="https://solutions.acs.org/resources/manage-my-account/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Manage My Account');">Manage My Account</a></li>
			</ul>
		</li>
        <li><a href="#">support</a>
            <ul>
                <li><a href="/page/demo/index.html">Website Demos & Tutorials</a></li>
                <li><a href="https://acs.service-now.com/acs"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Support FAQs');">Support FAQs </a></li>
                <li><a href="#"
                        onClick="SnapEngage.startLink();return false; ga('send', 'event', 'Top Nav', 'Menu', 'Live Chat with Agent');"
                        class="help help-chat">Live Chat with Agent</a></li>
                <li><a href="https://acsmediakit.org/digital/acs-pubs/?utm_source=Nav&amp;utm_medium=Pubs&amp;utm_campaign=CEN"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'For Advertisers');">For Advertisers</a></li>
                <li><a href="https://solutions.acs.org/help/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'For Librarians & Account Managers');">For
                        Librarians & Account Managers</a></li>
            </ul>
        </li>
        <li class="hidden-sm hidden-xs"><a href="#">pairing</a>
            <ul>
                <li><a class="header_burger-menu_pairadevice-link" href="/pairdevice">Pair a device</a></li>
                <li><a class="header_burger-menu_pairthisdevice-link" href="/action/devicePairingSubmitCode"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Pair this device');">Pair this device</a></li>
                <li><a class="header_burger-menu_pairedstatus" href="/action/devicePairingSubmitCode">Paired status</a>
                </li>
            </ul>
        </li>
        <li class="hidden-lg hidden-md">
            <a class="header_burger-menu_my-profile-link" href="/action/showPreferences">My Profile</a>
            <a class="header_burger-menu_login-link" href="/action/ssoRequestForLoginPage">Login</a>
            <a class="header_burger-menu_logout-link" href="#">Logout</a>
            <a class="header_burger-menu_pairadevice-link" href="/pairdevice">Pair a device</a>
            <a class="header_burger-menu_pairthisdevice-link" href="/action/devicePairingSubmitCode">Pair this
                device</a>
            <a class="header_burger-menu_pairedstatus" href="/action/devicePairingSubmitCode">Paired status</a>
        </li>
        <li><a href="#">about us</a>
            <ul>
                <li><a href="/page/about-us.html"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Overview');">Overview</a></li>
                <li><a href="http://acsopenscience.org"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'ACS & Open Access');">ACS & Open Access</a>
                </li>
                <li><a href="/#partners" onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Partners');">Partners</a></li>
                <li><a href="http://acsoncampus.acs.org"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Events');">Events</a></li>
            </ul>
        </li>
    </ul>
</div>
<div class="activity-container-tablet"><i aria-hidden="true" class="icon-close"></i></div>


<script type="text/javascript">
  (function() {
    var se = document.createElement('script'); se.type = 'text/javascript'; se.async = true;
    se.src = 'https://storage.googleapis.com/code.snapengage.com/js/921a4ec7-cecf-43a6-afa5-6cd1346520b1.js';
    var done = false;
    se.onload = se.onreadystatechange = function() {
      if (!done&&(!this.readyState||this.readyState==='loaded'||this.readyState==='complete')) {
        done = true;
        /* Place your SnapEngage JS API code below */
        /* SnapEngage.allowChatSound(true); Example JS API: Enable sounds for Visitors. */
      }
    };
    var s = document.getElementsByTagName('script')[0]; s.parentNode.insertBefore(se, s);
  })();
</script>

<style>
    #SnapABug_Button,
    #designstudio-button {
        display: none;
    }
</style>

</div>
</div>
</div>
</div></div></div>
</div>




        
        <div class="pub"><div aria-live="polite" aria-atomic="true" class="pub-modal"><div class="pub-modal_content loop-trap"><a href="#" aria-label="close" tabindex="0" class="pub-modal_close icon-close pull-right"></a><div class="pub-modal_row"><div class="pub-modal_left"><div class="pub-modal_left-content"><div class="pub-modal_control hidden-lg hidden-md"><span class="pub-modal_control-text">Publications</span><a href="#" title="Back button" class="pub-modal_back"><i class="icon-angle-left"></i></a></div><div class="pub-modal_types"><h6>CONTENT TYPES</h6><ul class="pub-modal_types-list"><li data-type="all" id="allID" class="pub-modal_types-active"><a href="#"><h4>All Types</h4></a></li></ul></div><div class="pub-modal_subjects hidden-sm hidden-xs"><h6>SUBJECTS</h6><ul class="pub-modal_subjects-list"></ul></div></div></div><div class="pub-modal_right"><div class="pub-modal_control hidden-lg hidden-md"><span class="pub-modal_control-text">Publications: All Types</span><a href="#" title="Back button" class="pub-modal_back"><i class="icon-angle-left"></i></a></div><div class="pub-modal_right--inner"><div class="pub-content"></div></div></div></div></div><input type="hidden" name="pubModalData" value="{&quot;types&quot;:[{&quot;code&quot;:&quot;journals&quot;,&quot;label&quot;:&quot;Journals&quot;},{&quot;code&quot;:&quot;books&quot;,&quot;label&quot;:&quot;Books and Reference&quot;},{&quot;code&quot;:&quot;news&quot;,&quot;label&quot;:&quot;News&quot;}],&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;,&quot;label&quot;:&quot;Analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;,&quot;label&quot;:&quot;Applied&quot;},{&quot;code&quot;:&quot;cat_biological&quot;,&quot;label&quot;:&quot;Biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;,&quot;label&quot;:&quot;Materials Science &amp; Engineering&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;,&quot;label&quot;:&quot;Organic-Inorganic&quot;},{&quot;code&quot;:&quot;cat_physical&quot;,&quot;label&quot;:&quot;Physical&quot;}],&quot;publications&quot;:[{&quot;char&quot;:&quot;A&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/achre4/2021/achre4.2021.54.issue-15/achre4.2021.54.issue-15/20210803/achre4.2021.54.issue-15.largecover.jpg&quot;,&quot;code&quot;:&quot;achre4&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Accounts of Chemical Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/achre4&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amrcda/2021/amrcda.2021.2.issue-7/amrcda.2021.2.issue-7/20210723/amrcda.2021.2.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;amrcda&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Accounts of Materials Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amrcda&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aastgj/2021/aastgj.2021.1.issue-3/aastgj.2021.1.issue-3/20210621/aastgj.2021.1.issue-3.largecover.jpg&quot;,&quot;code&quot;:&quot;aastgj&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;ACS Agricultural Science &amp; Technology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aastgj&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aabmcb/2021/aabmcb.2021.4.issue-7/aabmcb.2021.4.issue-7/20210719/aabmcb.2021.4.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aabmcb&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Bio Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aabmcb&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aaembp/2021/aaembp.2021.3.issue-7/aaembp.2021.3.issue-7/20210727/aaembp.2021.3.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aaembp&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Electronic Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aaembp&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aaemcq/2021/aaemcq.2021.4.issue-7/aaemcq.2021.4.issue-7/20210726/aaemcq.2021.4.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aaemcq&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Energy Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aaemcq&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aamick/2021/aamick.2021.13.issue-30/aamick.2021.13.issue-30/20210804/aamick.2021.13.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;aamick&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Materials &amp; Interfaces&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aamick&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aanmf6/2021/aanmf6.2021.4.issue-7/aanmf6.2021.4.issue-7/20210723/aanmf6.2021.4.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aanmf6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Nano Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aanmf6&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aapmcd/2021/aapmcd.2021.3.issue-7/aapmcd.2021.3.issue-7/20210709/aapmcd.2021.3.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aapmcd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Polymer Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aapmcd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/abmcb8/largecover.png&quot;,&quot;code&quot;:&quot;abmcb8&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;}],&quot;name&quot;:&quot;ACS Bio &amp; Med Chem Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/abmcb8&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/abseba/2021/abseba.2021.7.issue-7/abseba.2021.7.issue-7/20210712/abseba.2021.7.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;abseba&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Biomaterials Science &amp; Engineering&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/abseba&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/accacs/2021/accacs.2021.11.issue-14/accacs.2021.11.issue-14/20210716/accacs.2021.11.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;accacs&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Catalysis&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/accacs&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acscii/2021/acscii.2021.7.issue-7/acscii.2021.7.issue-7/20210728/acscii.2021.7.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;acscii&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Central Science&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acscii&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acbcct/2021/acbcct.2021.16.issue-7/acbcct.2021.16.issue-7/20210716/acbcct.2021.16.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;acbcct&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Chemical Biology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acbcct&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/achsc5/2021/achsc5.2021.28.issue-4/achsc5.2021.28.issue-4/20210726/achsc5.2021.28.issue-4.largecover.jpg&quot;,&quot;code&quot;:&quot;achsc5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Chemical Health &amp; Safety&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/achsc5&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acncdm/2021/acncdm.2021.12.issue-15/acncdm.2021.12.issue-15/20210804/acncdm.2021.12.issue-15.largecover.jpg&quot;,&quot;code&quot;:&quot;acncdm&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Chemical Neuroscience&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acncdm&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acsccc/2020/acsccc.2020.22.issue-12/acsccc.2020.22.issue-12/20201214/acsccc.2020.22.issue-12.largecover.jpg&quot;,&quot;code&quot;:&quot;acsccc&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Combinatorial Science&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acsccc&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aesccq/2021/aesccq.2021.5.issue-7/aesccq.2021.5.issue-7/20210715/aesccq.2021.5.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aesccq&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Earth and Space Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aesccq&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aelccp/2021/aelccp.2021.6.issue-7/aelccp.2021.6.issue-7/20210709/aelccp.2021.6.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aelccp&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Energy Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aelccp&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/aeacb3/largecover.png&quot;,&quot;code&quot;:&quot;aeacb3&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;}],&quot;name&quot;:&quot;ACS Engineering Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aeacb3&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/aeacc4/largecover.png&quot;,&quot;code&quot;:&quot;aeacc4&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;}],&quot;name&quot;:&quot;ACS Environmental Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aeacc4&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aeecco/2021/aeecco.2021.1.issue-7/aeecco.2021.1.issue-7/20210709/aeecco.2021.1.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aeecco&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;ACS ES&amp;T Engineering&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aeecco&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aewcaa/2021/aewcaa.2021.1.issue-7/aewcaa.2021.1.issue-7/20210709/aewcaa.2021.1.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aewcaa&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS ES&amp;T Water&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aewcaa&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/afsthl/2021/afsthl.2021.1.issue-6/afsthl.2021.1.issue-6/20210716/afsthl.2021.1.issue-6.largecover.jpg&quot;,&quot;code&quot;:&quot;afsthl&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Food Science &amp; Technology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/afsthl&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;styleguide&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;category.books&quot;}],&quot;name&quot;:&quot;ACS Guide to Scholarly Communication&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/styleguide&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;infocus&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;}],&quot;name&quot;:&quot;ACS In Focus&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/infocus&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aidcbc/2021/aidcbc.2021.7.issue-7/aidcbc.2021.7.issue-7/20210709/aidcbc.2021.7.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aidcbc&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Infectious Diseases&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aidcbc&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amlccd/2021/amlccd.2021.10.issue-7/amlccd.2021.10.issue-7/20210720/amlccd.2021.10.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;amlccd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Macro Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amlccd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/amacgu/largecover.png&quot;,&quot;code&quot;:&quot;amacgu&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;}],&quot;name&quot;:&quot;ACS Materials Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amacgu&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amlcef/2021/amlcef.2021.3.issue-8/amlcef.2021.3.issue-8/20210802/amlcef.2021.3.issue-8.largecover.jpg&quot;,&quot;code&quot;:&quot;amlcef&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Materials Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amlcef&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/amachv/largecover.png&quot;,&quot;code&quot;:&quot;amachv&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;}],&quot;name&quot;:&quot;ACS Measurement Science Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amachv&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amclct/2021/amclct.2021.12.issue-7/amclct.2021.12.issue-7/20210708/amclct.2021.12.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;amclct&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Medicinal Chemistry Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amclct&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ancac3/2021/ancac3.2021.15.issue-7/ancac3.2021.15.issue-7/20210727/ancac3.2021.15.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;ancac3&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Nano&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ancac3&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/anaccx/largecover.png&quot;,&quot;code&quot;:&quot;anaccx&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;}],&quot;name&quot;:&quot;ACS Nanoscience Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/anaccx&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acsodf/2021/acsodf.2021.6.issue-30/acsodf.2021.6.issue-30/20210803/acsodf.2021.6.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;acsodf&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Omega&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acsodf&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/aoiab5/largecover.png&quot;,&quot;code&quot;:&quot;aoiab5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;}],&quot;name&quot;:&quot;ACS Organic &amp; Inorganic Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aoiab5&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aptsfn/2021/aptsfn.2021.4.issue-3/aptsfn.2021.4.issue-3/20210611/aptsfn.2021.4.issue-3.largecover.jpg&quot;,&quot;code&quot;:&quot;aptsfn&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Pharmacology &amp; Translational Science&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aptsfn&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/apchd5/2021/apchd5.2021.8.issue-7/apchd5.2021.8.issue-7/20210721/apchd5.2021.8.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;apchd5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Photonics&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/apchd5&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/apcach/largecover.png&quot;,&quot;code&quot;:&quot;apcach&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;}],&quot;name&quot;:&quot;ACS Physical Chemistry Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/apcach&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/apaccd/largecover.png&quot;,&quot;code&quot;:&quot;apaccd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;}],&quot;name&quot;:&quot;ACS Polymers Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/apaccd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/books/content/reagents/2017/acsreagents/acsreagents/20170228/acsreagents.largecover.png&quot;,&quot;code&quot;:&quot;reagents&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;}],&quot;name&quot;:&quot;ACS Reagent Chemicals&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/reagents&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ascefj/2021/ascefj.2021.6.issue-7/ascefj.2021.6.issue-7/20210723/ascefj.2021.6.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;ascefj&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Sensors&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ascefj&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ascecg/2021/ascecg.2021.9.issue-30/ascecg.2021.9.issue-30/20210802/ascecg.2021.9.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;ascecg&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Sustainable Chemistry &amp; Engineering&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ascecg&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/books/content/symposium/2021/bk-2021-1379/bk-2021-1379/20210430-01/bk-2021-1379.largecover.jpg&quot;,&quot;code&quot;:&quot;symposium&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;category.books&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;383784032&quot;}],&quot;name&quot;:&quot;ACS Symposium Series&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/symposium&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/asbcd6/2021/asbcd6.2021.10.issue-7/asbcd6.2021.10.issue-7/20210716/asbcd6.2021.10.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;asbcd6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Synthetic Biology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/asbcd6&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;advances&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;category.books&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;383784032&quot;}],&quot;name&quot;:&quot;Advances in Chemistry&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/advances&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ancham/2021/ancham.2021.93.issue-30/ancham.2021.93.issue-30/20210803/ancham.2021.93.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;ancham&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Analytical Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ancham&quot;}]},{&quot;char&quot;:&quot;B&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/bichaw/2021/bichaw.2021.60.issue-30/bichaw.2021.60.issue-30/20210803/bichaw.2021.60.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;bichaw&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Biochemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bichaw&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/bcches/2021/bcches.2021.32.issue-7/bcches.2021.32.issue-7/20210721/bcches.2021.32.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;bcches&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Bioconjugate Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bcches&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/bomaf6/2021/bomaf6.2021.22.issue-7/bomaf6.2021.22.issue-7/20210712/bomaf6.2021.22.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;bomaf6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Biomacromolecules&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bomaf6&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/bipret/largecover.jpg&quot;,&quot;code&quot;:&quot;bipret&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;Biotechnology Progress&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bipret&quot;}]},{&quot;char&quot;:&quot;C&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/cgeabj/2021/cgeabj.2021.99.issue-28/cgeabj.2021.99.issue-28/20210802/cgeabj.2021.99.issue-28.largecover.jpg&quot;,&quot;code&quot;:&quot;cgeabj&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;}],&quot;name&quot;:&quot;C&amp;EN Global Enterprise&quot;,&quot;type&quot;:&quot;news&quot;,&quot;url&quot;:&quot;/journal/cgeabj&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/crtoec/2021/crtoec.2021.34.issue-7/crtoec.2021.34.issue-7/20210719/crtoec.2021.34.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;crtoec&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Chemical Research in Toxicology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/crtoec&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/chreay/2021/chreay.2021.121.issue-14/chreay.2021.121.issue-14/20210728/chreay.2021.121.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;chreay&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;articletoc&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Chemical Reviews&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/chreay&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/cmatex/2021/cmatex.2021.33.issue-14/cmatex.2021.33.issue-14/20210727/cmatex.2021.33.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;cmatex&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Chemistry of Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/cmatex&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/cgdefu/2021/cgdefu.2021.21.issue-8/cgdefu.2021.21.issue-8/20210804/cgdefu.2021.21.issue-8.largecover.jpg&quot;,&quot;code&quot;:&quot;cgdefu&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Crystal Growth &amp; Design&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/cgdefu&quot;}]},{&quot;char&quot;:&quot;E&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/enfuem/2021/enfuem.2021.35.issue-14/enfuem.2021.35.issue-14/20210715/enfuem.2021.35.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;enfuem&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Energy &amp; Fuels&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/enfuem&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/esthag/2021/esthag.2021.55.issue-15/esthag.2021.55.issue-15/20210803/esthag.2021.55.issue-15.largecover.jpg&quot;,&quot;code&quot;:&quot;esthag&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Environmental Science &amp; Technology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/esthag&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/estlcu/2021/estlcu.2021.8.issue-7/estlcu.2021.8.issue-7/20210713/estlcu.2021.8.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;estlcu&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Environmental Science &amp; Technology Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/estlcu&quot;}]},{&quot;char&quot;:&quot;I&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepra6.2&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;I&amp;EC Product Research and Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepra6.2&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iechad&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iechad&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iecac0&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Analytical Edition&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecac0&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iecjc0&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Chemical &amp; Engineering Data Series&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecjc0&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iecfa7&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Fundamentals&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecfa7&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepdaw&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Process Design and Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepdaw&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepra6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Product Research and Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepra6&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/iecred/2021/iecred.2021.60.issue-30/iecred.2021.60.issue-30/20210804/iecred.2021.60.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;iecred&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecred&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/inocaj/2021/inocaj.2021.60.issue-15/inocaj.2021.60.issue-15/20210802/inocaj.2021.60.issue-15.largecover.jpg&quot;,&quot;code&quot;:&quot;inocaj&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Inorganic Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/inocaj&quot;}]},{&quot;char&quot;:&quot;J&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jaaucr/2021/jaaucr.2021.1.issue-7/jaaucr.2021.1.issue-7/20210726/jaaucr.2021.1.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jaaucr&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;JACS Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jaaucr&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jafcau/2021/jafcau.2021.69.issue-30/jafcau.2021.69.issue-30/20210804/jafcau.2021.69.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;jafcau&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Agricultural and Food Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jafcau&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jceaax/2021/jceaax.2021.66.issue-7/jceaax.2021.66.issue-7/20210708/jceaax.2021.66.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jceaax&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical &amp; Engineering Data&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jceaax&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jci001&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Documentation&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jci001&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jceda8/2021/jceda8.2021.98.issue-7/jceda8.2021.98.issue-7/20210713/jceda8.2021.98.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jceda8&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;divched&quot;}],&quot;name&quot;:&quot;Journal of Chemical Education&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jceda8&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jcics1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Information and Computer Sciences&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jcics1&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jcisd8/2021/jcisd8.2021.61.issue-7/jcisd8.2021.61.issue-7/20210726/jcisd8.2021.61.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jcisd8&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Information and Modeling&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jcisd8&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jctcce/2021/jctcce.2021.17.issue-7/jctcce.2021.17.issue-7/20210713/jctcce.2021.17.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jctcce&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Theory and Computation&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jctcce&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iechad.1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Industrial &amp; Engineering Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iechad.1&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jmcmar.1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Medicinal and Pharmaceutical Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jmcmar.1&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-14/jmcmar.2021.64.issue-14/20210722/jmcmar.2021.64.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;jmcmar&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Medicinal Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jmcmar&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jnprdf/2021/jnprdf.2021.84.issue-7/jnprdf.2021.84.issue-7/20210723/jnprdf.2021.84.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jnprdf&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Natural Products&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jnprdf&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/joceah/2021/joceah.2021.86.issue-14/joceah.2021.86.issue-14/20210716/joceah.2021.86.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;joceah&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Organic Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/joceah&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jpchax&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpchax&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpcafh/2021/jpcafh.2021.125.issue-29/jpcafh.2021.125.issue-29/20210729/jpcafh.2021.125.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpcafh&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry A&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpcafh&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpcbfk/2021/jpcbfk.2021.125.issue-29/jpcbfk.2021.125.issue-29/20210729/jpcbfk.2021.125.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpcbfk&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry B&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpcbfk&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpccck/2021/jpccck.2021.125.issue-29/jpccck.2021.125.issue-29/20210729/jpccck.2021.125.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpccck&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry C&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpccck&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpclcd/2021/jpclcd.2021.12.issue-29/jpclcd.2021.12.issue-29/20210729/jpclcd.2021.12.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpclcd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpclcd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jprobs/2021/jprobs.2021.20.issue-7/jprobs.2021.20.issue-7/20210702/jprobs.2021.20.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jprobs&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Proteome Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jprobs&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jacsat/2021/jacsat.2021.143.issue-30/jacsat.2021.143.issue-30/20210804/jacsat.2021.143.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;jacsat&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of the American Chemical Society&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jacsat&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jamsef/2021/jamsef.2021.32.issue-8/jamsef.2021.32.issue-8/20210804/jamsef.2021.32.issue-8.largecover.jpg&quot;,&quot;code&quot;:&quot;jamsef&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of the American Society for Mass Spectrometry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jamsef&quot;}]},{&quot;char&quot;:&quot;L&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/langd5/2021/langd5.2021.37.issue-30/langd5.2021.37.issue-30/20210803/langd5.2021.37.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;langd5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Langmuir&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/langd5&quot;}]},{&quot;char&quot;:&quot;M&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/mamobx/2021/mamobx.2021.54.issue-14/mamobx.2021.54.issue-14/20210727/mamobx.2021.54.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;mamobx&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Macromolecules&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/mamobx&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/mpohbp/2021/mpohbp.2021.18.issue-8/mpohbp.2021.18.issue-8/20210802/mpohbp.2021.18.issue-8.largecover.jpg&quot;,&quot;code&quot;:&quot;mpohbp&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Molecular Pharmaceutics&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/mpohbp&quot;}]},{&quot;char&quot;:&quot;N&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/nalefd/2021/nalefd.2021.21.issue-14/nalefd.2021.21.issue-14/20210728/nalefd.2021.21.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;nalefd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Nano Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/nalefd&quot;}]},{&quot;char&quot;:&quot;O&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/orlef7/2021/orlef7.2021.23.issue-14/orlef7.2021.23.issue-14/20210716/orlef7.2021.23.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;orlef7&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Organic Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/orlef7&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/oprdfk/2021/oprdfk.2021.25.issue-7/oprdfk.2021.25.issue-7/20210716/oprdfk.2021.25.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;oprdfk&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Organic Process Research &amp; Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/oprdfk&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/orgnd7/2021/orgnd7.2021.40.issue-14/orgnd7.2021.40.issue-14/20210726/orgnd7.2021.40.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;orgnd7&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Organometallics&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/orgnd7&quot;}]},{&quot;char&quot;:&quot;P&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepra6.1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Product R&amp;D&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepra6.1&quot;}]}]}"/></input></div></div>
</header>




        
        <main data-widget-id="28284a6d-730d-4a56-93ad-909787c5ac1b" id="" class="content article"><article data-figures="https://pubs.acs.org/action/ajaxShowFigures?doi=10.1021%2Facs.jmedchem.8b00639&amp;ajax=true" data-references="https://pubs.acs.org/action/ajaxShowEnhancedAbstract?doi=10.1021%2Facs.jmedchem.8b00639&amp;ajax=true" data-enable-mathjax="true"><div class="figure-viewer"><div class="figure-viewer_row"><div class="figure-viewer_col loop-trap"><div aria-live="polite" aria-atomic="true" class="figure-viewer_modal"><a href="#" title="Close" aria-label="close" tabindex="0" class="figure-viewer_close icon-close"></a><h2 class="figure-viewer_label"><span class="figure-viewer_current"></span></h2><div class="figure-viewer_image"><a href="#" title="Next" class="figure-viewer_next icon-angle-right"></a><a href="#" title="Previous" class="figure-viewer_prev icon-angle-left"></a><div class="figure-viewer_image-content"><img src="" alt="Figure 1" class="fv-img"/></img><img src="/pb-assets/ux3/loading-1525090748317.gif" alt="Loading Img" class="loading-img"/></img></div></div><div class="figure-viewer_links"><a href="#" title="Download Hi-Res Image" target="_blank" class="figure-viewer_hi-res-link"><i class="icon-file-image-o"></i><span>Download Hi-Res Image</span></a><span class="fv-separator"></span><a href="#" title="Download to MS-PowerPoint" class="figure-viewer_ms-p-link"><i class="icon-file-powerpoint-o"></i><span>Download to MS-PowerPoint</span></a><span class="cit-this-container"><a href="/action/showCitFormats?doi=10.1021/acs.jmedchem.8b00639&amp;href=/doi/10.1021/acs.jmedchem.8b00639" title="Cite This" class="figure-viewer-cite-this-link"><i class="icon-check-circle"></i><span><strong>Cite This:</strong></span></a><span class="article_header-cite-this figure-viewer-cite-this"><span class="cit-fg-title"><i>J. Med. Chem.</i></span><span class="cit-fg-year"> 2018</span><span class="cit-fg-volume">, 61</span><span class="cit-fg-issue">, 22</span><span class="cit-fg-pageRange">, 9908-9930</span></span></span></div></div></div></div></div><div class="article_fullPage"><div class="article_header"><div class="articleHeaderDropzone5" data-pb-dropzone="articleHeaderDropzone5"><div class="advertisement">
	<div class="advertisement-link">
		<a href="http://acsmediakit.org">ADVERTISEMENT</a>
	</div>
	<div id="dfp-journal-article-leaderboard">
		<script type="text/javascript">
			$(document).ready(function() {
				setTimeout(function() {
					googletag.cmd.push(function() { googletag.display("dfp-journal-article-leaderboard"); });
				}, 1400);
			});
		</script>
	</div>
</div></div><div class="container container_scaled-down"><div class="row"><div class="col-xs-12.clearfix"><div class="article_header-left pull-left"><div class="article_header-dropzone-1"><div class="articleHeaderDropzone1" data-pb-dropzone="articleHeaderDropzone1"><div class="content-navigation clearfix"><a href="/toc/jmcmar/61/22" title="Return to Issue" id="returnToIssues" class="content-navigation__btn--return"><span>RETURN TO ISSUE</span></a><a href="/doi/10.1021/acs.jmedchem.8b01187" title="Previous" id="prevID" class="content-navigation__btn--pre"><i class="icon-angle-left"></i><span>PREV</span></a><span class="content-navigation__contentType">Article</span><a href="/doi/10.1021/acs.jmedchem.8b00834" title="Next" id="nextID" class="content-navigation__btn--next"><span>NEXT</span><i class="icon-angle-right"></i></a></div></div></div><div class="headerLogo_e-alertsMobile_container"><div class="article_header-logo hidden-lg"><div class="pj-badge"></div><a href="/journal/jmcmar" title="Journal Logo"><img src="/specs/ux3/releasedAssets/images/loader.gif" data-src="/na101/home/literatum/publisher/achs/journals/covergifs/jmcmar/title.png" alt="Journal Logo" /></img></a></div><div class="e-alertsMobile_container hidden-md hidden-lg"></div></div><h1 class="article_header-title"><span class="hlFld-Title">Discovery, Synthesis, and Evaluation of Oxynitidine Derivatives as Dual Inhibitors of DNA Topoisomerase IB (TOP1) and Tyrosyl-DNA Phosphodiesterase 1 (TDP1), and Potential Antitumor Agents</span></h1><ul class="loa"><li><span><span class="hlFld-ContribAuthor">Xiao-Ru Zhang</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Xiao-Ru Zhang</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">School of Pharmaceutical Sciences, Sun Yat-sen University, Guangzhou 510006, China</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Xiao-Ru++Zhang">Xiao-Ru Zhang</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Hao-Wen Wang</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Hao-Wen Wang</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">School of Pharmaceutical Sciences, Sun Yat-sen University, Guangzhou 510006, China</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Hao-Wen++Wang">Hao-Wen Wang</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Wen-Lin Tang</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Wen-Lin Tang</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">School of Pharmaceutical Sciences, Sun Yat-sen University, Guangzhou 510006, China</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Wen-Lin++Tang">Wen-Lin Tang</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Yu Zhang</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Yu Zhang</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">School of Pharmaceutical Sciences, Sun Yat-sen University, Guangzhou 510006, China</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Yu++Zhang">Yu Zhang</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Hui Yang</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Hui Yang</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">School of Pharmaceutical Sciences, Sun Yat-sen University, Guangzhou 510006, China</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Hui++Yang">Hui Yang</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">De-Xuan Hu</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">De-Xuan Hu</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">School of Pharmaceutical Sciences, Sun Yat-sen University, Guangzhou 510006, China</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=De-Xuan++Hu">De-Xuan Hu</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Azhar Ravji</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Azhar Ravji</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Developmental Therapeutics Branch and Laboratory of Molecular Pharmacology, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, Maryland 20892, United States</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Azhar++Ravji">Azhar Ravji</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Christophe Marchand</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Christophe Marchand</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Developmental Therapeutics Branch and Laboratory of Molecular Pharmacology, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, Maryland 20892, United States</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Christophe++Marchand">Christophe Marchand</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Evgeny Kiselev</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Evgeny Kiselev</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Developmental Therapeutics Branch and Laboratory of Molecular Pharmacology, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, Maryland 20892, United States</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Evgeny++Kiselev">Evgeny Kiselev</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Kwabena Ofori-Atta</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Kwabena Ofori-Atta</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Developmental Therapeutics Branch and Laboratory of Molecular Pharmacology, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, Maryland 20892, United States</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Kwabena++Ofori-Atta">Kwabena Ofori-Atta</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Keli Agama</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Keli Agama</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Developmental Therapeutics Branch and Laboratory of Molecular Pharmacology, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, Maryland 20892, United States</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Keli++Agama">Keli Agama</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Yves Pommier</span><strong>*</strong><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Yves Pommier</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Developmental Therapeutics Branch and Laboratory of Molecular Pharmacology, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, Maryland 20892, United States</div></div><span class="conrtib-corresp"><strong>*</strong>For Y.P.: phone, +1 (240) 760-6142; fax, +1 (240) 541-4475; E-mail, <a href="/cdn-cgi/l/email-protection#e0908f8d8d898592a08e8988ce878f96"><span class="__cf_email__" data-cfemail="1c6c73717175796e5c727574327b736a">[email protected]</span></a></span><span class="conrtib-corresp"></span><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Yves++Pommier">Yves Pommier</a></span></div></div></span></li><span class="comma-separator">, and </span><li><span><span class="hlFld-ContribAuthor">Lin-Kun An</span><strong>*</strong><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Lin-Kun An</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">School of Pharmaceutical Sciences, Sun Yat-sen University, Guangzhou 510006, China</div></div><span class="conrtib-corresp"><strong>*</strong>For L.A.: phone, +86-20-39943413; fax, +86-20-39943413; E-mail, <a href="/cdn-cgi/l/email-protection#6b0718180a07002b060a0207451812181e450e0f1e450805"><span class="__cf_email__" data-cfemail="e8849b9b898483a885898184c69b919b9dc68d8c9dc68b86">[email protected]</span></a></span><span class="conrtib-corresp"></span><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Lin-Kun++An">Lin-Kun An</a></span></div><div class="loa-info-orcid"><img src="/products/achs/releasedAssets/images/orchid.png" alt="Orcid" /></img><a href="http://orcid.org/0000-0002-6088-1503" title="Orcid link">http://orcid.org/0000-0002-6088-1503</a></div></div></span></li><span class="comma-separator"></span></ul><div class="article_header-meta clearfix"><div class="article_header-meta-left pull-left"><input type="hidden" name="journalCodeForjhpLink" value="jmcmar" /></input><input type="hidden" name="journalNameForjhpLink" value="Journal of Medicinal Chemistry" /></input><div class="article_header-cite-this"><a href="/action/showCitFormats?doi=10.1021%2Facs.jmedchem.8b00639&amp;href=/doi/10.1021%2Facs.jmedchem.8b00639" title="Cite This"><i class="icon-check-circle"></i><strong>Cite this: </strong></a><span class="cit-title"><i>J. Med. Chem.</i></span> <span class="cit-year-info"><span>2018</span></span><span class="cit-volume">, 61</span><span class="cit-issue">, 22</span><span class="cit-pageRange">, 9908–9930</span></div><div class="article_header-epubdate"><span class="pub-date epub-date">Publication Date</span><span class="web-text"> (Web)</span><span class="date-separator">:</span><span class="pub-date-value">October 18, 2018</span><div class="article_header-history base dropBlock"><a href="#" data-db-target-for="article_header-history" title="History" target="_self" class="" aria-expanded="false"><i class="icon-angle-down"></i><i class="icon-angle-up"></i></a><div data-db-target-of="article_header-history" class="dropBlock__holder" aria-hidden="true"><div class="articleHeaderHistoryDropzone" data-pb-dropzone="articleHeaderHistoryDropzone"><h4>Publication History</h4>




        
        <ul class="rlist article-chapter-history-list"><li><span class="item_label"><b>Received</b></span>23 April 2018</li><li><span class="item_label"><b>Published</b> online</span>18 October 2018</li><li><span class="item_label"><b>Published</b> in</span><span class="item_label-issue">issue</span> 21 November 2018</li></ul></div></div></div></div><div class="article_header-doiurl"><a href="https://doi.org/10.1021/acs.jmedchem.8b00639" title="DOI URL">https://doi.org/10.1021/acs.jmedchem.8b00639</a></div><div class="article_header-article-copyright"><strong>Copyright © 2018 American Chemical Society</strong></div><div class="article_rightPermissionsLink"><div class="articleHeaderDropzone4" data-pb-dropzone="articleHeaderDropzone4"><div class="articleRightsPermissionsLink"><a href="/servlet/linkout?type=rightslink&amp;url=startPage%3D9908%26pageCount%3D23%26copyright%3DAmerican%2BChemical%2BSociety%26author%3DXiao-Ru%2BZhang%252C%2BHao-Wen%2BWang%252C%2BWen-Lin%2BTang%252C%2Bet%2Bal%26orderBeanReset%3Dtrue%26imprint%3DAmerican%2BChemical%2BSociety%26volumeNum%3D61%26issueNum%3D22%26contentID%3Dacs.jmedchem.8b00639%26title%3DDiscovery%252C%2BSynthesis%252C%2Band%2BEvaluation%2Bof%2BOxynitidine%2BDerivatives%2Bas%2BDual%2BInhibitors%2Bof%2BDNA%2BTopoisomerase%2BIB%2B%2528TOP1%2529%2Band%2BTyrosyl-DNA%2BPhosphodiesterase%2B1%2B%2528TDP1%2529%252C%2Band%2BPotential%2BAntitumor%2BAgents%26numPages%3D23%26pa%3D%26issn%3D0022-2623%26publisherName%3Dacs%26publication%3Djmcmar%26rpt%3Dn%26endPage%3D9930%26publicationDate%3DNovember%2B2018">RIGHTS & PERMISSIONS</a></div></div></div><div class="article_header-access-block"><div class="article_header-open-access"></div><div class="article_header-access-icon"><img src="/products/achs/releasedAssets/images/subscribed.svg" alt="Subscribed Access" /></img></div></div></div><div class="article_header-meta-center pull-left"><div class="articleHeaderDropzone3" data-pb-dropzone="articleHeaderDropzone3"><div class="articleMetrics"><div class="articleMetrics_table"><div class="articleMetrics_row"><input type="hidden" name="articleMetricsDoi" value="10.1021/acs.jmedchem.8b00639"/></input><div class="articleMetrics_metric"><h6>Article Views</h6><div class="articleMetrics-val">2136</div></div><div class="articleMetrics_altmetric"><h6>Altmetric</h6><div class="articleMetrics-val articleMetrics_score">-</div><div class="altmetric-donut hidden"><div data-badge-details="right" data-badge-type="donut" data-hide-no-mentions="false" data-condensed="true" class="altmetric-embed"></div></div></div><div class="articleMetrics_count"><h6>Citations</h6><div class="articleMetrics-val"><a href="#citeThis" class="internalNav">22</a></div></div></div></div><div class="articleMetrics_about"><div class="base dropBlock"><a href="#" data-db-target-for="aboutArticleMetrics" class="article_aboutLink">LEARN ABOUT THESE METRICS</a><div data-db-target-of="aboutArticleMetrics" aria-live="polite" aria-atomic="true" role="alert" class="dropBlock__holder"><i aria-hidden="true" class="icon-close_thin"></i><p>Article Views are the COUNTER-compliant sum of full text article downloads since November 2008 (both PDF and HTML) across all institutions and individuals. These metrics are regularly updated to reflect usage leading up to the last few days.</p><p>Citations are the number of other articles citing this article, calculated by Crossref and updated daily.<a href="https://www.crossref.org/services/cited-by/" title="Find more information about Crossref citation counts"> Find more information about Crossref citation counts.</a></p><p>The Altmetric Attention Score is a quantitative measure of the attention that a research article has received online. Clicking on the donut icon will load a page at altmetric.com with additional details about the score and the social media presence for the given article. Find more information on<a href="https://help.altmetric.com/support/solutions/articles/6000233311-how-is-the-altmetric-attention-score-calculated" title="The Altmetric Attention Score and how the score is calculated"> the Altmetric Attention Score and how the score is calculated.</a></p></div></div></div></div></div></div><div class="article_header-meta-right"><div class="articleHeaderDropzone6" data-pb-dropzone="articleHeaderDropzone6"><div data-widget-def="UX3share" data-widget-id="787b5b92-0445-40f4-bdd2-9591d56f4a67" class="article_header-share share_label_visible">
        



        
        <script data-cfasync="false" src="/cdn-cgi/scripts/5c5dd728/cloudflare-static/email-decode.min.js"></script><script type="text/javascript" async="async" src="//s7.addthis.com/js/300/addthis_widget.js#pubid=xa-4faab26f2cff13a7"></script><div class="share"><div class="share_button"><span class="share__label">Share</span><a href="#" data-db-target-for="787b5b92-0445-40f4-bdd2-9591d56f4a67" data-db-switch="icon-close_thin" aria-label="share button" class="share__ctrl"><i aria-hidden="true" class="icon-Icon_Share"></i></a></div>



        
        <div class="achs-addto-mendeley"><input type="hidden" name="statusEndpoint" value="https://sso.acs.org/idp/status" class="statusEndpoint"/></input><input type="hidden" name="clientID" value="atypon-lives" class="clientID"/></input><input type="hidden" class="doi" value="10.1021/acs.jmedchem.8b00639" /></input><span class="achs-addto-mendeley_label achs-addto-mendeley_addToLabel">Add to</span><span class="achs-addto-mendeley_label achs-addto-mendeley_viewInLabel">View In</span><a title="Add to mendeley button" class="achs-addto-mendeley_button" tabindex="0"><i class="achs-addto-mendeley_icon icon-mendeley"></i><i class="achs-addto-mendeley_close icon-close"></i></a><div data-db-target-of="5423a74c-bbd8-47b1-9f43-99423ee72e5c" class="achs-addto-mendeley_list dropBlock__holder"><ul><li><a href="#" title="Add Full Text with Reference" class="achs-addto-mendeley_disabled-button add-full-document"><i class="icon-bookmark-o"></i><span>Add Full Text with Reference</span></a></li><li><a href="#" title="Add Description" class="achs-mendeley_button add-metadata-description"><i class="icon-mendeley"></i><span>Add Description</span></a></li></ul></div><a href="#" title="View in mendeley button" class="achs-addto-mendeley_viewin-button"><i class="icon-mendeley"></i></a><div class="achs_loader"><div class="achs_loader_dot"></div><div class="achs_loader_dot"></div><div class="achs_loader_dot"></div></div><input type="hidden" name="meta-data" value="{&quot;title&quot;:&quot;Discovery, Synthesis, and Evaluation of Oxynitidine Derivatives as Dual Inhibitors of DNA Topoisomerase IB (TOP1) and Tyrosyl-DNA Phosphodiesterase 1 (TDP1), and Potential Antitumor Agents&quot;,&quot;type&quot;:&quot;journal&quot;,&quot;authors&quot;:[{&quot;first_name&quot;:&quot;Xiao-Ru&quot;,&quot;last_name&quot;:&quot;Zhang&quot;},{&quot;first_name&quot;:&quot;Hao-Wen&quot;,&quot;last_name&quot;:&quot;Wang&quot;},{&quot;first_name&quot;:&quot;Wen-Lin&quot;,&quot;last_name&quot;:&quot;Tang&quot;},{&quot;first_name&quot;:&quot;Yu&quot;,&quot;last_name&quot;:&quot;Zhang&quot;},{&quot;first_name&quot;:&quot;Hui&quot;,&quot;last_name&quot;:&quot;Yang&quot;},{&quot;first_name&quot;:&quot;De-Xuan&quot;,&quot;last_name&quot;:&quot;Hu&quot;},{&quot;first_name&quot;:&quot;Azhar&quot;,&quot;last_name&quot;:&quot;Ravji&quot;},{&quot;first_name&quot;:&quot;Christophe&quot;,&quot;last_name&quot;:&quot;Marchand&quot;},{&quot;first_name&quot;:&quot;Evgeny&quot;,&quot;last_name&quot;:&quot;Kiselev&quot;},{&quot;first_name&quot;:&quot;Kwabena&quot;,&quot;last_name&quot;:&quot;Ofori-Atta&quot;},{&quot;first_name&quot;:&quot;Keli&quot;,&quot;last_name&quot;:&quot;Agama&quot;},{&quot;first_name&quot;:&quot;Yves&quot;,&quot;last_name&quot;:&quot;Pommier&quot;},{&quot;first_name&quot;:&quot;Lin-Kun&quot;,&quot;last_name&quot;:&quot;An&quot;}],&quot;source&quot;:&quot;Journal of Medicinal Chemistry&quot;,&quot;year&quot;:&quot;2018&quot;,&quot;month&quot;:&quot;10&quot;,&quot;day&quot;:&quot;18&quot;,&quot;issue&quot;:&quot;22&quot;,&quot;volume&quot;:&quot;61&quot;,&quot;pages&quot;:&quot;9908-9930&quot;,&quot;identifiers&quot;:{&quot;doi&quot;:&quot;10.1021/acs.jmedchem.8b00639&quot;},&quot;abstract&quot;:&quot;Tyrosyl–DNA phosphodiesterase 1 (TDP1) is a recently discovered enzyme repairing DNA lesions resulting from stalled topoisomerase IB (TOP1)–DNA covalent complex. Inhibiting TDP1 in conjunction with TOP1 inhibitors can boost the action of the latter. Herein, we report the discovery of the natural product oxynitidine scaffold as a novel chemotype for the development of TOP1 and TDP1 inhibitors. Three kinds of analogues, benzophenanthridinone, dihydrobenzophenanthridine, and benzophenanthridine derivatives, were synthesized and evaluated for both TOP1 and TDP1 inhibition and cytotoxicity. Analogue 19a showed high TOP1 inhibition (+++) and induced the formation of cellular TOP1cc and DNA damage, resulting in cancer cells apoptosis at nanomolar concentration range. In vivo studies indicated that 19a exhibits antitumor efficiency in HCT116 xenograft model. 41a exhibited additional TDP1 inhibition with IC50 value of 7 μM and synergistic effect with camptothecin in MCF-7 cells. This work will facilitate future effort&quot;}" class="meta-data"/></input><input type="hidden" name="mendeley-api-endpoint" value="https://api.mendeley.com/documents" class="mendeley-api-endpoint"/></input><input type="hidden" name="pub-access" value="full" class="pub-access"/></input><input type="hidden" name="library-url" value="https://www.mendeley.com/library/" class="library-url"/></input><input type="hidden" name="selected-share-option" class="selected-share-option"/></input></div>




        
        <div class="cit-download-dropdown"><span class="cit-download-dropdown_label">Export</span><a href="#" data-db-target-for="cit-download-dropdown_content" title="Download citation button" class="cit-download-dropdown_button"><span>RIS</span><i aria-hidden="true" aria-label="close" class="icon-close"></i></a><div data-db-target-of="cit-download-dropdown_content" class="cit-download-dropdown_content"><ul><li><a href="/action/downloadCitation?doi=10.1021%2Facs.jmedchem.8b00639&amp;include=cit&amp;format=ris&amp;direct=true&amp;downloadFileName=acs.jmedchem.8b00639" title="Citation"><span>Citation</span></a></li><li><a href="/action/downloadCitation?doi=10.1021%2Facs.jmedchem.8b00639&amp;include=abs&amp;format=ris&amp;direct=true&amp;downloadFileName=acs.jmedchem.8b00639" title="Citation and abstract"><span>Citation and abstract</span></a></li><li><a href="/action/downloadCitation?doi=10.1021%2Facs.jmedchem.8b00639&amp;include=ref&amp;format=ris&amp;direct=true&amp;downloadFileName=acs.jmedchem.8b00639" title="Citation and references"><span>Citation and references</span></a></li><li><a href="/action/showCitFormats?doi=10.1021%2Facs.jmedchem.8b00639&amp;include=cit&amp;format=ris&amp;direct=true&amp;downloadFileName=acs.jmedchem.8b00639&amp;href=/doi/10.1021/acs.jmedchem.8b00639" title="Cite This"><i class="icon-plus-square"></i><span>More Options</span></a></li></ul></div></div>
<div data-db-target-of="787b5b92-0445-40f4-bdd2-9591d56f4a67" id="787b5b92-0445-40f4-bdd2-9591d56f4a67_Pop" class="share__block dropBlock__holder fixed"><span class="sr-only">Share on</span><ul class="rlist w-slide--list addthis addthis_toolbox addthis_default_style addthis_32x32_style"><li><a role="link" class="addthis_button_facebook"><i aria-hidden="true" class="at-icon-wrapper icon-facebook"></i>Facebook</a></li><li><a role="link" class="addthis_button_twitter"><i aria-hidden="true" class="at-icon-wrapper icon-twitter"></i>Twitter</a></li><li><a role="link" class="addthis_button_wechat"><i aria-hidden="true" class="at-icon-wrapper icon-wechat"></i>Wechat</a></li><li><a role="link" class="addthis_button_linkedin"><i aria-hidden="true" class="at-icon-wrapper icon-linkedin"></i>Linked In</a></li><li><a role="link" class="addthis_button_reddit"><i aria-hidden="true" class="at-icon-wrapper icon-reddit"></i>Reddit</a></li></ul></div></div>

        </div></div></div></div><div class="article_header-footer"><div class="article_header-footer-left pull-left clearfix"><div class="article_header-links pull-left"><input class="pub-doi" type="hidden" name="pub-doi" value="10.1021/acs.jmedchem.8b00639" /></input><a href="/doi/pdf/10.1021/acs.jmedchem.8b00639" title="PDF" target="_blank" class="button_primary pdf-button"><i class="icon-file-pdf-o"></i><span>PDF (6 MB)
                            </span></a><a href="/servlet/linkout?suffix=s0&amp;dbid=16384&amp;doi=10.1021/acs.jmedchem.8b00639&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fid%3Ddoi%3A10.1021%252Facs.jmedchem.8b00639%26sid%3Dliteratum%253Aachs%26pmid%3D30336023%26genre%3Darticle%26aulast%3DZhang%26date%3D2018%26atitle%3DDiscovery%252C%2BSynthesis%252C%2Band%2BEvaluation%2Bof%2BOxynitidine%2BDerivatives%2Bas%2BDual%2BInhibitors%2Bof%2BDNA%2BTopoisomerase%2BIB%2B%2528TOP1%2529%2Band%2BTyrosyl-DNA%2BPhosphodiesterase%2B1%2B%2528TDP1%2529%252C%2Band%2BPotential%2BAntitumor%2BAgents%26jtitle%3DJournal%2Bof%2BMedicinal%2BChemistry%26title%3DJournal%2Bof%2BMedicinal%2BChemistry%26volume%3D61%26issue%3D22%26spage%3D9908%26epage%3D9930%26issn%3D0022-2623" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a><div class="articleHeaderDropzone8" data-pb-dropzone="articleHeaderDropzone8"><div class="external-alerts-management"><input type="hidden" name="pub-type" value="article" class="pub-type"/></input><input type="hidden" name="is-enabled" value="true" class="is-enabled"/></input><input type="hidden" name="is-authenticated" value="false" class="is-authenticated"/></input><input type="hidden" name="pub-code" value="jmcmar" class="pub-code"/></input><input type="hidden" name="linkout-url" value="https://preferences.acspubs.org/journals" class="linkout-url"/></input><button data-toggle="modal" data-target="#ealertsModal" class="ealerts-toggle-btn hidden"></button><a class="button_primary_2 niHeader_getEAlerts jhHeader_sub_info"><i class="icon-send"></i><i class="icon-envelope"></i><i class="icon-check"></i><span class="ealerts-btn-text">Get e-Alerts</span><i aria-hidden="true" aria-label="close" class="icon-close"></i></a><div class="ux-modal-container"><div id="ealertsModal" style="display: none;" aria-live="polite" aria-atomic="true" class="modal"><div class="modal__dialog"><div class="modal__body"><iframe src="" class="ealerts-frame"></iframe></div></div></div></div><input type="hidden" id="ealertsModalSrc" value="https://preferences.acspubs.org/jmcmar?ifr=1"/></input></div></div></div><div class="article_header-suppInfo pull-left"><i class="icon-supporting-info"></i><span class="article_header-suppInfo-text">Supporting Info (5)</span><span class="article_header-suppInfo-arrow">»</span><a href="#" data-slide-target=".tab__pane-suppInfo" title="Supporting Information" class="article_header-suppInfo-link-mobile hidden-sm hidden-md hidden-lg w-slide__btn">Supporting Information
                </a><a href="#article_content-right" title="Supporting Information" data-scrollDuration="1000" class="article_header-suppInfo-link internalNav hidden-xs">Supporting Information
                </a></div></div><div class="article_header-footer-right"><div class="articleHeaderDropzone7" data-pb-dropzone="articleHeaderDropzone7"><div class="article_header-footer-right"><div class="article_header-taxonomy"><span>SUBJECTS:</span><ul class="rlist--inline loa"><li><a href="/action/doSearch?ConceptID=290896" title="Cells">Cells</a>,</li><li><a href="/action/doSearch?ConceptID=292528" title="Inhibitors">Inhibitors</a>,</li><li><a href="/action/doSearch?ConceptID=291793" title="Inhibition">Inhibition</a>,</li><li><a href="/action/doSearch?ConceptID=291788" title="Reaction products">Reaction products</a>,</li><li><a href="/action/doSearch?ConceptID=291439" title="Genetics">Genetics</a></li></ul></div></div></div></div></div></div><div class="article_header-right pull-left hidden-md hidden-sm hidden-xs"><div class="articleHeaderDropzone2" data-pb-dropzone="articleHeaderDropzone2"><div class="cover-image"><div class="cover-image__image"><a href="/toc/jmcmar/61/22" title="Go to Journal of Medicinal Chemistry "><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-22/jmcmar.2018.61.issue-22/20181121/jmcmar.2018.61.issue-22.largecover.jpg" alt="Go to Journal of Medicinal Chemistry "/></img></a></div></div>




        
        
<script>
 $(document).ready(function() {
   $('.article_header .external-alerts-management .niHeader_getEAlerts').each(function(){
	 var Tab = $(this).attr("href");
	   if(typeof Tab != undefined && Tab != false){
		 console.log("Testing Tab");
		 $(this).attr('href','#');
	   }
   });
 });
 $(document).on('click', '.article_header .external-alerts-management .niHeader_getEAlerts', function (e) {
	 //do something
	 if($(this).hasClass('registered')){
	  //send data to analytics for registered users
	      ga('send','event','Registered e-Alert','Article Page Click','jmcmar');
	  }else{
	     //send data to analytics for non-registered users
	      ga('send','event','Get e-Alert','Article Page Click','jmcmar');
	  }
  });
</script>





        
        <div class="pj-badge"></div>




        
        <div class="aJhp_link"></div>
<a href="/action/doUpdateAlertSettings?action=addJournal&amp;journalCode=jmcmar" class="button_primary_2"><i class="icon-send"></i><span>Get e-Alerts</span></a></div></div></div></div></div></div></div><div class="article_abstract"><div class="container container_scaled-down"><div class="row"><div class="col-xs-12"><h2 class="article_abstract-title" id="Abstract">Abstract</h2><div class="article_abstract-content hlFld-Abstract" id="abstractBox"><figure id="_i1" data-index="0" class="article__inlineFigure article_abstract-img"><img class="inline-fig internalNav" src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-22/acs.jmedchem.8b00639/20181119/images/medium/jm-2018-00639p_0016.gif" alt="" id="tgr1" /></img><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-22/acs.jmedchem.8b00639/20181119/images/large/jm-2018-00639p_0016.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.8b00639&amp;id=_i1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><p class="articleBody_abstractText">Tyrosyl–DNA phosphodiesterase 1 (TDP1) is a recently discovered enzyme repairing DNA lesions resulting from stalled topoisomerase IB (TOP1)–DNA covalent complex. Inhibiting TDP1 in conjunction with TOP1 inhibitors can boost the action of the latter. Herein, we report the discovery of the natural product oxynitidine scaffold as a novel chemotype for the development of TOP1 and TDP1 inhibitors. Three kinds of analogues, benzophenanthridinone, dihydrobenzophenanthridine, and benzophenanthridine derivatives, were synthesized and evaluated for both TOP1 and TDP1 inhibition and cytotoxicity. Analogue <b>19a</b> showed high TOP1 inhibition (+++) and induced the formation of cellular TOP1cc and DNA damage, resulting in cancer cells apoptosis at nanomolar concentration range. In vivo studies indicated that <b>19a</b> exhibits antitumor efficiency in HCT116 xenograft model. <b>41a</b> exhibited additional TDP1 inhibition with IC<sub>50</sub> value of 7 μM and synergistic effect with camptothecin in MCF-7 cells. This work will facilitate future efforts for the discovery of natural product-based TOP1 and TDP1 inhibitors.</p></div></div></div></div></div><div class="article_content"><ul class="tab-nav-shortcut"><li><i class="icon-image"></i></li><li><i class="icon-link"></i></li><li><i class="icon-supporting-info"></i></li></ul><div class="container container_scaled-down"><div class="row"><div class="col-xs-12"><div class="article_content-table hlFld-FullText"><div class="article_content-row"><div class="article_content-left"><div id="sec1" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i2">Introduction</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_46261" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_46261" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p">Topoisomerase IB (TOP1) is an essential nuclear enzyme controlling the topology of DNA in many cellular metabolic processes.<a onclick="showRef(event, 'ref1 ref2 ref3 ref4'); return false;" href="javascript:void(0);" class="ref ref1 ref2 ref3 ref4">(1−4)</a> To perform its functions, TOP1 cleaves one strand of DNA by nucleophilic attack of its active site tyrosine on the DNA phosphodiester backbone (<a data-tab="pane-pcw-Figures" href="#fig1" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig1" id="" class=" internalNav">1</a></a>A), resulting in nicks in the target DNA as part of TOP1–DNA covalent cleavage complexes (TOP1cc, <a data-tab="pane-pcw-Figures" href="#fig1" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig1" id="" class=" internalNav">1</a></a>B). TOP1cc are transient intermediates under normal physiological circumstances and reverse via 5′-OH attack of the nicked strand on the TOP1–DNA phosphotyrosyl group, thus restoring the intact DNA and releasing TOP1.<a onclick="showRef(event, 'ref4 ref5'); return false;" href="javascript:void(0);" class="ref ref4 ref5">(4,5)</a> TOP1 inhibitors, such as camptothecin (<b>1</b>, <a href="/doi/suppl/10.1021/acs.jmedchem.8b00639/suppl_file/jm8b00639_si_001.pdf" class="ext-link">Figure 2S</a>, Supporting Information), bind at the interface of TOP1cc by intercalating between the base pairs at the site of cleavage and forming key hydrogen bonds with TOP1.<a onclick="showRef(event, 'ref6'); return false;" href="javascript:void(0);" class="ref ref6">(6)</a> This stabilizes TOP1cc and prevents further religation of the broken DNA. When replication and transcription machineries encounter the trapped TOP1cc, DNA damage is generated, triggering cell death.<a onclick="showRef(event, 'ref4 ref5'); return false;" href="javascript:void(0);" class="ref ref4 ref5">(4,5)</a> To date, four well-known camptothecin TOP1 inhibitors (<a href="/doi/suppl/10.1021/acs.jmedchem.8b00639/suppl_file/jm8b00639_si_001.pdf" class="ext-link">Figure 2S</a>, Supporting Information) have been approved for clinical treatment of cancers, including irinotecan (<b>2</b>) and topotecan (<b>3</b>), approved by the FDA,<a onclick="showRef(event, 'ref7 ref8 ref9'); return false;" href="javascript:void(0);" class="ref ref7 ref8 ref9">(7−9)</a> 10-hydroxycamptothecin (<b>4</b>, HCPT, in China), and belotecan (<b>5</b>, in South Korea).<a onclick="showRef(event, 'ref5 ref10 ref11'); return false;" href="javascript:void(0);" class="ref ref5 ref10 ref11">(5,10,11)</a> Therefore, TOP1 is a validated target for the discovery of antitumor agents.<a onclick="showRef(event, 'ref5 ref12 ref13 ref14'); return false;" href="javascript:void(0);" class="ref ref5 ref12 ref13 ref14">(5,12−14)</a></div><figure id="fig1" data-index="1" class="article__inlineFigure"><h2 class="fig-label">Figure 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-22/acs.jmedchem.8b00639/20181119/images/medium/jm-2018-00639p_0001.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-22/acs.jmedchem.8b00639/20181119/images/large/jm-2018-00639p_0001.jpeg" id="gr1" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 1. Schematic for TOP1 and TDP1 mediated biochemical reactions. (A) TOP1 binds to DNA and cleaves one strand of a dsDNA by forming a reversible covalent 3′-phosphotyrosyl bond. (B) The resulting TOP1cc may be trapped and stabilized by TOP1 inhibitors (black stick) such as camptothecin and indenoisoquinoline analogues, resulting in replication/transcription-mediated DNA damage and cell death. (C) TOP1cc could be proteolyzed to expose the DNA-3′-phosphotyrosyl bond, which can be cleaved by TDP1 to leave the 3′-phosphate end DNA (D). (E) The DNA breaks may be repaired sequentially by the XRCC-1 dependent base excision repair (BER) pathway.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-22/acs.jmedchem.8b00639/20181119/images/large/jm-2018-00639p_0001.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.8b00639&amp;id=fig1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">The DNA damage generated from TOP1cc can be repaired through several pathways, including homologous recombination (BRCA1, BRCA2, CtIP, Mre11, Rad52), cell cycle checkpoint signaling, XPF/ERCC1, Mre11, CtIP, and tyrosyl–DNA phosphodiesterase-dependent pathways, etc.<a onclick="showRef(event, 'ref15 ref16'); return false;" href="javascript:void(0);" class="ref ref15 ref16">(15,16)</a> Tyrosyl–DNA phosphodiesterase 1 (TDP1) is a member of the phospholipase D superfamily.<a onclick="showRef(event, 'ref17'); return false;" href="javascript:void(0);" class="ref ref17">(17)</a> It catalytically hydrolyzes the 3′-phosphotyrosyl bond (<a data-tab="pane-pcw-Figures" href="#fig1" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig1" id="" class=" internalNav">1</a></a>C) associated with TOP1cc. TDP1 generates DNA breaks with 5′-hydroxyl and 3′-phosphate ends (<a data-tab="pane-pcw-Figures" href="#fig1" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig1" id="" class=" internalNav">1</a></a>D) for further DNA repair by the XRCC-1-dependent pathway, including polynucleotide kinase phosphatase (PNKP), poly(ADP-ribose) polymerase 1 (PARP1), DNA ligase III (Lig3), and DNA polymerase β (Polβ), finally resulting in resealed DNA (<a data-tab="pane-pcw-Figures" href="#fig1" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig1" id="" class=" internalNav">1</a></a>E).<a onclick="showRef(event, 'ref18 ref19'); return false;" href="javascript:void(0);" class="ref ref18 ref19">(18,19)</a> In this pathway, TDP1-catalyzed hydrolysis of the 3′-phosphotyrosyl bond is a key step for initiating the repair of TOP1-mediated DNA damage. In addition, TDP1 catalyzes hydrolysis of 3′-blocking lesions generated by DNA oxidation and alkylation,<a onclick="showRef(event, 'ref20 ref21 ref22'); return false;" href="javascript:void(0);" class="ref ref20 ref21 ref22">(20−22)</a> as well as 5′-phosphotyrosyl bond involved in topoisomerase II-mediated DNA damage, implying a broader role of TDP1 in the maintenance of genomic stability.<a onclick="showRef(event, 'ref18 ref20 ref23 ref24'); return false;" href="javascript:void(0);" class="ref ref18 ref20 ref23 ref24">(18,20,23,24)</a> The physiological importance of TDP1 is further emphasized by the discovery of a rare neurodegenerative disease called spinocerebellar ataxia with axonal neuropathy (SCAN1), in which TDP1 bears a H493R mutation in its active site.<a onclick="showRef(event, 'ref25'); return false;" href="javascript:void(0);" class="ref ref25">(25)</a></div><div class="NLM_p">Because TDP1-deficient cells are hypersensitive to TOP1 inhibitors, it has been suggested that overexpression of TDP1 will confer resistance to TOP1-mediated DNA damage, and therefore TDP1 inhibitors would have the ability to sensitize cancer cells to TOP1 inhibitors.<a onclick="showRef(event, 'ref18'); return false;" href="javascript:void(0);" class="ref ref18">(18)</a> Indeed, cells overexpressing TDP1 show resistance to camptothecin.<a onclick="showRef(event, 'ref26 ref27'); return false;" href="javascript:void(0);" class="ref ref26 ref27">(26,27)</a> Conversely, TDP1 knockout mice, human cells deficient in TDP1 and the SCAN1 mutation all show hypersensitivity to camptothecin,<a onclick="showRef(event, 'ref20 ref28 ref29 ref30 ref31 ref32 ref33'); return false;" href="javascript:void(0);" class="ref ref20 ref28 ref29 ref30 ref31 ref32 ref33">(20,28−33)</a> and some TDP1 inhibitors show synergistic activity to camptothecin derivatives.<a onclick="showRef(event, 'ref34 ref35 ref36'); return false;" href="javascript:void(0);" class="ref ref34 ref35 ref36">(34−36)</a> Together, these observations imply that TDP1 is a rational target for the development of novel antitumor agent.<a onclick="showRef(event, 'ref18 ref37 ref38 ref39'); return false;" href="javascript:void(0);" class="ref ref18 ref37 ref38 ref39">(18,37−39)</a></div><div class="NLM_p">Because of the unique physiological functions of TOP1 and TDP1, the discovery of their inhibitors has attracted attention. As TOP1 inhibitors, camptothecin derivatives have been well investigated, and four derivatives (<b>2</b>–<b>5</b>, <a href="/doi/suppl/10.1021/acs.jmedchem.8b00639/suppl_file/jm8b00639_si_001.pdf" class="ext-link">Figure 2S</a>, Supporting Information) are clinically available, as well as several tumor-targeted derivatives currently in clinical trials. Despite their effectiveness in solid tumors, camptothecin inhibitors suffer from well-established limitations, including chemical instability under physiological condition, poor solubility, bone marrow dose-limiting toxicity, severe gastrointestinal toxicity,<a onclick="showRef(event, 'ref40'); return false;" href="javascript:void(0);" class="ref ref40">(40)</a> and drug efflux-mediated resistance.<a onclick="showRef(event, 'ref12'); return false;" href="javascript:void(0);" class="ref ref12">(12)</a> Because of these shortcomings, much attention is directed toward the discovery of noncamptothecin inhibitors. To date, noncamptothecin TOP1 inhibitors have been reported, and three chemotypes, including indolocarbazoles, dibenzonaphthyridinone, and indenoisoquinolines, have been developed. The indenoisoquinolines LMP744 (<b>48</b>, <a href="/doi/suppl/10.1021/acs.jmedchem.8b00639/suppl_file/jm8b00639_si_001.pdf" class="ext-link">Figure 2S</a>, Supporting Information), LMP400 (Indotecan), and LMP776 (Indimitecan) are in clinical trials.<a onclick="showRef(event, 'ref12 ref13 ref41 ref42 ref43'); return false;" href="javascript:void(0);" class="ref ref12 ref13 ref41 ref42 ref43">(12,13,41−43)</a></div><div class="NLM_p">Compared to TOP1 inhibitors, the discovery of TDP1 inhibitors was initiated relatively recently, and there is a limited number of chemotypes reported as TDP1 inhibitors, which leaves much room for development.<a onclick="showRef(event, 'ref37 ref39 ref44'); return false;" href="javascript:void(0);" class="ref ref37 ref39 ref44">(37,39,44)</a> Among TDP1 inhibitors, sodium orthovanadate (<b>7</b>, <a data-tab="pane-pcw-Figures" href="#fig2" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig2" id="" class=" internalNav">2</a></a>) was the first reported TDP1 inhibitor mimicking the DNA substrate in the transition state but with inhibition only at millimolar concentration.<a onclick="showRef(event, 'ref45 ref46'); return false;" href="javascript:void(0);" class="ref ref45 ref46">(45,46)</a> Recently, a few more potent inhibitors with IC<sub>50</sub> values at low micromolar or submicromolar concentrations have been reported, such as aminoglycoside neomycin,<a onclick="showRef(event, 'ref47'); return false;" href="javascript:void(0);" class="ref ref47">(47)</a> methyl-3,4-dephostatin,<a onclick="showRef(event, 'ref48'); return false;" href="javascript:void(0);" class="ref ref48">(48)</a> arylidenethioxothiazolicinone,<a onclick="showRef(event, 'ref49'); return false;" href="javascript:void(0);" class="ref ref49">(49)</a> thioxopyrimidinedione (CD00509),<a onclick="showRef(event, 'ref50'); return false;" href="javascript:void(0);" class="ref ref50">(50)</a> and benzopentathiepine.<a onclick="showRef(event, 'ref51'); return false;" href="javascript:void(0);" class="ref ref51">(51)</a> A few derivatives of the clinically developed TOP1 inhibitors, the indenoisoquinolines have been reported to also inhibit TDP1.<a onclick="showRef(event, 'ref52 ref53 ref54 ref55 ref56'); return false;" href="javascript:void(0);" class="ref ref52 ref53 ref54 ref55 ref56">(52−56)</a> The indenoisoquinoline <b>10</b> (<a data-tab="pane-pcw-Figures" href="#fig2" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig2" id="" class=" internalNav">2</a></a>) showed consistent TDP1 inhibition with IC<sub>50</sub> value of 1.52 μM.<a onclick="showRef(event, 'ref52'); return false;" href="javascript:void(0);" class="ref ref52">(52)</a> Recently, three chemotypes (<a data-tab="pane-pcw-Figures" href="#fig2" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig2" id="" class=" internalNav">2</a></a>), 7-hydroxycoumarin derivatives (<b>11</b>), usnic acid enamines (<b>8</b>), and aminoadamantanes (<b>9</b>), were reported to inhibit TDP1 and synergize with camptothecin derivatives.<a onclick="showRef(event, 'ref34 ref35 ref36'); return false;" href="javascript:void(0);" class="ref ref34 ref35 ref36">(34−36)</a></div><figure id="fig2" data-index="2" class="article__inlineFigure"><h2 class="fig-label">Figure 2</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-22/acs.jmedchem.8b00639/20181119/images/medium/jm-2018-00639p_0002.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-22/acs.jmedchem.8b00639/20181119/images/large/jm-2018-00639p_0002.jpeg" id="gr2" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 2. Structures of representative reported TDP1 inhibitors.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-22/acs.jmedchem.8b00639/20181119/images/large/jm-2018-00639p_0002.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.8b00639&amp;id=fig2"><span>Download MS PowerPoint Slide</span></a></div></div></figure></div><div id="sec2" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i3">Results and Discussion</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_10364" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_10364" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div id="sec2_1" class="NLM_sec NLM_sec_level_2"><div id="ac_i4" class="anchor-spacer"></div><h3 class="article-section__title" id="_i4"> Hit Discovery for TOP1 Inhibitor</h3><div class="NLM_p">Natural products are an important source for medicinal chemistry and drug development.<a onclick="showRef(event, 'ref57 ref58'); return false;" href="javascript:void(0);" class="ref ref57 ref58">(57,58)</a> To find novel TOP1 inhibitors, we screened our in-house natural product library containing more than 900 natural products using a TOP1-mediated DNA relaxation assay. Several chemotypes were found to inhibit TOP1, including meroterpenoid derivatives and oxynitidine (<b>6</b>, <a href="/doi/suppl/10.1021/acs.jmedchem.8b00639/suppl_file/jm8b00639_si_001.pdf" class="ext-link">Figure 1S</a>, Supporting Information). The meroterpenoid derivatives showed high TOP1 relaxing inhibition, but did not have the ability to trap and stabilize TOP1cc,<a onclick="showRef(event, 'ref59'); return false;" href="javascript:void(0);" class="ref ref59">(59)</a> and therefore could be classified as TOP1 catalytic inhibitors.<a onclick="showRef(event, 'ref60'); return false;" href="javascript:void(0);" class="ref ref60">(60)</a> By contrast, TOP1-mediated DNA cleavage assay indicated that <b>6</b> was able to induce the formation of TOP1cc in a dose-dependent manner (<a href="/doi/suppl/10.1021/acs.jmedchem.8b00639/suppl_file/jm8b00639_si_001.pdf" class="ext-link">Figure 1S</a>, Supporting Information). It is noteworthy that the cleavage sites induced by <b>6</b> are different from that induced by camptothecin and similar to the indenoisoquinoline <b>48</b> (<a href="/doi/suppl/10.1021/acs.jmedchem.8b00639/suppl_file/jm8b00639_si_001.pdf" class="ext-link">Figure 2S</a>, Supporting Information). For example, the cleavage sites 17, 35, and 79 can be induced by <b>6</b> and <b>48</b> but not by camptothecin, implying that this novel TOP1 inhibitor might target the genome at different sites and translate to different cellular effects compared with camptothecin.<a onclick="showRef(event, 'ref12'); return false;" href="javascript:void(0);" class="ref ref12">(12)</a></div><div class="NLM_p">It was reported that nitidine can intercalate into double-stranded DNA (dsDNA) and inhibit TOP1.<a onclick="showRef(event, 'ref61 ref62 ref63'); return false;" href="javascript:void(0);" class="ref ref61 ref62 ref63">(61−63)</a> Because <b>6</b> is the 6-oxo analogue of nitidine, a FRET melting assay using F10T (5′-<i>FAM</i>-dTATAGCTATAHEG-TATAGCTATA-<i>TAMRA</i>-3′) as substrate was conducted to detect the enhanced melting temperature (Δ<i>T</i><sub>m</sub>) and investigate the interaction of <b>6</b> with dsDNA. Intercalation of small molecules into dsDNA stabilizes the DNA double-helix structure, resulting in an increased melting temperature by about 5–8 °C.<a onclick="showRef(event, 'ref64'); return false;" href="javascript:void(0);" class="ref ref64">(64)</a> The FRET melting assay indicated that <b>6</b> showed low Δ<i>T</i><sub>m</sub> value (0.4 °C) compared to the intercalator <b>49</b> (<a href="/doi/suppl/10.1021/acs.jmedchem.8b00639/suppl_file/jm8b00639_si_001.pdf" class="ext-link">Figure 2S</a>, Supporting Information) with Δ<i>T</i><sub>m</sub> value of 5.8 °C (<a class="ref showTableEvent internalNav" data-ID="tbl1" href="#tbl1">Table <a class="ref showTableEvent internalNav" data-ID="tbl1" href="#tbl1">1</a></a>),<a onclick="showRef(event, 'ref65'); return false;" href="javascript:void(0);" class="ref ref65">(65)</a> implying that <b>6</b> seems not be a DNA intercalator.</div><div class="NLM_table-wrap" id="tbl1"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 1. TOP1 and TDP1 Inhibitions, Enhanced Melting Temperature with dsDNA and Cytotoxicity of the Indicated Compounds</div></div></div><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-22/acs.jmedchem.8b00639/20181119/images/medium/jm-2018-00639p_0013.gif" alt="" id="gr13" /></img><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-22/acs.jmedchem.8b00639/20181119/images/medium/jm-2018-00639p_0014.gif" alt="" id="gr14" /></img><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-22/acs.jmedchem.8b00639/20181119/images/medium/jm-2018-00639p_0015.gif" alt="" id="GRAPHIC-d7e668-autogenerated" /></img><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-t1fn1"><div class="footnote" id="t1fn1"><sup><sup>a</sup></sup><p class="last">TOP1 cleavage inhibitory activity of synthesized compounds was semiquantitatively expressed relative to CPT at 1 μM as follows: 0, no inhibition; +, between 20% and 50% activity; ++, between 50% and 75% activity; +++, between 75% and 95% activity; ++++, equal activity.</p></div><div class="footnote" id="t1fn2"><sup><sup>b</sup></sup><p class="last">TDP1 inhibition was determined by using a fluorescence assay and the percentage inhibition of the compounds at 100 μM concentration was calculated. Every experiment was repeated at least three times independently.</p></div><div class="footnote" id="t1fn3"><sup><sup>c</sup></sup><p class="last">Δ<i>T</i><sub>m</sub> = <i>T</i><sub>m</sub>(DNA + compound) – <i>T</i><sub>m</sub>(DNA). Every experiment was repeated at least twice independently.</p></div><div class="footnote" id="t1fn4"><sup><sup>d</sup></sup><p class="last">GI<sub>50</sub> values (means ± SD) were defined as the concentrations of compounds that resulted in 50% cell growth inhibition and obtained from MTT assay. Every experiment was repeated at least three times independently.</p></div><div class="footnote" id="t1fn5"><sup><sup>e</sup></sup><p class="last">“/” mean “ inapplicable”.</p></div><div class="footnote" id="t1fn6"><sup><sup>f</sup></sup><p class="last">“ND” mean “ not determined”.</p></div></div><div></div></div><div class="NLM_p last">These results indicate that the oxynitidine scaffold is a novel chemotype for discovery and development of new classes of TOP1 inhibitors.</div></div><div id="sec2_2" class="NLM_sec NLM_sec_level_2"><div id="ac_i6" class="anchor-spacer"></div><h3 class="article-section__title" id="_i6"> Chemistry</h3><div class="NLM_p">To synthesize the benzophenanthridinone derivatives, the synthetic route was designed as shown in <a class="ref internalNav" href="#sch1" aria-label="Scheme 1">Scheme 1</a> according to the method reported by Korivi et al.<a onclick="showRef(event, 'ref66'); return false;" href="javascript:void(0);" class="ref ref66">(66)</a> The reaction of 2-bromo-4,5-dimethoxybenzaldehyde with 2-hydroxyethylamine or 3-hydroxypropanylamine gave the imine intermediate <b>12a</b> or <b>12b</b> in 100% yield. To avoid oxidation during Swern oxidation at step e (<a class="ref internalNav" href="#sch1" aria-label="Scheme 1">Scheme 1</a>), the hydroxy groups of <b>12a</b> and <b>12b</b> were protected with methoxymethyl (MOM) group to give intermediates <b>13a</b> and <b>13b</b>, which were directly used without purification to react with <b>14</b>, prepared through Sonogashira coupling reaction from 5-bromobenzo[<i>d</i>][1,3]dioxole and 3-butyn-1-ol. Under Ni-based catalysis,<a onclick="showRef(event, 'ref67'); return false;" href="javascript:void(0);" class="ref ref67">(67)</a> the cyclization reaction of <b>13a</b>/<b>b</b> with <b>14</b> gave the intermediates <b>15a</b>/<b>b</b> in 45–57% yield for two steps (from <b>12a</b>/<b>b</b>). The structures of <b>15a</b> and <b>15b</b> were confirmed using 1D and 2D NMR spectra and HRMS. Following the Swern oxidation of the hydroxyl group of <b>15a</b> and <b>15b</b>,<a onclick="showRef(event, 'ref68'); return false;" href="javascript:void(0);" class="ref ref68">(68)</a> cyclization reaction under acid conditions gave the alcohol products <b>17a</b> and <b>17b</b> with simultaneous deprotection of MOM group.</div><figure id="sch1" data-index="3" class="article__inlineFigure"><h2 class="fig-label">Scheme 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-22/acs.jmedchem.8b00639/20181119/images/medium/jm-2018-00639p_0011.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-22/acs.jmedchem.8b00639/20181119/images/large/jm-2018-00639p_0011.jpeg" id="gr11" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 1. Synthesis of Compounds <b>19a</b>/<b>b</b>–<b>25a</b>/<b>b</b> and <b>26a</b>/<b>b</b>–<b>32a</b>/<b>b</b><sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-22/acs.jmedchem.8b00639/20181119/images/large/jm-2018-00639p_0011.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.8b00639&amp;id=sch1"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label"><sup>a</sup></span>Reagents and conditions: (a) MeOH, NH<sub>2</sub>(CH<sub>2</sub>)<sub>n</sub>OH, rt; (b) MOMCl, NaH, THF, 0 °C; (c) Pd(PPh<sub>3</sub>)<sub>4</sub>, CuI, pyrrolidine, H<sub>2</sub>O, 60 °C; (d) (i) N<sub>2</sub>, Ni(cod)<sub>2</sub>, P(<i>o</i>-Tol)<sub>3</sub>, MeCN, 80 °C, (ii) CsOH, K<sub>3</sub>[Fe(CN)<sub>6</sub>], MeOH, H<sub>2</sub>O, 80 °C; (e) (COCl)<sub>2</sub>, DMSO, TEA, DCM, −60 °C; (f) concd. hydrochloric acid, MeOH, rt; (g) SOCl<sub>2</sub>, TCM, TEA, rt; (h) amines (in pressure vessel for dimethylamine), PhMe, K<sub>2</sub>CO<sub>3</sub>, KI, reflux; (i) LiAlH<sub>4</sub>, THF, 0 °C.</p></p></figure><div class="NLM_p">Following the chlorination of <b>17a</b>/<b>b</b> with SOCl<sub>2</sub>, the target benzophenanthridinone derivatives (<b>19a</b>/<b>b</b>–<b>25a</b>/<b>b</b>) were obtained from the reaction of <b>18a</b>/<b>b</b> with the corresponding amines.</div><div class="NLM_p">The dihydrobenzophenanthridine derivatives (<b>26a</b>/<b>b</b>–<b>32a</b>/<b>b</b>) were obtained from the reduction of the corresponding benzophenanthridinone substrates (<b>19a</b>/<b>b</b>–<b>25a</b>/<b>b</b>) with LiAlH<sub>4</sub>.</div><div class="NLM_p">The structures of all the benzophenanthridinone and dihydrobenzophenanthridine derivatives were characterized through IR, NMR and HRMS spectra. The signals of the lactam carbonyl stretching vibration were between 1630 and 1642 cm<sup>–1</sup>. The structure of dihydrobenzophenanthridine derivative <b>20b</b> was also confirmed with X-ray single crystal analysis (<a data-tab="pane-pcw-Figures" href="#fig3" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig3" id="" class=" internalNav">3</a></a>).</div><figure id="fig3" data-index="4" class="article__inlineFigure"><h2 class="fig-label">Figure 3</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-22/acs.jmedchem.8b00639/20181119/images/medium/jm-2018-00639p_0003.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-22/acs.jmedchem.8b00639/20181119/images/large/jm-2018-00639p_0003.jpeg" id="gr3" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 3. Perspective ORTEP drawing of compound <b>20b</b>.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-22/acs.jmedchem.8b00639/20181119/images/large/jm-2018-00639p_0003.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.8b00639&amp;id=fig3"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">The 6-alkoxy substituted benzophenanthridinone derivatives (<b>39a</b>/<b>b</b>–<b>45a</b>/<b>b</b>) were synthesized as shown in <a class="ref internalNav" href="#sch2" aria-label="Scheme 2">Scheme 2</a>. The isoquinolinone <b>34</b> was obtained from the nickel-catalyzed cyclization of <b>14</b> and <b>33</b>, prepared from the reaction of 2-bromo-4,5-dimethoxybenzaldehyde with 4-methoxyphenylmethanamine. Following the Swern oxidation of <b>34</b>, the key intermediate <b>36</b> was prepared from the acid-catalytic cyclization of <b>35</b>, meanwhile, the <i>p</i>-methoxybenzyl (PMB) group was removed. As shown in <a class="ref internalNav" href="#sch2" aria-label="Scheme 2">Scheme 2</a>, two synthetic pathways were designed for the target products <b>39a</b>–<b>45a</b> (<a class="ref internalNav" href="#sch2" aria-label="Scheme 2">Scheme 2</a>, steps e and f) and <b>39b</b>–<b>45b</b> (<a class="ref internalNav" href="#sch2" aria-label="Scheme 2">Scheme 2</a>, steps g and h).</div><figure id="sch2" data-index="5" class="article__inlineFigure"><h2 class="fig-label">Scheme 2</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-22/acs.jmedchem.8b00639/20181119/images/medium/jm-2018-00639p_0012.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-22/acs.jmedchem.8b00639/20181119/images/large/jm-2018-00639p_0012.jpeg" id="gr12" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 2. Synthesis of Compounds <b>39a</b>/<b>b</b>–<b>45a</b>/<b>b</b><sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-22/acs.jmedchem.8b00639/20181119/images/large/jm-2018-00639p_0012.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.8b00639&amp;id=sch2"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label"><sup>a</sup></span>Reagents and conditions: (a) MeOH, rt; (b) (i) N<sub>2</sub>, compound <b>14</b>, Ni(cod)<sub>2</sub>, P(<i>o</i>-Tol)<sub>3</sub>, MeCN, 80 °C, (ii) CsOH, K<sub>3</sub>Fe(CN)<sub>6</sub>, MeOH, H<sub>2</sub>O, 80 °C; (c) (COCl)<sub>2</sub>, DMSO, TEA, DCM, −60 °C; (d) HCl, AcOH, rt; (e) POCl<sub>3</sub>, DMF, 100 °C; (f) HOCH<sub>2</sub>CH<sub>2</sub>R, THF, NaH, 70 °C; (g) Br(CH<sub>2</sub>)<sub>3</sub>Br, DMF, NaH, rt; (h) amines (in pressure vessel for dimethylamine), DMF, K<sub>2</sub>CO<sub>3</sub>, KI, rt.</p></p></figure><div class="NLM_p">Surprisingly, the reaction of <b>36</b> with 1,3-dibromopropane under strong base conditions (NaH) mainly gave the product <b>38</b> with 3-bromopropyl group attached to oxygen atom at 6-position in 86% yield (<a class="ref internalNav" href="#sch2" aria-label="Scheme 2">Scheme 2</a>, step g) but not the product with 3-bromopropyl group attached to the nitrogen atom of lactam similar to that reported in many publications.<a onclick="showRef(event, 'ref69 ref70 ref71'); return false;" href="javascript:void(0);" class="ref ref69 ref70 ref71">(69−71)</a> The reaction of <b>38</b> with amines gave the corresponding benzophenanthridines <b>39b</b>–<b>45b</b> with 3-alkylamino propoxy substituents at 6-position.</div><div class="NLM_p">The reaction of <b>36</b> with 1,2-dichloroethane gave a mixture of intermediate <b>46</b> (<a data-tab="pane-pcw-Figures" href="#fig4" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig4" id="" class=" internalNav">4</a></a>) and <b>18a</b>, which are inseparable through silica gel column chromatography. It was proposed that the 2-chloroethyl group might first attach to the oxygen atom at 6-position to give <b>46</b>. Compound <b>46</b> was not stable and would undergo a transformation according to the pathway proposed by Nguyen et al.,<a onclick="showRef(event, 'ref52'); return false;" href="javascript:void(0);" class="ref ref52">(52)</a> in which <b>46</b> undergoes intramolecular cyclization and elimination of chlorine atom to produce an intermediate <b>47</b> as shown in <a data-tab="pane-pcw-Figures" href="#fig4" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig4" id="" class=" internalNav">4</a></a>. Nucleophilic attack of the chloride anion to <b>47</b> gave the products <b>18a</b> or <b>46</b>, respectively. Therefore, the products <b>39a</b>–<b>45a</b> with the 2-alkylamino ethoxy group at 6-position were synthesized through the steps e and f of <a class="ref internalNav" href="#sch2" aria-label="Scheme 2">Scheme 2</a>, in which <b>36</b> first was chlorinated with POCl<sub>3</sub> to give intermediate <b>37</b>,<a onclick="showRef(event, 'ref72'); return false;" href="javascript:void(0);" class="ref ref72">(72)</a> and then reaction of <b>37</b> with 2-hydroxy ethylamines under strong base condition gave the target products <b>39a</b>–<b>45a</b>.</div><figure id="fig4" data-index="6" class="article__inlineFigure"><h2 class="fig-label">Figure 4</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-22/acs.jmedchem.8b00639/20181119/images/medium/jm-2018-00639p_0004.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-22/acs.jmedchem.8b00639/20181119/images/large/jm-2018-00639p_0004.jpeg" id="gr4" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 4. Possible transformation pathway of <b>46</b> into <b>18a</b>.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-22/acs.jmedchem.8b00639/20181119/images/large/jm-2018-00639p_0004.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.8b00639&amp;id=fig4"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p last">In summary, three groups of oxynitidine derivatives, the benzophenanthridinone, dihydrobenzophenanthridine, and benzophenanthridine derivatives, were synthesized and their identity and purity assessed through HRMS, 1D and 2D NMR spectra, and HPLC methods.</div></div><div id="sec2_3" class="NLM_sec NLM_sec_level_2"><div id="ac_i9" class="anchor-spacer"></div><h3 class="article-section__title" id="_i9"> TOP1 Inhibition</h3><div class="NLM_p">All synthesized compounds were evaluated for TOP1 inhibition through our TOP1-mediated cleavage assay using a 3′-[<sup>32</sup>P]-labeled double-stranded DNA fragment as substrate.<a onclick="showRef(event, 'ref73'); return false;" href="javascript:void(0);" class="ref ref73">(73)</a> The compounds were tested at 100, 10, 1, and 0.1 μM concentrations, using camptothecin <b>1</b> and indenoisoquinoline <b>48</b> as positive controls, and semiquantitatively scored on the basis of visual inspection of the number and intensities of the DNA cleavage bands relative to the TOP1 inhibition of <b>1</b> at 1 μM concentration: 0, no inhibitory activity; +, between 20% and 50% activity; ++, between 50% and 75% activity; +++, between 75% and 95% activity; ++++, equal activity to <b>1</b> (<a class="ref showTableEvent internalNav" data-ID="tbl1" href="#tbl1">Table <a class="ref showTableEvent internalNav" data-ID="tbl1" href="#tbl1">1</a></a>). For the benzophenanthridinone derivatives <b>19a</b>/<b>b</b>–<b>25a</b>/<b>b</b>, both alkylaminoethyl and alkylaminopropyl substituents attached to the nitrogen atom of lactam increased the TOP1 inhibition, except <b>23b</b> with 3-morpholinopropyl group attached at 5-position, which showed equal activity to that of parent molecule <b>6</b> (+/0, very minor activity less than 10% TOP1 inhibition of <b>1</b>). Bigger substituents at the 5-position decreased TOP1 inhibitory activity. Most benzophenanthridinone derivatives showed limited TOP1 inhibitory activity of +, except compounds <b>19a</b> (+++) and <b>21a</b> (++), with high and moderate TOP1 inhibitory activity, respectively. The compounds <b>17a</b> and <b>17b</b> with a hydroxy terminus showed slightly increased TOP1 inhibition of +. Compound <b>19a</b> was the most potent among the three synthesized chemotypes with TOP1 inhibition of +++. <a data-tab="pane-pcw-Figures" href="#fig5" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig5" id="" class=" internalNav">5</a></a>A demonstrates that <b>19a</b> exhibits cleavage sites similar to <b>48</b> but not to <b>1</b>. It was reported that the dibenzonaphthyridinone derivative, ARC-111, a TOP1 inhibitor that was developed in clinical trials,<a onclick="showRef(event, 'ref41'); return false;" href="javascript:void(0);" class="ref ref41">(41)</a> exhibits different cleavage sites from <b>1</b> and <b>48</b>,<a onclick="showRef(event, 'ref74'); return false;" href="javascript:void(0);" class="ref ref74">(74)</a> implying that, although <b>19a</b> and ARC-111 are structurally similar, they trap TOP1cc at different DNA sequences.</div><figure id="fig5" data-index="7" class="article__inlineFigure"><h2 class="fig-label">Figure 5</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-22/acs.jmedchem.8b00639/20181119/images/medium/jm-2018-00639p_0005.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-22/acs.jmedchem.8b00639/20181119/images/large/jm-2018-00639p_0005.jpeg" id="gr5" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 5. (A) Representative gel of TOP1-mediated DNA cleavage assay. Lane 1, DNA alone; lane 2, DNA and TOP1; lane 3, DNA and TOP1 with <b>1</b> (1 μM); lane 4, DNA and TOP1 with <b>48</b> (1 μM); lanes 5–8, DNA and TOP1 with <b>19a</b> at 0.1, 1.0, 10, and 100 μM concentration, respectively. The arrows at left indicate the cleavage site positions. The gel of TOP1-mediated unwinding assay using supercoiled pBR322 DNA (B) or relaxed pBR322 DNA (C) as substrate, respectively. Lane 1, DNA alone; lane 2, DNA and TOP1; lanes 3–5, DNA and TOP1 with the known DNA intercalator, ethidium bromide (EB) at 0.3, 0.6, 1.2 μg/mL, respectively; lanes 6–8, DNA and TOP1 with <b>19a</b> at 1, 3, 9 μM, respectively. Rx, relaxed DNA. Sc, supercoiled DNA. (D) Hypothetical binding mode of <b>19a</b> in the ternary TOP1–DNA–drug cleavage complex (PDB <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=1K4T">1K4T</a>). <b>19a</b> was shown as yellow carbon atoms ball and stick representation. All distances were measured from heavy atom to heavy atom.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-22/acs.jmedchem.8b00639/20181119/images/large/jm-2018-00639p_0005.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.8b00639&amp;id=fig5"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">Most of the dihydrobenzophenanthridine derivatives, such as <b>26a<i>/</i>b</b>–<b>31a</b>/<b>b</b> and <b>32a</b>, showed equal or slightly increased TOP1 inhibitory activity (+/0 or + ) compared to the parent <b>6</b>. Among this series of derivatives, the most potent compound <b>32b</b> with 3-imidazolylpropyl group at the 5-position showed moderate TOP1cc inhibitory activity (scored + +). Surprisingly, most of benzophenanthridine derivatives did not exhibit TOP1 inhibitory activity except compounds <b>40a</b> (+) and <b>43a</b> (+/0), showing weak activity.</div><div class="NLM_p last">Molecular modeling was performed to rationalize the molecular binding mode of the benzophenanthridinone derivatives within the TOP1–DNA complex. A hypothetical binding model was built using in silico docking from the X-ray crystal of the TOP1–DNA–ligand ternary complex (PDB <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=1K4T">1K4T</a>).<a onclick="showRef(event, 'ref75'); return false;" href="javascript:void(0);" class="ref ref75">(75)</a> Compounds were energy minimized and docked into the binding model. As shown in <a data-tab="pane-pcw-Figures" href="#fig5" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig5" id="" class=" internalNav">5</a></a>D, the benzophenanthridinone scaffold of <b>19a</b> intercalates in the DNA break made by TOP1 and readily stacks with the +1 and −1 base pairs flanking the DNA cleavage site. The A- and B-ring of <b>19a</b> stack with the bases of noncleaved strand (C and A), while the C- and D-ring stack with the scissile strand bases (G and T). In addition, the dimethylaminoethyl substituent of <b>19a</b> extends into the minor groove of the DNA. Also, a hydrogen bond (2.9 Å) was observed between the lactam oxygen atom and Arg364, implying the importance of hydrogen bond acceptor, which is consistent with the cytotoxicity of <b>19a</b> against the prostate cancer cells DU145-RC0.1, resistant cells with a R364H mutation in TOP1. DU145-RC0.1 cells showed high resistance to <b>19a</b> (<a class="ref showTableEvent internalNav" data-ID="tbl4" href="#tbl4">Table <a class="ref showTableEvent internalNav" data-ID="tbl4" href="#tbl4">4</a></a>). The interaction between the two oxygen atoms in the dioxole ring and Asn722 (3.7 Å) or Thr718 (3.6 Å), respectively, might also contribute to the trapping of TOP1cc.</div></div><div id="sec2_4" class="NLM_sec NLM_sec_level_2"><div id="ac_i10" class="anchor-spacer"></div><h3 class="article-section__title" id="_i10"> TDP1 Inhibition</h3><div class="NLM_p">Because of the unique function of TDP1 to repair TOP1-mediated DNA damage, and the recently reported inhibition of TDP1 by the indenoisoquinoline TOP1 inhibitors,<a onclick="showRef(event, 'ref54 ref55 ref56'); return false;" href="javascript:void(0);" class="ref ref54 ref55 ref56">(54−56)</a> TDP1 inhibition by the synthesized compounds were also screened through a fluorescence assay.<a onclick="showRef(event, 'ref50'); return false;" href="javascript:void(0);" class="ref ref50">(50)</a> A quenched fluorescent single-stranded oligonucleotide (5′-<i>FAM</i>-AGGATCTAAAAGACTT-<i>BHQ</i>-3′) was used as substrate. The compounds were tested at 100 μM concentration. Twelve of them, <b>19a</b>, <b>21b</b>, <b>22b</b>, <b>39a/b</b>, <b>40a</b>/<b>b</b>, <b>41a</b>/<b>b</b>, <b>42b</b>, and <b>44a</b>/<b>b</b>, exhibited TDP1 inhibition with the percentage inhibition ranging from 12% to 98% (<a class="ref showTableEvent internalNav" data-ID="tbl1" href="#tbl1">Table <a class="ref showTableEvent internalNav" data-ID="tbl1" href="#tbl1">1</a></a>). The most potent TOP1 inhibitor <b>19a</b> (+++) showed low TDP1 inhibition (12% at 100 μM). None of the dihydrobenzophenanthridine derivatives exhibited TDP1 inhibition up to 100 μM concentration.</div><div class="NLM_p">Seven compounds <b>39a</b>/<b>b</b>, <b>40a</b>/<b>b</b>, <b>41a</b>/<b>b</b>, and <b>42b</b> with notable TDP1 inhibition (>50%) were further tested to determine their IC<sub>50</sub> values (<a class="ref showTableEvent internalNav" data-ID="tbl2" href="#tbl2">Table <a class="ref showTableEvent internalNav" data-ID="tbl2" href="#tbl2">2</a></a>), expressed as the concentration of compound that inhibits 50% of TDP1 activity. Compound <b>41a</b> was the most potent with an IC<sub>50</sub> value of 7.0 ± 1.4 μM in a dose-dependent manner (<a data-tab="pane-pcw-Figures" href="#fig6" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig6" id="" class=" internalNav">6</a></a>A).</div><div class="NLM_table-wrap" id="tbl2"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 2. TDP1 Inhibition of the Active Compounds</div></div></div><div class="scrollable-table-wrap"><table class="table "><colgroup><col align="left" /></col><col align="char" char="±" /></col><col align="char" char="±" /></col></colgroup><thead><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center"> </th><th class="rowsep1 colsep0" colspan="2" align="center" char="±">IC<sub>50</sub> (μM)<a class="ref internalNav" href="#t2fn1" aria-label="a">a</a></th></tr><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center">compd</th><th class="colsep0 rowsep0" align="center" char="±">fluorescence assay</th><th class="colsep0 rowsep0" align="center" char="±">gel-based assay</th></tr></thead><tbody><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>39a</b></td><td class="colsep0 rowsep0" align="char" char="±">24 ± 0.80</td><td class="colsep0 rowsep0" align="char" char="±">16 ± 0.40</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>39b</b></td><td class="colsep0 rowsep0" align="char" char="±">18 ± 1.7</td><td class="colsep0 rowsep0" align="char" char="±">13 ± 4.0</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>40a</b></td><td class="colsep0 rowsep0" align="char" char="±">58 ± 20</td><td class="colsep0 rowsep0" align="char" char="±">40 ± 14</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>40b</b></td><td class="colsep0 rowsep0" align="char" char="±">15 ± 2.7</td><td class="colsep0 rowsep0" align="char" char="±">27 ± 5.2</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>41a</b></td><td class="colsep0 rowsep0" align="char" char="±">7.0 ± 1.4</td><td class="colsep0 rowsep0" align="char" char="±">8.2 ± 1.3</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>41b</b></td><td class="colsep0 rowsep0" align="char" char="±">20 ± 1.7</td><td class="colsep0 rowsep0" align="char" char="±">21 ± 1.2</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>42b</b></td><td class="colsep0 rowsep0" align="char" char="±">19 ± 4.8</td><td class="colsep0 rowsep0" align="char" char="±">20 ± 5.4</td></tr></tbody></table></div><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-t2fn1"><div class="footnote" id="t2fn1"><sup><sup>a</sup></sup><p class="last">IC<sub>50</sub> values were defined as the concentration of compound that inhibits 50% of enzyme activity. Every experiment was repeated at least three times independently.</p></div></div></div><figure id="fig6" data-index="8" class="article__inlineFigure"><h2 class="fig-label">Figure 6</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-22/acs.jmedchem.8b00639/20181119/images/medium/jm-2018-00639p_0006.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-22/acs.jmedchem.8b00639/20181119/images/large/jm-2018-00639p_0006.jpeg" id="gr6" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 6. (A) TDP1 inhibition curves of the active compounds determined using fluorescence assay. Tested concentrations were 0.41, 1.23, 3.70, 11.1, 33.3, and 100 μM. (B) Hypothetical binding mode of <b>41a</b> (red carbon atoms ball and stick representation) in the complex with TDP1 (PDB <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=1RFF">1RFF</a>). All distances were measured from heavy atom to heavy atom. (C) Representative TDP1 inhibition gels of active compounds. Lane 1, DNA alone; lane 2, DNA and recombinant TDP1; lanes 3–26, DNA, recombinant TDP1 and the active compounds at tested concentration. Tested concentrations were 0.05, 0.15, 0.46, 1.4, 4.1, 12.3, 37, and 111 μM. N14Y and N14P are the substrate and product of TDP1, respectively.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-22/acs.jmedchem.8b00639/20181119/images/large/jm-2018-00639p_0006.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.8b00639&amp;id=fig6"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">To further establish their TDP1 inhibition, these seven active compounds <b>39a</b>/<b>b</b>, <b>40a</b>/<b>b</b>, <b>41a</b>/<b>b</b>, and <b>42b</b>, were further tested by a gel-based assay, in which a single-stranded 5′-<sup>32</sup>P-labeled oligonucleotide N14Y containing 3′-phosphotyrosyl group was used as substrate.<a onclick="showRef(event, 'ref76'); return false;" href="javascript:void(0);" class="ref ref76">(76)</a> Their IC<sub>50</sub> values are summarized in <a class="ref showTableEvent internalNav" data-ID="tbl2" href="#tbl2">Table <a class="ref showTableEvent internalNav" data-ID="tbl2" href="#tbl2">2</a></a>. Compound <b>41a</b> was again found the most potent TDP1 inhibitor (IC<sub>50</sub> = 8.2 μM). Representative TDP1 inhibition gels are shown in <a data-tab="pane-pcw-Figures" href="#fig6" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig6" id="" class=" internalNav">6</a></a>C. The indenoisoquinoline <b>10</b> was used as the positive control.<a onclick="showRef(event, 'ref52'); return false;" href="javascript:void(0);" class="ref ref52">(52)</a> Five compounds, <b>39a</b>/<b>b</b>, <b>40b</b>, and <b>41a</b>/<b>b</b>, showed full inhibition at the highest concentration (111 μM) with progressive dose dependency.</div><div class="NLM_p last">To obtain a molecular view of the drug-induced TDP1 inhibition, a hypothetical binding model was built by using in silico docking. The TDP1 catalytic region containing two lysine residues (Lys265 and Lys495) and two histidine residues (His263 and His493) was constructed as the binding site from the TDP1 X-ray crystal structure (PDB <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=1RFF">1RFF</a>).<a onclick="showRef(event, 'ref77'); return false;" href="javascript:void(0);" class="ref ref77">(77)</a> The inhibitors were docked into the binding site. The hypothetical structure pose of the top-ranked <b>41a</b> is shown in <a data-tab="pane-pcw-Figures" href="#fig6" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig6" id="" class=" internalNav">6</a></a>B. The polycyclic core of <b>41a</b> lies along the DNA binding groove in the proximity of the catalytically important Phe259 residue, indicating a potential π–π stacking stabilizing drug TDP1 complex (<a data-tab="pane-pcw-Figures" href="#fig6" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig6" id="" class=" internalNav">6</a></a>B), while the pyrrolidinyl ethyl side chain is directed to the catalytic site of TDP1 through a narrow channel (<a href="/doi/suppl/10.1021/acs.jmedchem.8b00639/suppl_file/jm8b00639_si_001.pdf" class="ext-link">Figure 3S</a>, Supporting Information). Two hypothetical hydrogen bonds form between the nitrogen atom in the pyrrolidinyl group and the catalytic residues His493 (3.3 Å) and Asn283 (3.1 Å), implying the importance of the side chain to TDP1 inhibition. In addition, the 1,3-dioxole ring is close to Glu538, and hydrogen bond forms between the oxygen atom and the amide group of Glu358 with the distance of 3.7 Å, which might also contribute to TDP1 inhibition.</div></div><div id="sec2_5" class="NLM_sec NLM_sec_level_2"><div id="ac_i12" class="anchor-spacer"></div><h3 class="article-section__title" id="_i12"> Interaction with DNA</h3><div class="NLM_p">To evaluate the interaction of the synthesized compounds with DNA, FRET melting assays were performed using F10T as a self-annealing substrate. The Δ<i>T</i><sub>m</sub> values of the compounds are summarized in <a class="ref showTableEvent internalNav" data-ID="tbl1" href="#tbl1">Table <a class="ref showTableEvent internalNav" data-ID="tbl1" href="#tbl1">1</a></a>. The FRET melting assay indicated that none of the synthesized compounds significantly increase the melting temperature of F10T at 2 μM concentration and that <b>27b</b> has the highest Δ<i>T</i><sub>m</sub> value of 1.9 °C. Potent TOP1 inhibitor <b>19a</b> demonstrated a low Δ<i>T</i><sub>m</sub> value of 0.5 °C, implying that the synthesized compounds could not stabilize the DNA double helix and increase the melting temperature by acting as classical DNA intercalators.</div><div class="NLM_p">The binding of classical DNA intercalators between the base pair of circular DNA also produce TOP1-mediated unwinding effect, thereby limiting TOP1-mediated DNA relaxation.<a onclick="showRef(event, 'ref78'); return false;" href="javascript:void(0);" class="ref ref78">(78)</a> To further evaluate <b>19a</b>, TOP1-mediated unwinding assays in the presence of excess TOP1 were performed.<a onclick="showRef(event, 'ref79'); return false;" href="javascript:void(0);" class="ref ref79">(79)</a> As shown in <a data-tab="pane-pcw-Figures" href="#fig5" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig5" id="" class=" internalNav">5</a></a>B, the DNA intercalator ethidium bromide (EB) showed a distributed DNA ladder along with the increased tested concentration using supercoiled pBR322 DNA as substrate. On the contrary, <b>19a</b> produced no TOP1-mediated unwinding effect up to 9 μM concentration. The assay using relaxed pBR322 DNA as substrate was also performed (<a data-tab="pane-pcw-Figures" href="#fig5" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig5" id="" class=" internalNav">5</a></a>C)<a onclick="showRef(event, 'ref79'); return false;" href="javascript:void(0);" class="ref ref79">(79)</a> and confirmed that <b>19a</b> had no unwinding effect.</div><div class="NLM_p last">Thus, we conclude from the FRET and TOP1-mediated unwinding assays, the specificity for TOP1 of <b>19a</b> and its lack of detectable binding to DNA outside of TOP1cc.</div></div><div id="sec2_6" class="NLM_sec NLM_sec_level_2"><div id="ac_i13" class="anchor-spacer"></div><h3 class="article-section__title" id="_i13"> Cytotoxicity Assays</h3><div class="NLM_p">The cytotoxicity of the compounds was assessed by MTT assay against five human tumor cell lines, including colon cancer (HCT116), leukemia (CCRF-CEM), prostate cancer (DU-145), nonsmall cell lung cancer (A549), and hepatocarcinoma (Huh7) cell lines. The cells were incubated with the compounds for 72 h in a five-dose assay, with concentrations ranging from 0.01 to 100 μM. After drug treatments, MTT solution was added to measure the percentage of cellular growth. The GI<sub>50</sub> values, defined as the concentrations of the compounds that result in 50% cell growth inhibition, are plotted and summarized in <a class="ref showTableEvent internalNav" data-ID="tbl1" href="#tbl1">Table <a class="ref showTableEvent internalNav" data-ID="tbl1" href="#tbl1">1</a></a>.</div><div class="NLM_p">Compared to the parent <b>6</b>, most benzophenanthridinone derivatives <b>17a</b>/<b>b</b> and <b>19a</b>/<b>b</b>–<b>25a</b>/<b>b</b> showed increased cytotoxicity against the five human cancer cell lines, which is consistent with their TOP1 inhibition. Compound <b>19a</b> with the highest TOP1 potency (+++) also showed the highest cytotoxicity against these five cancer cell lines, with GI<sub>50</sub> values at nanomolar range (0.076 μM for HCT116, 0.029 μM for CCRF-CEM, 0.018 μM for DU145, 0.79 μM for A549, and 0.12 μM for Huh7). Although compounds <b>20a</b> and <b>22a</b> with alkylaminoethyl substituents at the 5-position showed weak TOP1 inhibition of +, they showed significant cytotoxicity against HCT116 (0.21 μM for <b>20a</b>, 0.16 μM for <b>22a</b>), CCRF-CEM (0.18 μM for <b>20a</b>, 0.32 μM for <b>22a</b>), and DU145 (0.054 μM for <b>20a</b>, 0.96 μM for <b>22a</b>) cell lines. Compound <b>21a</b> with TOP1 inhibition of ++ showed cytotoxicity against the CCRF-CEM (0.62 μM) and DU145 (0.19 μM) cell lines with GI<sub>50</sub> values at submicromolar range. Compared to the compounds with hydroxyl terminus (<b>17a</b>/<b>b</b>) on the side chain at the 5-position, the compounds with alkylamino termini, including dimethylamino (<b>19a/b</b>), diethylamino (<b>20a</b>/<b>b</b>), pyrrolidinyl (<b>21a</b>/<b>b</b>), and piperidinyl (<b>22a</b>/<b>b</b>) groups, showed increased cytotoxicity against HCT116 cells, while the morpholinyl (<b>23a</b>/<b>b</b>) and 4-methylpiperazinyl (<b>24a</b>/<b>b</b>) termini led to decreased cytotoxicity. Compounds <b>23a</b>/<b>b</b> and <b>24b</b> showed low cytotoxicity against A549 and Huh7 cell lines, with GI<sub>50</sub> values more than 100 μM. The compounds with shorter side chain at the 5-position showed more cytotoxicity than that with corresponding longer side chain against HCT116 cells, for example, <b>17a</b> vs <b>17b</b> and <b>19</b>–<b>23a</b> vs <b>19</b>–<b>23b</b>, exceptions are the compounds with 4-methylpiperazinyl (<b>24a</b>/<b>b</b>) and imidazolyl (<b>25a</b>/<b>b</b>) termini.</div><div class="NLM_p">Among the dihydrobenzophenanthridine derivatives (<b>26a</b>/<b>b</b>–<b>32a</b>/<b>b</b>), <b>26b</b> with diethylaminopropyl substituent at the 5-position exhibited the highest cytotoxicity against HCT116 (GI<sub>50</sub> = 0.27 μM), CCRF-CEM (GI<sub>50</sub> = 0.12 μM), and DU145 (GI<sub>50</sub> = 0.081 μM) cell lines. The other five dihydrobenzophenanthridine derivatives, <b>26a</b>, <b>28b</b>, <b>29b</b>, and <b>30a</b>/<b>b</b>, showed high cytotoxicity against CCRF-CEM cells with GI<sub>50</sub> values at submicromolar concentration, while two dihydrobenzophenanthridine derivatives <b>28b</b> and <b>29b</b> showed high cytotoxicity against HCT116 cells, with GI<sub>50</sub> values of 0.66 and 0.64 μM, respectively. <b>32b</b> showed increased cytotoxicity against these five cancer cell lines compared to parent <b>6</b>, which was consistent with its TOP1 inhibition of ++. Contrary to the benzophenanthridinones, the dihydrobenzophenanthridines with a shorter side chain at the 5-position showed lower cytotoxicity against HCT116 cells than that corresponding to compounds with a longer side chain (for example <b>26a</b>–<b>30a</b> vs <b>26b</b>–<b>30b</b>). Exceptions are the compounds with 4-methylpiperazinyl (<b>31a</b>/<b>b</b>) and imidazolyl (<b>32a</b>/<b>b</b>) termini.</div><div class="NLM_p">The benzophenanthridines (<b>39a</b>/<b>b</b>–<b>45a</b>/<b>b</b>) with alkoxy substituents at the 6-position generally showed decreased cytotoxicity compared to benzophenanthridinones (<b>19a</b>/<b>b</b>–<b>25a</b>/<b>b</b>) with the corresponding side chain at the 5-position. Although the benzophenanthridines <b>39a</b>/<b>b</b> and <b>41a</b>/<b>b</b> did not show TOP1 inhibition at up to 100 μM concentration, they had good TDP1 inhibitory activity, with IC<sub>50</sub> values at low micromolar concentration, and showed good cytotoxicity against four cancer cell lines, including CCRF-CEM, DU145, A549, and Huh7 cells, with GI<sub>50</sub> values between 1.29 and 8.95 μM, suggesting additional cellular targets.</div><div class="NLM_p">Compound <b>19a</b>, being the most potent inhibitor of TOP1 and the most cytotoxic, was selected and submitted to the National Cancer Institute (NCI, USA) for testing against the 60 tumor cell lines representing nine tissue types (NCI-60).<a onclick="showRef(event, 'ref80 ref81 ref82'); return false;" href="javascript:void(0);" class="ref ref80 ref81 ref82">(80−82)</a> According to the NCI established procedures, the cells were incubated with <b>19a</b> for 48 h and stained with sulforhodamine B dye. Cell growth inhibition (GI<sub>50</sub> in <a class="ref showTableEvent internalNav" data-ID="tbl3" href="#tbl3">Table <a class="ref showTableEvent internalNav" data-ID="tbl3" href="#tbl3">3</a></a>) was calculated relative to cells without treatment. High cytotoxicity was observed for <b>19a</b> with a mean graph midpoint (MGM) for growth inhibition of all cancer cell lines of 0.145 μM, and its GI<sub>50</sub> values against HCT116, SR, NCI-H522, and UACC-62 cell lines were at nanomolar range (<100 nM).</div><div class="NLM_table-wrap" id="tbl3"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 3. Cytotoxicity of <b>19a</b> against Individual NCI-60 Cell Lines</div></div></div><div class="scrollable-table-wrap"><table class="table "><colgroup><col align="left" /></col><col align="left" /></col><col align="char" char="." /></col><col /></col><col align="left" /></col><col align="left" /></col><col align="char" char="." /></col></colgroup><thead><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center">panel</th><th class="colsep0 rowsep0" align="center">cell line</th><th class="colsep0 rowsep0" align="center" char=".">GI<sub>50</sub> (μM)<a class="ref internalNav" href="#t3fn1" aria-label="a">a</a></th><th class="colsep0 rowsep0" align="center"> </th><th class="colsep0 rowsep0" align="center">panel</th><th class="colsep0 rowsep0" align="center">cell line</th><th class="colsep0 rowsep0" align="center" char=".">GI<sub>50</sub> (μM)</th></tr></thead><tbody><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left">MGM<a class="ref internalNav" href="#t3fn2" aria-label="b">b</a></td><td class="colsep0 rowsep0" align="char" char=".">0.145</td><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left">colon cancer</td><td class="colsep0 rowsep0" align="left">COLO 205</td><td class="colsep0 rowsep0" align="char" char=".">0.144</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">leukemia</td><td class="colsep0 rowsep0" align="left">CCRF-CEM</td><td class="colsep0 rowsep0" align="char" char=".">0.144</td><td class="colsep0 rowsep0" align="left">            </td><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left">HCC-2998</td><td class="colsep0 rowsep0" align="char" char=".">0.63</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left">K-562</td><td class="colsep0 rowsep0" align="char" char=".">0.156</td><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left">HCT116</td><td class="colsep0 rowsep0" align="char" char=".">0.0855</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left">MOLT-4</td><td class="colsep0 rowsep0" align="char" char=".">0.118</td><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left">HCT-15</td><td class="colsep0 rowsep0" align="char" char=".">0.427</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left">RPMI-8226</td><td class="colsep0 rowsep0" align="char" char=".">0.14</td><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left">HT29</td><td class="colsep0 rowsep0" align="char" char=".">0.149</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left">SR</td><td class="colsep0 rowsep0" align="char" char=".">0.0669</td><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left">KM12</td><td class="colsep0 rowsep0" align="char" char=".">0.875</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">non-small cell lung cancer</td><td class="colsep0 rowsep0" align="left">A549/ATCC</td><td class="colsep0 rowsep0" align="char" char=".">0.244</td><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left">SW-620</td><td class="colsep0 rowsep0" align="char" char=".">0.345</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left">EKVX</td><td class="colsep0 rowsep0" align="char" char=".">0.79</td><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left">renal cancer</td><td class="colsep0 rowsep0" align="left">786-0</td><td class="colsep0 rowsep0" align="char" char=".">0.166</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left">HOP-62</td><td class="colsep0 rowsep0" align="char" char=".">0.18</td><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left">A498</td><td class="colsep0 rowsep0" align="char" char=".">0.347</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left">HOP-92</td><td class="colsep0 rowsep0" align="char" char=".">0.558</td><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left">ACHN</td><td class="colsep0 rowsep0" align="char" char=".">0.16</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left">NCI-H226</td><td class="colsep0 rowsep0" align="char" char=".">0.512</td><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left">CAKI-1</td><td class="colsep0 rowsep0" align="char" char=".">0.186</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left">NCI-H23</td><td class="colsep0 rowsep0" align="char" char=".">0.201</td><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left">RXF 393</td><td class="colsep0 rowsep0" align="char" char=".">0.516</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left">NCI-H322M</td><td class="colsep0 rowsep0" align="char" char=".">0.428</td><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left">SN 12C</td><td class="colsep0 rowsep0" align="char" char=".">0.258</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left">NCI-H460</td><td class="colsep0 rowsep0" align="char" char=".">0.141</td><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left">TK-10</td><td class="colsep0 rowsep0" align="char" char=".">0.722</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left">NCI-H522</td><td class="colsep0 rowsep0" align="char" char=".">0.076</td><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left">UO-31</td><td class="colsep0 rowsep0" align="char" char=".">0.157</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">CNS cancer</td><td class="colsep0 rowsep0" align="left">SF-268</td><td class="colsep0 rowsep0" align="char" char=".">0.283</td><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left">breast cancer</td><td class="colsep0 rowsep0" align="left">MCF7</td><td class="colsep0 rowsep0" align="char" char=".">0.118</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left">SF-295</td><td class="colsep0 rowsep0" align="char" char=".">0.177</td><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left">MDA-MB-231/ATCC</td><td class="colsep0 rowsep0" align="char" char=".">0.826</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left">SF-539</td><td class="colsep0 rowsep0" align="char" char=".">0.186</td><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left">HS 578T</td><td class="colsep0 rowsep0" align="char" char=".">1.86</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left">SNB-19</td><td class="colsep0 rowsep0" align="char" char=".">0.233</td><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left">BT-549</td><td class="colsep0 rowsep0" align="char" char=".">0.291</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left">SNB-75</td><td class="colsep0 rowsep0" align="char" char=".">0.239</td><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left">T-47D</td><td class="colsep0 rowsep0" align="char" char=".">0.111</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left">U251</td><td class="colsep0 rowsep0" align="char" char=".">0.14</td><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left">MDA-MB-468</td><td class="colsep0 rowsep0" align="char" char=".">0.14</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">melanoma</td><td class="colsep0 rowsep0" align="left">LOX IMVI</td><td class="colsep0 rowsep0" align="char" char=".">0.112</td><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left">ovarian cancer</td><td class="colsep0 rowsep0" align="left">IGROV1</td><td class="colsep0 rowsep0" align="char" char=".">0.312</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left">MALME-3M</td><td class="colsep0 rowsep0" align="char" char=".">0.284</td><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left">OVCAR-3</td><td class="colsep0 rowsep0" align="char" char=".">0.582</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left">M14</td><td class="colsep0 rowsep0" align="char" char=".">0.149</td><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left">OVCAR-4</td><td class="colsep0 rowsep0" align="char" char=".">0.557</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left">MDA-MB-435</td><td class="colsep0 rowsep0" align="char" char=".">0.395</td><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left">OVCAR-5</td><td class="colsep0 rowsep0" align="char" char=".">0.595</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left">SK-MEL-2</td><td class="colsep0 rowsep0" align="char" char=".">0.886</td><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left">OVCAR-8</td><td class="colsep0 rowsep0" align="char" char=".">0.554</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left">SK-MEL-28</td><td class="colsep0 rowsep0" align="char" char=".">0.861</td><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left">NCI/ADR-RES</td><td class="colsep0 rowsep0" align="char" char=".">0.29</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left">SK-MEL-5</td><td class="colsep0 rowsep0" align="char" char=".">0.181</td><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left">SK-OV-3</td><td class="colsep0 rowsep0" align="char" char=".">0.24</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left">UACC-257</td><td class="colsep0 rowsep0" align="char" char=".">0.528</td><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left">prostate cancer</td><td class="colsep0 rowsep0" align="left">PC-3</td><td class="colsep0 rowsep0" align="char" char=".">0.317</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left">UACC-62</td><td class="colsep0 rowsep0" align="char" char=".">0.0966</td><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left">DU-145</td><td class="colsep0 rowsep0" align="char" char=".">0.215</td></tr></tbody></table></div><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-t3fn1"><div class="footnote" id="t3fn1"><sup><sup>a</sup></sup><p class="last">GI<sub>50</sub> values were defined as the compound concentrations that resulted in 50% cell growth inhibition. The cells were incubated for 2 days with the tested compounds.</p></div><div class="footnote" id="t3fn2"><sup><sup>b</sup></sup><p class="last">MGM: mean graph midpoint for growth inhibition of all human cancer cell lines.</p></div></div></div><div class="NLM_p">Because the NCI-60 database contains several thousand chemicals and anticancer drugs which have been tested across the cancer cell line panel<a onclick="showRef(event, 'ref82'); return false;" href="javascript:void(0);" class="ref ref82">(82)</a> (<a href="http://discover.nci.nih.gov/cellminer" class="extLink">http://discover.nci.nih.gov/cellminer</a> and <a href="http://discover.nci.nih.gov/cellminercdb" class="extLink">http://discover.nci.nih.gov/cellminercdb</a>), we were able to perform a pattern comparison analysis with <b>19a</b>. The drugs with the highest correlation with <b>19a</b> were all TOP1 inhibitors including camptothecin and its derivatives as well as the indenoisoquinolines. <a data-tab="pane-pcw-Figures" href="#fig7" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig7" id="" class=" internalNav">7</a></a> shows the high correlation between the cytotoxicity of <b>19a</b> and camptothecin and the clinical indenoisoquinoline LMP400.</div><figure id="fig7" data-index="9" class="article__inlineFigure"><h2 class="fig-label">Figure 7</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-22/acs.jmedchem.8b00639/20181119/images/medium/jm-2018-00639p_0007.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-22/acs.jmedchem.8b00639/20181119/images/large/jm-2018-00639p_0007.jpeg" id="gr7" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 7. Pattern comparison analysis of <b>19a</b> using GI<sub>50</sub> data from NCI-60 assays. Individual dots represent a cell line of the NCI-60. Red lines represent regression line. <i>R</i>-square values were 0.58 and 0.40 for camptothecin and the indenoisoquinoline indotecan (LMP400), respectively. <i>P</i>-values were <0.0001 for both comparisons.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-22/acs.jmedchem.8b00639/20181119/images/large/jm-2018-00639p_0007.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.8b00639&amp;id=fig7"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">The cytotoxicity of <b>19a</b> was further evaluated against a panel of isogenic camptothecin- and doxorubicin-resistant cell lines using MTT assay (<a class="ref showTableEvent internalNav" data-ID="tbl4" href="#tbl4">Table <a class="ref showTableEvent internalNav" data-ID="tbl4" href="#tbl4">4</a></a>). The HCT116-siTOP1 subline was developed by transfection of colon cancer parental cells HCT116 with short hairpin RNA vectors expressing siRNA for TOP1.<a onclick="showRef(event, 'ref83'); return false;" href="javascript:void(0);" class="ref ref83">(83)</a> Compared to the parental cell HCT116, the HCT116-siTOP1 subline showed 8.3-fold resistant to <b>1</b>, of which TOP1 is the only known cellular target,<a onclick="showRef(event, 'ref12 ref84'); return false;" href="javascript:void(0);" class="ref ref12 ref84">(12,84)</a> and about 5.9-fold to <b>19a</b>, implying that TOP1 is a major cellular target of <b>19a</b>.</div><div class="NLM_table-wrap" id="tbl4"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 4. Cytotoxicity of the <b>19a</b> in Drug-Resistant Isogenic Human Cancer Cell Lines</div></div></div><div class="scrollable-table-wrap"><table class="table "><colgroup><col align="left" /></col><col align="center" /></col><col align="center" /></col><col align="center" /></col></colgroup><thead><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center"> </th><th class="rowsep1 colsep0" colspan="2" align="center">GI<sub>50</sub> ± SD (μM)<a class="ref internalNav" href="#t4fn1" aria-label="a">a</a></th><th class="colsep0 rowsep0" align="center"> </th></tr><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center">compd</th><th class="colsep0 rowsep0" align="center">parental cell line</th><th class="colsep0 rowsep0" align="center">resistant subline</th><th class="colsep0 rowsep0" align="center">resistance ratio<a class="ref internalNav" href="#t4fn2" aria-label="b">b</a></th></tr></thead><tbody><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="center"><b>HCT116</b></td><td class="colsep0 rowsep0" align="center"><b>HCT116-siTOP1</b></td><td class="colsep0 rowsep0" align="center"> </td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>19a</b></td><td class="colsep0 rowsep0" align="center">0.076 ± 0.010</td><td class="colsep0 rowsep0" align="center">0.45 ± 0.31</td><td class="colsep0 rowsep0" align="center">5.9</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>1</b></td><td class="colsep0 rowsep0" align="center">0.009 ± 0.001</td><td class="colsep0 rowsep0" align="center">0.075 ± 0.014</td><td class="colsep0 rowsep0" align="center">8.3</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="center"><b>DU-145</b></td><td class="colsep0 rowsep0" align="center"><b>DU145-RC0.1</b></td><td class="colsep0 rowsep0" align="center"> </td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>19a</b></td><td class="colsep0 rowsep0" align="center">0.018 ± 0.002</td><td class="colsep0 rowsep0" align="center">2.38 ± 0.34</td><td class="colsep0 rowsep0" align="center">132</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>1</b></td><td class="colsep0 rowsep0" align="center">0.021 ± 0.016</td><td class="colsep0 rowsep0" align="center">4.73 ± 0.68</td><td class="colsep0 rowsep0" align="center">225</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="center"><b>MCF-7</b></td><td class="colsep0 rowsep0" align="center"><b>MCF-7/ADR</b></td><td class="colsep0 rowsep0" align="center"> </td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>19a</b></td><td class="colsep0 rowsep0" align="center">0.34 ± 0.098</td><td class="colsep0 rowsep0" align="center">0.95 ± 0.35</td><td class="colsep0 rowsep0" align="center">2.8</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">DOX</td><td class="colsep0 rowsep0" align="center">0.15 ± 0.003</td><td class="colsep0 rowsep0" align="center">11.67 ± 1.94</td><td class="colsep0 rowsep0" align="center">77.8</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="center"><b>HepG2</b></td><td class="colsep0 rowsep0" align="center"><b>HepG2/ADR</b></td><td class="colsep0 rowsep0" align="center"> </td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>19a</b></td><td class="colsep0 rowsep0" align="center">0.30 ± 0.050</td><td class="colsep0 rowsep0" align="center">3.20 ± 0.40</td><td class="colsep0 rowsep0" align="center">10.7</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">DOX</td><td class="colsep0 rowsep0" align="center">0.19 ± 0.048</td><td class="colsep0 rowsep0" align="center">9.04 ± 0.14</td><td class="colsep0 rowsep0" align="center">47.6</td></tr></tbody></table></div><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-t4fn1"><div class="footnote" id="t4fn1"><sup><sup>a</sup></sup><p class="last">GI<sub>50</sub> values (means ± SD) were defined as the concentrations of compounds that resulted in 50% cell growth inhibition and obtained from MTT assay. Every experiment was repeated at least three times.</p></div><div class="footnote" id="t4fn2"><sup><sup>b</sup></sup><p class="last">Resistance ratio was calculated by dividing the GI<sub>50</sub> of the mutant cell line by the GI<sub>50</sub> of the corresponding parental cell line.</p></div></div></div><div class="NLM_p">The camptothecin-resistant prostate cancer DU145-RC0.1 cells have a R364H mutation in TOP1 relative to the wild-type parental DU-145.<a onclick="showRef(event, 'ref85'); return false;" href="javascript:void(0);" class="ref ref85">(85)</a> The TOP1 with R364H mutation is catalytically active but leads to RC0.1 cells being resistant to <b>1</b> because the R364 residue is close to the catalytic tyrosine and can stabilize the open form of TOP1cc.<a onclick="showRef(event, 'ref75 ref86'); return false;" href="javascript:void(0);" class="ref ref75 ref86">(75,86)</a> The DU145-RC0.1 cells were highly resistant to <b>1</b> (225-fold) and <b>19a</b> (132-fold), which is consistent with the molecular modeling (<a data-tab="pane-pcw-Figures" href="#fig5" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig5" id="" class=" internalNav">5</a></a>D) showing hydrogen bonding between R364 and <b>19a</b>.</div><div class="NLM_p last">P-Glycoprotein (P-gp) mediated drug efflux is generally responsible for classical multiple drug resistance.<a onclick="showRef(event, 'ref87'); return false;" href="javascript:void(0);" class="ref ref87">(87)</a> The chemotherapeutic agent doxorubicin (DOX) is a substrate of P-gp, and both breast cancer MCF-7/ADR (77.8-fold) and hepatocellular HepG2/ADR sublines (47.6-fold), which overexpress P-gp, are highly resistant to doxorubicin (77.8- and 47.6-fold, respectively; <a class="ref showTableEvent internalNav" data-ID="tbl4" href="#tbl4">Table <a class="ref showTableEvent internalNav" data-ID="tbl4" href="#tbl4">4</a></a>).<a onclick="showRef(event, 'ref88'); return false;" href="javascript:void(0);" class="ref ref88">(88)</a> Compound <b>19a</b> appeared to be less a P-gp substrate (<a class="ref showTableEvent internalNav" data-ID="tbl4" href="#tbl4">Table <a class="ref showTableEvent internalNav" data-ID="tbl4" href="#tbl4">4</a></a>) with a resistance ratio of 2.8 (MCF-7/ADR:MCF-7) and 10.7 (HepG/ADR:HepG2), respectively.</div></div><div id="sec2_7" class="NLM_sec NLM_sec_level_2"><div id="ac_i16" class="anchor-spacer"></div><h3 class="article-section__title" id="_i16"> Synergistic Effects of <b>41a</b> and <b>41b</b> with Camptothecin</h3><div class="NLM_p">The combined effects of the TDP1 inhibitors <b>41a</b> and <b>41b</b> were tested with camptothecin in MCF-7 human breast cancer cells using MTT assay. As shown in <a data-tab="pane-pcw-Figures" href="#fig8" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig8" id="" class=" internalNav">8</a></a>A, after 96 h incubation at 37 °C, the cytotoxicity of camptothecin against MCF-7 cells increased in the presence of <b>41a</b>. At 2.5 μM concentration, almost 60% of cells were killed by camptothecin itself and over 90% of cells were killed when being coincubated with <b>41a</b> at 5 μM concentration, which implies that a supra-additive effect of <b>41a</b> with camptothecin is consistent with TDP1 inhibition in cells. Similarly, <b>41b</b> showed a synergistic effect with camptothecin in MCF-7 cells (<a data-tab="pane-pcw-Figures" href="#fig8" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig8" id="" class=" internalNav">8</a></a>B).</div><figure id="fig8" data-index="10" class="article__inlineFigure"><h2 class="fig-label">Figure 8</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-22/acs.jmedchem.8b00639/20181119/images/medium/jm-2018-00639p_0008.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-22/acs.jmedchem.8b00639/20181119/images/large/jm-2018-00639p_0008.jpeg" id="gr8" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 8. Synergistic effect of <b>41a</b> (A) and <b>41b</b> (B) with camptothecin. The MCF-7 cells were incubated with camptothecin and the tested compounds for 96 h. Every experiment was repeated four times.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-22/acs.jmedchem.8b00639/20181119/images/large/jm-2018-00639p_0008.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.8b00639&amp;id=fig8"><span>Download MS PowerPoint Slide</span></a></div></div></figure></div><div id="sec2_8" class="NLM_sec NLM_sec_level_2"><div id="ac_i17" class="anchor-spacer"></div><h3 class="article-section__title" id="_i17"> Induction of Cellular TOP1cc and DNA Damage by <b>19a</b></h3><div class="NLM_p">The immunocomplex of enzyme to DNA (ICE) assay was conducted to evaluate the induction of TOP1cc by <b>19a</b> in HCT116 cancer cells. <a data-tab="pane-pcw-Figures" href="#fig9" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig9" id="" class=" internalNav">9</a></a>A shows that <b>19a</b> induces cellular TOP1cc in a dose-dependent manner, similar to the positive control <b>1</b>.</div><figure id="fig9" data-index="11" class="article__inlineFigure"><h2 class="fig-label">Figure 9</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-22/acs.jmedchem.8b00639/20181119/images/medium/jm-2018-00639p_0009.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-22/acs.jmedchem.8b00639/20181119/images/large/jm-2018-00639p_0009.jpeg" id="gr9" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 9. (A) Induction of TOP1–DNA covalent cleavage complexes by in vivo complex of enzyme (ICE) assay in human colon cancer HCT116 cells. Upper: lane 1, untreated control; lanes 2 and 3, cells treated with <b>1</b> at 25 and 50 μM, respectively. Bottom: lanes 1–3, cells treated with <b>19a</b> at 25, 50, and 100 μM, respectively. (B) Flow cytometry histograms of apoptosis in HCT116 cells induced by <b>19a</b> at 0.5, 1, and 2 μM, respectively. (C) Histone γH2AX foci induced by <b>19a</b> in HCT116 cells. Cells were treated with <b>1</b> and <b>19a</b> at 1 μM for 3 h. DNA was stained with DAPI (blue).</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-22/acs.jmedchem.8b00639/20181119/images/large/jm-2018-00639p_0009.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.8b00639&amp;id=fig9"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p last">To assess the DNA damage in cancer cells induced by <b>19a</b>, γH2AX foci were assessed by immunofluorescence microscopy in human colon cancer HCT116 cells treated with <b>19a</b>. After incubation with <b>19a</b> for 3 h, HCT116 cells were stained with γH2AX antibodies. γH2AX foci were induced by <b>19a</b> at 1 μM concentration (<a data-tab="pane-pcw-Figures" href="#fig9" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig9" id="" class=" internalNav">9</a></a>C), consistent with DNA damage due to the trapping of cellular TOP1cc by <b>19a</b>.</div></div><div id="sec2_9" class="NLM_sec NLM_sec_level_2"><div id="ac_i18" class="anchor-spacer"></div><h3 class="article-section__title" id="_i18"> Cancer Cell Apoptosis Induced by <b>19a</b></h3><div class="NLM_p last">Flow cytometry assays were also conducted in HCT116 cells to assess the induction of apoptosis by <b>19a</b>. After being incubated with <b>19a</b> for 24 h, apoptotic HCT116 cells were detected. <a data-tab="pane-pcw-Figures" href="#fig9" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig9" id="" class=" internalNav">9</a></a>B shows that <b>19a</b> could significantly induce HCT116 cells apoptosis in a dose-dependent manner. Approximately 60.9% (25.11% early apoptotic cells and 35.8% late apoptotic cells) of the treated cells were scored as apoptotic following 24 h incubation with <b>19a</b> at 2 μM.</div></div><div id="sec2_10" class="NLM_sec NLM_sec_level_2"><div id="ac_i19" class="anchor-spacer"></div><h3 class="article-section__title" id="_i19"> Pharmacokinetics of <b>19a</b></h3><div class="NLM_p">In vivo pharmacokinetic (PK) study of <b>19a</b> was conducted in Sprague–Dawley (SD) rats. The SD rats were divided into two groups (<i>n</i> = 3) and treated by intravenous injection (iv) at 1 mg/kg dose and intragastrical administration (ig) at 5 mg/kg dose, respectively. Plasma samples were collected up to 24 h postdosing and the concentration of <b>19a</b> was measured. The PK parameters are summarized in <a class="ref showTableEvent internalNav" data-ID="tbl5" href="#tbl5">Table <a class="ref showTableEvent internalNav" data-ID="tbl5" href="#tbl5">5</a></a>. Following iv administration, the AUC<sub>0→24h</sub> was 119 ± 10 h·ng/mL and <i>T</i><sub>1/2</sub> was 0.855 ± 0.011 h. After oral administration, the <i>T</i><sub>max</sub>, <i>C</i><sub>max</sub>, and AUC<sub>0→24h</sub> were 1.17 ± 0.76 h, 23.5 ± 16 h·ng/mL, and 89.7 ± 36 h·ng/mL, respectively. The bioavailability (<i>F</i>) was 15.5%.</div><div class="NLM_table-wrap" id="tbl5"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 5. Pharmacokinetic Parameters of <b>19a</b></div></div></div><div class="scrollable-table-wrap"><table class="table "><colgroup><col align="left" /></col><col align="char" char="±" /></col><col align="char" char="±" /></col></colgroup><thead><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center"> </th><th class="rowsep1 colsep0" colspan="2" align="center" char="±">mean ± SD</th></tr><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center">parameters</th><th class="colsep0 rowsep0" align="center" char="±">iv (1 mg/kg)<a class="ref internalNav" href="#t5fn1" aria-label="a">a</a></th><th class="colsep0 rowsep0" align="center" char="±">ig (5 mg/kg)<a class="ref internalNav" href="#t5fn2" aria-label="b">b</a></th></tr></thead><tbody><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><i>T</i><sub>max</sub> (h)</td><td class="colsep0 rowsep0" align="char" char="±"> </td><td class="colsep0 rowsep0" align="char" char="±">1.17 ± 0.76</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><i>C</i><sub>max</sub> (ng/mL)</td><td class="colsep0 rowsep0" align="char" char="±"> </td><td class="colsep0 rowsep0" align="char" char="±">23.5 ± 16</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">AUC<sub>0→t</sub> (h·ng/mL)</td><td class="colsep0 rowsep0" align="char" char="±">119 ± 10</td><td class="colsep0 rowsep0" align="char" char="±">89.7 ± 36</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">AUC<sub>0→∞</sub> (h·ng/mL)</td><td class="colsep0 rowsep0" align="char" char="±">121 ± 10</td><td class="colsep0 rowsep0" align="char" char="±">109 ± 33</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">MRT<sub>INF</sub> (h)</td><td class="colsep0 rowsep0" align="char" char="±">1.01 ± 0.023</td><td class="colsep0 rowsep0" align="char" char="±">4.73 ± 3.3</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><i>T</i><sub>1/2</sub> (h)</td><td class="colsep0 rowsep0" align="char" char="±">0.855 ± 0.011</td><td class="colsep0 rowsep0" align="char" char="±">3.08 ± 3.4</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><i>F</i> (%)</td><td class="colsep0 rowsep0" align="char" char="±"> </td><td class="colsep0 rowsep0" align="char" char="±">15.5 ± 5.4</td></tr></tbody></table></div><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-t5fn1"><div class="footnote" id="t5fn1"><sup><sup>a</sup></sup><p class="last">iv means intravenous injection.</p></div><div class="footnote" id="t5fn2"><sup><sup>b</sup></sup><p class="last">ig means intragastrical administration.</p></div></div></div></div><div id="sec2_11" class="NLM_sec NLM_sec_level_2"><div id="ac_i21" class="anchor-spacer"></div><h3 class="article-section__title" id="_i21"> Acute Toxicity of <b>19a</b> in Vivo</h3><div class="NLM_p">To assess the toxicity of <b>19a</b>, Kunming male mice were randomly divided into six groups (<i>n</i> = 4) and administered with <b>19a</b> by ip injection at single doses of 300, 240, 192, 154, and 123 mg/kg, respectively. The control group was injected with sterile water. All mice survived after 7 days of administration with <b>19a</b> in the groups of 192 mg/kg dose (<a data-tab="pane-pcw-Figures" href="#fig10" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig10" id="" class=" internalNav">10</a></a>A), 154 mg/kg dose (data not shown), and 123 mg/kg dose (data not shown). Four mice died within 5 days in the 300 mg/kg group, and one mouse died within 7 days in the 240 mg/kg dose group (<a data-tab="pane-pcw-Figures" href="#fig10" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig10" id="" class=" internalNav">10</a></a>A).</div><figure id="fig10" data-index="12" class="article__inlineFigure"><h2 class="fig-label">Figure 10</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-22/acs.jmedchem.8b00639/20181119/images/medium/jm-2018-00639p_0010.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-22/acs.jmedchem.8b00639/20181119/images/large/jm-2018-00639p_0010.jpeg" id="gr10" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 10. Antitumor activity of <b>19a</b> in the HCT116 xenograft model. (A) Percent survival of mice treated with <b>19a</b> at doses of 300, 240, and 192 mg/kg. The effects of <b>19a</b> on body weight (B), tumor size (C), and tumor weight (D) at the dose of 5 and 10 mg/kg. Statistically significant difference in mean tumor weight compared with the control, **: <i>P</i> < 0.01.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-22/acs.jmedchem.8b00639/20181119/images/large/jm-2018-00639p_0010.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.8b00639&amp;id=fig10"><span>Download MS PowerPoint Slide</span></a></div></div></figure></div><div id="sec2_12" class="NLM_sec NLM_sec_level_2"><div id="ac_i22" class="anchor-spacer"></div><h3 class="article-section__title" id="_i22"> Antitumor Efficiency of <b>19a</b> in Vivo</h3><div class="NLM_p last">Because <b>19a</b> showed high TOP1 inhibition and cytotoxic activity in vitro, its antitumor efficiency in vivo was assessed in a human colon cancer HCT116 xenograft nude mice model. Male nude mice were randomly divided into three groups (<i>n</i> = 6) and administered with saline or with <b>19a</b> at 10 or 5 mg/kg dose by ip injection daily. Administration of <b>19a</b> significantly reduced tumor volume in a dose-dependent manner (<a data-tab="pane-pcw-Figures" href="#fig10" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig10" id="" class=" internalNav">10</a></a>C). Meanwhile, the mice treated with <b>19a</b> at 5 mg/kg dose showed no obvious body loss compared to the saline control group. Body weight loss was observed in the 10 mg/kg group (<a data-tab="pane-pcw-Figures" href="#fig10" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig10" id="" class=" internalNav">10</a></a>B). Tumor weight inhibitions (TWI) by <b>19a</b> were 59.6% (10 mg/kg, <i>P</i> < 0.01) and 32.7% (5 mg/kg) (<a data-tab="pane-pcw-Figures" href="#fig10" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig10" id="" class=" internalNav">10</a></a>D). These results demonstrate the antitumor activity of <b>19a</b>.</div></div></div><div id="sec3" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i23">Conclusions</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_54647" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_54647" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p last">Here we report that the natural product oxynitidine scaffold represents a productive chemotype for TOP1 and TDP1 inhibitors. In this work, three subgroups of oxynitidine derivatives (benzophenanthridinone, dihydrobenzophenanthridine, and benzophenanthridine derivatives) were synthesized and evaluated as inhibitors of TOP1 and TDP1 and for cytotoxicity against human cancer cell lines (HCT116, CCRF-CEM, DU-145, A549, and Huh7 cell lines). Enzyme- and cell-based assays show that the benzophenanthridinone derivative <b>19a</b> with dimethylaminoethyl substituent at the 5-position is potent at trapping TOP1cc (+++) and exhibits antiproliferative activity in human cancer cell lines at nanomolar concentration range GI<sub>50</sub> values. Compound <b>19a</b> also shows consistent antiproliferative activity in the NCI-60 cell lines with MGM value of 0.145 μM. Six benzophenanthridine derivatives, <b>39a</b>/<b>b</b>, <b>40b</b>, <b>41a</b>/<b>b</b>, and <b>42b</b>, exhibit TDP1 inhibition with IC<sub>50</sub> values between 7.0 and 24 μM in biochemical assays. Consistent with TDP1 inhibition, both <b>41a</b> and <b>41b</b> show synergy in combination with camptothecin in MCF-7 human breast cancer cells. Cell-based assays demonstrated that <b>19a</b> induces the formation of cellular TOP1cc and DNA damage in HCT116 cells, promotes apoptosis, and is a poor substrate of P-gp, a drug efflux protein responsible for multidrug resistance. The PK, acute toxicity, and antitumor efficiency of <b>19a</b> suggest its potential value for further development.</div></div><div id="sec4" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i24">Experimental Section</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_18717" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_18717" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div id="sec4_1" class="NLM_sec NLM_sec_level_2"><div id="ac_i25" class="anchor-spacer"></div><h3 class="article-section__title" id="_i25"> General Experiments</h3><div class="NLM_p">The major chemical reagents for synthesis were purchased from Alfa Aesar, Sigma-Aldrich Co., or Aladdin Reagent Database Inc. (Shanghai) and were used without further purification unless otherwise indicated. 4-(Benzo[<i>d</i>][1,3]dioxol-5-yl)but-3-yn-1-ol (<b>14</b>) was prepared in our lab according to the Korivi’s method.<a onclick="showRef(event, 'ref66'); return false;" href="javascript:void(0);" class="ref ref66">(66)</a> Chemical reaction courses were monitored by silica gel GF<sub>254</sub> thin layer chromatography (TLC). Melting points were determined in open capillary tubes on a MPA100 Optimelt automated melting point system without being corrected. Nuclear magnetic resonance spectra were recorded on a Bruker AVANCE III 400 MHz spectrometer using tetramethylsilane as an internal reference. Mass spectra were analyzed on an Agilent 6120 (Quadrupole LC-MS) mass spectrometer. The high-resolution mass spectra were analyzed on a SHIMADZU LCMS-IT-TOF mass spectrometer. All compounds tested for biological activities were analyzed by HPLC, and their purities were more than 95%. The analysis condition was detection at 220 nm, 1.0 mL/min flow rate, and a linear gradient of 50% to 15% PBS buffer (pH 3) and 50% to 85% MeOH in 35 min.</div><div class="NLM_p last">All animals were obtained from Laboratory Animal Center of Sun Yat-sen University. All procedures were approved by the Animal Ethics Committee of Sun Yat-sen University, in accordance with National Institute of Health and Nutrition Guidelines for the Care and Use of Laboratory Animals.</div></div><div id="sec4_2" class="NLM_sec NLM_sec_level_2"><div id="ac_i26" class="anchor-spacer"></div><h3 class="article-section__title" id="_i26"> General Procedure for Synthesis of Schiff’s Base <b>12a</b> and <b>12b</b></h3><div class="NLM_p">The reaction solution of 6-bromoveratraldehyde (9.8 g, 40 mmol) and amine (ethanolamine or 3-aminopropanol, 42 mmol) in methanol (200 mL) was stirred at room temperature for 12 h and then concentrated under reduced pressure. The residue was washed with petroleum ether (2 × 10 mL) to give a white solid, yield 100%. The Schiff’s base intermediates were pure as shown by their <sup>1</sup>H NMR spectra and were used for next synthesis without further purification.</div><div id="sec4_2_1" class="NLM_sec NLM_sec_level_3"><div id="ac_i27" class="anchor-spacer"></div><h4 class="article-section__title" id="_i27"> <i>N</i>-(2-Hydroxylethyl)-6-bromoveratraldimine (<b>12a</b>)</h4><div class="NLM_p last"><sup>1</sup>H NMR (CDCl<sub>3</sub>) δ 8.58 (s, 1H), 7.54 (s, 1H), 6.99 (s, 1H), 3.95–3.89 (m, 8H), 3.79 (t, <i>J</i> = 4.7 Hz, 2H).</div></div><div id="sec4_2_2" class="NLM_sec NLM_sec_level_3"><div id="ac_i28" class="anchor-spacer"></div><h4 class="article-section__title" id="_i28"> <i>N</i>-(3-Hydroxylprapyl)-6-bromoveratraldimine (<b>12b</b>)</h4><div class="NLM_p last"><sup>1</sup>H NMR (CDCl<sub>3</sub>) δ 8.53 (s, 1H), 7.45 (s, 1H), 7.00 (s, 1H), 3.91–3.86 (m, 8H), 3.82 (t, <i>J</i> = 6.2 Hz, 2H), 1.96 (quint, <i>J</i> = 6.0 Hz, 2H).</div></div></div><div id="sec4_3" class="NLM_sec NLM_sec_level_2"><div id="ac_i29" class="anchor-spacer"></div><h3 class="article-section__title" id="_i29"> General Procedure for the Synthesis of <b>13a</b> and <b>13b</b></h3><div class="NLM_p last">Under nitrogen gas, the solution of NaH (60%, 6.69 g, 167 mmol) in THF (100 mL) was stirred and cooled to 0 °C for 15 min and then added dropwise to a solution of <b>12a</b> (or <b>12b</b>, 33 mmol) in THF (100 mL). The reaction solution was stirred at 0 °C for 1 h, and then chloromethyl methyl ether (15 mL, 198 mmol) was added dropwise and stirred for 1 h. The reaction was quenched by the addition of ethanol (20 mL) at 0 °C. The reaction solution was concentrated under reduced pressure. The residue was dissolved in chloroform (100 mL) and was washed with saturated saline (3 × 50 mL). The organic layer was dried (MgSO<sub>4</sub>) overnight and concentrated under reduced pressure to give crude intermediates <b>13a</b> (or <b>13b</b>), which was used immediately for next synthesis without further purification.</div></div><div id="sec4_4" class="NLM_sec NLM_sec_level_2"><div id="ac_i30" class="anchor-spacer"></div><h3 class="article-section__title" id="_i30"> General Procedure for Synthesis of <b>15a</b> and <b>15b</b></h3><div class="NLM_p">Under nitrogen gas, the reaction solution of <b>13a</b> (or <b>13b</b>, 2.7 mmol), <b>14</b> (520 mg, 2.73 mmol), Ni(cod)<sub>2</sub> (40 mg, 0.14 mmol), and P(<i>o</i>-Tol)<sub>3</sub> (80 mg, 0.26 mmol) in freshly distilled MeCN (10 mL) was stirred at 80 °C for 3 h. Then K<sub>3</sub>[Fe(CN)<sub>6</sub>] (6.6 g, 20 mmol), CsOH solution (50% w/w in water, 3.6 mL, 40 mmol), MeOH (20 mL), and water (20 mL) were added. The reaction mixture was stirred vigorously at 80 °C for 12 h. The reaction mixture was cooled and extracted with chloroform (3 × 50 mL). The combined organic layers were dried (MgSO<sub>4</sub>) and concentrated under reduced pressure. The residue was purified by silica gel column chromatography to give the target product.</div><div id="sec4_4_1" class="NLM_sec NLM_sec_level_3"><div id="ac_i31" class="anchor-spacer"></div><h4 class="article-section__title" id="_i31"> 3-(Benzo[<i>d</i>][1,3]dioxol-5-yl)-4-(2-hydroxyethyl)-6,7-dimethoxy-2-(2-(methoxymethoxy)ethyl)isoquinolin-1(2<i>H</i>)-one (<b>15a</b>)</h4><div class="NLM_p last">White solid, yield 45% (from <b>12a</b>). <sup>1</sup>H NMR (CDCl<sub>3</sub>) δ 7.89 (s, 1H), 7.11 (s, 1H), 6.91 (d, <i>J</i> = 7.7 Hz, 1H), 6.79 (s, 1H), 6.77 (d, <i>J</i> = 7.9 Hz, 1H), 6.05 (s, 2H), 4.48 (s, 2H), 4.07–3.95 (m, 8H), 3.77–3.62 (m, 4H), 3.20 (s, 3H), 2.80–2.66 (m, 2H). <sup>13</sup>C NMR (CDCl<sub>3</sub>) δ 161.4, 153.6, 149.1, 148.0, 147.9, 140.1, 131.8, 128.3, 123.7, 119.1, 111.5, 110.5, 108.4, 108.1, 103.9, 101.5, 96.1, 64.4, 62.3, 56.1, 56.1, 55.0, 45.6, 32.1. ESI-MS <i>m</i>/<i>z</i>: 458.1 [M + H]<sup>+</sup>. The structure was further confirmed with 2D NMR spectra.</div></div><div id="sec4_4_2" class="NLM_sec NLM_sec_level_3"><div id="ac_i32" class="anchor-spacer"></div><h4 class="article-section__title" id="_i32"> 3-(Benzo[<i>d</i>][1,3]dioxol-5-yl)-4-(2-hydroxyethyl)-6,7-dimethoxy-2-(3-(methoxymethoxy)propyl)isoquinolin-1(2<i>H</i>)-one (<b>15b</b>)</h4><div class="NLM_p last">White solid, yield 57% (from <b>12b</b>). <sup>1</sup>H NMR (CDCl<sub>3</sub>) δ 7.90 (s, 1H), 7.11 (s, 1H), 6.92 (d, <i>J</i> = 8.4 Hz, 1H), 6.79–6.74 (m, 2H), 6.07 (s, 2H), 4.48 (s, 2H), 4.02 (s, 3H), 4.01 (s, 3H), 3.71 (t, <i>J</i> = 6.7 Hz, 2H), 3.44 (t, <i>J</i> = 6.3 Hz, 2H), 3.27 (s, 3H), 2.82–2.67 (m, 2H). <sup>13</sup>C NMR (CDCl<sub>3</sub>) δ 161.3, 153.4, 149.1, 148.0, 139.9, 131.7, 128.4, 123.4, 111.3, 110.1, 108.5, 108.1, 103.7, 101.6, 96.0, 93.0, 91.5, 65.3, 62.4, 56.2, 56.1, 55.1, 44.0, 32.0, 29.2. ESI-MS <i>m</i>/<i>z</i>: 472.2 [M + H]<sup>+</sup>. The structure was further confirmed with 2D NMR spectra.</div></div></div><div id="sec4_5" class="NLM_sec NLM_sec_level_2"><div id="ac_i33" class="anchor-spacer"></div><h3 class="article-section__title" id="_i33"> General Procedure for Synthesis of <b>16a</b> and <b>16b</b></h3><div class="NLM_p">To a solution of (COCl)<sub>2</sub> (215 μL, 2.5 mmol) in freshly distilled CH<sub>2</sub>Cl<sub>2</sub> (5 mL), DMSO (365 μL, 5 mmol) was added dropwise at −60 °C and the reaction solution was stirred for 15 min. A solution of <b>15a</b> (or <b>15b</b>, 0.5 mmol) in freshly distilled CH<sub>2</sub>Cl<sub>2</sub> (3 mL) was added dropwise and stirred at −60 °C for 30 min, and then Et<sub>3</sub>N (1.5 mL, 10 mmol) was added dropwise. The reaction solution was brought to room temperature and stirred for 2 h. The reaction was quenched by the addition of water (1 mL) at 0 °C. The reaction mixture was extracted with CH<sub>2</sub>Cl<sub>2</sub> (3 × 20 mL). The organic layer was washed with saturated saline (3 × 30 mL) and dried (MgSO<sub>4</sub>) overnight and then concentrated under reduced pressure. The residue was purified by silica gel column chromatography to give the target product.</div><div id="sec4_5_1" class="NLM_sec NLM_sec_level_3"><div id="ac_i34" class="anchor-spacer"></div><h4 class="article-section__title" id="_i34"> 2-(3-(Benzo[<i>d</i>][1,3]dioxol-5-yl)-6,7-dimethoxy-2-(2-(methoxymethoxy)ethyl)-1-oxo-1,2-dihydroisoquinolin-4-yl)acetaldehyde (<b>16a</b>)</h4><div class="NLM_p last">White solid, yield 85%. <sup>1</sup>H NMR (CDCl<sub>3</sub>) δ 9.57 (t, <i>J</i> = 1.8 Hz, 1H), 7.90 (s, 1H), 6.93 (d, <i>J</i> = 7.8 Hz, 1H), 6.81–6.73 (m, 3H), 6.08 (s, 2H), 4.50 (s, 2H), 4.09 (d, <i>J</i> = 6.8 Hz, 2H), 4.03 (s, 3H), 3.97 (s, 3H), 3.79–3.67 (m, 2H), 3.53–3.47 (m, 2H), 3.21 (s, 3H). <sup>13</sup>C NMR (CDCl<sub>3</sub>) δ 199.7, 161.6, 153.8, 149.3, 148.4, 148.2, 141.8, 131.6, 128.0, 123.7, 119.5, 110.2, 108.7, 108.3, 106.4, 103.4, 101.7, 96.2, 64.4, 56.2, 56.1, 55.1, 45.9, 44.6. ESI-MS <i>m</i>/<i>z</i>: 455.2 [M + H]<sup>+</sup>.</div></div><div id="sec4_5_2" class="NLM_sec NLM_sec_level_3"><div id="ac_i35" class="anchor-spacer"></div><h4 class="article-section__title" id="_i35"> 2-(3-(Benzo[<i>d</i>][1,3]dioxol-5-yl)-6,7-dimethoxy-2-(3-(methoxymethoxy)propyl)-1-oxo-1,2-dihydroisoquinolin-4-yl)acetaldehyde (<b>16b</b>)</h4><div class="NLM_p last">White solid, yield 87%. <sup>1</sup>H NMR (CDCl<sub>3</sub>) δ 9.58 (s, 1H), 7.91 (d, <i>J</i> = 2.4 Hz, 1H), 6.96–6.90 (m, 1H), 6.80–6.74 (m, 3H), 6.08 (s, 2H), 4.71–4.60 (m, 2H), 4.50 (s, 2H), 4.02 (s, 3H), 3.96 (s, 3H), 3.52–3.44 (m, 4H), 3.29 (s, 3H), 1.88–1.83 (m, 2H). <sup>13</sup>C NMR (CDCl<sub>3</sub>) δ 199.6, 161.4, 153.7, 149.3, 148.4, 148.3, 141.5, 131.4, 128.0, 123.3, 119.7, 109.8, 108.8, 108.4, 106.3, 103.4, 101.7, 96.1, 65.3, 56.2, 56.1, 55.1, 44.5, 44.3, 29.2. ESI-MS <i>m</i>/<i>z</i>: 470.2 [M + H]<sup>+</sup>.</div></div></div><div id="sec4_6" class="NLM_sec NLM_sec_level_2"><div id="ac_i36" class="anchor-spacer"></div><h3 class="article-section__title" id="_i36"> General Procedure for the Synthesis of <b>17a</b> and <b>17b</b></h3><div class="NLM_p">The reaction solution of <b>16a</b> (or <b>16b</b>, 0.5 mmol) and concentrated hydrochloric acid (0.4 mL) in MeOH (10 mL) was added to a 50 mL round-bottomed flask. The flask was sealed with a rubber stopper. The reaction solution was stirred at room temperature overnight, and then the formed precipitate was filtered and washed with saturated sodium bicarbonate and water consecutively. The crude solid was dried and purified by silica gel column chromatography to give the target product.</div><div id="sec4_6_1" class="NLM_sec NLM_sec_level_3"><div id="ac_i37" class="anchor-spacer"></div><h4 class="article-section__title" id="_i37"> 12-(2-Hydroxyethyl)-2,3-dimethoxy-[1,3]dioxolo[4′,5′:4,5]benzo[1,2-<i>c</i>]phenanthridin-13(12<i>H</i>)-one (<b>17a</b>)</h4><div class="NLM_p last">White solid, yield 97%, mp = 228.2–229.7 °C. <sup>1</sup>H NMR (CDCl<sub>3</sub>) δ 8.00 (d, <i>J</i> = 8.8 Hz, 1H), 7.91 (s, 1H), 7.59–7.57 (m, 2H), 7.25 (s, 1H), 7.19 (s, 1H), 6.11 (s, 2H), 5.08 (t, <i>J</i> = 5.6 Hz, 1H), 4.54 (t, <i>J</i> = 4.2 Hz, 2H), 4.37–4.33 (m, 2H), 4.12 (s, 3H), 4.06 (s, 3H). <sup>13</sup>C NMR (CDCl<sub>3</sub>) δ 165.8, 154.0, 149.8, 147.5, 147.5, 135.4, 131.9, 129.4, 123.8, 120.8, 118.7, 118.3, 117.3, 108.5, 105.0, 102.8, 102.0, 101.7, 64.0, 56.8, 56.3, 56.2. HRMS (ESI) <i>m</i>/<i>z</i>: 394.1276 [M + H]<sup>+</sup>, calcd for C<sub>22</sub>H<sub>20</sub>NO<sub>6</sub> 394.1285. ESI-MS <i>m</i>/<i>z</i>: 394.1 [M + H]<sup>+</sup>.</div></div><div id="sec4_6_2" class="NLM_sec NLM_sec_level_3"><div id="ac_i38" class="anchor-spacer"></div><h4 class="article-section__title" id="_i38"> 12-(3-Hydroxypropyl)-2,3-dimethoxy-[1,3]dioxolo[4′,5′:4,5]benzo[1,2-<i>c</i>]phenanthridin-13(12<i>H</i>)-one (<b>17b</b>)</h4><div class="NLM_p last">White solid, yield 96%, mp = 263.4–264.2 °C. <sup>1</sup>H NMR (CDCl<sub>3</sub>) δ 7.98 (d, <i>J</i> = 8.8 Hz, 1H), 7.92 (s, 1H), 7.60 (s, 1H), 7.59–7.55 (m, 2H), 7.19 (s, 1H), 6.12 (s, 2H), 4.72 (t, <i>J</i> = 6.6 Hz, 2H), 4.12 (s, 3H), 4.07 (s, 3H), 3.54 (t, <i>J</i> = 6.6 Hz, 2H), 2.16–2.07 (m, 2H). <sup>13</sup>C NMR (CDCl<sub>3</sub>) δ 165.0, 153.7, 149.8, 147.6, 147.4, 135.1, 131.7, 129.0, 123.5, 121.1, 119.4, 118.4, 117.5, 108.9, 104.9, 102.8, 102.3, 101.6, 60.1, 56.2, 56.2, 48.3, 32.8. HRMS (ESI) <i>m</i>/<i>z</i>: 408.1457 [M + H]<sup>+</sup>, calcd for C<sub>23</sub>H<sub>22</sub>NO<sub>6</sub> 408.1442. ESI-MS <i>m</i>/<i>z</i>: 408.1 [M + H]<sup>+</sup>.</div></div></div><div id="sec4_7" class="NLM_sec NLM_sec_level_2"><div id="ac_i39" class="anchor-spacer"></div><h3 class="article-section__title" id="_i39"> General Procedure for the Synthesis of <b>18a</b> and <b>18b</b></h3><div class="NLM_p">To a solution of <b>17a</b> (or <b>17b</b>, 0.5 mmol) in freshly distilled chloroform (10 mL), SOCl<sub>2</sub> (0.8 mL) was added dropwise through a syringe. The reaction solution was stirred at room temperature for 1 h and then quenched by the addition of water (5 mL) at 0 °C. The precipitate was filtered and washed with saturated sodium bicarbonate and water consecutively. The residue was purified by silica gel column chromatography to give the target product.</div><div id="sec4_7_1" class="NLM_sec NLM_sec_level_3"><div id="ac_i40" class="anchor-spacer"></div><h4 class="article-section__title" id="_i40"> 12-(2-Chloroethyl)-2,3-dimethoxy-[1,3]dioxolo[4′,5′:4,5]benzo[1,2-<i>c</i>]phenanthridin-13(12<i>H</i>)-one (<b>18a</b>)</h4><div class="NLM_p last">White solid, yield 94%, mp = 236.5–237.3 °C. <sup>1</sup>H NMR (DMSO) δ 8.83 (d, <i>J</i> = 9.0 Hz, 1H), 8.31 (s, 1H), 8.26 (s, 1H), 8.16 (d, <i>J</i> = 9.0 Hz, 1H), 7.72 (s, 1H), 7.68 (s, 1H), 6.33 (s, 2H), 5.76 (t, <i>J</i> = 9.0 Hz, 2H), 5.35 (t, <i>J</i> = 9.0 Hz, 2H), 4.20 (s, 3H), 4.04 (s, 3H). ESI-MS <i>m</i>/<i>z</i>: 412.1 (100%), 414.0 (33%) [M + H]<sup>+</sup>.</div></div><div id="sec4_7_2" class="NLM_sec NLM_sec_level_3"><div id="ac_i41" class="anchor-spacer"></div><h4 class="article-section__title" id="_i41"> 12-(3-Chloropropyl)-2,3-dimethoxy-[1,3]dioxolo[4′,5′:4,5]benzo[1,2-<i>c</i>]phenanthridin-13(12<i>H</i>)-one (<b>18b</b>)</h4><div class="NLM_p last">White solid, yield 96%, mp = 235.5–236.1 °C. <sup>1</sup>H NMR (CDCl<sub>3</sub>) δ 7.97 (d, <i>J</i> = 8.8 Hz, 1H), 7.89 (s, 1H), 7.59–7.55 (m, 2H), 7.51 (s, 1H), 7.19 (s, 1H), 6.12 (s, 2H), 4.69 (t, <i>J</i> = 6.8 Hz, 2H), 4.11 (s, 3H), 4.06 (s, 3H), 3.39 (t, <i>J</i> = 6.4 Hz, 2H), 2.43–2.33 (m, 2H). HRMS (ESI) <i>m</i>/<i>z</i>: 426.1090 [M + H]<sup>+</sup>, calcd for C<sub>23</sub>H<sub>21</sub>NO<sub>5</sub>Cl 426.1103. ESI-MS <i>m</i>/<i>z</i>: 426.1 (100%), 428.1 (33%) [M + H]<sup>+</sup>.</div></div></div><div id="sec4_8" class="NLM_sec NLM_sec_level_2"><div id="ac_i42" class="anchor-spacer"></div><h3 class="article-section__title" id="_i42"> General Procedure for the Synthesis of <b>19a</b>/<b>b</b>–<b>25a</b>/<b>b</b></h3><div class="NLM_p">The solution of <b>18a</b> (or <b>18b</b>, 0.87 mmol), NEt<sub>3</sub> (870 mg, 8.7 mmol), and amines (in pressure vessel for dimethylamine, 8.7 mmol) in PhMe (20 mL) was stirred and heated under reflux for 3–6 h, and then, cooled to room temperature. The solvent was evaporated under reduced pressure. The residue was purified by silica gel column chromatography to give the target product.</div><div id="sec4_8_1" class="NLM_sec NLM_sec_level_3"><div id="ac_i43" class="anchor-spacer"></div><h4 class="article-section__title" id="_i43"> 12-(2-(Dimethylamino)ethyl)-2,3-dimethoxy-[1,3]dioxolo[4′,5′:4,5]benzo[1,2-<i>c</i>]phenanthridin-13(12<i>H</i>)-one (<b>19a</b>)</h4><div class="NLM_p last">White solid, yield 65%, mp = 136.4–138.0 °C. IR (KBr, cm<sup>–1</sup>), 1632, 1611, 1590. <sup>1</sup>H NMR (CDCl<sub>3</sub>) δ 7.97 (d, <i>J</i> = 8.4 Hz, 1H), 7.91 (s, 1H), 7.66 (s, 1H), 7.57–7.54 (m, 2H), 7.18 (s, 1H), 6.10 (s, 2H), 4.66 (t, <i>J</i> = 7.0 Hz, 2H), 4.10 (s, 3H), 4.05 (s, 3H), 2.78 (t, <i>J</i> = 7.0 Hz, 2H), 2.21 (s, 6H). <sup>13</sup>C NMR (CDCl<sub>3</sub>) δ 164.7, 153.6, 149.7, 147.5, 147.3, 135.5, 131.7, 128.9, 123.3, 121.3, 119.6, 118.3, 117.3, 108.8, 104.8, 102.9, 102.3, 101.5, 57.6, 56.2, 56.1, 50.1, 45.5. HRMS (ESI) <i>m</i>/<i>z</i>: 421.1761 [M + H]<sup>+</sup>, calcd for C<sub>24</sub>H<sub>25</sub>N<sub>2</sub>O<sub>5</sub> 421.1758.</div></div><div id="sec4_8_2" class="NLM_sec NLM_sec_level_3"><div id="ac_i44" class="anchor-spacer"></div><h4 class="article-section__title" id="_i44"> 12-(3-(Dimethylamino)propyl)-2,3-dimethoxy-[1,3]dioxolo[4′,5′:4,5]benzo[1,2-<i>c</i>]phenanthridin-13(12<i>H</i>)-one (<b>19b</b>)</h4><div class="NLM_p last">White solid, yield 70%, mp = 173.2–174.3 °C. IR (KBr, cm<sup>–1</sup>), 1612 (sh), 1582. <sup>1</sup>H NMR (CDCl<sub>3</sub>) δ 7.97 (d, <i>J</i> = 8.4 Hz, 1H), 7.91 (s, 1H), 7.58–7.53 (m, 2H), 7.48 (s, 1H), 7.19 (s, 1H), 6.13 (s, 2H), 4.55 (t, <i>J</i> = 7.2 Hz, 2H), 4.12 (s, 3H), 4.07 (s, 3H), 2.51 (t, <i>J</i> = 7.2 Hz, 2H), 2.34 (s, 6H), 2.18 (quint, <i>J</i> = 7.2 Hz, 2H). <sup>13</sup>C NMR (CDCl<sub>3</sub>) δ 164.7, 153.6, 149.6, 147.5, 147.4, 135.3, 131.7, 129.0, 123.3, 121.0, 119.5, 118.3, 117.4, 108.8, 104.8, 102.9, 102.0, 101.6, 56.2, 56.1, 55.5, 49.7, 43.5, 25.1. HRMS (ESI) <i>m</i>/<i>z</i>: 435.1919 [M + H]<sup>+</sup>, calcd for C<sub>25</sub>H<sub>27</sub>N<sub>2</sub>O<sub>5</sub> 435.1914.</div></div><div id="sec4_8_3" class="NLM_sec NLM_sec_level_3"><div id="ac_i45" class="anchor-spacer"></div><h4 class="article-section__title" id="_i45"> 12-(2-(Diethylamino)ethyl)-2,3-dimethoxy-[1,3]dioxolo[4′,5′:4,5]benzo[1,2-<i>c</i>]phenanthridin-13(12<i>H</i>)-one (<b>20a</b>)</h4><div class="NLM_p last">White powder, yield 86%, mp = 129.1–129.5 °C. IR (KBr, cm<sup>–1</sup>), 1640, 1612, 1592. <sup>1</sup>H NMR (CDCl<sub>3</sub>) δ 7.96 (d, <i>J</i> = 8.4 Hz, 1H), 7.91 (s, 1H), 7.70 (s, 1H), 7.59–7.52 (m, 2H), 7.17 (s, 1H), 6.10 (s, 2H), 4.64 (t, <i>J</i> = 6.4 Hz, 2H), 4.10 (s, 3H), 4.05 (s, 3H), 2.82 (t, <i>J</i> = 6.4 Hz, 2H), 2.39 (q, <i>J</i> = 7.2 Hz, 4H), 0.83 (t, <i>J</i> = 7.2 Hz, 6H). <sup>13</sup>C NMR (CDCl<sub>3</sub>) δ 165.0, 153.7, 149.8, 147.6, 147.5, 135.8, 131.8, 129.2, 123.3, 121.3, 119.9, 118.5, 117.6, 109.0, 104.9, 103.0, 102.8, 101.7, 56.4, 56.3, 51.6, 50.6, 47.5, 12.0. HRMS (ESI) <i>m</i>/<i>z</i>: 449.2078 [M + H]<sup>+</sup>, calcd for C<sub>26</sub>H<sub>29</sub>N<sub>2</sub>O<sub>5</sub> 449.2071.</div></div><div id="sec4_8_4" class="NLM_sec NLM_sec_level_3"><div id="ac_i46" class="anchor-spacer"></div><h4 class="article-section__title" id="_i46"> 12-(3-(Diethylamino)propyl)-2,3-dimethoxy-[1,3]dioxolo[4′,5′:4,5]benzo[1,2-<i>c</i>]phenanthridin-13(12<i>H</i>)-one (<b>20b</b>)</h4><div class="NLM_p last">White solid, yield 60%, mp = 106.5–108.1 °C. IR (KBr, cm<sup>–1</sup>), 1637, 1613, 1581. <sup>1</sup>H NMR (CDCl<sub>3</sub>) δ 7.99 (d, <i>J</i> = 8.8 Hz, 1H), 7.92 (s, 1H), 7.59 (s, 1H), 7.57 (d, <i>J</i> = 8.8 Hz, 1H), 7.53 (s, 1H), 7.20 (s, 1H), 6.12 (s, 2H), 4.56 (t, <i>J</i> = 7.0 Hz, 2H), 4.13 (s, 3H), 4.07 (s, 3H), 2.63–2.43 (m, 6H), 2.22–2.10 (m, 2H), 0.98 (t, <i>J</i> = 6.5 Hz, 6H). <sup>13</sup>C NMR (CDCl<sub>3</sub>) δ 164.7, 153.6, 149.7, 147.6, 147.4, 135.4, 131.7, 129.0, 123.4, 121.2, 119.5, 118.4, 117.3, 108.7, 104.9, 102.8, 102.1, 101.6, 56.3, 56.2, 50.1, 49.4, 46.6, 25.3, 10.8. HRMS (ESI) <i>m</i>/<i>z</i>: 463.2233 [M + H]<sup>+</sup>, calcd for C<sub>27</sub>H<sub>31</sub>N<sub>2</sub>O<sub>5</sub> 463.2227. ESI-MS <i>m</i>/<i>z</i>: 463.2 [M + H]<sup>+</sup>. The structure was also confirmed with and single crystal analysis. Compound <b>20b</b> was crystallized from dichloromethane as white cubic crystals. Data collections for <b>20b</b> were performed at 103 K on a Xcalibur Nova diffractometer, using Cu Kα radiation (λ = 1.54184 Å). The determination of crystal class and unit cell parameters was carried out by CrysAlisPro. The raw frame data was processed using CrysAlisPro (Rigaku Oxford Diffraction) to yield the reflection data file. The structure of <b>20b</b> was solved by use of SHELXTL (Bruker, 2005) program. Refinement was performed on F<sup>2</sup> anisotropically for all the non-hydrogen atoms by the full-matrix least-squares method. The hydrogen atoms were placed at the calculated positions and were included in the structure calculation without further refinement of the parameters. Molecular formula = C<sub>27</sub>H<sub>32</sub>N<sub>2</sub>O<sub>4</sub>, molecular mass = 449.57, monoclinic, <i>a</i> = 9.41991(12) Å, <i>b</i> = 10.11440(12) Å, <i>c</i> = 23.7285(4) Å, β = 91.6653(13)°, <i>V</i> = 2259.82(5) Å<sup>3</sup>, T = 103 K, space group <i>P</i>2<sub>1</sub>/<i>c</i> (no. 14), Z = 4, μ (Cu Kα) = 0.710 mm<sup>–1</sup>, 10230 reflections measured, 4283 unique (R<sub>int</sub> = 0.0458) which were used in all calculations. The final R (reflections) = 0.0500, wR<sup>2</sup> (reflections) = 0.1495. Crystallographic data for compound <b>20b</b> has been deposited with the Cambridge Crystallographic Data Centre as supplementary publication number CCDC 1579803. Copies of the data can be obtained, free of charge, on application to CCDC, 12 Union Road, Cambridge CB2 1EZ, UK [fax: + 44(0)1223–336033 or e-mail: <a href="/cdn-cgi/l/email-protection#781c1d08170b110c381b1b1c1b561b191556191b560d13"><span class="__cf_email__" data-cfemail="bdd9d8cdd2ced4c9fddeded9de93dedcd093dcde93c8d6">[email protected]</span></a>].</div></div><div id="sec4_8_5" class="NLM_sec NLM_sec_level_3"><div id="ac_i47" class="anchor-spacer"></div><h4 class="article-section__title" id="_i47"> 2,3-Dimethoxy-12-(2-(pyrrolidin-1-yl)ethyl)-[1,3]dioxolo[4′,5′:4,5]benzo[1,2-<i>c</i>]phenanthridin-13(12<i>H</i>)-one (<b>21a</b>)</h4><div class="NLM_p last">White solid, yield 47%, mp = 209.2–210.3 °C. IR (KBr, cm<sup>–1</sup>), 1639, 1610, 1594. <sup>1</sup>H NMR (CDCl<sub>3</sub>) δ 7.93–7.88 (m, 2H), 7.65 (s, 1H), 7.52 (s, 1H), 7.49 (d, <i>J</i> = 8.8 Hz, 1H), 7.12 (s, 1H), 6.08 (s, 2H), 4.66 (t, <i>J</i> = 7.2 Hz, 2H), 4.08 (s, 3H), 4.05 (s, 3H), 2.91 (t, <i>J</i> = 7.2 Hz, 2H), 2.52–2.42 (m, 4H), 1.73–1.61 (m, 4H). <sup>13</sup>C NMR (CDCl<sub>3</sub>) δ 164.7, 153.5, 149.6, 147.5, 147.3, 135.4, 131.6, 129.0, 123.2, 121.1, 119.6, 118.2, 117.3, 108.8, 104.7, 102.8, 102.6, 101.5, 56.2, 56.1, 54.3, 54.1, 51.0, 23.6. HRMS (ESI) <i>m</i>/<i>z</i>: 447.1916 [M + H]<sup>+</sup>, calcd for C<sub>26</sub>H<sub>27</sub>N<sub>2</sub>O<sub>5</sub> 447.1914. ESI-MS <i>m</i>/<i>z</i>: 447.2 [M + H]<sup>+</sup>.</div></div><div id="sec4_8_6" class="NLM_sec NLM_sec_level_3"><div id="ac_i48" class="anchor-spacer"></div><h4 class="article-section__title" id="_i48"> 2,3-Dimethoxy-12-(3-(pyrrolidin-1-yl)propyl)-[1,3]dioxolo[4′,5′:4,5]benzo[1,2-<i>c</i>]phenanthridin-13(12<i>H</i>)-one (<b>21b</b>)</h4><div class="NLM_p last">White solid, yield 65%, mp = 205.8–207.4 °C. IR (KBr, cm<sup>–1</sup>), 1640, 1612, 1596. <sup>1</sup>H NMR (CDCl<sub>3</sub>) δ 7.95 (d, <i>J</i> = 8.8 Hz, 1H), 7.88 (s, 1H), 7.56 (s, 1H), 7.54 (d, <i>J</i> = 8.8 Hz, 1H), 7.48 (s, 1H), 7.16 (s, 1H), 6.10 (s, 2H), 4.57 (t, <i>J</i> = 7.2 Hz, 2H), 4.10 (s, 3H), 4.05 (s, 3H), 2.59 (s, br 4H), 2.52 (t, <i>J</i> = 7.2 Hz, 2H), 2.19 (quint, <i>J</i> = 7.2 Hz, 2H), 1.77 (s, br 4H). <sup>13</sup>C NMR (CDCl<sub>3</sub>) δ 164.7, 153.6, 149.7, 147.6, 147.4, 135.3, 131.7, 129.0, 123.4, 121.2, 119.5, 118.3, 117.3, 108.8, 104.9, 102.9, 102.1, 101.6, 56.2, 56.2, 53.8, 53.3, 49.9, 27.4, 23.4. HRMS (ESI) <i>m</i>/<i>z</i>: 461.2067 [M + H]<sup>+</sup>, calcd for C<sub>27</sub>H<sub>29</sub>N<sub>2</sub>O<sub>5</sub> 461.2071.</div></div><div id="sec4_8_7" class="NLM_sec NLM_sec_level_3"><div id="ac_i49" class="anchor-spacer"></div><h4 class="article-section__title" id="_i49"> 2,3-Dimethoxy-12-(2-(piperidin-1-yl)ethyl)-[1,3]dioxolo[4′,5′:4,5]benzo[1,2-<i>c</i>]phenanthridin-13(12<i>H</i>)-one (<b>22a</b>)</h4><div class="NLM_p last">White solid, yield 44%, mp = 178.3–180.1 °C. IR (KBr, cm<sup>–1</sup>), 1642, 1612, 1596. <sup>1</sup>H NMR (CDCl<sub>3</sub>) δ 7.98 (d, <i>J</i> = 8.8 Hz, 1H), 7.93 (s, 1H), 7.74 (s, 1H), 7.58 (s, 1H), 7.56 (d, <i>J</i> = 8.8 Hz, 1H), 7.19 (s, 1H), 6.12 (s, 2H), 4.69 (t, <i>J</i> = 6.6 Hz, 2H), 4.12 (s, 3H), 4.07 (s, 3H), 2.69 (t, <i>J</i> = 6.6 Hz, 2H), 2.34–2.23 (m, 4H), 1.40–1.29 (m, 6H). <sup>13</sup>C NMR (CDCl<sub>3</sub>) δ 165.0, 153.5, 149.5, 147.5, 147.3, 135.6, 131.6, 129.1, 123.2, 121.2, 119.7, 118.2, 117.5, 108.9, 104.7, 102.8, 102.7, 101.5, 57.2, 56.2, 56.1, 54.6, 49.8, 25.8, 24.2. HRMS (ESI) <i>m</i>/<i>z</i>: 461.2076 [M + H]<sup>+</sup>, calcd for C<sub>27</sub>H<sub>29</sub>N<sub>2</sub>O<sub>5</sub> 461.2071. ESI-MS <i>m</i>/<i>z</i>: 461.2 [M + H]<sup>+</sup>.</div></div><div id="sec4_8_8" class="NLM_sec NLM_sec_level_3"><div id="ac_i50" class="anchor-spacer"></div><h4 class="article-section__title" id="_i50"> 2,3-Dimethoxy-12-(3-(piperidin-1-yl)propyl)-[1,3]dioxolo[4′,5′:4,5]benzo[1,2-<i>c</i>]phenanthridin-13(12<i>H</i>)-one (<b>22b</b>)</h4><div class="NLM_p last">White solid, yield 60%, mp = 110.6–112.3 °C. IR (KBr, cm<sup>–1</sup>), 1639, 1612, 1592. <sup>1</sup>H NMR (CDCl<sub>3</sub>) δ 7.98 (d, <i>J</i> = 8.7 Hz, 1H), 7.91 (s, 1H), 7.60–7.55 (m, 2H), 7.48 (s, 1H), 7.19 (s, 1H), 6.10 (s, 2H), 4.55 (d, <i>J</i> = 7.2 Hz, 2H), 4.12 (s, 3H), 4.06 (s, 3H), 2.50 (d, <i>J</i> = 7.2 Hz, 2H), 2.34–2.13 (s, 6H), 1.51–1.30 (m, 6H). <sup>13</sup>C NMR (CDCl<sub>3</sub>) δ 164.6, 153.7, 149.7, 147.6, 147.5, 135.1, 131.7, 128.9, 123.5, 121.0, 119.4, 118.3, 117.4, 108.7, 104.9, 102.9, 102.0, 101.6, 56.2, 56.1, 55.7, 53.9, 50.1, 25.4, 25.2, 23.9. HRMS (ESI) <i>m</i>/<i>z</i>: 475.2227 [M + H]<sup>+</sup>, calcd for C<sub>28</sub>H<sub>31</sub>N<sub>2</sub>O<sub>5</sub> 475.2227.</div></div><div id="sec4_8_9" class="NLM_sec NLM_sec_level_3"><div id="ac_i51" class="anchor-spacer"></div><h4 class="article-section__title" id="_i51"> 2,3-Dimethoxy-12-(2-morpholinoethyl)-[1,3]dioxolo[4′,5′:4,5]benzo[1,2-<i>c</i>]phenanthridin-13(12<i>H</i>)-one (<b>23a</b>)</h4><div class="NLM_p last">White solid, yield 48%, mp = 220.5–221.1 °C. IR (KBr, cm<sup>–1</sup>), 1639, 1611, 1594. <sup>1</sup>H NMR (CDCl<sub>3</sub>) δ 7.93 (d, <i>J</i> = 8.7 Hz, 1H), 7.88 (s, 1H), 7.64 (s, 1H), 7.54 (s, 1H), 7.51 (d, <i>J</i> = 8.7 Hz, 1H), 7.14 (s, 1H), 6.09 (s, 2H), 4.66 (t, <i>J</i> = 6.2 Hz, 2H), 4.10 (s, 3H), 4.05 (s, 3H), 3.34 (s, br 4H), 2.67 (t, <i>J</i> = 6.2 Hz, 2H), 2.21 (s, br 4H). <sup>13</sup>C NMR (CDCl<sub>3</sub>) δ 165.2, 153.5, 149.6, 147.5, 147.4, 135.6, 131.5, 129.0, 123.2, 121.2, 119.7, 118.3, 117.6, 108.9, 104.8, 102.8, 102.5, 101.6, 66.9, 56.6, 56.2, 56.2, 53.4, 49.3. HRMS (ESI) <i>m</i>/<i>z</i>: 463.1875 [M + H]<sup>+</sup>, calcd for C<sub>26</sub>H<sub>27</sub>N<sub>2</sub>O<sub>6</sub> 463.1864. ESI-MS <i>m</i>/<i>z</i>: 463.2 [M + H]<sup>+</sup>.</div></div><div id="sec4_8_10" class="NLM_sec NLM_sec_level_3"><div id="ac_i52" class="anchor-spacer"></div><h4 class="article-section__title" id="_i52"> 2,3-Dimethoxy-12-(3-morpholinopropyl)-[1,3]dioxolo[4′,5′:4,5]benzo[1,2-<i>c</i>]phenanthridin-13(12<i>H</i>)-one (<b>23b</b>)</h4><div class="NLM_p last">White solid, yield 60%, mp = 203.1–205.0 °C. IR (KBr, cm<sup>–1</sup>), 1639, 1610, 1595. <sup>1</sup>H NMR (CDCl<sub>3</sub>) δ 7.94 (d, <i>J</i> = 8.5 Hz, 1H), 7.90 (s, 1H), 7.58–7.48 (m, 3H), 7.16 (s, 1H), 6.10 (s, 2H), 4.63 (t, <i>J</i> = 6.2 Hz, 2H), 4.10 (s, 3H), 4.05 (s, 3H), 3.42 (s, br 4H), 2.12 (s, br 4H), 2.08–1.96 (m, 4H). <sup>13</sup>C NMR (CDCl<sub>3</sub>) δ 164.6, 153.5, 149.7, 147.5, 147.2, 135.9, 131.6, 128.9, 123.0, 121.1, 119.7, 118.3, 117.2, 108.8, 104.8, 102.8, 102.4, 101.5, 66.9, 56.2, 56.2, 55.3, 53.3, 49.8, 25.3. HRMS (ESI) <i>m</i>/<i>z</i>: 477.2032 [M + H]<sup>+</sup>, calcd for C<sub>27</sub>H<sub>29</sub>N<sub>2</sub>O<sub>6</sub> 477.2020.</div></div><div id="sec4_8_11" class="NLM_sec NLM_sec_level_3"><div id="ac_i53" class="anchor-spacer"></div><h4 class="article-section__title" id="_i53"> 2,3-Dimethoxy-12-(2-(4-methylpiperazin-1-yl)ethyl)-[1,3]dioxolo[4′,5′:4,5]benzo[1,2-<i>c</i>]phenanthridin-13(12<i>H</i>)-one (<b>24a</b>)</h4><div class="NLM_p last">White solid, yield 42%, mp = 207.5–208.3 °C. IR (KBr, cm<sup>–1</sup>), 1635, 1613, 1590. <sup>1</sup>H NMR (CDCl<sub>3</sub>) δ 7.93 (d, <i>J</i> = 8.8 Hz, 1H), 7.89 (s, 1H), 7.61 (s, 1H), 7.54 (s, 1H), 7.52 (d, <i>J</i> = 8.8 Hz, 1H), 7.15 (s, 1H), 6.10 (s, 2H), 4.67 (t, <i>J</i> = 6.8 Hz, 2H), 4.10 (s, 3H), 4.05 (s, 3H), 2.67 (t, <i>J</i> = 6.8 Hz, 2H), 2.64–2.56 (m, 2H), 2.38–2.32 (m, 4H), 2.23–2.16 (m, 5H). <sup>13</sup>C NMR (CDCl<sub>3</sub>) δ 165.2, 153.5, 149.6, 147.5, 147.4, 135.5, 131.5, 129.0, 123.2, 121.2, 119.8, 118.2, 117.6, 109.0, 104.8, 102.8, 102.4, 101.5, 56.2, 56.2, 55.9, 54.7, 52.3, 49.5, 45.5. HRMS (ESI) <i>m</i>/<i>z</i>: 476.2177 [M + H]<sup>+</sup>, calcd for C<sub>27</sub>H<sub>30</sub>N<sub>3</sub>O<sub>5</sub> 476.2180. ESI-MS <i>m</i>/<i>z</i>: 476.2 [M + H]<sup>+</sup>.</div></div><div id="sec4_8_12" class="NLM_sec NLM_sec_level_3"><div id="ac_i54" class="anchor-spacer"></div><h4 class="article-section__title" id="_i54"> 2,3-Dimethoxy-12-(3-(4-methylpiperazin-1-yl)propyl)-[1,3]dioxolo[4′,5′:4,5]benzo[1,2-<i>c</i>]phenanthridin-13(12<i>H</i>)-one (<b>24b</b>)</h4><div class="NLM_p last">White solid, yield 41%, mp = 170.9–172.8 °C. IR (KBr, cm<sup>–1</sup>), 1631, 1614, 1590. <sup>1</sup>H NMR (CDCl<sub>3</sub>) δ 7.96 (d, <i>J</i> = 8.7 Hz, 1H), 7.91 (s, 1H), 7.56 (s, 1H), 7.54 (d, <i>J</i> = 8.7 Hz, 1H), 7.52 (s, 1H), 7.18 (s, 1H), 6.11 (s, 2H), 4.61 (t, <i>J</i> = 6.8 Hz, 2H), 4.10 (s, 3H), 4.05 (s, 3H), 2.33–2.08 (m, 13H), 1.99 (t, <i>J</i> = 6.8 Hz, 2H). <sup>13</sup>C NMR (CDCl<sub>3</sub>) δ 164.7, 153.5, 149.7, 147.5, 147.2, 135.8, 131.6, 128.9, 123.2, 121.4, 119.7, 118.3, 117.3, 108.8, 104.8, 102.8, 102.5, 101.5, 56.3, 56.2, 54.9, 52.5, 49.9, 45.8, 29.7, 25.7. HRMS (ESI) <i>m</i>/<i>z</i>: 490.2334 [M + H]<sup>+</sup>, calcd for C<sub>28</sub>H<sub>32</sub>N<sub>3</sub>O<sub>5</sub> 490.2336. ESI-MS <i>m</i>/<i>z</i>: 490.2 [M + H]<sup>+</sup>.</div></div><div id="sec4_8_13" class="NLM_sec NLM_sec_level_3"><div id="ac_i55" class="anchor-spacer"></div><h4 class="article-section__title" id="_i55"> 12-(2-(1<i>H</i>-Imidazol-1-yl)ethyl)-2,3-dimethoxy-[1,3]dioxolo[4′,5′:4,5]benzo[1,2-<i>c</i>]phenanthridin-13(12<i>H</i>)-one (<b>25a</b>)</h4><div class="NLM_p last">White powder, yield 88%, mp = 254.2–255.6 °C. IR (KBr, cm<sup>–1</sup>), 1630, 1609, 1588. <sup>1</sup>H NMR (CDCl<sub>3</sub>) δ 7.92–7.86 (m, 2H), 7.55–7.50 (m, 2H), 7.32 (s, 1H), 7.17 (s, 1H), 7.00 (s, 1H), 6.73 (s, 1H), 6.53 (s, 1H), 6.12 (s, 2H), 4.90 (t, <i>J</i> = 6.4 Hz, 2H), 4.37 (t, <i>J</i> = 6.4 Hz, 2H), 4.11 (s, 3H), 4.07 (s, 3H). <sup>13</sup>C NMR (CDCl<sub>3</sub>) δ 164.7, 154.0, 149.9, 147.7, 147.7, 137.2, 134.7, 131.7, 129.6, 129.2, 123.9, 120.6, 119.2, 118.5, 118.5, 117.8, 108.7, 105.3, 103.1, 101.8, 101.5, 56.4, 56.3, 51.9, 44.8. HRMS (ESI) <i>m</i>/<i>z</i>: 444.1550 [M + H]<sup>+</sup>, calcd for C<sub>25</sub>H<sub>22</sub>N<sub>3</sub>O<sub>5</sub> 444.1554. ESI-MS <i>m</i>/<i>z</i>: 444.1 [M + H]<sup>+</sup>.</div></div><div id="sec4_8_14" class="NLM_sec NLM_sec_level_3"><div id="ac_i56" class="anchor-spacer"></div><h4 class="article-section__title" id="_i56"> 12-(3-(1<i>H</i>-Imidazol-1-yl)propyl)-2,3-dimethoxy-[1,3]dioxolo[4′,5′:4,5]benzo[1,2-<i>c</i>]phenanthridin-13(12<i>H</i>)-one (<b>25b</b>)</h4><div class="NLM_p last">White powder, yield 86%, mp = 200.1–200.9 °C. IR (KBr, cm<sup>–1</sup>), 1631, 1610, 1591. <sup>1</sup>H NMR (CDCl<sub>3</sub>) δ 7.99 (d, <i>J</i> = 8.8 Hz, 1H), 7.90 (s, 1H), 7.60 (d, <i>J</i> = 8.8 Hz, 1H), 7.58 (s, 1H), 7.31 (s, 1H), 7.19 (s, 1H), 7.06 (s, 1H), 6.89 (s, 1H), 6.61 (s, 1H), 6.11 (s, 2H), 4.51 (t, <i>J</i> = 6.8 Hz, 2H), 4.12 (s, 3H), 4.07 (s, 3H), 3.71 (t, <i>J</i> = 6.8 Hz, 2H), 2.35 (quint, <i>J</i> = 6.8 Hz, 2H). <sup>13</sup>C NMR (CDCl<sub>3</sub>) δ 164.7, 153.9, 149.9, 147.8, 147.6, 136.9, 135.2, 131.8, 129.5, 129.0, 123.8, 121.1, 119.5, 118.6, 118.4, 117.5, 108.8, 105.1, 103.0, 101.8, 101.7, 56.4, 56.3, 48.8, 44.3, 30.2. HRMS (ESI) <i>m</i>/<i>z</i>: 458.1703 [M + H]<sup>+</sup>, calcd for C<sub>26</sub>H<sub>24</sub>N<sub>3</sub>O<sub>5</sub> 458.1710. ESI-MS <i>m</i>/<i>z</i>: 458.2 [M + H]<sup>+</sup>.</div></div></div><div id="sec4_9" class="NLM_sec NLM_sec_level_2"><div id="ac_i57" class="anchor-spacer"></div><h3 class="article-section__title" id="_i57"> General Procedure for Synthesis of <b>26a</b>/<b>b</b>–<b>32a</b>/<b>b</b></h3><div class="NLM_p">Under nitrogen gas, to a solution of oxynitidine analogue (<b>19a</b>/<b>b</b>–<b>25a</b>/<b>b</b>, 0.45 mmol) in dried THF (100 mL), the solution of LiAlH<sub>4</sub> (3.6 mL, 9.0 mmol) in THF was added at 0 °C dropwise, and then the reaction solution was stirred and heated under reflux for 3–6 h. The reaction was quenched by the addition of aqueous NaOH solution (5%, 5 mL) at 0 °C. The solvent was evaporated under reduced pressure. The residue was purified by silica gel column chromatography to give the target product.</div><div id="sec4_9_1" class="NLM_sec NLM_sec_level_3"><div id="ac_i58" class="anchor-spacer"></div><h4 class="article-section__title" id="_i58"> 2-(2,3-Dimethoxy-[1,3]dioxolo[4′,5′:4,5]benzo[1,2-<i>c</i>]phenanthridin-12(13<i>H</i>)-yl)-<i>N</i>,<i>N</i>-dimethylethan-1-amine (<b>26a</b>)</h4><div class="NLM_p last">White powder, yield 60%, mp = 109.4–109.6 °C. <sup>1</sup>H NMR (CDCl<sub>3</sub>) δ 7.74 (s, 1H), 7.68 (d, <i>J</i> = 8.8 Hz, 1H), 7.50 (d, <i>J</i> = 8.8 Hz, 1H), 7.30 (s, 1H), 7.12 (s, 1H), 6.80 (s, 1H), 6.06 (s, 2H), 4.21 (s, 2H), 4.00 (s, 3H), 3.95 (s, 3H), 2.88 (t, <i>J</i> = 6.4 Hz, 2H), 2.60 (t, <i>J</i> = 6.4 Hz, 2H), 2.24 (s, 6H). <sup>13</sup>C NMR (CDCl<sub>3</sub>) δ 148.8, 148.7, 148.2, 147.6, 142.9, 131.0, 126.6, 125.5, 125.2, 124.9, 123.9, 119.9, 110.2, 106.4, 104.5, 101.2, 100.8, 58.4, 56.3, 56.2, 50.8, 50.0, 46.0. HRMS (ESI) <i>m</i>/<i>z</i>: 407.1960 [M + H]<sup>+</sup>, calcd for C<sub>24</sub>H<sub>27</sub>N<sub>2</sub>O<sub>4</sub> 407.1965. ESI-MS <i>m</i>/<i>z</i>: 407.2 [M + H]<sup>+</sup>.</div></div><div id="sec4_9_2" class="NLM_sec NLM_sec_level_3"><div id="ac_i59" class="anchor-spacer"></div><h4 class="article-section__title" id="_i59"> 3-(2,3-Dimethoxy-[1,3]dioxolo[4′,5′:4,5]benzo[1,2-<i>c</i>]phenanthridin-12(13<i>H</i>)-yl)-<i>N</i>,<i>N</i>-dimethylpropan-1-amine (<b>26b</b>)</h4><div class="NLM_p last">White powder, yield 58%, mp = 82.4–83.0 °C. <sup>1</sup>H NMR (CDCl<sub>3</sub>) δ 7.68 (d, <i>J</i> = 8.8 Hz, 1H), 7.66 (s, 1H), 7.49 (d, <i>J</i> = 8.8 Hz, 1H), 7.30 (s, 1H), 7.11 (s, 1H), 6.78 (s, 1H), 6.05 (s, 2H), 4.16 (s, 2H), 3.99 (s, 3H), 3.95 (s, 3H), 2.75 (t, <i>J</i> = 7.6 Hz, 2H), 2.29 (t, <i>J</i> = 7.6 Hz, 2H), 2.21 (s, 6H), 1.81 (quint, <i>J</i> = 7.6 Hz, 2H). <sup>13</sup>C NMR (CDCl<sub>3</sub>) δ 148.9, 148.7, 148.2, 147.5, 143.0, 131.0, 126.6, 125.6, 125.1, 125.0, 123.9, 120.0, 110.1, 106.5, 104.5, 101.1, 100.8, 57.3, 56.3, 56.2, 50.0, 45.6, 26.8. HRMS (ESI) <i>m</i>/<i>z</i>: 421.2121 [M + H]<sup>+</sup>, calcd for C<sub>25</sub>H<sub>29</sub>N<sub>2</sub>O<sub>4</sub> 421.2122. ESI-MS <i>m</i>/<i>z</i>: 421.3 [M + H]<sup>+</sup>.</div></div><div id="sec4_9_3" class="NLM_sec NLM_sec_level_3"><div id="ac_i60" class="anchor-spacer"></div><h4 class="article-section__title" id="_i60"> 2-(2,3-Dimethoxy-[1,3]dioxolo[4′,5′:4,5]benzo[1,2-<i>c</i>]phenanthridin-12(13<i>H</i>)-yl)-<i>N</i>,<i>N</i>-diethylethan-1-amine (<b>27a</b>)</h4><div class="NLM_p last">White powder, yield 78%, mp = 68.1–68.2 °C. <sup>1</sup>H NMR (CDCl<sub>3</sub>) δ 7.80 (s, 1H), 7.67 (d, <i>J</i> = 8.4 Hz, 1H), 7.48 (d, <i>J</i> = 8.4 Hz, 1H), 7.30 (s, 1H), 7.11 (s, 1H), 6.78 (s, 1H), 6.04 (s, 2H), 4.20 (s, 2H), 3.99 (s, 3H), 3.94 (s, 3H), 2.88 (t, <i>J</i> = 6.4 Hz, 2H), 2.75 (t, <i>J</i> = 7.2 Hz, 2H), 2.50 (q, <i>J</i> = 7.2 Hz, 4H), 1.01 (t, <i>J</i> = 7.2 Hz, 6H). <sup>13</sup>C NMR (CDCl<sub>3</sub>) δ 149.0, 148.8, 148.2, 147.6, 143.1, 131.1, 126.6, 125.7, 125.4, 124.9, 123.7, 119.9, 110.3, 106.8, 104.5, 101.1, 101.0, 56.4, 56.3, 52.0, 50.9, 50.0, 47.4, 11.9. HRMS (ESI) <i>m</i>/<i>z</i>: 435.2281 [M + H]<sup>+</sup>, calcd for C<sub>26</sub>H<sub>31</sub>N<sub>2</sub>O<sub>4</sub> 435.2278.</div></div><div id="sec4_9_4" class="NLM_sec NLM_sec_level_3"><div id="ac_i61" class="anchor-spacer"></div><h4 class="article-section__title" id="_i61"> 3-(2,3-Dimethoxy-[1,3]dioxolo[4′,5′:4,5]benzo[1,2-<i>c</i>]phenanthridin-12(13<i>H</i>)-yl)-<i>N</i>,<i>N</i>-diethylpropan-1-amine (<b>27b</b>)</h4><div class="NLM_p last">White solid, yield 81%, mp = 119.5–121.5 °C. <sup>1</sup>H NMR (CDCl<sub>3</sub>) δ 7.68 (d, <i>J</i> = 8.5 Hz, 1H), 7.65 (s, 1H), 7.49 (d, <i>J</i> = 8.5 Hz, 1H), 7.30 (s, 1H), 7.11 (s, 1H), 6.79 (s, 1H), 6.05 (s, 2H), 4.17 (s, 2H), 3.99 (s, 3H), 3.95 (s, 3H), 2.74 (t, <i>J</i> = 7.6 Hz, 2H), 2.60–2.50 (m, 4H), 2.50–2.42 (m, 2H), 1.88–1.79 (m, 2H), 1.02 (t, <i>J</i> = 7.0 Hz, 6H). <sup>13</sup>C NMR (CDCl<sub>3</sub>) δ 148.8, 148.6, 148.1, 147.4, 143.0, 130.9, 126.5, 125.5, 125.0, 124.8, 123.7, 119.9, 110.0, 106.4, 104.4, 101.0, 100.7, 56.2, 56.1, 50.7, 50.1, 49.9, 46.8, 26.2, 11.6. HRMS (ESI) <i>m</i>/<i>z</i>: 449.2447 [M + H]<sup>+</sup>, calcd for C<sub>27</sub>H<sub>33</sub>N<sub>2</sub>O<sub>4</sub> 449.2435. ESI-MS <i>m</i>/<i>z</i>: 449.24 [M + H]<sup>+</sup>.</div></div><div id="sec4_9_5" class="NLM_sec NLM_sec_level_3"><div id="ac_i62" class="anchor-spacer"></div><h4 class="article-section__title" id="_i62"> 2,3-Dimethoxy-12-(2-(pyrrolidin-1-yl)ethyl)-12,13-dihydro-[1,3]dioxolo[4′,5′:4,5]benzo[1,2-<i>c</i>]phenanthridine (<b>28a</b>)</h4><div class="NLM_p last">White solid, yield 55%, mp = 84.3–85.8 °C. <sup>1</sup>H NMR (CDCl<sub>3</sub>) δ 7.70–7.64 (m, 2H), 7.48 (d, <i>J</i> = 8.5 Hz, 1H), 7.29 (s, 1H), 7.10 (s, 1H), 6.81 (s, 1H), 6.04 (s, 2H), 4.21 (s, 2H), 3.98 (s, 3H), 3.95 (s, 3H), 3.12 (d, <i>J</i> = 7.2 Hz, 2H), 2.86 (d, <i>J</i> = 7.2 Hz, 2H), 2.73–2.64 (m, 4H), 1.87–1.81 (m, 4H). <sup>13</sup>C NMR (CDCl<sub>3</sub>) δ 148.9, 148.7, 148.2, 147.5, 141.7, 130.9, 126.4, 125.3, 125.2, 125.1, 124.0, 119.8, 110.1, 106.5, 104.4, 101.1, 100.5, 56.2, 56.1, 54.2, 51.2, 50.3, 23.3. HRMS (ESI) <i>m</i>/<i>z</i>: 433.2120 [M + H]<sup>+</sup>, calcd for C<sub>26</sub>H<sub>29</sub>N<sub>2</sub>O<sub>4</sub> 433.2122. ESI-MS <i>m</i>/<i>z</i>: 433.2 [M + H]<sup>+</sup>.</div></div><div id="sec4_9_6" class="NLM_sec NLM_sec_level_3"><div id="ac_i63" class="anchor-spacer"></div><h4 class="article-section__title" id="_i63"> 2,3-Dimethoxy-12-(3-(pyrrolidin-1-yl)propyl)-12,13-dihydro-[1,3]dioxolo[4′,5′:4,5]benzo[1,2-<i>c</i>]phenanthridine (<b>28b</b>)</h4><div class="NLM_p last">White solid, yield 61%, mp = 135.8–137.5 °C. <sup>1</sup>H NMR (CDCl<sub>3</sub>) δ 7.70–7.64 (m, 2H), 7.47 (d, <i>J</i> = 8.5 Hz, 1H), 7.29 (s, 1H), 7.10 (s, 1H), 6.78 (s, 1H), 6.03 (s, 2H), 4.16 (s, 2H), 3.98 (s, 3H), 3.94 (s, 3H), 2.76 (t, <i>J</i> = 7.2 Hz, 2H), 2.54–2.47 (m, 6H), 1.93–1.83 (m, 2H), 1.78 (s, br 4H). <sup>13</sup>C NMR (CDCl<sub>3</sub>) δ 148.8, 148.6, 148.0, 147.4, 143.0, 130.9, 126.5, 125.4, 124.9, 124.9, 123.7, 119.9, 110.0, 106.4, 104.4, 101.0, 100.7, 56.2, 56.1, 54.2, 53.8, 49.8, 49.7, 27.8, 23.4. HRMS (ESI) <i>m</i>/<i>z</i>: 447.2273 [M + H]<sup>+</sup>, calcd for C<sub>27</sub>H<sub>31</sub>N<sub>2</sub>O<sub>4</sub> 447.2278.</div></div><div id="sec4_9_7" class="NLM_sec NLM_sec_level_3"><div id="ac_i64" class="anchor-spacer"></div><h4 class="article-section__title" id="_i64"> 2,3-Dimethoxy-12-(2-(piperidin-1-yl)ethyl)-12,13-dihydro-[1,3]dioxolo[4′,5′:4,5]benzo[1,2-<i>c</i>]phenanthridine (<b>29a</b>)</h4><div class="NLM_p last">White powder, yield 67%, mp = 140.4–141.5 °C. <sup>1</sup>H NMR (CDCl<sub>3</sub>) δ 7.82 (s, 1H), 7.67 (d, <i>J</i> = 8.4 Hz, 1H), 7.48 (d, <i>J</i> = 8.4 Hz, 1H), 7.29 (s, 1H), 7.11 (s, 1H), 6.79 (s, 1H), 6.05 (s, 2H), 4.23 (s, 2H), 3.99 (s, 3H), 3.95 (s, 3H), 2.92 (t, <i>J</i> = 5.8 Hz, 2H), 2.61 (t, <i>J</i> = 6.4 Hz, 2H), 2.47–2.26 (m, 4H), 1.67–1.57 (m, 6H). <sup>13</sup>C NMR (CDCl<sub>3</sub>) δ 148.9, 148.7, 148.2, 147.6, 143.0, 131.0, 126.6, 125.6, 125.4, 124.9, 123.8, 119.9, 110.3, 106.6, 104.4, 101.1, 101.1, 58.3, 56.3, 56.2, 55.3, 50.8, 49.2, 26.0, 24.5. HRMS (ESI) <i>m</i>/<i>z</i>: 447.2275 [M + H]<sup>+</sup>, calcd for C<sub>27</sub>H<sub>31</sub>N<sub>2</sub>O<sub>4</sub> 447.2278. ESI-MS <i>m</i>/<i>z</i>: 447.3 [M + H]<sup>+</sup>.</div></div><div id="sec4_9_8" class="NLM_sec NLM_sec_level_3"><div id="ac_i65" class="anchor-spacer"></div><h4 class="article-section__title" id="_i65"> 2,3-Dimethoxy-12-(3-(piperidin-1-yl)propyl)-12,13-dihydro-[1,3]dioxolo[4′,5′:4,5]benzo[1,2-<i>c</i>]phenanthridine (<b>29b</b>)</h4><div class="NLM_p last">White powder, yield 53%, mp = 131.0–131.5 °C. <sup>1</sup>H NMR (CDCl<sub>3</sub>) δ 7.68 (d, <i>J</i> = 8.4 Hz, 1H), 7.66 (s, 1H), 7.49 (d, <i>J</i> = 8.4 Hz, 1H), 7.30 (s, 1H), 7.11 (s, 1H), 6.78 (s, 1H), 6.05 (s, 2H), 4.16 (s, 2H), 3.99 (s, 3H), 3.95 (s, 3H), 2.73 (t, <i>J</i> = 7.6 Hz, 2H), 2.44–2.34 (m, 4H), 2.32 (t, <i>J</i> = 7.6 Hz, 2H), 1.86 (quint, <i>J</i> = 7.6 Hz, 2H), 1.62–1.55 (m, 6H). <sup>13</sup>C NMR (CDCl<sub>3</sub>) δ 148.9, 148.6, 148.2, 147.5, 143.1, 131.0, 126.6, 125.5, 125.0, 124.9, 123.9, 120.0, 110.1, 106.5, 104.5, 101.1, 100.8, 56.8, 56.3, 56.2, 54.8, 50.0, 49.9, 26.0, 24.5. HRMS (ESI) <i>m</i>/<i>z</i>: 461.2432 [M + H]<sup>+</sup>, calcd for C<sub>28</sub>H<sub>33</sub>N<sub>2</sub>O<sub>4</sub> 461.2435. ESI-MS <i>m</i>/<i>z</i>: 461.3 [M + H]<sup>+</sup>.</div></div><div id="sec4_9_9" class="NLM_sec NLM_sec_level_3"><div id="ac_i66" class="anchor-spacer"></div><h4 class="article-section__title" id="_i66"> 2,3-Dimethoxy-12-(2-morpholinoethyl)-12,13-dihydro-[1,3]dioxolo[4′,5′:4,5]benzo[1,2-<i>c</i>]phenanthridine (<b>30a</b>)</h4><div class="NLM_p last">White solid, yield 58%, mp = 119.9–121.5 °C. <sup>1</sup>H NMR (CDCl<sub>3</sub>) δ 7.95 (s, 1H), 7.69 (d, <i>J</i> = 8.6 Hz, 1H), 7.51 (d, <i>J</i> = 8.6 Hz, 1H), 7.32 (s, 1H), 7.13 (s, 1H), 6.80 (s, 1H), 6.07 (s, 2H), 4.25 (s, 2H), 4.01 (s, 3H), 3.97 (s, 3H), 3.75 (t, <i>J</i> = 4.6 Hz, 4H), 2.93 (t, <i>J</i> = 6.2 Hz, 2H), 2.62 (t, <i>J</i> = 6.2 Hz, 2H), 2.47 (t, <i>J</i> = 4.2 Hz, 4H). <sup>13</sup>C NMR (CDCl<sub>3</sub>) δ 148.8, 148.7, 148.1, 147.5, 142.7, 130.9, 126.5, 125.6, 125.2, 124.8, 123.7, 119.8, 110.1, 106.5, 104.3, 101.0, 100.9, 67.0, 57.9, 56.2, 56.1, 54.3, 50.7, 48.9. HRMS (ESI) <i>m</i>/<i>z</i>: 449.2073 [M + H]<sup>+</sup>, calcd for C<sub>26</sub>H<sub>29</sub>N<sub>2</sub>O<sub>5</sub> 449.2071. ESI-MS <i>m</i>/<i>z</i>: 449.2 [M + H]<sup>+</sup>.</div></div><div id="sec4_9_10" class="NLM_sec NLM_sec_level_3"><div id="ac_i67" class="anchor-spacer"></div><h4 class="article-section__title" id="_i67"> 2,3-Dimethoxy-12-(3-morpholinopropyl)-12,13-dihydro-[1,3]dioxolo[4′,5′:4,5]benzo[1,2-<i>c</i>]phenanthridine (<b>30b</b>)</h4><div class="NLM_p last">White solid, yield 72%, mp = 138.2–1139.9 °C. <sup>1</sup>H NMR (CDCl<sub>3</sub>) δ 7.70 (s, 1H), 7.68 (d, <i>J</i> = 8.5 Hz, 1H), 7.49 (d, <i>J</i> = 8.5 Hz, 1H), 7.30 (s, 1H), 7.11 (s, 1H), 6.77 (s, 1H), 6.05 (s, 2H), 4.16 (s, 2H), 3.99 (s, 3H), 3.95 (s, 3H), 3.72 (t, <i>J</i> = 4.4 Hz, 4H), 2.77 (t, <i>J</i> = 7.2 Hz, 2H), 2.44 (s, br 4H), 2.39 (d, <i>J</i> = 7.2 Hz, 2H), 1.83 (quint, <i>J</i> = 7.2 Hz, 2H). <sup>13</sup>C NMR (CDCl<sub>3</sub>) δ 148.8, 148.6, 148.1, 147.5, 142.9, 130.9, 126.5, 125.5, 124.9, 123.8, 119.9, 110.0, 106.4, 104.4, 101.0, 100.8, 67.0, 56.2, 56.1, 53.8, 49.8, 49.4, 25.3. HRMS (ESI) <i>m</i>/<i>z</i>: 463.2212 [M + H]<sup>+</sup>, calcd for C<sub>27</sub>H<sub>31</sub>N<sub>2</sub>O<sub>5</sub> 463.2227.</div></div><div id="sec4_9_11" class="NLM_sec NLM_sec_level_3"><div id="ac_i68" class="anchor-spacer"></div><h4 class="article-section__title" id="_i68"> 2,3-Dimethoxy-12-(2-(4-methylpiperazin-1-yl)ethyl)-12,13-dihydro-[1,3]dioxolo[4′,5′:4,5]benzo[1,2-<i>c</i>]phenanthridine (<b>31a</b>)</h4><div class="NLM_p last">White solid, yield 62%, mp = 165.8–167.0 °C. <sup>1</sup>H NMR (CDCl<sub>3</sub>) δ 7.86 (s, 1H), 7.67 (d, <i>J</i> = 8.6 Hz, 1H), 7.48 (d, <i>J</i> = 8.5 Hz, 1H), 7.30 (s, 1H), 7.11 (s, 1H), 6.78 (s, 1H), 6.05 (s, 2H), 4.23 (s, 2H), 3.99 (s, 3H), 3.95 (s, 3H), 2.90 (t, <i>J</i> = 6.4 Hz, 2H), 2.67–2.32 (m, 10H), 2.30 (s, 3H). <sup>13</sup>C NMR (CDCl<sub>3</sub>) δ 148.7, 148.6, 148.1, 147.5, 142.8, 130.9, 126.5, 125.5, 125.2, 124.8, 123.7, 119.8, 110.1, 106.4, 104.3, 101.0, 100.9, 57.4, 56.2, 56.1, 55.1, 53.7, 50.7, 49.2, 46.0. HRMS (ESI) <i>m</i>/<i>z</i>: 462.2398 [M + H]<sup>+</sup>, calcd for C<sub>27</sub>H<sub>32</sub>N<sub>3</sub>O<sub>4</sub> 462.2387. ESI-MS <i>m</i>/<i>z</i>: 462.2 [M + H]<sup>+</sup>.</div></div><div id="sec4_9_12" class="NLM_sec NLM_sec_level_3"><div id="ac_i69" class="anchor-spacer"></div><h4 class="article-section__title" id="_i69"> 2,3-Dimethoxy-12-(3-(4-methylpiperazin-1-yl)propyl)-12,13-dihydro-[1,3]dioxolo[4′,5′:4,5]benzo[1,2-<i>c</i>]phenanthridine (<b>31b</b>)</h4><div class="NLM_p last">White solid, yield 53%, mp = 52.9–54.8 °C. <sup>1</sup>H NMR (CDCl<sub>3</sub>) δ 7.71–7.65 (m, 2H), 7.49 (d, <i>J</i> = 8.5 Hz, 1H), 7.30 (s, 1H), 7.11 (s, 1H), 6.78 (s, 1H), 6.05 (s, 2H), 4.16 (s, 2H), 3.99 (s, 3H), 3.95 (s, 3H), 2.75 (t, <i>J</i> = 7.2 Hz, 2H), 2.60–2.35 (m, 10H), 2.29 (s, 3H), 1.84 (quint, <i>J</i> = 7.6 Hz, 2H). <sup>13</sup>C NMR (CDCl<sub>3</sub>) δ 148.8, 148.6, 148.0, 147.4, 142.9, 130.9, 126.5, 125.5, 124.9, 124.9, 123.8, 119.9, 110.0, 106.5, 104.4, 101.0, 100.8, 56.2, 56.1, 55.7, 55.0, 53.1, 49.8, 49.7, 45.9, 25.7. HRMS (ESI) <i>m</i>/<i>z</i>: 476.2525 [M + H]<sup>+</sup>, calcd for C<sub>28</sub>H<sub>34</sub>N<sub>3</sub>O<sub>4</sub> 476.2544.</div></div><div id="sec4_9_13" class="NLM_sec NLM_sec_level_3"><div id="ac_i70" class="anchor-spacer"></div><h4 class="article-section__title" id="_i70"> 12-(2-(1<i>H</i>-Imidazol-1-yl)ethyl)-2,3-dimethoxy-12,13-dihydro-[1,3]dioxolo[4′,5′:4,5]benzo[1,2-<i>c</i>]phenanthridine (<b>32a</b>)</h4><div class="NLM_p last">White powder, yield 67%, mp = 199.2–200.4 °C. <sup>1</sup>H NMR (CDCl<sub>3</sub>) δ 7.67 (d, <i>J</i> = 8.6 Hz, 1H), 7.56–7.46 (m, 2H), 7.31 (s, 1H), 7.13 (s, 1H), 7.10 (s, 1H), 6.96 (s, 1H), 6.93 (s, 1H), 6.74 (s, 1H), 6.04 (s, 2H), 4.12 (s, 2H), 4.09 (t, <i>J</i> = 6.4 Hz, 2H), 4.00 (s, 3H), 3.96 (s, 3H), 3.11 (t, <i>J</i> = 6.4 Hz, 2H). <sup>13</sup>C NMR (CDCl<sub>3</sub>) δ 149.2, 149.0, 148.5, 147.8, 141.4, 137.5, 131.1, 129.8, 126.3, 125.4, 125.4, 124.8, 124.5, 119.9, 119.3, 110.1, 106.8, 104.5, 101.3, 100.0, 56.4, 56.2, 52.7, 50.8, 45.5. HRMS (ESI) <i>m</i>/<i>z</i>: 430.1759 [M + H]<sup>+</sup>, calcd for C<sub>25</sub>H<sub>24</sub>N<sub>3</sub>O<sub>4</sub> 430.1761. ESI-MS <i>m</i>/<i>z</i>: 430.2 [M + H]<sup>+</sup>.</div></div><div id="sec4_9_14" class="NLM_sec NLM_sec_level_3"><div id="ac_i71" class="anchor-spacer"></div><h4 class="article-section__title" id="_i71"> 12-(3-(1<i>H</i>-Imidazol-1-yl)propyl)-2,3-dimethoxy-12,13-dihydro-[1,3]dioxolo[4′,5′:4,5]benzo[1,2-<i>c</i>]phenanthridine (<b>32b</b>)</h4><div class="NLM_p last">White powder, yield 55%, mp = 143.2–144.3 °C. <sup>1</sup>H NMR (CDCl<sub>3</sub>) δ 7.68 (d, <i>J</i> = 8.4 Hz, 1H), 7.54–7.49 (m, 2H), 7.38 (s, 1H), 7.31 (s, 1H), 7.12 (s, 1H), 7.02 (s, 1H), 6.83 (s, 1H), 6.75 (s, 1H), 6.06 (s, 2H), 4.14 (s, 2H), 4.00 (s, 3H), 3.95 (s, 3H), 3.92 (t, <i>J</i> = 7.2 Hz, 2H), 2.81 (t, <i>J</i> = 7.2 Hz, 2H), 2.08 (quint, <i>J</i> = 7.2 Hz, 2H). <sup>13</sup>C NMR (CDCl<sub>3</sub>) δ 149.1, 148.8, 148.3, 147.7, 142.0, 137.0, 131.0, 129.6, 126.4, 125.4, 125.2, 125.0, 124.2, 120.0, 118.8, 109.9, 106.6, 104.6, 101.2, 100.3, 56.3, 56.2, 50.8, 49.6, 45.1, 30.0. HRMS (ESI) <i>m</i>/<i>z</i>: 444.1920 [M + H]<sup>+</sup>, calcd for C<sub>26</sub>H<sub>26</sub>N<sub>3</sub>O<sub>4</sub> 444.1918.</div></div><div id="sec4_9_15" class="NLM_sec NLM_sec_level_3"><div id="ac_i72" class="anchor-spacer"></div><h4 class="article-section__title" id="_i72"> Synthesis of <i>N</i>-(4-Methoxybenzyl)-6-bromoveratraldimine (<b>33</b>)</h4><div class="NLM_p last">According to the “General Procedure for Synthesis of Schiff’s Base <b>12a</b> and <b>12b</b>”, compound <b>33</b> was prepared using 4-methoxybenzylamine as material. <sup>1</sup>H NMR (CDCl<sub>3</sub>) δ 8.64 (t, <i>J</i> = 1.3 Hz, 1H), 7.59 (s, 1H), 7.27–7.24 (m, 2H), 7.00 (s, 1H), 6.92–6.86 (m, 2H), 4.77 (s, 2H), 3.91 (s, 3H), 3.90 (s, 3H), 3.81 (s, 3H).</div></div><div id="sec4_9_16" class="NLM_sec NLM_sec_level_3"><div id="ac_i73" class="anchor-spacer"></div><h4 class="article-section__title" id="_i73"> Synthesis of 3-(Benzo[<i>d</i>][1,3]dioxol-5-yl)-4-(2-hydroxyethyl)-6,7-dimethoxy-2-(4-methoxybenzyl)isoquinolin-1(2<i>H</i>)-one (<b>34</b>)</h4><div class="NLM_p last">According to the “General Procedure for Synthesis of <b>15a</b> and <b>15b</b>”, compound <b>34</b> was prepared using <b>33</b> as material. White solid, yield 62%. <sup>1</sup>H NMR (CDCl<sub>3</sub>) δ 7.91 (s, 1H), 7.13 (s, 1H), 6.79–6.62 (m, 5H), 6.51–6.41 (m, 2H), 5.99 (s, 1H), 5.95 (s, 1H), 5.06 (d, <i>J</i> = 14.4 Hz, 1H), 4.94 (d, <i>J</i> = 14.1 Hz, 1H), 3.98 (s, 3H), 3.94 (s, 3H), 3.69 (s, 3H), 3.64 (t, <i>J</i> = 6.8 Hz, 2H), 2.77–2.64 (m, 2H). <sup>13</sup>C NMR (CDCl<sub>3</sub>) δ 161.7, 158.5, 153.6, 149.1, 147.9, 147.6, 140.0, 131.9, 130.0, 128.0, 128.0, 123.8, 119.7, 113.6, 111.9, 110.4, 108.5, 108.1, 104.0, 101.4, 62.2, 56.1, 56.1, 55.2, 48.6, 32.0. The structure was further confirmed with 2D NMR spectra.</div></div><div id="sec4_9_17" class="NLM_sec NLM_sec_level_3"><div id="ac_i74" class="anchor-spacer"></div><h4 class="article-section__title" id="_i74"> Synthesis of 2-(3-(Benzo[<i>d</i>][1,3]dioxol-5-yl)-6,7-dimethoxy-2-(4-methoxybenzyl)-1-oxo-1,2-dihydroisoquinolin-4-yl)acetaldehyde (<b>35</b>)</h4><div class="NLM_p last">According to the “General Procedure for Synthesis of <b>16a</b> and <b>16b</b>”, compound <b>35</b> was prepared using <b>34</b> as material. White solid, yield 82%. <sup>1</sup>H NMR (CDCl<sub>3</sub>) δ 9.56 (t, <i>J</i> = 2.0 Hz, 1H), 7.98 (s, 1H), 6.87–6.72 (m, 7H), 6.52 (s, 1H), 6.05 (s, 2H), 5.19 (d, <i>J</i> = 14.6 Hz, 1H), 5.06 (d, <i>J</i> = 14.7 Hz, 1H), 4.05 (s, 3H), 3.99 (s, 3H), 3.76 (s, 3H), 3.50 (d, <i>J</i> = 2.0 Hz, 2H). <sup>13</sup>C NMR (CDCl<sub>3</sub>) δ 199.6, 161.8, 158.6, 153.8, 149.4, 148.3, 148.0, 141.7, 131.6, 129.9, 128.1, 127.7, 123.7, 119.7, 113.7, 110.0, 108.8, 108.5, 106.6, 103.5, 101.6, 56.2, 56.1, 55.2, 48.8, 44.4. ESI-MS <i>m</i>/<i>z</i>: 488.2 [M + H]<sup>+</sup>.</div></div><div id="sec4_9_18" class="NLM_sec NLM_sec_level_3"><div id="ac_i75" class="anchor-spacer"></div><h4 class="article-section__title" id="_i75"> Synthesis of 2,3-Dimethoxy-[1,3]dioxolo[4′,5′:4,5]benzo[1,2-<i>c</i>]phenanthridin-13(12<i>H</i>)-one (<b>36</b>)</h4><div class="NLM_p last">The reaction solution of <b>35</b> (270 mg, 0.5 mmol) and concentrated hydrochloric acid (0.4 mL) in acetic acid (4 mL) was added to a 50 mL round-bottomed flask. The flask was sealed with a rubber stopper. The reaction solution was stirred at room temperature overnight, and then the formed precipitate was filtered and washed with saturated sodium bicarbonate and water consecutively. The crude solid was dried and purified by silica gel column chromatography to give white solid <b>36</b>, yield 62%. IR (KBr, cm<sup>–1</sup>), 1643 (sh), 1500. <sup>1</sup>H NMR (DMSO) δ 11.53 (s, 1 H), 8.36 (s, 1 H), 8.33 (d, <i>J</i> = 8.8 Hz, 1 H), 7.92 (s, 1 H), 7.75 (s, 1 H), 7.62 (d, <i>J</i> = 8.8 Hz, 1 H), 7.41 (s, 1 H), 6.18 (s, 2 H), 4.05 (s, 3 H), 3.93 (s, 3 H). ESI-MS <i>m</i>/<i>z</i>: 350.1 [M + H]<sup>+</sup>.</div></div><div id="sec4_9_19" class="NLM_sec NLM_sec_level_3"><div id="ac_i76" class="anchor-spacer"></div><h4 class="article-section__title" id="_i76"> Synthesis of 13-Chloro-2,3-dimethoxy-[1,3]dioxolo[4′,5′:4,5]benzo[1,2-<i>c</i>]phenanthridine (<b>37</b>)</h4><div class="NLM_p last">The reaction solution of <b>36</b> (350 mg, 1 mmol), POCl<sub>3</sub> (10 mL), and two drops of DMF was stirred at 100 °C overnight. The reaction was quenched by the addition of water (20 mL) at 0 °C and diluted with ethyl acetate (20 mL). The organic layer was washed with saturated sodium bicarbonate (10 mL) and water (10 mL) consecutively and then concentrated under reduced pressure. The residue was purified by silica gel column chromatography to give white solid <b>37</b>, yield 65%. <sup>1</sup>H NMR (CDCl<sub>3</sub>) δ 8.57 (s, 1H), 8.20 (d, <i>J</i> = 8.8 Hz, 1H), 7.84 (s, 1H), 7.80 (d, <i>J</i> = 8.8 Hz, 1H), 7.74 (s, 1H), 7.23 (s, 1H), 6.13 (s, 2H), 4.17 (s, 3H), 4.11 (s, 3H). The <sup>1</sup>H NMR spectrum is similar to that reported.<a onclick="showRef(event, 'ref72'); return false;" href="javascript:void(0);" class="ref ref72">(72)</a> ESI-MS <i>m</i>/<i>z</i>: 368.1 (100%), 370.0 (35%) [M + H]<sup>+</sup>.</div></div><div id="sec4_9_20" class="NLM_sec NLM_sec_level_3"><div id="ac_i77" class="anchor-spacer"></div><h4 class="article-section__title" id="_i77"> Synthesis of 13-(3-Bromopropoxy)-2,3-dimethoxy-[1,3]dioxolo[4′,5′:4,5]benzo[1,2-<i>c</i>]phenanthridine (<b>38</b>)</h4><div class="NLM_p last">The reaction solution of <b>36</b> (300 mg, 0.86 mmol) and NaH (60%, 105 mg, 2.7 mmol) in DMF (20 mL) was stirred at room temperature for 30 min. 1,3-Dibromopropane (869 mg, 4.3 mmol) was added and stirred at room temperature for 3 h, and then the reaction solution was added with water (10 mL) at 0 °C and diluted by ethyl acetate (50 mL). The organic layer was washed with saturated saline (3 × 20 mL) and dried over MgSO<sub>4</sub> and then concentrated under reduced pressure. The residue was purified by silica gel column chromatography to give white solid <b>38</b>, yield 86%. IR (KBr, cm<sup>–1</sup>), 1596. <sup>1</sup>H NMR (CDCl<sub>3</sub>) δ 8.47 (s, 1H), 8.08 (d, <i>J</i> = 8.8 Hz, 1H), 7.73 (s, 1H), 7.62 (t, <i>J</i> = 8.8 Hz, 1H), 7.60 (s, 1H), 7.19 (s, 1H), 6.09 (s, 2H), 4.88 (t, <i>J</i> = 7.0 Hz, 2H), 4.11 (s, 3H), 4.05 (s, 3H), 3.69 (d, <i>J</i> = 7.0 Hz, 2H), 2.57 (quint, <i>J</i> = 7.0 Hz, 2H). <sup>13</sup>C NMR (CDCl<sub>3</sub>) δ 156.9, 152.7, 149.2, 148.0, 147.8, 138.7, 131.0, 129.9, 128.1, 123.7, 118.2, 117.4, 113.7, 104.2, 104.2, 102.2, 102.0, 101.2, 63.8, 56.1, 56.0, 32.4, 30.4.). ESI-MS <i>m</i>/<i>z</i>: 470.0 (100%), 472.0 (100%) [M + H]<sup>+</sup>.</div></div></div><div id="sec4_10" class="NLM_sec NLM_sec_level_2"><div id="ac_i78" class="anchor-spacer"></div><h3 class="article-section__title" id="_i78"> General Procedure of Synthesis of <b>39a</b>–<b>45a</b></h3><div class="NLM_p">To a solution of ethanolamine derivatives (2 mmol) and NaH (2 mmol) in dried THF (50 mL), <b>37</b> (146 mg, 0.4 mmol) was added. The reaction solution was stirred at 70 °C overnight. The reaction was quenched by the addition of water (10 mL) at 0 °C. The solvent was evaporated under reduced pressure. The residue was purified by silica gel column chromatography to give the target compound, respectively.</div><div id="sec4_10_1" class="NLM_sec NLM_sec_level_3"><div id="ac_i79" class="anchor-spacer"></div><h4 class="article-section__title" id="_i79"> 2,3-Dimethoxy-13-(2-(dimethylamino)ethoxyl)-[1,3]dioxolo[4′,5′:4,5]benzo[1,2-<i>c</i>]phenanthridine (<b>39a</b>)</h4><div class="NLM_p last">White powder, yield 62%, mp = 159.8–160.5 °C. IR (KBr, cm<sup>–1</sup>), 1620, 1593. <sup>1</sup>H NMR (CDCl<sub>3</sub>) δ 8.54 (s, 1H), 8.17 (d, <i>J</i> = 8.8 Hz, 1H), 7.82 (s, 1H), 7.73 (s, 1H), 7.68 (d, <i>J</i> = 8.8 Hz, 1H), 7.23 (s, 1H), 6.11 (s, 2H), 4.91 (t, <i>J</i> = 5.6 Hz, 2H), 4.14 (s, 3H), 4.07 (s, 3H), 3.00 (t, <i>J</i> = 5.6 Hz, 2H), 2.46 (s, 6H). <sup>13</sup>C NMR (CDCl<sub>3</sub>) δ 157.2, 152.6, 149.2, 148.0, 147.8, 138.8, 131.0, 130.0, 128.2, 123.6, 118.3, 117.4, 113.9, 104.5, 104.3, 102.2, 102.1, 101.2, 64.2, 58.3, 56.1, 56.1, 46.2. HRMS (ESI) <i>m</i>/<i>z</i>: 421.1763 [M + H]<sup>+</sup>, calcd for C<sub>24</sub>H<sub>25</sub>N<sub>2</sub>O<sub>5</sub> 421.1758.</div></div><div id="sec4_10_2" class="NLM_sec NLM_sec_level_3"><div id="ac_i80" class="anchor-spacer"></div><h4 class="article-section__title" id="_i80"> 2,3-Dimethoxy-13-(2-(diethylamino)ethoxy)-[1,3]dioxolo[4′,5′:4,5]benzo[1,2-<i>c</i>]phenanthridine (<b>40a</b>)</h4><div class="NLM_p last">White solid, yield 50%, mp = 161.2–162.5 °C. IR (KBr, cm<sup>–1</sup>), 1620, 1591. <sup>1</sup>H NMR (CDCl<sub>3</sub>) δ 8.53 (s, 1H), 8.13 (d, <i>J</i> = 8.8 Hz, 1H), 7.77 (s, 1H), 7.68 (s, 1H), 7.64 (d, <i>J</i> = 8.8 Hz, 1H), 7.20 (s, 1H), 6.10 (s, 2H), 4.84 (t, <i>J</i> = 6.2 Hz, 2H), 4.12 (s, 3H), 4.05 (s, 3H), 3.11 (t, <i>J</i> = 6.2 Hz, 2H), 2.77 (q, <i>J</i> = 7.1 Hz, 4H), 1.17 (t, <i>J</i> = 7.1 Hz, 6H). <sup>13</sup>C NMR (CDCl<sub>3</sub>) δ 157.3, 152.6, 149.2, 148.0, 147.8, 138.9, 131.0, 129.9, 128.2, 123.6, 118.3, 117.3, 113.9, 104.5, 104.2, 102.2, 102.1, 101.1, 64.6, 56.0, 51.3, 48.2, 12.3. HRMS (ESI) <i>m</i>/<i>z</i>: 449.2079 [M + H]<sup>+</sup>, calcd for C<sub>26</sub>H<sub>29</sub>N<sub>2</sub>O<sub>5</sub> 449.2071. ESI-MS <i>m</i>/<i>z</i>: 449.2 [M + H]<sup>+</sup>.</div></div><div id="sec4_10_3" class="NLM_sec NLM_sec_level_3"><div id="ac_i81" class="anchor-spacer"></div><h4 class="article-section__title" id="_i81"> 2,3-Dimethoxy-13-(2-(pyrrolidin-1-yl)ethoxy)-[1,3]dioxolo[4′,5′:4,5]benzo[1,2-<i>c</i>]phenanthridine (<b>41a</b>)</h4><div class="NLM_p last">White powder, yield 53%, mp = 175.2–175.8 °C. IR (KBr, cm<sup>–1</sup>), 1620, 1593. <sup>1</sup>H NMR (CDCl<sub>3</sub>) δ 8.54 (s, 1H), 8.16 (d, <i>J</i> = 8.8 Hz, 1H), 7.81 (s, 1H), 7.72 (s, 1H), 7.67 (d, <i>J</i> = 8.8 Hz, 1H), 7.22 (s, 1H), 6.11 (s, 2H), 4.94 (t, <i>J</i> = 6.0 Hz, 2H), 4.14 (s, 3H), 4.07 (s, 3H), 3.16 (t, <i>J</i> = 6.0 Hz, 2H), 2.82–2.74 (m, 4H), 1.89–1.82 (m, 4H). <sup>13</sup>C NMR (CDCl<sub>3</sub>) δ 157.3, 152.7, 149.3, 148.1, 147.9, 138.9, 131.1, 130.0, 128.3, 123.7, 118.4, 117.5, 114.0, 104.6, 104.4, 102.3, 102.2, 101.3, 65.2, 56.2, 56.2, 55.1, 55.0, 23.7. HRMS (ESI) <i>m</i>/<i>z</i>: 447.1909 [M + H]<sup>+</sup>, calcd for C<sub>26</sub>H<sub>27</sub>N<sub>2</sub>O<sub>5</sub> 447.1914.</div></div><div id="sec4_10_4" class="NLM_sec NLM_sec_level_3"><div id="ac_i82" class="anchor-spacer"></div><h4 class="article-section__title" id="_i82"> 2,3-Dimethoxy-13-(2-(piperidin-1-yl)ethoxy)-[1,3]dioxolo[4′,5′:4,5]benzo[1,2-<i>c</i>]phenanthridine (<b>42a</b>)</h4><div class="NLM_p last">White powder, yield 43%, mp = 189.0–189.6 °C. IR (KBr, cm<sup>–1</sup>), 1620, 1594. <sup>1</sup>H NMR (CDCl<sub>3</sub>) δ 8.55 (s, 1H), 8.17 (d, <i>J</i> = 9.2 Hz, 1H), 7.81 (s, 1H), 7.71 (s, 1H), 7.67 (d, <i>J</i> = 8.8 Hz, 1H), 7.22 (s, 1H), 6.11 (s, 2H), 4.92 (t, <i>J</i> = 6.4 Hz, 2H), 4.14 (s, 3H), 4.07 (s, 3H), 3.03 (t, <i>J</i> = 6.4 Hz, 2H), 2.77–2.60 (m, 4H), 1.73–1.69 (m, 2H), 1.66–1.63 (m, 2H), 1.53–1.45 (m, 2H). <sup>13</sup>C NMR (CDCl<sub>3</sub>) δ 157.3, 152.8, 149.3, 148.1, 147.9, 139.0, 131.1, 130.1, 128.3, 123.7, 118.4, 117.5, 114.1, 104.6, 104.4, 102.3, 102.2, 101.3, 64.1, 58.0, 56.2, 55.3, 26.2, 24.4. HRMS (ESI) <i>m</i>/<i>z</i>: 461.2068 [M + H]<sup>+</sup>, calcd for C<sub>27</sub>H<sub>29</sub>N<sub>2</sub>O<sub>5</sub> 461.2071.</div></div><div id="sec4_10_5" class="NLM_sec NLM_sec_level_3"><div id="ac_i83" class="anchor-spacer"></div><h4 class="article-section__title" id="_i83"> 2,3-Dimethoxy-13-(2-morpholinoethoxy)-[1,3]dioxolo[4′,5′:4,5]benzo[1,2-<i>c</i>]phenanthridine (<b>43a</b>)</h4><div class="NLM_p last">White powder, yield 76%, mp = 198.4–199.6 °C. IR (KBr, cm<sup>–1</sup>), 1619, 1593. <sup>1</sup>H NMR (CDCl<sub>3</sub>) δ 8.53 (s, 1H), 8.17 (d, <i>J</i> = 8.8 Hz, 1H), 7.81 (s, 1H), 7.69–7.65 (m, 2H), 7.23 (s, 1H), 6.11 (s, 2H), 4.93 (t, <i>J</i> = 5.8 Hz, 2H), 4.14 (s, 3H), 4.07 (s, 3H), 3.82–3.75 (m, 4H), 3.05 (t, <i>J</i> = 5.8 Hz, 2H), 2.77–2.67 (m, 4H). <sup>13</sup>C NMR (CDCl<sub>3</sub>) δ 157.2, 152.8, 149.3, 148.1, 147.9, 138.9, 131.1, 130.1, 128.3, 123.8, 118.4, 117.5, 113.9, 104.4, 104.3, 102.3, 102.1, 101.3, 67.2, 63.8, 57.7, 56.2, 54.3. HRMS (ESI) <i>m</i>/<i>z</i>: 463.1859 [M + H]<sup>+</sup>, calcd for C<sub>26</sub>H<sub>27</sub>N<sub>2</sub>O<sub>6</sub> 463.1864.</div></div><div id="sec4_10_6" class="NLM_sec NLM_sec_level_3"><div id="ac_i84" class="anchor-spacer"></div><h4 class="article-section__title" id="_i84"> 2,3-Dimethoxy-13-(2-(4-methylpiperazin-1-yl)ethoxy)-[1,3]dioxolo[4′,5′:4,5]benzo[1,2-<i>c</i>]phenanthridine (<b>44a</b>)</h4><div class="NLM_p last">White powder, yield 74%, mp = 206.5–207.4 °C. IR (KBr, cm<sup>–1</sup>), 1622, 1596. <sup>1</sup>H NMR (CDCl<sub>3</sub>) δ 8.54 (s, 1H), 8.17 (d, <i>J</i> = 8.8 Hz, 1H), 7.82 (s, 1H), 7.73–7.63 (m, 2H), 7.23 (s, 1H), 6.11 (s, 2H), 4.92 (t, <i>J</i> = 6.4 Hz, 2H), 4.14 (s, 3H), 4.06 (s, 3H), 3.07 (t, <i>J</i> = 6.4 Hz, 2H), 2.92–2.65 (m, 4H), 2.65–2.41 (m, 4H), 2.32 (s, 3H). <sup>13</sup>C NMR (CDCl<sub>3</sub>) δ 157.2, 152.7, 149.3, 148.1, 147.9, 138.9, 131.1, 130.0, 128.3, 123.7, 118.3, 117.5, 113.9, 104.5, 104.3, 102.3, 102.2, 101.3, 64.1, 57.2, 56.1, 55.3, 53.8, 46.2. HRMS (ESI) <i>m</i>/<i>z</i>: 476.2179 [M + H]<sup>+</sup>, calcd for C<sub>27</sub>H<sub>30</sub>N<sub>3</sub>O<sub>5</sub> 476.2180.</div></div><div id="sec4_10_7" class="NLM_sec NLM_sec_level_3"><div id="ac_i85" class="anchor-spacer"></div><h4 class="article-section__title" id="_i85"> 13-(2-(1<i>H</i>-Imidazol-1-yl)ethoxy)-2,3-dimethoxy-[1,3]dioxolo[4′,5′:4,5]benzo[1,2-<i>c</i>]phenanthridine (<b>45a</b>)</h4><div class="NLM_p last">White powder, yield 56%, mp = 238.9–239.1 °C. IR (KBr, cm<sup>–1</sup>), 1621, 1597. <sup>1</sup>H NMR (CDCl<sub>3</sub>) δ 8.47 (s, 1H), 8.19 (d, <i>J</i> = 8.8 Hz, 1H), 7.83 (s, 1H), 7.71 (d, <i>J</i> = 8.8 Hz, 1H), 7.67 (s, 1H), 7.58 (s, 1H), 7.24 (s, 1H), 7.12–7.09 (m, 2H), 6.12 (s, 2H), 5.06 (t, <i>J</i> = 5.2 Hz, 2H), 4.59 (t, <i>J</i> = 5.2 Hz, 2H), 4.15 (s, 3H), 4.06 (s, 3H). <sup>13</sup>C NMR (CDCl<sub>3</sub>) δ 156.4, 153.1, 149.6, 148.2, 148.0, 138.5, 137.7, 131.3, 130.1, 129.8, 128.2, 124.2, 119.5, 118.4, 117.9, 113.6, 104.5, 104.1, 102.4, 101.9, 101.4, 64.9, 56.3, 56.2, 46.5. HRMS (ESI) <i>m</i>/<i>z</i>: 444.1557 [M + H]<sup>+</sup>, calcd for C<sub>25</sub>H<sub>22</sub>N<sub>3</sub>O<sub>5</sub> 444.1554.</div></div></div><div id="sec4_11" class="NLM_sec NLM_sec_level_2"><div id="ac_i86" class="anchor-spacer"></div><h3 class="article-section__title" id="_i86"> General Procedure for Synthesis of <b>39b</b>–<b>45b</b></h3><div class="NLM_p">The solution of <b>38</b> (221 mg, 0.47 mmol), K<sub>2</sub>CO<sub>3</sub> (163 mg, 1.18 mmol), KI (20 mg, 0.118 mmol), and amines (in pressure vessel for dimethylamine. 0.7 mmol) in DMF (20 mL) was stirred at room temperature overnight, and then the reaction solution was diluted with ethyl acetate (100 mL) and washed with saturated saline (3 × 50 mL). The organic layer was dried (MgSO<sub>4</sub>) and concentrated under reduced pressure. The residue was purified by silica gel column chromatography to give target product, respectively.</div><div id="sec4_11_1" class="NLM_sec NLM_sec_level_3"><div id="ac_i87" class="anchor-spacer"></div><h4 class="article-section__title" id="_i87"> 2,3-Dimethoxy-13-(3-(dimethylamino)propoxy)-[1,3]dioxolo[4′,5′:4,5]benzo[1,2-<i>c</i>]phenanthridine (<b>39b</b>)</h4><div class="NLM_p last">White powder, yield 82%, mp = 148.6–150.4 °C. IR (KBr, cm<sup>–1</sup>), 1618, 1593. <sup>1</sup>H NMR (CDCl<sub>3</sub>) δ 8.56 (s, 1H), 8.18 (d, <i>J</i> = 8.8 Hz, 1H), 7.83 (s, 1H), 7.72 (s, 1H), 7.68 (d, <i>J</i> = 8.8 Hz, 1H), 6.11 (s, 2H), 4.82 (t, <i>J</i> = 7.4 Hz, 1H), 4.14 (s, 3H), 4.07 (s, 3H), 2.60 (t, <i>J</i> = 7.4 Hz, 1H), 2.32 (s, 6H), 2.20 (quint, <i>J</i> = 7.4 Hz, 1H). <sup>13</sup>C NMR (CDCl<sub>3</sub>) δ 157.5, 152.7, 149.3, 148.0, 147.8, 139.0, 131.1, 130.0, 128.3, 123.6, 118.4, 117.4, 114.0, 104.5, 104.4, 102.3, 102.2, 101.2, 64.5, 57.0, 56.2, 56.2, 45.7, 27.5. HRMS (ESI) <i>m</i>/<i>z</i>: 435.1921 [M + H]<sup>+</sup>, calcd for C<sub>25</sub>H<sub>27</sub>N<sub>2</sub>O<sub>5</sub> 435.1914. ESI-MS <i>m</i>/<i>z</i>: 435.3 [M + H]<sup>+</sup>.</div></div><div id="sec4_11_2" class="NLM_sec NLM_sec_level_3"><div id="ac_i88" class="anchor-spacer"></div><h4 class="article-section__title" id="_i88"> 2,3-Dimethoxy-13-(3-diethylamino)propoxy)-[1,3]dioxolo[4′,5′:4,5]benzo[1,2-<i>c</i>]phenanthridine (<b>40b</b>)</h4><div class="NLM_p last">White powder, yield 61%, mp = 146.2–147.8 °C. IR (KBr, cm<sup>–1</sup>), 1620, 1594. <sup>1</sup>H NMR (DMSO) δ 8.45 (d, <i>J</i> = 9.0 Hz, 1H), 8.35 (s, 1H), 8.04 (s, 1H), 7.75 (d, <i>J</i> = 9.0 Hz, 1H), 7.57 (s, 1H), 7.43 (s, 1H), 6.19 (s, 2H), 4.71 (t, <i>J</i> = 6.4 Hz, 2H), 4.06 (s, 3H), 3.93 (s, 3H), 2.70 (t, <i>J</i> = 6.8 Hz, 2H), 2.53 (q, <i>J</i> = 7.2 Hz, 4H), 2.05 (quint, <i>J</i> = 6.8 Hz, 2H), 1.01 (t, <i>J</i> = 7.2 Hz, 6H). <sup>13</sup>C NMR (DMSO) δ 157.3, 153.3, 149.7, 148.2, 148.0, 138.3, 131.0, 130.1, 127.7, 123.9, 119.6, 117.5, 113.4, 104.7, 104.0, 103.6, 101.8, 101.4, 64.5, 56.4, 55.9, 49.1, 47.0, 26.4, 12.2. HRMS (ESI) <i>m</i>/<i>z</i>: 463.2233 [M + H]<sup>+</sup>, calcd for C<sub>27</sub>H<sub>31</sub>N<sub>2</sub>O<sub>5</sub> 463.2227. ESI-MS <i>m</i>/<i>z</i>: 463.2 [M + H]<sup>+</sup>.</div></div><div id="sec4_11_3" class="NLM_sec NLM_sec_level_3"><div id="ac_i89" class="anchor-spacer"></div><h4 class="article-section__title" id="_i89"> 2,3-Dimethoxy-13-(3-(pyrrolidin-1-yl)propoxy)-[1,3]dioxolo[4′,5′:4,5]benzo[1,2-<i>c</i>]phenanthridine (<b>41b</b>)</h4><div class="NLM_p last">White powder, yield 80%, mp = 162.8–163.9 °C. IR (KBr, cm<sup>–1</sup>), 1619, 1594. <sup>1</sup>H NMR (CDCl<sub>3</sub>) δ 8.48 (s, 1H), 8.07 (d, <i>J</i> = 8.8 Hz, 1H), 7.71 (s, 1H), 7.67–7.57 (m, 2H), 7.18 (s, 1H), 6.09 (s, 2H), 4.77 (t, <i>J</i> = 6.8 Hz, 2H), 4.10 (s, 3H), 4.05 (s, 3H), 2.78 (t, <i>J</i> = 6.8 Hz, 2H), 2.62 (s, br, 4H), 2.24 (quint, <i>J</i> = 6.8 Hz, 2H), 1.83 (s, br, 4H). <sup>13</sup>C NMR (CDCl<sub>3</sub>) δ 157.3, 152.5, 149.1, 147.9, 147.7, 138.8, 130.9, 129.9, 128.2, 123.5, 118.2, 117.2, 113.9, 104.3, 104.2, 102.1, 101.1, 64.5, 56.1, 56.0, 54.4, 53.7, 28.8, 23.5. HRMS (ESI) <i>m</i>/<i>z</i>: 461.2082 [M + H]<sup>+</sup>, calcd for C<sub>27</sub>H<sub>29</sub>N<sub>2</sub>O<sub>5</sub> 461.2071. ESI-MS <i>m</i>/<i>z</i>: 461.2 [M + H]<sup>+</sup>.</div></div><div id="sec4_11_4" class="NLM_sec NLM_sec_level_3"><div id="ac_i90" class="anchor-spacer"></div><h4 class="article-section__title" id="_i90"> 2,3-Dimethoxy-13-(3-(piperidin-1-yl)propoxy)-[1,3]dioxolo[4′,5′:4,5]benzo[1,2-<i>c</i>]phenanthridine (<b>42b</b>)</h4><div class="NLM_p last">White powder, yield, 81%, mp = 153.7–155.3 °C. IR (KBr, cm<sup>–1</sup>), 1618, 1593. <sup>1</sup>H NMR (CDCl<sub>3</sub>) δ 8.51 (s, 1H), 8.13 (d, <i>J</i> = 8.8 Hz, 1H), 7.77 (s, 1H), 7.69–7.60 (m, 2H), 7.21 (s, 1H), 6.10 (s, 2H), 4.78 (t, <i>J</i> = 6.2 Hz, 2H), 4.12 (s, 3H), 4.06 (s, 3H), 2.66 (t, <i>J</i> = 7.6 Hz, 2H), 2.51 (s, br, 4H), 2.24 (quint, <i>J</i> = 7.2 Hz, 2H), 1.72–1.58 (m, 4H), 1.55–1.41 (m, 2H). <sup>13</sup>C NMR (CDCl<sub>3</sub>) δ 157.4, 152.6, 149.2, 147.9, 147.7, 138.9, 130.9, 129.9, 128.2, 123.5, 118.3, 117.3, 113.9, 104.3, 104.3, 102.2, 102.1, 101.1, 64.6, 56.6, 56.1, 56.0, 54.7, 26.6, 25.9, 24.4. HRMS (ESI) <i>m</i>/<i>z</i>: 475.2229 [M + H]<sup>+</sup>, calcd for C<sub>28</sub>H<sub>31</sub>N<sub>2</sub>O<sub>5</sub> 475.2227. ESI-MS <i>m</i>/<i>z</i>: 475.2 [M + H]<sup>+</sup>.</div></div><div id="sec4_11_5" class="NLM_sec NLM_sec_level_3"><div id="ac_i91" class="anchor-spacer"></div><h4 class="article-section__title" id="_i91"> 2,3-Dimethoxy-13-(3-morpholinopropoxy)-[1,3]dioxolo[4′,5′:4,5]benzo[1,2-<i>c</i>]phenanthridine (<b>43b</b>)</h4><div class="NLM_p last">White powder, yield 65%, mp = 171.8–172.9 °C. IR (KBr, cm<sup>–1</sup>), 1618, 1593. <sup>1</sup>H NMR (CDCl<sub>3</sub>) δ 8.53 (s, 1H), 8.16 (d, <i>J</i> = 9.2 Hz, 1H), 7.82 (s, 1H), 7.69 (s, 1H), 7.67 (d, <i>J</i> = 8.8 Hz, 1H), 7.23 (s, 1H), 6.11 (s, 2H), 4.83 (t, <i>J</i> = 6.6 Hz, 2H), 4.13 (s, 3H), 4.07 (s, 3H), 3.76 (t, <i>J</i> = 4.8 Hz, 4H), 2.67 (t, <i>J</i> = 7.2 Hz, 2H), 2.56–2.53 (m, 4H), 2.22 (quint, <i>J</i> = 7.2 Hz, 2H). <sup>13</sup>C NMR (CDCl<sub>3</sub>) δ 157.3, 152.6, 149.2, 147.9, 147.7, 138.8, 130.9, 129.9, 128.2, 123.5, 118.2, 117.3, 113.9, 104.3, 104.3, 102.2, 102.0, 101.1, 67.0, 64.3, 56.1, 56.1, 56.0, 53.9, 26.3. HRMS (ESI) <i>m</i>/<i>z</i>: 477.2027 [M + H]<sup>+</sup>, calcd for C<sub>27</sub>H<sub>29</sub>N<sub>2</sub>O<sub>6</sub> 477.2020. ESI-MS <i>m</i>/<i>z</i>: 477.2 [M + H]<sup>+</sup>.</div></div><div id="sec4_11_6" class="NLM_sec NLM_sec_level_3"><div id="ac_i92" class="anchor-spacer"></div><h4 class="article-section__title" id="_i92"> 2,3-Dimethoxy-13-(3-(4-methylpiperazin-1-yl)propoxy)-[1,3]dioxolo[4′,5′:4,5]benzo[1,2-<i>c</i>]phenanthridine (<b>44b</b>)</h4><div class="NLM_p last">White powder, yield 65%, mp = 142.5–143.8 °C. IR (KBr, cm<sup>–1</sup>), 1619, 1593. <sup>1</sup>H NMR (CDCl<sub>3</sub>) δ 8.55 (s, 1H), 8.18 (d, <i>J</i> = 9.0 Hz, 1H), 7.83 (s, 1H), 7.70 (s, 1H), 7.68 (d, <i>J</i> = 8.8 Hz, 1H), 7.23 (s, 1H), 6.11 (s, 2H), 4.83 (t, <i>J</i> = 6.4 Hz, 2H), 4.14 (s, 3H), 4.07 (s, 3H), 2.70 (t, <i>J</i> = 7.2 Hz, 2H), 2.67–2.41 (m, 8H), 2.32 (s, 3H), 2.22 (quint, <i>J</i> = 7.2 Hz, 2H). <sup>13</sup>C NMR (CDCl<sub>3</sub>) δ 157.3, 152.6, 149.2, 147.9, 147.7, 138.9, 131.0, 129.9, 128.2, 123.5, 118.3, 117.3, 114.0, 104.4, 104.2, 102.2, 102.1, 101.1, 64.5, 56.1, 56.0, 55.8, 55.2, 53.4, 46.0, 26.7. HRMS (ESI) <i>m</i>/<i>z</i>: 490.2339 [M + H]<sup>+</sup>, calcd for C<sub>28</sub>H<sub>32</sub>N<sub>3</sub>O<sub>5</sub> 490.2336. ESI-MS <i>m</i>/<i>z</i>: 490.23 [M + H]<sup>+</sup>.</div></div><div id="sec4_11_7" class="NLM_sec NLM_sec_level_3"><div id="ac_i93" class="anchor-spacer"></div><h4 class="article-section__title" id="_i93"> 13-(3-(1<i>H</i>-Imidazol-1-yl)propoxy)-2,3-dimethoxy-[1,3]dioxolo[4′,5′:4,5]benzo[1,2-<i>c</i>]phenanthridine (<b>45b</b>)</h4><div class="NLM_p last">White powder, yield 62%, mp = 217.4–218.5 °C. IR (KBr, cm<sup>–1</sup>), 1618, 1591. <sup>1</sup>H NMR (CDCl<sub>3</sub>) δ 8.47 (s, 1H), 8.19 (d, <i>J</i> = 8.8 Hz, 1H), 7.84 (s, 1H), 7.70 (d, <i>J</i> = 8.8 Hz, 1H), 7.64 (s, 1H), 7.60 (s, 1H), 7.25 (s, 1H), 7.12 (s, 1H), 7.03 (s, 1H), 6.13 (s, 2H), 4.83 (t, <i>J</i> = 6.0 Hz, 2H), 4.28 (t, <i>J</i> = 6.8 Hz, 2H), 4.16 (s, 3H), 4.11 (s, 3H), 2.53 (quint, <i>J</i> = 6.4 Hz, 2H). <sup>13</sup>C NMR (CDCl<sub>3</sub>) δ 156.8, 152.9, 149.4, 148.1, 147.8, 138.6, 137.2, 131.2, 130.0, 129.8, 128.1, 123.9, 118.9, 118.2, 117.5, 113.6, 104.3, 104.1, 102.4, 101.9, 101.2, 62.6, 56.1, 56.1, 44.3, 30.7. HRMS (ESI) <i>m</i>/<i>z</i>: 458.1712 [M + H]<sup>+</sup>, calcd for C<sub>26</sub>H<sub>24</sub>N<sub>3</sub>O<sub>5</sub> 458.1710. ESI-MS <i>m</i>/<i>z</i>: 458.2 [M + H]<sup>+</sup>.</div></div></div><div id="sec4_12" class="NLM_sec NLM_sec_level_2"><div id="ac_i94" class="anchor-spacer"></div><h3 class="article-section__title" id="_i94"> TOP1-Mediated Cleavage Assay</h3><div class="NLM_p last">DNA cleavage assays were performed as previously reported.<a onclick="showRef(event, 'ref73'); return false;" href="javascript:void(0);" class="ref ref73">(73)</a> A 3′-[<sup>32</sup>P]-labeled 117-bp DNA oligonucleotide was prepared as previously described.<a onclick="showRef(event, 'ref73'); return false;" href="javascript:void(0);" class="ref ref73">(73)</a> Approximately 2 nM radiolabeled DNA substrate was incubated with recombinant TOP1 in 20 mL of reaction buffer (10 mM Tris-HCl pH 7.5, 50 mM KCl, 5 mM MgCl<sub>2</sub>, 0.1 mM EDTA, and 15 mg/mL BSA) at 25 °C for 20 min in the presence of various concentrations of test compounds. The reactions were terminated by adding SDS (0.5% final concentration), followed by the addition of two volumes of loading dye (80% formamide, 10 mM sodium hydroxide, 1 mM sodium EDTA, 0.1% xylene cyanol, and 0.1% bromophenol blue). Aliquots of each reaction mixture were subjected to 20% denaturing PAGE. Gels were dried and visualized by using a phosphoimager and ImageQuant software (Molecular Dynamics). Cleavage sites are numbered to reflect actual sites on the 117-bp oligonucleotide.</div></div><div id="sec4_13" class="NLM_sec NLM_sec_level_2"><div id="ac_i95" class="anchor-spacer"></div><h3 class="article-section__title" id="_i95"> TOP1-Mediated Unwinding Assay</h3><div class="NLM_p last">The unwinding assay was performed according to the reported method.<a onclick="showRef(event, 'ref78'); return false;" href="javascript:void(0);" class="ref ref78">(78)</a> Briefly, the reaction mixture (20 μL) contained supercoiled or relaxed pBR322 DNA (0.5 μg), tested compounds, and excess TOP1 (10 units) in relaxing buffer (10 mM Tris, pH 7.5, 0.1 mM EDTA, 5 mM MgCl<sub>2</sub>, 50 mM KCl, 1 mM DTT, 15 μg/mL acetylated BSA). The DNA was incubated with the tested compounds at room temperature for 10 min prior to the addition of TOP1. After being incubated for 30 min at 37 °C, the reaction was terminated by the addition of 4 mL of loading buffer. The results were analyzed using 1% agarose gel in TAE buffer at 5 V/cm. The gel was stained with gel red and visualized with a UV transilluminator.</div></div><div id="sec4_14" class="NLM_sec NLM_sec_level_2"><div id="ac_i96" class="anchor-spacer"></div><h3 class="article-section__title" id="_i96"> TDP1 Inhibition Assay</h3><div id="sec4_14_1" class="NLM_sec NLM_sec_level_3"><div id="ac_i97" class="anchor-spacer"></div><h4 class="article-section__title" id="_i97">A.  Fluorescence Assay</h4><div class="NLM_p last">The TDP1 fluorescence assay was conducted according to the reported method.<a onclick="showRef(event, 'ref50'); return false;" href="javascript:void(0);" class="ref ref50">(50)</a> Briefly, a linear oligonucleotide labeled with <i>FAM</i> (donorfluorophore, 6-carboxyfluorescein) and <i>BHQ</i> (Black Hole Quencher), 5′-<i>FAM</i>-AGGATCTAAAAGACTT-<i>BHQ</i>-3′ was designed as a linear quenched fluorescent substrate. TDP1 solution (20 μL/well, 0.02 μL of purified TDP1 (100 nM) in 10 mM Tris-HCl, pH 7.5, 50 mM KCl, 1 mM EDTA, 1 mM DTT) was dispensed into wells of a white 384-well plate (NEST). The tested compound solution in DMSO (5 μL) was pinned into assay plates and incubated at room temperature for 30 min. During this time, the plates were read by a Flash multimode reader (Molecular Devices) at Ex<sub>485</sub>/Em<sub>510</sub> nm to identify false-positive compounds that had autofluorescence. The linear oligonucleotide substrate (25 μL, 35 nM) was dispensed into the wells to start the reaction. The whole plate was immediately read five times using a kinetic read on the Flash multimode reader (Molecular Devices) (Ex<sub>485</sub>/Em<sub>510</sub> nm). TDP1 percentage inhibition of the tested compounds was calculated by comparing the rate of increase in fluorescence throughout time for the compound-treated wells to that of DMSO control wells.</div></div><div id="sec4_14_2" class="NLM_sec NLM_sec_level_3"><div id="ac_i98" class="anchor-spacer"></div><h4 class="article-section__title" id="_i98">B.  Gel-Based Assay<a onclick="showRef(event, 'ref76'); return false;" href="javascript:void(0);" class="ref ref76">(76)</a></h4><div class="NLM_p last">A 5′-[<sup>32</sup>P]-labeled single-stranded DNA oligonucleotide containing a 3′-phosphotyrosine (N14Y) was incubated at 1 nM with 10 pM recombinant human TDP1 in the absence or presence of inhibitor for 15 min at room temperature in buffer containing 50 mM Tris HCl, pH 7.5, 80 mM KCl, 2 mM EDTA, 1 mM DTT, 40 μg/mL BSA, and 0.01% Tween-20. Reactions were terminated by the addition of 1 volume of gel loading buffer [99.5% (v/v) formamide, 5 mM EDTA, 0.01% (w/v) xylene cyanol, and 0.01% (w/v) bromophenol blue]. Samples were subjected to a 16% denaturing PAGE. Gels were dried and exposed to a PhosphorImager screen (GE Healthcare). Gel images were scanned using a Typhoon FLA 9500 scanner (GE Healthcare), and densitometry analyses were performed using the ImageQuant software (GE Healthcare)</div></div></div><div id="sec4_14_3" class="NLM_sec NLM_sec_level_2"><div id="ac_i99" class="anchor-spacer"></div><h3 class="article-section__title" id="_i99"> Melecular Modeling</h3><div class="NLM_p">The X-ray crystal structures of the ternary TOP1–DNA–ligand complex (PDB <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=1K4T">1K4T</a>) was obtained and cleaned and inspected for errors and missing residues, hydrogens were added, and the water molecules and the ligand were deleted. The ternary complex ligand centroid coordinates for docking were defined using the ligand in the complex structure as the center of the binding pocket. Compounds were constructed and optimized using ChemDraw and saved in SDFfile formats and were corrected using MOE software. Hydrogens were added, and the ligands were minimized by the conjugate gradient method using the MMFF94x force field with MMFF94 charges, a distance-dependent dielectric function, and a 0.01 kcal/mol·Å energy gradient convergence criterion. Induced fit was used for docking with the default parameters. The top 30 docking poses per ligand were inspected visually following the docking runs. The highest-ranked poses for these ligands were merged into the crystal structure. Energy minimizations were performed for the highest-ranked poses for these ligands. The AMBER force field was utilized within the MOE software for energy minimization.</div><div class="NLM_p last">The TDP1 crystal structure (PDB <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=1RFF">1RFF</a>) was prepared by removing one of the monomers along with all crystallized waters, the polydeoxyribonucleotide, the TOP1-derived peptide residues, and all metal ions. LigX in AMBER10 force field with MOE. Site Finder was used to get the binding pocket containing Lys265, Lys495, and His493. Docking was performed with induced fit protocol in MOE. The top ligand-binding pose (lowest score) was selected and merged with the prepared protein. The AMBER force field was utilized within the MOE software for energy minimization. The calculation was terminated when the gradient reached a value of 0.05 kcal/mol·Å.</div></div><div id="sec4_14_4" class="NLM_sec NLM_sec_level_2"><div id="ac_i100" class="anchor-spacer"></div><h3 class="article-section__title" id="_i100"> FRET Melting Assay</h3><div class="NLM_p last">FRET melting assay was carried out on a real-time PCR apparatus as the following methods. The oligonucleotide labeled with <i>FAM</i> (donorfluorophore, 6-carboxyfluorescein) and <i>TAMRA</i> (acceptor fluorophore, 6-carboxytetramethylrhodamine), F10T (5′-<i>FAM</i>-d(TATAGCTATA-HEG-TATAGCTATA)-<i>TAMARA</i>-3′), was purchased from Sangon Biotech. In the experiment, the annealed oligonucleotide (final concentration of 0.4 μM) were incubated with the tested compounds (2 μM) in a total reaction volume of Tris-HCl buffer (10 mM, pH 7.4) containing 60 mM KCl at 37 °C for 0.5 h. Fluorescence melting curves were determined with a Roche LightCycler 2 real-time PCR machine with excitation at 470 nm and detection at 530 nm. Fluorescence readings were taken at an interval of 1 °C over the range 37–99 °C, with a constant temperature being maintained for 30 s prior to each reading to ensure a stable value.</div></div><div id="sec4_14_5" class="NLM_sec NLM_sec_level_2"><div id="ac_i101" class="anchor-spacer"></div><h3 class="article-section__title" id="_i101"> Cell Culture and MTT Assay</h3><div class="NLM_p">The cells were cultured on RPMI-1640 medium at 37 °C in a humidified atmosphere with 5% CO<sub>2</sub>. All cells to be tested in the following assays had a passage number of 3–6.</div><div class="NLM_p">For the cytotoxicity measurements, the cancer cells were treated with the compounds (predissolved in DMSO) at a five-dose assay ranging from 0.01 to 100 μM (0.001–10 μM for camptothecin) concentration. After incubation for 72 h at 37 °C, MTT solution (50 μL, 1 mg/mL) in PBS (PBS without MTT as the blank) was fed to each well of the culture plate (containing 100 mL medium). After 4 h incubation, the formazan crystal formed in the well was dissolved with 100 mL of DMSO for optical density reading at 570 nm.<a onclick="showRef(event, 'ref89'); return false;" href="javascript:void(0);" class="ref ref89">(89)</a> The GI<sub>50</sub> value was calculated by nonlinear regression analysis (GraphPad Prism).</div><div class="NLM_p last">For the drug combination experiments, human breast cancer MCF-7 cells were incubated with camptothecin and the tested compounds for 96 h at 37 °C, and then measured by MTT assay.</div></div><div id="sec4_14_6" class="NLM_sec NLM_sec_level_2"><div id="ac_i102" class="anchor-spacer"></div><h3 class="article-section__title" id="_i102"> Immunodetection of Cellular TOP1–DNA Complex</h3><div class="NLM_p last">The ICE assays for cellular TOP1–DNA adduct was performed according to the reported method.<a onclick="showRef(event, 'ref90'); return false;" href="javascript:void(0);" class="ref ref90">(90)</a> Briefly, mid log phase HCT-116 cells were incubated with drugs at the indicated concentration for 1 h, and then the cells were lysed with DNAzol reagent (1 mL) at 25 °C for 30 min. Ethanol (0.5 mL, 100%) was subsequently added and mixed with the lysate, and the solution was incubated overnight at −20 °C. The genomic DNA was collected by centrifugation (12000 rpm) at 25 °C for 10 min and washed with 75% ethanol. The precipitated DNA was dissolved in NaOH (8 mM, 0.2 mL). The pH value was adjusted to 7.2 by adding HEPES (1 M). After centrifugation, supernatant was used to quantify the DNA concentration. DNA (2 μg) was dissolved in 30 μL of NaH<sub>2</sub>PO<sub>4</sub> buffer (25 mM, pH 6.5) and then loaded onto nitrocellulose membranes. Membranes were incubated with rabbit monoclonal to human TOP1 (Abcam, 1:1000) overnight at 4 °C and then incubated with the appropriate HRP-conjugated secondary antibodies (Cell Signaling Technology, 1:3000) at room temperature for 1 h. Reactive dots were detected using Immobilon Western Chemiluminescent HRP substrate (Millipore).</div></div><div id="sec4_14_7" class="NLM_sec NLM_sec_level_2"><div id="ac_i103" class="anchor-spacer"></div><h3 class="article-section__title" id="_i103"> γH2AX Detection</h3><div class="NLM_p last">γH2AX staining was performed as described.<a onclick="showRef(event, 'ref74'); return false;" href="javascript:void(0);" class="ref ref74">(74)</a> Briefly, HCT116 cells (2 × 10<sup>4</sup> cells/mL) were grown in culture medium and treated with compounds for 3 h at 37 °C. After incubation, cells were fixed in 4% paraformaldehyde/PBS for 15 min at 25 °C and washed three times with PBS buffer. Cells were permeabilized with 0.5% Triton X-100 in PBS at 0 °C for 30 min. Dish was blocked with 5% goat serum/PBS at 37 °C for 3 h. Immunofluorescence assay was performed using standard methods, and the slides were incubated alternately with phospho-γH2AX (Ser139; no. 9718, Cell Signaling Technology) at 37 °C overnight. The coverslips were washed six times with blocking buffer and then incubated with antirabbit alexa 488-conjugated antibody (A21206, Life Technology) and 2.0 μg/mL of 4′,6-diamidino-2-phenylindole (DAPI, Invitrogen) at 37 °C for 2 h. The dishes were again washed six times with blocking buffer. Digital images were recorded using an LSM710 microscope (Zeiss, Germany) and analyzed with ZEN software.</div></div><div id="sec4_14_8" class="NLM_sec NLM_sec_level_2"><div id="ac_i104" class="anchor-spacer"></div><h3 class="article-section__title" id="_i104"> Flow Cytometry</h3><div class="NLM_p last">HCT116 cells (3.0 × 10<sup>5</sup> cells/mL) were grown in culture medium on a 6-well plate treated with compound at the indicated concentration for 24 h. Then the cells were harvested from the medium and washed with cold PBS, resuspended in 1× binding buffer, and then stained with 5.0 μL of FITC annexin V and 10.0 μL of propidium iodide (KeyGen Biotech, China) for 15 min in the dark. The stained cells were analyzed by using flow cytometry (BD, FACSCalibur, USA) within 1 h. The experiments were repeated three times independently.</div></div><div id="sec4_14_9" class="NLM_sec NLM_sec_level_2"><div id="ac_i105" class="anchor-spacer"></div><h3 class="article-section__title" id="_i105"> Pharmacokinetic Study in Rat</h3><div class="NLM_p last">Male SD rats (weighing 220–250 g, <i>n</i> = 3) were treated with compound <b>19a</b> predissolved in 10% DMSO and 10% Kolliphor HS15 (a nonionic solubilizer) by iv (1 mg/kg) and by ig administration (5 mg/kg), respectively. Blood samples (200 μL) were collected into heparinized tubes via the jugular vein at the following times: 0.083, 0.25, 0.5, 1, 2, 5, 7, and 24 h after dosing. Plasma samples (100 μL) were obtained after centrifugation for 10 min at 3000 rpm and stored at −20 °C until used for analysis. The plasma was detected through LC-MS-MS.</div></div><div id="sec4_14_10" class="NLM_sec NLM_sec_level_2"><div id="ac_i106" class="anchor-spacer"></div><h3 class="article-section__title" id="_i106"> In Vivo Acute Toxicity</h3><div class="NLM_p last">On the basis of the preliminary experiments, the Kuning male mice were randomly divided into six groups (<i>n</i> = 4) and administered by intraperitoneal (ip) injection. The control group was treated with an equivalent volume of sterile water. The testing groups were treated with compound <b>19a</b> in a single dose 300, 240, 192, 154, and 123 mg/kg, respectively. The mice were kept under observation for 7 days post-treatment in order to check for any behavioral (poisoning symptoms and body weight) and death. All animals were euthanized by cervical dislocation at the end of the experiments.</div></div><div id="sec4_14_11" class="NLM_sec NLM_sec_level_2"><div id="ac_i107" class="anchor-spacer"></div><h3 class="article-section__title" id="_i107"> In Vivo Antitumor Activity</h3><div class="NLM_p last">Athymic nude mice bearing the nu/nu gene were obtained from Laboratory Animal Center of Sun Yat-sen University and maintained in pathogen-free conditions to establish the model of xenografts of HCT116. Male nude mice 4–5 weeks old weighing 12–15 g were used. HCT116 tumor preinduced in the mice by subcutaneously injecting of HCT116 cells (100 μL, 1 × 10<sup>7</sup> cells) was implanted. When the implanted tumors had reached a volume of about 80 mm<sup>3</sup>, the mice were randomly divided into three groups (<i>n</i> = 6) and administered by ip injection. The testing groups were treated with <b>19a</b> in 10 and 5 mg/kg dose once every day, respectively. The negative control group was treated with an equivalent volume of saline. Tumor volumes (<i>V</i>) were monitored by caliper measurement of the length and width and calculated using the formula: <i>V</i> = (larger diameter × smaller diameter)<sup>2</sup>/2, and growth curves were plotted using average tumor volume within each experimental group at the set time points. At the end of the experiment, all of the animals were euthanized by cervical dislocation. The tumors were removed and weighed. The tumor weight inhibition (TWI) was calculated according to the formula: TWI = (1 – mean tumor weight of the experimental group/mean tumor weight of the control group) × 100%.</div></div><div id="sec4_15" class="NLM_sec NLM_sec_level_2"><div id="ac_i108" class="anchor-spacer"></div><h3 class="article-section__title" id="_i108"> Statistical Analysis</h3><div class="NLM_p last">All data are expressed as the mean ± standard deviation. Statistical comparisons were conducted using a one-way analysis of variance (ANOVA) using the Prism statistical software package (GraphPad Software, USA), followed by Tukey’s test.</div></div></div><div class="NLM_back"><div class="article_supporting-info" id="notes4"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i109"><a href="/doi/suppl/10.1021/acs.jmedchem.8b00639" class="ext-link">Supporting Information</a></h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_32465" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_32465" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><p class="last">The Supporting Information is available free of charge on the <a href="/" class="ext-link">ACS Publications website</a> at DOI: <a href="/doi/abs/10.1021/acs.jmedchem.8b00639" class="ext-link">10.1021/acs.jmedchem.8b00639</a>.<ul class="NLM_list-list_type-label" id="silist"><li><p class="inline">TOP1-mediated cleavage assay gel of compound <b>6</b> (<a href="/doi/suppl/10.1021/acs.jmedchem.8b00639/suppl_file/jm8b00639_si_001.pdf" class="ext-link">PDF</a>)</p></li><li><p class="inline">X-ray crystallography file of compound <b>20b</b> (<a href="/doi/suppl/10.1021/acs.jmedchem.8b00639/suppl_file/jm8b00639_si_002.cif" class="ext-link">CIF</a>)</p></li><li><p class="inline">Docking results of <b>19a</b> with TOP1cc (<a href="/doi/suppl/10.1021/acs.jmedchem.8b00639/suppl_file/jm8b00639_si_003.pdb" class="ext-link">PDB</a>)</p></li><li><p class="inline">Docking results of <b>41a</b> with TDP1 (<a href="/doi/suppl/10.1021/acs.jmedchem.8b00639/suppl_file/jm8b00639_si_004.pdb" class="ext-link">PDB</a>)</p></li><li><p class="inline">Molecular formula strings (<a href="/doi/suppl/10.1021/acs.jmedchem.8b00639/suppl_file/jm8b00639_si_005.csv" class="ext-link">CSV</a>)</p></li></ul></p><div class="supInfoBoxOnFTP "><div class="sup-info-attachments"><ul><li><a class="suppl-anchor" href="/doi/suppl/10.1021/acs.jmedchem.8b00639/suppl_file/jm8b00639_si_001.pdf">jm8b00639_si_001.pdf (486.42 kb)</a></li><li><a class="suppl-anchor" href="/doi/suppl/10.1021/acs.jmedchem.8b00639/suppl_file/jm8b00639_si_002.cif">jm8b00639_si_002.cif (389.8 kb)</a></li><li><a class="suppl-anchor" href="/doi/suppl/10.1021/acs.jmedchem.8b00639/suppl_file/jm8b00639_si_003.pdb">jm8b00639_si_003.pdb (913.44 kb)</a></li><li><a class="suppl-anchor" href="/doi/suppl/10.1021/acs.jmedchem.8b00639/suppl_file/jm8b00639_si_004.pdb">jm8b00639_si_004.pdb (561.94 kb)</a></li><li><a class="suppl-anchor" href="/doi/suppl/10.1021/acs.jmedchem.8b00639/suppl_file/jm8b00639_si_005.csv">jm8b00639_si_005.csv (7.63 kb)</a></li></ul></div></div></div><div class="testing" data-doi="10.1021/acs.jmedchem.8b00639" data-url="https://widgets.figshare.com/static/figshare.js" id="figshare-widget"></div><div class="TermsAndConditionsDropzone3" data-pb-dropzone="TermsAndConditionsDropzone3"><div data-widget-def="UX3HTMLWidget" data-widget-id="85b54935-30e9-4058-a6d2-0b40fb754a85" class="mb-4">
        



        
            <h2 class="">
                Terms & Conditions
            </h2>
        
        <p>Most electronic Supporting Information files are available without a subscription to ACS Web Editions. Such files may be downloaded by article for research use (if there is a public use license linked to the relevant article, that license may permit other uses). Permission may be obtained from ACS for other uses through requests via the RightsLink permission system: <a href="/page/copyright/permissions.html" title="RightsLink">http://pubs.acs.org/page/copyright/permissions.html</a>.</p>

        </div></div><div class="authorInformationSection"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="authorInformationSection">Author Information</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_80805" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_80805" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><ul><li><span class="author-information-subsection-header">Corresponding Authors</span><ul><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Yves Pommier</span> - <span class="hlFld-Affiliation affiliation">Developmental
Therapeutics Branch and Laboratory of Molecular Pharmacology, Center
for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, Maryland 20892, United States</span>; 
    <span class="author-email">
                Email: <a href="/cdn-cgi/l/email-protection#7f0f101212161a0d3f11161751181009"><span class="__cf_email__" data-cfemail="2757484a4a4e425567494e4f09404851">[email protected]</span></a></span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Lin-Kun An</span> - <span class="hlFld-Affiliation affiliation">School
of Pharmaceutical Sciences, Sun Yat-sen
University, Guangzhou 510006, China</span>; 
    <span class="author-orcid"><img src="/products/achs/releasedAssets/images/orchid.png" alt="Orcid" /></img><a href="http://orcid.org/0000-0002-6088-1503" title="Orcid link">http://orcid.org/0000-0002-6088-1503</a>; 
    </span><span class="author-email">
                Email: <a href="/cdn-cgi/l/email-protection#90fce3e3f1fcfbd0fdf1f9fcbee3e9e3e5bef5f4e5bef3fe"><span class="__cf_email__" data-cfemail="7519060614191e3518141c195b060c06005b1011005b161b">[email protected]</span></a></span></div></li></ul></li><li><span class="author-information-subsection-header">Authors</span><ul><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Xiao-Ru Zhang</span> - <span class="hlFld-Affiliation affiliation">School
of Pharmaceutical Sciences, Sun Yat-sen
University, Guangzhou 510006, China</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Hao-Wen Wang</span> - <span class="hlFld-Affiliation affiliation">School
of Pharmaceutical Sciences, Sun Yat-sen
University, Guangzhou 510006, China</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Wen-Lin Tang</span> - <span class="hlFld-Affiliation affiliation">School
of Pharmaceutical Sciences, Sun Yat-sen
University, Guangzhou 510006, China</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Yu Zhang</span> - <span class="hlFld-Affiliation affiliation">School
of Pharmaceutical Sciences, Sun Yat-sen
University, Guangzhou 510006, China</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Hui Yang</span> - <span class="hlFld-Affiliation affiliation">School
of Pharmaceutical Sciences, Sun Yat-sen
University, Guangzhou 510006, China</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">De-Xuan Hu</span> - <span class="hlFld-Affiliation affiliation">School
of Pharmaceutical Sciences, Sun Yat-sen
University, Guangzhou 510006, China</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Azhar Ravji</span> - <span class="hlFld-Affiliation affiliation">Developmental
Therapeutics Branch and Laboratory of Molecular Pharmacology, Center
for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, Maryland 20892, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Christophe Marchand</span> - <span class="hlFld-Affiliation affiliation">Developmental
Therapeutics Branch and Laboratory of Molecular Pharmacology, Center
for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, Maryland 20892, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Evgeny Kiselev</span> - <span class="hlFld-Affiliation affiliation">Developmental
Therapeutics Branch and Laboratory of Molecular Pharmacology, Center
for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, Maryland 20892, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Kwabena Ofori-Atta</span> - <span class="hlFld-Affiliation affiliation">Developmental
Therapeutics Branch and Laboratory of Molecular Pharmacology, Center
for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, Maryland 20892, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Keli Agama</span> - <span class="hlFld-Affiliation affiliation">Developmental
Therapeutics Branch and Laboratory of Molecular Pharmacology, Center
for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, Maryland 20892, United States</span></div></li></ul></li><li><span class="author-information-subsection-header">Author Contributions</span><p>X.-R.Z. and H.-W.W. contributed equally.</p></li><li></li><li><span class="author-information-subsection-header">Notes</span><div class="authorInformation_notesSection">The authors declare no competing financial interest.<br /></br></div></li></ul></div><div class="ack" id="ack1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i111">Acknowledgments</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_78875" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_78875" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><p class="last">This work was supported by the National Natural Science Foundation of China (no. 81373257), Natural Science Foundation of Guangdong Province (no. S2013010015609), and supported by the Intramural Program of the National Cancer Institute (Center for Cancer Research), National Institutes of Health, Bethesda, Maryland, USA (Z01 BC 006150-19).</p></div><table summary="" class="NLM_def-list" id="dl1"><tr><td colspan="2" class="NLM_title">Abbreviations Used</td></tr><tr><td class="NLM_term">TOP1</td><td class="NLM_def"><p class="first last">topoisomerase IB</p></td></tr><tr><td class="NLM_term">TOP1cc</td><td class="NLM_def"><p class="first last">TOP1 cleavage complex</p></td></tr><tr><td class="NLM_term">TDP1</td><td class="NLM_def"><p class="first last">tyrosyl DNA-phosphodiesterase 1</p></td></tr><tr><td class="NLM_term">dsDNA</td><td class="NLM_def"><p class="first last">double-stranded DNA</p></td></tr><tr><td class="NLM_term">P-gp</td><td class="NLM_def"><p class="first last">P-glycoprotein</p></td></tr><tr><td class="NLM_term">ICE</td><td class="NLM_def"><p class="first last">immunocomplex of enzyme to DNA</p></td></tr><tr><td class="NLM_term">FRET</td><td class="NLM_def"><p class="first last">fluorescence resonance energy transfer</p></td></tr><tr><td class="NLM_term">MOM</td><td class="NLM_def"><p class="first last">methoxymethyl</p></td></tr><tr><td class="NLM_term">PMB</td><td class="NLM_def"><p class="first last"><i>p</i>-methoxybenzyl</p></td></tr><tr><td class="NLM_term">NMR</td><td class="NLM_def"><p class="first last">nuclear magnetic resonance</p></td></tr><tr><td class="NLM_term">HRMS</td><td class="NLM_def"><p class="first last">high-resolution mass spectra</p></td></tr><tr><td class="NLM_term">TLC</td><td class="NLM_def"><p class="first last">thin layer chromatography</p></td></tr><tr><td class="NLM_term">HPLC</td><td class="NLM_def"><p class="first last">high performance liquid chromatography</p></td></tr></table><div class="refs-header-label"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i113">References</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_37757" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_37757" class="dropBlock__holder"></div></div></div></div></div><hr /></hr></div><p class="references-count">
            This article references 90 other publications.
        </p><ol id="references" class="useLabel"><li id="ref1"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref1'); return false;" data-citation="" class="refNumLink">1</a></strong><div class="NLM_citation" id="cit1"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Stewart, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Redinbo, M. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Qiu, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hol, W. G. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Champoux, J. J.</span></span> <span> </span><span class="NLM_article-title">A model for the mechanism of human topoisomerase I</span>. <i>Science</i> <span class="NLM_year" style="font-weight: bold;">1998</span>,  <span class="NLM_volume"><i>279</i></span>,  <span class="NLM_fpage">1534</span>– <span class="NLM_lpage">1541</span>, <span class="refDoi"> DOI: 10.1126/science.279.5356.1534</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00639&amp;key=10.1126%2Fscience.279.5356.1534" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00639&amp;key=9488652" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00639&amp;key=1%3ACAS%3A528%3ADyaK1cXhs1Kmurk%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=279&publication_year=1998&pages=1534-1541&author=L.+Stewartauthor=M.+R.+Redinboauthor=X.+Qiuauthor=W.+G.+J.+Holauthor=J.+J.+Champoux&title=A+model+for+the+mechanism+of+human+topoisomerase+I&doi=10.1126%2Fscience.279.5356.1534"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit1R"><div class="casContent"><span class="casTitleNuber">1</span><div class="casTitle"><span class="NLM_cas:atitle">A model for the mechanism of human topoisomerase I</span></div><div class="casAuthors">Stewart, Lance; Redinbo, Matthew R.; Qiu, Xiayang; Hol, Wim G. J.; Champoux, James J.</div><div class="citationInfo"><span class="NLM_cas:title">Science (Washington, D. C.)</span>
        (<span class="NLM_cas:date">1998</span>),
    <span class="NLM_cas:volume">279</span>
        (<span class="NLM_cas:issue">5356</span>),
    <span class="NLM_cas:pages">1534-1540</span>CODEN:
                <span class="NLM_cas:coden">SCIEAS</span>;
        ISSN:<span class="NLM_cas:issn">0036-8075</span>.
    
            (<span class="NLM_cas:orgname">American Association for the Advancement of Science</span>)
        </div><div class="casAbstract">The 3-dimensional structure of a 70-kDa N-terminally truncated form of human DNA topoisomerase I in complex with a 22-base-pair duplex oligonucleotide, detd. to a resoln. of 2.8 Å, revealed all of the structural elements of the enzyme that contact DNA.  The linker region that connects the central core of the enzyme to the C-terminal domain assumed a coiled-coil configuration and protruded away from the remainder of the enzyme.  The pos. charged DNA-proximal surface of the liner made only a few contacts with the DNA downstream of the cleavage site.  In combination with the crystal structures of reconstituted human topoisomerase I before and after DNA cleavage, this information suggested which amino acid residues are involved in catalyzing phosphodiester bond breakage and religation.  The structures also led to the proposal that the topoisomerization step occurs by a mechanism termed "controlled rotation.".</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoaj4qczHgbVbVg90H21EOLACvtfcHk0ljCB7v7oOOqVw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK1cXhs1Kmurk%253D&md5=bf63a56b0cc238c80be98cb95ca398fe</span></div><a href="/servlet/linkout?suffix=cit1&amp;dbid=16384&amp;doi=10.1126%2Fscience.279.5356.1534&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1126%252Fscience.279.5356.1534%26sid%3Dliteratum%253Aachs%26aulast%3DStewart%26aufirst%3DL.%26aulast%3DRedinbo%26aufirst%3DM.%2BR.%26aulast%3DQiu%26aufirst%3DX.%26aulast%3DHol%26aufirst%3DW.%2BG.%2BJ.%26aulast%3DChampoux%26aufirst%3DJ.%2BJ.%26atitle%3DA%2520model%2520for%2520the%2520mechanism%2520of%2520human%2520topoisomerase%2520I%26jtitle%3DScience%26date%3D1998%26volume%3D279%26spage%3D1534%26epage%3D1541%26doi%3D10.1126%2Fscience.279.5356.1534" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref2"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref2'); return false;" data-citation="" class="refNumLink">2</a></strong><div class="NLM_citation" id="cit2"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Champoux, J. J.</span></span> <span> </span><span class="NLM_article-title">DNA topoisomerases: structure, function, and mechanism</span>. <i>Annu. Rev. Biochem.</i> <span class="NLM_year" style="font-weight: bold;">2001</span>,  <span class="NLM_volume"><i>70</i></span>,  <span class="NLM_fpage">369</span>– <span class="NLM_lpage">413</span>, <span class="refDoi"> DOI: 10.1146/annurev.biochem.70.1.369</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00639&amp;key=10.1146%2Fannurev.biochem.70.1.369" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00639&amp;key=11395412" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00639&amp;key=1%3ACAS%3A528%3ADC%252BD3MXlsVeht7Y%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=70&publication_year=2001&pages=369-413&author=J.+J.+Champoux&title=DNA+topoisomerases%3A+structure%2C+function%2C+and+mechanism&doi=10.1146%2Fannurev.biochem.70.1.369"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit2R"><div class="casContent"><span class="casTitleNuber">2</span><div class="casTitle"><span class="NLM_cas:atitle">DNA topoisomerases: structure, function, and mechanism</span></div><div class="casAuthors">Champoux, James J.</div><div class="citationInfo"><span class="NLM_cas:title">Annual Review of Biochemistry</span>
        (<span class="NLM_cas:date">2001</span>),
    <span class="NLM_cas:volume">70</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">369-413</span>CODEN:
                <span class="NLM_cas:coden">ARBOAW</span>;
        ISSN:<span class="NLM_cas:issn">0066-4154</span>.
    
            (<span class="NLM_cas:orgname">Annual Reviews Inc.</span>)
        </div><div class="casAbstract">A review with 196 refs.  DNA topoisomerases solve the topol. problems assocd. with DNA replication, transcription, recombination, and chromatin remodeling by introducing temporary single- or double-strand breaks in the DNA.  In addn., these enzymes fine-tune the steady-state level of DNA supercoiling both to facilitate protein interactions with the DNA and to prevent excessive supercoiling that is deleterious.  In recent years, the crystal structures of a no. of topoisomerase fragments, representing nearly all of the known classes of enzymes, have been solved.  These structures provide remarkable insights into the mechanisms of these enzymes and complement previous conclusions based on biochem. analyses.  Surprisingly, despite little or no sequence homol., both type IA and type IIA topoisomerases from prokaryotes and the type IIA enzymes from eukaryotes share structural folds that appear to reflect functional motifs within crit. regions of the enzymes.  The type IB enzymes are structurally distinct from all other known topoisomerases but are similar to a class of enzymes referred to as tyrosine recombinases.  The structural themes common to all topoisomerases include hinged clamps that open and close to bind DNA, the presence of DNA binding cavities for temporary storage of DNA segments, and the coupling of protein conformational changes to DNA rotation or DNA movement.  For the type II topoisomerases, the binding and hydrolysis of ATP further modulate conformational changes in the enzymes to effect changes in DNA topol.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGq5Y4rDyIYy17Vg90H21EOLACvtfcHk0lif0BmbWWE2rQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3MXlsVeht7Y%253D&md5=67c3e38eb4fcb85527b33d7077309482</span></div><a href="/servlet/linkout?suffix=cit2&amp;dbid=16384&amp;doi=10.1146%2Fannurev.biochem.70.1.369&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1146%252Fannurev.biochem.70.1.369%26sid%3Dliteratum%253Aachs%26aulast%3DChampoux%26aufirst%3DJ.%2BJ.%26atitle%3DDNA%2520topoisomerases%253A%2520structure%252C%2520function%252C%2520and%2520mechanism%26jtitle%3DAnnu.%2520Rev.%2520Biochem.%26date%3D2001%26volume%3D70%26spage%3D369%26epage%3D413%26doi%3D10.1146%2Fannurev.biochem.70.1.369" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref3"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref3'); return false;" data-citation="" class="refNumLink">3</a></strong><div class="NLM_citation" id="cit3"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Wang, J. C.</span></span> <span> </span><span class="NLM_article-title">DNA topoisomerases</span>. <i>Annu. Rev. Biochem.</i> <span class="NLM_year" style="font-weight: bold;">1996</span>,  <span class="NLM_volume"><i>65</i></span>,  <span class="NLM_fpage">635</span>– <span class="NLM_lpage">692</span>, <span class="refDoi"> DOI: 10.1146/annurev.bi.65.070196.003223</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00639&amp;key=10.1146%2Fannurev.bi.65.070196.003223" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00639&amp;key=8811192" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00639&amp;key=1%3ACAS%3A528%3ADyaK28XktFamur0%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=65&publication_year=1996&pages=635-692&author=J.+C.+Wang&title=DNA+topoisomerases&doi=10.1146%2Fannurev.bi.65.070196.003223"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit3R"><div class="casContent"><span class="casTitleNuber">3</span><div class="casTitle"><span class="NLM_cas:atitle">DNA topoisomerases</span></div><div class="casAuthors">Wang, James C.</div><div class="citationInfo"><span class="NLM_cas:title">Annual Review of Biochemistry</span>
        (<span class="NLM_cas:date">1996</span>),
    <span class="NLM_cas:volume">65</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">635-692</span>CODEN:
                <span class="NLM_cas:coden">ARBOAW</span>;
        ISSN:<span class="NLM_cas:issn">0066-4154</span>.
    
            (<span class="NLM_cas:orgname">Annual Reviews</span>)
        </div><div class="casAbstract">A review, with 610 refs.  The various problems of disentangling DNA strands or duplexes in a cell are all rooted in the double-helical structure of DNA.  Three distinct subfamilies of enzymes, known as the DNA topoisomerases, have evolved to solve these problems.  This review focuses on work in the past decade on the mechanisms and cellular functions of these enzymes.  Newly discovered members and recent biochem. and structural results are reviewed, and mechanistic implications of these results are summarized.  The primary cellular functions of these enzymes, including their roles in replication, transcription, chromosome condensation, and the maintenance of genome stability, are then discussed.  The review ends with a summary of the regulation of the cellular levels of these enzymes and a discussion of their assocn. with other cellular proteins.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGog_BfdOibiUrVg90H21EOLACvtfcHk0lif0BmbWWE2rQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK28XktFamur0%253D&md5=7f783337b59dc0797e4f3d56e66fb499</span></div><a href="/servlet/linkout?suffix=cit3&amp;dbid=16384&amp;doi=10.1146%2Fannurev.bi.65.070196.003223&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1146%252Fannurev.bi.65.070196.003223%26sid%3Dliteratum%253Aachs%26aulast%3DWang%26aufirst%3DJ.%2BC.%26atitle%3DDNA%2520topoisomerases%26jtitle%3DAnnu.%2520Rev.%2520Biochem.%26date%3D1996%26volume%3D65%26spage%3D635%26epage%3D692%26doi%3D10.1146%2Fannurev.bi.65.070196.003223" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref4"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref4'); return false;" data-citation="" class="refNumLink">4</a></strong><div class="NLM_citation" id="cit4"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Pommier, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sun, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Huang, S. N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nitiss, J. L.</span></span> <span> </span><span class="NLM_article-title">Roles of eukaryotic topoisomerases in transcription, replication and genomic stability</span>. <i>Nat. Rev. Mol. Cell Biol.</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>17</i></span>,  <span class="NLM_fpage">703</span>– <span class="NLM_lpage">721</span>, <span class="refDoi"> DOI: 10.1038/nrm.2016.111</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00639&amp;key=10.1038%2Fnrm.2016.111" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00639&amp;key=27649880" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00639&amp;key=1%3ACAS%3A528%3ADC%252BC28XhsFemsbvO" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=17&publication_year=2016&pages=703-721&author=Y.+Pommierauthor=Y.+Sunauthor=S.+N.+Huangauthor=J.+L.+Nitiss&title=Roles+of+eukaryotic+topoisomerases+in+transcription%2C+replication+and+genomic+stability&doi=10.1038%2Fnrm.2016.111"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit4R"><div class="casContent"><span class="casTitleNuber">4</span><div class="casTitle"><span class="NLM_cas:atitle">Roles of eukaryotic topoisomerases in transcription, replication and genomic stability</span></div><div class="casAuthors">Pommier, Yves; Sun, Yilun; Huang, Shar-yin N.; Nitiss, John L.</div><div class="citationInfo"><span class="NLM_cas:title">Nature Reviews Molecular Cell Biology</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">17</span>
        (<span class="NLM_cas:issue">11</span>),
    <span class="NLM_cas:pages">703-721</span>CODEN:
                <span class="NLM_cas:coden">NRMCBP</span>;
        ISSN:<span class="NLM_cas:issn">1471-0072</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">A review.  Topoisomerases introduce transient DNA breaks to relax supercoiled DNA, remove catenanes and enable chromosome segregation.  Human cells encode six topoisomerases (TOP1, TOP1mt, TOP2α, TOP2β, TOP3α and TOP3β), which act on a broad range of DNA and RNA substrates at the nuclear and mitochondrial genomes.  Their catalytic intermediates, the topoisomerase cleavage complexes (TOPcc), are therapeutic targets of various anticancer drugs.  TOPcc can also form on damaged DNA during replication and transcription, and engage specific repair pathways, such as those mediated by tyrosyl-DNA phosphodiesterase 1 (TDP1) and TDP2 and by endonucleases (MRE11, XPF-ERCC1 and MUS81).  Here, we review the roles of topoisomerases in mediating chromatin dynamics, transcription, replication, DNA damage repair and genomic stability, and discuss how deregulation of topoisomerases can cause neurodegenerative diseases, immune disorders and cancer.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGp2RnRxdI5gv7Vg90H21EOLACvtfcHk0lif0BmbWWE2rQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28XhsFemsbvO&md5=d1e6b3015a76a21ff92502f7e4eb5016</span></div><a href="/servlet/linkout?suffix=cit4&amp;dbid=16384&amp;doi=10.1038%2Fnrm.2016.111&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnrm.2016.111%26sid%3Dliteratum%253Aachs%26aulast%3DPommier%26aufirst%3DY.%26aulast%3DSun%26aufirst%3DY.%26aulast%3DHuang%26aufirst%3DS.%2BN.%26aulast%3DNitiss%26aufirst%3DJ.%2BL.%26atitle%3DRoles%2520of%2520eukaryotic%2520topoisomerases%2520in%2520transcription%252C%2520replication%2520and%2520genomic%2520stability%26jtitle%3DNat.%2520Rev.%2520Mol.%2520Cell%2520Biol.%26date%3D2016%26volume%3D17%26spage%3D703%26epage%3D721%26doi%3D10.1038%2Fnrm.2016.111" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref5"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref5'); return false;" data-citation="" class="refNumLink">5</a></strong><div class="NLM_citation" id="cit5"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Pommier, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Leo, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Marchand, C.</span></span> <span> </span><span class="NLM_article-title">DNA topoisomerases and their poisoning by anticancer and antibacterial drugs</span>. <i>Chem. Biol.</i> <span class="NLM_year" style="font-weight: bold;">2010</span>,  <span class="NLM_volume"><i>17</i></span>,  <span class="NLM_fpage">421</span>– <span class="NLM_lpage">433</span>, <span class="refDoi"> DOI: 10.1016/j.chembiol.2010.04.012</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00639&amp;key=10.1016%2Fj.chembiol.2010.04.012" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00639&amp;key=20534341" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00639&amp;key=1%3ACAS%3A528%3ADC%252BC3cXmslCjsLY%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=17&publication_year=2010&pages=421-433&author=Y.+Pommierauthor=E.+Leoauthor=H.+Zhangauthor=C.+Marchand&title=DNA+topoisomerases+and+their+poisoning+by+anticancer+and+antibacterial+drugs&doi=10.1016%2Fj.chembiol.2010.04.012"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit5R"><div class="casContent"><span class="casTitleNuber">5</span><div class="casTitle"><span class="NLM_cas:atitle">DNA Topoisomerases and Their Poisoning by Anticancer and Antibacterial Drugs</span></div><div class="casAuthors">Pommier, Yves; Leo, Elisabetta; Zhang, Hong-Liang; Marchand, Christophe</div><div class="citationInfo"><span class="NLM_cas:title">Chemistry & Biology (Cambridge, MA, United States)</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">17</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">421-433</span>CODEN:
                <span class="NLM_cas:coden">CBOLE2</span>;
        ISSN:<span class="NLM_cas:issn">1074-5521</span>.
    
            (<span class="NLM_cas:orgname">Cell Press</span>)
        </div><div class="casAbstract">A review.  DNA topoisomerases are the targets of important anticancer and antibacterial drugs.  Camptothecins and novel noncamptothecins in clin. development (indenoisoquinolines and ARC-111) target eukaryotic type IB topoisomerases (Top1), whereas human type IIA topoisomerases (Top2α and Top2β) are the targets of the widely used anticancer agents etoposide, anthracyclines (doxorubicin, daunorubicin), and mitoxantrone.  Bacterial type II topoisomerases (gyrase and Topo IV) are the targets of quinolones and aminocoumarin antibiotics.  This review focuses on the mol. and biochem. characteristics of topoisomerases and their inhibitors.  We also discuss the common mechanism of action of topoisomerase poisons by interfacial inhibition and trapping of topoisomerase cleavage complexes.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqr6m1st3bchbVg90H21EOLACvtfcHk0ljX0j_2iMkjTA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXmslCjsLY%253D&md5=ab00ffa6d0e8bf0c433b154e2a4b484a</span></div><a href="/servlet/linkout?suffix=cit5&amp;dbid=16384&amp;doi=10.1016%2Fj.chembiol.2010.04.012&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.chembiol.2010.04.012%26sid%3Dliteratum%253Aachs%26aulast%3DPommier%26aufirst%3DY.%26aulast%3DLeo%26aufirst%3DE.%26aulast%3DZhang%26aufirst%3DH.%26aulast%3DMarchand%26aufirst%3DC.%26atitle%3DDNA%2520topoisomerases%2520and%2520their%2520poisoning%2520by%2520anticancer%2520and%2520antibacterial%2520drugs%26jtitle%3DChem.%2520Biol.%26date%3D2010%26volume%3D17%26spage%3D421%26epage%3D433%26doi%3D10.1016%2Fj.chembiol.2010.04.012" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref6"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref6'); return false;" data-citation="" class="refNumLink">6</a></strong><div class="NLM_citation" id="cit6"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Pommier, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Marchand, C.</span></span> <span> </span><span class="NLM_article-title">Interfacial inhibitors: targeting macromolecular complexes</span>. <i>Nat. Rev. Drug Discovery</i> <span class="NLM_year" style="font-weight: bold;">2012</span>,  <span class="NLM_volume"><i>11</i></span>,  <span class="NLM_fpage">25</span>– <span class="NLM_lpage">36</span>, <span class="refDoi"> DOI: 10.1038/nrd3404</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00639&amp;key=10.1038%2Fnrd3404" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00639&amp;key=1%3ACAS%3A528%3ADC%252BC3MXhs1aitr3F" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=11&publication_year=2012&pages=25-36&author=Y.+Pommierauthor=C.+Marchand&title=Interfacial+inhibitors%3A+targeting+macromolecular+complexes&doi=10.1038%2Fnrd3404"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit6R"><div class="casContent"><span class="casTitleNuber">6</span><div class="casTitle"><span class="NLM_cas:atitle">Interfacial inhibitors: targeting macromolecular complexes</span></div><div class="casAuthors">Pommier, Yves; Marchand, Christophe</div><div class="citationInfo"><span class="NLM_cas:title">Nature Reviews Drug Discovery</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">11</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">25-36</span>CODEN:
                <span class="NLM_cas:coden">NRDDAG</span>;
        ISSN:<span class="NLM_cas:issn">1474-1776</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">A review.  Interfacial inhibitors belong to a broad class of natural products and synthetic drugs that are commonly used to treat cancers as well as bacterial and HIV infections.  They bind selectively to interfaces as macromol. machines assemble and are set in motion.  The bound drugs transiently arrest the targeted mol. machines, which can initiate allosteric effects, or desynchronize macromol. machines that normally function in concert.  Here, we review five archetypical examples of interfacial inhibitors: the camptothecins, etoposide, the quinolone antibiotics, the vinca alkaloids and the novel anti-HIV inhibitor raltegravir.  We discuss the common and diverging elements between interfacial and allosteric inhibitors and give a perspective for the rationale and methods used to discover novel interfacial inhibitors.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpjeQ4_1kAh-bVg90H21EOLACvtfcHk0ljX0j_2iMkjTA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXhs1aitr3F&md5=e69c1b97286dc65855ee8784203d4d85</span></div><a href="/servlet/linkout?suffix=cit6&amp;dbid=16384&amp;doi=10.1038%2Fnrd3404&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnrd3404%26sid%3Dliteratum%253Aachs%26aulast%3DPommier%26aufirst%3DY.%26aulast%3DMarchand%26aufirst%3DC.%26atitle%3DInterfacial%2520inhibitors%253A%2520targeting%2520macromolecular%2520complexes%26jtitle%3DNat.%2520Rev.%2520Drug%2520Discovery%26date%3D2012%26volume%3D11%26spage%3D25%26epage%3D36%26doi%3D10.1038%2Fnrd3404" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref7"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref7'); return false;" data-citation="" class="refNumLink">7</a></strong><div class="NLM_citation" id="cit7"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Choi, S. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tsuchida, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yang, H. W.</span></span> <span> </span><span class="NLM_article-title">Oral versus intraperitoneal administration of irinotecan in the treatment of human neuroblastoma in nude mice</span>. <i>Cancer Lett.</i> <span class="NLM_year" style="font-weight: bold;">1998</span>,  <span class="NLM_volume"><i>124</i></span>,  <span class="NLM_fpage">15</span>– <span class="NLM_lpage">21</span>, <span class="refDoi"> DOI: 10.1016/S0304-3835(97)00428-X</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00639&amp;key=10.1016%2FS0304-3835%2897%2900428-X" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00639&amp;key=9500186" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00639&amp;key=1%3ACAS%3A528%3ADyaK1cXnt12nsA%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=124&publication_year=1998&pages=15-21&author=S.+H.+Choiauthor=Y.+Tsuchidaauthor=H.+W.+Yang&title=Oral+versus+intraperitoneal+administration+of+irinotecan+in+the+treatment+of+human+neuroblastoma+in+nude+mice&doi=10.1016%2FS0304-3835%2897%2900428-X"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit7R"><div class="casContent"><span class="casTitleNuber">7</span><div class="casTitle"><span class="NLM_cas:atitle">Oral versus intraperitoneal administration of irinotecan in the treatment of human neuroblastoma in nude mice</span></div><div class="casAuthors">Choi, Seung-Hoon; Tsuchida, Yoshiaki; Yang, Hong-Wei</div><div class="citationInfo"><span class="NLM_cas:title">Cancer Letters (Shannon, Ireland)</span>
        (<span class="NLM_cas:date">1998</span>),
    <span class="NLM_cas:volume">124</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">15-21</span>CODEN:
                <span class="NLM_cas:coden">CALEDQ</span>;
        ISSN:<span class="NLM_cas:issn">0304-3835</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Science Ireland Ltd.</span>)
        </div><div class="casAbstract">The present study evaluated the plasma pharmacokinetics of irinotecan (CPT-11) and its effects against a human neuroblastoma in xenograft, given by different administration routes.  One-third of the LD50 was administered either i.p. (59 mg/kg mouse wt. (MW)) or orally (404 mg/kg MW) to nude mice.  The plasma levels of CPT-11 and its active metabolite SN-38 decreased rapidly when CPT-11 was administered i.p., but remained relatively high for 4-8 h after oral administration.  Then, a human neuroblastoma xenograft was inoculated in another set of 21 nude mice.  When the estd. tumor wt. reached 150-200 mg, CPT-11 was administered in the total LD50 either i.p. or orally in three doses at 4-day intervals (q4d ×3) to the mice in each exptl. group.  Oral administration was superior to i.p. injection in terms of tumor inhibition and to be an effective route for CPT-11 administration in the treatment of human neuroblastoma in nude mice.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrP3PS7OMs8FLVg90H21EOLACvtfcHk0ljX0j_2iMkjTA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK1cXnt12nsA%253D%253D&md5=31c482bafc89daa777d1de50898e1c98</span></div><a href="/servlet/linkout?suffix=cit7&amp;dbid=16384&amp;doi=10.1016%2FS0304-3835%2897%2900428-X&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS0304-3835%252897%252900428-X%26sid%3Dliteratum%253Aachs%26aulast%3DChoi%26aufirst%3DS.%2BH.%26aulast%3DTsuchida%26aufirst%3DY.%26aulast%3DYang%26aufirst%3DH.%2BW.%26atitle%3DOral%2520versus%2520intraperitoneal%2520administration%2520of%2520irinotecan%2520in%2520the%2520treatment%2520of%2520human%2520neuroblastoma%2520in%2520nude%2520mice%26jtitle%3DCancer%2520Lett.%26date%3D1998%26volume%3D124%26spage%3D15%26epage%3D21%26doi%3D10.1016%2FS0304-3835%2897%2900428-X" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref8"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref8'); return false;" data-citation="" class="refNumLink">8</a></strong><div class="NLM_citation" id="cit8"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Brogden, R. N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wiseman, L. R.</span></span> <span> </span><span class="NLM_article-title">Topotecan a review of its potential in advanced ovarian cancer</span>. <i>Drugs</i> <span class="NLM_year" style="font-weight: bold;">1998</span>,  <span class="NLM_volume"><i>56</i></span>,  <span class="NLM_fpage">709</span>– <span class="NLM_lpage">723</span>, <span class="refDoi"> DOI: 10.2165/00003495-199856040-00017</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00639&amp;key=10.2165%2F00003495-199856040-00017" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=56&publication_year=1998&pages=709-723&author=R.+N.+Brogdenauthor=L.+R.+Wiseman&title=Topotecan+a+review+of+its+potential+in+advanced+ovarian+cancer&doi=10.2165%2F00003495-199856040-00017"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit8&amp;dbid=16384&amp;doi=10.2165%2F00003495-199856040-00017&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.2165%252F00003495-199856040-00017%26sid%3Dliteratum%253Aachs%26aulast%3DBrogden%26aufirst%3DR.%2BN.%26aulast%3DWiseman%26aufirst%3DL.%2BR.%26atitle%3DTopotecan%2520a%2520review%2520of%2520its%2520potential%2520in%2520advanced%2520ovarian%2520cancer%26jtitle%3DDrugs%26date%3D1998%26volume%3D56%26spage%3D709%26epage%3D723%26doi%3D10.2165%2F00003495-199856040-00017" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref9"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref9'); return false;" data-citation="" class="refNumLink">9</a></strong><div class="NLM_citation" id="cit9"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Bracher, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tremmel, T.</span></span> <span> </span><span class="NLM_article-title">From lead to drug utilizing a mannich reaction: The topotecan story</span>. <i>Arch. Pharm.</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>350</i></span>,  <span class="NLM_fpage">e1600236</span>, <span class="refDoi"> DOI: 10.1002/ardp.201600236</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00639&amp;key=10.1002%2Fardp.201600236" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=350&publication_year=2017&pages=e1600236&author=F.+Bracherauthor=T.+Tremmel&title=From+lead+to+drug+utilizing+a+mannich+reaction%3A+The+topotecan+story&doi=10.1002%2Fardp.201600236"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit9&amp;dbid=16384&amp;doi=10.1002%2Fardp.201600236&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fardp.201600236%26sid%3Dliteratum%253Aachs%26aulast%3DBracher%26aufirst%3DF.%26aulast%3DTremmel%26aufirst%3DT.%26atitle%3DFrom%2520lead%2520to%2520drug%2520utilizing%2520a%2520mannich%2520reaction%253A%2520The%2520topotecan%2520story%26jtitle%3DArch.%2520Pharm.%26date%3D2017%26volume%3D350%26spage%3De1600236%26doi%3D10.1002%2Fardp.201600236" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref10"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref10'); return false;" data-citation="" class="refNumLink">10</a></strong><div class="NLM_citation" id="cit10"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cai, Q.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liu, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sun, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chambless, B.</span></span> <span> </span><span class="NLM_article-title">Preclinical pharmacology of the natural product anticancer agent 10-hydroxycamptothecin, an inhibitor of topoisomerase I</span>. <i>Cancer Chemother. Pharmacol.</i> <span class="NLM_year" style="font-weight: bold;">1998</span>,  <span class="NLM_volume"><i>41</i></span>,  <span class="NLM_fpage">257</span>– <span class="NLM_lpage">267</span>, <span class="refDoi"> DOI: 10.1007/s002800050738</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00639&amp;key=10.1007%2Fs002800050738" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00639&amp;key=9488594" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00639&amp;key=1%3ACAS%3A528%3ADyaK1cXovVSgtA%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=41&publication_year=1998&pages=257-267&author=R.+Zhangauthor=Y.+Liauthor=Q.+Caiauthor=T.+Liuauthor=H.+Sunauthor=B.+Chambless&title=Preclinical+pharmacology+of+the+natural+product+anticancer+agent+10-hydroxycamptothecin%2C+an+inhibitor+of+topoisomerase+I&doi=10.1007%2Fs002800050738"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit10R"><div class="casContent"><span class="casTitleNuber">10</span><div class="casTitle"><span class="NLM_cas:atitle">Preclinical pharmacology of the natural product anticancer agent 10-hydroxycamptothecin, an inhibitor of topoisomerase I</span></div><div class="casAuthors">Zhang, Rui Wen; Li, Yu Feng; Cai, Qiu Yin; Liu, Tie Pu; Sun, He; Chambless, Brandon</div><div class="citationInfo"><span class="NLM_cas:title">Cancer Chemotherapy and Pharmacology</span>
        (<span class="NLM_cas:date">1998</span>),
    <span class="NLM_cas:volume">41</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">257-267</span>CODEN:
                <span class="NLM_cas:coden">CCPHDZ</span>;
        ISSN:<span class="NLM_cas:issn">0344-5704</span>.
    
            (<span class="NLM_cas:orgname">Springer-Verlag</span>)
        </div><div class="casAbstract">Pharmacokinetics, tissue distribution, metab., and elimination of 10-hydroxycamptothecin (HCPT), an alkaloid isolated from the Chinese tree Camptotheca acuminata were studied in rats after i.v. injection of 1, 3, or 10 mg/kg.  Following i.v. administration at doses of 3 or 10 mg/kg, the blood plasma concn.-time profile for lactone HCPT could be best described by a 3-compartment model, with terminal elimination half-lives of 140.4 and 428.6 min, resp.  A 2-compartment model was used to fit the plasma concn.-time curve at 1 mg/kg, with a terminal elimination half-life of 30.5 min.  Carboxylate HCPT had a longer half-life than the lactone form of HCPT.  During the initial 6 h after dosing urinary excretion was the major route of elimination, and fecal excretion became the major route of elimination thereafter.  HCPT was widely distributed to various tissues including the enterohepatic system, kidney, and bone marrow.  The lactone form of HCPT was detectable in various tissues examd. ≤72 h after dosing at all the 3 test doses.  HCPT glucuronides were present in plasma, urine, feces, and various tissues.  No toxicity was obsd. at doses of 1 or 3 mg/kg.  Polyuria and hematuria were obsd. only during the initial 3 h after dosing at 10 mg/kg.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoQxe6kJIOhH7Vg90H21EOLACvtfcHk0lgFRdc8J8_3Yw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK1cXovVSgtA%253D%253D&md5=542c5d001270eb8b4b2d80934903c7e1</span></div><a href="/servlet/linkout?suffix=cit10&amp;dbid=16384&amp;doi=10.1007%2Fs002800050738&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1007%252Fs002800050738%26sid%3Dliteratum%253Aachs%26aulast%3DZhang%26aufirst%3DR.%26aulast%3DLi%26aufirst%3DY.%26aulast%3DCai%26aufirst%3DQ.%26aulast%3DLiu%26aufirst%3DT.%26aulast%3DSun%26aufirst%3DH.%26aulast%3DChambless%26aufirst%3DB.%26atitle%3DPreclinical%2520pharmacology%2520of%2520the%2520natural%2520product%2520anticancer%2520agent%252010-hydroxycamptothecin%252C%2520an%2520inhibitor%2520of%2520topoisomerase%2520I%26jtitle%3DCancer%2520Chemother.%2520Pharmacol.%26date%3D1998%26volume%3D41%26spage%3D257%26epage%3D267%26doi%3D10.1007%2Fs002800050738" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref11"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref11'); return false;" data-citation="" class="refNumLink">11</a></strong><div class="NLM_citation" id="cit11"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Shao, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Huang, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fu, J.</span></span> <span> </span><span class="NLM_article-title">Clinical study on treatment of non-small cell lung cancer with 10-hydroxycamptothecin</span>. <i>Chin. J. Clin. Oncol.</i> <span class="NLM_year" style="font-weight: bold;">2003</span>,  <span class="NLM_volume"><i>30</i></span>,  <span class="NLM_fpage">26</span>– <span class="NLM_lpage">28</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=30&publication_year=2003&pages=26-28&author=J.+Shaoauthor=F.+Huangauthor=J.+Fu&title=Clinical+study+on+treatment+of+non-small+cell+lung+cancer+with+10-hydroxycamptothecin"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit11&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DShao%26aufirst%3DJ.%26aulast%3DHuang%26aufirst%3DF.%26aulast%3DFu%26aufirst%3DJ.%26atitle%3DClinical%2520study%2520on%2520treatment%2520of%2520non-small%2520cell%2520lung%2520cancer%2520with%252010-hydroxycamptothecin%26jtitle%3DChin.%2520J.%2520Clin.%2520Oncol.%26date%3D2003%26volume%3D30%26spage%3D26%26epage%3D28" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref12"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref12'); return false;" data-citation="" class="refNumLink">12</a></strong><div class="NLM_citation" id="cit12"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Pommier, Y.</span></span> <span> </span><span class="NLM_article-title">Topoisomerase I inhibitors: camptothecins and beyond</span>. <i>Nat. Rev. Cancer</i> <span class="NLM_year" style="font-weight: bold;">2006</span>,  <span class="NLM_volume"><i>6</i></span>,  <span class="NLM_fpage">789</span>– <span class="NLM_lpage">802</span>, <span class="refDoi"> DOI: 10.1038/nrc1977</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00639&amp;key=10.1038%2Fnrc1977" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00639&amp;key=16990856" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00639&amp;key=1%3ACAS%3A528%3ADC%252BD28XpvVClsr0%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=6&publication_year=2006&pages=789-802&author=Y.+Pommier&title=Topoisomerase+I+inhibitors%3A+camptothecins+and+beyond&doi=10.1038%2Fnrc1977"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit12R"><div class="casContent"><span class="casTitleNuber">12</span><div class="casTitle"><span class="NLM_cas:atitle">Topoisomerase I inhibitors: camptothecins and beyond</span></div><div class="casAuthors">Pommier, Yves</div><div class="citationInfo"><span class="NLM_cas:title">Nature Reviews Cancer</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">6</span>
        (<span class="NLM_cas:issue">10</span>),
    <span class="NLM_cas:pages">789-802</span>CODEN:
                <span class="NLM_cas:coden">NRCAC4</span>;
        ISSN:<span class="NLM_cas:issn">1474-175X</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">A review.  Nuclear DNA topoisomerase I (TOP1) is an essential human enzyme.  It is the only known target of the alkaloid camptothecin, from which the potent anticancer agents irinotecan and topotecan are derived.  As camptothecins bind at the interface of the TOP1-DNA complex, they represent a paradigm for interfacial inhibitors that reversibly trap macromol. complexes.  Several camptothecin and noncamptothecin derivs. are being developed to further increase antitumor activity and reduce side effects.  The mechanisms and mol. determinants of tumor response to TOP1 inhibitors are reviewed, and rational combinations of TOP1 inhibitors with other drugs are considered based on current knowledge of repair and checkpoint pathways that are assocd. with TOP1-mediated DNA damage.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrl5lxd3qfkwbVg90H21EOLACvtfcHk0lgFRdc8J8_3Yw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28XpvVClsr0%253D&md5=a437970077c0edbbab602b296fcd092a</span></div><a href="/servlet/linkout?suffix=cit12&amp;dbid=16384&amp;doi=10.1038%2Fnrc1977&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnrc1977%26sid%3Dliteratum%253Aachs%26aulast%3DPommier%26aufirst%3DY.%26atitle%3DTopoisomerase%2520I%2520inhibitors%253A%2520camptothecins%2520and%2520beyond%26jtitle%3DNat.%2520Rev.%2520Cancer%26date%3D2006%26volume%3D6%26spage%3D789%26epage%3D802%26doi%3D10.1038%2Fnrc1977" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref13"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref13'); return false;" data-citation="" class="refNumLink">13</a></strong><div class="NLM_citation" id="cit13"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Pommier, Y.</span></span> <span> </span><span class="NLM_article-title">DNA Topoisomerase I Inhibitors: chemistry, biology, and interfacial inhibition</span>. <i>Chem. Rev.</i> <span class="NLM_year" style="font-weight: bold;">2009</span>,  <span class="NLM_volume"><i>109</i></span>,  <span class="NLM_fpage">2894</span>– <span class="NLM_lpage">2902</span>, <span class="refDoi"> DOI: 10.1021/cr900097c</span> </span><div class="citationLinks">[<a href="/doi/10.1021/cr900097c" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref13/cit13&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00639&amp;key=1%3ACAS%3A528%3ADC%252BD1MXmsFals7o%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=109&publication_year=2009&pages=2894-2902&author=Y.+Pommier&title=DNA+Topoisomerase+I+Inhibitors%3A+chemistry%2C+biology%2C+and+interfacial+inhibition&doi=10.1021%2Fcr900097c"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit13R"><div class="casContent"><span class="casTitleNuber">13</span><div class="casTitle"><span class="NLM_cas:atitle">DNA Topoisomerase I Inhibitors: Chemistry, Biology, and Interfacial Inhibition</span></div><div class="casAuthors">Pommier, Yves</div><div class="citationInfo"><span class="NLM_cas:title">Chemical Reviews (Washington, DC, United States)</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">109</span>
        (<span class="NLM_cas:issue">7</span>),
    <span class="NLM_cas:pages">2894-2902</span>CODEN:
                <span class="NLM_cas:coden">CHREAY</span>;
        ISSN:<span class="NLM_cas:issn">0009-2665</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">A review on DNA topoisomerase I inhibitors as anticancer drugs.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGp8qSNXYdDat7Vg90H21EOLACvtfcHk0lgXi5HB8hX5Qw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXmsFals7o%253D&md5=438bcf21b446a6b87634dd362d9467e4</span></div><a href="/servlet/linkout?suffix=cit13&amp;dbid=16384&amp;doi=10.1021%2Fcr900097c&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fcr900097c%26sid%3Dliteratum%253Aachs%26aulast%3DPommier%26aufirst%3DY.%26atitle%3DDNA%2520Topoisomerase%2520I%2520Inhibitors%253A%2520chemistry%252C%2520biology%252C%2520and%2520interfacial%2520inhibition%26jtitle%3DChem.%2520Rev.%26date%3D2009%26volume%3D109%26spage%3D2894%26epage%3D2902%26doi%3D10.1021%2Fcr900097c" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref14"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref14'); return false;" data-citation="" class="refNumLink">14</a></strong><div class="NLM_citation" id="cit14"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Beretta, G. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Perego, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zunino, F.</span></span> <span> </span><span class="NLM_article-title">Targeting topoisomerase I: molecular mechanisms and cellular determinants of response to topoisomerase I inhibitors</span>. <i>Expert Opin. Ther. Targets</i> <span class="NLM_year" style="font-weight: bold;">2008</span>,  <span class="NLM_volume"><i>12</i></span>,  <span class="NLM_fpage">1243</span>– <span class="NLM_lpage">1256</span>, <span class="refDoi"> DOI: 10.1517/14728222.12.10.1243</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref14/cit14&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00639&amp;key=10.1517%2F14728222.12.10.1243" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref14/cit14&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00639&amp;key=18781823" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref14/cit14&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00639&amp;key=1%3ACAS%3A528%3ADC%252BD1cXhtFSmsrjF" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=12&publication_year=2008&pages=1243-1256&author=G.+L.+Berettaauthor=P.+Peregoauthor=F.+Zunino&title=Targeting+topoisomerase+I%3A+molecular+mechanisms+and+cellular+determinants+of+response+to+topoisomerase+I+inhibitors&doi=10.1517%2F14728222.12.10.1243"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit14R"><div class="casContent"><span class="casTitleNuber">14</span><div class="casTitle"><span class="NLM_cas:atitle">Targeting topoisomerase I: molecular mechanisms and cellular determinants of response to topoisomerase I inhibitors</span></div><div class="casAuthors">Beretta, Giovanni Luca; Perego, Paola; Zunino, Franco</div><div class="citationInfo"><span class="NLM_cas:title">Expert Opinion on Therapeutic Targets</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">12</span>
        (<span class="NLM_cas:issue">10</span>),
    <span class="NLM_cas:pages">1243-1256</span>CODEN:
                <span class="NLM_cas:coden">EOTTAO</span>;
        ISSN:<span class="NLM_cas:issn">1472-8222</span>.
    
            (<span class="NLM_cas:orgname">Informa Healthcare</span>)
        </div><div class="casAbstract">A review.  Background: Topoisomerase I is required for DNA relaxation during crit. cellular functions.  The identification of camptothecins as specific enzyme inhibitors and their clin. efficacy have stimulated extensive efforts to exploit topoisomerase I as a tumor target and explain the putative mechanisms of antitumor-specific action.  Objective: This review provides an overview of the recent achievements in the development of topoisomerase I inhibitors and in the explanation of the biol. pathways involved in tumor response.  Results/conclusion: In spite of the difficulty to identify novel topoisomerase I inhibitors with improved pharmacol. properties, a growing body of evidence supports the possibility of optimizing the therapeutic profile of available agents.  The explanation of defense mechanisms and the mol. determinants of tumor cell response is expected to provide a basis for the design of combination approaches for optimization of topoisomerase I inhibitors-based therapy.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGojS1iFZFc4BbVg90H21EOLACvtfcHk0lgXi5HB8hX5Qw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXhtFSmsrjF&md5=4d8838b6df1138977c61b914d15cf689</span></div><a href="/servlet/linkout?suffix=cit14&amp;dbid=16384&amp;doi=10.1517%2F14728222.12.10.1243&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1517%252F14728222.12.10.1243%26sid%3Dliteratum%253Aachs%26aulast%3DBeretta%26aufirst%3DG.%2BL.%26aulast%3DPerego%26aufirst%3DP.%26aulast%3DZunino%26aufirst%3DF.%26atitle%3DTargeting%2520topoisomerase%2520I%253A%2520molecular%2520mechanisms%2520and%2520cellular%2520determinants%2520of%2520response%2520to%2520topoisomerase%2520I%2520inhibitors%26jtitle%3DExpert%2520Opin.%2520Ther.%2520Targets%26date%3D2008%26volume%3D12%26spage%3D1243%26epage%3D1256%26doi%3D10.1517%2F14728222.12.10.1243" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref15"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref15'); return false;" data-citation="" class="refNumLink">15</a></strong><div class="NLM_citation" id="cit15"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Pommier, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Barcelo, J. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rao, V. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sordet, O.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jobson, A. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Thibaut, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Miao, Z. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Seiler, J. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Marchand, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Agama, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nitiss, J. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Redon, C.</span></span> <span> </span><span class="NLM_article-title">Repair of topoisomerase I-mediated DNA damage</span>. <i>Prog. Nucleic Acid Res. Mol. Biol.</i> <span class="NLM_year" style="font-weight: bold;">2006</span>,  <span class="NLM_volume"><i>81</i></span>,  <span class="NLM_fpage">179</span>– <span class="NLM_lpage">229</span>, <span class="refDoi"> DOI: 10.1016/S0079-6603(06)81005-6</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref15/cit15&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00639&amp;key=10.1016%2FS0079-6603%2806%2981005-6" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref15/cit15&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00639&amp;key=16891172" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref15/cit15&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00639&amp;key=1%3ACAS%3A528%3ADC%252BD1cXktVShtrY%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=81&publication_year=2006&pages=179-229&author=Y.+Pommierauthor=J.+M.+Barceloauthor=V.+A.+Raoauthor=O.+Sordetauthor=A.+G.+Jobsonauthor=L.+Thibautauthor=Z.+H.+Miaoauthor=J.+A.+Seilerauthor=H.+Zhangauthor=C.+Marchandauthor=K.+Agamaauthor=J.+L.+Nitissauthor=C.+Redon&title=Repair+of+topoisomerase+I-mediated+DNA+damage&doi=10.1016%2FS0079-6603%2806%2981005-6"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit15R"><div class="casContent"><span class="casTitleNuber">15</span><div class="casTitle"><span class="NLM_cas:atitle">Repair of topoisomerase I-mediated DNA damage</span></div><div class="casAuthors">Pommier, Yves; Barcelo, Juana M.; Rao, V. Ashutosh; Sordet, Olivier; Jobson, Andrew G.; Thibaut, Laurent; Miao, Ze-Hong; Seiler, Jennifer A.; Zhang, Hongliang; Marchand, Christophe; Agama, Keli; Nitiss, John L.; Redon, Christophe</div><div class="citationInfo"><span class="NLM_cas:title">Progress in Nucleic Acid Research and Molecular Biology</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">81</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">179-229</span>CODEN:
                <span class="NLM_cas:coden">PNMBAF</span>;
        ISSN:<span class="NLM_cas:issn">0079-6603</span>.
    
            (<span class="NLM_cas:orgname">Elsevier</span>)
        </div><div class="casAbstract">A review.  Topoisomerase I (Top1) is an abundant and essential enzyme.  Top1 is the selective target of camptothecins, which are effective anticancer agents.  Top1-DNA cleavage complexes can also be trapped by various endogenous and exogenous DNA lesions including mismatches, abasic sites, and carcinogenic adducts.  Tyrosyl-DNA phosphodiesterase (Tdp1) is one of the repair enzymes for Top1-DNA covalent complexes.  Tdp1 forms a multiprotein complex that includes poly(ADP-ribose) polymerase (PARP).  PARP-deficient cells are hypersensitive to camptothecins and functionally deficient for Tdp1.  We will review developments in several pathways involved in the repair of Top1 cleavage complexes and the role of Chk1 and Chk2 checkpoint kinases in the cellular responses to Top1 inhibitors.  The genes conferring camptothecin hypersensitivity are compiled for humans, budding yeast, and fission yeast.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGodCZGu6Axl5LVg90H21EOLACvtfcHk0lgXi5HB8hX5Qw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXktVShtrY%253D&md5=3f27a8ddd1f80db31af81eee975f495e</span></div><a href="/servlet/linkout?suffix=cit15&amp;dbid=16384&amp;doi=10.1016%2FS0079-6603%2806%2981005-6&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS0079-6603%252806%252981005-6%26sid%3Dliteratum%253Aachs%26aulast%3DPommier%26aufirst%3DY.%26aulast%3DBarcelo%26aufirst%3DJ.%2BM.%26aulast%3DRao%26aufirst%3DV.%2BA.%26aulast%3DSordet%26aufirst%3DO.%26aulast%3DJobson%26aufirst%3DA.%2BG.%26aulast%3DThibaut%26aufirst%3DL.%26aulast%3DMiao%26aufirst%3DZ.%2BH.%26aulast%3DSeiler%26aufirst%3DJ.%2BA.%26aulast%3DZhang%26aufirst%3DH.%26aulast%3DMarchand%26aufirst%3DC.%26aulast%3DAgama%26aufirst%3DK.%26aulast%3DNitiss%26aufirst%3DJ.%2BL.%26aulast%3DRedon%26aufirst%3DC.%26atitle%3DRepair%2520of%2520topoisomerase%2520I-mediated%2520DNA%2520damage%26jtitle%3DProg.%2520Nucleic%2520Acid%2520Res.%2520Mol.%2520Biol.%26date%3D2006%26volume%3D81%26spage%3D179%26epage%3D229%26doi%3D10.1016%2FS0079-6603%2806%2981005-6" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref16"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref16'); return false;" data-citation="" class="refNumLink">16</a></strong><div class="NLM_citation" id="cit16"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Maede, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shimizu, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fukushima, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kogame, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nakamura, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Miki, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Takeda, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pommier, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Murai, J.</span></span> <span> </span><span class="NLM_article-title">Differential and common DNA repair pathways for topoisomerase I- and II-targeted drugs in a genetic DT40 repair cell screen panel</span>. <i>Mol. Cancer Ther.</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>13</i></span>,  <span class="NLM_fpage">214</span>– <span class="NLM_lpage">220</span>, <span class="refDoi"> DOI: 10.1158/1535-7163.MCT-13-0551</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref16/cit16&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00639&amp;key=10.1158%2F1535-7163.MCT-13-0551" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref16/cit16&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00639&amp;key=24130054" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref16/cit16&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00639&amp;key=1%3ACAS%3A528%3ADC%252BC2cXnsFSmsg%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=13&publication_year=2014&pages=214-220&author=Y.+Maedeauthor=H.+Shimizuauthor=T.+Fukushimaauthor=T.+Kogameauthor=T.+Nakamuraauthor=T.+Mikiauthor=S.+Takedaauthor=Y.+Pommierauthor=J.+Murai&title=Differential+and+common+DNA+repair+pathways+for+topoisomerase+I-+and+II-targeted+drugs+in+a+genetic+DT40+repair+cell+screen+panel&doi=10.1158%2F1535-7163.MCT-13-0551"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit16R"><div class="casContent"><span class="casTitleNuber">16</span><div class="casTitle"><span class="NLM_cas:atitle">Differential and Common DNA Repair Pathways for Topoisomerase I- and II-Targeted Drugs in a Genetic DT40 Repair Cell Screen Panel</span></div><div class="casAuthors">Maede, Yuko; Shimizu, Hiroyasu; Fukushima, Toru; Kogame, Toshiaki; Nakamura, Terukazu; Miki, Tsuneharu; Takeda, Shunichi; Pommier, Yves; Murai, Junko</div><div class="citationInfo"><span class="NLM_cas:title">Molecular Cancer Therapeutics</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">13</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">214-220</span>CODEN:
                <span class="NLM_cas:coden">MCTOCF</span>;
        ISSN:<span class="NLM_cas:issn">1535-7163</span>.
    
            (<span class="NLM_cas:orgname">American Association for Cancer Research</span>)
        </div><div class="casAbstract">Clin. topoisomerase I (Top1) and II (Top2) inhibitors trap topoisomerases on DNA, thereby inducing protein-linked DNA breaks.  Cancer cells resist the drugs by removing topoisomerase-DNA complexes, and repairing the drug-induced DNA double-strand breaks (DSB) by homologous recombination and nonhomologous end joining (NHEJ).  Because numerous enzymes and cofactors are involved in the removal of the topoisomerase-DNA complexes and DSB repair, it has been challenging to comprehensively analyze the relative contribution of multiple genetic pathways in vertebrate cells.  Comprehending the relative contribution of individual repair factors would give insights into the lesions induced by the inhibitors and genetic determinants of response.  Ultimately, this information would be useful to target specific pathways to augment the therapeutic activity of topoisomerase inhibitors.  To this end, we put together 48 isogenic DT40 mutant cells deficient in DNA repair and generated one cell line deficient in autophagy (ATG5).  Sensitivity profiles were established for three clin. relevant Top1 inhibitors (camptothecin and the indenoisoquinolines LMP400 and LMP776) and three Top2 inhibitors (etoposide, doxorubicin, and ICRF-193).  Highly significant correlations were found among Top1 inhibitors as well as Top2 inhibitors, whereas the profiles of Top1 inhibitors were different from those of Top2 inhibitors.  Most distinct repair pathways between Top1 and Top2 inhibitors include NHEJ, TDP1, TDP2, PARP1, and Fanconi Anemia genes, whereas homologous recombination seems relevant esp. for Top1 and, to a lesser extent, for Top2 inhibitors.  We also found and discuss differential pathways among Top1 inhibitors and Top2 inhibitors.  Mol Cancer Ther; 13(1); 214-20. ©2013 AACR.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqrLkuEffSz27Vg90H21EOLACvtfcHk0lgZ_bBQa9_YwQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXnsFSmsg%253D%253D&md5=346456ce64a6e142fb9df968cdc9f05e</span></div><a href="/servlet/linkout?suffix=cit16&amp;dbid=16384&amp;doi=10.1158%2F1535-7163.MCT-13-0551&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1158%252F1535-7163.MCT-13-0551%26sid%3Dliteratum%253Aachs%26aulast%3DMaede%26aufirst%3DY.%26aulast%3DShimizu%26aufirst%3DH.%26aulast%3DFukushima%26aufirst%3DT.%26aulast%3DKogame%26aufirst%3DT.%26aulast%3DNakamura%26aufirst%3DT.%26aulast%3DMiki%26aufirst%3DT.%26aulast%3DTakeda%26aufirst%3DS.%26aulast%3DPommier%26aufirst%3DY.%26aulast%3DMurai%26aufirst%3DJ.%26atitle%3DDifferential%2520and%2520common%2520DNA%2520repair%2520pathways%2520for%2520topoisomerase%2520I-%2520and%2520II-targeted%2520drugs%2520in%2520a%2520genetic%2520DT40%2520repair%2520cell%2520screen%2520panel%26jtitle%3DMol.%2520Cancer%2520Ther.%26date%3D2014%26volume%3D13%26spage%3D214%26epage%3D220%26doi%3D10.1158%2F1535-7163.MCT-13-0551" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref17"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref17'); return false;" data-citation="" class="refNumLink">17</a></strong><div class="NLM_citation" id="cit17"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Interthal, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pouliot, J. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Champoux, J. J.</span></span> <span> </span><span class="NLM_article-title">The tyrosyl-DNA phosphodiesterase Tdp1 is a member of the phospholipase D superfamily</span>. <i>Proc. Natl. Acad. Sci. U. S. A.</i> <span class="NLM_year" style="font-weight: bold;">2001</span>,  <span class="NLM_volume"><i>98</i></span>,  <span class="NLM_fpage">12009</span>– <span class="NLM_lpage">12014</span>, <span class="refDoi"> DOI: 10.1073/pnas.211429198</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref17/cit17&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00639&amp;key=10.1073%2Fpnas.211429198" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref17/cit17&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00639&amp;key=11572945" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref17/cit17&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00639&amp;key=1%3ACAS%3A528%3ADC%252BD3MXns1Cjs78%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=98&publication_year=2001&pages=12009-12014&author=H.+Interthalauthor=J.+J.+Pouliotauthor=J.+J.+Champoux&title=The+tyrosyl-DNA+phosphodiesterase+Tdp1+is+a+member+of+the+phospholipase+D+superfamily&doi=10.1073%2Fpnas.211429198"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit17R"><div class="casContent"><span class="casTitleNuber">17</span><div class="casTitle"><span class="NLM_cas:atitle">The tyrosyl-DNA phosphodiesterase Tdp1 is a member of the phospholipase D superfamily</span></div><div class="casAuthors">Interthal, Heidrun; Pouliot, Jeffrey J.; Champoux, James J.</div><div class="citationInfo"><span class="NLM_cas:title">Proceedings of the National Academy of Sciences of the United States of America</span>
        (<span class="NLM_cas:date">2001</span>),
    <span class="NLM_cas:volume">98</span>
        (<span class="NLM_cas:issue">21</span>),
    <span class="NLM_cas:pages">12009-12014</span>CODEN:
                <span class="NLM_cas:coden">PNASA6</span>;
        ISSN:<span class="NLM_cas:issn">0027-8424</span>.
    
            (<span class="NLM_cas:orgname">National Academy of Sciences</span>)
        </div><div class="casAbstract">The phospholipase D (PLD) superfamily is a diverse group of proteins that includes enzymes involved in phospholipid metab., a bacterial toxin, poxvirus envelope proteins, and bacterial nucleases.  Based on sequence comparisons, we show here that the tyrosyl-DNA phosphodiesterase (Tdp1) that has been implicated in the repair of topoisomerase I covalent complexes with DNA contains two unusual HKD signature motifs that place the enzyme in a distinct class within the PLD superfamily.  Mutagenesis studies with the human enzyme in which the invariant histidines and lysines of the HKD motifs are changed confirm that these highly conserved residues are essential for Tdp1 activity.  Furthermore, we show that, like other members of the family for which it has been examd., the reaction involves the formation of an intermediate in which the cleaved substrate is covalently linked to the enzyme.  These results reveal that the hydrolytic reaction catalyzed by Tdp1 occurs by the phosphoryl transfer chem. that is common to all members of the PLD superfamily.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrWp0n2V1_HBbVg90H21EOLACvtfcHk0lgZ_bBQa9_YwQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3MXns1Cjs78%253D&md5=08c751ddc8ffa2550ff3acec3b71d41a</span></div><a href="/servlet/linkout?suffix=cit17&amp;dbid=16384&amp;doi=10.1073%2Fpnas.211429198&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1073%252Fpnas.211429198%26sid%3Dliteratum%253Aachs%26aulast%3DInterthal%26aufirst%3DH.%26aulast%3DPouliot%26aufirst%3DJ.%2BJ.%26aulast%3DChampoux%26aufirst%3DJ.%2BJ.%26atitle%3DThe%2520tyrosyl-DNA%2520phosphodiesterase%2520Tdp1%2520is%2520a%2520member%2520of%2520the%2520phospholipase%2520D%2520superfamily%26jtitle%3DProc.%2520Natl.%2520Acad.%2520Sci.%2520U.%2520S.%2520A.%26date%3D2001%26volume%3D98%26spage%3D12009%26epage%3D12014%26doi%3D10.1073%2Fpnas.211429198" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref18"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref18'); return false;" data-citation="" class="refNumLink">18</a></strong><div class="NLM_citation" id="cit18"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Dexheimer, T. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Antony, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Marchand, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pommier, Y.</span></span> <span> </span><span class="NLM_article-title">Tyrosyl-DNA phosphodiesterase as a target for anticancer therapy</span>. <i>Anti-Cancer Agents Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2008</span>,  <span class="NLM_volume"><i>8</i></span>,  <span class="NLM_fpage">381</span>– <span class="NLM_lpage">389</span>, <span class="refDoi"> DOI: 10.2174/187152008784220357</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref18/cit18&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00639&amp;key=10.2174%2F187152008784220357" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref18/cit18&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00639&amp;key=18473723" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref18/cit18&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00639&amp;key=1%3ACAS%3A528%3ADC%252BD1cXkvV2iurs%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=8&publication_year=2008&pages=381-389&author=T.+S.+Dexheimerauthor=S.+Antonyauthor=C.+Marchandauthor=Y.+Pommier&title=Tyrosyl-DNA+phosphodiesterase+as+a+target+for+anticancer+therapy&doi=10.2174%2F187152008784220357"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit18R"><div class="casContent"><span class="casTitleNuber">18</span><div class="casTitle"><span class="NLM_cas:atitle">Tyrosyl-DNA phosphodiesterase as a target for anticancer therapy</span></div><div class="casAuthors">Dexheimer, Thomas S.; Antony, Smitha; Marchand, Christophe; Pommier, Yves</div><div class="citationInfo"><span class="NLM_cas:title">Anti-Cancer Agents in Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">8</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">381-389</span>CODEN:
                <span class="NLM_cas:coden">AAMCE4</span>;
        ISSN:<span class="NLM_cas:issn">1871-5206</span>.
    
            (<span class="NLM_cas:orgname">Bentham Science Publishers Ltd.</span>)
        </div><div class="casAbstract">A review.  Tyrosyl-DNA phosphodiesterase 1 (Tdp1) is a recently discovered enzyme that catalyzes the hydrolysis of 3'-phosphotyrosyl bonds.  Such linkages form in vivo following the DNA processing activity of topoisomerase I (Top1).  For this reason, Tdp1 has been implicated in the repair of irreversible Top1-DNA covalent complexes, which can be generated by either exogenous or endogenous factors.  Tdp1 has been regarded as a potential therapeutic co-target of Top1 in that it seemingly counteracts the effects of Top1 inhibitors, such as camptothecin and its clin. used derivs.  Thus, by reducing the repair of Top1-DNA lesions, Tdp1 inhibitors have the potential to augment the anticancer activity of Top1 inhibitors provided there is a presence of genetic abnormalities related to DNA checkpoint and repair pathways.  Human Tdp1 can also hydrolyze other 3'-end DNA alterations including 3'-phosphoglycolates and 3'-abasic sites indicating it may function as a general 3'-DNA phosphodiesterase and repair enzyme.  The importance of Tdp1 in humans is highlighted by the observation that a recessive mutation in the human TDP1 gene is responsible for the inherited disorder, spinocerebellar ataxia with axonal neuropathy (SCAN1).  This review provides a summary of the biochem. and cellular processes performed by Tdp1 as well as the rationale behind the development of Tdp1 inhibitors for anticancer therapy.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGp1Oyb-NTvZtLVg90H21EOLACvtfcHk0lgZ_bBQa9_YwQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXkvV2iurs%253D&md5=82be43ceb8d832abb994ab3494fbc119</span></div><a href="/servlet/linkout?suffix=cit18&amp;dbid=16384&amp;doi=10.2174%2F187152008784220357&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.2174%252F187152008784220357%26sid%3Dliteratum%253Aachs%26aulast%3DDexheimer%26aufirst%3DT.%2BS.%26aulast%3DAntony%26aufirst%3DS.%26aulast%3DMarchand%26aufirst%3DC.%26aulast%3DPommier%26aufirst%3DY.%26atitle%3DTyrosyl-DNA%2520phosphodiesterase%2520as%2520a%2520target%2520for%2520anticancer%2520therapy%26jtitle%3DAnti-Cancer%2520Agents%2520Med.%2520Chem.%26date%3D2008%26volume%3D8%26spage%3D381%26epage%3D389%26doi%3D10.2174%2F187152008784220357" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref19"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref19'); return false;" data-citation="" class="refNumLink">19</a></strong><div class="NLM_citation" id="cit19"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Yang, S. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Burgin, A. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Huizenga, J. B. N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Robertson, C. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yao, K. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nash, H. A.</span></span> <span> </span><span class="NLM_article-title">A eukaryotic enzyme that can disjoin dead-end covalent complexes between DNA and type I topoisomerases</span>. <i>Proc. Natl. Acad. Sci. U. S. A.</i> <span class="NLM_year" style="font-weight: bold;">1996</span>,  <span class="NLM_volume"><i>93</i></span>,  <span class="NLM_fpage">11534</span>– <span class="NLM_lpage">11539</span>, <span class="refDoi"> DOI: 10.1073/pnas.93.21.11534</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref19/cit19&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00639&amp;key=10.1073%2Fpnas.93.21.11534" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref19/cit19&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00639&amp;key=8876170" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref19/cit19&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00639&amp;key=1%3ACAS%3A528%3ADyaK28Xmtlagt7o%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=93&publication_year=1996&pages=11534-11539&author=S.+W.+Yangauthor=A.+B.+Burginauthor=J.+B.+N.+Huizengaauthor=C.+A.+Robertsonauthor=K.+C.+Yaoauthor=H.+A.+Nash&title=A+eukaryotic+enzyme+that+can+disjoin+dead-end+covalent+complexes+between+DNA+and+type+I+topoisomerases&doi=10.1073%2Fpnas.93.21.11534"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit19R"><div class="casContent"><span class="casTitleNuber">19</span><div class="casTitle"><span class="NLM_cas:atitle">A eukaryotic enzyme that can disjoin dead-end covalent complexes between DNA and type I topoisomerases</span></div><div class="casAuthors">Yang, Shu-wei; Burgin, Alex B., Jr.; Huizenga, Beth N.; Robertson, Carol A.; Yao, Kevin C.; Nash, Howard A.</div><div class="citationInfo"><span class="NLM_cas:title">Proceedings of the National Academy of Sciences of the United States of America</span>
        (<span class="NLM_cas:date">1996</span>),
    <span class="NLM_cas:volume">93</span>
        (<span class="NLM_cas:issue">21</span>),
    <span class="NLM_cas:pages">11534-11539</span>CODEN:
                <span class="NLM_cas:coden">PNASA6</span>;
        ISSN:<span class="NLM_cas:issn">0027-8424</span>.
    
            (<span class="NLM_cas:orgname">National Academy of Sciences</span>)
        </div><div class="casAbstract">The covalent joining of topoisomerases to DNA is normally a transient step in the reaction cycle of these important enzymes.  However, under a variety of circumstances, the covalent complex is converted to a long-lived or dead-end product that can result in chromosome breakage and cell death.  We have discovered and partially purified an enzyme that specifically cleaves the chem. bond that joins the active site tyrosine of topoisomerases to the 3' end of DNA.  The reaction products made by the purified enzyme on a variety of model substrates indicate that the enzyme cleanly hydrolyzes the tyrosine-DNA phosphodiester linkage, thereby liberating a DNA terminated with a 3' phosphate.  The wide distribution of this phosphodiesterase in eukaryotes and its specificity for tyrosine linked to the 3' end but not the 5' end of DNA suggest that it plays a role in the repair of DNA trapped in complexes involving eukaryotic topoisomerase I.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrWltrYXnjURrVg90H21EOLACvtfcHk0lgIW-d9b3gyBw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK28Xmtlagt7o%253D&md5=3ad78920c695f68ab0ae414af56ef333</span></div><a href="/servlet/linkout?suffix=cit19&amp;dbid=16384&amp;doi=10.1073%2Fpnas.93.21.11534&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1073%252Fpnas.93.21.11534%26sid%3Dliteratum%253Aachs%26aulast%3DYang%26aufirst%3DS.%2BW.%26aulast%3DBurgin%26aufirst%3DA.%2BB.%26aulast%3DHuizenga%26aufirst%3DJ.%2BB.%2BN.%26aulast%3DRobertson%26aufirst%3DC.%2BA.%26aulast%3DYao%26aufirst%3DK.%2BC.%26aulast%3DNash%26aufirst%3DH.%2BA.%26atitle%3DA%2520eukaryotic%2520enzyme%2520that%2520can%2520disjoin%2520dead-end%2520covalent%2520complexes%2520between%2520DNA%2520and%2520type%2520I%2520topoisomerases%26jtitle%3DProc.%2520Natl.%2520Acad.%2520Sci.%2520U.%2520S.%2520A.%26date%3D1996%26volume%3D93%26spage%3D11534%26epage%3D11539%26doi%3D10.1073%2Fpnas.93.21.11534" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref20"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref20'); return false;" data-citation="" class="refNumLink">20</a></strong><div class="NLM_citation" id="cit20"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Murai, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Huang, S. Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Das, B. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dexheimer, T. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Takeda, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pommier, Y.</span></span> <span> </span><span class="NLM_article-title">Tyrosyl-DNA phosphodiesterase 1 (TDP1) repairs DNA damage induced by topoisomerases I and II and base alkylation in vertebrate cells</span>. <i>J. Biol. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2012</span>,  <span class="NLM_volume"><i>287</i></span>,  <span class="NLM_fpage">12848</span>– <span class="NLM_lpage">12857</span>, <span class="refDoi"> DOI: 10.1074/jbc.M111.333963</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref20/cit20&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00639&amp;key=10.1074%2Fjbc.M111.333963" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref20/cit20&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00639&amp;key=22375014" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref20/cit20&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00639&amp;key=1%3ACAS%3A528%3ADC%252BC38XlsFCitr4%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=287&publication_year=2012&pages=12848-12857&author=J.+Muraiauthor=S.+Y.+Huangauthor=B.+B.+Dasauthor=T.+S.+Dexheimerauthor=S.+Takedaauthor=Y.+Pommier&title=Tyrosyl-DNA+phosphodiesterase+1+%28TDP1%29+repairs+DNA+damage+induced+by+topoisomerases+I+and+II+and+base+alkylation+in+vertebrate+cells&doi=10.1074%2Fjbc.M111.333963"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit20R"><div class="casContent"><span class="casTitleNuber">20</span><div class="casTitle"><span class="NLM_cas:atitle">Tyrosyl-DNA Phosphodiesterase 1 (TDP1) Repairs DNA Damage Induced by Topoisomerases I and II and Base Alkylation in Vertebrate Cells</span></div><div class="casAuthors">Murai, Junko; Huang, Shar-yin N.; Das, Benu Brata; Dexheimer, Thomas S.; Takeda, Shunichi; Pommier, Yves</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Biological Chemistry</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">287</span>
        (<span class="NLM_cas:issue">16</span>),
    <span class="NLM_cas:pages">12848-12857</span>CODEN:
                <span class="NLM_cas:coden">JBCHA3</span>;
        ISSN:<span class="NLM_cas:issn">0021-9258</span>.
    
            (<span class="NLM_cas:orgname">American Society for Biochemistry and Molecular Biology</span>)
        </div><div class="casAbstract">Tyrosyl-DNA phosphodiesterase 1 (Tdp1) repairs topoisomerase I cleavage complexes (Top1cc) by hydrolyzing their 3'-phosphotyrosyl DNA bonds and repairs bleomycin-induced DNA damage by hydrolyzing 3'-phosphoglycolates.  Yeast Tdp1 has also been implicated in the repair of topoisomerase II-DNA cleavage complexes (Top2cc).  To det. whether vertebrate Tdp1 is involved in the repair of various DNA end-blocking lesions, we generated Tdp1 knock-out cells in chicken DT40 cells (Tdp1-/-) and Tdp1-complemented DT40 cells with human TDP1.  We found that Tdp1-/- cells were not only hypersensitive to camptothecin and bleomycin but also to etoposide, Me methanesulfonate (MMS), H2O2, and ionizing radiation.  We also show they were deficient in mitochondrial Tdp1 activity.  In biochem. assays, recombinant human TDP1 was found to process 5'-phosphotyrosyl DNA ends when they mimic the 5'-overhangs of Top2cc.  Tdp1 also processes 3'-deoxyribose phosphates generated from hydrolysis of abasic sites, which is consistent with the hypersensitivity of Tdp1-/- cells to MMS and H2O2.  Because recent studies established that CtIP (RBBP8) together with BRCA1 also repairs topoisomerase-mediated DNA damage, we generated dual Tdp1-CtIP-deficient DT40 cells.  Our results show that Tdp1 and CtIP act in parallel pathways for the repair of Top1cc and MMS-induced lesions but are epistatic for Top2cc.  Together, our findings reveal a broad involvement of Tdp1 in DNA repair and clarify the role of human TDP1 in the repair of Top2-induced DNA damage.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqovA7wdm9JUrVg90H21EOLACvtfcHk0lgIW-d9b3gyBw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38XlsFCitr4%253D&md5=2ad3a40dca2fb504e333168c065d4cd6</span></div><a href="/servlet/linkout?suffix=cit20&amp;dbid=16384&amp;doi=10.1074%2Fjbc.M111.333963&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1074%252Fjbc.M111.333963%26sid%3Dliteratum%253Aachs%26aulast%3DMurai%26aufirst%3DJ.%26aulast%3DHuang%26aufirst%3DS.%2BY.%26aulast%3DDas%26aufirst%3DB.%2BB.%26aulast%3DDexheimer%26aufirst%3DT.%2BS.%26aulast%3DTakeda%26aufirst%3DS.%26aulast%3DPommier%26aufirst%3DY.%26atitle%3DTyrosyl-DNA%2520phosphodiesterase%25201%2520%2528TDP1%2529%2520repairs%2520DNA%2520damage%2520induced%2520by%2520topoisomerases%2520I%2520and%2520II%2520and%2520base%2520alkylation%2520in%2520vertebrate%2520cells%26jtitle%3DJ.%2520Biol.%2520Chem.%26date%3D2012%26volume%3D287%26spage%3D12848%26epage%3D12857%26doi%3D10.1074%2Fjbc.M111.333963" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref21"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref21'); return false;" data-citation="" class="refNumLink">21</a></strong><div class="NLM_citation" id="cit21"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Interthal, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chen, H. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Champoux, J. J.</span></span> <span> </span><span class="NLM_article-title">Human Tdp1 cleaves a broad spectrum of substrates including phosphoamide linkages</span>. <i>J. Biol. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2005</span>,  <span class="NLM_volume"><i>280</i></span>,  <span class="NLM_fpage">36518</span>– <span class="NLM_lpage">36528</span>, <span class="refDoi"> DOI: 10.1074/jbc.M508898200</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref21/cit21&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00639&amp;key=10.1074%2Fjbc.M508898200" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=280&publication_year=2005&pages=36518-36528&author=H.+Interthalauthor=H.+J.+Chenauthor=J.+J.+Champoux&title=Human+Tdp1+cleaves+a+broad+spectrum+of+substrates+including+phosphoamide+linkages&doi=10.1074%2Fjbc.M508898200"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit21&amp;dbid=16384&amp;doi=10.1074%2Fjbc.M508898200&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1074%252Fjbc.M508898200%26sid%3Dliteratum%253Aachs%26aulast%3DInterthal%26aufirst%3DH.%26aulast%3DChen%26aufirst%3DH.%2BJ.%26aulast%3DChampoux%26aufirst%3DJ.%2BJ.%26atitle%3DHuman%2520Tdp1%2520cleaves%2520a%2520broad%2520spectrum%2520of%2520substrates%2520including%2520phosphoamide%2520linkages%26jtitle%3DJ.%2520Biol.%2520Chem.%26date%3D2005%26volume%3D280%26spage%3D36518%26epage%3D36528%26doi%3D10.1074%2Fjbc.M508898200" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref22"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref22'); return false;" data-citation="" class="refNumLink">22</a></strong><div class="NLM_citation" id="cit22"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Menon, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Povirk, L. F.</span></span> <span> </span><span class="NLM_article-title">End-processing nucleases and phosphodiesterases: An elite supporting cast for the non-homologous end joining pathway of DNA double-strand break repair</span>. <i>DNA Repair</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>43</i></span>,  <span class="NLM_fpage">57</span>– <span class="NLM_lpage">68</span>, <span class="refDoi"> DOI: 10.1016/j.dnarep.2016.05.011</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref22/cit22&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00639&amp;key=10.1016%2Fj.dnarep.2016.05.011" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref22/cit22&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00639&amp;key=27262532" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref22/cit22&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00639&amp;key=1%3ACAS%3A528%3ADC%252BC28Xpt1elurc%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=43&publication_year=2016&pages=57-68&author=V.+Menonauthor=L.+F.+Povirk&title=End-processing+nucleases+and+phosphodiesterases%3A+An+elite+supporting+cast+for+the+non-homologous+end+joining+pathway+of+DNA+double-strand+break+repair&doi=10.1016%2Fj.dnarep.2016.05.011"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit22R"><div class="casContent"><span class="casTitleNuber">22</span><div class="casTitle"><span class="NLM_cas:atitle">End-processing nucleases and phosphodiesterases: An elite supporting cast for the non-homologous end joining pathway of DNA double-strand break repair</span></div><div class="casAuthors">Menon, Vijay; Povirk, Lawrence F.</div><div class="citationInfo"><span class="NLM_cas:title">DNA Repair</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">43</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">57-68</span>CODEN:
                <span class="NLM_cas:coden">DRNEAR</span>;
        ISSN:<span class="NLM_cas:issn">1568-7864</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">A review.  Nonhomologous end joining (NHEJ) is an error-prone DNA double-strand break repair pathway that is active throughout the cell cycle.  A substantial fraction of NHEJ repair events show deletions and, less often, insertions in the repair joints, suggesting an end-processing step comprising the removal of mismatched or damaged nucleotides by nucleases and other phosphodiesterases, as well as subsequent strand extension by polymerases.  A wide range of nucleases, including Artemis, Metnase, APLF, Mre11, CtIP, APE1, APE2 and WRN, are biochem. competent to carry out such double-strand break end processing, and have been implicated in NHEJ by at least circumstantial evidence.  Several addnl. DNA end-specific phosphodiesterases, including TDP1, TDP2 and aprataxin are available to resolve various non-nucleotide moieties at DSB ends.  This review summarizes the biochem. specificities of these enzymes and the evidence for their participation in the NHEJ pathway.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoBeVbkMPo6PLVg90H21EOLACvtfcHk0lgIW-d9b3gyBw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28Xpt1elurc%253D&md5=8a7ac0b43c8462e3423bb86c27d116a0</span></div><a href="/servlet/linkout?suffix=cit22&amp;dbid=16384&amp;doi=10.1016%2Fj.dnarep.2016.05.011&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.dnarep.2016.05.011%26sid%3Dliteratum%253Aachs%26aulast%3DMenon%26aufirst%3DV.%26aulast%3DPovirk%26aufirst%3DL.%2BF.%26atitle%3DEnd-processing%2520nucleases%2520and%2520phosphodiesterases%253A%2520An%2520elite%2520supporting%2520cast%2520for%2520the%2520non-homologous%2520end%2520joining%2520pathway%2520of%2520DNA%2520double-strand%2520break%2520repair%26jtitle%3DDNA%2520Repair%26date%3D2016%26volume%3D43%26spage%3D57%26epage%3D68%26doi%3D10.1016%2Fj.dnarep.2016.05.011" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref23"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref23'); return false;" data-citation="" class="refNumLink">23</a></strong><div class="NLM_citation" id="cit23"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Ashour, M. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Atteya, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">El-Khamisy, S. F.</span></span> <span> </span><span class="NLM_article-title">Topoisomerase-mediated chromosomal break repair: an emerging player in many games</span>. <i>Nat. Rev. Cancer</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>15</i></span>,  <span class="NLM_fpage">137</span>– <span class="NLM_lpage">151</span>, <span class="refDoi"> DOI: 10.1038/nrc3892</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref23/cit23&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00639&amp;key=10.1038%2Fnrc3892" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref23/cit23&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00639&amp;key=25693836" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref23/cit23&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00639&amp;key=1%3ACAS%3A528%3ADC%252BC2MXjtVSlurw%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=15&publication_year=2015&pages=137-151&author=M.+E.+Ashourauthor=R.+Atteyaauthor=S.+F.+El-Khamisy&title=Topoisomerase-mediated+chromosomal+break+repair%3A+an+emerging+player+in+many+games&doi=10.1038%2Fnrc3892"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit23R"><div class="casContent"><span class="casTitleNuber">23</span><div class="casTitle"><span class="NLM_cas:atitle">Topoisomerase-mediated chromosomal break repair: an emerging player in many games</span></div><div class="casAuthors">Ashour, Mohamed E.; Atteya, Reham; El-Khamisy, Sherif F.</div><div class="citationInfo"><span class="NLM_cas:title">Nature Reviews Cancer</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">15</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">137-151</span>CODEN:
                <span class="NLM_cas:coden">NRCAC4</span>;
        ISSN:<span class="NLM_cas:issn">1474-175X</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">A review.  The mammalian genome is constantly challenged by exogenous and endogenous threats.  Although much is known about the mechanisms that maintain DNA and RNA integrity, we know surprisingly little about the mechanisms that underpin the pathol. and tissue specificity of many disorders caused by defective responses to DNA or RNA damage.  Of the different types of endogenous damage, protein-linked DNA breaks (PDBs) are emerging as an important player in cancer development and therapy.  PDBs can arise during the abortive activity of DNA topoisomerases, a class of enzymes that modulate DNA topol. during several chromosomal transactions, such as gene transcription and DNA replication, recombination and repair.  In this Review, we discuss the mechanisms underpinning topoisomerase-induced PDB formation and repair with a focus on their role during gene transcription and the development of tissue-specific cancers.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoWemuoEWlx5bVg90H21EOLACvtfcHk0licIhTDRESu3w"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXjtVSlurw%253D&md5=0768267e31e9e525528c6834a2c4df28</span></div><a href="/servlet/linkout?suffix=cit23&amp;dbid=16384&amp;doi=10.1038%2Fnrc3892&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnrc3892%26sid%3Dliteratum%253Aachs%26aulast%3DAshour%26aufirst%3DM.%2BE.%26aulast%3DAtteya%26aufirst%3DR.%26aulast%3DEl-Khamisy%26aufirst%3DS.%2BF.%26atitle%3DTopoisomerase-mediated%2520chromosomal%2520break%2520repair%253A%2520an%2520emerging%2520player%2520in%2520many%2520games%26jtitle%3DNat.%2520Rev.%2520Cancer%26date%3D2015%26volume%3D15%26spage%3D137%26epage%3D151%26doi%3D10.1038%2Fnrc3892" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref24"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref24'); return false;" data-citation="" class="refNumLink">24</a></strong><div class="NLM_citation" id="cit24"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Nitiss, K. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Malik, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">He, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">White, S. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nitiss, J. L.</span></span> <span> </span><span class="NLM_article-title">Tyrosyl-DNA phosphodiesterase (Tdp1) participates in the repair of Top2-mediated DNA damage</span>. <i>Proc. Natl. Acad. Sci. U. S. A.</i> <span class="NLM_year" style="font-weight: bold;">2006</span>,  <span class="NLM_volume"><i>103</i></span>,  <span class="NLM_fpage">8953</span>– <span class="NLM_lpage">8958</span>, <span class="refDoi"> DOI: 10.1073/pnas.0603455103</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref24/cit24&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00639&amp;key=10.1073%2Fpnas.0603455103" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=103&publication_year=2006&pages=8953-8958&author=K.+C.+Nitissauthor=M.+Malikauthor=X.+Heauthor=S.+W.+Whiteauthor=J.+L.+Nitiss&title=Tyrosyl-DNA+phosphodiesterase+%28Tdp1%29+participates+in+the+repair+of+Top2-mediated+DNA+damage&doi=10.1073%2Fpnas.0603455103"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit24&amp;dbid=16384&amp;doi=10.1073%2Fpnas.0603455103&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1073%252Fpnas.0603455103%26sid%3Dliteratum%253Aachs%26aulast%3DNitiss%26aufirst%3DK.%2BC.%26aulast%3DMalik%26aufirst%3DM.%26aulast%3DHe%26aufirst%3DX.%26aulast%3DWhite%26aufirst%3DS.%2BW.%26aulast%3DNitiss%26aufirst%3DJ.%2BL.%26atitle%3DTyrosyl-DNA%2520phosphodiesterase%2520%2528Tdp1%2529%2520participates%2520in%2520the%2520repair%2520of%2520Top2-mediated%2520DNA%2520damage%26jtitle%3DProc.%2520Natl.%2520Acad.%2520Sci.%2520U.%2520S.%2520A.%26date%3D2006%26volume%3D103%26spage%3D8953%26epage%3D8958%26doi%3D10.1073%2Fpnas.0603455103" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref25"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref25'); return false;" data-citation="" class="refNumLink">25</a></strong><div class="NLM_citation" id="cit25"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Takashima, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Boerkoel, C. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">John, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Saifi, G. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Salih, M. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Armstrong, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mao, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Quiocho, F. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Roa, B. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nakagawa, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Stockton, D. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lupski, J. R.</span></span> <span> </span><span class="NLM_article-title">Mutation of TDP1, encoding a topoisomerase I-dependent DNA damage repair enzyme, in spinocerebellar ataxia with axonal neuropathy</span>. <i>Nat. Genet.</i> <span class="NLM_year" style="font-weight: bold;">2002</span>,  <span class="NLM_volume"><i>32</i></span>,  <span class="NLM_fpage">267</span>– <span class="NLM_lpage">272</span>, <span class="refDoi"> DOI: 10.1038/ng987</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref25/cit25&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00639&amp;key=10.1038%2Fng987" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref25/cit25&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00639&amp;key=12244316" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref25/cit25&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00639&amp;key=1%3ACAS%3A528%3ADC%252BD38XotlaisLs%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=32&publication_year=2002&pages=267-272&author=H.+Takashimaauthor=C.+F.+Boerkoelauthor=J.+Johnauthor=G.+M.+Saifiauthor=M.+A.+Salihauthor=D.+Armstrongauthor=Y.+Maoauthor=F.+A.+Quiochoauthor=B.+B.+Roaauthor=M.+Nakagawaauthor=D.+W.+Stocktonauthor=J.+R.+Lupski&title=Mutation+of+TDP1%2C+encoding+a+topoisomerase+I-dependent+DNA+damage+repair+enzyme%2C+in+spinocerebellar+ataxia+with+axonal+neuropathy&doi=10.1038%2Fng987"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit25R"><div class="casContent"><span class="casTitleNuber">25</span><div class="casTitle"><span class="NLM_cas:atitle">Mutation of TDP1, encoding a topoisomerase I-dependent DNA damage repair enzyme, in spinocerebellar ataxia with axonal neuropathy</span></div><div class="casAuthors">Takashima, Hiroshi; Boerkoel, Cornelius F.; John, Joy; Saifi, Gulam Mustafa; Salih, Mustafa A. M.; Armstrong, Dawna; Mao, Yuxin; Quiocho, Florante A.; Roa, Benjamin B.; Nakagawa, Masanori; Stockton, David W.; Lupski, James R.</div><div class="citationInfo"><span class="NLM_cas:title">Nature Genetics</span>
        (<span class="NLM_cas:date">2002</span>),
    <span class="NLM_cas:volume">32</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">267-272</span>CODEN:
                <span class="NLM_cas:coden">NGENEC</span>;
        ISSN:<span class="NLM_cas:issn">1061-4036</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">Tyrosyl-DNA phosphodiesterase 1 (TDP1) repairs covalently bound topoisomerase I-DNA complexes and is essential for preventing the formation of double-strand breaks that result when stalled topoisomerase I complexes interfere with DNA replication in yeast.  Here we show that a deficiency of this DNA repair pathway in humans does not predispose to neoplasia or dysfunctions in rapidly replicating tissues, but instead causes spinocerebellar ataxia with axonal neuropathy (SCAN1) by affecting large, terminally differentiated, non-dividing neuronal cells.  Using genome-wide linkage mapping and a positional candidate approach in a Saudi Arabian family affected with autosomal recessive SCAN1, we identified a homozygous mutation in TDP1 (A1478G) that results in the substitution of histidine 493 with an arginine residue.  The His493 residue is conserved in TDP1 across species and is located in the active site of the enzyme.  Protein modeling predicts that mutation of this amino acid to arginine will disrupt the sym. structure of the active site.  We propose that loss-of-function mutations in TDP1 may cause SCAN1 either by interfering with DNA transcription or by inducing apoptosis in postmitotic neurons.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrXe_yuV1_hHrVg90H21EOLACvtfcHk0licIhTDRESu3w"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD38XotlaisLs%253D&md5=0c89852fe1b3dba6b50b93105e7fefca</span></div><a href="/servlet/linkout?suffix=cit25&amp;dbid=16384&amp;doi=10.1038%2Fng987&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fng987%26sid%3Dliteratum%253Aachs%26aulast%3DTakashima%26aufirst%3DH.%26aulast%3DBoerkoel%26aufirst%3DC.%2BF.%26aulast%3DJohn%26aufirst%3DJ.%26aulast%3DSaifi%26aufirst%3DG.%2BM.%26aulast%3DSalih%26aufirst%3DM.%2BA.%26aulast%3DArmstrong%26aufirst%3DD.%26aulast%3DMao%26aufirst%3DY.%26aulast%3DQuiocho%26aufirst%3DF.%2BA.%26aulast%3DRoa%26aufirst%3DB.%2BB.%26aulast%3DNakagawa%26aufirst%3DM.%26aulast%3DStockton%26aufirst%3DD.%2BW.%26aulast%3DLupski%26aufirst%3DJ.%2BR.%26atitle%3DMutation%2520of%2520TDP1%252C%2520encoding%2520a%2520topoisomerase%2520I-dependent%2520DNA%2520damage%2520repair%2520enzyme%252C%2520in%2520spinocerebellar%2520ataxia%2520with%2520axonal%2520neuropathy%26jtitle%3DNat.%2520Genet.%26date%3D2002%26volume%3D32%26spage%3D267%26epage%3D272%26doi%3D10.1038%2Fng987" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref26"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref26'); return false;" data-citation="" class="refNumLink">26</a></strong><div class="NLM_citation" id="cit26"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Barthelmes, H. U.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Habermeyer, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Christensen, M. O.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mielke, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Interthal, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pouliot, J. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Boege, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Marko, D.</span></span> <span> </span><span class="NLM_article-title">TDP1 overexpression in human cells counteracts DNA damage mediated by topoisomerases I and II</span>. <i>J. Biol. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2004</span>,  <span class="NLM_volume"><i>279</i></span>,  <span class="NLM_fpage">55618</span>– <span class="NLM_lpage">55625</span>, <span class="refDoi"> DOI: 10.1074/jbc.M405042200</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref26/cit26&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00639&amp;key=10.1074%2Fjbc.M405042200" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref26/cit26&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00639&amp;key=15494395" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref26/cit26&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00639&amp;key=1%3ACAS%3A528%3ADC%252BD2cXhtFeis7nK" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=279&publication_year=2004&pages=55618-55625&author=H.+U.+Barthelmesauthor=M.+Habermeyerauthor=M.+O.+Christensenauthor=C.+Mielkeauthor=H.+Interthalauthor=J.+J.+Pouliotauthor=F.+Boegeauthor=D.+Marko&title=TDP1+overexpression+in+human+cells+counteracts+DNA+damage+mediated+by+topoisomerases+I+and+II&doi=10.1074%2Fjbc.M405042200"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit26R"><div class="casContent"><span class="casTitleNuber">26</span><div class="casTitle"><span class="NLM_cas:atitle">TDP1 Overexpression in Human Cells Counteracts DNA Damage Mediated by Topoisomerases I and II</span></div><div class="casAuthors">Barthelmes, Hans U.; Habermeyer, Michael; Christensen, Morten O.; Mielke, Christian; Interthal, Heidrun; Pouliot, Jeffrey J.; Boege, Fritz; Marko, Doris</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Biological Chemistry</span>
        (<span class="NLM_cas:date">2004</span>),
    <span class="NLM_cas:volume">279</span>
        (<span class="NLM_cas:issue">53</span>),
    <span class="NLM_cas:pages">55618-55625</span>CODEN:
                <span class="NLM_cas:coden">JBCHA3</span>;
        ISSN:<span class="NLM_cas:issn">0021-9258</span>.
    
            (<span class="NLM_cas:orgname">American Society for Biochemistry and Molecular Biology</span>)
        </div><div class="casAbstract">Tyrosyl DNA phosphodiesterase 1 (TDP1) is a repair enzyme that removes adducts, e.g. of topoisomerase I from the 3'-phosphate of DNA breaks.  When expressed in human cells as a biofluorescent chimera, TDP1 appeared more mobile than topoisomerase I, less accumulated in nucleoli, and not chromosome-bound at early mitosis.  Upon exposure to camptothecin, both proteins were cleared from nucleoli and rendered less mobile in the nucleoplasm.  However, with TDP1, this happened much more slowly, reflecting most likely the redistribution of nucleolar structures upon inhibition of rDNA transcription.  Thus, a steady assocn. of TDP1 with topoisomerase I seems unlikely, whereas its integration into repair complexes assembled subsequently to the stabilization of DNA·topoisomerase I intermediates is supported.  Cells expressing GFP-tagged TDP1 > 100-fold in excess of endogenous TDP1 exhibited a significant redn. of DNA damage induced by the topoisomerase I poison camptothecin and could be selected by that drug.  Surprisingly, DNA damage induced by the topoisomerase II poison VP-16 was also diminished to a similar extent, whereas DNA damage independent of topoisomerase I or II was not affected.  Overexpression of the inactive mutant GFP-TDP1H263A at similar levels did not reduce DNA damage by camptothecin or VP-16.  These observations confirm a requirement of active TDP1 for the repair of topoisomerase I-mediated DNA damage.  Our data also suggest a role of TDP1 in the repair of DNA damage mediated by topoisomerase II, which is less clear.  Since overexpression of TDP1 did not compromise cell proliferation, it could be a pleiotropic resistance mechanism in cancer therapy.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpWkEIwTlRFcbVg90H21EOLACvtfcHk0licIhTDRESu3w"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2cXhtFeis7nK&md5=8cf785584cf8a50c5c075947ad907a6c</span></div><a href="/servlet/linkout?suffix=cit26&amp;dbid=16384&amp;doi=10.1074%2Fjbc.M405042200&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1074%252Fjbc.M405042200%26sid%3Dliteratum%253Aachs%26aulast%3DBarthelmes%26aufirst%3DH.%2BU.%26aulast%3DHabermeyer%26aufirst%3DM.%26aulast%3DChristensen%26aufirst%3DM.%2BO.%26aulast%3DMielke%26aufirst%3DC.%26aulast%3DInterthal%26aufirst%3DH.%26aulast%3DPouliot%26aufirst%3DJ.%2BJ.%26aulast%3DBoege%26aufirst%3DF.%26aulast%3DMarko%26aufirst%3DD.%26atitle%3DTDP1%2520overexpression%2520in%2520human%2520cells%2520counteracts%2520DNA%2520damage%2520mediated%2520by%2520topoisomerases%2520I%2520and%2520II%26jtitle%3DJ.%2520Biol.%2520Chem.%26date%3D2004%26volume%3D279%26spage%3D55618%26epage%3D55625%26doi%3D10.1074%2Fjbc.M405042200" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref27"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref27'); return false;" data-citation="" class="refNumLink">27</a></strong><div class="NLM_citation" id="cit27"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Nivens, M. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Felder, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Galloway, A. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pena, M. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pouliot, J. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Spencer, H. T.</span></span> <span> </span><span class="NLM_article-title">Engineered resistance to camptothecin and antifolates by retroviral coexpression of tyrosyl DNA phosphodiesterase-I and thymidylate synthase</span>. <i>Cancer Chemother. Pharmacol.</i> <span class="NLM_year" style="font-weight: bold;">2004</span>,  <span class="NLM_volume"><i>53</i></span>,  <span class="NLM_fpage">107</span>– <span class="NLM_lpage">115</span>, <span class="refDoi"> DOI: 10.1007/s00280-003-0717-6</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref27/cit27&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00639&amp;key=10.1007%2Fs00280-003-0717-6" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref27/cit27&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00639&amp;key=14605862" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref27/cit27&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00639&amp;key=1%3ACAS%3A528%3ADC%252BD3sXhtVSjsLfL" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=53&publication_year=2004&pages=107-115&author=M.+C.+Nivensauthor=T.+Felderauthor=A.+H.+Gallowayauthor=M.+M.+Penaauthor=J.+J.+Pouliotauthor=H.+T.+Spencer&title=Engineered+resistance+to+camptothecin+and+antifolates+by+retroviral+coexpression+of+tyrosyl+DNA+phosphodiesterase-I+and+thymidylate+synthase&doi=10.1007%2Fs00280-003-0717-6"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit27R"><div class="casContent"><span class="casTitleNuber">27</span><div class="casTitle"><span class="NLM_cas:atitle">Engineered resistance to camptothecin and antifolates by retroviral coexpression of tyrosyl DNA phosphodiesterase-I and thymidylate synthase</span></div><div class="casAuthors">Nivens, Michael C.; Felder, Takita; Galloway, Amanda H.; Pena, Maria Marjorette O.; Pouliot, Jeffery J.; Spencer, H. Trent</div><div class="citationInfo"><span class="NLM_cas:title">Cancer Chemotherapy and Pharmacology</span>
        (<span class="NLM_cas:date">2004</span>),
    <span class="NLM_cas:volume">53</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">107-115</span>CODEN:
                <span class="NLM_cas:coden">CCPHDZ</span>;
        ISSN:<span class="NLM_cas:issn">0344-5704</span>.
    
            (<span class="NLM_cas:orgname">Springer-Verlag</span>)
        </div><div class="casAbstract">Purpose: Gene transfer of cDNA sequences that confer drug resistance can be used (1) to protect hematopoietic cells against the toxic effects of chemotherapy, (2) for in vivo enrichment of genetically engineered cells and (3) to protect cytotoxic T lymphocytes in drug-resistant immunotherapy approaches for the treatment of cancer.  We have previously developed strategies to confer resistance to agents targeting thymidylate synthase (TS) and have now expanded our drug resistance strategies to include retroviral expression of tyrosyl-DNA phosphodiesterase (TDP-I), an enzyme recently implicated in the repair of topoisomerase-I (Top-I)/DNA lesions induced by camptothecin (CPT).  The combination of TS and Top-I inhibition has been shown to be an effective treatment for several types of cancer.  Materials and methods: Retroviral vectors were generated that individually encoded TS and TDP-I or that coexpressed both enzymes.  Murine fibroblast and Chinese hamster lung transfectants were generated with the vectors and resistance to TS- and Top-I-directed inhibitors was tested.  Murine bone marrow progenitor cells were also transduced using recombinant retroviruses encoding TS and TDP-I and the degree of drug resistance conferred to gene-modified cells was tested.  Results: Enforced expression of TDP-I increased TDP-I activity in gene-modified cells and conferred up to threefold resistance to CPT.  The degree of resistance was dependent on the duration of drug treatment.  Simultaneous expression of the TS gene encoding E. coli TS optimized for expression in mammalian cells (optecTS) and TDP-I conferred extremely high-level resistance to concurrent treatment with the TS-inhibitor BW1843U89 and CPT.  Furthermore, by direct anal. of DNA fragmentation using the comet assay, substantial protection was conferred (fourfold) against DNA fragmentation assocd. with combination drug treatments by dual enzyme expression compared to non-modified cells.  Hematopoietic progenitor assays of murine bone marrow cells transduced with retroviral vectors encoding TS and TDP-I showed that bone marrow cells could be protected from the cytotoxic effects of TS and Top-I inhibition.  Conclusions: Enforced expression of optecTS and TDP-I conferred antifolate and CPT resistance to genetically modified cells.  Addnl., this work further illustrated a role for TDP-I in the repair of dead-end Top-I complexes and implied that TDP-I expression anal. may aid in predicting the therapeutic effectiveness of the CPT class of compds.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqwmN-FmI203rVg90H21EOLACvtfcHk0lg7itK4-tFbdQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3sXhtVSjsLfL&md5=dad651aab3a7deaf4f6ad5c7a188f595</span></div><a href="/servlet/linkout?suffix=cit27&amp;dbid=16384&amp;doi=10.1007%2Fs00280-003-0717-6&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1007%252Fs00280-003-0717-6%26sid%3Dliteratum%253Aachs%26aulast%3DNivens%26aufirst%3DM.%2BC.%26aulast%3DFelder%26aufirst%3DT.%26aulast%3DGalloway%26aufirst%3DA.%2BH.%26aulast%3DPena%26aufirst%3DM.%2BM.%26aulast%3DPouliot%26aufirst%3DJ.%2BJ.%26aulast%3DSpencer%26aufirst%3DH.%2BT.%26atitle%3DEngineered%2520resistance%2520to%2520camptothecin%2520and%2520antifolates%2520by%2520retroviral%2520coexpression%2520of%2520tyrosyl%2520DNA%2520phosphodiesterase-I%2520and%2520thymidylate%2520synthase%26jtitle%3DCancer%2520Chemother.%2520Pharmacol.%26date%3D2004%26volume%3D53%26spage%3D107%26epage%3D115%26doi%3D10.1007%2Fs00280-003-0717-6" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref28"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref28'); return false;" data-citation="" class="refNumLink">28</a></strong><div class="NLM_citation" id="cit28"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Hirano, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Interthal, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Huang, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nakamura, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Deguchi, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Choi, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bhattacharjee, M. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Arimura, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Umehara, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Izumo, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Northrop, J. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Salih, M. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Inoue, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Armstrong, D. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Champoux, J. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Takashima, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Boerkoel, C. F.</span></span> <span> </span><span class="NLM_article-title">Spinocerebellar ataxia with axonal neuropathy: consequence of a Tdp1 recessive neomorphic mutation?</span>. <i>EMBO J.</i> <span class="NLM_year" style="font-weight: bold;">2007</span>,  <span class="NLM_volume"><i>26</i></span>,  <span class="NLM_fpage">4732</span>– <span class="NLM_lpage">4743</span>, <span class="refDoi"> DOI: 10.1038/sj.emboj.7601885</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref28/cit28&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00639&amp;key=10.1038%2Fsj.emboj.7601885" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref28/cit28&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00639&amp;key=17948061" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref28/cit28&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00639&amp;key=1%3ACAS%3A528%3ADC%252BD2sXht12gtbfE" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=26&publication_year=2007&pages=4732-4743&author=R.+Hiranoauthor=H.+Interthalauthor=C.+Huangauthor=T.+Nakamuraauthor=K.+Deguchiauthor=K.+Choiauthor=M.+B.+Bhattacharjeeauthor=K.+Arimuraauthor=F.+Umeharaauthor=S.+Izumoauthor=J.+L.+Northropauthor=M.+A.+Salihauthor=K.+Inoueauthor=D.+L.+Armstrongauthor=J.+J.+Champouxauthor=H.+Takashimaauthor=C.+F.+Boerkoel&title=Spinocerebellar+ataxia+with+axonal+neuropathy%3A+consequence+of+a+Tdp1+recessive+neomorphic+mutation%3F&doi=10.1038%2Fsj.emboj.7601885"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit28R"><div class="casContent"><span class="casTitleNuber">28</span><div class="casTitle"><span class="NLM_cas:atitle">Spinocerebellar ataxia with axonal neuropathy: consequence of a Tdp1 recessive neomorphic mutation?</span></div><div class="casAuthors">Hirano, Ryuki; Interthal, Heidrun; Huang, Cheng; Nakamura, Tomonori; Deguchi, Kimiko; Choi, Kunho; Bhattacharjee, Meenakshi B.; Arimura, Kimiyoshi; Umehara, Fujio; Izumo, Shuji; Northrop, Jennifer L.; Salih, Mustafa A. M.; Inoue, Ken; Armstrong, Dawna L.; Champoux, James J.; Takashima, Hiroshi; Boerkoel, Cornelius F.</div><div class="citationInfo"><span class="NLM_cas:title">EMBO Journal</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">26</span>
        (<span class="NLM_cas:issue">22</span>),
    <span class="NLM_cas:pages">4732-4743</span>CODEN:
                <span class="NLM_cas:coden">EMJODG</span>;
        ISSN:<span class="NLM_cas:issn">0261-4189</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">Tyrosyl-DNA phosphodiesterase 1 (Tdp1) cleaves the phosphodiester bond between a covalently stalled topoisomerase I (Topo I) and the 3' end of DNA.  Stalling of Topo I at DNA strand breaks is induced by endogenous DNA damage and the Topo I-specific anticancer drug camptothecin (CPT).  The H493R mutation of Tdp1 causes the neurodegenerative disorder spinocerebellar ataxia with axonal neuropathy (SCAN1).  Contrary to the hypothesis that SCAN1 arises from catalytically inactive Tdp1, Tdp1-/- mice are indistinguishable from wild-type mice, phys., histol., behaviorally, and electrophysiol.  However, compared to wild-type mice, Tdp1-/- mice are hypersensitive to CPT and bleomycin but not to etoposide.  Consistent with earlier in vitro studies, we show that the H493R Tdp1 mutant protein retains residual activity and becomes covalently trapped on the DNA after CPT treatment of SCAN1 cells.  This result provides a direct demonstration that Tdp1 repairs Topo I covalent lesions in vivo and suggests that SCAN1 arises from the recessive neomorphic mutation H493R.  This is a novel mechanism for disease since neomorphic mutations are generally dominant.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrpFUzVNpCYabVg90H21EOLACvtfcHk0lg7itK4-tFbdQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2sXht12gtbfE&md5=39df0c57b16b2fb362a386e096afe040</span></div><a href="/servlet/linkout?suffix=cit28&amp;dbid=16384&amp;doi=10.1038%2Fsj.emboj.7601885&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fsj.emboj.7601885%26sid%3Dliteratum%253Aachs%26aulast%3DHirano%26aufirst%3DR.%26aulast%3DInterthal%26aufirst%3DH.%26aulast%3DHuang%26aufirst%3DC.%26aulast%3DNakamura%26aufirst%3DT.%26aulast%3DDeguchi%26aufirst%3DK.%26aulast%3DChoi%26aufirst%3DK.%26aulast%3DBhattacharjee%26aufirst%3DM.%2BB.%26aulast%3DArimura%26aufirst%3DK.%26aulast%3DUmehara%26aufirst%3DF.%26aulast%3DIzumo%26aufirst%3DS.%26aulast%3DNorthrop%26aufirst%3DJ.%2BL.%26aulast%3DSalih%26aufirst%3DM.%2BA.%26aulast%3DInoue%26aufirst%3DK.%26aulast%3DArmstrong%26aufirst%3DD.%2BL.%26aulast%3DChampoux%26aufirst%3DJ.%2BJ.%26aulast%3DTakashima%26aufirst%3DH.%26aulast%3DBoerkoel%26aufirst%3DC.%2BF.%26atitle%3DSpinocerebellar%2520ataxia%2520with%2520axonal%2520neuropathy%253A%2520consequence%2520of%2520a%2520Tdp1%2520recessive%2520neomorphic%2520mutation%253F%26jtitle%3DEMBO%2520J.%26date%3D2007%26volume%3D26%26spage%3D4732%26epage%3D4743%26doi%3D10.1038%2Fsj.emboj.7601885" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref29"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref29'); return false;" data-citation="" class="refNumLink">29</a></strong><div class="NLM_citation" id="cit29"><span><span class="NLM_contrib-group"><span class="NLM_string-name">El-Khamisy, S. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Katyal, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Patel, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ju, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">McKinnon, P. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Caldecott, K. W.</span></span> <span> </span><span class="NLM_article-title">Synergistic decrease of DNA single-strand break repair rates in mouse neural cells lacking both Tdp1 and aprataxin</span>. <i>DNA Repair</i> <span class="NLM_year" style="font-weight: bold;">2009</span>,  <span class="NLM_volume"><i>8</i></span>,  <span class="NLM_fpage">760</span>– <span class="NLM_lpage">766</span>, <span class="refDoi"> DOI: 10.1016/j.dnarep.2009.02.002</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref29/cit29&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00639&amp;key=10.1016%2Fj.dnarep.2009.02.002" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref29/cit29&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00639&amp;key=19303373" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref29/cit29&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00639&amp;key=1%3ACAS%3A528%3ADC%252BD1MXmsVGju78%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=8&publication_year=2009&pages=760-766&author=S.+F.+El-Khamisyauthor=S.+Katyalauthor=P.+Patelauthor=L.+Juauthor=P.+J.+McKinnonauthor=K.+W.+Caldecott&title=Synergistic+decrease+of+DNA+single-strand+break+repair+rates+in+mouse+neural+cells+lacking+both+Tdp1+and+aprataxin&doi=10.1016%2Fj.dnarep.2009.02.002"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit29R"><div class="casContent"><span class="casTitleNuber">29</span><div class="casTitle"><span class="NLM_cas:atitle">Synergistic decrease of DNA single-strand break repair rates in mouse neural cells lacking both Tdp1 and aprataxin</span></div><div class="casAuthors">El-Khamisy, Sherif F.; Katyal, Sachin; Patel, Poorvi; Ju, Limei; McKinnon, Peter J.; Caldecott, Keith W.</div><div class="citationInfo"><span class="NLM_cas:title">DNA Repair</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">8</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">760-766</span>CODEN:
                <span class="NLM_cas:coden">DRNEAR</span>;
        ISSN:<span class="NLM_cas:issn">1568-7864</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">Ataxia oculomotor apraxia-1 (AOA1) is an autosomal recessive neurodegenerative disease that results from mutations of aprataxin (APTX).  APTX assocs. with the DNA single- and double-strand break repair machinery and is able to remove AMP from 5'-termini at DNA strand breaks in vitro.  However, attempts to establish a DNA strand break repair defect in APTX-defective cells have proved conflicting and unclear.  We reasoned that this may reflect that DNA strand breaks with 5'-AMP represent only a minor subset of breaks induced in cells, and/or the availability of alternative mechanisms for removing AMP from 5'-termini.  Here, we have attempted to increase the dependency of chromosomal single- and double-strand break repair on aprataxin activity by slowing the rate of repair of 3'-termini in aprataxin-defective neural cells, thereby increasing the likelihood that the 5'-termini at such breaks become adenylated and/or block alternative repair mechanisms.  To do this, we generated a mouse model in which APTX is deleted together with tyrosyl DNA phosphodiesterase (TDP1), an enzyme that repairs 3'-termini at a subset of single-strand breaks (SSBs), including those with 3'-topoisomerase-1 (Top1) peptide.  Notably, the global rate of repair of oxidative and alkylation-induced SSBs was significantly slower in Tdp1 -/-/Aptx -/- double knockout quiescent mouse astrocytes compared with Tdp1 -/- or Aptx -/- single knockouts.  In contrast, camptothecin-induced Top1-SSBs accumulated to similar levels in Tdp1 -/- and Tdp1 -/-/Aptx -/- double knockout astrocytes.  Finally, we failed to identify a measurable defect in double-strand break repair in Tdp1 -/-, Aptx -/- or Tdp1 -/-/Aptx -/- astrocytes.  These data provide direct evidence for a requirement for aprataxin during chromosomal single-strand break repair in primary neural cells lacking Tdp1.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpNBIcmYZzPOLVg90H21EOLACvtfcHk0lg7itK4-tFbdQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXmsVGju78%253D&md5=33ea9ce56b8626c83b1e0e40b6372e3f</span></div><a href="/servlet/linkout?suffix=cit29&amp;dbid=16384&amp;doi=10.1016%2Fj.dnarep.2009.02.002&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.dnarep.2009.02.002%26sid%3Dliteratum%253Aachs%26aulast%3DEl-Khamisy%26aufirst%3DS.%2BF.%26aulast%3DKatyal%26aufirst%3DS.%26aulast%3DPatel%26aufirst%3DP.%26aulast%3DJu%26aufirst%3DL.%26aulast%3DMcKinnon%26aufirst%3DP.%2BJ.%26aulast%3DCaldecott%26aufirst%3DK.%2BW.%26atitle%3DSynergistic%2520decrease%2520of%2520DNA%2520single-strand%2520break%2520repair%2520rates%2520in%2520mouse%2520neural%2520cells%2520lacking%2520both%2520Tdp1%2520and%2520aprataxin%26jtitle%3DDNA%2520Repair%26date%3D2009%26volume%3D8%26spage%3D760%26epage%3D766%26doi%3D10.1016%2Fj.dnarep.2009.02.002" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref30"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref30'); return false;" data-citation="" class="refNumLink">30</a></strong><div class="NLM_citation" id="cit30"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Das, B. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Antony, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gupta, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dexheimer, T. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Redon, C. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Garfield, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shiloh, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pommier, Y.</span></span> <span> </span><span class="NLM_article-title">Optimal function of the DNA repair enzyme TDP1 requires its phosphorylation by ATM and/or DNA-PK</span>. <i>EMBO J.</i> <span class="NLM_year" style="font-weight: bold;">2009</span>,  <span class="NLM_volume"><i>28</i></span>,  <span class="NLM_fpage">3667</span>– <span class="NLM_lpage">3680</span>, <span class="refDoi"> DOI: 10.1038/emboj.2009.302</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref30/cit30&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00639&amp;key=10.1038%2Femboj.2009.302" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref30/cit30&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00639&amp;key=19851285" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref30/cit30&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00639&amp;key=1%3ACAS%3A528%3ADC%252BD1MXht1KqsLbJ" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=28&publication_year=2009&pages=3667-3680&author=B.+B.+Dasauthor=S.+Antonyauthor=S.+Guptaauthor=T.+S.+Dexheimerauthor=C.+E.+Redonauthor=S.+Garfieldauthor=Y.+Shilohauthor=Y.+Pommier&title=Optimal+function+of+the+DNA+repair+enzyme+TDP1+requires+its+phosphorylation+by+ATM+and%2For+DNA-PK&doi=10.1038%2Femboj.2009.302"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit30R"><div class="casContent"><span class="casTitleNuber">30</span><div class="casTitle"><span class="NLM_cas:atitle">Optimal function of the DNA repair enzyme TDP1 requires its phosphorylation by ATM and/or DNA-PK</span></div><div class="casAuthors">Das, Benu Brata; Antony, Smitha; Gupta, Shalu; Dexheimer, Thomas S.; Redon, Christophe E.; Garfield, Susan; Shiloh, Yosef; Pommier, Yves</div><div class="citationInfo"><span class="NLM_cas:title">EMBO Journal</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">28</span>
        (<span class="NLM_cas:issue">23</span>),
    <span class="NLM_cas:pages">3667-3680</span>CODEN:
                <span class="NLM_cas:coden">EMJODG</span>;
        ISSN:<span class="NLM_cas:issn">0261-4189</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">Human tyrosyl-DNA phosphodiesterase (TDP1) hydrolyzes the phosphodiester bond at a DNA 3'-end linked to a tyrosyl moiety.  This type of linkage is found at stalled topoisomerase I (Top1)-DNA covalent complexes, and TDP1 has been implicated in the repair of such complexes.  Here, we show that Top1-assocd. DNA double-stranded breaks (DSBs) induce the phosphorylation of TDP1 at S81.  This phosphorylation is mediated by the protein kinases: ataxia-telangiectasia-mutated (ATM) and DNA-dependent protein kinase (DNA-PK).  Phosphorylated TDP1 forms nuclear foci that co-localize with those of phosphorylated histone H2AX (γH2AX).  Both Top1-induced replication- and transcription-mediated DNA damages induce TDP1 phosphorylation.  Furthermore, we show that S81 phosphorylation stabilizes TDP1, induces the formation of XRCC1 (X-ray cross-complementing group 1)-TDP1 complexes and enhances the mobilization of TDP1 to DNA damage sites.  Finally, we provide evidence that TDP1-S81 phosphorylation promotes cell survival and DNA repair in response to CPT-induced DSBs.  Together; our findings provide a new mechanism for TDP1 post-translational regulation by ATM and DNA-PK.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrboUgcsxZlJ7Vg90H21EOLACvtfcHk0lgoaGZxgB9oEA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXht1KqsLbJ&md5=49fd7ac1bcc126871fe35011a028c030</span></div><a href="/servlet/linkout?suffix=cit30&amp;dbid=16384&amp;doi=10.1038%2Femboj.2009.302&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Femboj.2009.302%26sid%3Dliteratum%253Aachs%26aulast%3DDas%26aufirst%3DB.%2BB.%26aulast%3DAntony%26aufirst%3DS.%26aulast%3DGupta%26aufirst%3DS.%26aulast%3DDexheimer%26aufirst%3DT.%2BS.%26aulast%3DRedon%26aufirst%3DC.%2BE.%26aulast%3DGarfield%26aufirst%3DS.%26aulast%3DShiloh%26aufirst%3DY.%26aulast%3DPommier%26aufirst%3DY.%26atitle%3DOptimal%2520function%2520of%2520the%2520DNA%2520repair%2520enzyme%2520TDP1%2520requires%2520its%2520phosphorylation%2520by%2520ATM%2520and%252For%2520DNA-PK%26jtitle%3DEMBO%2520J.%26date%3D2009%26volume%3D28%26spage%3D3667%26epage%3D3680%26doi%3D10.1038%2Femboj.2009.302" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref31"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref31'); return false;" data-citation="" class="refNumLink">31</a></strong><div class="NLM_citation" id="cit31"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Katyal, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">El-Khamisy, S. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Russell, H. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ju, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Caldecott, K. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">McKinnon, P. J.</span></span> <span> </span><span class="NLM_article-title">TDP1 facilitates chromosomal single-strand break repair in neurons and is neuroprotective in vivo</span>. <i>EMBO J.</i> <span class="NLM_year" style="font-weight: bold;">2007</span>,  <span class="NLM_volume"><i>26</i></span>,  <span class="NLM_fpage">4720</span>– <span class="NLM_lpage">4731</span>, <span class="refDoi"> DOI: 10.1038/sj.emboj.7601869</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref31/cit31&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00639&amp;key=10.1038%2Fsj.emboj.7601869" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref31/cit31&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00639&amp;key=17914460" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref31/cit31&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00639&amp;key=1%3ACAS%3A528%3ADC%252BD2sXht12gtbfF" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=26&publication_year=2007&pages=4720-4731&author=S.+Katyalauthor=S.+F.+El-Khamisyauthor=H.+R.+Russellauthor=Y.+Liauthor=L.+Juauthor=K.+W.+Caldecottauthor=P.+J.+McKinnon&title=TDP1+facilitates+chromosomal+single-strand+break+repair+in+neurons+and+is+neuroprotective+in+vivo&doi=10.1038%2Fsj.emboj.7601869"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit31R"><div class="casContent"><span class="casTitleNuber">31</span><div class="casTitle"><span class="NLM_cas:atitle">TDP1 facilitates chromosomal single-strand break repair in neurons and is neuroprotective in vivo</span></div><div class="casAuthors">Katyal, Sachin; El-Khamisy, Sherif F.; Russell, Helen R.; Li, Yang; Ju, Limei; Caldecott, Keith W.; McKinnon, Peter J.</div><div class="citationInfo"><span class="NLM_cas:title">EMBO Journal</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">26</span>
        (<span class="NLM_cas:issue">22</span>),
    <span class="NLM_cas:pages">4720-4731</span>CODEN:
                <span class="NLM_cas:coden">EMJODG</span>;
        ISSN:<span class="NLM_cas:issn">0261-4189</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">Defective Tyrosyl-DNA phosphodiesterase 1 (TDP1) can cause spinocerebellar ataxia with axonal neuropathy (SCAN1), a neurodegenerative syndrome assocd. with marked cerebellar atrophy and peripheral neuropathy.  Although SCAN1 lymphoblastoid cells show pronounced defects in the repair of chromosomal single-strand breaks (SSBs), it is unknown if this DNA repair activity is important for neurons or for preventing neurodegeneration.  Therefore, we generated Tdp1-/- mice to assess the role of Tdp1 in the nervous system.  Using both in vitro and in vivo assays, we found that cerebellar neurons or primary astrocytes derived from Tdp1-/- mice display an inability to rapidly repair DNA SSBs assocd. with Top1-DNA complexes or oxidative damage.  Moreover, loss of Tdp1 resulted in age-dependent and progressive cerebellar atrophy.  Tdp1-/- mice treated with topotecan, a drug that increases levels of Top1-DNA complexes, also demonstrated significant loss of intestinal and hematopoietic progenitor cells.  These data indicate that TDP1 is required for neural homeostasis, and reveal a widespread requisite for TDP1 function in response to acutely elevated levels of Top1-assocd. DNA strand breaks.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrCynHEqfbsSLVg90H21EOLACvtfcHk0lgoaGZxgB9oEA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2sXht12gtbfF&md5=4c0b2aa60255f2fa28ff3150f05b15f2</span></div><a href="/servlet/linkout?suffix=cit31&amp;dbid=16384&amp;doi=10.1038%2Fsj.emboj.7601869&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fsj.emboj.7601869%26sid%3Dliteratum%253Aachs%26aulast%3DKatyal%26aufirst%3DS.%26aulast%3DEl-Khamisy%26aufirst%3DS.%2BF.%26aulast%3DRussell%26aufirst%3DH.%2BR.%26aulast%3DLi%26aufirst%3DY.%26aulast%3DJu%26aufirst%3DL.%26aulast%3DCaldecott%26aufirst%3DK.%2BW.%26aulast%3DMcKinnon%26aufirst%3DP.%2BJ.%26atitle%3DTDP1%2520facilitates%2520chromosomal%2520single-strand%2520break%2520repair%2520in%2520neurons%2520and%2520is%2520neuroprotective%2520in%2520vivo%26jtitle%3DEMBO%2520J.%26date%3D2007%26volume%3D26%26spage%3D4720%26epage%3D4731%26doi%3D10.1038%2Fsj.emboj.7601869" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref32"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref32'); return false;" data-citation="" class="refNumLink">32</a></strong><div class="NLM_citation" id="cit32"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Perego, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cossa, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tinelli, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Corna, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Carenini, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gatti, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">De Cesare, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ciusani, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zunino, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Luison, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Canevari, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zaffaroni, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Beretta, G. L.</span></span> <span> </span><span class="NLM_article-title">Role of tyrosyl-DNA phosphodiesterase 1 and inter-players in regulation of tumor cell sensitivity to topoisomerase I inhibition</span>. <i>Biochem. Pharmacol.</i> <span class="NLM_year" style="font-weight: bold;">2012</span>,  <span class="NLM_volume"><i>83</i></span>,  <span class="NLM_fpage">27</span>– <span class="NLM_lpage">36</span>, <span class="refDoi"> DOI: 10.1016/j.bcp.2011.09.021</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref32/cit32&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00639&amp;key=10.1016%2Fj.bcp.2011.09.021" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=83&publication_year=2012&pages=27-36&author=P.+Peregoauthor=G.+Cossaauthor=S.+Tinelliauthor=E.+Cornaauthor=N.+Careniniauthor=L.+Gattiauthor=M.+De+Cesareauthor=E.+Ciusaniauthor=F.+Zuninoauthor=E.+Luisonauthor=S.+Canevariauthor=N.+Zaffaroniauthor=G.+L.+Beretta&title=Role+of+tyrosyl-DNA+phosphodiesterase+1+and+inter-players+in+regulation+of+tumor+cell+sensitivity+to+topoisomerase+I+inhibition&doi=10.1016%2Fj.bcp.2011.09.021"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit32&amp;dbid=16384&amp;doi=10.1016%2Fj.bcp.2011.09.021&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bcp.2011.09.021%26sid%3Dliteratum%253Aachs%26aulast%3DPerego%26aufirst%3DP.%26aulast%3DCossa%26aufirst%3DG.%26aulast%3DTinelli%26aufirst%3DS.%26aulast%3DCorna%26aufirst%3DE.%26aulast%3DCarenini%26aufirst%3DN.%26aulast%3DGatti%26aufirst%3DL.%26aulast%3DDe%2BCesare%26aufirst%3DM.%26aulast%3DCiusani%26aufirst%3DE.%26aulast%3DZunino%26aufirst%3DF.%26aulast%3DLuison%26aufirst%3DE.%26aulast%3DCanevari%26aufirst%3DS.%26aulast%3DZaffaroni%26aufirst%3DN.%26aulast%3DBeretta%26aufirst%3DG.%2BL.%26atitle%3DRole%2520of%2520tyrosyl-DNA%2520phosphodiesterase%25201%2520and%2520inter-players%2520in%2520regulation%2520of%2520tumor%2520cell%2520sensitivity%2520to%2520topoisomerase%2520I%2520inhibition%26jtitle%3DBiochem.%2520Pharmacol.%26date%3D2012%26volume%3D83%26spage%3D27%26epage%3D36%26doi%3D10.1016%2Fj.bcp.2011.09.021" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref33"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref33'); return false;" data-citation="" class="refNumLink">33</a></strong><div class="NLM_citation" id="cit33"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Alagoz, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wells, O. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">El-Khamisy, S. F.</span></span> <span> </span><span class="NLM_article-title">TDP1 deficiency sensitizes human cells to base damage via distinct topoisomerase I and PARP mechanisms with potential applications for cancer therapy</span>. <i>Nucleic Acids Res.</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>42</i></span>,  <span class="NLM_fpage">3089</span>– <span class="NLM_lpage">3103</span>, <span class="refDoi"> DOI: 10.1093/nar/gkt1260</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref33/cit33&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00639&amp;key=10.1093%2Fnar%2Fgkt1260" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=42&publication_year=2014&pages=3089-3103&author=M.+Alagozauthor=O.+S.+Wellsauthor=S.+F.+El-Khamisy&title=TDP1+deficiency+sensitizes+human+cells+to+base+damage+via+distinct+topoisomerase+I+and+PARP+mechanisms+with+potential+applications+for+cancer+therapy&doi=10.1093%2Fnar%2Fgkt1260"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit33&amp;dbid=16384&amp;doi=10.1093%2Fnar%2Fgkt1260&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1093%252Fnar%252Fgkt1260%26sid%3Dliteratum%253Aachs%26aulast%3DAlagoz%26aufirst%3DM.%26aulast%3DWells%26aufirst%3DO.%2BS.%26aulast%3DEl-Khamisy%26aufirst%3DS.%2BF.%26atitle%3DTDP1%2520deficiency%2520sensitizes%2520human%2520cells%2520to%2520base%2520damage%2520via%2520distinct%2520topoisomerase%2520I%2520and%2520PARP%2520mechanisms%2520with%2520potential%2520applications%2520for%2520cancer%2520therapy%26jtitle%3DNucleic%2520Acids%2520Res.%26date%3D2014%26volume%3D42%26spage%3D3089%26epage%3D3103%26doi%3D10.1093%2Fnar%2Fgkt1260" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref34"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref34'); return false;" data-citation="" class="refNumLink">34</a></strong><div class="NLM_citation" id="cit34"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Zakharenko, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Luzina, O.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Koval, O.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nilov, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gushchina, I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dyrkheeva, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Svedas, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Salakhutdinov, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lavrik, O.</span></span> <span> </span><span class="NLM_article-title">Tyrosyl-DNA phosphodiesterase 1 inhibitors: usnic acid enamines enhance the cytotoxic effect of camptothecin</span>. <i>J. Nat. Prod.</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>79</i></span>,  <span class="NLM_fpage">2961</span>– <span class="NLM_lpage">2967</span>, <span class="refDoi"> DOI: 10.1021/acs.jnatprod.6b00979</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acs.jnatprod.6b00979" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref34/cit34&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00639&amp;key=1%3ACAS%3A528%3ADC%252BC28XhvVeltrbI" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=79&publication_year=2016&pages=2961-2967&author=A.+Zakharenkoauthor=O.+Luzinaauthor=O.+Kovalauthor=D.+Nilovauthor=I.+Gushchinaauthor=N.+Dyrkheevaauthor=V.+Svedasauthor=N.+Salakhutdinovauthor=O.+Lavrik&title=Tyrosyl-DNA+phosphodiesterase+1+inhibitors%3A+usnic+acid+enamines+enhance+the+cytotoxic+effect+of+camptothecin&doi=10.1021%2Facs.jnatprod.6b00979"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit34R"><div class="casContent"><span class="casTitleNuber">34</span><div class="casTitle"><span class="NLM_cas:atitle">Tyrosyl-DNA Phosphodiesterase 1 Inhibitors: Usnic Acid Enamines Enhance the Cytotoxic Effect of Camptothecin</span></div><div class="casAuthors">Zakharenko, Alexandra; Luzina, Olga; Koval, Olga; Nilov, Dmitry; Gushchina, Irina; Dyrkheeva, Nadezhda; Svedas, Vytas; Salakhutdinov, Nariman; Lavrik, Olga</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Natural Products</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">79</span>
        (<span class="NLM_cas:issue">11</span>),
    <span class="NLM_cas:pages">2961-2967</span>CODEN:
                <span class="NLM_cas:coden">JNPRDF</span>;
        ISSN:<span class="NLM_cas:issn">0163-3864</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society-American Society of Pharmacognosy</span>)
        </div><div class="casAbstract">Tyrosyl-DNA phosphodiesterase 1 (TDP1) is a repair enzyme for stalled DNA-topoisomerase 1 (Top1) cleavage complexes and other 3'-end DNA lesions.  TDP1 is a perspective target for anticancer therapy based on Top1-poison mediated DNA damage.  Several novel usnic acid derivs. with an enamine moiety have been synthesized and tested as inhibitors of TDP1.  The enamines of usnic acid showed IC50 values in the range of 0.16 to 2.0 μM.  These compds. revealed moderate cytotoxicity against human tumor MCF-7 cells.  These new compds. enhanced the cytotoxicity of the established Top1 poison camptothecin by an order of magnitude.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoRWIxdncprlbVg90H21EOLACvtfcHk0liKhQrZMihE9w"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28XhvVeltrbI&md5=e18a247aaea40561cb59972717771054</span></div><a href="/servlet/linkout?suffix=cit34&amp;dbid=16384&amp;doi=10.1021%2Facs.jnatprod.6b00979&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facs.jnatprod.6b00979%26sid%3Dliteratum%253Aachs%26aulast%3DZakharenko%26aufirst%3DA.%26aulast%3DLuzina%26aufirst%3DO.%26aulast%3DKoval%26aufirst%3DO.%26aulast%3DNilov%26aufirst%3DD.%26aulast%3DGushchina%26aufirst%3DI.%26aulast%3DDyrkheeva%26aufirst%3DN.%26aulast%3DSvedas%26aufirst%3DV.%26aulast%3DSalakhutdinov%26aufirst%3DN.%26aulast%3DLavrik%26aufirst%3DO.%26atitle%3DTyrosyl-DNA%2520phosphodiesterase%25201%2520inhibitors%253A%2520usnic%2520acid%2520enamines%2520enhance%2520the%2520cytotoxic%2520effect%2520of%2520camptothecin%26jtitle%3DJ.%2520Nat.%2520Prod.%26date%3D2016%26volume%3D79%26spage%3D2961%26epage%3D2967%26doi%3D10.1021%2Facs.jnatprod.6b00979" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref35"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref35'); return false;" data-citation="" class="refNumLink">35</a></strong><div class="NLM_citation" id="cit35"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Khomenko, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zakharenko, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Odarchenko, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Arabshahi, H. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sannikova, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zakharova, O.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Korchagina, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Reynisson, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Volcho, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Salakhutdinov, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lavrik, O.</span></span> <span> </span><span class="NLM_article-title">New inhibitors of tyrosyl-DNA phosphodiesterase I (Tdp 1) combining 7-hydroxycoumarin and monoterpenoid moieties</span>. <i>Bioorg. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>24</i></span>,  <span class="NLM_fpage">5573</span>– <span class="NLM_lpage">5581</span>, <span class="refDoi"> DOI: 10.1016/j.bmc.2016.09.016</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref35/cit35&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00639&amp;key=10.1016%2Fj.bmc.2016.09.016" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=24&publication_year=2016&pages=5573-5581&author=T.+Khomenkoauthor=A.+Zakharenkoauthor=T.+Odarchenkoauthor=H.+J.+Arabshahiauthor=V.+Sannikovaauthor=O.+Zakharovaauthor=D.+Korchaginaauthor=J.+Reynissonauthor=K.+Volchoauthor=N.+Salakhutdinovauthor=O.+Lavrik&title=New+inhibitors+of+tyrosyl-DNA+phosphodiesterase+I+%28Tdp+1%29+combining+7-hydroxycoumarin+and+monoterpenoid+moieties&doi=10.1016%2Fj.bmc.2016.09.016"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit35&amp;dbid=16384&amp;doi=10.1016%2Fj.bmc.2016.09.016&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmc.2016.09.016%26sid%3Dliteratum%253Aachs%26aulast%3DKhomenko%26aufirst%3DT.%26aulast%3DZakharenko%26aufirst%3DA.%26aulast%3DOdarchenko%26aufirst%3DT.%26aulast%3DArabshahi%26aufirst%3DH.%2BJ.%26aulast%3DSannikova%26aufirst%3DV.%26aulast%3DZakharova%26aufirst%3DO.%26aulast%3DKorchagina%26aufirst%3DD.%26aulast%3DReynisson%26aufirst%3DJ.%26aulast%3DVolcho%26aufirst%3DK.%26aulast%3DSalakhutdinov%26aufirst%3DN.%26aulast%3DLavrik%26aufirst%3DO.%26atitle%3DNew%2520inhibitors%2520of%2520tyrosyl-DNA%2520phosphodiesterase%2520I%2520%2528Tdp%25201%2529%2520combining%25207-hydroxycoumarin%2520and%2520monoterpenoid%2520moieties%26jtitle%3DBioorg.%2520Med.%2520Chem.%26date%3D2016%26volume%3D24%26spage%3D5573%26epage%3D5581%26doi%3D10.1016%2Fj.bmc.2016.09.016" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref36"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref36'); return false;" data-citation="" class="refNumLink">36</a></strong><div class="NLM_citation" id="cit36"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Ponomarev, K. Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Suslov, E. V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zakharenko, A. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zakharova, O. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rogachev, A. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Korchagina, D. V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zafar, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Reynisson, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nefedov, A. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Volcho, K. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Salakhutdinov, N. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lavrik, O. I.</span></span> <span> </span><span class="NLM_article-title">Aminoadamantanes containing monoterpene-derived fragments as potent tyrosyl-DNA phosphodiesterase 1 inhibitors</span>. <i>Bioorg. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>76</i></span>,  <span class="NLM_fpage">392</span>– <span class="NLM_lpage">399</span>, <span class="refDoi"> DOI: 10.1016/j.bioorg.2017.12.005</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref36/cit36&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00639&amp;key=10.1016%2Fj.bioorg.2017.12.005" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref36/cit36&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00639&amp;key=29248742" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref36/cit36&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00639&amp;key=1%3ACAS%3A528%3ADC%252BC2sXhvFykur%252FI" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=76&publication_year=2018&pages=392-399&author=K.+Y.+Ponomarevauthor=E.+V.+Suslovauthor=A.+L.+Zakharenkoauthor=O.+D.+Zakharovaauthor=A.+D.+Rogachevauthor=D.+V.+Korchaginaauthor=A.+Zafarauthor=J.+Reynissonauthor=A.+A.+Nefedovauthor=K.+P.+Volchoauthor=N.+F.+Salakhutdinovauthor=O.+I.+Lavrik&title=Aminoadamantanes+containing+monoterpene-derived+fragments+as+potent+tyrosyl-DNA+phosphodiesterase+1+inhibitors&doi=10.1016%2Fj.bioorg.2017.12.005"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit36R"><div class="casContent"><span class="casTitleNuber">36</span><div class="casTitle"><span class="NLM_cas:atitle">Aminoadamantanes containing monoterpene-derived fragments as potent tyrosyl-DNA phosphodiesterase 1 inhibitors</span></div><div class="casAuthors">Ponomarev, Konstantin Yu.; Suslov, Evgeniy V.; Zakharenko, Alexandra L.; Zakharova, Olga D.; Rogachev, Artem D.; Korchagina, Dina V.; Zafar, Ayesha; Reynisson, Johannes; Nefedov, Andrey A.; Volcho, Konstantin P.; Salakhutdinov, Nariman F.; Lavrik, Olga I.</div><div class="citationInfo"><span class="NLM_cas:title">Bioorganic Chemistry</span>
        (<span class="NLM_cas:date">2018</span>),
    <span class="NLM_cas:volume">76</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">392-399</span>CODEN:
                <span class="NLM_cas:coden">BOCMBM</span>;
        ISSN:<span class="NLM_cas:issn">0045-2068</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">The ability of a no. of nitrogen-contg. compds. that simultaneously carry the adamantane and monoterpene moieties to inhibit Tdp1, an important enzyme of the DNA repair system, is studied.  Inhibition of this enzyme has the potential to overcome chemotherapeutic resistance of some tumor types.  Compd. (+)-3c synthesized from 1-aminoadamantane and (+)-myrtenal, and compd. 4a produced from 2-aminoadamantane and citronellal were found to be most potent as they inhibited Tdp1 with IC50 values of 6 and 3.5 μM, resp.  These compds. proved to have low cytotoxicity in colon HCT-116 and lung A-549 human tumor cell lines (CC50 > 50 μM).  It was demonstrated that compd. 4a at 10 μM enhanced cytotoxicity of topotecan, a topoisomerase 1 poison in clin. use, against HCT-116 more than fivefold and to a lesser extent of 1.5 increase in potency for A-549.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGp7FoEXVhB937Vg90H21EOLACvtfcHk0liKhQrZMihE9w"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2sXhvFykur%252FI&md5=c89d8aef5748976cf221ab776804d03a</span></div><a href="/servlet/linkout?suffix=cit36&amp;dbid=16384&amp;doi=10.1016%2Fj.bioorg.2017.12.005&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bioorg.2017.12.005%26sid%3Dliteratum%253Aachs%26aulast%3DPonomarev%26aufirst%3DK.%2BY.%26aulast%3DSuslov%26aufirst%3DE.%2BV.%26aulast%3DZakharenko%26aufirst%3DA.%2BL.%26aulast%3DZakharova%26aufirst%3DO.%2BD.%26aulast%3DRogachev%26aufirst%3DA.%2BD.%26aulast%3DKorchagina%26aufirst%3DD.%2BV.%26aulast%3DZafar%26aufirst%3DA.%26aulast%3DReynisson%26aufirst%3DJ.%26aulast%3DNefedov%26aufirst%3DA.%2BA.%26aulast%3DVolcho%26aufirst%3DK.%2BP.%26aulast%3DSalakhutdinov%26aufirst%3DN.%2BF.%26aulast%3DLavrik%26aufirst%3DO.%2BI.%26atitle%3DAminoadamantanes%2520containing%2520monoterpene-derived%2520fragments%2520as%2520potent%2520tyrosyl-DNA%2520phosphodiesterase%25201%2520inhibitors%26jtitle%3DBioorg.%2520Chem.%26date%3D2018%26volume%3D76%26spage%3D392%26epage%3D399%26doi%3D10.1016%2Fj.bioorg.2017.12.005" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref37"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref37'); return false;" data-citation="" class="refNumLink">37</a></strong><div class="NLM_citation" id="cit37"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Huang, S.-y. N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pommier, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Marchand, C.</span></span> <span> </span><span class="NLM_article-title">Tyrosyl-DNA phosphodiesterase 1 (Tdp1) inhibitors</span>. <i>Expert Opin. Ther. Pat.</i> <span class="NLM_year" style="font-weight: bold;">2011</span>,  <span class="NLM_volume"><i>21</i></span>,  <span class="NLM_fpage">1285</span>– <span class="NLM_lpage">1292</span>, <span class="refDoi"> DOI: 10.1517/13543776.2011.604314</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref37/cit37&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00639&amp;key=10.1517%2F13543776.2011.604314" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref37/cit37&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00639&amp;key=21843105" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref37/cit37&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00639&amp;key=1%3ACAS%3A528%3ADC%252BC3MXhtVWnurfK" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=21&publication_year=2011&pages=1285-1292&author=S.-y.+N.+Huangauthor=Y.+Pommierauthor=C.+Marchand&title=Tyrosyl-DNA+phosphodiesterase+1+%28Tdp1%29+inhibitors&doi=10.1517%2F13543776.2011.604314"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit37R"><div class="casContent"><span class="casTitleNuber">37</span><div class="casTitle"><span class="NLM_cas:atitle">Tyrosyl-DNA Phosphodiesterase 1 (Tdp1) inhibitors</span></div><div class="casAuthors">Huang, Shar-yin N.; Pommier, Yves; Marchand, Christophe</div><div class="citationInfo"><span class="NLM_cas:title">Expert Opinion on Therapeutic Patents</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">21</span>
        (<span class="NLM_cas:issue">9</span>),
    <span class="NLM_cas:pages">1285-1292</span>CODEN:
                <span class="NLM_cas:coden">EOTPEG</span>;
        ISSN:<span class="NLM_cas:issn">1354-3776</span>.
    
            (<span class="NLM_cas:orgname">Informa Healthcare</span>)
        </div><div class="casAbstract">A review.  Inhibitors of topoisomerase I (Top1) that result in stalled Top1 cleavage complexes (Top1cc) are commonly employed against cancer.  Combination chemotherapy with DNA repair inhibitors can potentially improve response to these widely used chemotherapeutics.  One line of inquiry focuses on inhibitors of tyrosyl-DNA phosphodiesterase 1 (Tdp1), a repair enzyme for Top1cc.  Tdp1 catalyzes the hydrolysis of DNA adducts covalently linked to the 3'-phosphate of DNA, including Top1-derived peptides and also 3'-phosphoglycolates.  Tdp1 inhibitors should synergize not only with Top1-targeting drugs (camptothecins, indenoisoquinolines), but also with bleomycin, topoisomerase II (Top2) inhibitors (etoposide, doxorubicin) and DNA alkylating agents.  Here, we summarize the structure-activity relationship obtained from the reported Tdp1 inhibitors.  Better understanding of Top1cc repair in vivo coupled with detailed structural studies on Tdp1-inhibitor interaction will be crucial in guiding the rational design of Tdp1 inhibitors.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoTQ1eWsSHiebVg90H21EOLACvtfcHk0lhp5Fx4lT-WnQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXhtVWnurfK&md5=159aa1443c8ad694fe6eead535a8c687</span></div><a href="/servlet/linkout?suffix=cit37&amp;dbid=16384&amp;doi=10.1517%2F13543776.2011.604314&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1517%252F13543776.2011.604314%26sid%3Dliteratum%253Aachs%26aulast%3DHuang%26aufirst%3DS.-y.%2BN.%26aulast%3DPommier%26aufirst%3DY.%26aulast%3DMarchand%26aufirst%3DC.%26atitle%3DTyrosyl-DNA%2520phosphodiesterase%25201%2520%2528Tdp1%2529%2520inhibitors%26jtitle%3DExpert%2520Opin.%2520Ther.%2520Pat.%26date%3D2011%26volume%3D21%26spage%3D1285%26epage%3D1292%26doi%3D10.1517%2F13543776.2011.604314" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref38"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref38'); return false;" data-citation="" class="refNumLink">38</a></strong><div class="NLM_citation" id="cit38"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Comeaux, E. Q.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">van Waardenburg, R. C. A. M.</span></span> <span> </span><span class="NLM_article-title">Tyrosyl-DNA phosphodiesterase I resolves both naturally and chemically induced DNA adducts and its potential as a therapeutic target</span>. <i>Drug Metab. Rev.</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>46</i></span>,  <span class="NLM_fpage">494</span>– <span class="NLM_lpage">507</span>, <span class="refDoi"> DOI: 10.3109/03602532.2014.971957</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref38/cit38&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00639&amp;key=10.3109%2F03602532.2014.971957" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref38/cit38&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00639&amp;key=25327705" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref38/cit38&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00639&amp;key=1%3ACAS%3A528%3ADC%252BC2cXhvVGgsbzN" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=46&publication_year=2014&pages=494-507&author=E.+Q.+Comeauxauthor=R.+C.+A.+M.+van+Waardenburg&title=Tyrosyl-DNA+phosphodiesterase+I+resolves+both+naturally+and+chemically+induced+DNA+adducts+and+its+potential+as+a+therapeutic+target&doi=10.3109%2F03602532.2014.971957"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit38R"><div class="casContent"><span class="casTitleNuber">38</span><div class="casTitle"><span class="NLM_cas:atitle">Tyrosyl-DNA phosphodiesterase I resolves both naturally and chemically induced DNA adducts and its potential as a therapeutic target</span></div><div class="casAuthors">Comeaux, Evan Q.; van Waardenburg, Robert C. A. M.</div><div class="citationInfo"><span class="NLM_cas:title">Drug Metabolism Reviews</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">46</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">494-507</span>CODEN:
                <span class="NLM_cas:coden">DMTRAR</span>;
        ISSN:<span class="NLM_cas:issn">0360-2532</span>.
    
            (<span class="NLM_cas:orgname">Informa Healthcare</span>)
        </div><div class="casAbstract">DNA is subject to a wide range of insults, resulting from endogenous and exogenous sources that need to be metabolized/resolved to maintain genome integrity.  Tyrosyl-DNA phosphodiesterase I (Tdp1) is a eukaryotic DNA repair enzyme that catalyzes the removal of covalent 3'-DNA adducts.  As a phospholipase D superfamily member Tdp1 utilizes two catalytic histidines each within a His-Lys-Asn motif.  Tdp1 was discovered for its ability to hydrolyze the 3'-phospho-tyrosyl that in the cell covalently links DNA Topoisomerase I (Topo1) and DNA.  Tdp1's list of substrates has since grown and can be divided into two groups: protein-DNA adducts, such as camptothecin stabilized Topo1-DNA adducts, and modified nucleotides, including oxidized nucleotides and chain terminating nucleoside analogs.  Since many of Tdp1's substrates are generated by clin. relevant chemotherapeutics, Tdp1 became a therapeutic target for molecularly targeted small mols.  Tdp1's unique catalytic cycle allows for two different targeting strategies: (1) the intuitive inhibition of Tdp1 catalysis to prevent Tdp1-mediated repair of chemotherapeutically induced DNA adducts, thereby enhancing their toxicity and (2) stabilization of the Tdp1-DNA covalent reaction intermediate, prevents resoln. of Tdp1-DNA adduct and increases the half-life of this potentially toxic DNA adduct.  This concept is best illustrated by a catalytic Tdp1 mutant that forms the mol. basis of the autosomal recessive neurodegenerative disease spinocerebellar ataxia with axonal neuropathy, and results in an increased stability of its Tdp1-DNA reaction intermediate.  Here, we will discuss Tdp1 catalysis from a structure-function perspective, Tdp1 substrates and Tdp1 potential as a therapeutic target.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqQu-Tqidjb0rVg90H21EOLACvtfcHk0lhp5Fx4lT-WnQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXhvVGgsbzN&md5=b7d187702ad24661a7a670f974d64ec3</span></div><a href="/servlet/linkout?suffix=cit38&amp;dbid=16384&amp;doi=10.3109%2F03602532.2014.971957&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.3109%252F03602532.2014.971957%26sid%3Dliteratum%253Aachs%26aulast%3DComeaux%26aufirst%3DE.%2BQ.%26aulast%3Dvan%2BWaardenburg%26aufirst%3DR.%2BC.%2BA.%2BM.%26atitle%3DTyrosyl-DNA%2520phosphodiesterase%2520I%2520resolves%2520both%2520naturally%2520and%2520chemically%2520induced%2520DNA%2520adducts%2520and%2520its%2520potential%2520as%2520a%2520therapeutic%2520target%26jtitle%3DDrug%2520Metab.%2520Rev.%26date%3D2014%26volume%3D46%26spage%3D494%26epage%3D507%26doi%3D10.3109%2F03602532.2014.971957" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref39"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref39'); return false;" data-citation="" class="refNumLink">39</a></strong><div class="NLM_citation" id="cit39"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Laev, S. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Salakhutdinov, N. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lavrik, O. I.</span></span> <span> </span><span class="NLM_article-title">Tyrosyl-DNA phosphodiesterase inhibitors: Progress and potential</span>. <i>Bioorg. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>24</i></span>,  <span class="NLM_fpage">5017</span>– <span class="NLM_lpage">5027</span>, <span class="refDoi"> DOI: 10.1016/j.bmc.2016.09.045</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref39/cit39&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00639&amp;key=10.1016%2Fj.bmc.2016.09.045" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref39/cit39&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00639&amp;key=27687971" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref39/cit39&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00639&amp;key=1%3ACAS%3A528%3ADC%252BC28XhsFOku7fM" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=24&publication_year=2016&pages=5017-5027&author=S.+S.+Laevauthor=N.+F.+Salakhutdinovauthor=O.+I.+Lavrik&title=Tyrosyl-DNA+phosphodiesterase+inhibitors%3A+Progress+and+potential&doi=10.1016%2Fj.bmc.2016.09.045"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit39R"><div class="casContent"><span class="casTitleNuber">39</span><div class="casTitle"><span class="NLM_cas:atitle">Tyrosyl-DNA phosphodiesterase inhibitors: Progress and potential</span></div><div class="casAuthors">Laev, Sergey S.; Salakhutdinov, Nariman F.; Lavrik, Olga I.</div><div class="citationInfo"><span class="NLM_cas:title">Bioorganic & Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">24</span>
        (<span class="NLM_cas:issue">21</span>),
    <span class="NLM_cas:pages">5017-5027</span>CODEN:
                <span class="NLM_cas:coden">BMECEP</span>;
        ISSN:<span class="NLM_cas:issn">0968-0896</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">A review.  DNA topoisomerases are essential during transcription and replication.  The therapeutic mechanism of action of topoisomerase inhibitors is enzyme poisoning rather than catalytic inhibition.  Tyrosyl-DNA phosphodiesterases 1 or 2 were found as DNA repair enzymes hydrolyzing the covalent bond between the tyrosyl residue of topoisomerases I or II and the 3'- or 5'-phosphate groups in DNA, resp.  Tyrosyl-DNA phosphodiesterase 1 is a key enzyme in DNA repair machinery and a promising target for antitumor and neurodegenerative therapy.  Inhibitors of tyrosyl-DNA phosphodiesterase 1 could act synergistically with topoisomerase I inhibitors and thereby potentiate the effects of topoisomerase I poisons.  Tyrosyl-DNA phosphodiesterase 2 is an enzyme that specifically repairs DNA damages induced by topoisomerase II poisons and causes resistance to these drugs.  Selective inhibition of tyrosyl-DNA phosphodiesterase 2 may be a novel approach to overcome intrinsic or acquired resistance to topoisomerase II-targeted drug therapy.  Thus, agents that inhibit tyrosyl-DNA phosphodiesterases 1 and 2 have many applications in biochem. and physiol. research and they have the potential to become anticancer and antiviral drugs.  The structures, mechanism of action and therapeutic rationale of tyrosyl-DNA phosphodiesterase inhibitors and their development for combinations with topoisomerase inhibitors and DNA damaging agents are discussed.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGp5aNMaBXRtn7Vg90H21EOLACvtfcHk0lhp5Fx4lT-WnQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28XhsFOku7fM&md5=ce014f1069a979cc5d148695751ac31c</span></div><a href="/servlet/linkout?suffix=cit39&amp;dbid=16384&amp;doi=10.1016%2Fj.bmc.2016.09.045&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmc.2016.09.045%26sid%3Dliteratum%253Aachs%26aulast%3DLaev%26aufirst%3DS.%2BS.%26aulast%3DSalakhutdinov%26aufirst%3DN.%2BF.%26aulast%3DLavrik%26aufirst%3DO.%2BI.%26atitle%3DTyrosyl-DNA%2520phosphodiesterase%2520inhibitors%253A%2520Progress%2520and%2520potential%26jtitle%3DBioorg.%2520Med.%2520Chem.%26date%3D2016%26volume%3D24%26spage%3D5017%26epage%3D5027%26doi%3D10.1016%2Fj.bmc.2016.09.045" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref40"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref40'); return false;" data-citation="" class="refNumLink">40</a></strong><div class="NLM_citation" id="cit40"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Lian, Q.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Xu, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yan, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Huang, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ding, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sun, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bi, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ding, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sun, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Geng, M.</span></span> <span> </span><span class="NLM_article-title">Chemotherapy-induced intestinal inflammatory responses are mediated by exosome secretion of double-strand DNA via AIM2 inflammasome activation</span>. <i>Cell Res.</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>27</i></span>,  <span class="NLM_fpage">784</span>– <span class="NLM_lpage">800</span>, <span class="refDoi"> DOI: 10.1038/cr.2017.54</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref40/cit40&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00639&amp;key=10.1038%2Fcr.2017.54" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref40/cit40&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00639&amp;key=28409562" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref40/cit40&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00639&amp;key=1%3ACAS%3A528%3ADC%252BC2sXmtVCqtrc%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=27&publication_year=2017&pages=784-800&author=Q.+Lianauthor=J.+Xuauthor=S.+Yanauthor=M.+Huangauthor=H.+Dingauthor=X.+Sunauthor=A.+Biauthor=J.+Dingauthor=B.+Sunauthor=M.+Geng&title=Chemotherapy-induced+intestinal+inflammatory+responses+are+mediated+by+exosome+secretion+of+double-strand+DNA+via+AIM2+inflammasome+activation&doi=10.1038%2Fcr.2017.54"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit40R"><div class="casContent"><span class="casTitleNuber">40</span><div class="casTitle"><span class="NLM_cas:atitle">Chemotherapy-induced intestinal inflammatory responses are mediated by exosome secretion of double-strand DNA via AIM2 inflammasome activation</span></div><div class="casAuthors">Lian, Qiaoshi; Xu, Jun; Yan, Shanshan; Huang, Min; Ding, Honghua; Sun, Xiaoyu; Bi, Aiwei; Ding, Jian; Sun, Bing; Geng, Meiyu</div><div class="citationInfo"><span class="NLM_cas:title">Cell Research</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">27</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">784-800</span>CODEN:
                <span class="NLM_cas:coden">CREEB6</span>;
        ISSN:<span class="NLM_cas:issn">1001-0602</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">Chemotherapies are known often to induce severe gastrointestinal tract toxicity but the underlying mechanism remains unclear.  This study considers the widely applied cytotoxic agent irinotecan (CPT-11) as a representative agent and demonstrates that treatment induces massive release of double-strand DNA from the intestine that accounts for the dose-limiting intestinal toxicity of the compd.  Specifically, "self-DNA" released through exosome secretion enters the cytosol of innate immune cells and activates the AIM2 (absent in melanoma 2) inflammasome.  This leads to mature IL-1β and IL-18 secretion and induces intestinal mucositis and late-onset diarrhoea.  Interestingly, abrogation of AIM2 signalling, either in AIM2-deficient mice or by a pharmacol. inhibitor such as thalidomide, significantly reduces the incidence of drug-induced diarrhoea without affecting the anticancer efficacy of CPT-11.  These findings provide mechanistic insights into how chemotherapy triggers innate immune responses causing intestinal toxicity, and reveal new chemotherapy regimens that maintain anti-tumor effects but circumvent the assocd. adverse inflammatory response.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpKNUp5ZVGDErVg90H21EOLACvtfcHk0lhyWXWWLxDsdg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2sXmtVCqtrc%253D&md5=8577ec415ca7fb0a111163b342b3860f</span></div><a href="/servlet/linkout?suffix=cit40&amp;dbid=16384&amp;doi=10.1038%2Fcr.2017.54&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fcr.2017.54%26sid%3Dliteratum%253Aachs%26aulast%3DLian%26aufirst%3DQ.%26aulast%3DXu%26aufirst%3DJ.%26aulast%3DYan%26aufirst%3DS.%26aulast%3DHuang%26aufirst%3DM.%26aulast%3DDing%26aufirst%3DH.%26aulast%3DSun%26aufirst%3DX.%26aulast%3DBi%26aufirst%3DA.%26aulast%3DDing%26aufirst%3DJ.%26aulast%3DSun%26aufirst%3DB.%26aulast%3DGeng%26aufirst%3DM.%26atitle%3DChemotherapy-induced%2520intestinal%2520inflammatory%2520responses%2520are%2520mediated%2520by%2520exosome%2520secretion%2520of%2520double-strand%2520DNA%2520via%2520AIM2%2520inflammasome%2520activation%26jtitle%3DCell%2520Res.%26date%3D2017%26volume%3D27%26spage%3D784%26epage%3D800%26doi%3D10.1038%2Fcr.2017.54" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref41"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref41'); return false;" data-citation="" class="refNumLink">41</a></strong><div class="NLM_citation" id="cit41"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Li, T.-K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Houghton, P. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Desai, S. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Daroui, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liu, A. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hars, E. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ruchelman, A. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">LaVoie, E. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liu, L. F.</span></span> <span> </span><span class="NLM_article-title">Characterization of ARC-111 as a novel topoisomerase I-targeting anticancer drug</span>. <i>Cancer Res.</i> <span class="NLM_year" style="font-weight: bold;">2003</span>,  <span class="NLM_volume"><i>63</i></span>,  <span class="NLM_fpage">8400</span>– <span class="NLM_lpage">8407</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref41/cit41&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00639&amp;key=14679002" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref41/cit41&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00639&amp;key=1%3ACAS%3A528%3ADC%252BD3sXpvVagtb0%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=63&publication_year=2003&pages=8400-8407&author=T.-K.+Liauthor=P.+J.+Houghtonauthor=S.+D.+Desaiauthor=P.+Darouiauthor=A.+A.+Liuauthor=E.+S.+Harsauthor=A.+L.+Ruchelmanauthor=E.+J.+LaVoieauthor=L.+F.+Liu&title=Characterization+of+ARC-111+as+a+novel+topoisomerase+I-targeting+anticancer+drug"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit41R"><div class="casContent"><span class="casTitleNuber">41</span><div class="casTitle"><span class="NLM_cas:atitle">Characterization of ARC-111 as a Novel Topoisomerase I-Targeting Anticancer Drug</span></div><div class="casAuthors">Li, Tsai-Kun; Houghton, Peter J.; Desai, Shyamal D.; Daroui, Parima; Liu, Angela A.; Hars, Eszter S.; Ruchelman, Alexander L.; LaVoie, Edmond J.; Liu, Leroy F.</div><div class="citationInfo"><span class="NLM_cas:title">Cancer Research</span>
        (<span class="NLM_cas:date">2003</span>),
    <span class="NLM_cas:volume">63</span>
        (<span class="NLM_cas:issue">23</span>),
    <span class="NLM_cas:pages">8400-8407</span>CODEN:
                <span class="NLM_cas:coden">CNREA8</span>;
        ISSN:<span class="NLM_cas:issn">0008-5472</span>.
    
            (<span class="NLM_cas:orgname">American Association for Cancer Research</span>)
        </div><div class="casAbstract">8,9-Dimethoxy-5-(2-N,N-dimethylaminoethyl)-2,3-methylenedioxy-5H-dibenzo[c,h][1,6] naphthyridin-6-one (ARC-111, topovale) is a new synthetic antitumor agent.  In the current study, we show that ARC-111 is highly potent in scid mice carrying human tumor xenografts.  ARC-111 was shown to be as active as camptothecin (CPT)-11 in the HCT-8 colon tumor model, and compared favorably with CPT-11 and topotecan in the SKNEP anaplastic Wilms' tumor model.  In tissue culture models, ARC-111 exhibited low nM cytotoxicity against a panel of cancer cells.  ARC-111 cytotoxicity as well as ARC-111-induced apoptosis was reduced >100-fold in CPT-resistant topoisomerase I (TOP1)-deficient P388/CPT45 cells as compared with P388 cells.  Similarly, ARC-111 cytotoxicity was greatly reduced in CPT-resistant CPT-K5 and U937/CR cells, which express CPT-resistant mutant TOP1, suggesting that the cytotoxic target of ARC-111 is TOP1.  Indeed, ARC-111, like CPT, was shown to induce reversible TOP1 cleavage complexes in tumor cells as evidenced by specific redn. of the TOP1 immunoreactive band in a band depletion assay, as well as elevation of small ubiquitin modifier-TOP1 conjugate levels and activation of 26S proteasome-mediated degrdn. of TOP1.  Unlike CPT, ARC-111 is not a substrate for the ATP-binding cassette transporter breast cancer resistance protein.  In addn., ARC-111 cytotoxicity was not significantly reduced in the presence of human serum albumin.  These results suggest that ARC-111 is a promising new TOP1-targeting antitumor drug with a different drug resistance profile than CPT.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGopJxPJna3TObVg90H21EOLACvtfcHk0lhyWXWWLxDsdg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3sXpvVagtb0%253D&md5=9d7823f2cf3c6910c85d1012109427e0</span></div><a href="/servlet/linkout?suffix=cit41&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DLi%26aufirst%3DT.-K.%26aulast%3DHoughton%26aufirst%3DP.%2BJ.%26aulast%3DDesai%26aufirst%3DS.%2BD.%26aulast%3DDaroui%26aufirst%3DP.%26aulast%3DLiu%26aufirst%3DA.%2BA.%26aulast%3DHars%26aufirst%3DE.%2BS.%26aulast%3DRuchelman%26aufirst%3DA.%2BL.%26aulast%3DLaVoie%26aufirst%3DE.%2BJ.%26aulast%3DLiu%26aufirst%3DL.%2BF.%26atitle%3DCharacterization%2520of%2520ARC-111%2520as%2520a%2520novel%2520topoisomerase%2520I-targeting%2520anticancer%2520drug%26jtitle%3DCancer%2520Res.%26date%3D2003%26volume%3D63%26spage%3D8400%26epage%3D8407" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref42"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref42'); return false;" data-citation="" class="refNumLink">42</a></strong><div class="NLM_citation" id="cit42"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Teicher, B. A.</span></span> <span> </span><span class="NLM_article-title">Next generation topoisomerase I inhibitors: rationale and biomarker strategies</span>. <i>Biochem. Pharmacol.</i> <span class="NLM_year" style="font-weight: bold;">2008</span>,  <span class="NLM_volume"><i>75</i></span>,  <span class="NLM_fpage">1262</span>– <span class="NLM_lpage">1271</span>, <span class="refDoi"> DOI: 10.1016/j.bcp.2007.10.016</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref42/cit42&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00639&amp;key=10.1016%2Fj.bcp.2007.10.016" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=75&publication_year=2008&pages=1262-1271&author=B.+A.+Teicher&title=Next+generation+topoisomerase+I+inhibitors%3A+rationale+and+biomarker+strategies&doi=10.1016%2Fj.bcp.2007.10.016"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit42&amp;dbid=16384&amp;doi=10.1016%2Fj.bcp.2007.10.016&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bcp.2007.10.016%26sid%3Dliteratum%253Aachs%26aulast%3DTeicher%26aufirst%3DB.%2BA.%26atitle%3DNext%2520generation%2520topoisomerase%2520I%2520inhibitors%253A%2520rationale%2520and%2520biomarker%2520strategies%26jtitle%3DBiochem.%2520Pharmacol.%26date%3D2008%26volume%3D75%26spage%3D1262%26epage%3D1271%26doi%3D10.1016%2Fj.bcp.2007.10.016" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref43"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref43'); return false;" data-citation="" class="refNumLink">43</a></strong><div class="NLM_citation" id="cit43"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Burton, J. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mazcko, C. N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">LeBlanc, A. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Covey, J. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ji, J. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kinders, R. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Parchment, R. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Khanna, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Paoloni, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lana, S. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Weishaar, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">London, C. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kisseberth, W. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Krick, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Vail, D. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Childress, M. O.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bryan, J. N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Barber, L. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ehrhart, E. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kent, M. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fan, T. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kow, K. Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Northup, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wilson-Robles, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tomaszewski, J. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Holleran, J. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Muzzio, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Eiseman, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Beumer, J. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Doroshow, J. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pommier, Y.</span></span> <span> </span><span class="NLM_article-title">NCI comparative oncology program testing of non-camptothecin indenoisoquinoline topoisomerase I inhibitors in naturally occurring canine lymphoma</span>. <i>Clin. Cancer Res.</i> <span class="NLM_year" style="font-weight: bold;">2018</span>, <span class="refDoi"> DOI: 10.1158/1078-0432.CCR-18-1498</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref43/cit43&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00639&amp;key=10.1158%2F1078-0432.CCR-18-1498" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref43/cit43&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00639&amp;key=30061364" title="">PubMed</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2018&author=J.+H.+Burtonauthor=C.+N.+Mazckoauthor=A.+K.+LeBlancauthor=J.+M.+Coveyauthor=J.+J.+Jiauthor=R.+J.+Kindersauthor=R.+E.+Parchmentauthor=C.+Khannaauthor=M.+Paoloniauthor=S.+E.+Lanaauthor=K.+Weishaarauthor=C.+A.+Londonauthor=W.+C.+Kisseberthauthor=E.+Krickauthor=D.+M.+Vailauthor=M.+O.+Childressauthor=J.+N.+Bryanauthor=L.+G.+Barberauthor=E.+J.+Ehrhartauthor=M.+S.+Kentauthor=T.+M.+Fanauthor=K.+Y.+Kowauthor=N.+Northupauthor=H.+Wilson-Roblesauthor=J.+E.+Tomaszewskiauthor=J.+L.+Holleranauthor=M.+Muzzioauthor=J.+Eisemanauthor=J.+H.+Beumerauthor=J.+H.+Doroshowauthor=Y.+Pommier&title=NCI+comparative+oncology+program+testing+of+non-camptothecin+indenoisoquinoline+topoisomerase+I+inhibitors+in+naturally+occurring+canine+lymphoma&doi=10.1158%2F1078-0432.CCR-18-1498"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit43&amp;dbid=16384&amp;doi=10.1158%2F1078-0432.CCR-18-1498&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1158%252F1078-0432.CCR-18-1498%26sid%3Dliteratum%253Aachs%26aulast%3DBurton%26aufirst%3DJ.%2BH.%26aulast%3DMazcko%26aufirst%3DC.%2BN.%26aulast%3DLeBlanc%26aufirst%3DA.%2BK.%26aulast%3DCovey%26aufirst%3DJ.%2BM.%26aulast%3DJi%26aufirst%3DJ.%2BJ.%26aulast%3DKinders%26aufirst%3DR.%2BJ.%26aulast%3DParchment%26aufirst%3DR.%2BE.%26aulast%3DKhanna%26aufirst%3DC.%26aulast%3DPaoloni%26aufirst%3DM.%26aulast%3DLana%26aufirst%3DS.%2BE.%26aulast%3DWeishaar%26aufirst%3DK.%26aulast%3DLondon%26aufirst%3DC.%2BA.%26aulast%3DKisseberth%26aufirst%3DW.%2BC.%26aulast%3DKrick%26aufirst%3DE.%26aulast%3DVail%26aufirst%3DD.%2BM.%26aulast%3DChildress%26aufirst%3DM.%2BO.%26aulast%3DBryan%26aufirst%3DJ.%2BN.%26aulast%3DBarber%26aufirst%3DL.%2BG.%26aulast%3DEhrhart%26aufirst%3DE.%2BJ.%26aulast%3DKent%26aufirst%3DM.%2BS.%26aulast%3DFan%26aufirst%3DT.%2BM.%26aulast%3DKow%26aufirst%3DK.%2BY.%26aulast%3DNorthup%26aufirst%3DN.%26aulast%3DWilson-Robles%26aufirst%3DH.%26aulast%3DTomaszewski%26aufirst%3DJ.%2BE.%26aulast%3DHolleran%26aufirst%3DJ.%2BL.%26aulast%3DMuzzio%26aufirst%3DM.%26aulast%3DEiseman%26aufirst%3DJ.%26aulast%3DBeumer%26aufirst%3DJ.%2BH.%26aulast%3DDoroshow%26aufirst%3DJ.%2BH.%26aulast%3DPommier%26aufirst%3DY.%26atitle%3DNCI%2520comparative%2520oncology%2520program%2520testing%2520of%2520non-camptothecin%2520indenoisoquinoline%2520topoisomerase%2520I%2520inhibitors%2520in%2520naturally%2520occurring%2520canine%2520lymphoma%26jtitle%3DClin.%2520Cancer%2520Res.%26date%3D2018%26doi%3D10.1158%2F1078-0432.CCR-18-1498" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref44"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref44'); return false;" data-citation="" class="refNumLink">44</a></strong><div class="NLM_citation" id="cit44"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Hu, Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, H. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">An, L. K.</span></span> <span> </span><span class="NLM_article-title">Tyrosyl-DNA phosphodiesterases: potential targets for cancer treatment</span>. <i>Acta Pharm. Sin.</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>51</i></span>,  <span class="NLM_fpage">215</span>– <span class="NLM_lpage">225</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref44/cit44&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00639&amp;key=1%3ACAS%3A280%3ADC%252BC1MbislCmuw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=51&publication_year=2016&pages=215-225&author=Z.+Huauthor=H.+W.+Wangauthor=L.+K.+An&title=Tyrosyl-DNA+phosphodiesterases%3A+potential+targets+for+cancer+treatment"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit44R"><div class="casContent"><span class="casTitleNuber">44</span><div class="casTitle"><span class="NLM_cas:atitle">Tyrosyl-DNA phosphodiesterases: potential targets for cancer treatment</span></div><div class="casAuthors">Hu Zhu; Wang Hao-wen; An Lin-kun</div><div class="citationInfo"><span class="NLM_cas:title">Yao xue xue bao = Acta pharmaceutica Sinica</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">51</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">215-25</span>
        ISSN:<span class="NLM_cas:issn">0513-4870</span>.
    </div><div class="casAbstract">DNA topoisomerases-mediated DNA damages are generated from exogenous and endogenous effects, which need to be metabolized or repaired to maintain genome stability involving in many of repair enzymes.  Tyrosyl-DNA phosphodiesterase 1(TDP1) and tyrosyl-DNA phosphodiesterase 2(TDP2) are two DNA repair enzymes discovered recently.  TDP1 and TDP2 have the ability to hydrolyze the tyrosyl-phosphodiester bond of the phenol of tyrosine with 3'- and 5'-DNA end, respectively, which are contained in the metabolites of the damaged DNA mediated by topoisomerase 1 and topoisomerase 2, respectively.  The abnormal activation and expression of TDP1 or TDP2 is the important reason for cancer development.  Therefore, TDP1 and TDP2 have been regarded as potential targets in cancer therapy.  In this review, we discuss the rationales of their potential as targets and development of their inhibitors together with topoisomerase poisons or DNA damaging agents.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcQZlfYPqtGKR4kFb3mqPUYDfW6udTcc2eaUDD3_vJVvtbntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BC1MbislCmuw%253D%253D&md5=99618fbd18fcbd6bcecd47826a4f2b97</span></div><a href="/servlet/linkout?suffix=cit44&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DHu%26aufirst%3DZ.%26aulast%3DWang%26aufirst%3DH.%2BW.%26aulast%3DAn%26aufirst%3DL.%2BK.%26atitle%3DTyrosyl-DNA%2520phosphodiesterases%253A%2520potential%2520targets%2520for%2520cancer%2520treatment%26jtitle%3DActa%2520Pharm.%2520Sin.%26date%3D2016%26volume%3D51%26spage%3D215%26epage%3D225" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref45"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref45'); return false;" data-citation="" class="refNumLink">45</a></strong><div class="NLM_citation" id="cit45"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Davies, D. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Interthal, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Champoux, J. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hol, W. G. J.</span></span> <span> </span><span class="NLM_article-title">Insights into substrate binding and catalytic mechanism of human tyrosyl-DNA phosphodiesterase (Tdp1) from vanadate and tungstate-inhibited structures</span>. <i>J. Mol. Biol.</i> <span class="NLM_year" style="font-weight: bold;">2002</span>,  <span class="NLM_volume"><i>324</i></span>,  <span class="NLM_fpage">917</span>– <span class="NLM_lpage">932</span>, <span class="refDoi"> DOI: 10.1016/S0022-2836(02)01154-3</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref45/cit45&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00639&amp;key=10.1016%2FS0022-2836%2802%2901154-3" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref45/cit45&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00639&amp;key=12470949" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref45/cit45&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00639&amp;key=1%3ACAS%3A528%3ADC%252BD38XpsF2kurY%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=324&publication_year=2002&pages=917-932&author=D.+R.+Daviesauthor=H.+Interthalauthor=J.+J.+Champouxauthor=W.+G.+J.+Hol&title=Insights+into+substrate+binding+and+catalytic+mechanism+of+human+tyrosyl-DNA+phosphodiesterase+%28Tdp1%29+from+vanadate+and+tungstate-inhibited+structures&doi=10.1016%2FS0022-2836%2802%2901154-3"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit45R"><div class="casContent"><span class="casTitleNuber">45</span><div class="casTitle"><span class="NLM_cas:atitle">Insights into Substrate Binding and Catalytic Mechanism of Human Tyrosyl-DNA Phosphodiesterase (Tdp1) from Vanadate and Tungstate-inhibited Structures</span></div><div class="casAuthors">Davies, Douglas R.; Interthal, Heidrun; Champoux, James J.; Hol, Wim G. J.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Molecular Biology</span>
        (<span class="NLM_cas:date">2002</span>),
    <span class="NLM_cas:volume">324</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">917-932</span>CODEN:
                <span class="NLM_cas:coden">JMOBAK</span>;
        ISSN:<span class="NLM_cas:issn">0022-2836</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Science Ltd.</span>)
        </div><div class="casAbstract">Tyrosyl-DNA phosphodiesterase (Tdp1) is a DNA repair enzyme that catalyzes the hydrolysis of a phosphodiester bond between a tyrosine residue and a DNA 3'-phosphate.  The only known example of such a linkage in eukaryotic cells occurs normally as a transient link between a type IB topoisomerase and DNA.  Thus human Tdp1 is thought to be responsible for repairing lesions that occur when topoisomerase I becomes stalled on the DNA in the cell.  Tdp1 has also been shown to remove glycolate from single-stranded DNA contg. a 3'-phosphoglycolate, suggesting a role for Tdp1 in repair of free-radical mediated DNA double-strand breaks.  We report the three-dimensional structures of human Tdp1 bound to the phosphate transition state analogs vanadate and tungstate.  Each structure shows the inhibitor covalently bound to His263, confirming that this residue is the nucleophile in the first step of the catalytic reaction.  Vanadate in the Tdp1-vanadate structure has a trigonal bipyramidal geometry that mimics the transition state for hydrolysis of a phosphodiester bond, while Tdp1-tungstate displays unusual octahedral coordination.  The presence of low-occupancy tungstate mols. along the narrow groove of the substrate binding cleft is suggestive evidence that this groove binds ssDNA.  In both cases, glycerol from the cryoprotectant soln. became liganded to the vanadate or tungstate inhibitor mols. in a bidentate 1,2-diol fashion.  These structural models allow predictions to be made regarding the specific binding mode of the substrate and the mechanism of catalysis.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqK8h8pfQyO4LVg90H21EOLACvtfcHk0lhBpevOvj2YGw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD38XpsF2kurY%253D&md5=6dedb178fa7dc3ec57ed3fd0bd5d7bb1</span></div><a href="/servlet/linkout?suffix=cit45&amp;dbid=16384&amp;doi=10.1016%2FS0022-2836%2802%2901154-3&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS0022-2836%252802%252901154-3%26sid%3Dliteratum%253Aachs%26aulast%3DDavies%26aufirst%3DD.%2BR.%26aulast%3DInterthal%26aufirst%3DH.%26aulast%3DChampoux%26aufirst%3DJ.%2BJ.%26aulast%3DHol%26aufirst%3DW.%2BG.%2BJ.%26atitle%3DInsights%2520into%2520substrate%2520binding%2520and%2520catalytic%2520mechanism%2520of%2520human%2520tyrosyl-DNA%2520phosphodiesterase%2520%2528Tdp1%2529%2520from%2520vanadate%2520and%2520tungstate-inhibited%2520structures%26jtitle%3DJ.%2520Mol.%2520Biol.%26date%3D2002%26volume%3D324%26spage%3D917%26epage%3D932%26doi%3D10.1016%2FS0022-2836%2802%2901154-3" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref46"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref46'); return false;" data-citation="" class="refNumLink">46</a></strong><div class="NLM_citation" id="cit46"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Davies, D. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Interthal, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Champoux, J. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hol, W. G. J.</span></span> <span> </span><span class="NLM_article-title">Crystal structure of a transition state mimic for Tdp1 assembled from vanadate, DNA, and a topoisomerase I-derived peptide</span>. <i>Chem. Biol.</i> <span class="NLM_year" style="font-weight: bold;">2003</span>,  <span class="NLM_volume"><i>10</i></span>,  <span class="NLM_fpage">139</span>– <span class="NLM_lpage">147</span>, <span class="refDoi"> DOI: 10.1016/S1074-5521(03)00021-8</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref46/cit46&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00639&amp;key=10.1016%2FS1074-5521%2803%2900021-8" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref46/cit46&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00639&amp;key=12618186" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref46/cit46&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00639&amp;key=1%3ACAS%3A528%3ADC%252BD3sXhs1Crsrs%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=10&publication_year=2003&pages=139-147&author=D.+R.+Daviesauthor=H.+Interthalauthor=J.+J.+Champouxauthor=W.+G.+J.+Hol&title=Crystal+structure+of+a+transition+state+mimic+for+Tdp1+assembled+from+vanadate%2C+DNA%2C+and+a+topoisomerase+I-derived+peptide&doi=10.1016%2FS1074-5521%2803%2900021-8"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit46R"><div class="casContent"><span class="casTitleNuber">46</span><div class="casTitle"><span class="NLM_cas:atitle">Crystal structure of a transition state mimic for Tdp1 assembled from vanadate, DNA, and a topoisomerase I-derived peptide</span></div><div class="casAuthors">Davies, Douglas R.; Interthal, Heidrun; Champoux, James J.; Hol, Wim G. J.</div><div class="citationInfo"><span class="NLM_cas:title">Chemistry & Biology</span>
        (<span class="NLM_cas:date">2003</span>),
    <span class="NLM_cas:volume">10</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">139-147</span>CODEN:
                <span class="NLM_cas:coden">CBOLE2</span>;
        ISSN:<span class="NLM_cas:issn">1074-5521</span>.
    
            (<span class="NLM_cas:orgname">Cell Press</span>)
        </div><div class="casAbstract">Tyrosyl-DNA phosphodiesterase (Tdp1) is a member of the phospholipase D superfamily and acts as a DNA repair enzyme that removes stalled topoisomerase I- DNA complexes by hydrolyzing the bond between a tyrosine side chain and a DNA 3' phosphate.  Despite the complexity of the substrate of this phosphodiesterase, vanadate succeeded in linking human Tdp1, a tyrosine-contg. peptide, and a single-stranded DNA oligonucleotide into a quaternary complex that mimics the transition state for the first step of the catalytic reaction.  The conformation of the bound substrate mimic gives compelling evidence that the topoisomerase I-DNA complex must undergo extensive modification prior to cleavage by Tdp1.  The structure also illustrates that the use of vanadate as the central moiety in high-order complexes has the potential to be a general method for capturing protein-substrate interactions for phosphoryl transfer enzymes, even when the substrates are large, complicated, and unusual.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqrNJv97ppHfbVg90H21EOLACvtfcHk0lhBpevOvj2YGw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3sXhs1Crsrs%253D&md5=9ce9e926b648eca1bd6a5335eaa30cb7</span></div><a href="/servlet/linkout?suffix=cit46&amp;dbid=16384&amp;doi=10.1016%2FS1074-5521%2803%2900021-8&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS1074-5521%252803%252900021-8%26sid%3Dliteratum%253Aachs%26aulast%3DDavies%26aufirst%3DD.%2BR.%26aulast%3DInterthal%26aufirst%3DH.%26aulast%3DChampoux%26aufirst%3DJ.%2BJ.%26aulast%3DHol%26aufirst%3DW.%2BG.%2BJ.%26atitle%3DCrystal%2520structure%2520of%2520a%2520transition%2520state%2520mimic%2520for%2520Tdp1%2520assembled%2520from%2520vanadate%252C%2520DNA%252C%2520and%2520a%2520topoisomerase%2520I-derived%2520peptide%26jtitle%3DChem.%2520Biol.%26date%3D2003%26volume%3D10%26spage%3D139%26epage%3D147%26doi%3D10.1016%2FS1074-5521%2803%2900021-8" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref47"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref47'); return false;" data-citation="" class="refNumLink">47</a></strong><div class="NLM_citation" id="cit47"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Liao, Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Thibaut, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jobson, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pommier, Y.</span></span> <span> </span><span class="NLM_article-title">Inhibition of human tyrosyl-DNA phosphodiesterase by aminoglycoside antibiotics and ribosome inhibitors</span>. <i>Mol. Pharmacol.</i> <span class="NLM_year" style="font-weight: bold;">2006</span>,  <span class="NLM_volume"><i>70</i></span>,  <span class="NLM_fpage">366</span>– <span class="NLM_lpage">372</span>, <span class="refDoi"> DOI: 10.1124/mol.105.021865</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref47/cit47&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00639&amp;key=10.1124%2Fmol.105.021865" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=70&publication_year=2006&pages=366-372&author=Z.+Liaoauthor=L.+Thibautauthor=A.+Jobsonauthor=Y.+Pommier&title=Inhibition+of+human+tyrosyl-DNA+phosphodiesterase+by+aminoglycoside+antibiotics+and+ribosome+inhibitors&doi=10.1124%2Fmol.105.021865"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit47&amp;dbid=16384&amp;doi=10.1124%2Fmol.105.021865&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1124%252Fmol.105.021865%26sid%3Dliteratum%253Aachs%26aulast%3DLiao%26aufirst%3DZ.%26aulast%3DThibaut%26aufirst%3DL.%26aulast%3DJobson%26aufirst%3DA.%26aulast%3DPommier%26aufirst%3DY.%26atitle%3DInhibition%2520of%2520human%2520tyrosyl-DNA%2520phosphodiesterase%2520by%2520aminoglycoside%2520antibiotics%2520and%2520ribosome%2520inhibitors%26jtitle%3DMol.%2520Pharmacol.%26date%3D2006%26volume%3D70%26spage%3D366%26epage%3D372%26doi%3D10.1124%2Fmol.105.021865" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref48"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref48'); return false;" data-citation="" class="refNumLink">48</a></strong><div class="NLM_citation" id="cit48"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Marchand, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lea, W. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jadhav, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dexheimer, T. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Austin, C. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Inglese, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pommier, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Simeonov, A.</span></span> <span> </span><span class="NLM_article-title">Identification of phosphotyrosine mimetic inhibitors of human tyrosyl-DNA phosphodiesterase I by a novel AlphaScreen high-throughput assay</span>. <i>Mol. Cancer Ther.</i> <span class="NLM_year" style="font-weight: bold;">2009</span>,  <span class="NLM_volume"><i>8</i></span>,  <span class="NLM_fpage">240</span>– <span class="NLM_lpage">248</span>, <span class="refDoi"> DOI: 10.1158/1535-7163.MCT-08-0878</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref48/cit48&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00639&amp;key=10.1158%2F1535-7163.MCT-08-0878" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref48/cit48&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00639&amp;key=19139134" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref48/cit48&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00639&amp;key=1%3ACAS%3A528%3ADC%252BD1MXjvFSltw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=8&publication_year=2009&pages=240-248&author=C.+Marchandauthor=W.+A.+Leaauthor=A.+Jadhavauthor=T.+S.+Dexheimerauthor=C.+P.+Austinauthor=J.+Ingleseauthor=Y.+Pommierauthor=A.+Simeonov&title=Identification+of+phosphotyrosine+mimetic+inhibitors+of+human+tyrosyl-DNA+phosphodiesterase+I+by+a+novel+AlphaScreen+high-throughput+assay&doi=10.1158%2F1535-7163.MCT-08-0878"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit48R"><div class="casContent"><span class="casTitleNuber">48</span><div class="casTitle"><span class="NLM_cas:atitle">Identification of phosphotyrosine mimetic inhibitors of human tyrosyl-DNA phosphodiesterase I by a novel AlphaScreen high-throughput assay</span></div><div class="casAuthors">Marchand, Christophe; Lea, Wendy A.; Jadhav, Ajit; Dexheimer, Thomas S.; Austin, Christopher P.; Inglese, James; Pommier, Yves; Simeonov, Anton</div><div class="citationInfo"><span class="NLM_cas:title">Molecular Cancer Therapeutics</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">8</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">240-248</span>CODEN:
                <span class="NLM_cas:coden">MCTOCF</span>;
        ISSN:<span class="NLM_cas:issn">1535-7163</span>.
    
            (<span class="NLM_cas:orgname">American Association for Cancer Research</span>)
        </div><div class="casAbstract">Tyrosyl-DNA phosphodiesterase I (Tdp1) resolves topoisomerase I (Top1)-DNA adducts accumulated from natural DNA damage as well as from the action of certain anticancer drugs.  Tdp1 catalyzes the hydrolysis of the phosphodiester bond between the catalytic tyrosine residue of topoisomerase I and the DNA 3'-phosphate.  Only a limited no. of weak inhibitors have been reported for Tdp1, and there is an unmet need to identify novel chemotypes through screening of chem. libraries.  Herein, we present an easily configured, highly miniaturized, and robust Tdp1 assay using the AlphaScreen technol.  Uninhibited enzyme reaction is assocd. with low signal, whereas inhibition leads to a gain of signal, making the present assay format esp. attractive for automated large-collection high-throughput screening.  We report the identification and initial characterization of four previously unreported inhibitors of Tdp1.  Among them, suramin, NF449, and methyl-3,4-dephostatin are phosphotyrosine mimetics that may act as Tdp1 substrate decoys.  We also report a novel biochem. assay using the SCAN1 Tdp1 mutant to study the mechanism of action of methyl-3,4-dephostatin.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqw2O21mqWopLVg90H21EOLACvtfcHk0liMDquFbA3Hcw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXjvFSltw%253D%253D&md5=05a32d97be998b397a5dc3586b81bef4</span></div><a href="/servlet/linkout?suffix=cit48&amp;dbid=16384&amp;doi=10.1158%2F1535-7163.MCT-08-0878&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1158%252F1535-7163.MCT-08-0878%26sid%3Dliteratum%253Aachs%26aulast%3DMarchand%26aufirst%3DC.%26aulast%3DLea%26aufirst%3DW.%2BA.%26aulast%3DJadhav%26aufirst%3DA.%26aulast%3DDexheimer%26aufirst%3DT.%2BS.%26aulast%3DAustin%26aufirst%3DC.%2BP.%26aulast%3DInglese%26aufirst%3DJ.%26aulast%3DPommier%26aufirst%3DY.%26aulast%3DSimeonov%26aufirst%3DA.%26atitle%3DIdentification%2520of%2520phosphotyrosine%2520mimetic%2520inhibitors%2520of%2520human%2520tyrosyl-DNA%2520phosphodiesterase%2520I%2520by%2520a%2520novel%2520AlphaScreen%2520high-throughput%2520assay%26jtitle%3DMol.%2520Cancer%2520Ther.%26date%3D2009%26volume%3D8%26spage%3D240%26epage%3D248%26doi%3D10.1158%2F1535-7163.MCT-08-0878" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref49"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref49'); return false;" data-citation="" class="refNumLink">49</a></strong><div class="NLM_citation" id="cit49"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Sirivolu, V. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Vernekar, S. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Marchand, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Naumova, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chergui, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Renaud, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Stephen, A. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chen, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sham, Y. Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pommier, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, Z.</span></span> <span> </span><span class="NLM_article-title">5-Arylidenethioxothiazolidinones as inhibitors of tyrosyl-DNA phosphodiesterase I</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2012</span>,  <span class="NLM_volume"><i>55</i></span>,  <span class="NLM_fpage">8671</span>– <span class="NLM_lpage">8684</span>, <span class="refDoi"> DOI: 10.1021/jm3008773</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm3008773" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=55&publication_year=2012&pages=8671-8684&author=V.+R.+Sirivoluauthor=S.+K.+Vernekarauthor=C.+Marchandauthor=A.+Naumovaauthor=A.+Cherguiauthor=A.+Renaudauthor=A.+G.+Stephenauthor=F.+Chenauthor=Y.+Y.+Shamauthor=Y.+Pommierauthor=Z.+Wang&title=5-Arylidenethioxothiazolidinones+as+inhibitors+of+tyrosyl-DNA+phosphodiesterase+I&doi=10.1021%2Fjm3008773"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit49&amp;dbid=16384&amp;doi=10.1021%2Fjm3008773&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm3008773%26sid%3Dliteratum%253Aachs%26aulast%3DSirivolu%26aufirst%3DV.%2BR.%26aulast%3DVernekar%26aufirst%3DS.%2BK.%26aulast%3DMarchand%26aufirst%3DC.%26aulast%3DNaumova%26aufirst%3DA.%26aulast%3DChergui%26aufirst%3DA.%26aulast%3DRenaud%26aufirst%3DA.%26aulast%3DStephen%26aufirst%3DA.%2BG.%26aulast%3DChen%26aufirst%3DF.%26aulast%3DSham%26aufirst%3DY.%2BY.%26aulast%3DPommier%26aufirst%3DY.%26aulast%3DWang%26aufirst%3DZ.%26atitle%3D5-Arylidenethioxothiazolidinones%2520as%2520inhibitors%2520of%2520tyrosyl-DNA%2520phosphodiesterase%2520I%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2012%26volume%3D55%26spage%3D8671%26epage%3D8684%26doi%3D10.1021%2Fjm3008773" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref50"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref50'); return false;" data-citation="" class="refNumLink">50</a></strong><div class="NLM_citation" id="cit50"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Dean, R. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fam, H. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">An, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Choi, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shimizu, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jones, S. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Boerkoel, C. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Interthal, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pfeifer, T. A.</span></span> <span> </span><span class="NLM_article-title">Identification of a putative Tdp1 inhibitor (CD00509) by in vitro and cell-based assays</span>. <i>J. Biomol. Screening</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>19</i></span>,  <span class="NLM_fpage">1372</span>– <span class="NLM_lpage">1382</span>, <span class="refDoi"> DOI: 10.1177/1087057114546551</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref50/cit50&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00639&amp;key=10.1177%2F1087057114546551" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref50/cit50&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00639&amp;key=25117203" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref50/cit50&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00639&amp;key=1%3ACAS%3A528%3ADC%252BC2cXitFGgs7nJ" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=19&publication_year=2014&pages=1372-1382&author=R.+A.+Deanauthor=H.+K.+Famauthor=J.+Anauthor=K.+Choiauthor=Y.+Shimizuauthor=S.+J.+Jonesauthor=C.+F.+Boerkoelauthor=H.+Interthalauthor=T.+A.+Pfeifer&title=Identification+of+a+putative+Tdp1+inhibitor+%28CD00509%29+by+in+vitro+and+cell-based+assays&doi=10.1177%2F1087057114546551"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit50R"><div class="casContent"><span class="casTitleNuber">50</span><div class="casTitle"><span class="NLM_cas:atitle">Identification of a putative Tdp1 inhibitor (CD00509) by in vitro and cell-based assays</span></div><div class="casAuthors">Dean, Richard A.; Fam, Hok Khim; An, Jianghong; Choi, Kunho; Shimizu, Yoko; Jones, Steven J. M.; Boerkoel, Cornelius F.; Interthal, Heidrun; Pfeifer, Tom A.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Biomolecular Screening</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">19</span>
        (<span class="NLM_cas:issue">10</span>),
    <span class="NLM_cas:pages">1372-1382</span>CODEN:
                <span class="NLM_cas:coden">JBISF3</span>;
        ISSN:<span class="NLM_cas:issn">1087-0571</span>.
    
            (<span class="NLM_cas:orgname">Sage Publications</span>)
        </div><div class="casAbstract">Mutations of DNA repair pathways contribute to tumorigenesis and provide a therapeutic target for synthetic lethal interactions in tumor cells.  Given that tyrosyl-DNA phosphodiesterase 1 (Tdp1) repairs stalled topoisomerase-I DNA complexes, we hypothesized that inhibition of Tdp1 has synthetic lethal effects in some cancers.  To test this, we screened tumor arrays for Tdp1 expression and obsd. that Tdp1 is expressed in many tumors, including more than 90% of human breast tumors.  Subsequent chem. screening identified putative Tdp1 inhibitors.  Treatment of control human mammary epithelial cells and the breast cancer cell line MCF-7 with compd. CD00509 preferentially sensitized MCF- 7 cells to camptothecin and decreased cell proliferation 25% more than camptothecin treatment alone.  This suggests that CD00509 specifically targeted Tdp1 in vitro, and CD00509 increased the sensitivity of wild-type murine embryonic fibroblasts (MEFs) to camptothecin to a degree comparable to that of Tdp1-/- MEFs.  In addn., consistent with poly ADPribose polymerase-1 (PARP-1) collaborating with Tdp1 in DNA repair, combined Tdp1 and PARP-1 inhibition was more detrimental to MCF-7 cells than either treatment alone, whereas the combination was not additively harmful to control mammary cells.  We conclude that targeting Tdp1 in anticancer therapy preferentially enhances the sensitivity of some breast cancer cells to camptothecin and may be an effective adjuvant for breast cancer therapy.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGp9JJs__w2bnLVg90H21EOLACvtfcHk0liMDquFbA3Hcw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXitFGgs7nJ&md5=01019816a3bf5e716e007ad40157a711</span></div><a href="/servlet/linkout?suffix=cit50&amp;dbid=16384&amp;doi=10.1177%2F1087057114546551&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1177%252F1087057114546551%26sid%3Dliteratum%253Aachs%26aulast%3DDean%26aufirst%3DR.%2BA.%26aulast%3DFam%26aufirst%3DH.%2BK.%26aulast%3DAn%26aufirst%3DJ.%26aulast%3DChoi%26aufirst%3DK.%26aulast%3DShimizu%26aufirst%3DY.%26aulast%3DJones%26aufirst%3DS.%2BJ.%26aulast%3DBoerkoel%26aufirst%3DC.%2BF.%26aulast%3DInterthal%26aufirst%3DH.%26aulast%3DPfeifer%26aufirst%3DT.%2BA.%26atitle%3DIdentification%2520of%2520a%2520putative%2520Tdp1%2520inhibitor%2520%2528CD00509%2529%2520by%2520in%2520vitro%2520and%2520cell-based%2520assays%26jtitle%3DJ.%2520Biomol.%2520Screening%26date%3D2014%26volume%3D19%26spage%3D1372%26epage%3D1382%26doi%3D10.1177%2F1087057114546551" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref51"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref51'); return false;" data-citation="" class="refNumLink">51</a></strong><div class="NLM_citation" id="cit51"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Zakharenko, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Khomenko, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhukova, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Koval, O.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zakharova, O.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Anarbaev, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lebedeva, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Korchagina, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Komarova, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Vasiliev, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Reynisson, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Volcho, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Salakhutdinov, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lavrik, O.</span></span> <span> </span><span class="NLM_article-title">Synthesis and biological evaluation of novel tyrosyl-DNA phosphodiesterase 1 inhibitors with a benzopentathiepine moiety</span>. <i>Bioorg. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>23</i></span>,  <span class="NLM_fpage">2044</span>– <span class="NLM_lpage">2052</span>, <span class="refDoi"> DOI: 10.1016/j.bmc.2015.03.020</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref51/cit51&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00639&amp;key=10.1016%2Fj.bmc.2015.03.020" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=23&publication_year=2015&pages=2044-2052&author=A.+Zakharenkoauthor=T.+Khomenkoauthor=S.+Zhukovaauthor=O.+Kovalauthor=O.+Zakharovaauthor=R.+Anarbaevauthor=N.+Lebedevaauthor=D.+Korchaginaauthor=N.+Komarovaauthor=V.+Vasilievauthor=J.+Reynissonauthor=K.+Volchoauthor=N.+Salakhutdinovauthor=O.+Lavrik&title=Synthesis+and+biological+evaluation+of+novel+tyrosyl-DNA+phosphodiesterase+1+inhibitors+with+a+benzopentathiepine+moiety&doi=10.1016%2Fj.bmc.2015.03.020"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit51&amp;dbid=16384&amp;doi=10.1016%2Fj.bmc.2015.03.020&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmc.2015.03.020%26sid%3Dliteratum%253Aachs%26aulast%3DZakharenko%26aufirst%3DA.%26aulast%3DKhomenko%26aufirst%3DT.%26aulast%3DZhukova%26aufirst%3DS.%26aulast%3DKoval%26aufirst%3DO.%26aulast%3DZakharova%26aufirst%3DO.%26aulast%3DAnarbaev%26aufirst%3DR.%26aulast%3DLebedeva%26aufirst%3DN.%26aulast%3DKorchagina%26aufirst%3DD.%26aulast%3DKomarova%26aufirst%3DN.%26aulast%3DVasiliev%26aufirst%3DV.%26aulast%3DReynisson%26aufirst%3DJ.%26aulast%3DVolcho%26aufirst%3DK.%26aulast%3DSalakhutdinov%26aufirst%3DN.%26aulast%3DLavrik%26aufirst%3DO.%26atitle%3DSynthesis%2520and%2520biological%2520evaluation%2520of%2520novel%2520tyrosyl-DNA%2520phosphodiesterase%25201%2520inhibitors%2520with%2520a%2520benzopentathiepine%2520moiety%26jtitle%3DBioorg.%2520Med.%2520Chem.%26date%3D2015%26volume%3D23%26spage%3D2044%26epage%3D2052%26doi%3D10.1016%2Fj.bmc.2015.03.020" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref52"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref52'); return false;" data-citation="" class="refNumLink">52</a></strong><div class="NLM_citation" id="cit52"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Nguyen, T. X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Morrell, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Conda-Sheridan, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Marchand, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Agama, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bermingam, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Stephen, A. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chergui, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Naumova, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fisher, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">O’Keefe, B. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pommier, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cushman, M.</span></span> <span> </span><span class="NLM_article-title">Synthesis and biological evaluation of the first dual tyrosyl-DNA phosphodiesterase I (Tdp1)-topoisomerase I (Top1) inhibitors</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2012</span>,  <span class="NLM_volume"><i>55</i></span>,  <span class="NLM_fpage">4457</span>– <span class="NLM_lpage">4478</span>, <span class="refDoi"> DOI: 10.1021/jm300335n</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm300335n" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref52/cit52&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00639&amp;key=1%3ACAS%3A528%3ADC%252BC38XmtFartrY%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=55&publication_year=2012&pages=4457-4478&author=T.+X.+Nguyenauthor=A.+Morrellauthor=M.+Conda-Sheridanauthor=C.+Marchandauthor=K.+Agamaauthor=A.+Bermingamauthor=A.+G.+Stephenauthor=A.+Cherguiauthor=A.+Naumovaauthor=R.+Fisherauthor=B.+R.+O%E2%80%99Keefeauthor=Y.+Pommierauthor=M.+Cushman&title=Synthesis+and+biological+evaluation+of+the+first+dual+tyrosyl-DNA+phosphodiesterase+I+%28Tdp1%29-topoisomerase+I+%28Top1%29+inhibitors&doi=10.1021%2Fjm300335n"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit52R"><div class="casContent"><span class="casTitleNuber">52</span><div class="casTitle"><span class="NLM_cas:atitle">Synthesis and Biological Evaluation of the First Dual Tyrosyl-DNA Phosphodiesterase I (Tdp1)-Topoisomerase I (Top1) Inhibitors</span></div><div class="casAuthors">Nguyen, Trung Xuan; Morrell, Andrew; Conda-Sheridan, Martin; Marchand, Christophe; Agama, Keli; Berminham, Alun; Stephen, Andrew G.; Chergui, Adel; Naumova, Alena; Fisher, Robert; O'Keefe, Barry R.; Pommier, Yves; Cushman, Mark</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">55</span>
        (<span class="NLM_cas:issue">9</span>),
    <span class="NLM_cas:pages">4457-4478</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Substances with dual tyrosyl-DNA phosphodiesterase I-topoisomerase I inhibitory activity in one low mol. wt. compd. would constitute a unique class of anticancer agents that could potentially have significant advantages over drugs that work against the individual enzymes.  The present study demonstrates the successful synthesis and evaluation of the first dual Top1-Tdp1 inhibitors, which are based on the indenoisoquinoline chemotype.  One bis(indenoisoquinoline) (I.2TFA) had significant activity against human Tdp1 (IC50 = 1.52 ± 0.05 μM), and it was also equipotent to camptothecin as a Top1 inhibitor.  Significant insights into enzyme-drug interactions were gained via structure-activity relationship studies of the series.  The present results also document the failure of the previously reported sulfonyl ester pharmacophore to confer Tdp1 inhibition in this indenoisoquinoline class of inhibitors even though it was demonstrated to work well for the steroid NSC 88915 (7).  The current study will facilitate future efforts to optimize dual Top1-Tdp1 inhibitors.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpHBLLYpVMf5rVg90H21EOLACvtfcHk0lh_9NTYMqXLQQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38XmtFartrY%253D&md5=c6f74f01e36da72fe9d5e0c435b9e3dd</span></div><a href="/servlet/linkout?suffix=cit52&amp;dbid=16384&amp;doi=10.1021%2Fjm300335n&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm300335n%26sid%3Dliteratum%253Aachs%26aulast%3DNguyen%26aufirst%3DT.%2BX.%26aulast%3DMorrell%26aufirst%3DA.%26aulast%3DConda-Sheridan%26aufirst%3DM.%26aulast%3DMarchand%26aufirst%3DC.%26aulast%3DAgama%26aufirst%3DK.%26aulast%3DBermingam%26aufirst%3DA.%26aulast%3DStephen%26aufirst%3DA.%2BG.%26aulast%3DChergui%26aufirst%3DA.%26aulast%3DNaumova%26aufirst%3DA.%26aulast%3DFisher%26aufirst%3DR.%26aulast%3DO%25E2%2580%2599Keefe%26aufirst%3DB.%2BR.%26aulast%3DPommier%26aufirst%3DY.%26aulast%3DCushman%26aufirst%3DM.%26atitle%3DSynthesis%2520and%2520biological%2520evaluation%2520of%2520the%2520first%2520dual%2520tyrosyl-DNA%2520phosphodiesterase%2520I%2520%2528Tdp1%2529-topoisomerase%2520I%2520%2528Top1%2529%2520inhibitors%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2012%26volume%3D55%26spage%3D4457%26epage%3D4478%26doi%3D10.1021%2Fjm300335n" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref53"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref53'); return false;" data-citation="" class="refNumLink">53</a></strong><div class="NLM_citation" id="cit53"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Conda-Sheridan, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Reddy, P. V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Morrell, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cobb, B. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Marchand, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Agama, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chergui, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Renaud, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Stephen, A. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bindu, L. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pommier, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cushman, M.</span></span> <span> </span><span class="NLM_article-title">Synthesis and biological evaluation of indenoisoquinolines that inhibit both tyrosyl-DNA phosphodiesterase I (Tdp1) and topoisomerase I (Top1)</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2013</span>,  <span class="NLM_volume"><i>56</i></span>,  <span class="NLM_fpage">182</span>– <span class="NLM_lpage">200</span>, <span class="refDoi"> DOI: 10.1021/jm3014458</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm3014458" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref53/cit53&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00639&amp;key=1%3ACAS%3A528%3ADC%252BC38XhvVyitbvN" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=56&publication_year=2013&pages=182-200&author=M.+Conda-Sheridanauthor=P.+V.+Reddyauthor=A.+Morrellauthor=B.+T.+Cobbauthor=C.+Marchandauthor=K.+Agamaauthor=A.+Cherguiauthor=A.+Renaudauthor=A.+G.+Stephenauthor=L.+K.+Binduauthor=Y.+Pommierauthor=M.+Cushman&title=Synthesis+and+biological+evaluation+of+indenoisoquinolines+that+inhibit+both+tyrosyl-DNA+phosphodiesterase+I+%28Tdp1%29+and+topoisomerase+I+%28Top1%29&doi=10.1021%2Fjm3014458"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit53R"><div class="casContent"><span class="casTitleNuber">53</span><div class="casTitle"><span class="NLM_cas:atitle">Synthesis and biological evaluation of indenoisoquinolines that inhibit both Tyrosyl-DNA phosphodiesterase I (Tdp1) and Topoisomerase I (Top1)</span></div><div class="casAuthors">Conda-Sheridan, Martin; Reddy, P. V. Narasimha; Morrell, Andrew; Cobb, Brooklyn T.; Marchand, Christophe; Agama, Keli; Chergui, Adel; Renaud, Amelie; Stephen, Andrew G.; Bindu, Lakshman K.; Pommier, Yves; Cushman, Mark</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">56</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">182-200</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Tyrosyl-DNA phosphodiesterase I (Tdp1) plays a key role in the repair of damaged DNA resulting from the topoisomerase I (Top1) inhibitor camptothecin and a variety of other DNA-damaging anticancer agents.  This report documents the design, synthesis, and evaluation of new indenoisoquinolines e. g., I that are dual inhibitors of both Tdp1 and Top1.  Enzyme inhibitory data and cytotoxicity data from human cancer cell cultures were used to establish structure-activity relationships.  The potencies of the indenoisoquinolines against Tdp1 ranged from 5 μM to 111 μM, which places the more active compds. among the most potent known inhibitors of this target.  The cytotoxicity mean graph midpoints ranged from 0.02 to 2.34 μM.  Dual Tdp1-Top1 inhibitors are of interest because the Top1 and Tdp1 inhibitory activities could theor. work synergistically to create more effective anticancer agents.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr4X-QxF_UW9LVg90H21EOLACvtfcHk0lh_9NTYMqXLQQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38XhvVyitbvN&md5=5441a5d126a969b1ba435c3e00f03fc1</span></div><a href="/servlet/linkout?suffix=cit53&amp;dbid=16384&amp;doi=10.1021%2Fjm3014458&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm3014458%26sid%3Dliteratum%253Aachs%26aulast%3DConda-Sheridan%26aufirst%3DM.%26aulast%3DReddy%26aufirst%3DP.%2BV.%26aulast%3DMorrell%26aufirst%3DA.%26aulast%3DCobb%26aufirst%3DB.%2BT.%26aulast%3DMarchand%26aufirst%3DC.%26aulast%3DAgama%26aufirst%3DK.%26aulast%3DChergui%26aufirst%3DA.%26aulast%3DRenaud%26aufirst%3DA.%26aulast%3DStephen%26aufirst%3DA.%2BG.%26aulast%3DBindu%26aufirst%3DL.%2BK.%26aulast%3DPommier%26aufirst%3DY.%26aulast%3DCushman%26aufirst%3DM.%26atitle%3DSynthesis%2520and%2520biological%2520evaluation%2520of%2520indenoisoquinolines%2520that%2520inhibit%2520both%2520tyrosyl-DNA%2520phosphodiesterase%2520I%2520%2528Tdp1%2529%2520and%2520topoisomerase%2520I%2520%2528Top1%2529%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2013%26volume%3D56%26spage%3D182%26epage%3D200%26doi%3D10.1021%2Fjm3014458" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref54"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref54'); return false;" data-citation="" class="refNumLink">54</a></strong><div class="NLM_citation" id="cit54"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Lv, P. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Agama, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Marchand, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pommier, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cushman, M.</span></span> <span> </span><span class="NLM_article-title">Design, synthesis, and biological evaluation of O-2-modified indenoisoquinolines as dual topoisomerase I-tyrosyl-DNA phosphodiesterase I inhibitors</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>57</i></span>,  <span class="NLM_fpage">4324</span>– <span class="NLM_lpage">4336</span>, <span class="refDoi"> DOI: 10.1021/jm500294a</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm500294a" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=57&publication_year=2014&pages=4324-4336&author=P.+C.+Lvauthor=K.+Agamaauthor=C.+Marchandauthor=Y.+Pommierauthor=M.+Cushman&title=Design%2C+synthesis%2C+and+biological+evaluation+of+O-2-modified+indenoisoquinolines+as+dual+topoisomerase+I-tyrosyl-DNA+phosphodiesterase+I+inhibitors&doi=10.1021%2Fjm500294a"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit54&amp;dbid=16384&amp;doi=10.1021%2Fjm500294a&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm500294a%26sid%3Dliteratum%253Aachs%26aulast%3DLv%26aufirst%3DP.%2BC.%26aulast%3DAgama%26aufirst%3DK.%26aulast%3DMarchand%26aufirst%3DC.%26aulast%3DPommier%26aufirst%3DY.%26aulast%3DCushman%26aufirst%3DM.%26atitle%3DDesign%252C%2520synthesis%252C%2520and%2520biological%2520evaluation%2520of%2520O-2-modified%2520indenoisoquinolines%2520as%2520dual%2520topoisomerase%2520I-tyrosyl-DNA%2520phosphodiesterase%2520I%2520inhibitors%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2014%26volume%3D57%26spage%3D4324%26epage%3D4336%26doi%3D10.1021%2Fjm500294a" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref55"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref55'); return false;" data-citation="" class="refNumLink">55</a></strong><div class="NLM_citation" id="cit55"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Nguyen, T. X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Abdelmalak, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Marchand, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Agama, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pommier, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cushman, M.</span></span> <span> </span><span class="NLM_article-title">Synthesis and biological evaluation of nitrated 7-, 8-, 9-, and 10-hydroxyindenoisoquinolines as potential dual topoisomerase I (Top1)-tyrosyl-DNA phosphodiesterase I (TDP1) inhibitors</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>58</i></span>,  <span class="NLM_fpage">3188</span>– <span class="NLM_lpage">3208</span>, <span class="refDoi"> DOI: 10.1021/acs.jmedchem.5b00136</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acs.jmedchem.5b00136" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=58&publication_year=2015&pages=3188-3208&author=T.+X.+Nguyenauthor=M.+Abdelmalakauthor=C.+Marchandauthor=K.+Agamaauthor=Y.+Pommierauthor=M.+Cushman&title=Synthesis+and+biological+evaluation+of+nitrated+7-%2C+8-%2C+9-%2C+and+10-hydroxyindenoisoquinolines+as+potential+dual+topoisomerase+I+%28Top1%29-tyrosyl-DNA+phosphodiesterase+I+%28TDP1%29+inhibitors&doi=10.1021%2Facs.jmedchem.5b00136"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit55&amp;dbid=16384&amp;doi=10.1021%2Facs.jmedchem.5b00136&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facs.jmedchem.5b00136%26sid%3Dliteratum%253Aachs%26aulast%3DNguyen%26aufirst%3DT.%2BX.%26aulast%3DAbdelmalak%26aufirst%3DM.%26aulast%3DMarchand%26aufirst%3DC.%26aulast%3DAgama%26aufirst%3DK.%26aulast%3DPommier%26aufirst%3DY.%26aulast%3DCushman%26aufirst%3DM.%26atitle%3DSynthesis%2520and%2520biological%2520evaluation%2520of%2520nitrated%25207-%252C%25208-%252C%25209-%252C%2520and%252010-hydroxyindenoisoquinolines%2520as%2520potential%2520dual%2520topoisomerase%2520I%2520%2528Top1%2529-tyrosyl-DNA%2520phosphodiesterase%2520I%2520%2528TDP1%2529%2520inhibitors%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2015%26volume%3D58%26spage%3D3188%26epage%3D3208%26doi%3D10.1021%2Facs.jmedchem.5b00136" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref56"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref56'); return false;" data-citation="" class="refNumLink">56</a></strong><div class="NLM_citation" id="cit56"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Wang, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Elsayed, M. S. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Plescia, C. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ravji, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Redon, C. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kiselev, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Marchand, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zeleznik, O.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Agama, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pommier, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cushman, M.</span></span> <span> </span><span class="NLM_article-title">Synthesis and biological evaluation of the first triple inhibitors of human topoisomerase 1, tyrosyl-DNA phosphodiesterase 1 (Tdp1), and tyrosyl-DNA phosphodiesterase 2 (Tdp2)</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>60</i></span>,  <span class="NLM_fpage">3275</span>– <span class="NLM_lpage">3288</span>, <span class="refDoi"> DOI: 10.1021/acs.jmedchem.6b01565</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acs.jmedchem.6b01565" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref56/cit56&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00639&amp;key=1%3ACAS%3A528%3ADC%252BC2sXmtV2ksLg%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=60&publication_year=2017&pages=3275-3288&author=P.+Wangauthor=M.+S.+A.+Elsayedauthor=C.+B.+Plesciaauthor=A.+Ravjiauthor=C.+E.+Redonauthor=E.+Kiselevauthor=C.+Marchandauthor=O.+Zeleznikauthor=K.+Agamaauthor=Y.+Pommierauthor=M.+Cushman&title=Synthesis+and+biological+evaluation+of+the+first+triple+inhibitors+of+human+topoisomerase+1%2C+tyrosyl-DNA+phosphodiesterase+1+%28Tdp1%29%2C+and+tyrosyl-DNA+phosphodiesterase+2+%28Tdp2%29&doi=10.1021%2Facs.jmedchem.6b01565"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit56R"><div class="casContent"><span class="casTitleNuber">56</span><div class="casTitle"><span class="NLM_cas:atitle">Synthesis and Biological Evaluation of the First Triple Inhibitors of Human Topoisomerase 1, Tyrosyl-DNA Phosphodiesterase 1 (Tdp1), and Tyrosyl-DNA Phosphodiesterase 2 (Tdp2)</span></div><div class="casAuthors">Wang, Ping; Elsayed, Mohamed S. A.; Plescia, Caroline B.; Ravji, Azhar; Redon, Christophe E.; Kiselev, Evgeny; Marchand, Christophe; Zeleznik, Olga; Agama, Keli; Pommier, Yves; Cushman, Mark</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">60</span>
        (<span class="NLM_cas:issue">8</span>),
    <span class="NLM_cas:pages">3275-3288</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Tdp1 and Tdp2 are two tyrosyl-DNA phosphodiesterases that can repair damaged DNA resulting from topoisomerase inhibitors and a variety of other DNA-damaging agents.  Both Tdp1 and Tdp2 inhibition could hypothetically potentiate the cytotoxicities of topoisomerase inhibitors.  This study reports the successful structure-based design and synthesis of new 7-azaindenoisoquinolines I that act as triple inhibitors of Top1, Tdp1, and Tdp2.  Enzyme inhibitory data and cytotoxicity data from human cancer cell cultures establish that modification of the lactam side chain of the 7-azaindenoisoquinolines can modulate their inhibitory potencies and selectivities vs. Top1, Tdp1, and Tdp2.  Mol. modeling of selected target compds. bound to Top1, Tdp1, and Tdp2 was used to design the inhibitors and facilitate the structure-activity relation anal.  The monitoring of DNA damage by γ-H2AX foci formation in human PBMCs (lymphocytes) and acute lymphoblastic leukemia CCRF-CEM cells documented significantly more DNA damage in the cancer cells vs. normal cells.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrqwZT0U9BVo7Vg90H21EOLACvtfcHk0liiEnUu7Ttq7w"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2sXmtV2ksLg%253D&md5=f7007ee2a9fc0423efdbf791f4550f57</span></div><a href="/servlet/linkout?suffix=cit56&amp;dbid=16384&amp;doi=10.1021%2Facs.jmedchem.6b01565&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facs.jmedchem.6b01565%26sid%3Dliteratum%253Aachs%26aulast%3DWang%26aufirst%3DP.%26aulast%3DElsayed%26aufirst%3DM.%2BS.%2BA.%26aulast%3DPlescia%26aufirst%3DC.%2BB.%26aulast%3DRavji%26aufirst%3DA.%26aulast%3DRedon%26aufirst%3DC.%2BE.%26aulast%3DKiselev%26aufirst%3DE.%26aulast%3DMarchand%26aufirst%3DC.%26aulast%3DZeleznik%26aufirst%3DO.%26aulast%3DAgama%26aufirst%3DK.%26aulast%3DPommier%26aufirst%3DY.%26aulast%3DCushman%26aufirst%3DM.%26atitle%3DSynthesis%2520and%2520biological%2520evaluation%2520of%2520the%2520first%2520triple%2520inhibitors%2520of%2520human%2520topoisomerase%25201%252C%2520tyrosyl-DNA%2520phosphodiesterase%25201%2520%2528Tdp1%2529%252C%2520and%2520tyrosyl-DNA%2520phosphodiesterase%25202%2520%2528Tdp2%2529%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2017%26volume%3D60%26spage%3D3275%26epage%3D3288%26doi%3D10.1021%2Facs.jmedchem.6b01565" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref57"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref57'); return false;" data-citation="" class="refNumLink">57</a></strong><div class="NLM_citation" id="cit57"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Rodrigues, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Reker, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schneider, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schneider, G.</span></span> <span> </span><span class="NLM_article-title">Counting on natural products for drug design</span>. <i>Nat. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>8</i></span>,  <span class="NLM_fpage">531</span>– <span class="NLM_lpage">541</span>, <span class="refDoi"> DOI: 10.1038/nchem.2479</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref57/cit57&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00639&amp;key=10.1038%2Fnchem.2479" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref57/cit57&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00639&amp;key=27219696" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref57/cit57&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00639&amp;key=1%3ACAS%3A528%3ADC%252BC28XmslSrsbk%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=8&publication_year=2016&pages=531-541&author=T.+Rodriguesauthor=D.+Rekerauthor=P.+Schneiderauthor=G.+Schneider&title=Counting+on+natural+products+for+drug+design&doi=10.1038%2Fnchem.2479"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit57R"><div class="casContent"><span class="casTitleNuber">57</span><div class="casTitle"><span class="NLM_cas:atitle">Counting on natural products for drug design</span></div><div class="casAuthors">Rodrigues, Tiago; Reker, Daniel; Schneider, Petra; Schneider, Gisbert</div><div class="citationInfo"><span class="NLM_cas:title">Nature Chemistry</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">8</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">531-541</span>CODEN:
                <span class="NLM_cas:coden">NCAHBB</span>;
        ISSN:<span class="NLM_cas:issn">1755-4330</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">A review.  Natural products and their mol. frameworks have a long tradition as valuable starting points for medicinal chem. and drug discovery.  Recently, there has been a revitalization of interest in the inclusion of these chemotypes in compd. collections for screening and achieving selective target modulation.  Here the authors discuss natural-product-inspired drug discovery with a focus on recent advances in the design of synthetically tractable small mols. that mimic nature's chem.  The authors highlight the potential of innovative computational tools in processing structurally complex natural products to predict their macromol. targets and attempt to forecast the role that natural-product-derived fragments and fragment-like natural products will play in next-generation drug discovery.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrNR16z66-NgLVg90H21EOLACvtfcHk0liiEnUu7Ttq7w"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28XmslSrsbk%253D&md5=3f6391192d648de2a54524afafd6203a</span></div><a href="/servlet/linkout?suffix=cit57&amp;dbid=16384&amp;doi=10.1038%2Fnchem.2479&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnchem.2479%26sid%3Dliteratum%253Aachs%26aulast%3DRodrigues%26aufirst%3DT.%26aulast%3DReker%26aufirst%3DD.%26aulast%3DSchneider%26aufirst%3DP.%26aulast%3DSchneider%26aufirst%3DG.%26atitle%3DCounting%2520on%2520natural%2520products%2520for%2520drug%2520design%26jtitle%3DNat.%2520Chem.%26date%3D2016%26volume%3D8%26spage%3D531%26epage%3D541%26doi%3D10.1038%2Fnchem.2479" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref58"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref58'); return false;" data-citation="" class="refNumLink">58</a></strong><div class="NLM_citation" id="cit58"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Xiao, Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Morris-Natschke, S. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lee, K. H.</span></span> <span> </span><span class="NLM_article-title">Strategies for the optimization of natural leads to anticancer drugs or drug candidates</span>. <i>Med. Res. Rev.</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>36</i></span>,  <span class="NLM_fpage">32</span>– <span class="NLM_lpage">91</span>, <span class="refDoi"> DOI: 10.1002/med.21377</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref58/cit58&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00639&amp;key=10.1002%2Fmed.21377" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref58/cit58&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00639&amp;key=26359649" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref58/cit58&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00639&amp;key=1%3ACAS%3A528%3ADC%252BC2MXitVagsb%252FJ" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=36&publication_year=2016&pages=32-91&author=Z.+Xiaoauthor=S.+L.+Morris-Natschkeauthor=K.+H.+Lee&title=Strategies+for+the+optimization+of+natural+leads+to+anticancer+drugs+or+drug+candidates&doi=10.1002%2Fmed.21377"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit58R"><div class="casContent"><span class="casTitleNuber">58</span><div class="casTitle"><span class="NLM_cas:atitle">Strategies for the Optimization of Natural Leads to Anticancer Drugs or Drug Candidates</span></div><div class="casAuthors">Xiao, Zhiyan; Morris-Natschke, Susan L.; Lee, Kuo-Hsiung</div><div class="citationInfo"><span class="NLM_cas:title">Medicinal Research Reviews</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">36</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">32-91</span>CODEN:
                <span class="NLM_cas:coden">MRREDD</span>;
        ISSN:<span class="NLM_cas:issn">0198-6325</span>.
    
            (<span class="NLM_cas:orgname">John Wiley & Sons, Inc.</span>)
        </div><div class="casAbstract">A review.  Natural products have made significant contribution to cancer chemotherapy over the past decades and remain an indispensable source of mol. and mechanistic diversity for anticancer drug discovery.  More often than not, natural products may serve as leads for further drug development rather than as effective anticancer drugs by themselves.  Generally, optimization of natural leads into anticancer drugs or drug candidates should not only address drug efficacy, but also improve absorption, distribution, metab., excretion, and toxicity (ADMET) profiles and chem. accessibility assocd. with the natural leads.  Optimization strategies involve direct chem. manipulation of functional groups, structure-activity relationship directed optimization and pharmacophore-oriented mol. design based on the natural templates.  Both fundamental medicinal chem. principles (e.g., bioisosterism) and state-of-the-art computer-aided drug design techniques (e.g., structure-based design) can be applied to facilitate optimization efforts.  In this review, the strategies to optimize natural leads to anticancer drugs or drug candidates are illustrated with examples and described according to their purposes.  Furthermore, successful case studies on lead optimization of bioactive compds. performed in the Natural Products Research Labs. at UNC are highlighted.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGo6SGKXSp6ip7Vg90H21EOLACvtfcHk0lg5_EPIYK3JOQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXitVagsb%252FJ&md5=dc8c68d23f1f8e9ff6e98847a69558c4</span></div><a href="/servlet/linkout?suffix=cit58&amp;dbid=16384&amp;doi=10.1002%2Fmed.21377&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fmed.21377%26sid%3Dliteratum%253Aachs%26aulast%3DXiao%26aufirst%3DZ.%26aulast%3DMorris-Natschke%26aufirst%3DS.%2BL.%26aulast%3DLee%26aufirst%3DK.%2BH.%26atitle%3DStrategies%2520for%2520the%2520optimization%2520of%2520natural%2520leads%2520to%2520anticancer%2520drugs%2520or%2520drug%2520candidates%26jtitle%3DMed.%2520Res.%2520Rev.%26date%3D2016%26volume%3D36%26spage%3D32%26epage%3D91%26doi%3D10.1002%2Fmed.21377" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref59"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref59'); return false;" data-citation="" class="refNumLink">59</a></strong><div class="NLM_citation" id="cit59"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Qin, X. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yu, Q.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yan, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Khan, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Feng, M. Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, P. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hao, X. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">An, L. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liu, H. Y.</span></span> <span> </span><span class="NLM_article-title">Meroterpenoids with antitumor activities from guava (Psidium guajava)</span>. <i>J. Agric. Food Chem.</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>65</i></span>,  <span class="NLM_fpage">4993</span>– <span class="NLM_lpage">4999</span>, <span class="refDoi"> DOI: 10.1021/acs.jafc.7b01762</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acs.jafc.7b01762" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref59/cit59&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00639&amp;key=1%3ACAS%3A528%3ADC%252BC2sXptFeltbo%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=65&publication_year=2017&pages=4993-4999&author=X.+J.+Qinauthor=Q.+Yuauthor=H.+Yanauthor=A.+Khanauthor=M.+Y.+Fengauthor=P.+P.+Liauthor=X.+J.+Haoauthor=L.+K.+Anauthor=H.+Y.+Liu&title=Meroterpenoids+with+antitumor+activities+from+guava+%28Psidium+guajava%29&doi=10.1021%2Facs.jafc.7b01762"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit59R"><div class="casContent"><span class="casTitleNuber">59</span><div class="casTitle"><span class="NLM_cas:atitle">Meroterpenoids with Antitumor Activities from Guava (Psidium guajava)</span></div><div class="casAuthors">Qin, Xu-Jie; Yu, Qian; Yan, Huan; Khan, Afsar; Feng, Mi-Yan; Li, Pan-Pan; Hao, Xiao-Jiang; An, Lin-Kun; Liu, Hai-Yang</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Agricultural and Food Chemistry</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">65</span>
        (<span class="NLM_cas:issue">24</span>),
    <span class="NLM_cas:pages">4993-4999</span>CODEN:
                <span class="NLM_cas:coden">JAFCAU</span>;
        ISSN:<span class="NLM_cas:issn">0021-8561</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Psidium guajava L., a species native to South America, has been widely cultivated in the tropical and subtropical areas of China for its popular fruits.  The preliminary anal. by liq. chromatog.-UV (LC-UV) indicated the presence of meroterpenoids in the fruits of P. guajava (guava).  Subsequent fractionation of the petroleum ether ext. resulted in the identification of two new meroterpenoids, psiguajavadials A (I) and B (II), together with 14 previously described meroterpenoids.  Their structures were fully elucidated by comprehensive spectroscopic techniques and theor. calcns.  All of the meroterpenoids showed cytotoxicities against five human cancer cell lines, with guajadial B (12) being the most effective having an IC50 value of 150 nM toward A549 cells.  Furthermore, biochem. topoisomerase I (Top1) assay revealed that psiguajavadial A, psiguajavadial B, guajadial B, guajadial C, and guajadial F acted as Top1 catalytic inhibitors and delayed Top1 poison-mediated DNA damage.  The flow cytometric anal. indicated that the new meroterpenoids psiguajavadials A and B could induce apoptosis of HCT116 cells.  These data suggest that meroterpenoids from guava fruit could be used for the development of antitumor agents.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqUPHFiIaUiGbVg90H21EOLACvtfcHk0lg5_EPIYK3JOQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2sXptFeltbo%253D&md5=27cebbe906a3a057a83dfe1e54bfcc89</span></div><a href="/servlet/linkout?suffix=cit59&amp;dbid=16384&amp;doi=10.1021%2Facs.jafc.7b01762&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facs.jafc.7b01762%26sid%3Dliteratum%253Aachs%26aulast%3DQin%26aufirst%3DX.%2BJ.%26aulast%3DYu%26aufirst%3DQ.%26aulast%3DYan%26aufirst%3DH.%26aulast%3DKhan%26aufirst%3DA.%26aulast%3DFeng%26aufirst%3DM.%2BY.%26aulast%3DLi%26aufirst%3DP.%2BP.%26aulast%3DHao%26aufirst%3DX.%2BJ.%26aulast%3DAn%26aufirst%3DL.%2BK.%26aulast%3DLiu%26aufirst%3DH.%2BY.%26atitle%3DMeroterpenoids%2520with%2520antitumor%2520activities%2520from%2520guava%2520%2528Psidium%2520guajava%2529%26jtitle%3DJ.%2520Agric.%2520Food%2520Chem.%26date%3D2017%26volume%3D65%26spage%3D4993%26epage%3D4999%26doi%3D10.1021%2Facs.jafc.7b01762" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref60"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref60'); return false;" data-citation="" class="refNumLink">60</a></strong><div class="NLM_citation" id="cit60"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Wu, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wu, X. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Agama, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pommier, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Du, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gu, L. Q.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Huang, Z. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">An, L. K.</span></span> <span> </span><span class="NLM_article-title">A novel DNA topoisomerase I inhibitor with different mechanism from camptothecin induces G2/M phase cell cycle arrest to K562 cells</span>. <i>Biochemistry</i> <span class="NLM_year" style="font-weight: bold;">2010</span>,  <span class="NLM_volume"><i>49</i></span>,  <span class="NLM_fpage">10131</span>– <span class="NLM_lpage">10136</span>, <span class="refDoi"> DOI: 10.1021/bi1009419</span> </span><div class="citationLinks">[<a href="/doi/10.1021/bi1009419" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=49&publication_year=2010&pages=10131-10136&author=N.+Wuauthor=X.+W.+Wuauthor=K.+Agamaauthor=Y.+Pommierauthor=J.+Duauthor=D.+Liauthor=L.+Q.+Guauthor=Z.+S.+Huangauthor=L.+K.+An&title=A+novel+DNA+topoisomerase+I+inhibitor+with+different+mechanism+from+camptothecin+induces+G2%2FM+phase+cell+cycle+arrest+to+K562+cells&doi=10.1021%2Fbi1009419"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit60&amp;dbid=16384&amp;doi=10.1021%2Fbi1009419&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fbi1009419%26sid%3Dliteratum%253Aachs%26aulast%3DWu%26aufirst%3DN.%26aulast%3DWu%26aufirst%3DX.%2BW.%26aulast%3DAgama%26aufirst%3DK.%26aulast%3DPommier%26aufirst%3DY.%26aulast%3DDu%26aufirst%3DJ.%26aulast%3DLi%26aufirst%3DD.%26aulast%3DGu%26aufirst%3DL.%2BQ.%26aulast%3DHuang%26aufirst%3DZ.%2BS.%26aulast%3DAn%26aufirst%3DL.%2BK.%26atitle%3DA%2520novel%2520DNA%2520topoisomerase%2520I%2520inhibitor%2520with%2520different%2520mechanism%2520from%2520camptothecin%2520induces%2520G2%252FM%2520phase%2520cell%2520cycle%2520arrest%2520to%2520K562%2520cells%26jtitle%3DBiochemistry%26date%3D2010%26volume%3D49%26spage%3D10131%26epage%3D10136%26doi%3D10.1021%2Fbi1009419" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref61"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref61'); return false;" data-citation="" class="refNumLink">61</a></strong><div class="NLM_citation" id="cit61"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Wang, L. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Johnson, R. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hecht, S. M.</span></span> <span> </span><span class="NLM_article-title">Inhibition of topoisomerase I function by nitidine and fagaronine</span>. <i>Chem. Res. Toxicol.</i> <span class="NLM_year" style="font-weight: bold;">1993</span>,  <span class="NLM_volume"><i>6</i></span>,  <span class="NLM_fpage">813</span>– <span class="NLM_lpage">818</span>, <span class="refDoi"> DOI: 10.1021/tx00036a010</span> </span><div class="citationLinks">[<a href="/doi/10.1021/tx00036a010" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=6&publication_year=1993&pages=813-818&author=L.+K.+Wangauthor=R.+K.+Johnsonauthor=S.+M.+Hecht&title=Inhibition+of+topoisomerase+I+function+by+nitidine+and+fagaronine&doi=10.1021%2Ftx00036a010"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit61&amp;dbid=16384&amp;doi=10.1021%2Ftx00036a010&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Ftx00036a010%26sid%3Dliteratum%253Aachs%26aulast%3DWang%26aufirst%3DL.%2BK.%26aulast%3DJohnson%26aufirst%3DR.%2BK.%26aulast%3DHecht%26aufirst%3DS.%2BM.%26atitle%3DInhibition%2520of%2520topoisomerase%2520I%2520function%2520by%2520nitidine%2520and%2520fagaronine%26jtitle%3DChem.%2520Res.%2520Toxicol.%26date%3D1993%26volume%3D6%26spage%3D813%26epage%3D818%26doi%3D10.1021%2Ftx00036a010" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref62"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref62'); return false;" data-citation="" class="refNumLink">62</a></strong><div class="NLM_citation" id="cit62"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Holden, J. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wall, M. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wani, M. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Manikumar, G.</span></span> <span> </span><span class="NLM_article-title">Human DNA topoisomerase I: quantitative analysis of the effects of camptothecin analogs and the benzophenanthridine alkaloids nitidine and 6-ethoxydihydronitidine on DNA topoisomerase I-induced DNA strand breakage</span>. <i>Arch. Biochem. Biophys.</i> <span class="NLM_year" style="font-weight: bold;">1999</span>,  <span class="NLM_volume"><i>370</i></span>,  <span class="NLM_fpage">66</span>– <span class="NLM_lpage">76</span>, <span class="refDoi"> DOI: 10.1006/abbi.1999.1355</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref62/cit62&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00639&amp;key=10.1006%2Fabbi.1999.1355" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=370&publication_year=1999&pages=66-76&author=J.+A.+Holdenauthor=M.+E.+Wallauthor=M.+C.+Waniauthor=G.+Manikumar&title=Human+DNA+topoisomerase+I%3A+quantitative+analysis+of+the+effects+of+camptothecin+analogs+and+the+benzophenanthridine+alkaloids+nitidine+and+6-ethoxydihydronitidine+on+DNA+topoisomerase+I-induced+DNA+strand+breakage&doi=10.1006%2Fabbi.1999.1355"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit62&amp;dbid=16384&amp;doi=10.1006%2Fabbi.1999.1355&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1006%252Fabbi.1999.1355%26sid%3Dliteratum%253Aachs%26aulast%3DHolden%26aufirst%3DJ.%2BA.%26aulast%3DWall%26aufirst%3DM.%2BE.%26aulast%3DWani%26aufirst%3DM.%2BC.%26aulast%3DManikumar%26aufirst%3DG.%26atitle%3DHuman%2520DNA%2520topoisomerase%2520I%253A%2520quantitative%2520analysis%2520of%2520the%2520effects%2520of%2520camptothecin%2520analogs%2520and%2520the%2520benzophenanthridine%2520alkaloids%2520nitidine%2520and%25206-ethoxydihydronitidine%2520on%2520DNA%2520topoisomerase%2520I-induced%2520DNA%2520strand%2520breakage%26jtitle%3DArch.%2520Biochem.%2520Biophys.%26date%3D1999%26volume%3D370%26spage%3D66%26epage%3D76%26doi%3D10.1006%2Fabbi.1999.1355" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref63"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref63'); return false;" data-citation="" class="refNumLink">63</a></strong><div class="NLM_citation" id="cit63"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Bai, L. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhao, Z. Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cai, Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jiang, Z. H.</span></span> <span> </span><span class="NLM_article-title">DNA-binding affinities and sequence selectivity of quaternary benzophenanthridine alkaloids sanguinarine, chelerythrine, and nitidine</span>. <i>Bioorg. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2006</span>,  <span class="NLM_volume"><i>14</i></span>,  <span class="NLM_fpage">5439</span>– <span class="NLM_lpage">5445</span>, <span class="refDoi"> DOI: 10.1016/j.bmc.2006.05.012</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref63/cit63&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00639&amp;key=10.1016%2Fj.bmc.2006.05.012" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=14&publication_year=2006&pages=5439-5445&author=L.+P.+Baiauthor=Z.+Z.+Zhaoauthor=Z.+Caiauthor=Z.+H.+Jiang&title=DNA-binding+affinities+and+sequence+selectivity+of+quaternary+benzophenanthridine+alkaloids+sanguinarine%2C+chelerythrine%2C+and+nitidine&doi=10.1016%2Fj.bmc.2006.05.012"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit63&amp;dbid=16384&amp;doi=10.1016%2Fj.bmc.2006.05.012&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmc.2006.05.012%26sid%3Dliteratum%253Aachs%26aulast%3DBai%26aufirst%3DL.%2BP.%26aulast%3DZhao%26aufirst%3DZ.%2BZ.%26aulast%3DCai%26aufirst%3DZ.%26aulast%3DJiang%26aufirst%3DZ.%2BH.%26atitle%3DDNA-binding%2520affinities%2520and%2520sequence%2520selectivity%2520of%2520quaternary%2520benzophenanthridine%2520alkaloids%2520sanguinarine%252C%2520chelerythrine%252C%2520and%2520nitidine%26jtitle%3DBioorg.%2520Med.%2520Chem.%26date%3D2006%26volume%3D14%26spage%3D5439%26epage%3D5445%26doi%3D10.1016%2Fj.bmc.2006.05.012" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref64"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref64'); return false;" data-citation="" class="refNumLink">64</a></strong><div class="NLM_citation" id="cit64"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Kumar, C. V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Turner, R. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Asuncion, E. H.</span></span> <span> </span><span class="NLM_article-title">Groove binding of a styrylcyanine dye to the DNA double helix: the salt effect</span>. <i>J. Photochem. Photobiol., A</i> <span class="NLM_year" style="font-weight: bold;">1993</span>,  <span class="NLM_volume"><i>74</i></span>,  <span class="NLM_fpage">231</span>– <span class="NLM_lpage">238</span>, <span class="refDoi"> DOI: 10.1016/1010-6030(93)80121-O</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref64/cit64&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00639&amp;key=10.1016%2F1010-6030%2893%2980121-O" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref64/cit64&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00639&amp;key=1%3ACAS%3A528%3ADyaK3sXms1Gktr0%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=74&publication_year=1993&pages=231-238&author=C.+V.+Kumarauthor=R.+S.+Turnerauthor=E.+H.+Asuncion&title=Groove+binding+of+a+styrylcyanine+dye+to+the+DNA+double+helix%3A+the+salt+effect&doi=10.1016%2F1010-6030%2893%2980121-O"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit64R"><div class="casContent"><span class="casTitleNuber">64</span><div class="casTitle"><span class="NLM_cas:atitle">Groove binding of a styrylcyanine dye to the DNA double helix: the salt effect</span></div><div class="casAuthors">Kumar, C. V.; Turner, R. S.; Asuncion, E. H.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Photochemistry and Photobiology, A:  Chemistry</span>
        (<span class="NLM_cas:date">1993</span>),
    <span class="NLM_cas:volume">74</span>
        (<span class="NLM_cas:issue">2-3</span>),
    <span class="NLM_cas:pages">231-8</span>CODEN:
                <span class="NLM_cas:coden">JPPCEJ</span>;
        ISSN:<span class="NLM_cas:issn">1010-6030</span>.
    </div><div class="casAbstract">The cationic styryl dye DSMI binds to the double helical DNA with a high affinity.  A red shift of the absorption spectrum and hypochromism accompany the binding of DSMI to calf thymus DNA.  The fluorescence yields increase dramatically when DSMI binds to DNA, with no shifts in the emission max.  These spectral changes are in contrast to the behavior obsd. with many fluorescent intercalators.  Groove binding rather than intercalation of the dye was suggested to be the cause of these spectral changes, based on a variety of exptl. results.  Consistent with groove binding, the fluorescence enhancements were greater with poly(dA-dT) when compared with poly(dG-dC).  The addn. of salt or a strong electrolyte to the soln. releases the DNA-bound dye cations from the groove and causes a decrease in the fluorescence yield.  Therefore, when the dye binds to DNA, the fluorescence quenching with anionic quenchers was enhanced dramatically, in contrast to the expected protection of the probe fluorescence by the DNA helix.  Binding of DSMI to DNA inhibits the non-radiative deactivation of the excited state, perhaps owing to the restriction imposed by the narrow minor groove of the DNA.  The steric constraints imposed on the dye owing to the binding in the groove result in enhanced fluorescence yields and longer fluorescence lifetimes.  Since the lifetimes of the DNA-bound dye were still in the nanosecond range, it is very likely that groove binding of the dye permits twisting in the excited state, which may be important in the excited state dynamics of this class of dyes.  The large fluorescence enhancements obsd. when DSMI binds to the helix and the poor fluorescence yield of the dye in the absence of DNA suggests that DSMI should be quite useful in the staining of DNA gels and for the detection of very low concns. of DNA.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGp0G9PUHMDD4bVg90H21EOLACvtfcHk0ljN15gmtzWrRQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK3sXms1Gktr0%253D&md5=4c39dfcf313b5d98f127239385a6c711</span></div><a href="/servlet/linkout?suffix=cit64&amp;dbid=16384&amp;doi=10.1016%2F1010-6030%2893%2980121-O&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252F1010-6030%252893%252980121-O%26sid%3Dliteratum%253Aachs%26aulast%3DKumar%26aufirst%3DC.%2BV.%26aulast%3DTurner%26aufirst%3DR.%2BS.%26aulast%3DAsuncion%26aufirst%3DE.%2BH.%26atitle%3DGroove%2520binding%2520of%2520a%2520styrylcyanine%2520dye%2520to%2520the%2520DNA%2520double%2520helix%253A%2520the%2520salt%2520effect%26jtitle%3DJ.%2520Photochem.%2520Photobiol.%252C%2520A%26date%3D1993%26volume%3D74%26spage%3D231%26epage%3D238%26doi%3D10.1016%2F1010-6030%2893%2980121-O" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref65"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref65'); return false;" data-citation="" class="refNumLink">65</a></strong><div class="NLM_citation" id="cit65"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Tan, J.-H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ou, T.-M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hou, J.-Q.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lu, Y.-J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Huang, S.-L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Luo, H.-B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wu, J.-Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Huang, Z.-S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wong, K.-Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gu, L.-Q.</span></span> <span> </span><span class="NLM_article-title">Isaindigotone derivatives: a new class of highly selective ligands for telomeric G-quadruplex DNA</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2009</span>,  <span class="NLM_volume"><i>52</i></span>,  <span class="NLM_fpage">2825</span>– <span class="NLM_lpage">2835</span>, <span class="refDoi"> DOI: 10.1021/jm801600m</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm801600m" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref65/cit65&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00639&amp;key=1%3ACAS%3A528%3ADC%252BD1MXktF2gtb4%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=52&publication_year=2009&pages=2825-2835&author=J.-H.+Tanauthor=T.-M.+Ouauthor=J.-Q.+Houauthor=Y.-J.+Luauthor=S.-L.+Huangauthor=H.-B.+Luoauthor=J.-Y.+Wuauthor=Z.-S.+Huangauthor=K.-Y.+Wongauthor=L.-Q.+Gu&title=Isaindigotone+derivatives%3A+a+new+class+of+highly+selective+ligands+for+telomeric+G-quadruplex+DNA&doi=10.1021%2Fjm801600m"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit65R"><div class="casContent"><span class="casTitleNuber">65</span><div class="casTitle"><span class="NLM_cas:atitle">Isaindigotone Derivatives: A New Class of Highly Selective Ligands for Telomeric G-Quadruplex DNA</span></div><div class="casAuthors">Tan, Jia-Heng; Ou, Tian-Miao; Hou, Jin-Qiang; Lu, Yu-Jing; Huang, Shi-Liang; Luo, Hai-Bin; Wu, Jian-Yong; Huang, Zhi-Shu; Wong, Kwok-Yin; Gu, Lian-Quan</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">52</span>
        (<span class="NLM_cas:issue">9</span>),
    <span class="NLM_cas:pages">2825-2835</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Four isaindigotone derivs. designed as telomeric G-quadruplex ligands have been synthesized and characterized.  The unfused arom. rings in these compds. allow a flexible and adaptive conformation in G-quadruplex recognition.  The interaction of human telomeric G-quadruplex DNA with these designed ligands was explored by means of FRET melting, fluorescence titrn., CD spectroscopy, continuous variation, and mol. modeling studies.  Our results showed that the adaptive scaffold might not only allow the ligands to well occupy the G-quartet but also perfectly bind to the grooves of the G-quadruplex.  The synergetic effect of the multiple binding modes might be responsible for the improved binding ability and high selectivity of these ligands toward G-quadruplex over duplex DNA.  Long-term exposure of HL60 and CA46 cancer cells to compd. I showed a remarkable decrease in population growth, cellular senescence phenotype, and shortening of the telomere length, which is consistent with the behavior of an effective telomeric G-quadruplex ligand and telomerase inhibitor.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqOsJ3zOmz9PLVg90H21EOLACvtfcHk0ljN15gmtzWrRQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXktF2gtb4%253D&md5=bd333ba813b3afc4d9ea89ca0925ed3d</span></div><a href="/servlet/linkout?suffix=cit65&amp;dbid=16384&amp;doi=10.1021%2Fjm801600m&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm801600m%26sid%3Dliteratum%253Aachs%26aulast%3DTan%26aufirst%3DJ.-H.%26aulast%3DOu%26aufirst%3DT.-M.%26aulast%3DHou%26aufirst%3DJ.-Q.%26aulast%3DLu%26aufirst%3DY.-J.%26aulast%3DHuang%26aufirst%3DS.-L.%26aulast%3DLuo%26aufirst%3DH.-B.%26aulast%3DWu%26aufirst%3DJ.-Y.%26aulast%3DHuang%26aufirst%3DZ.-S.%26aulast%3DWong%26aufirst%3DK.-Y.%26aulast%3DGu%26aufirst%3DL.-Q.%26atitle%3DIsaindigotone%2520derivatives%253A%2520a%2520new%2520class%2520of%2520highly%2520selective%2520ligands%2520for%2520telomeric%2520G-quadruplex%2520DNA%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2009%26volume%3D52%26spage%3D2825%26epage%3D2835%26doi%3D10.1021%2Fjm801600m" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref66"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref66'); return false;" data-citation="" class="refNumLink">66</a></strong><div class="NLM_citation" id="cit66"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Korivi, R. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cheng, C. H.</span></span> <span> </span><span class="NLM_article-title">Protecting-group-free total synthesis of isoquinoline alkaloids by nickel-catalyzed annulation of o-halobenzaldimine with an alkyne as the key step</span>. <i>Chem. - Eur. J.</i> <span class="NLM_year" style="font-weight: bold;">2010</span>,  <span class="NLM_volume"><i>16</i></span>,  <span class="NLM_fpage">282</span>– <span class="NLM_lpage">287</span>, <span class="refDoi"> DOI: 10.1002/chem.200902275</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref66/cit66&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00639&amp;key=10.1002%2Fchem.200902275" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref66/cit66&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00639&amp;key=19904781" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref66/cit66&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00639&amp;key=1%3ACAS%3A528%3ADC%252BD1MXhs1WksLvL" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=16&publication_year=2010&pages=282-287&author=R.+P.+Koriviauthor=C.+H.+Cheng&title=Protecting-group-free+total+synthesis+of+isoquinoline+alkaloids+by+nickel-catalyzed+annulation+of+o-halobenzaldimine+with+an+alkyne+as+the+key+step&doi=10.1002%2Fchem.200902275"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit66R"><div class="casContent"><span class="casTitleNuber">66</span><div class="casTitle"><span class="NLM_cas:atitle">Protecting-Group-Free Total Synthesis of Isoquinoline Alkaloids by Nickel-Catalyzed Annulation of o-Halobenzaldimine with an Alkyne as the Key Step</span></div><div class="casAuthors">Korivi, Rajendra Prasad; Cheng, Chien-Hong</div><div class="citationInfo"><span class="NLM_cas:title">Chemistry - A European Journal</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">16</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">282-287, S282/1-S282/30</span>CODEN:
                <span class="NLM_cas:coden">CEUJED</span>;
        ISSN:<span class="NLM_cas:issn">0947-6539</span>.
    
            (<span class="NLM_cas:orgname">Wiley-VCH Verlag GmbH & Co. KGaA</span>)
        </div><div class="casAbstract">An efficient short total synthesis of benzo[c]phenanthridine alkaloids including oxyavicine (I), oxynitidine (II), and oxysanguinarine (III) is described.  Thus, N-methyl-o-bromobenzaldimines undergo regioselective cyclization with 4-(benzo[d][1,3]dioxol-5-yl)but-3-yn-1-ol in the presence of [Ni(cod)2] (cod=1,5-cyclooctadiene).  In situ oxidn. of the resultant isoquinolinium salts gives isoquinolinone derivs. with benzo[d][1,3]dioxol-5-yl substitution at the C3 atom and a (CH2)2OH group at the C4 atom.  Later, oxidn. of the alc. group in the isoquinolinone derivs. to the aldehyde moiety followed by acid-catalyzed cyclization and dehydration completes the total syntheses to give I, II and III in 67, 65, and 60% yields, resp.  The synthesis requires four steps from o-bromobenzaldehyde derivs.  Transformations of these alkaloids to the other alkaloids in this family are also discussed herein.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoTyBinXqeEKrVg90H21EOLACvtfcHk0ljN15gmtzWrRQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXhs1WksLvL&md5=54c0314b0b23dd14a814a26264ee0183</span></div><a href="/servlet/linkout?suffix=cit66&amp;dbid=16384&amp;doi=10.1002%2Fchem.200902275&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fchem.200902275%26sid%3Dliteratum%253Aachs%26aulast%3DKorivi%26aufirst%3DR.%2BP.%26aulast%3DCheng%26aufirst%3DC.%2BH.%26atitle%3DProtecting-group-free%2520total%2520synthesis%2520of%2520isoquinoline%2520alkaloids%2520by%2520nickel-catalyzed%2520annulation%2520of%2520o-halobenzaldimine%2520with%2520an%2520alkyne%2520as%2520the%2520key%2520step%26jtitle%3DChem.%2520-%2520Eur.%2520J.%26date%3D2010%26volume%3D16%26spage%3D282%26epage%3D287%26doi%3D10.1002%2Fchem.200902275" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref67"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref67'); return false;" data-citation="" class="refNumLink">67</a></strong><div class="NLM_citation" id="cit67"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Liu, C. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Korivi, R. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cheng, C. H.</span></span> <span> </span><span class="NLM_article-title">Cobalt-catalyzed regioselective synthesis of indenamine from o-iodobenzaldimine and alkyne: intriguing difference to the nickel-catalyzed reaction</span>. <i>Chem. - Eur. J.</i> <span class="NLM_year" style="font-weight: bold;">2008</span>,  <span class="NLM_volume"><i>14</i></span>,  <span class="NLM_fpage">9503</span>– <span class="NLM_lpage">9506</span>, <span class="refDoi"> DOI: 10.1002/chem.200801457</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref67/cit67&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00639&amp;key=10.1002%2Fchem.200801457" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref67/cit67&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00639&amp;key=18810733" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref67/cit67&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00639&amp;key=1%3ACAS%3A528%3ADC%252BD1cXhsVSntb%252FF" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=14&publication_year=2008&pages=9503-9506&author=C.+C.+Liuauthor=R.+P.+Koriviauthor=C.+H.+Cheng&title=Cobalt-catalyzed+regioselective+synthesis+of+indenamine+from+o-iodobenzaldimine+and+alkyne%3A+intriguing+difference+to+the+nickel-catalyzed+reaction&doi=10.1002%2Fchem.200801457"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit67R"><div class="casContent"><span class="casTitleNuber">67</span><div class="casTitle"><span class="NLM_cas:atitle">Cobalt-catalyzed regioselective synthesis of indenamine from o-iodobenzaldimine and alkyne: intriguing difference to the nickel-catalyzed reaction</span></div><div class="casAuthors">Liu, Chuan-Che; Korivi, Rajendra Prasad; Cheng, Chien-Hong</div><div class="citationInfo"><span class="NLM_cas:title">Chemistry - A European Journal</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">14</span>
        (<span class="NLM_cas:issue">31</span>),
    <span class="NLM_cas:pages">9503-9506</span>CODEN:
                <span class="NLM_cas:coden">CEUJED</span>;
        ISSN:<span class="NLM_cas:issn">0947-6539</span>.
    
            (<span class="NLM_cas:orgname">Wiley-VCH Verlag GmbH & Co. KGaA</span>)
        </div><div class="casAbstract">In contrast to nickel- and palladium-catalyzed reactions, the cobalt-catalyzed reaction from from o-iodobenzaldimine and alkyne gave indenamine derivs. instead of isoquinoline derivs.  The difference of the regiochem. and product formation with respect to the nickel-catalyzed reaction was explained.  The indenamines are readily converted to the corresponding indenimines in the presence of tetrabutylammonium fluoride and can then be hydrolyzed to indenones.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGp1GKZvQYnLrLVg90H21EOLACvtfcHk0ljyVRRjPByLIw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXhsVSntb%252FF&md5=f9148261c9fd7c71f3e9dac54f969b72</span></div><a href="/servlet/linkout?suffix=cit67&amp;dbid=16384&amp;doi=10.1002%2Fchem.200801457&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fchem.200801457%26sid%3Dliteratum%253Aachs%26aulast%3DLiu%26aufirst%3DC.%2BC.%26aulast%3DKorivi%26aufirst%3DR.%2BP.%26aulast%3DCheng%26aufirst%3DC.%2BH.%26atitle%3DCobalt-catalyzed%2520regioselective%2520synthesis%2520of%2520indenamine%2520from%2520o-iodobenzaldimine%2520and%2520alkyne%253A%2520intriguing%2520difference%2520to%2520the%2520nickel-catalyzed%2520reaction%26jtitle%3DChem.%2520-%2520Eur.%2520J.%26date%3D2008%26volume%3D14%26spage%3D9503%26epage%3D9506%26doi%3D10.1002%2Fchem.200801457" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref68"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref68'); return false;" data-citation="" class="refNumLink">68</a></strong><div class="NLM_citation" id="cit68"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Omura, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sharma, A. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Swern, D.</span></span> <span> </span><span class="NLM_article-title">Dimethyl sulfoxide-trifltioroacetic anhydride: a new reagent for oxidation of alcohols to carbonyls</span>. <i>J. Org. Chem.</i> <span class="NLM_year" style="font-weight: bold;">1976</span>,  <span class="NLM_volume"><i>41</i></span>,  <span class="NLM_fpage">957</span>– <span class="NLM_lpage">962</span>, <span class="refDoi"> DOI: 10.1021/jo00868a012</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jo00868a012" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=41&publication_year=1976&pages=957-962&author=K.+Omuraauthor=A.+K.+Sharmaauthor=D.+Swern&title=Dimethyl+sulfoxide-trifltioroacetic+anhydride%3A+a+new+reagent+for+oxidation+of+alcohols+to+carbonyls&doi=10.1021%2Fjo00868a012"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit68&amp;dbid=16384&amp;doi=10.1021%2Fjo00868a012&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjo00868a012%26sid%3Dliteratum%253Aachs%26aulast%3DOmura%26aufirst%3DK.%26aulast%3DSharma%26aufirst%3DA.%2BK.%26aulast%3DSwern%26aufirst%3DD.%26atitle%3DDimethyl%2520sulfoxide-trifltioroacetic%2520anhydride%253A%2520a%2520new%2520reagent%2520for%2520oxidation%2520of%2520alcohols%2520to%2520carbonyls%26jtitle%3DJ.%2520Org.%2520Chem.%26date%3D1976%26volume%3D41%26spage%3D957%26epage%3D962%26doi%3D10.1021%2Fjo00868a012" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref69"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref69'); return false;" data-citation="" class="refNumLink">69</a></strong><div class="NLM_citation" id="cit69"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Kiselev, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">DeGuire, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Morrell, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Agama, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dexheimer, T. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pommier, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cushman, M.</span></span> <span> </span><span class="NLM_article-title">7-azaindenoisoquinolines as topoisomerase I inhibitors and potential anticancer agents</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2011</span>,  <span class="NLM_volume"><i>54</i></span>,  <span class="NLM_fpage">6106</span>– <span class="NLM_lpage">6116</span>, <span class="refDoi"> DOI: 10.1021/jm200719v</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm200719v" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref69/cit69&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00639&amp;key=1%3ACAS%3A528%3ADC%252BC3MXpvFSnsbg%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=54&publication_year=2011&pages=6106-6116&author=E.+Kiselevauthor=S.+DeGuireauthor=A.+Morrellauthor=K.+Agamaauthor=T.+S.+Dexheimerauthor=Y.+Pommierauthor=M.+Cushman&title=7-azaindenoisoquinolines+as+topoisomerase+I+inhibitors+and+potential+anticancer+agents&doi=10.1021%2Fjm200719v"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit69R"><div class="casContent"><span class="casTitleNuber">69</span><div class="casTitle"><span class="NLM_cas:atitle">7-Azaindenoisoquinolines as Topoisomerase I Inhibitors and Potential Anticancer Agents</span></div><div class="casAuthors">Kiselev, Evgeny; DeGuire, Sean; Morrell, Andrew; Agama, Keli; Dexheimer, Thomas S.; Pommier, Yves; Cushman, Mark</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">54</span>
        (<span class="NLM_cas:issue">17</span>),
    <span class="NLM_cas:pages">6106-6116</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">A series of 7-azaindenoisoquinoline topoisomerase I (Top1) inhibitors have been prepd. to investigate the effect of increased electron affinity of the arom. system on the ability to stabilize the Top1-DNA cleavage complex.  Ab initio calcns. suggest that introduction of nitrogen into the arom. system of the indenoisoquinolines would facilitate charge transfer complex formation with DNA, thus improving the π-π stacking interactions.  The present study shows that 7-azaindenoisoquinolines, e.g. I (R = Me2N, 1-imidazolyl, HOCH2CH2NH), demonstrate improved water soly. without any decrease in Top1 inhibitory activity or cytotoxicity.  Anal. of the biol. results reveals that smaller lactam ring substituents enable intercalation into both free DNA and Top1-DNA cleavage complex, whereas larger substituents only allow binding to the cleavage complex but not free DNA.  Free DNA binding suppresses Top1-catalyzed DNA cleavage at high drug concns., whereas DNA cleavage and inhibition of religation occurs at low drug concn.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqEwcEqjS2N5LVg90H21EOLACvtfcHk0lj5iSIwuqFEzQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXpvFSnsbg%253D&md5=23d9925cfecda6c6d636de85e348832f</span></div><a href="/servlet/linkout?suffix=cit69&amp;dbid=16384&amp;doi=10.1021%2Fjm200719v&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm200719v%26sid%3Dliteratum%253Aachs%26aulast%3DKiselev%26aufirst%3DE.%26aulast%3DDeGuire%26aufirst%3DS.%26aulast%3DMorrell%26aufirst%3DA.%26aulast%3DAgama%26aufirst%3DK.%26aulast%3DDexheimer%26aufirst%3DT.%2BS.%26aulast%3DPommier%26aufirst%3DY.%26aulast%3DCushman%26aufirst%3DM.%26atitle%3D7-azaindenoisoquinolines%2520as%2520topoisomerase%2520I%2520inhibitors%2520and%2520potential%2520anticancer%2520agents%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2011%26volume%3D54%26spage%3D6106%26epage%3D6116%26doi%3D10.1021%2Fjm200719v" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref70"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref70'); return false;" data-citation="" class="refNumLink">70</a></strong><div class="NLM_citation" id="cit70"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Kiselev, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sooryakumar, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Agama, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cushman, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pommier, Y.</span></span> <span> </span><span class="NLM_article-title">Optimization of the lactam side chain of 7-azaindenoisoquinoline topoisomerase I inhibitors and mechanism of action studies in cancer cells</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>57</i></span>,  <span class="NLM_fpage">1289</span>– <span class="NLM_lpage">1298</span>, <span class="refDoi"> DOI: 10.1021/jm401471v</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm401471v" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref70/cit70&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00639&amp;key=1%3ACAS%3A528%3ADC%252BC2cXitVartr8%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=57&publication_year=2014&pages=1289-1298&author=E.+Kiselevauthor=D.+Sooryakumarauthor=K.+Agamaauthor=M.+Cushmanauthor=Y.+Pommier&title=Optimization+of+the+lactam+side+chain+of+7-azaindenoisoquinoline+topoisomerase+I+inhibitors+and+mechanism+of+action+studies+in+cancer+cells&doi=10.1021%2Fjm401471v"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit70R"><div class="casContent"><span class="casTitleNuber">70</span><div class="casTitle"><span class="NLM_cas:atitle">Optimization of the Lactam Side Chain of 7-Azaindenoisoquinoline Topoisomerase I Inhibitors and Mechanism of Action Studies in Cancer Cells</span></div><div class="casAuthors">Kiselev, Evgeny; Sooryakumar, Dhriti; Agama, Keli; Cushman, Mark; Pommier, Yves</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">57</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">1289-1298</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Optimization of the lactam ω-aminoalkyl substituents in a series of 7-azaindenoisoquinolines resulted in new anticancer agents with improved Top1 inhibitory potencies and cancer cell cytotoxicities.  The new compds. 14-17 and 19 exhibited mean graph midpoint cytotoxicity (GI50) values of 21-71 nM in the NCI panel of 60 human cancer cell cultures.  Ternary 7-azaindenoisoquinoline-DNA-Top1 cleavage complexes that persist for up to 6 h were detected in HCT116 colon cancer cells.  Ternary complexes contg. 7-azaindenoisoquinolines were significantly more stable than those in which camptothecin was incorporated.  DNA content distribution histograms showed S-phase block 3 h after drug removal.  Drug-induced DNA damage in HCT116 cells was revealed by induction of the histone γ-H2AX marker.  The 7-azaindenoisoquinolines were able to partially overcome resistance in several drug-resistant cell lines, and they were not substrates for the ABCB1 drug efflux transporter.  Mol. modeling studies indicate that the 7-azaindenoisoquinolines intercalate at the DNA cleavage site in DNA-Top1 covalent complexes with the lactam side chain projecting into the major groove.  Overall, the results indicate that the 7-azaindenoisoquinolines are promising anticancer agents that merit further development.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrxOWg6LqPWqrVg90H21EOLACvtfcHk0lj5iSIwuqFEzQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXitVartr8%253D&md5=114c720750253fdaf4c80cd5ff1d743e</span></div><a href="/servlet/linkout?suffix=cit70&amp;dbid=16384&amp;doi=10.1021%2Fjm401471v&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm401471v%26sid%3Dliteratum%253Aachs%26aulast%3DKiselev%26aufirst%3DE.%26aulast%3DSooryakumar%26aufirst%3DD.%26aulast%3DAgama%26aufirst%3DK.%26aulast%3DCushman%26aufirst%3DM.%26aulast%3DPommier%26aufirst%3DY.%26atitle%3DOptimization%2520of%2520the%2520lactam%2520side%2520chain%2520of%25207-azaindenoisoquinoline%2520topoisomerase%2520I%2520inhibitors%2520and%2520mechanism%2520of%2520action%2520studies%2520in%2520cancer%2520cells%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2014%26volume%3D57%26spage%3D1289%26epage%3D1298%26doi%3D10.1021%2Fjm401471v" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref71"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref71'); return false;" data-citation="" class="refNumLink">71</a></strong><div class="NLM_citation" id="cit71"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Elsayed, M. S. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Su, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sethi, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Agama, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ravji, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Redon, C. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kiselev, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Horzmann, K. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Freeman, J. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pommier, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cushman, M.</span></span> <span> </span><span class="NLM_article-title">Design and synthesis of chlorinated and fluorinated 7-azaindenoisoquinolines as potent cytotoxic anticancer agents that inhibit topoisomerase I</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>60</i></span>,  <span class="NLM_fpage">5364</span>– <span class="NLM_lpage">5376</span>, <span class="refDoi"> DOI: 10.1021/acs.jmedchem.6b01870</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acs.jmedchem.6b01870" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref71/cit71&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00639&amp;key=1%3ACAS%3A528%3ADC%252BC2sXhtVKnur7O" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=60&publication_year=2017&pages=5364-5376&author=M.+S.+A.+Elsayedauthor=Y.+Suauthor=P.+Wangauthor=T.+Sethiauthor=K.+Agamaauthor=A.+Ravjiauthor=C.+E.+Redonauthor=E.+Kiselevauthor=K.+A.+Horzmannauthor=J.+L.+Freemanauthor=Y.+Pommierauthor=M.+Cushman&title=Design+and+synthesis+of+chlorinated+and+fluorinated+7-azaindenoisoquinolines+as+potent+cytotoxic+anticancer+agents+that+inhibit+topoisomerase+I&doi=10.1021%2Facs.jmedchem.6b01870"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit71R"><div class="casContent"><span class="casTitleNuber">71</span><div class="casTitle"><span class="NLM_cas:atitle">Design and Synthesis of Chlorinated and Fluorinated 7-Azaindenoisoquinolines as Potent Cytotoxic Anticancer Agents That Inhibit Topoisomerase I</span></div><div class="casAuthors">Elsayed, Mohamed S. A.; Su, Yafan; Wang, Ping; Sethi, Taresh; Agama, Keli; Ravji, Azhar; Redon, Christophe E.; Kiselev, Evgeny; Horzmann, Katharine A.; Freeman, Jennifer L.; Pommier, Yves; Cushman, Mark</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">60</span>
        (<span class="NLM_cas:issue">13</span>),
    <span class="NLM_cas:pages">5364-5376</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">The 7-azaindenoisoquinolines are cytotoxic topoisomerase I (Top1) inhibitors.  Previously reported representatives bear a 3-nitro group.  The present report documents the replacement of the potentially genotoxic 3-nitro group by 3-chloro and 3-fluoro substituents, resulting in compds. with high Top1 inhibitory activities and potent cytotoxicities in human cancer cell cultures and reduced lethality in an animal model.  Some of the new Top1 inhibitors also possess moderate inhibitory activities against tyrosyl-DNA phosphodiesterase 1 (TDP1) and tyrosyl-DNA phosphodiesterase 2 (TDP2), two enzymes that are involved in DNA damage repair resulting from Top1 inhibitors, and they produce significantly more DNA damage in cancer cells than in normal cells.  Eighteen of the new compds. had cytotoxicity mean-graph midpoint (MGM) GI50 values in the submicromolar (0.033-0.630 μM) range.  Compds. I and II are the most potent in human cancer cell cultures with MGM GI50 values of 0.063 and 0.033 μM, respectively.  Possible binding modes to Top1 and TDP1were investigated by mol. modeling.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqRgy6fIbq0FLVg90H21EOLACvtfcHk0lj5iSIwuqFEzQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2sXhtVKnur7O&md5=3b22f12a9b5483e5a28a3a6775ac4210</span></div><a href="/servlet/linkout?suffix=cit71&amp;dbid=16384&amp;doi=10.1021%2Facs.jmedchem.6b01870&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facs.jmedchem.6b01870%26sid%3Dliteratum%253Aachs%26aulast%3DElsayed%26aufirst%3DM.%2BS.%2BA.%26aulast%3DSu%26aufirst%3DY.%26aulast%3DWang%26aufirst%3DP.%26aulast%3DSethi%26aufirst%3DT.%26aulast%3DAgama%26aufirst%3DK.%26aulast%3DRavji%26aufirst%3DA.%26aulast%3DRedon%26aufirst%3DC.%2BE.%26aulast%3DKiselev%26aufirst%3DE.%26aulast%3DHorzmann%26aufirst%3DK.%2BA.%26aulast%3DFreeman%26aufirst%3DJ.%2BL.%26aulast%3DPommier%26aufirst%3DY.%26aulast%3DCushman%26aufirst%3DM.%26atitle%3DDesign%2520and%2520synthesis%2520of%2520chlorinated%2520and%2520fluorinated%25207-azaindenoisoquinolines%2520as%2520potent%2520cytotoxic%2520anticancer%2520agents%2520that%2520inhibit%2520topoisomerase%2520I%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2017%26volume%3D60%26spage%3D5364%26epage%3D5376%26doi%3D10.1021%2Facs.jmedchem.6b01870" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref72"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref72'); return false;" data-citation="" class="refNumLink">72</a></strong><div class="NLM_citation" id="cit72"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Janin, Y. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bisagni, E.</span></span> <span> </span><span class="NLM_article-title">A formal new access to the benzo[c]phenanthridine alkaloids, synthesis of nitidine and O-methyl fagaronine analogues</span>. <i>Tetrahedron</i> <span class="NLM_year" style="font-weight: bold;">1993</span>,  <span class="NLM_volume"><i>49</i></span>,  <span class="NLM_fpage">10305</span>– <span class="NLM_lpage">10316</span>, <span class="refDoi"> DOI: 10.1016/S0040-4020(01)80559-7</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref72/cit72&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00639&amp;key=10.1016%2FS0040-4020%2801%2980559-7" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=49&publication_year=1993&pages=10305-10316&author=Y.+L.+Janinauthor=E.+Bisagni&title=A+formal+new+access+to+the+benzo%5Bc%5Dphenanthridine+alkaloids%2C+synthesis+of+nitidine+and+O-methyl+fagaronine+analogues&doi=10.1016%2FS0040-4020%2801%2980559-7"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit72&amp;dbid=16384&amp;doi=10.1016%2FS0040-4020%2801%2980559-7&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS0040-4020%252801%252980559-7%26sid%3Dliteratum%253Aachs%26aulast%3DJanin%26aufirst%3DY.%2BL.%26aulast%3DBisagni%26aufirst%3DE.%26atitle%3DA%2520formal%2520new%2520access%2520to%2520the%2520benzo%255Bc%255Dphenanthridine%2520alkaloids%252C%2520synthesis%2520of%2520nitidine%2520and%2520O-methyl%2520fagaronine%2520analogues%26jtitle%3DTetrahedron%26date%3D1993%26volume%3D49%26spage%3D10305%26epage%3D10316%26doi%3D10.1016%2FS0040-4020%2801%2980559-7" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref73"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref73'); return false;" data-citation="" class="refNumLink">73</a></strong><div class="NLM_citation" id="cit73"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Dexheimer, T. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pommier, Y.</span></span> <span> </span><span class="NLM_article-title">DNA cleavage assay for the identification of topoisomerase I inhibitors</span>. <i>Nat. Protoc.</i> <span class="NLM_year" style="font-weight: bold;">2008</span>,  <span class="NLM_volume"><i>3</i></span>,  <span class="NLM_fpage">1736</span>– <span class="NLM_lpage">1750</span>, <span class="refDoi"> DOI: 10.1038/nprot.2008.174</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref73/cit73&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00639&amp;key=10.1038%2Fnprot.2008.174" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref73/cit73&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00639&amp;key=18927559" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref73/cit73&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00639&amp;key=1%3ACAS%3A528%3ADC%252BD1cXht1GgtLbO" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=3&publication_year=2008&pages=1736-1750&author=T.+S.+Dexheimerauthor=Y.+Pommier&title=DNA+cleavage+assay+for+the+identification+of+topoisomerase+I+inhibitors&doi=10.1038%2Fnprot.2008.174"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit73R"><div class="casContent"><span class="casTitleNuber">73</span><div class="casTitle"><span class="NLM_cas:atitle">DNA cleavage assay for the identification of topoisomerase I inhibitors</span></div><div class="casAuthors">Dexheimer, Thomas S.; Pommier, Yves</div><div class="citationInfo"><span class="NLM_cas:title">Nature Protocols</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">3</span>
        (<span class="NLM_cas:issue">11</span>),
    <span class="NLM_cas:pages">1736-1750</span>CODEN:
                <span class="NLM_cas:coden">NPARDW</span>;
        ISSN:<span class="NLM_cas:issn">1750-2799</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">A review.  The inhibition of DNA topoisomerase I (Top1) has proven to be a successful approach in the design of anticancer agents.  However, despite the clin. successes of the camptothecin derivs., a significant need for less toxic and more chem. stable Top1 inhibitors still persists.  Here, we describe one of the most frequently used protocols to identify novel Top1 inhibitors.  These methods use uniquely 3'-radiolabeled DNA substrates and denaturing polyacrylamide gel electrophoresis to provide evidence for the Top1-mediated DNA cleaving activity of potential Top1 inhibitors.  These assays allow comparison of the effectiveness of different drugs in stabilizing the Top1-DNA intermediate or cleavage (cleavable) complex.  A variation on these assays is also presented, which provides a suitable system for detg. whether the inhibitor blocks the forward cleavage or religation reactions by measuring the reversibility of the drug-induced Top1-DNA cleavage complexes.  This entire protocol can be completed in ∼2 d.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoVKYmp2bCwu7Vg90H21EOLACvtfcHk0ljtBgYdDBSUJg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXht1GgtLbO&md5=ad5aa65100610b358be19276bada5fbd</span></div><a href="/servlet/linkout?suffix=cit73&amp;dbid=16384&amp;doi=10.1038%2Fnprot.2008.174&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnprot.2008.174%26sid%3Dliteratum%253Aachs%26aulast%3DDexheimer%26aufirst%3DT.%2BS.%26aulast%3DPommier%26aufirst%3DY.%26atitle%3DDNA%2520cleavage%2520assay%2520for%2520the%2520identification%2520of%2520topoisomerase%2520I%2520inhibitors%26jtitle%3DNat.%2520Protoc.%26date%3D2008%26volume%3D3%26spage%3D1736%26epage%3D1750%26doi%3D10.1038%2Fnprot.2008.174" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref74"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref74'); return false;" data-citation="" class="refNumLink">74</a></strong><div class="NLM_citation" id="cit74"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Sooryakumar, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dexheimer, T. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Teicher, B. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pommier, Y.</span></span> <span> </span><span class="NLM_article-title">Molecular and cellular pharmacology of the novel noncamptothecin topoisomerase I inhibitor Genz-644282</span>. <i>Mol. Cancer Ther.</i> <span class="NLM_year" style="font-weight: bold;">2011</span>,  <span class="NLM_volume"><i>10</i></span>,  <span class="NLM_fpage">1490</span>– <span class="NLM_lpage">1499</span>, <span class="refDoi"> DOI: 10.1158/1535-7163.MCT-10-1043</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref74/cit74&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00639&amp;key=10.1158%2F1535-7163.MCT-10-1043" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref74/cit74&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00639&amp;key=21636699" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref74/cit74&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00639&amp;key=1%3ACAS%3A528%3ADC%252BC3MXhtFSqtLbE" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=10&publication_year=2011&pages=1490-1499&author=D.+Sooryakumarauthor=T.+S.+Dexheimerauthor=B.+A.+Teicherauthor=Y.+Pommier&title=Molecular+and+cellular+pharmacology+of+the+novel+noncamptothecin+topoisomerase+I+inhibitor+Genz-644282&doi=10.1158%2F1535-7163.MCT-10-1043"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit74R"><div class="casContent"><span class="casTitleNuber">74</span><div class="casTitle"><span class="NLM_cas:atitle">Molecular and cellular pharmacology of the novel noncamptothecin topoisomerase I inhibitor Genz-644282</span></div><div class="casAuthors">Sooryakumar, Dhriti; Dexheimer, Thomas S.; Teicher, Beverly A.; Pommier, Yves</div><div class="citationInfo"><span class="NLM_cas:title">Molecular Cancer Therapeutics</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">10</span>
        (<span class="NLM_cas:issue">8</span>),
    <span class="NLM_cas:pages">1490-1499</span>CODEN:
                <span class="NLM_cas:coden">MCTOCF</span>;
        ISSN:<span class="NLM_cas:issn">1535-7163</span>.
    
            (<span class="NLM_cas:orgname">American Association for Cancer Research</span>)
        </div><div class="casAbstract">Camptothecin derivs. are powerful anticancer drugs because of their ability to trap topoisomerase I (Top1)-DNA cleavage complexes.  However, they exhibit clin. limitations due to the instability of their α-hydroxylactone six-membered E-ring structure.  In addn., they exhibit bone marrow and intestinal toxicity, esp. in adults, and are drug efflux substrates.  Here, we report a novel Top1 inhibitor, Genz-644282.  We show that Genz-644282 and its metabolites induce Top1 cleavage at similar, as well as unique genomic positions, compared with camptothecin.  The compd. also induces protein-linked DNA breaks and Top1-DNA cleavage complexes that persist longer after compd. removal than camptothecin.  Concn.-dependent and persistent γH2AX formation was readily obsd. in cells treated with Genz-644282, and was present in greater than 50% of the cell population following 24 h compd. exposure.  The compd. shows partial cross-resistance in cell lines resistant to camptothecin.  These cell lines include the human prostate DU145RC0.1 and the leukemic CEM/C2 cells.  Limited cross-resistance to Genz-644282 was also found in the Top1 knockdown colon cancer (HCT116) and breast cancer (MCF7) cell lines and in human adenocarcinoma cells (KB31/KBV1) that overexpress (P-glycoprotein, ABCB1), a member of the ATP-binding cassette family of cell surface transport proteins known to confer MDR.  Together, our results provide the first mol. and cellular characterization of Genz-644282 and its clin. relevant metabolites.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr-rOnt_rP4X7Vg90H21EOLACvtfcHk0ljtBgYdDBSUJg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXhtFSqtLbE&md5=8f095f9c31d5f7fd987abc67777d4333</span></div><a href="/servlet/linkout?suffix=cit74&amp;dbid=16384&amp;doi=10.1158%2F1535-7163.MCT-10-1043&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1158%252F1535-7163.MCT-10-1043%26sid%3Dliteratum%253Aachs%26aulast%3DSooryakumar%26aufirst%3DD.%26aulast%3DDexheimer%26aufirst%3DT.%2BS.%26aulast%3DTeicher%26aufirst%3DB.%2BA.%26aulast%3DPommier%26aufirst%3DY.%26atitle%3DMolecular%2520and%2520cellular%2520pharmacology%2520of%2520the%2520novel%2520noncamptothecin%2520topoisomerase%2520I%2520inhibitor%2520Genz-644282%26jtitle%3DMol.%2520Cancer%2520Ther.%26date%3D2011%26volume%3D10%26spage%3D1490%26epage%3D1499%26doi%3D10.1158%2F1535-7163.MCT-10-1043" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref75"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref75'); return false;" data-citation="" class="refNumLink">75</a></strong><div class="NLM_citation" id="cit75"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Staker, B. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hjerrild, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Feese, M. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Behnke, C. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Burgin, A. B.,  Jr.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Stewart, L.</span></span> <span> </span><span class="NLM_article-title">The mechanism of topoisomerase I poisoning by a camptothecin analog</span>. <i>Proc. Natl. Acad. Sci. U. S. A.</i> <span class="NLM_year" style="font-weight: bold;">2002</span>,  <span class="NLM_volume"><i>99</i></span>,  <span class="NLM_fpage">15387</span>– <span class="NLM_lpage">15392</span>, <span class="refDoi"> DOI: 10.1073/pnas.242259599</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref75/cit75&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00639&amp;key=10.1073%2Fpnas.242259599" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref75/cit75&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00639&amp;key=12426403" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref75/cit75&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00639&amp;key=1%3ACAS%3A528%3ADC%252BD3sXjvVGh" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=99&publication_year=2002&pages=15387-15392&author=B.+L.+Stakerauthor=K.+Hjerrildauthor=M.+D.+Feeseauthor=C.+A.+Behnkeauthor=A.+B.+Burginauthor=L.+Stewart&title=The+mechanism+of+topoisomerase+I+poisoning+by+a+camptothecin+analog&doi=10.1073%2Fpnas.242259599"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit75R"><div class="casContent"><span class="casTitleNuber">75</span><div class="casTitle"><span class="NLM_cas:atitle">The mechanism of topoisomerase I poisoning by a camptothecin analog</span></div><div class="casAuthors">Staker, Bart L.; Hjerrild, Kathryn; Feese, Michael D.; Behnke, Craig A.; Burgin, Alex B., Jr.; Stewart, Lance</div><div class="citationInfo"><span class="NLM_cas:title">Proceedings of the National Academy of Sciences of the United States of America</span>
        (<span class="NLM_cas:date">2002</span>),
    <span class="NLM_cas:volume">99</span>
        (<span class="NLM_cas:issue">24</span>),
    <span class="NLM_cas:pages">15387-15392</span>CODEN:
                <span class="NLM_cas:coden">PNASA6</span>;
        ISSN:<span class="NLM_cas:issn">0027-8424</span>.
    
            (<span class="NLM_cas:orgname">National Academy of Sciences</span>)
        </div><div class="casAbstract">We report the x-ray crystal structure of human topoisomerase I covalently joined to double-stranded DNA and bound to the clin. approved anticancer agent topotecan.  Topotecan mimics a DNA base pair and binds at the site of DNA cleavage by intercalating between the upstream (-1) and downstream (+1) base pairs.  Intercalation displaces the downstream DNA, thus preventing re-ligation of the cleaved strand.  By specifically binding to the enzyme-substrate complex, topotecan acts as an uncompetitive inhibitor.  The structure can explain several of the known structure-activity relationships of the camptothecin family of anticancer drugs and suggests that there are at least two classes of mutations that can produce a drug-resistant enzyme.  The first class includes changes to residues that contribute to direct interactions with the drug, whereas a second class would alter interactions with the DNA and thereby destabilize the drug-binding site.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr6ZhyvRMWZBLVg90H21EOLACvtfcHk0ljtBgYdDBSUJg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3sXjvVGh&md5=fe1f9e01f0277f8d46e8726ba7866bdb</span></div><a href="/servlet/linkout?suffix=cit75&amp;dbid=16384&amp;doi=10.1073%2Fpnas.242259599&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1073%252Fpnas.242259599%26sid%3Dliteratum%253Aachs%26aulast%3DStaker%26aufirst%3DB.%2BL.%26aulast%3DHjerrild%26aufirst%3DK.%26aulast%3DFeese%26aufirst%3DM.%2BD.%26aulast%3DBehnke%26aufirst%3DC.%2BA.%26aulast%3DBurgin%26aufirst%3DA.%2BB.%26aulast%3DStewart%26aufirst%3DL.%26atitle%3DThe%2520mechanism%2520of%2520topoisomerase%2520I%2520poisoning%2520by%2520a%2520camptothecin%2520analog%26jtitle%3DProc.%2520Natl.%2520Acad.%2520Sci.%2520U.%2520S.%2520A.%26date%3D2002%26volume%3D99%26spage%3D15387%26epage%3D15392%26doi%3D10.1073%2Fpnas.242259599" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref76"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref76'); return false;" data-citation="" class="refNumLink">76</a></strong><div class="NLM_citation" id="cit76"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Dexheimer, T. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gediya, L. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Stephen, A. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Weidlich, I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Antony, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Marchand, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Interthal, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nicklaus, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fisher, R. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Njar, V. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pommier, Y.</span></span> <span> </span><span class="NLM_article-title">4-Pregnen-21-ol-3,20-dione-21-(4-bromobenzenesulfonate) (NSC 88915) and related novel steroid derivatives as tyrosyl-DNA phosphodiesterase (Tdp1) inhibitors</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2009</span>,  <span class="NLM_volume"><i>52</i></span>,  <span class="NLM_fpage">7122</span>– <span class="NLM_lpage">7131</span>, <span class="refDoi"> DOI: 10.1021/jm901061s</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm901061s" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=52&publication_year=2009&pages=7122-7131&author=T.+S.+Dexheimerauthor=L.+K.+Gediyaauthor=A.+G.+Stephenauthor=I.+Weidlichauthor=S.+Antonyauthor=C.+Marchandauthor=H.+Interthalauthor=M.+Nicklausauthor=R.+J.+Fisherauthor=V.+C.+Njarauthor=Y.+Pommier&title=4-Pregnen-21-ol-3%2C20-dione-21-%284-bromobenzenesulfonate%29+%28NSC+88915%29+and+related+novel+steroid+derivatives+as+tyrosyl-DNA+phosphodiesterase+%28Tdp1%29+inhibitors&doi=10.1021%2Fjm901061s"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit76&amp;dbid=16384&amp;doi=10.1021%2Fjm901061s&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm901061s%26sid%3Dliteratum%253Aachs%26aulast%3DDexheimer%26aufirst%3DT.%2BS.%26aulast%3DGediya%26aufirst%3DL.%2BK.%26aulast%3DStephen%26aufirst%3DA.%2BG.%26aulast%3DWeidlich%26aufirst%3DI.%26aulast%3DAntony%26aufirst%3DS.%26aulast%3DMarchand%26aufirst%3DC.%26aulast%3DInterthal%26aufirst%3DH.%26aulast%3DNicklaus%26aufirst%3DM.%26aulast%3DFisher%26aufirst%3DR.%2BJ.%26aulast%3DNjar%26aufirst%3DV.%2BC.%26aulast%3DPommier%26aufirst%3DY.%26atitle%3D4-Pregnen-21-ol-3%252C20-dione-21-%25284-bromobenzenesulfonate%2529%2520%2528NSC%252088915%2529%2520and%2520related%2520novel%2520steroid%2520derivatives%2520as%2520tyrosyl-DNA%2520phosphodiesterase%2520%2528Tdp1%2529%2520inhibitors%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2009%26volume%3D52%26spage%3D7122%26epage%3D7131%26doi%3D10.1021%2Fjm901061s" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref77"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref77'); return false;" data-citation="" class="refNumLink">77</a></strong><div class="NLM_citation" id="cit77"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Davies, D. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Interthal, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Champoux, J. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hol, W. G. J.</span></span> <span> </span><span class="NLM_article-title">Explorations of peptide and oligonucleotide binding sites of Tdp1 using vanadate complexes</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2004</span>,  <span class="NLM_volume"><i>47</i></span>,  <span class="NLM_fpage">829</span>– <span class="NLM_lpage">837</span>, <span class="refDoi"> DOI: 10.1021/jm030487x</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm030487x" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=47&publication_year=2004&pages=829-837&author=D.+R.+Daviesauthor=H.+Interthalauthor=J.+J.+Champouxauthor=W.+G.+J.+Hol&title=Explorations+of+peptide+and+oligonucleotide+binding+sites+of+Tdp1+using+vanadate+complexes&doi=10.1021%2Fjm030487x"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit77&amp;dbid=16384&amp;doi=10.1021%2Fjm030487x&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm030487x%26sid%3Dliteratum%253Aachs%26aulast%3DDavies%26aufirst%3DD.%2BR.%26aulast%3DInterthal%26aufirst%3DH.%26aulast%3DChampoux%26aufirst%3DJ.%2BJ.%26aulast%3DHol%26aufirst%3DW.%2BG.%2BJ.%26atitle%3DExplorations%2520of%2520peptide%2520and%2520oligonucleotide%2520binding%2520sites%2520of%2520Tdp1%2520using%2520vanadate%2520complexes%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2004%26volume%3D47%26spage%3D829%26epage%3D837%26doi%3D10.1021%2Fjm030487x" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref78"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref78'); return false;" data-citation="" class="refNumLink">78</a></strong><div class="NLM_citation" id="cit78"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Pommier, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Covey, J. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kerrigan, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Markovits, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pham, R.</span></span> <span> </span><span class="NLM_article-title">DNA unwinding and inhibition of mouse leukemia L1210 DNA topoisomerase I by intercalators</span>. <i>Nucleic Acids Res.</i> <span class="NLM_year" style="font-weight: bold;">1987</span>,  <span class="NLM_volume"><i>15</i></span>,  <span class="NLM_fpage">6713</span>– <span class="NLM_lpage">6731</span>, <span class="refDoi"> DOI: 10.1093/nar/15.16.6713</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref78/cit78&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00639&amp;key=10.1093%2Fnar%2F15.16.6713" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=15&publication_year=1987&pages=6713-6731&author=Y.+Pommierauthor=J.+M.+Coveyauthor=D.+Kerriganauthor=J.+Markovitsauthor=R.+Pham&title=DNA+unwinding+and+inhibition+of+mouse+leukemia+L1210+DNA+topoisomerase+I+by+intercalators&doi=10.1093%2Fnar%2F15.16.6713"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit78&amp;dbid=16384&amp;doi=10.1093%2Fnar%2F15.16.6713&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1093%252Fnar%252F15.16.6713%26sid%3Dliteratum%253Aachs%26aulast%3DPommier%26aufirst%3DY.%26aulast%3DCovey%26aufirst%3DJ.%2BM.%26aulast%3DKerrigan%26aufirst%3DD.%26aulast%3DMarkovits%26aufirst%3DJ.%26aulast%3DPham%26aufirst%3DR.%26atitle%3DDNA%2520unwinding%2520and%2520inhibition%2520of%2520mouse%2520leukemia%2520L1210%2520DNA%2520topoisomerase%2520I%2520by%2520intercalators%26jtitle%3DNucleic%2520Acids%2520Res.%26date%3D1987%26volume%3D15%26spage%3D6713%26epage%3D6731%26doi%3D10.1093%2Fnar%2F15.16.6713" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref79"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref79'); return false;" data-citation="" class="refNumLink">79</a></strong><div class="NLM_citation" id="cit79"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Pommier, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Covey, J. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kerrigan, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Markovits, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pham, R.</span></span> <span> </span><span class="NLM_article-title">DNA unwinding and inhibition of mouse leukemia L1210 DNA topoisomerase I by intercalators</span>. <i>Nucleic Acids Res.</i> <span class="NLM_year" style="font-weight: bold;">1987</span>,  <span class="NLM_volume"><i>15</i></span>,  <span class="NLM_fpage">6713</span>– <span class="NLM_lpage">6731</span>, <span class="refDoi"> DOI: 10.1093/nar/15.16.6713</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref79/cit79&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00639&amp;key=10.1093%2Fnar%2F15.16.6713" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=15&publication_year=1987&pages=6713-6731&author=Y.+Pommierauthor=J.+M.+Coveyauthor=D.+Kerriganauthor=J.+Markovitsauthor=R.+Pham&title=DNA+unwinding+and+inhibition+of+mouse+leukemia+L1210+DNA+topoisomerase+I+by+intercalators&doi=10.1093%2Fnar%2F15.16.6713"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit79&amp;dbid=16384&amp;doi=10.1093%2Fnar%2F15.16.6713&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1093%252Fnar%252F15.16.6713%26sid%3Dliteratum%253Aachs%26aulast%3DPommier%26aufirst%3DY.%26aulast%3DCovey%26aufirst%3DJ.%2BM.%26aulast%3DKerrigan%26aufirst%3DD.%26aulast%3DMarkovits%26aufirst%3DJ.%26aulast%3DPham%26aufirst%3DR.%26atitle%3DDNA%2520unwinding%2520and%2520inhibition%2520of%2520mouse%2520leukemia%2520L1210%2520DNA%2520topoisomerase%2520I%2520by%2520intercalators%26jtitle%3DNucleic%2520Acids%2520Res.%26date%3D1987%26volume%3D15%26spage%3D6713%26epage%3D6731%26doi%3D10.1093%2Fnar%2F15.16.6713" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref80"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref80'); return false;" data-citation="" class="refNumLink">80</a></strong><div class="NLM_citation" id="cit80"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Shoemaker, R. H.</span></span> <span> </span><span class="NLM_article-title">The NCI60 human tumour cell line anticancer drug screen</span>. <i>Nat. Rev. Cancer</i> <span class="NLM_year" style="font-weight: bold;">2006</span>,  <span class="NLM_volume"><i>6</i></span>,  <span class="NLM_fpage">813</span>– <span class="NLM_lpage">823</span>, <span class="refDoi"> DOI: 10.1038/nrc1951</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref80/cit80&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00639&amp;key=10.1038%2Fnrc1951" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref80/cit80&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00639&amp;key=16990858" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref80/cit80&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00639&amp;key=1%3ACAS%3A528%3ADC%252BD28XpvVCmu7c%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=6&publication_year=2006&pages=813-823&author=R.+H.+Shoemaker&title=The+NCI60+human+tumour+cell+line+anticancer+drug+screen&doi=10.1038%2Fnrc1951"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit80R"><div class="casContent"><span class="casTitleNuber">80</span><div class="casTitle"><span class="NLM_cas:atitle">The NCI60 human tumour cell line anticancer drug screen</span></div><div class="casAuthors">Shoemaker, Robert H.</div><div class="citationInfo"><span class="NLM_cas:title">Nature Reviews Cancer</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">6</span>
        (<span class="NLM_cas:issue">10</span>),
    <span class="NLM_cas:pages">813-823</span>CODEN:
                <span class="NLM_cas:coden">NRCAC4</span>;
        ISSN:<span class="NLM_cas:issn">1474-175X</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">A review.  The US National Cancer Institute (NCI) 60 human tumor cell line anticancer drug screen (NCI60) was developed in the late 1980s as an in vitro drug-discovery tool intended to supplant the use of transplantable animal tumors in anticancer drug screening.  This screening model was rapidly recognized as a rich source of information about the mechanisms of growth inhibition and tumor-cell kill.  Recently, its role has changed to that of a service screen supporting the cancer research community.  The author reviews the development, use and productivity of the screen, highlighting several outcomes that have contributed to advances in cancer chemotherapy.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr0ysyTSc1-p7Vg90H21EOLACvtfcHk0lgTEhaiHaqZfA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28XpvVCmu7c%253D&md5=c6c1a074b9dc7e138f45734499769284</span></div><a href="/servlet/linkout?suffix=cit80&amp;dbid=16384&amp;doi=10.1038%2Fnrc1951&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnrc1951%26sid%3Dliteratum%253Aachs%26aulast%3DShoemaker%26aufirst%3DR.%2BH.%26atitle%3DThe%2520NCI60%2520human%2520tumour%2520cell%2520line%2520anticancer%2520drug%2520screen%26jtitle%3DNat.%2520Rev.%2520Cancer%26date%3D2006%26volume%3D6%26spage%3D813%26epage%3D823%26doi%3D10.1038%2Fnrc1951" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref81"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref81'); return false;" data-citation="" class="refNumLink">81</a></strong><div class="NLM_citation" id="cit81"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Holbeck, S. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Collins, J. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Doroshow, J. H.</span></span> <span> </span><span class="NLM_article-title">Analysis of Food and Drug Administration-approved anticancer agents in the NCI60 panel of human tumor cell lines</span>. <i>Mol. Cancer Ther.</i> <span class="NLM_year" style="font-weight: bold;">2010</span>,  <span class="NLM_volume"><i>9</i></span>,  <span class="NLM_fpage">1451</span>– <span class="NLM_lpage">1460</span>, <span class="refDoi"> DOI: 10.1158/1535-7163.MCT-10-0106</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref81/cit81&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00639&amp;key=10.1158%2F1535-7163.MCT-10-0106" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref81/cit81&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00639&amp;key=20442306" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref81/cit81&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00639&amp;key=1%3ACAS%3A528%3ADC%252BC3cXlslektbY%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=9&publication_year=2010&pages=1451-1460&author=S.+L.+Holbeckauthor=J.+M.+Collinsauthor=J.+H.+Doroshow&title=Analysis+of+Food+and+Drug+Administration-approved+anticancer+agents+in+the+NCI60+panel+of+human+tumor+cell+lines&doi=10.1158%2F1535-7163.MCT-10-0106"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit81R"><div class="casContent"><span class="casTitleNuber">81</span><div class="casTitle"><span class="NLM_cas:atitle">Analysis of Food and Drug Administration-Approved Anticancer Agents in the NCI60 Panel of Human Tumor Cell Lines</span></div><div class="casAuthors">Holbeck, Susan L.; Collins, Jerry M.; Doroshow, James H.</div><div class="citationInfo"><span class="NLM_cas:title">Molecular Cancer Therapeutics</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">9</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">1451-1460</span>CODEN:
                <span class="NLM_cas:coden">MCTOCF</span>;
        ISSN:<span class="NLM_cas:issn">1535-7163</span>.
    
            (<span class="NLM_cas:orgname">American Association for Cancer Research</span>)
        </div><div class="casAbstract">Since the early 1990s the Developmental Therapeutics Program of the National Cancer Institute (NCI) has utilized a panel of 60 human tumor cell lines (NCI60) representing 9 tissue types to screen for potential new anticancer agents.  To date, about 100,000 compds. and 50,000 natural product exts. have been screened.  Early in this program it was discovered that the pattern of growth inhibition in these cell lines was similar for compds. of similar mechanism.  The development of the COMPARE algorithm provided a means by which investigators, starting with a compd. of interest, could identify other compds. whose pattern of growth inhibition was similar.  With extensive mol. characterization of these cell lines, COMPARE and other user-defined algorithms have been used to link patterns of mol. expression and drug sensitivity.  We describe here the results of screening current Food and Drug Administration (FDA)-approved anticancer agents in the NCI60 screen, with an emphasis on those agents that target signal transduction.  We analyzed results from agents with mechanisms of action presumed to be similar; we also carried out a hierarchical clustering of all of these agents.  The addn. of data from recently approved anticancer agents will increase the utility of the NCI60 databases to the cancer research community.  These data are freely accessible to the public on the DTP website (http://dtp.cancer.gov/).  The FDA-approved anticancer agents are themselves available from the NCI as a plated set of compds. for research use.  Mol Cancer Ther; 9(5); 1451-60.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqStY8k37YNdLVg90H21EOLACvtfcHk0lhFSfj1RsFAzg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXlslektbY%253D&md5=cd87602a9fb3e4b1eb196abb4bb91f1a</span></div><a href="/servlet/linkout?suffix=cit81&amp;dbid=16384&amp;doi=10.1158%2F1535-7163.MCT-10-0106&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1158%252F1535-7163.MCT-10-0106%26sid%3Dliteratum%253Aachs%26aulast%3DHolbeck%26aufirst%3DS.%2BL.%26aulast%3DCollins%26aufirst%3DJ.%2BM.%26aulast%3DDoroshow%26aufirst%3DJ.%2BH.%26atitle%3DAnalysis%2520of%2520Food%2520and%2520Drug%2520Administration-approved%2520anticancer%2520agents%2520in%2520the%2520NCI60%2520panel%2520of%2520human%2520tumor%2520cell%2520lines%26jtitle%3DMol.%2520Cancer%2520Ther.%26date%3D2010%26volume%3D9%26spage%3D1451%26epage%3D1460%26doi%3D10.1158%2F1535-7163.MCT-10-0106" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref82"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref82'); return false;" data-citation="" class="refNumLink">82</a></strong><div class="NLM_citation" id="cit82"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Reinhold, W. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sunshine, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Varma, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Doroshow, J. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pommier, Y.</span></span> <span> </span><span class="NLM_article-title">Using cellMiner 1.6 for systems pharmacology and genomic analysis of the NCI-60</span>. <i>Clin. Cancer Res.</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>21</i></span>,  <span class="NLM_fpage">3841</span>– <span class="NLM_lpage">3852</span>, <span class="refDoi"> DOI: 10.1158/1078-0432.CCR-15-0335</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref82/cit82&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00639&amp;key=10.1158%2F1078-0432.CCR-15-0335" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref82/cit82&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00639&amp;key=26048278" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref82/cit82&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00639&amp;key=1%3ACAS%3A528%3ADC%252BC2MXhsVCrsLfM" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=21&publication_year=2015&pages=3841-3852&author=W.+C.+Reinholdauthor=M.+Sunshineauthor=S.+Varmaauthor=J.+H.+Doroshowauthor=Y.+Pommier&title=Using+cellMiner+1.6+for+systems+pharmacology+and+genomic+analysis+of+the+NCI-60&doi=10.1158%2F1078-0432.CCR-15-0335"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit82R"><div class="casContent"><span class="casTitleNuber">82</span><div class="casTitle"><span class="NLM_cas:atitle">Using CellMiner 1.6 for Systems Pharmacology and Genomic Analysis of the NCI-60</span></div><div class="casAuthors">Reinhold, William C.; Sunshine, Margot; Varma, Sudhir; Doroshow, James H.; Pommier, Yves</div><div class="citationInfo"><span class="NLM_cas:title">Clinical Cancer Research</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">21</span>
        (<span class="NLM_cas:issue">17</span>),
    <span class="NLM_cas:pages">3841-3852</span>CODEN:
                <span class="NLM_cas:coden">CCREF4</span>;
        ISSN:<span class="NLM_cas:issn">1078-0432</span>.
    
            (<span class="NLM_cas:orgname">American Association for Cancer Research</span>)
        </div><div class="casAbstract">The NCI-60 cancer cell line panel provides a premier model for data integration, and systems pharmacol. being the largest publicly available database of anticancer drug activity, genomic, mol., and phenotypic data.  It comprises gene expression (25,722 transcripts), microRNAs (360 miRNAs), whole-genome DNA copy no. (23,413 genes), whole-exome sequencing (variants for 16,568 genes), protein levels (94 genes), and cytotoxic activity (20,861 compds.).  Included are 158 FDA-approved drugs and 79 that are in clin. trials.  To improve data accessibility to bioinformaticists and non-bioinformaticists alike, we have developed the CellMiner web-based tools.  Here, we describe the newest CellMiner version, including integration of novel databases and tools assocd. with whole-exome sequencing and protein expression, and review the tools.  Included are (i) "Cell line signature" for DNA, RNA, protein, and drugs; (ii) "Cross correlations" for up to 150 input genes, microRNAs, and compds. in a single query; (iii) "Pattern comparison" to identify connections among drugs, gene expression, genomic variants, microRNA, and protein expressions; (iv) "Genetic variation vs. drug visualization" to identify potential new drug:gene DNA variant relationships; and (v) "Genetic variant summation" designed to provide a synopsis of mutational burden on any pathway or gene group for up to 150 genes.  Together, these tools allow users to flexibly query the NCI-60 data for potential relationships between genomic, mol., and pharmacol. parameters in a manner specific to the user's area of expertise.  Examples for both gain- (RAS) and loss-of-function (PTEN) alterations are provided.  Clin Cancer Res; 21(17); 3841-52. ©2015 AACR.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGo_ibthuFKkfbVg90H21EOLACvtfcHk0lhFSfj1RsFAzg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXhsVCrsLfM&md5=3072d4c59c550ed785f66a6fb25cde15</span></div><a href="/servlet/linkout?suffix=cit82&amp;dbid=16384&amp;doi=10.1158%2F1078-0432.CCR-15-0335&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1158%252F1078-0432.CCR-15-0335%26sid%3Dliteratum%253Aachs%26aulast%3DReinhold%26aufirst%3DW.%2BC.%26aulast%3DSunshine%26aufirst%3DM.%26aulast%3DVarma%26aufirst%3DS.%26aulast%3DDoroshow%26aufirst%3DJ.%2BH.%26aulast%3DPommier%26aufirst%3DY.%26atitle%3DUsing%2520cellMiner%25201.6%2520for%2520systems%2520pharmacology%2520and%2520genomic%2520analysis%2520of%2520the%2520NCI-60%26jtitle%3DClin.%2520Cancer%2520Res.%26date%3D2015%26volume%3D21%26spage%3D3841%26epage%3D3852%26doi%3D10.1158%2F1078-0432.CCR-15-0335" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref83"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref83'); return false;" data-citation="" class="refNumLink">83</a></strong><div class="NLM_citation" id="cit83"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Miao, Z. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Player, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shankavaram, U.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, Y. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zimonjic, D. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lorenzi, P. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liao, Z. Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liu, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shimura, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, H. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Meng, L. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, Y. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kawasaki, E. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Popescu, N. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Aladjem, M. I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Goldstein, D. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Weinstein, J. N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pommier, Y.</span></span> <span> </span><span class="NLM_article-title">Nonclassic functions of human topoisomerase I: genome-wide and pharmacologic analyses</span>. <i>Cancer Res.</i> <span class="NLM_year" style="font-weight: bold;">2007</span>,  <span class="NLM_volume"><i>67</i></span>,  <span class="NLM_fpage">8752</span>– <span class="NLM_lpage">8761</span>, <span class="refDoi"> DOI: 10.1158/0008-5472.CAN-06-4554</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref83/cit83&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00639&amp;key=10.1158%2F0008-5472.CAN-06-4554" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=67&publication_year=2007&pages=8752-8761&author=Z.+H.+Miaoauthor=A.+Playerauthor=U.+Shankavaramauthor=Y.+H.+Wangauthor=D.+B.+Zimonjicauthor=P.+L.+Lorenziauthor=Z.+Y.+Liaoauthor=H.+Liuauthor=T.+Shimuraauthor=H.+L.+Zhangauthor=L.+H.+Mengauthor=Y.+W.+Zhangauthor=E.+S.+Kawasakiauthor=N.+C.+Popescuauthor=M.+I.+Aladjemauthor=D.+J.+Goldsteinauthor=J.+N.+Weinsteinauthor=Y.+Pommier&title=Nonclassic+functions+of+human+topoisomerase+I%3A+genome-wide+and+pharmacologic+analyses&doi=10.1158%2F0008-5472.CAN-06-4554"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit83&amp;dbid=16384&amp;doi=10.1158%2F0008-5472.CAN-06-4554&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1158%252F0008-5472.CAN-06-4554%26sid%3Dliteratum%253Aachs%26aulast%3DMiao%26aufirst%3DZ.%2BH.%26aulast%3DPlayer%26aufirst%3DA.%26aulast%3DShankavaram%26aufirst%3DU.%26aulast%3DWang%26aufirst%3DY.%2BH.%26aulast%3DZimonjic%26aufirst%3DD.%2BB.%26aulast%3DLorenzi%26aufirst%3DP.%2BL.%26aulast%3DLiao%26aufirst%3DZ.%2BY.%26aulast%3DLiu%26aufirst%3DH.%26aulast%3DShimura%26aufirst%3DT.%26aulast%3DZhang%26aufirst%3DH.%2BL.%26aulast%3DMeng%26aufirst%3DL.%2BH.%26aulast%3DZhang%26aufirst%3DY.%2BW.%26aulast%3DKawasaki%26aufirst%3DE.%2BS.%26aulast%3DPopescu%26aufirst%3DN.%2BC.%26aulast%3DAladjem%26aufirst%3DM.%2BI.%26aulast%3DGoldstein%26aufirst%3DD.%2BJ.%26aulast%3DWeinstein%26aufirst%3DJ.%2BN.%26aulast%3DPommier%26aufirst%3DY.%26atitle%3DNonclassic%2520functions%2520of%2520human%2520topoisomerase%2520I%253A%2520genome-wide%2520and%2520pharmacologic%2520analyses%26jtitle%3DCancer%2520Res.%26date%3D2007%26volume%3D67%26spage%3D8752%26epage%3D8761%26doi%3D10.1158%2F0008-5472.CAN-06-4554" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref84"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref84'); return false;" data-citation="" class="refNumLink">84</a></strong><div class="NLM_citation" id="cit84"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Hsiang, Y. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hertzberg, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hecht, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liu, L.</span></span> <span> </span><span class="NLM_article-title">Camptothecin induces protein-linked DNA breaks via mammalian DNA topoisomerase I</span>. <i>J. Biol. Chem.</i> <span class="NLM_year" style="font-weight: bold;">1985</span>,  <span class="NLM_volume"><i>260</i></span>,  <span class="NLM_fpage">14873</span>– <span class="NLM_lpage">14878</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref84/cit84&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00639&amp;key=2997227" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref84/cit84&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00639&amp;key=1%3ACAS%3A528%3ADyaL2MXlsFemt7c%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=260&publication_year=1985&pages=14873-14878&author=Y.+H.+Hsiangauthor=R.+Hertzbergauthor=S.+Hechtauthor=L.+Liu&title=Camptothecin+induces+protein-linked+DNA+breaks+via+mammalian+DNA+topoisomerase+I"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit84R"><div class="casContent"><span class="casTitleNuber">84</span><div class="casTitle"><span class="NLM_cas:atitle">Camptothecin induces protein-linked DNA breaks via mammalian DNA topoisomerase I</span></div><div class="casAuthors">Hsiang, Yaw Huei; Hertzberg, Robert; Hecht, Sidney; Liu, Leroy F.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Biological Chemistry</span>
        (<span class="NLM_cas:date">1985</span>),
    <span class="NLM_cas:volume">260</span>
        (<span class="NLM_cas:issue">27</span>),
    <span class="NLM_cas:pages">14873-8</span>CODEN:
                <span class="NLM_cas:coden">JBCHA3</span>;
        ISSN:<span class="NLM_cas:issn">0021-9258</span>.
    </div><div class="casAbstract">Camptothecin (I)  [7689-03-4], a cytotoxic drug, is a strong inhibitor of nucleic acid synthesis in mammalian cells and a potent inducer of strand breaks in chromosomal DNA.  Neither equil. dialysis nor unwinding measurement indicated any interaction between camptothecin and purified DNA.  However, I induces extensive single-strand DNA breaks in systems contg. purified mammalian DNA topoisomerase  [80449-01-0] I.  DNA breakage in vitro is immediate and reversible.  Analyses of camptothecin-induced DNA breaks show that topoisomerase I is covalently linked to the 3' end of the broken DNA.  In addn., I inhibits the catalytic activity of mammalian DNA topoisomerase I.  Apparently, I blocks the rejoining step of the breakage-reunion reaction of mammalian DNA topoisomerase I; this blockade results in the accumulation of a cleavable complex which resembles the transient intermediate proposed for eukaryotic DNA topoisomerase I.  The inhibition of nucleic acid synthesis and the induction of DNA strand breaks obsd. in vivo may be related to the formation of this drug-induced cleavable complex.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGp4OWZ16tDJsbVg90H21EOLACvtfcHk0liBe5KpHMBQww"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaL2MXlsFemt7c%253D&md5=d5811c51314199e69d2fad324720b1aa</span></div><a href="/servlet/linkout?suffix=cit84&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DHsiang%26aufirst%3DY.%2BH.%26aulast%3DHertzberg%26aufirst%3DR.%26aulast%3DHecht%26aufirst%3DS.%26aulast%3DLiu%26aufirst%3DL.%26atitle%3DCamptothecin%2520induces%2520protein-linked%2520DNA%2520breaks%2520via%2520mammalian%2520DNA%2520topoisomerase%2520I%26jtitle%3DJ.%2520Biol.%2520Chem.%26date%3D1985%26volume%3D260%26spage%3D14873%26epage%3D14878" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref85"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref85'); return false;" data-citation="" class="refNumLink">85</a></strong><div class="NLM_citation" id="cit85"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Urasaki, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Laco, G. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pourquier, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Takebayashi, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kohlhagen, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gioffre, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chatterjee, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pantazis, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pommier, Y.</span></span> <span> </span><span class="NLM_article-title">Characterization of a novel topoisomerase I mutation from a camptothecin resistant human prostate cancer cell line</span>. <i>Cancer Res.</i> <span class="NLM_year" style="font-weight: bold;">2001</span>,  <span class="NLM_volume"><i>61</i></span>,  <span class="NLM_fpage">1964</span>– <span class="NLM_lpage">1969</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=61&publication_year=2001&pages=1964-1969&author=Y.+Urasakiauthor=G.+S.+Lacoauthor=P.+Pourquierauthor=Y.+Takebayashiauthor=G.+Kohlhagenauthor=C.+Gioffreauthor=H.+Zhangauthor=D.+Chatterjeeauthor=P.+Pantazisauthor=Y.+Pommier&title=Characterization+of+a+novel+topoisomerase+I+mutation+from+a+camptothecin+resistant+human+prostate+cancer+cell+line"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit85&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DUrasaki%26aufirst%3DY.%26aulast%3DLaco%26aufirst%3DG.%2BS.%26aulast%3DPourquier%26aufirst%3DP.%26aulast%3DTakebayashi%26aufirst%3DY.%26aulast%3DKohlhagen%26aufirst%3DG.%26aulast%3DGioffre%26aufirst%3DC.%26aulast%3DZhang%26aufirst%3DH.%26aulast%3DChatterjee%26aufirst%3DD.%26aulast%3DPantazis%26aufirst%3DP.%26aulast%3DPommier%26aufirst%3DY.%26atitle%3DCharacterization%2520of%2520a%2520novel%2520topoisomerase%2520I%2520mutation%2520from%2520a%2520camptothecin%2520resistant%2520human%2520prostate%2520cancer%2520cell%2520line%26jtitle%3DCancer%2520Res.%26date%3D2001%26volume%3D61%26spage%3D1964%26epage%3D1969" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref86"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref86'); return false;" data-citation="" class="refNumLink">86</a></strong><div class="NLM_citation" id="cit86"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Staker, B. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Feese, M. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cushman, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pommier, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zembower, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Stewart, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Burgin, A. B.</span></span> <span> </span><span class="NLM_article-title">Structures of three classes of anticancer agents bound to the human topoisomerase I-DNA covalent complex</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2005</span>,  <span class="NLM_volume"><i>48</i></span>,  <span class="NLM_fpage">2336</span>– <span class="NLM_lpage">2345</span>, <span class="refDoi"> DOI: 10.1021/jm049146p</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm049146p" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref86/cit86&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00639&amp;key=1%3ACAS%3A528%3ADC%252BD2MXhslajtro%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=48&publication_year=2005&pages=2336-2345&author=B.+L.+Stakerauthor=M.+D.+Feeseauthor=M.+Cushmanauthor=Y.+Pommierauthor=D.+Zembowerauthor=L.+Stewartauthor=A.+B.+Burgin&title=Structures+of+three+classes+of+anticancer+agents+bound+to+the+human+topoisomerase+I-DNA+covalent+complex&doi=10.1021%2Fjm049146p"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit86R"><div class="casContent"><span class="casTitleNuber">86</span><div class="casTitle"><span class="NLM_cas:atitle">Structures of Three Classes of Anticancer Agents Bound to the Human Topoisomerase I-DNA Covalent Complex</span></div><div class="casAuthors">Staker, Bart L.; Feese, Michael D.; Cushman, Mark; Pommier, Yves; Zembower, David; Stewart, Lance; Burgin, Alex B.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2005</span>),
    <span class="NLM_cas:volume">48</span>
        (<span class="NLM_cas:issue">7</span>),
    <span class="NLM_cas:pages">2336-2345</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Human topoisomerase I (top1) is the mol. target of a diverse set of anticancer compds., including the camptothecins, indolocarbazoles, and indenoisoquinolines.  These compds. bind to a transient top1-DNA covalent complex and inhibit the resealing of a single-strand nick that the enzyme creates to relieve superhelical tension in duplex DNA.  The authors report the x-ray crystal structures of the human top1-DNA complex bound with camptothecin and representative members of the indenoisoquinoline and indolocarbazole classes of top1 poisons.  The planar nature of all three structurally diverse classes allows them to intercalate between DNA base pairs at the site of single-strand cleavage.  All three classes of compds. have a free electron pair near Arg364, a residue that if mutated confers resistance to all three classes of drugs.  The common intercalative binding mode is augmented by unexpected chemotype-specific contacts with amino acid residues Asn352 and Glu356, which adopt alternative side-chain conformations to accommodate the bound compds.  These new x-ray structures explain how very different mols. can stabilize top1-DNA covalent complexes and will aid the rational design of completely novel structural classes of anticancer drugs.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpvtOcEkHplxLVg90H21EOLACvtfcHk0liBe5KpHMBQww"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2MXhslajtro%253D&md5=ed236ed57668e8491966b836ceaacac4</span></div><a href="/servlet/linkout?suffix=cit86&amp;dbid=16384&amp;doi=10.1021%2Fjm049146p&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm049146p%26sid%3Dliteratum%253Aachs%26aulast%3DStaker%26aufirst%3DB.%2BL.%26aulast%3DFeese%26aufirst%3DM.%2BD.%26aulast%3DCushman%26aufirst%3DM.%26aulast%3DPommier%26aufirst%3DY.%26aulast%3DZembower%26aufirst%3DD.%26aulast%3DStewart%26aufirst%3DL.%26aulast%3DBurgin%26aufirst%3DA.%2BB.%26atitle%3DStructures%2520of%2520three%2520classes%2520of%2520anticancer%2520agents%2520bound%2520to%2520the%2520human%2520topoisomerase%2520I-DNA%2520covalent%2520complex%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2005%26volume%3D48%26spage%3D2336%26epage%3D2345%26doi%3D10.1021%2Fjm049146p" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref87"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref87'); return false;" data-citation="" class="refNumLink">87</a></strong><div class="NLM_citation" id="cit87"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Wu, C. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hsieh, C. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wu, Y. S.</span></span> <span> </span><span class="NLM_article-title">The emergence of drug transporter-mediated multidrug resistance to cancer chemotherapy</span>. <i>Mol. Pharmaceutics</i> <span class="NLM_year" style="font-weight: bold;">2011</span>,  <span class="NLM_volume"><i>8</i></span>,  <span class="NLM_fpage">1996</span>– <span class="NLM_lpage">2011</span>, <span class="refDoi"> DOI: 10.1021/mp200261n</span> </span><div class="citationLinks">[<a href="/doi/10.1021/mp200261n" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref87/cit87&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00639&amp;key=1%3ACAS%3A528%3ADC%252BC3MXptlert74%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=8&publication_year=2011&pages=1996-2011&author=C.+P.+Wuauthor=C.+H.+Hsiehauthor=Y.+S.+Wu&title=The+emergence+of+drug+transporter-mediated+multidrug+resistance+to+cancer+chemotherapy&doi=10.1021%2Fmp200261n"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit87R"><div class="casContent"><span class="casTitleNuber">87</span><div class="casTitle"><span class="NLM_cas:atitle">The Emergence of Drug Transporter-Mediated Multidrug Resistance to Cancer Chemotherapy</span></div><div class="casAuthors">Wu, Chung-Pu; Hsieh, Chia-Hung; Wu, Yu-Shan</div><div class="citationInfo"><span class="NLM_cas:title">Molecular Pharmaceutics</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">8</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">1996-2011</span>CODEN:
                <span class="NLM_cas:coden">MPOHBP</span>;
        ISSN:<span class="NLM_cas:issn">1543-8384</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">A review.  Chemotherapy is currently one of the most effective ways to treat metastatic cancers.  However, of the various mechanisms that are involved in conferring resistance, upregulation of drug efflux ATP-binding cassette (ABC) transporters, such as P-glycoprotein (ABCB1), multidrug resistance protein 1 (ABCC1) and ABCG2, has become a major obstacle to cancer chemotherapy and seriously affects the clin. outcome.  To date, at least 15 ABC drug transporters have been identified and characterized to transport and confer resistance to practically the entire spectrum of cancer drugs, causing multidrug resistance (MDR) in cancers.  Unfortunately, despite decades of research, there is still no real soln. to MDR.  This review highlights some of the major findings, the roles and problems assocd. with MDR-linked ABC drug transporters in metastatic cancers and solid tumors, and the current strategies to improve the clin. outcome in cancer chemotherapy.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpRXYw8gOc5m7Vg90H21EOLACvtfcHk0liBe5KpHMBQww"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXptlert74%253D&md5=f28ff271be9eceb7cebbfe1cd3676c20</span></div><a href="/servlet/linkout?suffix=cit87&amp;dbid=16384&amp;doi=10.1021%2Fmp200261n&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fmp200261n%26sid%3Dliteratum%253Aachs%26aulast%3DWu%26aufirst%3DC.%2BP.%26aulast%3DHsieh%26aufirst%3DC.%2BH.%26aulast%3DWu%26aufirst%3DY.%2BS.%26atitle%3DThe%2520emergence%2520of%2520drug%2520transporter-mediated%2520multidrug%2520resistance%2520to%2520cancer%2520chemotherapy%26jtitle%3DMol.%2520Pharmaceutics%26date%3D2011%26volume%3D8%26spage%3D1996%26epage%3D2011%26doi%3D10.1021%2Fmp200261n" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref88"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref88'); return false;" data-citation="" class="refNumLink">88</a></strong><div class="NLM_citation" id="cit88"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Zhu, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lou, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tang, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bu, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yin, S.</span></span> <span> </span><span class="NLM_article-title">Jatrophane Diterpenoids as Modulators of P-Glycoprotein-Dependent Multidrug Resistance (MDR): Advances of Structure-Activity Relationships and Discovery of Promising MDR Reversal Agents</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>59</i></span>,  <span class="NLM_fpage">6353</span>– <span class="NLM_lpage">6369</span>, <span class="refDoi"> DOI: 10.1021/acs.jmedchem.6b00605</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acs.jmedchem.6b00605" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref88/cit88&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00639&amp;key=1%3ACAS%3A528%3ADC%252BC28XhtVSrtb%252FI" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=59&publication_year=2016&pages=6353-6369&author=J.+Zhuauthor=R.+Wangauthor=L.+Louauthor=W.+Liauthor=G.+Tangauthor=X.+Buauthor=S.+Yin&title=Jatrophane+Diterpenoids+as+Modulators+of+P-Glycoprotein-Dependent+Multidrug+Resistance+%28MDR%29%3A+Advances+of+Structure-Activity+Relationships+and+Discovery+of+Promising+MDR+Reversal+Agents&doi=10.1021%2Facs.jmedchem.6b00605"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit88R"><div class="casContent"><span class="casTitleNuber">88</span><div class="casTitle"><span class="NLM_cas:atitle">Jatrophane Diterpenoids as Modulators of P-Glycoprotein-Dependent Multidrug Resistance (MDR): Advances of Structure-Activity Relationships and Discovery of Promising MDR Reversal Agents</span></div><div class="casAuthors">Zhu, Jianyong; Wang, Ruimin; Lou, Lanlan; Li, Wei; Tang, Guihua; Bu, Xianzhang; Yin, Sheng</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">59</span>
        (<span class="NLM_cas:issue">13</span>),
    <span class="NLM_cas:pages">6353-6369</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">The phytochem. study of Pedilanthus tithymaloides led to the isolation of 13 jatrophane diterpenoids (1-13), of which eight (1-8) are new.  Subsequent structural modification of the major components by esterification, hydrolysis, hydrogenation, or epoxidn. yielded 22 new derivs. (14-35).  Thus, a jatrophane library contg. two series of compds. was established to screen for P-glycoprotein (Pgp)-dependent MDR modulators.  The activity was evaluated through a combination of Rho123 efflux and chemoreversal assays on adriamycin resistant human hepatocellular carcinoma cell line HepG2 (HepG2/ADR) and adriamycin resistant human breast adenocarcinoma cell line MCF-7 (MCF-7/ADR).  Compds. 19, 25, and 26 were identified as potent MDR modulators with greater chemoreversal ability and less cytotoxicity than the third-generation drug tariquidar.  The structure-activity relationship (SAR) was discussed, which showed that modifications beyond just increasing the lipophilicity of this class of Pgp inhibitors are beneficial to the activity.  Compd. 26, which exhibited a remarkable metabolic stability in vitro and a favorable antitumor effect in vivo, would serve as a promising lead for the development of new MDR reversal agents.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGobYTCdHUEwx7Vg90H21EOLACvtfcHk0lgZansWypHMpA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28XhtVSrtb%252FI&md5=3980b1349ffea40674e82fff3fba2f5d</span></div><a href="/servlet/linkout?suffix=cit88&amp;dbid=16384&amp;doi=10.1021%2Facs.jmedchem.6b00605&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facs.jmedchem.6b00605%26sid%3Dliteratum%253Aachs%26aulast%3DZhu%26aufirst%3DJ.%26aulast%3DWang%26aufirst%3DR.%26aulast%3DLou%26aufirst%3DL.%26aulast%3DLi%26aufirst%3DW.%26aulast%3DTang%26aufirst%3DG.%26aulast%3DBu%26aufirst%3DX.%26aulast%3DYin%26aufirst%3DS.%26atitle%3DJatrophane%2520Diterpenoids%2520as%2520Modulators%2520of%2520P-Glycoprotein-Dependent%2520Multidrug%2520Resistance%2520%2528MDR%2529%253A%2520Advances%2520of%2520Structure-Activity%2520Relationships%2520and%2520Discovery%2520of%2520Promising%2520MDR%2520Reversal%2520Agents%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2016%26volume%3D59%26spage%3D6353%26epage%3D6369%26doi%3D10.1021%2Facs.jmedchem.6b00605" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref89"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref89'); return false;" data-citation="" class="refNumLink">89</a></strong><div class="NLM_citation" id="cit89"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Carmichael, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">DeGraff, W. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gazdar, A. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Minna, J. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mitchell, J. B.</span></span> <span> </span><span class="NLM_article-title">Evaluation of a tetrazolium-based semiautomated colorimetrie assay: assessment of chemosensitivity testing</span>. <i>Cancer Res.</i> <span class="NLM_year" style="font-weight: bold;">1987</span>,  <span class="NLM_volume"><i>47</i></span>,  <span class="NLM_fpage">936</span>– <span class="NLM_lpage">942</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=47&publication_year=1987&pages=936-942&author=J.+Carmichaelauthor=W.+G.+DeGraffauthor=A.+F.+Gazdarauthor=J.+D.+Minnaauthor=J.+B.+Mitchell&title=Evaluation+of+a+tetrazolium-based+semiautomated+colorimetrie+assay%3A+assessment+of+chemosensitivity+testing"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit89&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DCarmichael%26aufirst%3DJ.%26aulast%3DDeGraff%26aufirst%3DW.%2BG.%26aulast%3DGazdar%26aufirst%3DA.%2BF.%26aulast%3DMinna%26aufirst%3DJ.%2BD.%26aulast%3DMitchell%26aufirst%3DJ.%2BB.%26atitle%3DEvaluation%2520of%2520a%2520tetrazolium-based%2520semiautomated%2520colorimetrie%2520assay%253A%2520assessment%2520of%2520chemosensitivity%2520testing%26jtitle%3DCancer%2520Res.%26date%3D1987%26volume%3D47%26spage%3D936%26epage%3D942" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref90"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref90'); return false;" data-citation="" class="refNumLink">90</a></strong><div class="NLM_citation" id="cit90"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Yalowich, J. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wu, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kanagasabai, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hornbaker, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hasinoff, B. B.</span></span> <span> </span><span class="NLM_article-title">The anticancer thiosemicarbazones Dp44mT and triapine lack inhibitory effects as catalytic inhibitors or poisons of DNA topoisomerase IIalpha</span>. <i>Biochem. Pharmacol.</i> <span class="NLM_year" style="font-weight: bold;">2012</span>,  <span class="NLM_volume"><i>84</i></span>,  <span class="NLM_fpage">52</span>– <span class="NLM_lpage">58</span>, <span class="refDoi"> DOI: 10.1016/j.bcp.2012.03.021</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref90/cit90&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00639&amp;key=10.1016%2Fj.bcp.2012.03.021" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=84&publication_year=2012&pages=52-58&author=J.+C.+Yalowichauthor=X.+Wuauthor=R.+Zhangauthor=R.+Kanagasabaiauthor=M.+Hornbakerauthor=B.+B.+Hasinoff&title=The+anticancer+thiosemicarbazones+Dp44mT+and+triapine+lack+inhibitory+effects+as+catalytic+inhibitors+or+poisons+of+DNA+topoisomerase+IIalpha&doi=10.1016%2Fj.bcp.2012.03.021"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit90&amp;dbid=16384&amp;doi=10.1016%2Fj.bcp.2012.03.021&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bcp.2012.03.021%26sid%3Dliteratum%253Aachs%26aulast%3DYalowich%26aufirst%3DJ.%2BC.%26aulast%3DWu%26aufirst%3DX.%26aulast%3DZhang%26aufirst%3DR.%26aulast%3DKanagasabai%26aufirst%3DR.%26aulast%3DHornbaker%26aufirst%3DM.%26aulast%3DHasinoff%26aufirst%3DB.%2BB.%26atitle%3DThe%2520anticancer%2520thiosemicarbazones%2520Dp44mT%2520and%2520triapine%2520lack%2520inhibitory%2520effects%2520as%2520catalytic%2520inhibitors%2520or%2520poisons%2520of%2520DNA%2520topoisomerase%2520IIalpha%26jtitle%3DBiochem.%2520Pharmacol.%26date%3D2012%26volume%3D84%26spage%3D52%26epage%3D58%26doi%3D10.1016%2Fj.bcp.2012.03.021" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li></ol></div><script data-cfasync="false" src="/cdn-cgi/scripts/5c5dd728/cloudflare-static/email-decode.min.js"></script><script type="text/javascript">window.refViewer={'ref1':['cit1'],'ref2':['cit2'],'ref3':['cit3'],'ref4':['cit4'],'ref5':['cit5'],'ref6':['cit6'],'ref7':['cit7'],'ref8':['cit8'],'ref9':['cit9'],'ref10':['cit10'],'ref11':['cit11'],'ref12':['cit12'],'ref13':['cit13'],'ref14':['cit14'],'ref15':['cit15'],'ref16':['cit16'],'ref17':['cit17'],'ref18':['cit18'],'ref19':['cit19'],'ref20':['cit20'],'ref21':['cit21'],'ref22':['cit22'],'ref23':['cit23'],'ref24':['cit24'],'ref25':['cit25'],'ref26':['cit26'],'ref27':['cit27'],'ref28':['cit28'],'ref29':['cit29'],'ref30':['cit30'],'ref31':['cit31'],'ref32':['cit32'],'ref33':['cit33'],'ref34':['cit34'],'ref35':['cit35'],'ref36':['cit36'],'ref37':['cit37'],'ref38':['cit38'],'ref39':['cit39'],'ref40':['cit40'],'ref41':['cit41'],'ref42':['cit42'],'ref43':['cit43'],'ref44':['cit44'],'ref45':['cit45'],'ref46':['cit46'],'ref47':['cit47'],'ref48':['cit48'],'ref49':['cit49'],'ref50':['cit50'],'ref51':['cit51'],'ref52':['cit52'],'ref53':['cit53'],'ref54':['cit54'],'ref55':['cit55'],'ref56':['cit56'],'ref57':['cit57'],'ref58':['cit58'],'ref59':['cit59'],'ref60':['cit60'],'ref61':['cit61'],'ref62':['cit62'],'ref63':['cit63'],'ref64':['cit64'],'ref65':['cit65'],'ref66':['cit66'],'ref67':['cit67'],'ref68':['cit68'],'ref69':['cit69'],'ref70':['cit70'],'ref71':['cit71'],'ref72':['cit72'],'ref73':['cit73'],'ref74':['cit74'],'ref75':['cit75'],'ref76':['cit76'],'ref77':['cit77'],'ref78':['cit78'],'ref79':['cit79'],'ref80':['cit80'],'ref81':['cit81'],'ref82':['cit82'],'ref83':['cit83'],'ref84':['cit84'],'ref85':['cit85'],'ref86':['cit86'],'ref87':['cit87'],'ref88':['cit88'],'ref89':['cit89'],'ref90':['cit90']}</script><div class="articleCitedByDropzone" data-pb-dropzone="articleCitedByDropzone"><div class="cited-by"><div class="article_content-header cited-content_header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="citeThis">Cited By</h2></div></div></div><hr/></hr><div class="cited-by__content"><div class="cited-content hlFld-Abstract"><p>This article is cited by 22 publications.</p><ol class="cited-content_cbyCitation"><li><span class="cited-content_cbyCitation_article-contributors">De-Xuan Hu, Wen-Lin Tang, Yu Zhang, Hao Yang, Wenjie Wang, Keli Agama, Yves Pommier, <span class="NLM_string-name hlFld-ContribAuthor">Lin-Kun An</span>. </span><span class="cited-content_cbyCitation_article-title">Synthesis of Methoxy-, Methylenedioxy-, Hydroxy-, and Halo-Substituted Benzophenanthridinone Derivatives as DNA Topoisomerase IB (TOP1) and Tyrosyl-DNA Phosphodiesterase 1 (TDP1) Inhibitors and Their Biological Activity for Drug-Resistant Cancer. </span><span class="cited-content_cbyCitation_journal-name">Journal of Medicinal Chemistry</span><span> <strong>2021,</strong> <em>64 </em>
                                    (11)
                                     , 7617-7629. <a href="https://doi.org/10.1021/acs.jmedchem.1c00318" title="DOI URL">https://doi.org/10.1021/acs.jmedchem.1c00318</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.jmedchem.1c00318&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.jmedchem.1c00318%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Medicinal%2520Chemistry%26atitle%3DSynthesis%252Bof%252BMethoxy-%25252C%252BMethylenedioxy-%25252C%252BHydroxy-%25252C%252Band%252BHalo-Substituted%252BBenzophenanthridinone%252BDerivatives%252Bas%252BDNA%252BTopoisomerase%252BIB%252B%252528TOP1%252529%252Band%252BTyrosyl-DNA%252BPhosphodiesterase%252B1%252B%252528TDP1%252529%252BInhibitors%252Band%252BTheir%252BBiological%252BActivity%252Bfor%252BDrug-Resistant%252BCancer%26aulast%3DHu%26aufirst%3DDe-Xuan%26date%3D2021%26date%3D2021%26date%3D2021%26date%3D20022021%26date%3D19052021%26volume%3D64%26issue%3D11%26spage%3D7617%26epage%3D7629" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors">Jiye Wang, Zengrui Wu, Yayuan Peng, Weihua Li, Guixia Liu, <span class="NLM_string-name hlFld-ContribAuthor">Yun Tang</span>. </span><span class="cited-content_cbyCitation_article-title">Pathway-Based Drug Repurposing with DPNetinfer: A Method to Predict Drug–Pathway Associations via Network-Based Approaches. </span><span class="cited-content_cbyCitation_journal-name">Journal of Chemical Information and Modeling</span><span> <strong>2021,</strong> <em>61 </em>
                                    (5)
                                     , 2475-2485. <a href="https://doi.org/10.1021/acs.jcim.1c00009" title="DOI URL">https://doi.org/10.1021/acs.jcim.1c00009</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.jcim.1c00009&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.jcim.1c00009%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Chemical%2520Information%2520and%2520Modeling%26atitle%3DPathway-Based%252BDrug%252BRepurposing%252Bwith%252BDPNetinfer%25253A%252BA%252BMethod%252Bto%252BPredict%252BDrug%2525E2%252580%252593Pathway%252BAssociations%252Bvia%252BNetwork-Based%252BApproaches%26aulast%3DWang%26aufirst%3DJiye%26date%3D2021%26date%3D2021%26date%3D2021%26date%3D05012021%26date%3D26042021%26volume%3D61%26issue%3D5%26spage%3D2475%26epage%3D2485" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors">Kiho Kim, Hangyeol Choi, Dahye Kang, <span class="NLM_string-name hlFld-ContribAuthor">Sungwoo Hong</span>. </span><span class="cited-content_cbyCitation_article-title">Visible-Light Excitation of Quinolinone-Containing Substrates Enables Divergent Radical Cyclizations. </span><span class="cited-content_cbyCitation_journal-name">Organic Letters</span><span> <strong>2019,</strong> <em>21 </em>
                                    (9)
                                     , 3417-3421. <a href="https://doi.org/10.1021/acs.orglett.9b01155" title="DOI URL">https://doi.org/10.1021/acs.orglett.9b01155</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.orglett.9b01155&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.orglett.9b01155%26sid%3Dliteratum%253Aachs%26jtitle%3DOrganic%2520Letters%26atitle%3DVisible-Light%252BExcitation%252Bof%252BQuinolinone-Containing%252BSubstrates%252BEnables%252BDivergent%252BRadical%252BCyclizations%26aulast%3DKim%26aufirst%3DKiho%26date%3D2019%26date%3D2019%26date%3D2019%26date%3D02042019%26date%3D22042019%26volume%3D21%26issue%3D9%26spage%3D3417%26epage%3D3421" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Yu  Zhang</span>, <span class="hlFld-ContribAuthor ">Xiao‐Zhi  He</span>, <span class="hlFld-ContribAuthor ">Hao  Yang</span>, <span class="hlFld-ContribAuthor ">Hai‐Yang  Liu</span>, <span class="hlFld-ContribAuthor ">Lin‐Kun  An</span>. </span><span class="cited-content_cbyCitation_article-title">Robustadial A and B from
              
                Eucalyptus globulus
              
              Labill. and their anticancer activity as selective
              tyrosyl‐DNA
              phosphodiesterase 2 inhibitors. </span><span class="cited-content_cbyCitation_journal-name">Phytotherapy Research</span><span> <strong>2021,</strong> <em>111 </em><a href="https://doi.org/10.1002/ptr.7207" title="DOI URL">https://doi.org/10.1002/ptr.7207</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1002/ptr.7207&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1002%2Fptr.7207%26sid%3Dliteratum%253Aachs%26jtitle%3DPhytotherapy%2520Research%26atitle%3DRobustadial%252BA%252Band%252BB%252Bfrom%252BEucalyptus%252Bglobulus%252BLabill.%252Band%252Btheir%252Banticancer%252Bactivity%252Bas%252Bselective%252Btyrosyl%2525E2%252580%252590DNA%252Bphosphodiesterase%252B2%252Binhibitors%26aulast%3DZhang%26aufirst%3DYu%26date%3D2021%26date%3D2021%26volume%3D111" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Jingzhi  Sui</span>, <span class="hlFld-ContribAuthor ">Yun  He</span>, <span class="hlFld-ContribAuthor ">Tao  Wang</span>, <span class="hlFld-ContribAuthor ">Yong  Liang</span>, <span class="hlFld-ContribAuthor ">Zunting  Zhang</span>. </span><span class="cited-content_cbyCitation_article-title">Synthesis of
              Trans
              ‐4
              a
              ,12
              b
              /3,4‐Dihydrodibenzo[
              f
              ,
              h
              ]quinolin‐2(1
              H
              )‐Ones and Dibenzo[
              f
              ,
              h
              ]quinolin‐2(1
              H
              )‐Ones
              via
              Irradiation of 6‐Biphenylpyridine‐2(1
              H
              )‐Ones. </span><span class="cited-content_cbyCitation_journal-name">Advanced Synthesis & Catalysis</span><span> <strong>2021,</strong> <em>363 </em>
                                    (14)
                                     , 3554-3559. <a href="https://doi.org/10.1002/adsc.202100509" title="DOI URL">https://doi.org/10.1002/adsc.202100509</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1002/adsc.202100509&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1002%2Fadsc.202100509%26sid%3Dliteratum%253Aachs%26jtitle%3DAdvanced%2520Synthesis%2520%2526%2520Catalysis%26atitle%3DSynthesis%252Bof%252BTrans%252B%2525E2%252580%2525904%252Ba%252B%25252C12%252Bb%252B%25252F3%25252C4%2525E2%252580%252590Dihydrodibenzo%25255B%252Bf%252B%25252C%252Bh%252B%25255Dquinolin%2525E2%252580%2525902%2525281%252BH%252B%252529%2525E2%252580%252590Ones%252Band%252BDibenzo%25255B%252Bf%252B%25252C%252Bh%252B%25255Dquinolin%2525E2%252580%2525902%2525281%252BH%252B%252529%2525E2%252580%252590Ones%252Bvia%252BIrradiation%252Bof%252B6%2525E2%252580%252590Biphenylpyridine%2525E2%252580%2525902%2525281%252BH%252B%252529%2525E2%252580%252590Ones%26aulast%3DSui%26aufirst%3DJingzhi%26date%3D2021%26date%3D2021%26volume%3D363%26issue%3D14%26spage%3D3554%26epage%3D3559" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Ann-Katrine  Jakobsen</span>, <span class="hlFld-ContribAuthor ">Josephine Geertsen  Keller</span>, <span class="hlFld-ContribAuthor ">María  Gonzalez</span>, <span class="hlFld-ContribAuthor ">Endika  Martin-Encinas</span>, <span class="hlFld-ContribAuthor ">Francisco  Palacios</span>, <span class="hlFld-ContribAuthor ">Concepcion  Alonso</span>, <span class="hlFld-ContribAuthor ">Birgitta Ruth  Knudsen</span>, <span class="hlFld-ContribAuthor ">Magnus  Stougaard</span>. </span><span class="cited-content_cbyCitation_article-title">A Dual-Sensor-Based Screening System for In Vitro Selection of TDP1 Inhibitors. </span><span class="cited-content_cbyCitation_journal-name">Sensors</span><span> <strong>2021,</strong> <em>21 </em>
                                    (14)
                                     , 4832. <a href="https://doi.org/10.3390/s21144832" title="DOI URL">https://doi.org/10.3390/s21144832</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.3390/s21144832&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.3390%2Fs21144832%26sid%3Dliteratum%253Aachs%26jtitle%3DSensors%26atitle%3DA%252BDual-Sensor-Based%252BScreening%252BSystem%252Bfor%252BIn%252BVitro%252BSelection%252Bof%252BTDP1%252BInhibitors%26aulast%3DJakobsen%26aufirst%3DAnn-Katrine%26date%3D2021%26date%3D2021%26volume%3D21%26issue%3D14%26spage%3D4832" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Asier  Selas</span>, <span class="hlFld-ContribAuthor ">Endika  Martin-Encinas</span>, <span class="hlFld-ContribAuthor ">Maria  Fuertes</span>, <span class="hlFld-ContribAuthor ">Carme  Masdeu</span>, <span class="hlFld-ContribAuthor ">Gloria  Rubiales</span>, <span class="hlFld-ContribAuthor ">Francisco  Palacios</span>, <span class="hlFld-ContribAuthor ">Concepción  Alonso</span>. </span><span class="cited-content_cbyCitation_article-title">A patent review of topoisomerase I inhibitors (2016–present). </span><span class="cited-content_cbyCitation_journal-name">Expert Opinion on Therapeutic Patents</span><span> <strong>2021,</strong> <em>31 </em>
                                    (6)
                                     , 473-508. <a href="https://doi.org/10.1080/13543776.2021.1879051" title="DOI URL">https://doi.org/10.1080/13543776.2021.1879051</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1080/13543776.2021.1879051&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1080%2F13543776.2021.1879051%26sid%3Dliteratum%253Aachs%26jtitle%3DExpert%2520Opinion%2520on%2520Therapeutic%2520Patents%26atitle%3DA%252Bpatent%252Breview%252Bof%252Btopoisomerase%252BI%252Binhibitors%252B%2525282016%2525E2%252580%252593present%252529%26aulast%3DSelas%26aufirst%3DAsier%26date%3D2021%26date%3D2021%26volume%3D31%26issue%3D6%26spage%3D473%26epage%3D508" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Elizaveta D.  Gladkova</span>, <span class="hlFld-ContribAuthor ">Arina A.  Chepanova</span>, <span class="hlFld-ContribAuthor ">Ekaterina S.  Ilina</span>, <span class="hlFld-ContribAuthor ">Alexandra L.  Zakharenko</span>, <span class="hlFld-ContribAuthor ">Jóhannes  Reynisson</span>, <span class="hlFld-ContribAuthor ">Olga A.  Luzina</span>, <span class="hlFld-ContribAuthor ">Konstantin P.  Volcho</span>, <span class="hlFld-ContribAuthor ">Olga I.  Lavrik</span>, <span class="hlFld-ContribAuthor ">Nariman F.  Salakhutdinov</span>. </span><span class="cited-content_cbyCitation_article-title">Discovery of Novel Sultone Fused Berberine Derivatives as Promising Tdp1 Inhibitors. </span><span class="cited-content_cbyCitation_journal-name">Molecules</span><span> <strong>2021,</strong> <em>26 </em>
                                    (7)
                                     , 1945. <a href="https://doi.org/10.3390/molecules26071945" title="DOI URL">https://doi.org/10.3390/molecules26071945</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.3390/molecules26071945&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.3390%2Fmolecules26071945%26sid%3Dliteratum%253Aachs%26jtitle%3DMolecules%26atitle%3DDiscovery%252Bof%252BNovel%252BSultone%252BFused%252BBerberine%252BDerivatives%252Bas%252BPromising%252BTdp1%252BInhibitors%26aulast%3DGladkova%26aufirst%3DElizaveta%2BD.%26date%3D2021%26date%3D2021%26volume%3D26%26issue%3D7%26spage%3D1945" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Shaista  Amin</span>, <span class="hlFld-ContribAuthor ">M. Mumtaz  Alam</span>, <span class="hlFld-ContribAuthor ">Mymoona  Akhter</span>, <span class="hlFld-ContribAuthor ">A. K.  Najmi</span>, <span class="hlFld-ContribAuthor ">Nadeem  Siddiqui</span>, <span class="hlFld-ContribAuthor ">Asif  Husain</span>, <span class="hlFld-ContribAuthor ">M.  Shaquiquzzaman</span>. </span><span class="cited-content_cbyCitation_article-title">A review on synthetic procedures and applications of phosphorus oxychloride (POCl
              3
              ) in the last biennial period (2018–19). </span><span class="cited-content_cbyCitation_journal-name">Phosphorus, Sulfur, and Silicon and the Related Elements</span><span> <strong>2021,</strong> <em>196 </em>
                                    (3)
                                     , 211-274. <a href="https://doi.org/10.1080/10426507.2020.1831499" title="DOI URL">https://doi.org/10.1080/10426507.2020.1831499</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1080/10426507.2020.1831499&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1080%2F10426507.2020.1831499%26sid%3Dliteratum%253Aachs%26jtitle%3DPhosphorus%252C%2520Sulfur%252C%2520and%2520Silicon%2520and%2520the%2520Related%2520Elements%26atitle%3DA%252Breview%252Bon%252Bsynthetic%252Bprocedures%252Band%252Bapplications%252Bof%252Bphosphorus%252Boxychloride%252B%252528POCl%252B3%252B%252529%252Bin%252Bthe%252Blast%252Bbiennial%252Bperiod%252B%2525282018%2525E2%252580%25259319%252529%26aulast%3DAmin%26aufirst%3DShaista%26date%3D2021%26date%3D2020%26volume%3D196%26issue%3D3%26spage%3D211%26epage%3D274" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Emma  Baglini</span>, <span class="hlFld-ContribAuthor ">Silvia  Salerno</span>, <span class="hlFld-ContribAuthor ">Elisabetta  Barresi</span>, <span class="hlFld-ContribAuthor ">Marco  Robello</span>, <span class="hlFld-ContribAuthor ">Federico  Da Settimo</span>, <span class="hlFld-ContribAuthor ">Sabrina  Taliani</span>, <span class="hlFld-ContribAuthor ">Anna Maria  Marini</span>. </span><span class="cited-content_cbyCitation_article-title">Multiple Topoisomerase I (TopoI), Topoisomerase II (TopoII) and Tyrosyl-DNA Phosphodiesterase (TDP) inhibitors in the development of anticancer drugs. </span><span class="cited-content_cbyCitation_journal-name">European Journal of Pharmaceutical Sciences</span><span> <strong>2021,</strong> <em>156 </em>, 105594. <a href="https://doi.org/10.1016/j.ejps.2020.105594" title="DOI URL">https://doi.org/10.1016/j.ejps.2020.105594</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.ejps.2020.105594&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.ejps.2020.105594%26sid%3Dliteratum%253Aachs%26jtitle%3DEuropean%2520Journal%2520of%2520Pharmaceutical%2520Sciences%26atitle%3DMultiple%252BTopoisomerase%252BI%252B%252528TopoI%252529%25252C%252BTopoisomerase%252BII%252B%252528TopoII%252529%252Band%252BTyrosyl-DNA%252BPhosphodiesterase%252B%252528TDP%252529%252Binhibitors%252Bin%252Bthe%252Bdevelopment%252Bof%252Banticancer%252Bdrugs%26aulast%3DBaglini%26aufirst%3DEmma%26date%3D2021%26volume%3D156%26spage%3D105594" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Elizaveta D.  Gladkova</span>, <span class="hlFld-ContribAuthor ">Ivan V.  Nechepurenko</span>, <span class="hlFld-ContribAuthor ">Roman A.  Bredikhin</span>, <span class="hlFld-ContribAuthor ">Arina A.  Chepanova</span>, <span class="hlFld-ContribAuthor ">Alexandra L.  Zakharenko</span>, <span class="hlFld-ContribAuthor ">Olga A.  Luzina</span>, <span class="hlFld-ContribAuthor ">Ekaterina S.  Ilina</span>, <span class="hlFld-ContribAuthor ">Nadezhda S.  Dyrkheeva</span>, <span class="hlFld-ContribAuthor ">Evgeniya M.  Mamontova</span>, <span class="hlFld-ContribAuthor ">Rashid O.  Anarbaev</span>, <span class="hlFld-ContribAuthor ">Jóhannes  Reynisson</span>, <span class="hlFld-ContribAuthor ">Konstantin P.  Volcho</span>, <span class="hlFld-ContribAuthor ">Nariman F.  Salakhutdinov</span>, <span class="hlFld-ContribAuthor ">Olga I.  Lavrik</span>. </span><span class="cited-content_cbyCitation_article-title">The First Berberine-Based Inhibitors of Tyrosyl-DNA Phosphodiesterase 1 (Tdp1), an Important DNA Repair Enzyme. </span><span class="cited-content_cbyCitation_journal-name">International Journal of Molecular Sciences</span><span> <strong>2020,</strong> <em>21 </em>
                                    (19)
                                     , 7162. <a href="https://doi.org/10.3390/ijms21197162" title="DOI URL">https://doi.org/10.3390/ijms21197162</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.3390/ijms21197162&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.3390%2Fijms21197162%26sid%3Dliteratum%253Aachs%26jtitle%3DInternational%2520Journal%2520of%2520Molecular%2520Sciences%26atitle%3DThe%252BFirst%252BBerberine-Based%252BInhibitors%252Bof%252BTyrosyl-DNA%252BPhosphodiesterase%252B1%252B%252528Tdp1%252529%25252C%252Ban%252BImportant%252BDNA%252BRepair%252BEnzyme%26aulast%3DGladkova%26aufirst%3DElizaveta%2BD.%26date%3D2020%26date%3D2020%26volume%3D21%26issue%3D19%26spage%3D7162" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Yali  Song</span>, <span class="hlFld-ContribAuthor ">Siran  Feng</span>, <span class="hlFld-ContribAuthor ">Jiajia  Feng</span>, <span class="hlFld-ContribAuthor ">Jinjiao  Dong</span>, <span class="hlFld-ContribAuthor ">Kan  Yang</span>, <span class="hlFld-ContribAuthor ">Zhenming  Liu</span>, <span class="hlFld-ContribAuthor ">Xiaoqiang  Qiao</span>. </span><span class="cited-content_cbyCitation_article-title">Synthesis and biological evaluation of novel pyrazoline derivatives containing indole skeleton as anti-cancer agents targeting topoisomerase II. </span><span class="cited-content_cbyCitation_journal-name">European Journal of Medicinal Chemistry</span><span> <strong>2020,</strong> <em>200 </em>, 112459. <a href="https://doi.org/10.1016/j.ejmech.2020.112459" title="DOI URL">https://doi.org/10.1016/j.ejmech.2020.112459</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.ejmech.2020.112459&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.ejmech.2020.112459%26sid%3Dliteratum%253Aachs%26jtitle%3DEuropean%2520Journal%2520of%2520Medicinal%2520Chemistry%26atitle%3DSynthesis%252Band%252Bbiological%252Bevaluation%252Bof%252Bnovel%252Bpyrazoline%252Bderivatives%252Bcontaining%252Bindole%252Bskeleton%252Bas%252Banti-cancer%252Bagents%252Btargeting%252Btopoisomerase%252BII%26aulast%3DSong%26aufirst%3DYali%26date%3D2020%26volume%3D200%26spage%3D112459" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Long-Gao  Xiao</span>, <span class="hlFld-ContribAuthor ">Yu  Zhang</span>, <span class="hlFld-ContribAuthor ">Hong-Li  Zhang</span>, <span class="hlFld-ContribAuthor ">Ding  Li</span>, <span class="hlFld-ContribAuthor ">Qiong  Gu</span>, <span class="hlFld-ContribAuthor ">Gui-Hua  Tang</span>, <span class="hlFld-ContribAuthor ">Qian  Yu</span>, <span class="hlFld-ContribAuthor ">Lin-Kun  An</span>. </span><span class="cited-content_cbyCitation_article-title">Spiroconyone A, a new phytosterol with a spiro [5,6] ring system from
              Conyza japonica. </span><span class="cited-content_cbyCitation_journal-name">Organic & Biomolecular Chemistry</span><span> <strong>2020,</strong> <em>18 </em>
                                    (27)
                                     , 5130-5136. <a href="https://doi.org/10.1039/D0OB00666A" title="DOI URL">https://doi.org/10.1039/D0OB00666A</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1039/D0OB00666A&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1039%2FD0OB00666A%26sid%3Dliteratum%253Aachs%26jtitle%3DOrganic%2520%2526%2520Biomolecular%2520Chemistry%26atitle%3DSpiroconyone%252BA%25252C%252Ba%252Bnew%252Bphytosterol%252Bwith%252Ba%252Bspiro%252B%25255B5%25252C6%25255D%252Bring%252Bsystem%252Bfrom%252BConyza%252Bjaponica%26aulast%3DXiao%26aufirst%3DLong-Gao%26date%3D2020%26date%3D2020%26volume%3D18%26issue%3D27%26spage%3D5130%26epage%3D5136" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Hong-Li  Zhang</span>, <span class="hlFld-ContribAuthor ">Yu  Zhang</span>, <span class="hlFld-ContribAuthor ">Xue-Long  Yan</span>, <span class="hlFld-ContribAuthor ">Long-Gao  Xiao</span>, <span class="hlFld-ContribAuthor ">De-Xuan  Hu</span>, <span class="hlFld-ContribAuthor ">Qian  Yu</span>, <span class="hlFld-ContribAuthor ">Lin-Kun  An</span>. </span><span class="cited-content_cbyCitation_article-title">Secondary metabolites from Isodon ternifolius (D. Don) Kudo and their anticancer activity as DNA topoisomerase IB and Tyrosyl-DNA phosphodiesterase 1 inhibitors. </span><span class="cited-content_cbyCitation_journal-name">Bioorganic & Medicinal Chemistry</span><span> <strong>2020,</strong> <em>28 </em>
                                    (11)
                                     , 115527. <a href="https://doi.org/10.1016/j.bmc.2020.115527" title="DOI URL">https://doi.org/10.1016/j.bmc.2020.115527</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.bmc.2020.115527&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.bmc.2020.115527%26sid%3Dliteratum%253Aachs%26jtitle%3DBioorganic%2520%2526%2520Medicinal%2520Chemistry%26atitle%3DSecondary%252Bmetabolites%252Bfrom%252BIsodon%252Bternifolius%252B%252528D.%252BDon%252529%252BKudo%252Band%252Btheir%252Banticancer%252Bactivity%252Bas%252BDNA%252Btopoisomerase%252BIB%252Band%252BTyrosyl-DNA%252Bphosphodiesterase%252B1%252Binhibitors%26aulast%3DZhang%26aufirst%3DHong-Li%26date%3D2020%26volume%3D28%26issue%3D11%26spage%3D115527" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Chao  Mei</span>, <span class="hlFld-ContribAuthor ">Lin  Lei</span>, <span class="hlFld-ContribAuthor ">Li-Ming  Tan</span>, <span class="hlFld-ContribAuthor ">Xiao-Jing  Xu</span>, <span class="hlFld-ContribAuthor ">Bai-Mei  He</span>, <span class="hlFld-ContribAuthor ">Chao  Luo</span>, <span class="hlFld-ContribAuthor ">Ji-Ye  Yin</span>, <span class="hlFld-ContribAuthor ">Xi  Li</span>, <span class="hlFld-ContribAuthor ">Wei  Zhang</span>, <span class="hlFld-ContribAuthor ">Hong-Hao  Zhou</span>, <span class="hlFld-ContribAuthor ">Zhao-Qian  Liu</span>. </span><span class="cited-content_cbyCitation_article-title">The role of single strand break repair pathways in cellular responses to camptothecin induced DNA damage. </span><span class="cited-content_cbyCitation_journal-name">Biomedicine & Pharmacotherapy</span><span> <strong>2020,</strong> <em>125 </em>, 109875. <a href="https://doi.org/10.1016/j.biopha.2020.109875" title="DOI URL">https://doi.org/10.1016/j.biopha.2020.109875</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.biopha.2020.109875&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.biopha.2020.109875%26sid%3Dliteratum%253Aachs%26jtitle%3DBiomedicine%2520%2526%2520Pharmacotherapy%26atitle%3DThe%252Brole%252Bof%252Bsingle%252Bstrand%252Bbreak%252Brepair%252Bpathways%252Bin%252Bcellular%252Bresponses%252Bto%252Bcamptothecin%252Binduced%252BDNA%252Bdamage%26aulast%3DMei%26aufirst%3DChao%26date%3D2020%26volume%3D125%26spage%3D109875" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Bing  Shu</span>, <span class="hlFld-ContribAuthor ">Qian  Yu</span>, <span class="hlFld-ContribAuthor ">De-xuan  Hu</span>, <span class="hlFld-ContribAuthor ">Tong  Che</span>, <span class="hlFld-ContribAuthor ">Shang-shi  Zhang</span>, <span class="hlFld-ContribAuthor ">Ding  Li</span>. </span><span class="cited-content_cbyCitation_article-title">Synthesis and biological evaluation of novel indole-pyrazoline hybrid derivatives as potential topoisomerase 1 inhibitors. </span><span class="cited-content_cbyCitation_journal-name">Bioorganic & Medicinal Chemistry Letters</span><span> <strong>2020,</strong> <em>30 </em>
                                    (4)
                                     , 126925. <a href="https://doi.org/10.1016/j.bmcl.2019.126925" title="DOI URL">https://doi.org/10.1016/j.bmcl.2019.126925</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.bmcl.2019.126925&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.bmcl.2019.126925%26sid%3Dliteratum%253Aachs%26jtitle%3DBioorganic%2520%2526%2520Medicinal%2520Chemistry%2520Letters%26atitle%3DSynthesis%252Band%252Bbiological%252Bevaluation%252Bof%252Bnovel%252Bindole-pyrazoline%252Bhybrid%252Bderivatives%252Bas%252Bpotential%252Btopoisomerase%252B1%252Binhibitors%26aulast%3DShu%26aufirst%3DBing%26date%3D2020%26volume%3D30%26issue%3D4%26spage%3D126925" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Zhan-Yong  Tang</span>, <span class="hlFld-ContribAuthor ">Yu  Zhang</span>, <span class="hlFld-ContribAuthor ">Yu-Ting  Chen</span>, <span class="hlFld-ContribAuthor ">Qian  Yu</span>, <span class="hlFld-ContribAuthor ">Lin-Kun  An</span>. </span><span class="cited-content_cbyCitation_article-title">The first small fluorescent probe as Tyrosyl-DNA phosphodiesterase 1 (TDP1) substrate. </span><span class="cited-content_cbyCitation_journal-name">Dyes and Pigments</span><span> <strong>2019,</strong> <em>169 </em>, 45-50. <a href="https://doi.org/10.1016/j.dyepig.2019.05.010" title="DOI URL">https://doi.org/10.1016/j.dyepig.2019.05.010</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.dyepig.2019.05.010&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.dyepig.2019.05.010%26sid%3Dliteratum%253Aachs%26jtitle%3DDyes%2520and%2520Pigments%26atitle%3DThe%252Bfirst%252Bsmall%252Bfluorescent%252Bprobe%252Bas%252BTyrosyl-DNA%252Bphosphodiesterase%252B1%252B%252528TDP1%252529%252Bsubstrate%26aulast%3DTang%26aufirst%3DZhan-Yong%26date%3D2019%26volume%3D169%26spage%3D45%26epage%3D50" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Wenjie  Wang</span>, <span class="hlFld-ContribAuthor ">Monica  Rodriguez-Silva</span>, <span class="hlFld-ContribAuthor ">Arlet M.  Acanda de la Rocha</span>, <span class="hlFld-ContribAuthor ">Aizik L.  Wolf</span>, <span class="hlFld-ContribAuthor ">Yanhao  Lai</span>, <span class="hlFld-ContribAuthor ">Yuan  Liu</span>, <span class="hlFld-ContribAuthor ">William C.  Reinhold</span>, <span class="hlFld-ContribAuthor ">Yves  Pommier</span>, <span class="hlFld-ContribAuthor ">Jeremy W.  Chambers</span>, <span class="hlFld-ContribAuthor ">Yuk-Ching  Tse-Dinh</span>. </span><span class="cited-content_cbyCitation_article-title">Tyrosyl-DNA Phosphodiesterase 1 and Topoisomerase I Activities as Predictive Indicators for Glioblastoma Susceptibility to Genotoxic Agents. </span><span class="cited-content_cbyCitation_journal-name">Cancers</span><span> <strong>2019,</strong> <em>11 </em>
                                    (10)
                                     , 1416. <a href="https://doi.org/10.3390/cancers11101416" title="DOI URL">https://doi.org/10.3390/cancers11101416</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.3390/cancers11101416&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.3390%2Fcancers11101416%26sid%3Dliteratum%253Aachs%26jtitle%3DCancers%26atitle%3DTyrosyl-DNA%252BPhosphodiesterase%252B1%252Band%252BTopoisomerase%252BI%252BActivities%252Bas%252BPredictive%252BIndicators%252Bfor%252BGlioblastoma%252BSusceptibility%252Bto%252BGenotoxic%252BAgents%26aulast%3DWang%26aufirst%3DWenjie%26date%3D2019%26date%3D2019%26volume%3D11%26issue%3D10%26spage%3D1416" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Wen-Lin  Tang</span>, <span class="hlFld-ContribAuthor ">Yu  Zhang</span>, <span class="hlFld-ContribAuthor ">De-Xuan  Hu</span>, <span class="hlFld-ContribAuthor ">Hui  Yang</span>, <span class="hlFld-ContribAuthor ">Qian  Yu</span>, <span class="hlFld-ContribAuthor ">Jian-Wen  Chen</span>, <span class="hlFld-ContribAuthor ">Keli  Agama</span>, <span class="hlFld-ContribAuthor ">Yves  Pommier</span>, <span class="hlFld-ContribAuthor ">Lin-Kun  An</span>. </span><span class="cited-content_cbyCitation_article-title">Synthesis and biological evaluation of 5-aminoethyl benzophenanthridone derivatives as DNA topoisomerase IB inhibitors. </span><span class="cited-content_cbyCitation_journal-name">European Journal of Medicinal Chemistry</span><span> <strong>2019,</strong> <em>178 </em>, 81-92. <a href="https://doi.org/10.1016/j.ejmech.2019.05.074" title="DOI URL">https://doi.org/10.1016/j.ejmech.2019.05.074</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.ejmech.2019.05.074&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.ejmech.2019.05.074%26sid%3Dliteratum%253Aachs%26jtitle%3DEuropean%2520Journal%2520of%2520Medicinal%2520Chemistry%26atitle%3DSynthesis%252Band%252Bbiological%252Bevaluation%252Bof%252B5-aminoethyl%252Bbenzophenanthridone%252Bderivatives%252Bas%252BDNA%252Btopoisomerase%252BIB%252Binhibitors%26aulast%3DTang%26aufirst%3DWen-Lin%26date%3D2019%26volume%3D178%26spage%3D81%26epage%3D92" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Alexandra  Zakharenko</span>, <span class="hlFld-ContribAuthor ">Nadezhda  Dyrkheeva</span>, <span class="hlFld-ContribAuthor ">Olga  Lavrik</span>. </span><span class="cited-content_cbyCitation_article-title">Dual DNA topoisomerase 1 and tyrosyl‐DNA phosphodiesterase 1 inhibition for improved anticancer activity. </span><span class="cited-content_cbyCitation_journal-name">Medicinal Research Reviews</span><span> <strong>2019,</strong> <em>39 </em>
                                    (4)
                                     , 1427-1441. <a href="https://doi.org/10.1002/med.21587" title="DOI URL">https://doi.org/10.1002/med.21587</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1002/med.21587&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1002%2Fmed.21587%26sid%3Dliteratum%253Aachs%26jtitle%3DMedicinal%2520Research%2520Reviews%26atitle%3DDual%252BDNA%252Btopoisomerase%252B1%252Band%252Btyrosyl%2525E2%252580%252590DNA%252Bphosphodiesterase%252B1%252Binhibition%252Bfor%252Bimproved%252Banticancer%252Bactivity%26aulast%3DZakharenko%26aufirst%3DAlexandra%26date%3D2019%26date%3D2019%26volume%3D39%26issue%3D4%26spage%3D1427%26epage%3D1441" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Arina A.  Chepanova</span>, <span class="hlFld-ContribAuthor ">Evgenii S.  Mozhaitsev</span>, <span class="hlFld-ContribAuthor ">Aldar A.  Munkuev</span>, <span class="hlFld-ContribAuthor ">Evgeniy V.  Suslov</span>, <span class="hlFld-ContribAuthor ">Dina V.  Korchagina</span>, <span class="hlFld-ContribAuthor ">Olga D.  Zakharova</span>, <span class="hlFld-ContribAuthor ">Alexandra L.  Zakharenko</span>, <span class="hlFld-ContribAuthor ">Jinal  Patel</span>, <span class="hlFld-ContribAuthor ">Daniel M.  Ayine-Tora</span>, <span class="hlFld-ContribAuthor ">Jóhannes  Reynisson</span>, <span class="hlFld-ContribAuthor ">Ivanhoe K. H.  Leung</span>, <span class="hlFld-ContribAuthor ">Konstantin P.  Volcho</span>, <span class="hlFld-ContribAuthor ">Nariman F.  Salakhutdinov</span>, <span class="hlFld-ContribAuthor ">Olga I.  Lavrik</span>. </span><span class="cited-content_cbyCitation_article-title">The Development of Tyrosyl-DNA Phosphodiesterase 1 Inhibitors. Combination of Monoterpene and Adamantine Moieties via Amide or Thioamide Bridges. </span><span class="cited-content_cbyCitation_journal-name">Applied Sciences</span><span> <strong>2019,</strong> <em>9 </em>
                                    (13)
                                     , 2767. <a href="https://doi.org/10.3390/app9132767" title="DOI URL">https://doi.org/10.3390/app9132767</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.3390/app9132767&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.3390%2Fapp9132767%26sid%3Dliteratum%253Aachs%26jtitle%3DApplied%2520Sciences%26atitle%3DThe%252BDevelopment%252Bof%252BTyrosyl-DNA%252BPhosphodiesterase%252B1%252BInhibitors.%252BCombination%252Bof%252BMonoterpene%252Band%252BAdamantine%252BMoieties%252Bvia%252BAmide%252Bor%252BThioamide%252BBridges%26aulast%3DChepanova%26aufirst%3DArina%2BA.%26date%3D2019%26date%3D2019%26volume%3D9%26issue%3D13%26spage%3D2767" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Evgenii S.  Mozhaitsev</span>, <span class="hlFld-ContribAuthor ">Alexandra L.  Zakharenko</span>, <span class="hlFld-ContribAuthor ">Evgeniy V.  Suslov</span>, <span class="hlFld-ContribAuthor ">Dina V.  Korchagina</span>, <span class="hlFld-ContribAuthor ">Olga D.  Zakharova</span>, <span class="hlFld-ContribAuthor ">Inna A.  Vasil'eva</span>, <span class="hlFld-ContribAuthor ">Arina A.  Chepanova</span>, <span class="hlFld-ContribAuthor ">Ellena  Black</span>, <span class="hlFld-ContribAuthor ">Jinal  Patel</span>, <span class="hlFld-ContribAuthor ">Raina  Chand</span>, <span class="hlFld-ContribAuthor ">Jóhannes  Reynisson</span>, <span class="hlFld-ContribAuthor ">Ivanhoe K.H.  Leung</span>, <span class="hlFld-ContribAuthor ">Konstantin P.  Volcho</span>, <span class="hlFld-ContribAuthor ">Nariman F.  Salakhutdinov</span>, <span class="hlFld-ContribAuthor ">Olga I.  Lavrik</span>. </span><span class="cited-content_cbyCitation_article-title">Novel Inhibitors of DNA Repair Enzyme TDP1 Combining Monoterpenoid and Adamantane Fragments. </span><span class="cited-content_cbyCitation_journal-name">Anti-Cancer Agents in Medicinal Chemistry</span><span> <strong>2019,</strong> <em>19 </em>
                                    (4)
                                     , 463-472. <a href="https://doi.org/10.2174/1871520619666181207094243" title="DOI URL">https://doi.org/10.2174/1871520619666181207094243</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.2174/1871520619666181207094243&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.2174%2F1871520619666181207094243%26sid%3Dliteratum%253Aachs%26jtitle%3DAnti-Cancer%2520Agents%2520in%2520Medicinal%2520Chemistry%26atitle%3DNovel%252BInhibitors%252Bof%252BDNA%252BRepair%252BEnzyme%252BTDP1%252BCombining%252BMonoterpenoid%252Band%252BAdamantane%252BFragments%26aulast%3DMozhaitsev%26aufirst%3DEvgenii%2BS.%26date%3D2019%26volume%3D19%26issue%3D4%26spage%3D463%26epage%3D472" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li></ol></div></div></div></div></div><div class="article_content-right" id="article_content-right" tabindex="0"><div class="tab tab--flex"><div class="tab__close"><i class="icon-close" tabindex="0" aria-label="close the sidebar."></i></div><ul role="tablist" class="rlist tab__nav"><li role="presentation" class="active"><a id="pane-m1con" href="#pane-m1" aria-controls="pane-m1" role="tab" data-toggle="tab" title="Figures" aria-selected="true" class="active empty" aria-label="Figures"><i class="icon-image"></i><span>Figures</span></a></li><li role="presentation"><a id="pane-m2con" href="#pane-m2" aria-controls="pane-m2" role="tab" data-toggle="tab" title="References" aria-selected="false" class="empty"><i class="icon-link"></i><span>References</span></a></li><li role="presentation"><a id="pane-m3con" href="#pane-m3" aria-controls="pane-m3" role="tab" data-toggle="tab" title="Support Info" aria-selected="false" class="empty tab__nav-suppInfo"><i class="icon-supporting-info"></i><span>Support Info</span></a></li></ul><div class="paneContainer"><ul class="rlist tab__content"><li id="pane-m1" aria-labelledby="pane-m1" class="tab__pane tab__pane-figures active empty"><figure data-id="_i1" data-index="0" class="article__inlineFigure"><h2 class="fig-label">Abstract</h2><img class="rightTab-fig internalNav" src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-22/acs.jmedchem.8b00639/20181119/images/medium/jm-2018-00639p_0016.gif" alt="" id="tgr1" /></img><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-22/acs.jmedchem.8b00639/20181119/images/large/jm-2018-00639p_0016.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.8b00639&amp;id=_i1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig1" data-index="1" class="article__inlineFigure"><h2 class="fig-label">Figure 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-22/acs.jmedchem.8b00639/20181119/images/medium/jm-2018-00639p_0001.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-22/acs.jmedchem.8b00639/20181119/images/large/jm-2018-00639p_0001.jpeg" id="rightTab-gr1" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 1. Schematic for TOP1 and TDP1 mediated biochemical reactions. (A) TOP1 binds to DNA and cleaves one strand of a dsDNA by forming a reversible covalent 3′-phosphotyrosyl bond. (B) The resulting TOP1cc may be trapped and stabilized by TOP1 inhibitors (black stick) such as camptothecin and indenoisoquinoline analogues, resulting in replication/transcription-mediated DNA damage and cell death. (C) TOP1cc could be proteolyzed to expose the DNA-3′-phosphotyrosyl bond, which can be cleaved by TDP1 to leave the 3′-phosphate end DNA (D). (E) The DNA breaks may be repaired sequentially by the XRCC-1 dependent base excision repair (BER) pathway.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-22/acs.jmedchem.8b00639/20181119/images/large/jm-2018-00639p_0001.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.8b00639&amp;id=fig1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig2" data-index="2" class="article__inlineFigure"><h2 class="fig-label">Figure 2</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-22/acs.jmedchem.8b00639/20181119/images/medium/jm-2018-00639p_0002.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-22/acs.jmedchem.8b00639/20181119/images/large/jm-2018-00639p_0002.jpeg" id="rightTab-gr2" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 2. Structures of representative reported TDP1 inhibitors.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-22/acs.jmedchem.8b00639/20181119/images/large/jm-2018-00639p_0002.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.8b00639&amp;id=fig2"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="sch1" data-index="3" class="article__inlineFigure"><h2 class="fig-label">Scheme 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-22/acs.jmedchem.8b00639/20181119/images/medium/jm-2018-00639p_0011.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-22/acs.jmedchem.8b00639/20181119/images/large/jm-2018-00639p_0011.jpeg" id="rightTab-gr11" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 1. Synthesis of Compounds <b>19a</b>/<b>b</b>–<b>25a</b>/<b>b</b> and <b>26a</b>/<b>b</b>–<b>32a</b>/<b>b</b><sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-22/acs.jmedchem.8b00639/20181119/images/large/jm-2018-00639p_0011.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.8b00639&amp;id=sch1"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label"><sup>a</sup></span>Reagents and conditions: (a) MeOH, NH<sub>2</sub>(CH<sub>2</sub>)<sub>n</sub>OH, rt; (b) MOMCl, NaH, THF, 0 °C; (c) Pd(PPh<sub>3</sub>)<sub>4</sub>, CuI, pyrrolidine, H<sub>2</sub>O, 60 °C; (d) (i) N<sub>2</sub>, Ni(cod)<sub>2</sub>, P(<i>o</i>-Tol)<sub>3</sub>, MeCN, 80 °C, (ii) CsOH, K<sub>3</sub>[Fe(CN)<sub>6</sub>], MeOH, H<sub>2</sub>O, 80 °C; (e) (COCl)<sub>2</sub>, DMSO, TEA, DCM, −60 °C; (f) concd. hydrochloric acid, MeOH, rt; (g) SOCl<sub>2</sub>, TCM, TEA, rt; (h) amines (in pressure vessel for dimethylamine), PhMe, K<sub>2</sub>CO<sub>3</sub>, KI, reflux; (i) LiAlH<sub>4</sub>, THF, 0 °C.</p></p></figure><figure data-id="fig3" data-index="4" class="article__inlineFigure"><h2 class="fig-label">Figure 3</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-22/acs.jmedchem.8b00639/20181119/images/medium/jm-2018-00639p_0003.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-22/acs.jmedchem.8b00639/20181119/images/large/jm-2018-00639p_0003.jpeg" id="rightTab-gr3" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 3. Perspective ORTEP drawing of compound <b>20b</b>.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-22/acs.jmedchem.8b00639/20181119/images/large/jm-2018-00639p_0003.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.8b00639&amp;id=fig3"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="sch2" data-index="5" class="article__inlineFigure"><h2 class="fig-label">Scheme 2</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-22/acs.jmedchem.8b00639/20181119/images/medium/jm-2018-00639p_0012.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-22/acs.jmedchem.8b00639/20181119/images/large/jm-2018-00639p_0012.jpeg" id="rightTab-gr12" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 2. Synthesis of Compounds <b>39a</b>/<b>b</b>–<b>45a</b>/<b>b</b><sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-22/acs.jmedchem.8b00639/20181119/images/large/jm-2018-00639p_0012.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.8b00639&amp;id=sch2"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label"><sup>a</sup></span>Reagents and conditions: (a) MeOH, rt; (b) (i) N<sub>2</sub>, compound <b>14</b>, Ni(cod)<sub>2</sub>, P(<i>o</i>-Tol)<sub>3</sub>, MeCN, 80 °C, (ii) CsOH, K<sub>3</sub>Fe(CN)<sub>6</sub>, MeOH, H<sub>2</sub>O, 80 °C; (c) (COCl)<sub>2</sub>, DMSO, TEA, DCM, −60 °C; (d) HCl, AcOH, rt; (e) POCl<sub>3</sub>, DMF, 100 °C; (f) HOCH<sub>2</sub>CH<sub>2</sub>R, THF, NaH, 70 °C; (g) Br(CH<sub>2</sub>)<sub>3</sub>Br, DMF, NaH, rt; (h) amines (in pressure vessel for dimethylamine), DMF, K<sub>2</sub>CO<sub>3</sub>, KI, rt.</p></p></figure><figure data-id="fig4" data-index="6" class="article__inlineFigure"><h2 class="fig-label">Figure 4</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-22/acs.jmedchem.8b00639/20181119/images/medium/jm-2018-00639p_0004.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-22/acs.jmedchem.8b00639/20181119/images/large/jm-2018-00639p_0004.jpeg" id="rightTab-gr4" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 4. Possible transformation pathway of <b>46</b> into <b>18a</b>.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-22/acs.jmedchem.8b00639/20181119/images/large/jm-2018-00639p_0004.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.8b00639&amp;id=fig4"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig5" data-index="7" class="article__inlineFigure"><h2 class="fig-label">Figure 5</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-22/acs.jmedchem.8b00639/20181119/images/medium/jm-2018-00639p_0005.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-22/acs.jmedchem.8b00639/20181119/images/large/jm-2018-00639p_0005.jpeg" id="rightTab-gr5" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 5. (A) Representative gel of TOP1-mediated DNA cleavage assay. Lane 1, DNA alone; lane 2, DNA and TOP1; lane 3, DNA and TOP1 with <b>1</b> (1 μM); lane 4, DNA and TOP1 with <b>48</b> (1 μM); lanes 5–8, DNA and TOP1 with <b>19a</b> at 0.1, 1.0, 10, and 100 μM concentration, respectively. The arrows at left indicate the cleavage site positions. The gel of TOP1-mediated unwinding assay using supercoiled pBR322 DNA (B) or relaxed pBR322 DNA (C) as substrate, respectively. Lane 1, DNA alone; lane 2, DNA and TOP1; lanes 3–5, DNA and TOP1 with the known DNA intercalator, ethidium bromide (EB) at 0.3, 0.6, 1.2 μg/mL, respectively; lanes 6–8, DNA and TOP1 with <b>19a</b> at 1, 3, 9 μM, respectively. Rx, relaxed DNA. Sc, supercoiled DNA. (D) Hypothetical binding mode of <b>19a</b> in the ternary TOP1–DNA–drug cleavage complex (PDB <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=1K4T">1K4T</a>). <b>19a</b> was shown as yellow carbon atoms ball and stick representation. All distances were measured from heavy atom to heavy atom.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-22/acs.jmedchem.8b00639/20181119/images/large/jm-2018-00639p_0005.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.8b00639&amp;id=fig5"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig6" data-index="8" class="article__inlineFigure"><h2 class="fig-label">Figure 6</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-22/acs.jmedchem.8b00639/20181119/images/medium/jm-2018-00639p_0006.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-22/acs.jmedchem.8b00639/20181119/images/large/jm-2018-00639p_0006.jpeg" id="rightTab-gr6" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 6. (A) TDP1 inhibition curves of the active compounds determined using fluorescence assay. Tested concentrations were 0.41, 1.23, 3.70, 11.1, 33.3, and 100 μM. (B) Hypothetical binding mode of <b>41a</b> (red carbon atoms ball and stick representation) in the complex with TDP1 (PDB <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=1RFF">1RFF</a>). All distances were measured from heavy atom to heavy atom. (C) Representative TDP1 inhibition gels of active compounds. Lane 1, DNA alone; lane 2, DNA and recombinant TDP1; lanes 3–26, DNA, recombinant TDP1 and the active compounds at tested concentration. Tested concentrations were 0.05, 0.15, 0.46, 1.4, 4.1, 12.3, 37, and 111 μM. N14Y and N14P are the substrate and product of TDP1, respectively.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-22/acs.jmedchem.8b00639/20181119/images/large/jm-2018-00639p_0006.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.8b00639&amp;id=fig6"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig7" data-index="9" class="article__inlineFigure"><h2 class="fig-label">Figure 7</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-22/acs.jmedchem.8b00639/20181119/images/medium/jm-2018-00639p_0007.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-22/acs.jmedchem.8b00639/20181119/images/large/jm-2018-00639p_0007.jpeg" id="rightTab-gr7" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 7. Pattern comparison analysis of <b>19a</b> using GI<sub>50</sub> data from NCI-60 assays. Individual dots represent a cell line of the NCI-60. Red lines represent regression line. <i>R</i>-square values were 0.58 and 0.40 for camptothecin and the indenoisoquinoline indotecan (LMP400), respectively. <i>P</i>-values were <0.0001 for both comparisons.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-22/acs.jmedchem.8b00639/20181119/images/large/jm-2018-00639p_0007.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.8b00639&amp;id=fig7"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig8" data-index="10" class="article__inlineFigure"><h2 class="fig-label">Figure 8</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-22/acs.jmedchem.8b00639/20181119/images/medium/jm-2018-00639p_0008.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-22/acs.jmedchem.8b00639/20181119/images/large/jm-2018-00639p_0008.jpeg" id="rightTab-gr8" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 8. Synergistic effect of <b>41a</b> (A) and <b>41b</b> (B) with camptothecin. The MCF-7 cells were incubated with camptothecin and the tested compounds for 96 h. Every experiment was repeated four times.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-22/acs.jmedchem.8b00639/20181119/images/large/jm-2018-00639p_0008.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.8b00639&amp;id=fig8"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig9" data-index="11" class="article__inlineFigure"><h2 class="fig-label">Figure 9</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-22/acs.jmedchem.8b00639/20181119/images/medium/jm-2018-00639p_0009.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-22/acs.jmedchem.8b00639/20181119/images/large/jm-2018-00639p_0009.jpeg" id="rightTab-gr9" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 9. (A) Induction of TOP1–DNA covalent cleavage complexes by in vivo complex of enzyme (ICE) assay in human colon cancer HCT116 cells. Upper: lane 1, untreated control; lanes 2 and 3, cells treated with <b>1</b> at 25 and 50 μM, respectively. Bottom: lanes 1–3, cells treated with <b>19a</b> at 25, 50, and 100 μM, respectively. (B) Flow cytometry histograms of apoptosis in HCT116 cells induced by <b>19a</b> at 0.5, 1, and 2 μM, respectively. (C) Histone γH2AX foci induced by <b>19a</b> in HCT116 cells. Cells were treated with <b>1</b> and <b>19a</b> at 1 μM for 3 h. DNA was stained with DAPI (blue).</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-22/acs.jmedchem.8b00639/20181119/images/large/jm-2018-00639p_0009.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.8b00639&amp;id=fig9"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig10" data-index="12" class="article__inlineFigure"><h2 class="fig-label">Figure 10</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-22/acs.jmedchem.8b00639/20181119/images/medium/jm-2018-00639p_0010.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-22/acs.jmedchem.8b00639/20181119/images/large/jm-2018-00639p_0010.jpeg" id="rightTab-gr10" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 10. Antitumor activity of <b>19a</b> in the HCT116 xenograft model. (A) Percent survival of mice treated with <b>19a</b> at doses of 300, 240, and 192 mg/kg. The effects of <b>19a</b> on body weight (B), tumor size (C), and tumor weight (D) at the dose of 5 and 10 mg/kg. Statistically significant difference in mean tumor weight compared with the control, **: <i>P</i> < 0.01.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-22/acs.jmedchem.8b00639/20181119/images/large/jm-2018-00639p_0010.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.8b00639&amp;id=fig10"><span>Download MS PowerPoint Slide</span></a></div></div></figure></li><li id="pane-m2" aria-labelledby="pane-m2" class="tab__pane tab__pane-references empty"><div class="refs-header-label"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="rightTab-_i113">References</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_82237" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_82237" class="dropBlock__holder"></div></div></div></div></div><hr /></hr></div><p class="rightTab-references-count">
            This article references 90 other publications.
        </p><ol id="rightTab-references" class="useLabel"><li id="rightTab-ref1"><div class="reference"><strong class="refLabel"><a href="#ref1" class="rightTabRefNumLink">1</a></strong><div class="NLM_citation" id="rightTab-cit1"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Stewart, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Redinbo, M. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Qiu, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hol, W. G. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Champoux, J. J.</span></span> <span> </span><span class="NLM_article-title">A model for the mechanism of human topoisomerase I</span>. <i>Science</i> <span class="NLM_year" style="font-weight: bold;">1998</span>,  <span class="NLM_volume"><i>279</i></span>,  <span class="NLM_fpage">1534</span>– <span class="NLM_lpage">1541</span>, <span class="refDoi"> DOI: 10.1126/science.279.5356.1534</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00639&amp;key=10.1126%2Fscience.279.5356.1534" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00639&amp;key=9488652" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00639&amp;key=1%3ACAS%3A528%3ADyaK1cXhs1Kmurk%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=279&publication_year=1998&pages=1534-1541&author=L.+Stewartauthor=M.+R.+Redinboauthor=X.+Qiuauthor=W.+G.+J.+Holauthor=J.+J.+Champoux&title=A+model+for+the+mechanism+of+human+topoisomerase+I&doi=10.1126%2Fscience.279.5356.1534"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit1R"><div class="casContent"><span class="casTitleNuber">1</span><div class="casTitle"><span class="NLM_cas:atitle">A model for the mechanism of human topoisomerase I</span></div><div class="casAuthors">Stewart, Lance; Redinbo, Matthew R.; Qiu, Xiayang; Hol, Wim G. J.; Champoux, James J.</div><div class="citationInfo"><span class="NLM_cas:title">Science (Washington, D. C.)</span>
        (<span class="NLM_cas:date">1998</span>),
    <span class="NLM_cas:volume">279</span>
        (<span class="NLM_cas:issue">5356</span>),
    <span class="NLM_cas:pages">1534-1540</span>CODEN:
                <span class="NLM_cas:coden">SCIEAS</span>;
        ISSN:<span class="NLM_cas:issn">0036-8075</span>.
    
            (<span class="NLM_cas:orgname">American Association for the Advancement of Science</span>)
        </div><div class="casAbstract">The 3-dimensional structure of a 70-kDa N-terminally truncated form of human DNA topoisomerase I in complex with a 22-base-pair duplex oligonucleotide, detd. to a resoln. of 2.8 Å, revealed all of the structural elements of the enzyme that contact DNA.  The linker region that connects the central core of the enzyme to the C-terminal domain assumed a coiled-coil configuration and protruded away from the remainder of the enzyme.  The pos. charged DNA-proximal surface of the liner made only a few contacts with the DNA downstream of the cleavage site.  In combination with the crystal structures of reconstituted human topoisomerase I before and after DNA cleavage, this information suggested which amino acid residues are involved in catalyzing phosphodiester bond breakage and religation.  The structures also led to the proposal that the topoisomerization step occurs by a mechanism termed "controlled rotation.".</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoaj4qczHgbVbVg90H21EOLACvtfcHk0lhGJxQ55DycTA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK1cXhs1Kmurk%253D&md5=bf63a56b0cc238c80be98cb95ca398fe</span></div><a href="/servlet/linkout?suffix=cit1&amp;dbid=16384&amp;doi=10.1126%2Fscience.279.5356.1534&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1126%252Fscience.279.5356.1534%26sid%3Dliteratum%253Aachs%26aulast%3DStewart%26aufirst%3DL.%26aulast%3DRedinbo%26aufirst%3DM.%2BR.%26aulast%3DQiu%26aufirst%3DX.%26aulast%3DHol%26aufirst%3DW.%2BG.%2BJ.%26aulast%3DChampoux%26aufirst%3DJ.%2BJ.%26atitle%3DA%2520model%2520for%2520the%2520mechanism%2520of%2520human%2520topoisomerase%2520I%26jtitle%3DScience%26date%3D1998%26volume%3D279%26spage%3D1534%26epage%3D1541%26doi%3D10.1126%2Fscience.279.5356.1534" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref2"><div class="reference"><strong class="refLabel"><a href="#ref2" class="rightTabRefNumLink">2</a></strong><div class="NLM_citation" id="rightTab-cit2"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Champoux, J. J.</span></span> <span> </span><span class="NLM_article-title">DNA topoisomerases: structure, function, and mechanism</span>. <i>Annu. Rev. Biochem.</i> <span class="NLM_year" style="font-weight: bold;">2001</span>,  <span class="NLM_volume"><i>70</i></span>,  <span class="NLM_fpage">369</span>– <span class="NLM_lpage">413</span>, <span class="refDoi"> DOI: 10.1146/annurev.biochem.70.1.369</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00639&amp;key=10.1146%2Fannurev.biochem.70.1.369" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00639&amp;key=11395412" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00639&amp;key=1%3ACAS%3A528%3ADC%252BD3MXlsVeht7Y%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=70&publication_year=2001&pages=369-413&author=J.+J.+Champoux&title=DNA+topoisomerases%3A+structure%2C+function%2C+and+mechanism&doi=10.1146%2Fannurev.biochem.70.1.369"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit2R"><div class="casContent"><span class="casTitleNuber">2</span><div class="casTitle"><span class="NLM_cas:atitle">DNA topoisomerases: structure, function, and mechanism</span></div><div class="casAuthors">Champoux, James J.</div><div class="citationInfo"><span class="NLM_cas:title">Annual Review of Biochemistry</span>
        (<span class="NLM_cas:date">2001</span>),
    <span class="NLM_cas:volume">70</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">369-413</span>CODEN:
                <span class="NLM_cas:coden">ARBOAW</span>;
        ISSN:<span class="NLM_cas:issn">0066-4154</span>.
    
            (<span class="NLM_cas:orgname">Annual Reviews Inc.</span>)
        </div><div class="casAbstract">A review with 196 refs.  DNA topoisomerases solve the topol. problems assocd. with DNA replication, transcription, recombination, and chromatin remodeling by introducing temporary single- or double-strand breaks in the DNA.  In addn., these enzymes fine-tune the steady-state level of DNA supercoiling both to facilitate protein interactions with the DNA and to prevent excessive supercoiling that is deleterious.  In recent years, the crystal structures of a no. of topoisomerase fragments, representing nearly all of the known classes of enzymes, have been solved.  These structures provide remarkable insights into the mechanisms of these enzymes and complement previous conclusions based on biochem. analyses.  Surprisingly, despite little or no sequence homol., both type IA and type IIA topoisomerases from prokaryotes and the type IIA enzymes from eukaryotes share structural folds that appear to reflect functional motifs within crit. regions of the enzymes.  The type IB enzymes are structurally distinct from all other known topoisomerases but are similar to a class of enzymes referred to as tyrosine recombinases.  The structural themes common to all topoisomerases include hinged clamps that open and close to bind DNA, the presence of DNA binding cavities for temporary storage of DNA segments, and the coupling of protein conformational changes to DNA rotation or DNA movement.  For the type II topoisomerases, the binding and hydrolysis of ATP further modulate conformational changes in the enzymes to effect changes in DNA topol.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGq5Y4rDyIYy17Vg90H21EOLACvtfcHk0limjEruy1mkJQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3MXlsVeht7Y%253D&md5=67c3e38eb4fcb85527b33d7077309482</span></div><a href="/servlet/linkout?suffix=cit2&amp;dbid=16384&amp;doi=10.1146%2Fannurev.biochem.70.1.369&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1146%252Fannurev.biochem.70.1.369%26sid%3Dliteratum%253Aachs%26aulast%3DChampoux%26aufirst%3DJ.%2BJ.%26atitle%3DDNA%2520topoisomerases%253A%2520structure%252C%2520function%252C%2520and%2520mechanism%26jtitle%3DAnnu.%2520Rev.%2520Biochem.%26date%3D2001%26volume%3D70%26spage%3D369%26epage%3D413%26doi%3D10.1146%2Fannurev.biochem.70.1.369" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref3"><div class="reference"><strong class="refLabel"><a href="#ref3" class="rightTabRefNumLink">3</a></strong><div class="NLM_citation" id="rightTab-cit3"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Wang, J. C.</span></span> <span> </span><span class="NLM_article-title">DNA topoisomerases</span>. <i>Annu. Rev. Biochem.</i> <span class="NLM_year" style="font-weight: bold;">1996</span>,  <span class="NLM_volume"><i>65</i></span>,  <span class="NLM_fpage">635</span>– <span class="NLM_lpage">692</span>, <span class="refDoi"> DOI: 10.1146/annurev.bi.65.070196.003223</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00639&amp;key=10.1146%2Fannurev.bi.65.070196.003223" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00639&amp;key=8811192" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00639&amp;key=1%3ACAS%3A528%3ADyaK28XktFamur0%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=65&publication_year=1996&pages=635-692&author=J.+C.+Wang&title=DNA+topoisomerases&doi=10.1146%2Fannurev.bi.65.070196.003223"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit3R"><div class="casContent"><span class="casTitleNuber">3</span><div class="casTitle"><span class="NLM_cas:atitle">DNA topoisomerases</span></div><div class="casAuthors">Wang, James C.</div><div class="citationInfo"><span class="NLM_cas:title">Annual Review of Biochemistry</span>
        (<span class="NLM_cas:date">1996</span>),
    <span class="NLM_cas:volume">65</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">635-692</span>CODEN:
                <span class="NLM_cas:coden">ARBOAW</span>;
        ISSN:<span class="NLM_cas:issn">0066-4154</span>.
    
            (<span class="NLM_cas:orgname">Annual Reviews</span>)
        </div><div class="casAbstract">A review, with 610 refs.  The various problems of disentangling DNA strands or duplexes in a cell are all rooted in the double-helical structure of DNA.  Three distinct subfamilies of enzymes, known as the DNA topoisomerases, have evolved to solve these problems.  This review focuses on work in the past decade on the mechanisms and cellular functions of these enzymes.  Newly discovered members and recent biochem. and structural results are reviewed, and mechanistic implications of these results are summarized.  The primary cellular functions of these enzymes, including their roles in replication, transcription, chromosome condensation, and the maintenance of genome stability, are then discussed.  The review ends with a summary of the regulation of the cellular levels of these enzymes and a discussion of their assocn. with other cellular proteins.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGog_BfdOibiUrVg90H21EOLACvtfcHk0limjEruy1mkJQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK28XktFamur0%253D&md5=7f783337b59dc0797e4f3d56e66fb499</span></div><a href="/servlet/linkout?suffix=cit3&amp;dbid=16384&amp;doi=10.1146%2Fannurev.bi.65.070196.003223&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1146%252Fannurev.bi.65.070196.003223%26sid%3Dliteratum%253Aachs%26aulast%3DWang%26aufirst%3DJ.%2BC.%26atitle%3DDNA%2520topoisomerases%26jtitle%3DAnnu.%2520Rev.%2520Biochem.%26date%3D1996%26volume%3D65%26spage%3D635%26epage%3D692%26doi%3D10.1146%2Fannurev.bi.65.070196.003223" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref4"><div class="reference"><strong class="refLabel"><a href="#ref4" class="rightTabRefNumLink">4</a></strong><div class="NLM_citation" id="rightTab-cit4"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Pommier, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sun, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Huang, S. N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nitiss, J. L.</span></span> <span> </span><span class="NLM_article-title">Roles of eukaryotic topoisomerases in transcription, replication and genomic stability</span>. <i>Nat. Rev. Mol. Cell Biol.</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>17</i></span>,  <span class="NLM_fpage">703</span>– <span class="NLM_lpage">721</span>, <span class="refDoi"> DOI: 10.1038/nrm.2016.111</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00639&amp;key=10.1038%2Fnrm.2016.111" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00639&amp;key=27649880" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00639&amp;key=1%3ACAS%3A528%3ADC%252BC28XhsFemsbvO" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=17&publication_year=2016&pages=703-721&author=Y.+Pommierauthor=Y.+Sunauthor=S.+N.+Huangauthor=J.+L.+Nitiss&title=Roles+of+eukaryotic+topoisomerases+in+transcription%2C+replication+and+genomic+stability&doi=10.1038%2Fnrm.2016.111"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit4R"><div class="casContent"><span class="casTitleNuber">4</span><div class="casTitle"><span class="NLM_cas:atitle">Roles of eukaryotic topoisomerases in transcription, replication and genomic stability</span></div><div class="casAuthors">Pommier, Yves; Sun, Yilun; Huang, Shar-yin N.; Nitiss, John L.</div><div class="citationInfo"><span class="NLM_cas:title">Nature Reviews Molecular Cell Biology</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">17</span>
        (<span class="NLM_cas:issue">11</span>),
    <span class="NLM_cas:pages">703-721</span>CODEN:
                <span class="NLM_cas:coden">NRMCBP</span>;
        ISSN:<span class="NLM_cas:issn">1471-0072</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">A review.  Topoisomerases introduce transient DNA breaks to relax supercoiled DNA, remove catenanes and enable chromosome segregation.  Human cells encode six topoisomerases (TOP1, TOP1mt, TOP2α, TOP2β, TOP3α and TOP3β), which act on a broad range of DNA and RNA substrates at the nuclear and mitochondrial genomes.  Their catalytic intermediates, the topoisomerase cleavage complexes (TOPcc), are therapeutic targets of various anticancer drugs.  TOPcc can also form on damaged DNA during replication and transcription, and engage specific repair pathways, such as those mediated by tyrosyl-DNA phosphodiesterase 1 (TDP1) and TDP2 and by endonucleases (MRE11, XPF-ERCC1 and MUS81).  Here, we review the roles of topoisomerases in mediating chromatin dynamics, transcription, replication, DNA damage repair and genomic stability, and discuss how deregulation of topoisomerases can cause neurodegenerative diseases, immune disorders and cancer.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGp2RnRxdI5gv7Vg90H21EOLACvtfcHk0limjEruy1mkJQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28XhsFemsbvO&md5=d1e6b3015a76a21ff92502f7e4eb5016</span></div><a href="/servlet/linkout?suffix=cit4&amp;dbid=16384&amp;doi=10.1038%2Fnrm.2016.111&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnrm.2016.111%26sid%3Dliteratum%253Aachs%26aulast%3DPommier%26aufirst%3DY.%26aulast%3DSun%26aufirst%3DY.%26aulast%3DHuang%26aufirst%3DS.%2BN.%26aulast%3DNitiss%26aufirst%3DJ.%2BL.%26atitle%3DRoles%2520of%2520eukaryotic%2520topoisomerases%2520in%2520transcription%252C%2520replication%2520and%2520genomic%2520stability%26jtitle%3DNat.%2520Rev.%2520Mol.%2520Cell%2520Biol.%26date%3D2016%26volume%3D17%26spage%3D703%26epage%3D721%26doi%3D10.1038%2Fnrm.2016.111" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref5"><div class="reference"><strong class="refLabel"><a href="#ref5" class="rightTabRefNumLink">5</a></strong><div class="NLM_citation" id="rightTab-cit5"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Pommier, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Leo, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Marchand, C.</span></span> <span> </span><span class="NLM_article-title">DNA topoisomerases and their poisoning by anticancer and antibacterial drugs</span>. <i>Chem. Biol.</i> <span class="NLM_year" style="font-weight: bold;">2010</span>,  <span class="NLM_volume"><i>17</i></span>,  <span class="NLM_fpage">421</span>– <span class="NLM_lpage">433</span>, <span class="refDoi"> DOI: 10.1016/j.chembiol.2010.04.012</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00639&amp;key=10.1016%2Fj.chembiol.2010.04.012" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00639&amp;key=20534341" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00639&amp;key=1%3ACAS%3A528%3ADC%252BC3cXmslCjsLY%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=17&publication_year=2010&pages=421-433&author=Y.+Pommierauthor=E.+Leoauthor=H.+Zhangauthor=C.+Marchand&title=DNA+topoisomerases+and+their+poisoning+by+anticancer+and+antibacterial+drugs&doi=10.1016%2Fj.chembiol.2010.04.012"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit5R"><div class="casContent"><span class="casTitleNuber">5</span><div class="casTitle"><span class="NLM_cas:atitle">DNA Topoisomerases and Their Poisoning by Anticancer and Antibacterial Drugs</span></div><div class="casAuthors">Pommier, Yves; Leo, Elisabetta; Zhang, Hong-Liang; Marchand, Christophe</div><div class="citationInfo"><span class="NLM_cas:title">Chemistry & Biology (Cambridge, MA, United States)</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">17</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">421-433</span>CODEN:
                <span class="NLM_cas:coden">CBOLE2</span>;
        ISSN:<span class="NLM_cas:issn">1074-5521</span>.
    
            (<span class="NLM_cas:orgname">Cell Press</span>)
        </div><div class="casAbstract">A review.  DNA topoisomerases are the targets of important anticancer and antibacterial drugs.  Camptothecins and novel noncamptothecins in clin. development (indenoisoquinolines and ARC-111) target eukaryotic type IB topoisomerases (Top1), whereas human type IIA topoisomerases (Top2α and Top2β) are the targets of the widely used anticancer agents etoposide, anthracyclines (doxorubicin, daunorubicin), and mitoxantrone.  Bacterial type II topoisomerases (gyrase and Topo IV) are the targets of quinolones and aminocoumarin antibiotics.  This review focuses on the mol. and biochem. characteristics of topoisomerases and their inhibitors.  We also discuss the common mechanism of action of topoisomerase poisons by interfacial inhibition and trapping of topoisomerase cleavage complexes.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqr6m1st3bchbVg90H21EOLACvtfcHk0liJc_Q_5__ehw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXmslCjsLY%253D&md5=ab00ffa6d0e8bf0c433b154e2a4b484a</span></div><a href="/servlet/linkout?suffix=cit5&amp;dbid=16384&amp;doi=10.1016%2Fj.chembiol.2010.04.012&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.chembiol.2010.04.012%26sid%3Dliteratum%253Aachs%26aulast%3DPommier%26aufirst%3DY.%26aulast%3DLeo%26aufirst%3DE.%26aulast%3DZhang%26aufirst%3DH.%26aulast%3DMarchand%26aufirst%3DC.%26atitle%3DDNA%2520topoisomerases%2520and%2520their%2520poisoning%2520by%2520anticancer%2520and%2520antibacterial%2520drugs%26jtitle%3DChem.%2520Biol.%26date%3D2010%26volume%3D17%26spage%3D421%26epage%3D433%26doi%3D10.1016%2Fj.chembiol.2010.04.012" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref6"><div class="reference"><strong class="refLabel"><a href="#ref6" class="rightTabRefNumLink">6</a></strong><div class="NLM_citation" id="rightTab-cit6"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Pommier, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Marchand, C.</span></span> <span> </span><span class="NLM_article-title">Interfacial inhibitors: targeting macromolecular complexes</span>. <i>Nat. Rev. Drug Discovery</i> <span class="NLM_year" style="font-weight: bold;">2012</span>,  <span class="NLM_volume"><i>11</i></span>,  <span class="NLM_fpage">25</span>– <span class="NLM_lpage">36</span>, <span class="refDoi"> DOI: 10.1038/nrd3404</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00639&amp;key=10.1038%2Fnrd3404" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00639&amp;key=1%3ACAS%3A528%3ADC%252BC3MXhs1aitr3F" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=11&publication_year=2012&pages=25-36&author=Y.+Pommierauthor=C.+Marchand&title=Interfacial+inhibitors%3A+targeting+macromolecular+complexes&doi=10.1038%2Fnrd3404"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit6R"><div class="casContent"><span class="casTitleNuber">6</span><div class="casTitle"><span class="NLM_cas:atitle">Interfacial inhibitors: targeting macromolecular complexes</span></div><div class="casAuthors">Pommier, Yves; Marchand, Christophe</div><div class="citationInfo"><span class="NLM_cas:title">Nature Reviews Drug Discovery</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">11</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">25-36</span>CODEN:
                <span class="NLM_cas:coden">NRDDAG</span>;
        ISSN:<span class="NLM_cas:issn">1474-1776</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">A review.  Interfacial inhibitors belong to a broad class of natural products and synthetic drugs that are commonly used to treat cancers as well as bacterial and HIV infections.  They bind selectively to interfaces as macromol. machines assemble and are set in motion.  The bound drugs transiently arrest the targeted mol. machines, which can initiate allosteric effects, or desynchronize macromol. machines that normally function in concert.  Here, we review five archetypical examples of interfacial inhibitors: the camptothecins, etoposide, the quinolone antibiotics, the vinca alkaloids and the novel anti-HIV inhibitor raltegravir.  We discuss the common and diverging elements between interfacial and allosteric inhibitors and give a perspective for the rationale and methods used to discover novel interfacial inhibitors.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpjeQ4_1kAh-bVg90H21EOLACvtfcHk0liJc_Q_5__ehw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXhs1aitr3F&md5=e69c1b97286dc65855ee8784203d4d85</span></div><a href="/servlet/linkout?suffix=cit6&amp;dbid=16384&amp;doi=10.1038%2Fnrd3404&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnrd3404%26sid%3Dliteratum%253Aachs%26aulast%3DPommier%26aufirst%3DY.%26aulast%3DMarchand%26aufirst%3DC.%26atitle%3DInterfacial%2520inhibitors%253A%2520targeting%2520macromolecular%2520complexes%26jtitle%3DNat.%2520Rev.%2520Drug%2520Discovery%26date%3D2012%26volume%3D11%26spage%3D25%26epage%3D36%26doi%3D10.1038%2Fnrd3404" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref7"><div class="reference"><strong class="refLabel"><a href="#ref7" class="rightTabRefNumLink">7</a></strong><div class="NLM_citation" id="rightTab-cit7"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Choi, S. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tsuchida, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yang, H. W.</span></span> <span> </span><span class="NLM_article-title">Oral versus intraperitoneal administration of irinotecan in the treatment of human neuroblastoma in nude mice</span>. <i>Cancer Lett.</i> <span class="NLM_year" style="font-weight: bold;">1998</span>,  <span class="NLM_volume"><i>124</i></span>,  <span class="NLM_fpage">15</span>– <span class="NLM_lpage">21</span>, <span class="refDoi"> DOI: 10.1016/S0304-3835(97)00428-X</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00639&amp;key=10.1016%2FS0304-3835%2897%2900428-X" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00639&amp;key=9500186" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00639&amp;key=1%3ACAS%3A528%3ADyaK1cXnt12nsA%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=124&publication_year=1998&pages=15-21&author=S.+H.+Choiauthor=Y.+Tsuchidaauthor=H.+W.+Yang&title=Oral+versus+intraperitoneal+administration+of+irinotecan+in+the+treatment+of+human+neuroblastoma+in+nude+mice&doi=10.1016%2FS0304-3835%2897%2900428-X"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit7R"><div class="casContent"><span class="casTitleNuber">7</span><div class="casTitle"><span class="NLM_cas:atitle">Oral versus intraperitoneal administration of irinotecan in the treatment of human neuroblastoma in nude mice</span></div><div class="casAuthors">Choi, Seung-Hoon; Tsuchida, Yoshiaki; Yang, Hong-Wei</div><div class="citationInfo"><span class="NLM_cas:title">Cancer Letters (Shannon, Ireland)</span>
        (<span class="NLM_cas:date">1998</span>),
    <span class="NLM_cas:volume">124</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">15-21</span>CODEN:
                <span class="NLM_cas:coden">CALEDQ</span>;
        ISSN:<span class="NLM_cas:issn">0304-3835</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Science Ireland Ltd.</span>)
        </div><div class="casAbstract">The present study evaluated the plasma pharmacokinetics of irinotecan (CPT-11) and its effects against a human neuroblastoma in xenograft, given by different administration routes.  One-third of the LD50 was administered either i.p. (59 mg/kg mouse wt. (MW)) or orally (404 mg/kg MW) to nude mice.  The plasma levels of CPT-11 and its active metabolite SN-38 decreased rapidly when CPT-11 was administered i.p., but remained relatively high for 4-8 h after oral administration.  Then, a human neuroblastoma xenograft was inoculated in another set of 21 nude mice.  When the estd. tumor wt. reached 150-200 mg, CPT-11 was administered in the total LD50 either i.p. or orally in three doses at 4-day intervals (q4d ×3) to the mice in each exptl. group.  Oral administration was superior to i.p. injection in terms of tumor inhibition and to be an effective route for CPT-11 administration in the treatment of human neuroblastoma in nude mice.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrP3PS7OMs8FLVg90H21EOLACvtfcHk0lgj60lwu-Iz-w"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK1cXnt12nsA%253D%253D&md5=31c482bafc89daa777d1de50898e1c98</span></div><a href="/servlet/linkout?suffix=cit7&amp;dbid=16384&amp;doi=10.1016%2FS0304-3835%2897%2900428-X&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS0304-3835%252897%252900428-X%26sid%3Dliteratum%253Aachs%26aulast%3DChoi%26aufirst%3DS.%2BH.%26aulast%3DTsuchida%26aufirst%3DY.%26aulast%3DYang%26aufirst%3DH.%2BW.%26atitle%3DOral%2520versus%2520intraperitoneal%2520administration%2520of%2520irinotecan%2520in%2520the%2520treatment%2520of%2520human%2520neuroblastoma%2520in%2520nude%2520mice%26jtitle%3DCancer%2520Lett.%26date%3D1998%26volume%3D124%26spage%3D15%26epage%3D21%26doi%3D10.1016%2FS0304-3835%2897%2900428-X" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref8"><div class="reference"><strong class="refLabel"><a href="#ref8" class="rightTabRefNumLink">8</a></strong><div class="NLM_citation" id="rightTab-cit8"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Brogden, R. N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wiseman, L. R.</span></span> <span> </span><span class="NLM_article-title">Topotecan a review of its potential in advanced ovarian cancer</span>. <i>Drugs</i> <span class="NLM_year" style="font-weight: bold;">1998</span>,  <span class="NLM_volume"><i>56</i></span>,  <span class="NLM_fpage">709</span>– <span class="NLM_lpage">723</span>, <span class="refDoi"> DOI: 10.2165/00003495-199856040-00017</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00639&amp;key=10.2165%2F00003495-199856040-00017" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=56&publication_year=1998&pages=709-723&author=R.+N.+Brogdenauthor=L.+R.+Wiseman&title=Topotecan+a+review+of+its+potential+in+advanced+ovarian+cancer&doi=10.2165%2F00003495-199856040-00017"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit8&amp;dbid=16384&amp;doi=10.2165%2F00003495-199856040-00017&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.2165%252F00003495-199856040-00017%26sid%3Dliteratum%253Aachs%26aulast%3DBrogden%26aufirst%3DR.%2BN.%26aulast%3DWiseman%26aufirst%3DL.%2BR.%26atitle%3DTopotecan%2520a%2520review%2520of%2520its%2520potential%2520in%2520advanced%2520ovarian%2520cancer%26jtitle%3DDrugs%26date%3D1998%26volume%3D56%26spage%3D709%26epage%3D723%26doi%3D10.2165%2F00003495-199856040-00017" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref9"><div class="reference"><strong class="refLabel"><a href="#ref9" class="rightTabRefNumLink">9</a></strong><div class="NLM_citation" id="rightTab-cit9"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Bracher, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tremmel, T.</span></span> <span> </span><span class="NLM_article-title">From lead to drug utilizing a mannich reaction: The topotecan story</span>. <i>Arch. Pharm.</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>350</i></span>,  <span class="NLM_fpage">e1600236</span>, <span class="refDoi"> DOI: 10.1002/ardp.201600236</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00639&amp;key=10.1002%2Fardp.201600236" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=350&publication_year=2017&pages=e1600236&author=F.+Bracherauthor=T.+Tremmel&title=From+lead+to+drug+utilizing+a+mannich+reaction%3A+The+topotecan+story&doi=10.1002%2Fardp.201600236"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit9&amp;dbid=16384&amp;doi=10.1002%2Fardp.201600236&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fardp.201600236%26sid%3Dliteratum%253Aachs%26aulast%3DBracher%26aufirst%3DF.%26aulast%3DTremmel%26aufirst%3DT.%26atitle%3DFrom%2520lead%2520to%2520drug%2520utilizing%2520a%2520mannich%2520reaction%253A%2520The%2520topotecan%2520story%26jtitle%3DArch.%2520Pharm.%26date%3D2017%26volume%3D350%26spage%3De1600236%26doi%3D10.1002%2Fardp.201600236" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref10"><div class="reference"><strong class="refLabel"><a href="#ref10" class="rightTabRefNumLink">10</a></strong><div class="NLM_citation" id="rightTab-cit10"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cai, Q.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liu, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sun, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chambless, B.</span></span> <span> </span><span class="NLM_article-title">Preclinical pharmacology of the natural product anticancer agent 10-hydroxycamptothecin, an inhibitor of topoisomerase I</span>. <i>Cancer Chemother. Pharmacol.</i> <span class="NLM_year" style="font-weight: bold;">1998</span>,  <span class="NLM_volume"><i>41</i></span>,  <span class="NLM_fpage">257</span>– <span class="NLM_lpage">267</span>, <span class="refDoi"> DOI: 10.1007/s002800050738</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00639&amp;key=10.1007%2Fs002800050738" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00639&amp;key=9488594" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00639&amp;key=1%3ACAS%3A528%3ADyaK1cXovVSgtA%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=41&publication_year=1998&pages=257-267&author=R.+Zhangauthor=Y.+Liauthor=Q.+Caiauthor=T.+Liuauthor=H.+Sunauthor=B.+Chambless&title=Preclinical+pharmacology+of+the+natural+product+anticancer+agent+10-hydroxycamptothecin%2C+an+inhibitor+of+topoisomerase+I&doi=10.1007%2Fs002800050738"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit10R"><div class="casContent"><span class="casTitleNuber">10</span><div class="casTitle"><span class="NLM_cas:atitle">Preclinical pharmacology of the natural product anticancer agent 10-hydroxycamptothecin, an inhibitor of topoisomerase I</span></div><div class="casAuthors">Zhang, Rui Wen; Li, Yu Feng; Cai, Qiu Yin; Liu, Tie Pu; Sun, He; Chambless, Brandon</div><div class="citationInfo"><span class="NLM_cas:title">Cancer Chemotherapy and Pharmacology</span>
        (<span class="NLM_cas:date">1998</span>),
    <span class="NLM_cas:volume">41</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">257-267</span>CODEN:
                <span class="NLM_cas:coden">CCPHDZ</span>;
        ISSN:<span class="NLM_cas:issn">0344-5704</span>.
    
            (<span class="NLM_cas:orgname">Springer-Verlag</span>)
        </div><div class="casAbstract">Pharmacokinetics, tissue distribution, metab., and elimination of 10-hydroxycamptothecin (HCPT), an alkaloid isolated from the Chinese tree Camptotheca acuminata were studied in rats after i.v. injection of 1, 3, or 10 mg/kg.  Following i.v. administration at doses of 3 or 10 mg/kg, the blood plasma concn.-time profile for lactone HCPT could be best described by a 3-compartment model, with terminal elimination half-lives of 140.4 and 428.6 min, resp.  A 2-compartment model was used to fit the plasma concn.-time curve at 1 mg/kg, with a terminal elimination half-life of 30.5 min.  Carboxylate HCPT had a longer half-life than the lactone form of HCPT.  During the initial 6 h after dosing urinary excretion was the major route of elimination, and fecal excretion became the major route of elimination thereafter.  HCPT was widely distributed to various tissues including the enterohepatic system, kidney, and bone marrow.  The lactone form of HCPT was detectable in various tissues examd. ≤72 h after dosing at all the 3 test doses.  HCPT glucuronides were present in plasma, urine, feces, and various tissues.  No toxicity was obsd. at doses of 1 or 3 mg/kg.  Polyuria and hematuria were obsd. only during the initial 3 h after dosing at 10 mg/kg.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoQxe6kJIOhH7Vg90H21EOLACvtfcHk0lgj60lwu-Iz-w"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK1cXovVSgtA%253D%253D&md5=542c5d001270eb8b4b2d80934903c7e1</span></div><a href="/servlet/linkout?suffix=cit10&amp;dbid=16384&amp;doi=10.1007%2Fs002800050738&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1007%252Fs002800050738%26sid%3Dliteratum%253Aachs%26aulast%3DZhang%26aufirst%3DR.%26aulast%3DLi%26aufirst%3DY.%26aulast%3DCai%26aufirst%3DQ.%26aulast%3DLiu%26aufirst%3DT.%26aulast%3DSun%26aufirst%3DH.%26aulast%3DChambless%26aufirst%3DB.%26atitle%3DPreclinical%2520pharmacology%2520of%2520the%2520natural%2520product%2520anticancer%2520agent%252010-hydroxycamptothecin%252C%2520an%2520inhibitor%2520of%2520topoisomerase%2520I%26jtitle%3DCancer%2520Chemother.%2520Pharmacol.%26date%3D1998%26volume%3D41%26spage%3D257%26epage%3D267%26doi%3D10.1007%2Fs002800050738" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref11"><div class="reference"><strong class="refLabel"><a href="#ref11" class="rightTabRefNumLink">11</a></strong><div class="NLM_citation" id="rightTab-cit11"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Shao, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Huang, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fu, J.</span></span> <span> </span><span class="NLM_article-title">Clinical study on treatment of non-small cell lung cancer with 10-hydroxycamptothecin</span>. <i>Chin. J. Clin. Oncol.</i> <span class="NLM_year" style="font-weight: bold;">2003</span>,  <span class="NLM_volume"><i>30</i></span>,  <span class="NLM_fpage">26</span>– <span class="NLM_lpage">28</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=30&publication_year=2003&pages=26-28&author=J.+Shaoauthor=F.+Huangauthor=J.+Fu&title=Clinical+study+on+treatment+of+non-small+cell+lung+cancer+with+10-hydroxycamptothecin"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit11&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DShao%26aufirst%3DJ.%26aulast%3DHuang%26aufirst%3DF.%26aulast%3DFu%26aufirst%3DJ.%26atitle%3DClinical%2520study%2520on%2520treatment%2520of%2520non-small%2520cell%2520lung%2520cancer%2520with%252010-hydroxycamptothecin%26jtitle%3DChin.%2520J.%2520Clin.%2520Oncol.%26date%3D2003%26volume%3D30%26spage%3D26%26epage%3D28" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref12"><div class="reference"><strong class="refLabel"><a href="#ref12" class="rightTabRefNumLink">12</a></strong><div class="NLM_citation" id="rightTab-cit12"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Pommier, Y.</span></span> <span> </span><span class="NLM_article-title">Topoisomerase I inhibitors: camptothecins and beyond</span>. <i>Nat. Rev. Cancer</i> <span class="NLM_year" style="font-weight: bold;">2006</span>,  <span class="NLM_volume"><i>6</i></span>,  <span class="NLM_fpage">789</span>– <span class="NLM_lpage">802</span>, <span class="refDoi"> DOI: 10.1038/nrc1977</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00639&amp;key=10.1038%2Fnrc1977" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00639&amp;key=16990856" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00639&amp;key=1%3ACAS%3A528%3ADC%252BD28XpvVClsr0%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=6&publication_year=2006&pages=789-802&author=Y.+Pommier&title=Topoisomerase+I+inhibitors%3A+camptothecins+and+beyond&doi=10.1038%2Fnrc1977"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit12R"><div class="casContent"><span class="casTitleNuber">12</span><div class="casTitle"><span class="NLM_cas:atitle">Topoisomerase I inhibitors: camptothecins and beyond</span></div><div class="casAuthors">Pommier, Yves</div><div class="citationInfo"><span class="NLM_cas:title">Nature Reviews Cancer</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">6</span>
        (<span class="NLM_cas:issue">10</span>),
    <span class="NLM_cas:pages">789-802</span>CODEN:
                <span class="NLM_cas:coden">NRCAC4</span>;
        ISSN:<span class="NLM_cas:issn">1474-175X</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">A review.  Nuclear DNA topoisomerase I (TOP1) is an essential human enzyme.  It is the only known target of the alkaloid camptothecin, from which the potent anticancer agents irinotecan and topotecan are derived.  As camptothecins bind at the interface of the TOP1-DNA complex, they represent a paradigm for interfacial inhibitors that reversibly trap macromol. complexes.  Several camptothecin and noncamptothecin derivs. are being developed to further increase antitumor activity and reduce side effects.  The mechanisms and mol. determinants of tumor response to TOP1 inhibitors are reviewed, and rational combinations of TOP1 inhibitors with other drugs are considered based on current knowledge of repair and checkpoint pathways that are assocd. with TOP1-mediated DNA damage.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrl5lxd3qfkwbVg90H21EOLACvtfcHk0liC87_-wZ9hfQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28XpvVClsr0%253D&md5=a437970077c0edbbab602b296fcd092a</span></div><a href="/servlet/linkout?suffix=cit12&amp;dbid=16384&amp;doi=10.1038%2Fnrc1977&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnrc1977%26sid%3Dliteratum%253Aachs%26aulast%3DPommier%26aufirst%3DY.%26atitle%3DTopoisomerase%2520I%2520inhibitors%253A%2520camptothecins%2520and%2520beyond%26jtitle%3DNat.%2520Rev.%2520Cancer%26date%3D2006%26volume%3D6%26spage%3D789%26epage%3D802%26doi%3D10.1038%2Fnrc1977" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref13"><div class="reference"><strong class="refLabel"><a href="#ref13" class="rightTabRefNumLink">13</a></strong><div class="NLM_citation" id="rightTab-cit13"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Pommier, Y.</span></span> <span> </span><span class="NLM_article-title">DNA Topoisomerase I Inhibitors: chemistry, biology, and interfacial inhibition</span>. <i>Chem. Rev.</i> <span class="NLM_year" style="font-weight: bold;">2009</span>,  <span class="NLM_volume"><i>109</i></span>,  <span class="NLM_fpage">2894</span>– <span class="NLM_lpage">2902</span>, <span class="refDoi"> DOI: 10.1021/cr900097c</span> </span><div class="citationLinks">[<a href="/doi/10.1021/cr900097c" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref13/cit13&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00639&amp;key=1%3ACAS%3A528%3ADC%252BD1MXmsFals7o%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=109&publication_year=2009&pages=2894-2902&author=Y.+Pommier&title=DNA+Topoisomerase+I+Inhibitors%3A+chemistry%2C+biology%2C+and+interfacial+inhibition&doi=10.1021%2Fcr900097c"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit13R"><div class="casContent"><span class="casTitleNuber">13</span><div class="casTitle"><span class="NLM_cas:atitle">DNA Topoisomerase I Inhibitors: Chemistry, Biology, and Interfacial Inhibition</span></div><div class="casAuthors">Pommier, Yves</div><div class="citationInfo"><span class="NLM_cas:title">Chemical Reviews (Washington, DC, United States)</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">109</span>
        (<span class="NLM_cas:issue">7</span>),
    <span class="NLM_cas:pages">2894-2902</span>CODEN:
                <span class="NLM_cas:coden">CHREAY</span>;
        ISSN:<span class="NLM_cas:issn">0009-2665</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">A review on DNA topoisomerase I inhibitors as anticancer drugs.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGp8qSNXYdDat7Vg90H21EOLACvtfcHk0liC87_-wZ9hfQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXmsFals7o%253D&md5=438bcf21b446a6b87634dd362d9467e4</span></div><a href="/servlet/linkout?suffix=cit13&amp;dbid=16384&amp;doi=10.1021%2Fcr900097c&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fcr900097c%26sid%3Dliteratum%253Aachs%26aulast%3DPommier%26aufirst%3DY.%26atitle%3DDNA%2520Topoisomerase%2520I%2520Inhibitors%253A%2520chemistry%252C%2520biology%252C%2520and%2520interfacial%2520inhibition%26jtitle%3DChem.%2520Rev.%26date%3D2009%26volume%3D109%26spage%3D2894%26epage%3D2902%26doi%3D10.1021%2Fcr900097c" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref14"><div class="reference"><strong class="refLabel"><a href="#ref14" class="rightTabRefNumLink">14</a></strong><div class="NLM_citation" id="rightTab-cit14"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Beretta, G. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Perego, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zunino, F.</span></span> <span> </span><span class="NLM_article-title">Targeting topoisomerase I: molecular mechanisms and cellular determinants of response to topoisomerase I inhibitors</span>. <i>Expert Opin. Ther. Targets</i> <span class="NLM_year" style="font-weight: bold;">2008</span>,  <span class="NLM_volume"><i>12</i></span>,  <span class="NLM_fpage">1243</span>– <span class="NLM_lpage">1256</span>, <span class="refDoi"> DOI: 10.1517/14728222.12.10.1243</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref14/cit14&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00639&amp;key=10.1517%2F14728222.12.10.1243" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref14/cit14&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00639&amp;key=18781823" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref14/cit14&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00639&amp;key=1%3ACAS%3A528%3ADC%252BD1cXhtFSmsrjF" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=12&publication_year=2008&pages=1243-1256&author=G.+L.+Berettaauthor=P.+Peregoauthor=F.+Zunino&title=Targeting+topoisomerase+I%3A+molecular+mechanisms+and+cellular+determinants+of+response+to+topoisomerase+I+inhibitors&doi=10.1517%2F14728222.12.10.1243"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit14R"><div class="casContent"><span class="casTitleNuber">14</span><div class="casTitle"><span class="NLM_cas:atitle">Targeting topoisomerase I: molecular mechanisms and cellular determinants of response to topoisomerase I inhibitors</span></div><div class="casAuthors">Beretta, Giovanni Luca; Perego, Paola; Zunino, Franco</div><div class="citationInfo"><span class="NLM_cas:title">Expert Opinion on Therapeutic Targets</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">12</span>
        (<span class="NLM_cas:issue">10</span>),
    <span class="NLM_cas:pages">1243-1256</span>CODEN:
                <span class="NLM_cas:coden">EOTTAO</span>;
        ISSN:<span class="NLM_cas:issn">1472-8222</span>.
    
            (<span class="NLM_cas:orgname">Informa Healthcare</span>)
        </div><div class="casAbstract">A review.  Background: Topoisomerase I is required for DNA relaxation during crit. cellular functions.  The identification of camptothecins as specific enzyme inhibitors and their clin. efficacy have stimulated extensive efforts to exploit topoisomerase I as a tumor target and explain the putative mechanisms of antitumor-specific action.  Objective: This review provides an overview of the recent achievements in the development of topoisomerase I inhibitors and in the explanation of the biol. pathways involved in tumor response.  Results/conclusion: In spite of the difficulty to identify novel topoisomerase I inhibitors with improved pharmacol. properties, a growing body of evidence supports the possibility of optimizing the therapeutic profile of available agents.  The explanation of defense mechanisms and the mol. determinants of tumor cell response is expected to provide a basis for the design of combination approaches for optimization of topoisomerase I inhibitors-based therapy.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGojS1iFZFc4BbVg90H21EOLACvtfcHk0liC87_-wZ9hfQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXhtFSmsrjF&md5=4d8838b6df1138977c61b914d15cf689</span></div><a href="/servlet/linkout?suffix=cit14&amp;dbid=16384&amp;doi=10.1517%2F14728222.12.10.1243&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1517%252F14728222.12.10.1243%26sid%3Dliteratum%253Aachs%26aulast%3DBeretta%26aufirst%3DG.%2BL.%26aulast%3DPerego%26aufirst%3DP.%26aulast%3DZunino%26aufirst%3DF.%26atitle%3DTargeting%2520topoisomerase%2520I%253A%2520molecular%2520mechanisms%2520and%2520cellular%2520determinants%2520of%2520response%2520to%2520topoisomerase%2520I%2520inhibitors%26jtitle%3DExpert%2520Opin.%2520Ther.%2520Targets%26date%3D2008%26volume%3D12%26spage%3D1243%26epage%3D1256%26doi%3D10.1517%2F14728222.12.10.1243" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref15"><div class="reference"><strong class="refLabel"><a href="#ref15" class="rightTabRefNumLink">15</a></strong><div class="NLM_citation" id="rightTab-cit15"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Pommier, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Barcelo, J. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rao, V. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sordet, O.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jobson, A. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Thibaut, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Miao, Z. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Seiler, J. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Marchand, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Agama, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nitiss, J. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Redon, C.</span></span> <span> </span><span class="NLM_article-title">Repair of topoisomerase I-mediated DNA damage</span>. <i>Prog. Nucleic Acid Res. Mol. Biol.</i> <span class="NLM_year" style="font-weight: bold;">2006</span>,  <span class="NLM_volume"><i>81</i></span>,  <span class="NLM_fpage">179</span>– <span class="NLM_lpage">229</span>, <span class="refDoi"> DOI: 10.1016/S0079-6603(06)81005-6</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref15/cit15&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00639&amp;key=10.1016%2FS0079-6603%2806%2981005-6" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref15/cit15&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00639&amp;key=16891172" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref15/cit15&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00639&amp;key=1%3ACAS%3A528%3ADC%252BD1cXktVShtrY%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=81&publication_year=2006&pages=179-229&author=Y.+Pommierauthor=J.+M.+Barceloauthor=V.+A.+Raoauthor=O.+Sordetauthor=A.+G.+Jobsonauthor=L.+Thibautauthor=Z.+H.+Miaoauthor=J.+A.+Seilerauthor=H.+Zhangauthor=C.+Marchandauthor=K.+Agamaauthor=J.+L.+Nitissauthor=C.+Redon&title=Repair+of+topoisomerase+I-mediated+DNA+damage&doi=10.1016%2FS0079-6603%2806%2981005-6"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit15R"><div class="casContent"><span class="casTitleNuber">15</span><div class="casTitle"><span class="NLM_cas:atitle">Repair of topoisomerase I-mediated DNA damage</span></div><div class="casAuthors">Pommier, Yves; Barcelo, Juana M.; Rao, V. Ashutosh; Sordet, Olivier; Jobson, Andrew G.; Thibaut, Laurent; Miao, Ze-Hong; Seiler, Jennifer A.; Zhang, Hongliang; Marchand, Christophe; Agama, Keli; Nitiss, John L.; Redon, Christophe</div><div class="citationInfo"><span class="NLM_cas:title">Progress in Nucleic Acid Research and Molecular Biology</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">81</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">179-229</span>CODEN:
                <span class="NLM_cas:coden">PNMBAF</span>;
        ISSN:<span class="NLM_cas:issn">0079-6603</span>.
    
            (<span class="NLM_cas:orgname">Elsevier</span>)
        </div><div class="casAbstract">A review.  Topoisomerase I (Top1) is an abundant and essential enzyme.  Top1 is the selective target of camptothecins, which are effective anticancer agents.  Top1-DNA cleavage complexes can also be trapped by various endogenous and exogenous DNA lesions including mismatches, abasic sites, and carcinogenic adducts.  Tyrosyl-DNA phosphodiesterase (Tdp1) is one of the repair enzymes for Top1-DNA covalent complexes.  Tdp1 forms a multiprotein complex that includes poly(ADP-ribose) polymerase (PARP).  PARP-deficient cells are hypersensitive to camptothecins and functionally deficient for Tdp1.  We will review developments in several pathways involved in the repair of Top1 cleavage complexes and the role of Chk1 and Chk2 checkpoint kinases in the cellular responses to Top1 inhibitors.  The genes conferring camptothecin hypersensitivity are compiled for humans, budding yeast, and fission yeast.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGodCZGu6Axl5LVg90H21EOLACvtfcHk0lgQOVsXUE8syA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXktVShtrY%253D&md5=3f27a8ddd1f80db31af81eee975f495e</span></div><a href="/servlet/linkout?suffix=cit15&amp;dbid=16384&amp;doi=10.1016%2FS0079-6603%2806%2981005-6&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS0079-6603%252806%252981005-6%26sid%3Dliteratum%253Aachs%26aulast%3DPommier%26aufirst%3DY.%26aulast%3DBarcelo%26aufirst%3DJ.%2BM.%26aulast%3DRao%26aufirst%3DV.%2BA.%26aulast%3DSordet%26aufirst%3DO.%26aulast%3DJobson%26aufirst%3DA.%2BG.%26aulast%3DThibaut%26aufirst%3DL.%26aulast%3DMiao%26aufirst%3DZ.%2BH.%26aulast%3DSeiler%26aufirst%3DJ.%2BA.%26aulast%3DZhang%26aufirst%3DH.%26aulast%3DMarchand%26aufirst%3DC.%26aulast%3DAgama%26aufirst%3DK.%26aulast%3DNitiss%26aufirst%3DJ.%2BL.%26aulast%3DRedon%26aufirst%3DC.%26atitle%3DRepair%2520of%2520topoisomerase%2520I-mediated%2520DNA%2520damage%26jtitle%3DProg.%2520Nucleic%2520Acid%2520Res.%2520Mol.%2520Biol.%26date%3D2006%26volume%3D81%26spage%3D179%26epage%3D229%26doi%3D10.1016%2FS0079-6603%2806%2981005-6" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref16"><div class="reference"><strong class="refLabel"><a href="#ref16" class="rightTabRefNumLink">16</a></strong><div class="NLM_citation" id="rightTab-cit16"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Maede, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shimizu, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fukushima, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kogame, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nakamura, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Miki, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Takeda, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pommier, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Murai, J.</span></span> <span> </span><span class="NLM_article-title">Differential and common DNA repair pathways for topoisomerase I- and II-targeted drugs in a genetic DT40 repair cell screen panel</span>. <i>Mol. Cancer Ther.</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>13</i></span>,  <span class="NLM_fpage">214</span>– <span class="NLM_lpage">220</span>, <span class="refDoi"> DOI: 10.1158/1535-7163.MCT-13-0551</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref16/cit16&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00639&amp;key=10.1158%2F1535-7163.MCT-13-0551" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref16/cit16&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00639&amp;key=24130054" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref16/cit16&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00639&amp;key=1%3ACAS%3A528%3ADC%252BC2cXnsFSmsg%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=13&publication_year=2014&pages=214-220&author=Y.+Maedeauthor=H.+Shimizuauthor=T.+Fukushimaauthor=T.+Kogameauthor=T.+Nakamuraauthor=T.+Mikiauthor=S.+Takedaauthor=Y.+Pommierauthor=J.+Murai&title=Differential+and+common+DNA+repair+pathways+for+topoisomerase+I-+and+II-targeted+drugs+in+a+genetic+DT40+repair+cell+screen+panel&doi=10.1158%2F1535-7163.MCT-13-0551"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit16R"><div class="casContent"><span class="casTitleNuber">16</span><div class="casTitle"><span class="NLM_cas:atitle">Differential and Common DNA Repair Pathways for Topoisomerase I- and II-Targeted Drugs in a Genetic DT40 Repair Cell Screen Panel</span></div><div class="casAuthors">Maede, Yuko; Shimizu, Hiroyasu; Fukushima, Toru; Kogame, Toshiaki; Nakamura, Terukazu; Miki, Tsuneharu; Takeda, Shunichi; Pommier, Yves; Murai, Junko</div><div class="citationInfo"><span class="NLM_cas:title">Molecular Cancer Therapeutics</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">13</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">214-220</span>CODEN:
                <span class="NLM_cas:coden">MCTOCF</span>;
        ISSN:<span class="NLM_cas:issn">1535-7163</span>.
    
            (<span class="NLM_cas:orgname">American Association for Cancer Research</span>)
        </div><div class="casAbstract">Clin. topoisomerase I (Top1) and II (Top2) inhibitors trap topoisomerases on DNA, thereby inducing protein-linked DNA breaks.  Cancer cells resist the drugs by removing topoisomerase-DNA complexes, and repairing the drug-induced DNA double-strand breaks (DSB) by homologous recombination and nonhomologous end joining (NHEJ).  Because numerous enzymes and cofactors are involved in the removal of the topoisomerase-DNA complexes and DSB repair, it has been challenging to comprehensively analyze the relative contribution of multiple genetic pathways in vertebrate cells.  Comprehending the relative contribution of individual repair factors would give insights into the lesions induced by the inhibitors and genetic determinants of response.  Ultimately, this information would be useful to target specific pathways to augment the therapeutic activity of topoisomerase inhibitors.  To this end, we put together 48 isogenic DT40 mutant cells deficient in DNA repair and generated one cell line deficient in autophagy (ATG5).  Sensitivity profiles were established for three clin. relevant Top1 inhibitors (camptothecin and the indenoisoquinolines LMP400 and LMP776) and three Top2 inhibitors (etoposide, doxorubicin, and ICRF-193).  Highly significant correlations were found among Top1 inhibitors as well as Top2 inhibitors, whereas the profiles of Top1 inhibitors were different from those of Top2 inhibitors.  Most distinct repair pathways between Top1 and Top2 inhibitors include NHEJ, TDP1, TDP2, PARP1, and Fanconi Anemia genes, whereas homologous recombination seems relevant esp. for Top1 and, to a lesser extent, for Top2 inhibitors.  We also found and discuss differential pathways among Top1 inhibitors and Top2 inhibitors.  Mol Cancer Ther; 13(1); 214-20. ©2013 AACR.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqrLkuEffSz27Vg90H21EOLACvtfcHk0lgQOVsXUE8syA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXnsFSmsg%253D%253D&md5=346456ce64a6e142fb9df968cdc9f05e</span></div><a href="/servlet/linkout?suffix=cit16&amp;dbid=16384&amp;doi=10.1158%2F1535-7163.MCT-13-0551&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1158%252F1535-7163.MCT-13-0551%26sid%3Dliteratum%253Aachs%26aulast%3DMaede%26aufirst%3DY.%26aulast%3DShimizu%26aufirst%3DH.%26aulast%3DFukushima%26aufirst%3DT.%26aulast%3DKogame%26aufirst%3DT.%26aulast%3DNakamura%26aufirst%3DT.%26aulast%3DMiki%26aufirst%3DT.%26aulast%3DTakeda%26aufirst%3DS.%26aulast%3DPommier%26aufirst%3DY.%26aulast%3DMurai%26aufirst%3DJ.%26atitle%3DDifferential%2520and%2520common%2520DNA%2520repair%2520pathways%2520for%2520topoisomerase%2520I-%2520and%2520II-targeted%2520drugs%2520in%2520a%2520genetic%2520DT40%2520repair%2520cell%2520screen%2520panel%26jtitle%3DMol.%2520Cancer%2520Ther.%26date%3D2014%26volume%3D13%26spage%3D214%26epage%3D220%26doi%3D10.1158%2F1535-7163.MCT-13-0551" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref17"><div class="reference"><strong class="refLabel"><a href="#ref17" class="rightTabRefNumLink">17</a></strong><div class="NLM_citation" id="rightTab-cit17"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Interthal, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pouliot, J. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Champoux, J. J.</span></span> <span> </span><span class="NLM_article-title">The tyrosyl-DNA phosphodiesterase Tdp1 is a member of the phospholipase D superfamily</span>. <i>Proc. Natl. Acad. Sci. U. S. A.</i> <span class="NLM_year" style="font-weight: bold;">2001</span>,  <span class="NLM_volume"><i>98</i></span>,  <span class="NLM_fpage">12009</span>– <span class="NLM_lpage">12014</span>, <span class="refDoi"> DOI: 10.1073/pnas.211429198</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref17/cit17&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00639&amp;key=10.1073%2Fpnas.211429198" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref17/cit17&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00639&amp;key=11572945" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref17/cit17&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00639&amp;key=1%3ACAS%3A528%3ADC%252BD3MXns1Cjs78%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=98&publication_year=2001&pages=12009-12014&author=H.+Interthalauthor=J.+J.+Pouliotauthor=J.+J.+Champoux&title=The+tyrosyl-DNA+phosphodiesterase+Tdp1+is+a+member+of+the+phospholipase+D+superfamily&doi=10.1073%2Fpnas.211429198"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit17R"><div class="casContent"><span class="casTitleNuber">17</span><div class="casTitle"><span class="NLM_cas:atitle">The tyrosyl-DNA phosphodiesterase Tdp1 is a member of the phospholipase D superfamily</span></div><div class="casAuthors">Interthal, Heidrun; Pouliot, Jeffrey J.; Champoux, James J.</div><div class="citationInfo"><span class="NLM_cas:title">Proceedings of the National Academy of Sciences of the United States of America</span>
        (<span class="NLM_cas:date">2001</span>),
    <span class="NLM_cas:volume">98</span>
        (<span class="NLM_cas:issue">21</span>),
    <span class="NLM_cas:pages">12009-12014</span>CODEN:
                <span class="NLM_cas:coden">PNASA6</span>;
        ISSN:<span class="NLM_cas:issn">0027-8424</span>.
    
            (<span class="NLM_cas:orgname">National Academy of Sciences</span>)
        </div><div class="casAbstract">The phospholipase D (PLD) superfamily is a diverse group of proteins that includes enzymes involved in phospholipid metab., a bacterial toxin, poxvirus envelope proteins, and bacterial nucleases.  Based on sequence comparisons, we show here that the tyrosyl-DNA phosphodiesterase (Tdp1) that has been implicated in the repair of topoisomerase I covalent complexes with DNA contains two unusual HKD signature motifs that place the enzyme in a distinct class within the PLD superfamily.  Mutagenesis studies with the human enzyme in which the invariant histidines and lysines of the HKD motifs are changed confirm that these highly conserved residues are essential for Tdp1 activity.  Furthermore, we show that, like other members of the family for which it has been examd., the reaction involves the formation of an intermediate in which the cleaved substrate is covalently linked to the enzyme.  These results reveal that the hydrolytic reaction catalyzed by Tdp1 occurs by the phosphoryl transfer chem. that is common to all members of the PLD superfamily.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrWp0n2V1_HBbVg90H21EOLACvtfcHk0lj-K29ftfGzdQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3MXns1Cjs78%253D&md5=08c751ddc8ffa2550ff3acec3b71d41a</span></div><a href="/servlet/linkout?suffix=cit17&amp;dbid=16384&amp;doi=10.1073%2Fpnas.211429198&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1073%252Fpnas.211429198%26sid%3Dliteratum%253Aachs%26aulast%3DInterthal%26aufirst%3DH.%26aulast%3DPouliot%26aufirst%3DJ.%2BJ.%26aulast%3DChampoux%26aufirst%3DJ.%2BJ.%26atitle%3DThe%2520tyrosyl-DNA%2520phosphodiesterase%2520Tdp1%2520is%2520a%2520member%2520of%2520the%2520phospholipase%2520D%2520superfamily%26jtitle%3DProc.%2520Natl.%2520Acad.%2520Sci.%2520U.%2520S.%2520A.%26date%3D2001%26volume%3D98%26spage%3D12009%26epage%3D12014%26doi%3D10.1073%2Fpnas.211429198" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref18"><div class="reference"><strong class="refLabel"><a href="#ref18" class="rightTabRefNumLink">18</a></strong><div class="NLM_citation" id="rightTab-cit18"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Dexheimer, T. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Antony, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Marchand, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pommier, Y.</span></span> <span> </span><span class="NLM_article-title">Tyrosyl-DNA phosphodiesterase as a target for anticancer therapy</span>. <i>Anti-Cancer Agents Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2008</span>,  <span class="NLM_volume"><i>8</i></span>,  <span class="NLM_fpage">381</span>– <span class="NLM_lpage">389</span>, <span class="refDoi"> DOI: 10.2174/187152008784220357</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref18/cit18&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00639&amp;key=10.2174%2F187152008784220357" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref18/cit18&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00639&amp;key=18473723" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref18/cit18&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00639&amp;key=1%3ACAS%3A528%3ADC%252BD1cXkvV2iurs%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=8&publication_year=2008&pages=381-389&author=T.+S.+Dexheimerauthor=S.+Antonyauthor=C.+Marchandauthor=Y.+Pommier&title=Tyrosyl-DNA+phosphodiesterase+as+a+target+for+anticancer+therapy&doi=10.2174%2F187152008784220357"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit18R"><div class="casContent"><span class="casTitleNuber">18</span><div class="casTitle"><span class="NLM_cas:atitle">Tyrosyl-DNA phosphodiesterase as a target for anticancer therapy</span></div><div class="casAuthors">Dexheimer, Thomas S.; Antony, Smitha; Marchand, Christophe; Pommier, Yves</div><div class="citationInfo"><span class="NLM_cas:title">Anti-Cancer Agents in Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">8</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">381-389</span>CODEN:
                <span class="NLM_cas:coden">AAMCE4</span>;
        ISSN:<span class="NLM_cas:issn">1871-5206</span>.
    
            (<span class="NLM_cas:orgname">Bentham Science Publishers Ltd.</span>)
        </div><div class="casAbstract">A review.  Tyrosyl-DNA phosphodiesterase 1 (Tdp1) is a recently discovered enzyme that catalyzes the hydrolysis of 3'-phosphotyrosyl bonds.  Such linkages form in vivo following the DNA processing activity of topoisomerase I (Top1).  For this reason, Tdp1 has been implicated in the repair of irreversible Top1-DNA covalent complexes, which can be generated by either exogenous or endogenous factors.  Tdp1 has been regarded as a potential therapeutic co-target of Top1 in that it seemingly counteracts the effects of Top1 inhibitors, such as camptothecin and its clin. used derivs.  Thus, by reducing the repair of Top1-DNA lesions, Tdp1 inhibitors have the potential to augment the anticancer activity of Top1 inhibitors provided there is a presence of genetic abnormalities related to DNA checkpoint and repair pathways.  Human Tdp1 can also hydrolyze other 3'-end DNA alterations including 3'-phosphoglycolates and 3'-abasic sites indicating it may function as a general 3'-DNA phosphodiesterase and repair enzyme.  The importance of Tdp1 in humans is highlighted by the observation that a recessive mutation in the human TDP1 gene is responsible for the inherited disorder, spinocerebellar ataxia with axonal neuropathy (SCAN1).  This review provides a summary of the biochem. and cellular processes performed by Tdp1 as well as the rationale behind the development of Tdp1 inhibitors for anticancer therapy.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGp1Oyb-NTvZtLVg90H21EOLACvtfcHk0lj-K29ftfGzdQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXkvV2iurs%253D&md5=82be43ceb8d832abb994ab3494fbc119</span></div><a href="/servlet/linkout?suffix=cit18&amp;dbid=16384&amp;doi=10.2174%2F187152008784220357&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.2174%252F187152008784220357%26sid%3Dliteratum%253Aachs%26aulast%3DDexheimer%26aufirst%3DT.%2BS.%26aulast%3DAntony%26aufirst%3DS.%26aulast%3DMarchand%26aufirst%3DC.%26aulast%3DPommier%26aufirst%3DY.%26atitle%3DTyrosyl-DNA%2520phosphodiesterase%2520as%2520a%2520target%2520for%2520anticancer%2520therapy%26jtitle%3DAnti-Cancer%2520Agents%2520Med.%2520Chem.%26date%3D2008%26volume%3D8%26spage%3D381%26epage%3D389%26doi%3D10.2174%2F187152008784220357" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref19"><div class="reference"><strong class="refLabel"><a href="#ref19" class="rightTabRefNumLink">19</a></strong><div class="NLM_citation" id="rightTab-cit19"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Yang, S. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Burgin, A. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Huizenga, J. B. N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Robertson, C. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yao, K. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nash, H. A.</span></span> <span> </span><span class="NLM_article-title">A eukaryotic enzyme that can disjoin dead-end covalent complexes between DNA and type I topoisomerases</span>. <i>Proc. Natl. Acad. Sci. U. S. A.</i> <span class="NLM_year" style="font-weight: bold;">1996</span>,  <span class="NLM_volume"><i>93</i></span>,  <span class="NLM_fpage">11534</span>– <span class="NLM_lpage">11539</span>, <span class="refDoi"> DOI: 10.1073/pnas.93.21.11534</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref19/cit19&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00639&amp;key=10.1073%2Fpnas.93.21.11534" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref19/cit19&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00639&amp;key=8876170" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref19/cit19&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00639&amp;key=1%3ACAS%3A528%3ADyaK28Xmtlagt7o%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=93&publication_year=1996&pages=11534-11539&author=S.+W.+Yangauthor=A.+B.+Burginauthor=J.+B.+N.+Huizengaauthor=C.+A.+Robertsonauthor=K.+C.+Yaoauthor=H.+A.+Nash&title=A+eukaryotic+enzyme+that+can+disjoin+dead-end+covalent+complexes+between+DNA+and+type+I+topoisomerases&doi=10.1073%2Fpnas.93.21.11534"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit19R"><div class="casContent"><span class="casTitleNuber">19</span><div class="casTitle"><span class="NLM_cas:atitle">A eukaryotic enzyme that can disjoin dead-end covalent complexes between DNA and type I topoisomerases</span></div><div class="casAuthors">Yang, Shu-wei; Burgin, Alex B., Jr.; Huizenga, Beth N.; Robertson, Carol A.; Yao, Kevin C.; Nash, Howard A.</div><div class="citationInfo"><span class="NLM_cas:title">Proceedings of the National Academy of Sciences of the United States of America</span>
        (<span class="NLM_cas:date">1996</span>),
    <span class="NLM_cas:volume">93</span>
        (<span class="NLM_cas:issue">21</span>),
    <span class="NLM_cas:pages">11534-11539</span>CODEN:
                <span class="NLM_cas:coden">PNASA6</span>;
        ISSN:<span class="NLM_cas:issn">0027-8424</span>.
    
            (<span class="NLM_cas:orgname">National Academy of Sciences</span>)
        </div><div class="casAbstract">The covalent joining of topoisomerases to DNA is normally a transient step in the reaction cycle of these important enzymes.  However, under a variety of circumstances, the covalent complex is converted to a long-lived or dead-end product that can result in chromosome breakage and cell death.  We have discovered and partially purified an enzyme that specifically cleaves the chem. bond that joins the active site tyrosine of topoisomerases to the 3' end of DNA.  The reaction products made by the purified enzyme on a variety of model substrates indicate that the enzyme cleanly hydrolyzes the tyrosine-DNA phosphodiester linkage, thereby liberating a DNA terminated with a 3' phosphate.  The wide distribution of this phosphodiesterase in eukaryotes and its specificity for tyrosine linked to the 3' end but not the 5' end of DNA suggest that it plays a role in the repair of DNA trapped in complexes involving eukaryotic topoisomerase I.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrWltrYXnjURrVg90H21EOLACvtfcHk0lj-K29ftfGzdQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK28Xmtlagt7o%253D&md5=3ad78920c695f68ab0ae414af56ef333</span></div><a href="/servlet/linkout?suffix=cit19&amp;dbid=16384&amp;doi=10.1073%2Fpnas.93.21.11534&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1073%252Fpnas.93.21.11534%26sid%3Dliteratum%253Aachs%26aulast%3DYang%26aufirst%3DS.%2BW.%26aulast%3DBurgin%26aufirst%3DA.%2BB.%26aulast%3DHuizenga%26aufirst%3DJ.%2BB.%2BN.%26aulast%3DRobertson%26aufirst%3DC.%2BA.%26aulast%3DYao%26aufirst%3DK.%2BC.%26aulast%3DNash%26aufirst%3DH.%2BA.%26atitle%3DA%2520eukaryotic%2520enzyme%2520that%2520can%2520disjoin%2520dead-end%2520covalent%2520complexes%2520between%2520DNA%2520and%2520type%2520I%2520topoisomerases%26jtitle%3DProc.%2520Natl.%2520Acad.%2520Sci.%2520U.%2520S.%2520A.%26date%3D1996%26volume%3D93%26spage%3D11534%26epage%3D11539%26doi%3D10.1073%2Fpnas.93.21.11534" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref20"><div class="reference"><strong class="refLabel"><a href="#ref20" class="rightTabRefNumLink">20</a></strong><div class="NLM_citation" id="rightTab-cit20"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Murai, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Huang, S. Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Das, B. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dexheimer, T. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Takeda, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pommier, Y.</span></span> <span> </span><span class="NLM_article-title">Tyrosyl-DNA phosphodiesterase 1 (TDP1) repairs DNA damage induced by topoisomerases I and II and base alkylation in vertebrate cells</span>. <i>J. Biol. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2012</span>,  <span class="NLM_volume"><i>287</i></span>,  <span class="NLM_fpage">12848</span>– <span class="NLM_lpage">12857</span>, <span class="refDoi"> DOI: 10.1074/jbc.M111.333963</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref20/cit20&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00639&amp;key=10.1074%2Fjbc.M111.333963" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref20/cit20&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00639&amp;key=22375014" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref20/cit20&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00639&amp;key=1%3ACAS%3A528%3ADC%252BC38XlsFCitr4%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=287&publication_year=2012&pages=12848-12857&author=J.+Muraiauthor=S.+Y.+Huangauthor=B.+B.+Dasauthor=T.+S.+Dexheimerauthor=S.+Takedaauthor=Y.+Pommier&title=Tyrosyl-DNA+phosphodiesterase+1+%28TDP1%29+repairs+DNA+damage+induced+by+topoisomerases+I+and+II+and+base+alkylation+in+vertebrate+cells&doi=10.1074%2Fjbc.M111.333963"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit20R"><div class="casContent"><span class="casTitleNuber">20</span><div class="casTitle"><span class="NLM_cas:atitle">Tyrosyl-DNA Phosphodiesterase 1 (TDP1) Repairs DNA Damage Induced by Topoisomerases I and II and Base Alkylation in Vertebrate Cells</span></div><div class="casAuthors">Murai, Junko; Huang, Shar-yin N.; Das, Benu Brata; Dexheimer, Thomas S.; Takeda, Shunichi; Pommier, Yves</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Biological Chemistry</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">287</span>
        (<span class="NLM_cas:issue">16</span>),
    <span class="NLM_cas:pages">12848-12857</span>CODEN:
                <span class="NLM_cas:coden">JBCHA3</span>;
        ISSN:<span class="NLM_cas:issn">0021-9258</span>.
    
            (<span class="NLM_cas:orgname">American Society for Biochemistry and Molecular Biology</span>)
        </div><div class="casAbstract">Tyrosyl-DNA phosphodiesterase 1 (Tdp1) repairs topoisomerase I cleavage complexes (Top1cc) by hydrolyzing their 3'-phosphotyrosyl DNA bonds and repairs bleomycin-induced DNA damage by hydrolyzing 3'-phosphoglycolates.  Yeast Tdp1 has also been implicated in the repair of topoisomerase II-DNA cleavage complexes (Top2cc).  To det. whether vertebrate Tdp1 is involved in the repair of various DNA end-blocking lesions, we generated Tdp1 knock-out cells in chicken DT40 cells (Tdp1-/-) and Tdp1-complemented DT40 cells with human TDP1.  We found that Tdp1-/- cells were not only hypersensitive to camptothecin and bleomycin but also to etoposide, Me methanesulfonate (MMS), H2O2, and ionizing radiation.  We also show they were deficient in mitochondrial Tdp1 activity.  In biochem. assays, recombinant human TDP1 was found to process 5'-phosphotyrosyl DNA ends when they mimic the 5'-overhangs of Top2cc.  Tdp1 also processes 3'-deoxyribose phosphates generated from hydrolysis of abasic sites, which is consistent with the hypersensitivity of Tdp1-/- cells to MMS and H2O2.  Because recent studies established that CtIP (RBBP8) together with BRCA1 also repairs topoisomerase-mediated DNA damage, we generated dual Tdp1-CtIP-deficient DT40 cells.  Our results show that Tdp1 and CtIP act in parallel pathways for the repair of Top1cc and MMS-induced lesions but are epistatic for Top2cc.  Together, our findings reveal a broad involvement of Tdp1 in DNA repair and clarify the role of human TDP1 in the repair of Top2-induced DNA damage.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqovA7wdm9JUrVg90H21EOLACvtfcHk0lgjZDIrf3krsQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38XlsFCitr4%253D&md5=2ad3a40dca2fb504e333168c065d4cd6</span></div><a href="/servlet/linkout?suffix=cit20&amp;dbid=16384&amp;doi=10.1074%2Fjbc.M111.333963&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1074%252Fjbc.M111.333963%26sid%3Dliteratum%253Aachs%26aulast%3DMurai%26aufirst%3DJ.%26aulast%3DHuang%26aufirst%3DS.%2BY.%26aulast%3DDas%26aufirst%3DB.%2BB.%26aulast%3DDexheimer%26aufirst%3DT.%2BS.%26aulast%3DTakeda%26aufirst%3DS.%26aulast%3DPommier%26aufirst%3DY.%26atitle%3DTyrosyl-DNA%2520phosphodiesterase%25201%2520%2528TDP1%2529%2520repairs%2520DNA%2520damage%2520induced%2520by%2520topoisomerases%2520I%2520and%2520II%2520and%2520base%2520alkylation%2520in%2520vertebrate%2520cells%26jtitle%3DJ.%2520Biol.%2520Chem.%26date%3D2012%26volume%3D287%26spage%3D12848%26epage%3D12857%26doi%3D10.1074%2Fjbc.M111.333963" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref21"><div class="reference"><strong class="refLabel"><a href="#ref21" class="rightTabRefNumLink">21</a></strong><div class="NLM_citation" id="rightTab-cit21"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Interthal, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chen, H. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Champoux, J. J.</span></span> <span> </span><span class="NLM_article-title">Human Tdp1 cleaves a broad spectrum of substrates including phosphoamide linkages</span>. <i>J. Biol. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2005</span>,  <span class="NLM_volume"><i>280</i></span>,  <span class="NLM_fpage">36518</span>– <span class="NLM_lpage">36528</span>, <span class="refDoi"> DOI: 10.1074/jbc.M508898200</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref21/cit21&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00639&amp;key=10.1074%2Fjbc.M508898200" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=280&publication_year=2005&pages=36518-36528&author=H.+Interthalauthor=H.+J.+Chenauthor=J.+J.+Champoux&title=Human+Tdp1+cleaves+a+broad+spectrum+of+substrates+including+phosphoamide+linkages&doi=10.1074%2Fjbc.M508898200"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit21&amp;dbid=16384&amp;doi=10.1074%2Fjbc.M508898200&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1074%252Fjbc.M508898200%26sid%3Dliteratum%253Aachs%26aulast%3DInterthal%26aufirst%3DH.%26aulast%3DChen%26aufirst%3DH.%2BJ.%26aulast%3DChampoux%26aufirst%3DJ.%2BJ.%26atitle%3DHuman%2520Tdp1%2520cleaves%2520a%2520broad%2520spectrum%2520of%2520substrates%2520including%2520phosphoamide%2520linkages%26jtitle%3DJ.%2520Biol.%2520Chem.%26date%3D2005%26volume%3D280%26spage%3D36518%26epage%3D36528%26doi%3D10.1074%2Fjbc.M508898200" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref22"><div class="reference"><strong class="refLabel"><a href="#ref22" class="rightTabRefNumLink">22</a></strong><div class="NLM_citation" id="rightTab-cit22"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Menon, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Povirk, L. F.</span></span> <span> </span><span class="NLM_article-title">End-processing nucleases and phosphodiesterases: An elite supporting cast for the non-homologous end joining pathway of DNA double-strand break repair</span>. <i>DNA Repair</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>43</i></span>,  <span class="NLM_fpage">57</span>– <span class="NLM_lpage">68</span>, <span class="refDoi"> DOI: 10.1016/j.dnarep.2016.05.011</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref22/cit22&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00639&amp;key=10.1016%2Fj.dnarep.2016.05.011" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref22/cit22&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00639&amp;key=27262532" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref22/cit22&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00639&amp;key=1%3ACAS%3A528%3ADC%252BC28Xpt1elurc%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=43&publication_year=2016&pages=57-68&author=V.+Menonauthor=L.+F.+Povirk&title=End-processing+nucleases+and+phosphodiesterases%3A+An+elite+supporting+cast+for+the+non-homologous+end+joining+pathway+of+DNA+double-strand+break+repair&doi=10.1016%2Fj.dnarep.2016.05.011"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit22R"><div class="casContent"><span class="casTitleNuber">22</span><div class="casTitle"><span class="NLM_cas:atitle">End-processing nucleases and phosphodiesterases: An elite supporting cast for the non-homologous end joining pathway of DNA double-strand break repair</span></div><div class="casAuthors">Menon, Vijay; Povirk, Lawrence F.</div><div class="citationInfo"><span class="NLM_cas:title">DNA Repair</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">43</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">57-68</span>CODEN:
                <span class="NLM_cas:coden">DRNEAR</span>;
        ISSN:<span class="NLM_cas:issn">1568-7864</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">A review.  Nonhomologous end joining (NHEJ) is an error-prone DNA double-strand break repair pathway that is active throughout the cell cycle.  A substantial fraction of NHEJ repair events show deletions and, less often, insertions in the repair joints, suggesting an end-processing step comprising the removal of mismatched or damaged nucleotides by nucleases and other phosphodiesterases, as well as subsequent strand extension by polymerases.  A wide range of nucleases, including Artemis, Metnase, APLF, Mre11, CtIP, APE1, APE2 and WRN, are biochem. competent to carry out such double-strand break end processing, and have been implicated in NHEJ by at least circumstantial evidence.  Several addnl. DNA end-specific phosphodiesterases, including TDP1, TDP2 and aprataxin are available to resolve various non-nucleotide moieties at DSB ends.  This review summarizes the biochem. specificities of these enzymes and the evidence for their participation in the NHEJ pathway.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoBeVbkMPo6PLVg90H21EOLACvtfcHk0lgjZDIrf3krsQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28Xpt1elurc%253D&md5=8a7ac0b43c8462e3423bb86c27d116a0</span></div><a href="/servlet/linkout?suffix=cit22&amp;dbid=16384&amp;doi=10.1016%2Fj.dnarep.2016.05.011&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.dnarep.2016.05.011%26sid%3Dliteratum%253Aachs%26aulast%3DMenon%26aufirst%3DV.%26aulast%3DPovirk%26aufirst%3DL.%2BF.%26atitle%3DEnd-processing%2520nucleases%2520and%2520phosphodiesterases%253A%2520An%2520elite%2520supporting%2520cast%2520for%2520the%2520non-homologous%2520end%2520joining%2520pathway%2520of%2520DNA%2520double-strand%2520break%2520repair%26jtitle%3DDNA%2520Repair%26date%3D2016%26volume%3D43%26spage%3D57%26epage%3D68%26doi%3D10.1016%2Fj.dnarep.2016.05.011" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref23"><div class="reference"><strong class="refLabel"><a href="#ref23" class="rightTabRefNumLink">23</a></strong><div class="NLM_citation" id="rightTab-cit23"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Ashour, M. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Atteya, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">El-Khamisy, S. F.</span></span> <span> </span><span class="NLM_article-title">Topoisomerase-mediated chromosomal break repair: an emerging player in many games</span>. <i>Nat. Rev. Cancer</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>15</i></span>,  <span class="NLM_fpage">137</span>– <span class="NLM_lpage">151</span>, <span class="refDoi"> DOI: 10.1038/nrc3892</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref23/cit23&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00639&amp;key=10.1038%2Fnrc3892" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref23/cit23&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00639&amp;key=25693836" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref23/cit23&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00639&amp;key=1%3ACAS%3A528%3ADC%252BC2MXjtVSlurw%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=15&publication_year=2015&pages=137-151&author=M.+E.+Ashourauthor=R.+Atteyaauthor=S.+F.+El-Khamisy&title=Topoisomerase-mediated+chromosomal+break+repair%3A+an+emerging+player+in+many+games&doi=10.1038%2Fnrc3892"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit23R"><div class="casContent"><span class="casTitleNuber">23</span><div class="casTitle"><span class="NLM_cas:atitle">Topoisomerase-mediated chromosomal break repair: an emerging player in many games</span></div><div class="casAuthors">Ashour, Mohamed E.; Atteya, Reham; El-Khamisy, Sherif F.</div><div class="citationInfo"><span class="NLM_cas:title">Nature Reviews Cancer</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">15</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">137-151</span>CODEN:
                <span class="NLM_cas:coden">NRCAC4</span>;
        ISSN:<span class="NLM_cas:issn">1474-175X</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">A review.  The mammalian genome is constantly challenged by exogenous and endogenous threats.  Although much is known about the mechanisms that maintain DNA and RNA integrity, we know surprisingly little about the mechanisms that underpin the pathol. and tissue specificity of many disorders caused by defective responses to DNA or RNA damage.  Of the different types of endogenous damage, protein-linked DNA breaks (PDBs) are emerging as an important player in cancer development and therapy.  PDBs can arise during the abortive activity of DNA topoisomerases, a class of enzymes that modulate DNA topol. during several chromosomal transactions, such as gene transcription and DNA replication, recombination and repair.  In this Review, we discuss the mechanisms underpinning topoisomerase-induced PDB formation and repair with a focus on their role during gene transcription and the development of tissue-specific cancers.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoWemuoEWlx5bVg90H21EOLACvtfcHk0lgjZDIrf3krsQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXjtVSlurw%253D&md5=0768267e31e9e525528c6834a2c4df28</span></div><a href="/servlet/linkout?suffix=cit23&amp;dbid=16384&amp;doi=10.1038%2Fnrc3892&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnrc3892%26sid%3Dliteratum%253Aachs%26aulast%3DAshour%26aufirst%3DM.%2BE.%26aulast%3DAtteya%26aufirst%3DR.%26aulast%3DEl-Khamisy%26aufirst%3DS.%2BF.%26atitle%3DTopoisomerase-mediated%2520chromosomal%2520break%2520repair%253A%2520an%2520emerging%2520player%2520in%2520many%2520games%26jtitle%3DNat.%2520Rev.%2520Cancer%26date%3D2015%26volume%3D15%26spage%3D137%26epage%3D151%26doi%3D10.1038%2Fnrc3892" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref24"><div class="reference"><strong class="refLabel"><a href="#ref24" class="rightTabRefNumLink">24</a></strong><div class="NLM_citation" id="rightTab-cit24"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Nitiss, K. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Malik, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">He, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">White, S. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nitiss, J. L.</span></span> <span> </span><span class="NLM_article-title">Tyrosyl-DNA phosphodiesterase (Tdp1) participates in the repair of Top2-mediated DNA damage</span>. <i>Proc. Natl. Acad. Sci. U. S. A.</i> <span class="NLM_year" style="font-weight: bold;">2006</span>,  <span class="NLM_volume"><i>103</i></span>,  <span class="NLM_fpage">8953</span>– <span class="NLM_lpage">8958</span>, <span class="refDoi"> DOI: 10.1073/pnas.0603455103</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref24/cit24&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00639&amp;key=10.1073%2Fpnas.0603455103" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=103&publication_year=2006&pages=8953-8958&author=K.+C.+Nitissauthor=M.+Malikauthor=X.+Heauthor=S.+W.+Whiteauthor=J.+L.+Nitiss&title=Tyrosyl-DNA+phosphodiesterase+%28Tdp1%29+participates+in+the+repair+of+Top2-mediated+DNA+damage&doi=10.1073%2Fpnas.0603455103"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit24&amp;dbid=16384&amp;doi=10.1073%2Fpnas.0603455103&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1073%252Fpnas.0603455103%26sid%3Dliteratum%253Aachs%26aulast%3DNitiss%26aufirst%3DK.%2BC.%26aulast%3DMalik%26aufirst%3DM.%26aulast%3DHe%26aufirst%3DX.%26aulast%3DWhite%26aufirst%3DS.%2BW.%26aulast%3DNitiss%26aufirst%3DJ.%2BL.%26atitle%3DTyrosyl-DNA%2520phosphodiesterase%2520%2528Tdp1%2529%2520participates%2520in%2520the%2520repair%2520of%2520Top2-mediated%2520DNA%2520damage%26jtitle%3DProc.%2520Natl.%2520Acad.%2520Sci.%2520U.%2520S.%2520A.%26date%3D2006%26volume%3D103%26spage%3D8953%26epage%3D8958%26doi%3D10.1073%2Fpnas.0603455103" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref25"><div class="reference"><strong class="refLabel"><a href="#ref25" class="rightTabRefNumLink">25</a></strong><div class="NLM_citation" id="rightTab-cit25"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Takashima, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Boerkoel, C. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">John, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Saifi, G. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Salih, M. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Armstrong, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mao, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Quiocho, F. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Roa, B. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nakagawa, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Stockton, D. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lupski, J. R.</span></span> <span> </span><span class="NLM_article-title">Mutation of TDP1, encoding a topoisomerase I-dependent DNA damage repair enzyme, in spinocerebellar ataxia with axonal neuropathy</span>. <i>Nat. Genet.</i> <span class="NLM_year" style="font-weight: bold;">2002</span>,  <span class="NLM_volume"><i>32</i></span>,  <span class="NLM_fpage">267</span>– <span class="NLM_lpage">272</span>, <span class="refDoi"> DOI: 10.1038/ng987</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref25/cit25&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00639&amp;key=10.1038%2Fng987" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref25/cit25&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00639&amp;key=12244316" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref25/cit25&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00639&amp;key=1%3ACAS%3A528%3ADC%252BD38XotlaisLs%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=32&publication_year=2002&pages=267-272&author=H.+Takashimaauthor=C.+F.+Boerkoelauthor=J.+Johnauthor=G.+M.+Saifiauthor=M.+A.+Salihauthor=D.+Armstrongauthor=Y.+Maoauthor=F.+A.+Quiochoauthor=B.+B.+Roaauthor=M.+Nakagawaauthor=D.+W.+Stocktonauthor=J.+R.+Lupski&title=Mutation+of+TDP1%2C+encoding+a+topoisomerase+I-dependent+DNA+damage+repair+enzyme%2C+in+spinocerebellar+ataxia+with+axonal+neuropathy&doi=10.1038%2Fng987"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit25R"><div class="casContent"><span class="casTitleNuber">25</span><div class="casTitle"><span class="NLM_cas:atitle">Mutation of TDP1, encoding a topoisomerase I-dependent DNA damage repair enzyme, in spinocerebellar ataxia with axonal neuropathy</span></div><div class="casAuthors">Takashima, Hiroshi; Boerkoel, Cornelius F.; John, Joy; Saifi, Gulam Mustafa; Salih, Mustafa A. M.; Armstrong, Dawna; Mao, Yuxin; Quiocho, Florante A.; Roa, Benjamin B.; Nakagawa, Masanori; Stockton, David W.; Lupski, James R.</div><div class="citationInfo"><span class="NLM_cas:title">Nature Genetics</span>
        (<span class="NLM_cas:date">2002</span>),
    <span class="NLM_cas:volume">32</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">267-272</span>CODEN:
                <span class="NLM_cas:coden">NGENEC</span>;
        ISSN:<span class="NLM_cas:issn">1061-4036</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">Tyrosyl-DNA phosphodiesterase 1 (TDP1) repairs covalently bound topoisomerase I-DNA complexes and is essential for preventing the formation of double-strand breaks that result when stalled topoisomerase I complexes interfere with DNA replication in yeast.  Here we show that a deficiency of this DNA repair pathway in humans does not predispose to neoplasia or dysfunctions in rapidly replicating tissues, but instead causes spinocerebellar ataxia with axonal neuropathy (SCAN1) by affecting large, terminally differentiated, non-dividing neuronal cells.  Using genome-wide linkage mapping and a positional candidate approach in a Saudi Arabian family affected with autosomal recessive SCAN1, we identified a homozygous mutation in TDP1 (A1478G) that results in the substitution of histidine 493 with an arginine residue.  The His493 residue is conserved in TDP1 across species and is located in the active site of the enzyme.  Protein modeling predicts that mutation of this amino acid to arginine will disrupt the sym. structure of the active site.  We propose that loss-of-function mutations in TDP1 may cause SCAN1 either by interfering with DNA transcription or by inducing apoptosis in postmitotic neurons.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrXe_yuV1_hHrVg90H21EOLACvtfcHk0lgoB22bI2CyWA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD38XotlaisLs%253D&md5=0c89852fe1b3dba6b50b93105e7fefca</span></div><a href="/servlet/linkout?suffix=cit25&amp;dbid=16384&amp;doi=10.1038%2Fng987&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fng987%26sid%3Dliteratum%253Aachs%26aulast%3DTakashima%26aufirst%3DH.%26aulast%3DBoerkoel%26aufirst%3DC.%2BF.%26aulast%3DJohn%26aufirst%3DJ.%26aulast%3DSaifi%26aufirst%3DG.%2BM.%26aulast%3DSalih%26aufirst%3DM.%2BA.%26aulast%3DArmstrong%26aufirst%3DD.%26aulast%3DMao%26aufirst%3DY.%26aulast%3DQuiocho%26aufirst%3DF.%2BA.%26aulast%3DRoa%26aufirst%3DB.%2BB.%26aulast%3DNakagawa%26aufirst%3DM.%26aulast%3DStockton%26aufirst%3DD.%2BW.%26aulast%3DLupski%26aufirst%3DJ.%2BR.%26atitle%3DMutation%2520of%2520TDP1%252C%2520encoding%2520a%2520topoisomerase%2520I-dependent%2520DNA%2520damage%2520repair%2520enzyme%252C%2520in%2520spinocerebellar%2520ataxia%2520with%2520axonal%2520neuropathy%26jtitle%3DNat.%2520Genet.%26date%3D2002%26volume%3D32%26spage%3D267%26epage%3D272%26doi%3D10.1038%2Fng987" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref26"><div class="reference"><strong class="refLabel"><a href="#ref26" class="rightTabRefNumLink">26</a></strong><div class="NLM_citation" id="rightTab-cit26"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Barthelmes, H. U.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Habermeyer, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Christensen, M. O.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mielke, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Interthal, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pouliot, J. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Boege, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Marko, D.</span></span> <span> </span><span class="NLM_article-title">TDP1 overexpression in human cells counteracts DNA damage mediated by topoisomerases I and II</span>. <i>J. Biol. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2004</span>,  <span class="NLM_volume"><i>279</i></span>,  <span class="NLM_fpage">55618</span>– <span class="NLM_lpage">55625</span>, <span class="refDoi"> DOI: 10.1074/jbc.M405042200</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref26/cit26&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00639&amp;key=10.1074%2Fjbc.M405042200" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref26/cit26&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00639&amp;key=15494395" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref26/cit26&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00639&amp;key=1%3ACAS%3A528%3ADC%252BD2cXhtFeis7nK" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=279&publication_year=2004&pages=55618-55625&author=H.+U.+Barthelmesauthor=M.+Habermeyerauthor=M.+O.+Christensenauthor=C.+Mielkeauthor=H.+Interthalauthor=J.+J.+Pouliotauthor=F.+Boegeauthor=D.+Marko&title=TDP1+overexpression+in+human+cells+counteracts+DNA+damage+mediated+by+topoisomerases+I+and+II&doi=10.1074%2Fjbc.M405042200"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit26R"><div class="casContent"><span class="casTitleNuber">26</span><div class="casTitle"><span class="NLM_cas:atitle">TDP1 Overexpression in Human Cells Counteracts DNA Damage Mediated by Topoisomerases I and II</span></div><div class="casAuthors">Barthelmes, Hans U.; Habermeyer, Michael; Christensen, Morten O.; Mielke, Christian; Interthal, Heidrun; Pouliot, Jeffrey J.; Boege, Fritz; Marko, Doris</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Biological Chemistry</span>
        (<span class="NLM_cas:date">2004</span>),
    <span class="NLM_cas:volume">279</span>
        (<span class="NLM_cas:issue">53</span>),
    <span class="NLM_cas:pages">55618-55625</span>CODEN:
                <span class="NLM_cas:coden">JBCHA3</span>;
        ISSN:<span class="NLM_cas:issn">0021-9258</span>.
    
            (<span class="NLM_cas:orgname">American Society for Biochemistry and Molecular Biology</span>)
        </div><div class="casAbstract">Tyrosyl DNA phosphodiesterase 1 (TDP1) is a repair enzyme that removes adducts, e.g. of topoisomerase I from the 3'-phosphate of DNA breaks.  When expressed in human cells as a biofluorescent chimera, TDP1 appeared more mobile than topoisomerase I, less accumulated in nucleoli, and not chromosome-bound at early mitosis.  Upon exposure to camptothecin, both proteins were cleared from nucleoli and rendered less mobile in the nucleoplasm.  However, with TDP1, this happened much more slowly, reflecting most likely the redistribution of nucleolar structures upon inhibition of rDNA transcription.  Thus, a steady assocn. of TDP1 with topoisomerase I seems unlikely, whereas its integration into repair complexes assembled subsequently to the stabilization of DNA·topoisomerase I intermediates is supported.  Cells expressing GFP-tagged TDP1 > 100-fold in excess of endogenous TDP1 exhibited a significant redn. of DNA damage induced by the topoisomerase I poison camptothecin and could be selected by that drug.  Surprisingly, DNA damage induced by the topoisomerase II poison VP-16 was also diminished to a similar extent, whereas DNA damage independent of topoisomerase I or II was not affected.  Overexpression of the inactive mutant GFP-TDP1H263A at similar levels did not reduce DNA damage by camptothecin or VP-16.  These observations confirm a requirement of active TDP1 for the repair of topoisomerase I-mediated DNA damage.  Our data also suggest a role of TDP1 in the repair of DNA damage mediated by topoisomerase II, which is less clear.  Since overexpression of TDP1 did not compromise cell proliferation, it could be a pleiotropic resistance mechanism in cancer therapy.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpWkEIwTlRFcbVg90H21EOLACvtfcHk0lgoB22bI2CyWA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2cXhtFeis7nK&md5=8cf785584cf8a50c5c075947ad907a6c</span></div><a href="/servlet/linkout?suffix=cit26&amp;dbid=16384&amp;doi=10.1074%2Fjbc.M405042200&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1074%252Fjbc.M405042200%26sid%3Dliteratum%253Aachs%26aulast%3DBarthelmes%26aufirst%3DH.%2BU.%26aulast%3DHabermeyer%26aufirst%3DM.%26aulast%3DChristensen%26aufirst%3DM.%2BO.%26aulast%3DMielke%26aufirst%3DC.%26aulast%3DInterthal%26aufirst%3DH.%26aulast%3DPouliot%26aufirst%3DJ.%2BJ.%26aulast%3DBoege%26aufirst%3DF.%26aulast%3DMarko%26aufirst%3DD.%26atitle%3DTDP1%2520overexpression%2520in%2520human%2520cells%2520counteracts%2520DNA%2520damage%2520mediated%2520by%2520topoisomerases%2520I%2520and%2520II%26jtitle%3DJ.%2520Biol.%2520Chem.%26date%3D2004%26volume%3D279%26spage%3D55618%26epage%3D55625%26doi%3D10.1074%2Fjbc.M405042200" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref27"><div class="reference"><strong class="refLabel"><a href="#ref27" class="rightTabRefNumLink">27</a></strong><div class="NLM_citation" id="rightTab-cit27"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Nivens, M. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Felder, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Galloway, A. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pena, M. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pouliot, J. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Spencer, H. T.</span></span> <span> </span><span class="NLM_article-title">Engineered resistance to camptothecin and antifolates by retroviral coexpression of tyrosyl DNA phosphodiesterase-I and thymidylate synthase</span>. <i>Cancer Chemother. Pharmacol.</i> <span class="NLM_year" style="font-weight: bold;">2004</span>,  <span class="NLM_volume"><i>53</i></span>,  <span class="NLM_fpage">107</span>– <span class="NLM_lpage">115</span>, <span class="refDoi"> DOI: 10.1007/s00280-003-0717-6</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref27/cit27&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00639&amp;key=10.1007%2Fs00280-003-0717-6" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref27/cit27&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00639&amp;key=14605862" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref27/cit27&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00639&amp;key=1%3ACAS%3A528%3ADC%252BD3sXhtVSjsLfL" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=53&publication_year=2004&pages=107-115&author=M.+C.+Nivensauthor=T.+Felderauthor=A.+H.+Gallowayauthor=M.+M.+Penaauthor=J.+J.+Pouliotauthor=H.+T.+Spencer&title=Engineered+resistance+to+camptothecin+and+antifolates+by+retroviral+coexpression+of+tyrosyl+DNA+phosphodiesterase-I+and+thymidylate+synthase&doi=10.1007%2Fs00280-003-0717-6"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit27R"><div class="casContent"><span class="casTitleNuber">27</span><div class="casTitle"><span class="NLM_cas:atitle">Engineered resistance to camptothecin and antifolates by retroviral coexpression of tyrosyl DNA phosphodiesterase-I and thymidylate synthase</span></div><div class="casAuthors">Nivens, Michael C.; Felder, Takita; Galloway, Amanda H.; Pena, Maria Marjorette O.; Pouliot, Jeffery J.; Spencer, H. Trent</div><div class="citationInfo"><span class="NLM_cas:title">Cancer Chemotherapy and Pharmacology</span>
        (<span class="NLM_cas:date">2004</span>),
    <span class="NLM_cas:volume">53</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">107-115</span>CODEN:
                <span class="NLM_cas:coden">CCPHDZ</span>;
        ISSN:<span class="NLM_cas:issn">0344-5704</span>.
    
            (<span class="NLM_cas:orgname">Springer-Verlag</span>)
        </div><div class="casAbstract">Purpose: Gene transfer of cDNA sequences that confer drug resistance can be used (1) to protect hematopoietic cells against the toxic effects of chemotherapy, (2) for in vivo enrichment of genetically engineered cells and (3) to protect cytotoxic T lymphocytes in drug-resistant immunotherapy approaches for the treatment of cancer.  We have previously developed strategies to confer resistance to agents targeting thymidylate synthase (TS) and have now expanded our drug resistance strategies to include retroviral expression of tyrosyl-DNA phosphodiesterase (TDP-I), an enzyme recently implicated in the repair of topoisomerase-I (Top-I)/DNA lesions induced by camptothecin (CPT).  The combination of TS and Top-I inhibition has been shown to be an effective treatment for several types of cancer.  Materials and methods: Retroviral vectors were generated that individually encoded TS and TDP-I or that coexpressed both enzymes.  Murine fibroblast and Chinese hamster lung transfectants were generated with the vectors and resistance to TS- and Top-I-directed inhibitors was tested.  Murine bone marrow progenitor cells were also transduced using recombinant retroviruses encoding TS and TDP-I and the degree of drug resistance conferred to gene-modified cells was tested.  Results: Enforced expression of TDP-I increased TDP-I activity in gene-modified cells and conferred up to threefold resistance to CPT.  The degree of resistance was dependent on the duration of drug treatment.  Simultaneous expression of the TS gene encoding E. coli TS optimized for expression in mammalian cells (optecTS) and TDP-I conferred extremely high-level resistance to concurrent treatment with the TS-inhibitor BW1843U89 and CPT.  Furthermore, by direct anal. of DNA fragmentation using the comet assay, substantial protection was conferred (fourfold) against DNA fragmentation assocd. with combination drug treatments by dual enzyme expression compared to non-modified cells.  Hematopoietic progenitor assays of murine bone marrow cells transduced with retroviral vectors encoding TS and TDP-I showed that bone marrow cells could be protected from the cytotoxic effects of TS and Top-I inhibition.  Conclusions: Enforced expression of optecTS and TDP-I conferred antifolate and CPT resistance to genetically modified cells.  Addnl., this work further illustrated a role for TDP-I in the repair of dead-end Top-I complexes and implied that TDP-I expression anal. may aid in predicting the therapeutic effectiveness of the CPT class of compds.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqwmN-FmI203rVg90H21EOLACvtfcHk0lgbjRdMvGrRIg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3sXhtVSjsLfL&md5=dad651aab3a7deaf4f6ad5c7a188f595</span></div><a href="/servlet/linkout?suffix=cit27&amp;dbid=16384&amp;doi=10.1007%2Fs00280-003-0717-6&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1007%252Fs00280-003-0717-6%26sid%3Dliteratum%253Aachs%26aulast%3DNivens%26aufirst%3DM.%2BC.%26aulast%3DFelder%26aufirst%3DT.%26aulast%3DGalloway%26aufirst%3DA.%2BH.%26aulast%3DPena%26aufirst%3DM.%2BM.%26aulast%3DPouliot%26aufirst%3DJ.%2BJ.%26aulast%3DSpencer%26aufirst%3DH.%2BT.%26atitle%3DEngineered%2520resistance%2520to%2520camptothecin%2520and%2520antifolates%2520by%2520retroviral%2520coexpression%2520of%2520tyrosyl%2520DNA%2520phosphodiesterase-I%2520and%2520thymidylate%2520synthase%26jtitle%3DCancer%2520Chemother.%2520Pharmacol.%26date%3D2004%26volume%3D53%26spage%3D107%26epage%3D115%26doi%3D10.1007%2Fs00280-003-0717-6" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref28"><div class="reference"><strong class="refLabel"><a href="#ref28" class="rightTabRefNumLink">28</a></strong><div class="NLM_citation" id="rightTab-cit28"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Hirano, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Interthal, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Huang, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nakamura, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Deguchi, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Choi, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bhattacharjee, M. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Arimura, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Umehara, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Izumo, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Northrop, J. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Salih, M. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Inoue, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Armstrong, D. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Champoux, J. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Takashima, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Boerkoel, C. F.</span></span> <span> </span><span class="NLM_article-title">Spinocerebellar ataxia with axonal neuropathy: consequence of a Tdp1 recessive neomorphic mutation?</span>. <i>EMBO J.</i> <span class="NLM_year" style="font-weight: bold;">2007</span>,  <span class="NLM_volume"><i>26</i></span>,  <span class="NLM_fpage">4732</span>– <span class="NLM_lpage">4743</span>, <span class="refDoi"> DOI: 10.1038/sj.emboj.7601885</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref28/cit28&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00639&amp;key=10.1038%2Fsj.emboj.7601885" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref28/cit28&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00639&amp;key=17948061" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref28/cit28&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00639&amp;key=1%3ACAS%3A528%3ADC%252BD2sXht12gtbfE" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=26&publication_year=2007&pages=4732-4743&author=R.+Hiranoauthor=H.+Interthalauthor=C.+Huangauthor=T.+Nakamuraauthor=K.+Deguchiauthor=K.+Choiauthor=M.+B.+Bhattacharjeeauthor=K.+Arimuraauthor=F.+Umeharaauthor=S.+Izumoauthor=J.+L.+Northropauthor=M.+A.+Salihauthor=K.+Inoueauthor=D.+L.+Armstrongauthor=J.+J.+Champouxauthor=H.+Takashimaauthor=C.+F.+Boerkoel&title=Spinocerebellar+ataxia+with+axonal+neuropathy%3A+consequence+of+a+Tdp1+recessive+neomorphic+mutation%3F&doi=10.1038%2Fsj.emboj.7601885"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit28R"><div class="casContent"><span class="casTitleNuber">28</span><div class="casTitle"><span class="NLM_cas:atitle">Spinocerebellar ataxia with axonal neuropathy: consequence of a Tdp1 recessive neomorphic mutation?</span></div><div class="casAuthors">Hirano, Ryuki; Interthal, Heidrun; Huang, Cheng; Nakamura, Tomonori; Deguchi, Kimiko; Choi, Kunho; Bhattacharjee, Meenakshi B.; Arimura, Kimiyoshi; Umehara, Fujio; Izumo, Shuji; Northrop, Jennifer L.; Salih, Mustafa A. M.; Inoue, Ken; Armstrong, Dawna L.; Champoux, James J.; Takashima, Hiroshi; Boerkoel, Cornelius F.</div><div class="citationInfo"><span class="NLM_cas:title">EMBO Journal</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">26</span>
        (<span class="NLM_cas:issue">22</span>),
    <span class="NLM_cas:pages">4732-4743</span>CODEN:
                <span class="NLM_cas:coden">EMJODG</span>;
        ISSN:<span class="NLM_cas:issn">0261-4189</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">Tyrosyl-DNA phosphodiesterase 1 (Tdp1) cleaves the phosphodiester bond between a covalently stalled topoisomerase I (Topo I) and the 3' end of DNA.  Stalling of Topo I at DNA strand breaks is induced by endogenous DNA damage and the Topo I-specific anticancer drug camptothecin (CPT).  The H493R mutation of Tdp1 causes the neurodegenerative disorder spinocerebellar ataxia with axonal neuropathy (SCAN1).  Contrary to the hypothesis that SCAN1 arises from catalytically inactive Tdp1, Tdp1-/- mice are indistinguishable from wild-type mice, phys., histol., behaviorally, and electrophysiol.  However, compared to wild-type mice, Tdp1-/- mice are hypersensitive to CPT and bleomycin but not to etoposide.  Consistent with earlier in vitro studies, we show that the H493R Tdp1 mutant protein retains residual activity and becomes covalently trapped on the DNA after CPT treatment of SCAN1 cells.  This result provides a direct demonstration that Tdp1 repairs Topo I covalent lesions in vivo and suggests that SCAN1 arises from the recessive neomorphic mutation H493R.  This is a novel mechanism for disease since neomorphic mutations are generally dominant.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrpFUzVNpCYabVg90H21EOLACvtfcHk0lgbjRdMvGrRIg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2sXht12gtbfE&md5=39df0c57b16b2fb362a386e096afe040</span></div><a href="/servlet/linkout?suffix=cit28&amp;dbid=16384&amp;doi=10.1038%2Fsj.emboj.7601885&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fsj.emboj.7601885%26sid%3Dliteratum%253Aachs%26aulast%3DHirano%26aufirst%3DR.%26aulast%3DInterthal%26aufirst%3DH.%26aulast%3DHuang%26aufirst%3DC.%26aulast%3DNakamura%26aufirst%3DT.%26aulast%3DDeguchi%26aufirst%3DK.%26aulast%3DChoi%26aufirst%3DK.%26aulast%3DBhattacharjee%26aufirst%3DM.%2BB.%26aulast%3DArimura%26aufirst%3DK.%26aulast%3DUmehara%26aufirst%3DF.%26aulast%3DIzumo%26aufirst%3DS.%26aulast%3DNorthrop%26aufirst%3DJ.%2BL.%26aulast%3DSalih%26aufirst%3DM.%2BA.%26aulast%3DInoue%26aufirst%3DK.%26aulast%3DArmstrong%26aufirst%3DD.%2BL.%26aulast%3DChampoux%26aufirst%3DJ.%2BJ.%26aulast%3DTakashima%26aufirst%3DH.%26aulast%3DBoerkoel%26aufirst%3DC.%2BF.%26atitle%3DSpinocerebellar%2520ataxia%2520with%2520axonal%2520neuropathy%253A%2520consequence%2520of%2520a%2520Tdp1%2520recessive%2520neomorphic%2520mutation%253F%26jtitle%3DEMBO%2520J.%26date%3D2007%26volume%3D26%26spage%3D4732%26epage%3D4743%26doi%3D10.1038%2Fsj.emboj.7601885" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref29"><div class="reference"><strong class="refLabel"><a href="#ref29" class="rightTabRefNumLink">29</a></strong><div class="NLM_citation" id="rightTab-cit29"><span><span class="NLM_contrib-group"><span class="NLM_string-name">El-Khamisy, S. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Katyal, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Patel, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ju, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">McKinnon, P. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Caldecott, K. W.</span></span> <span> </span><span class="NLM_article-title">Synergistic decrease of DNA single-strand break repair rates in mouse neural cells lacking both Tdp1 and aprataxin</span>. <i>DNA Repair</i> <span class="NLM_year" style="font-weight: bold;">2009</span>,  <span class="NLM_volume"><i>8</i></span>,  <span class="NLM_fpage">760</span>– <span class="NLM_lpage">766</span>, <span class="refDoi"> DOI: 10.1016/j.dnarep.2009.02.002</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref29/cit29&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00639&amp;key=10.1016%2Fj.dnarep.2009.02.002" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref29/cit29&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00639&amp;key=19303373" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref29/cit29&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00639&amp;key=1%3ACAS%3A528%3ADC%252BD1MXmsVGju78%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=8&publication_year=2009&pages=760-766&author=S.+F.+El-Khamisyauthor=S.+Katyalauthor=P.+Patelauthor=L.+Juauthor=P.+J.+McKinnonauthor=K.+W.+Caldecott&title=Synergistic+decrease+of+DNA+single-strand+break+repair+rates+in+mouse+neural+cells+lacking+both+Tdp1+and+aprataxin&doi=10.1016%2Fj.dnarep.2009.02.002"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit29R"><div class="casContent"><span class="casTitleNuber">29</span><div class="casTitle"><span class="NLM_cas:atitle">Synergistic decrease of DNA single-strand break repair rates in mouse neural cells lacking both Tdp1 and aprataxin</span></div><div class="casAuthors">El-Khamisy, Sherif F.; Katyal, Sachin; Patel, Poorvi; Ju, Limei; McKinnon, Peter J.; Caldecott, Keith W.</div><div class="citationInfo"><span class="NLM_cas:title">DNA Repair</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">8</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">760-766</span>CODEN:
                <span class="NLM_cas:coden">DRNEAR</span>;
        ISSN:<span class="NLM_cas:issn">1568-7864</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">Ataxia oculomotor apraxia-1 (AOA1) is an autosomal recessive neurodegenerative disease that results from mutations of aprataxin (APTX).  APTX assocs. with the DNA single- and double-strand break repair machinery and is able to remove AMP from 5'-termini at DNA strand breaks in vitro.  However, attempts to establish a DNA strand break repair defect in APTX-defective cells have proved conflicting and unclear.  We reasoned that this may reflect that DNA strand breaks with 5'-AMP represent only a minor subset of breaks induced in cells, and/or the availability of alternative mechanisms for removing AMP from 5'-termini.  Here, we have attempted to increase the dependency of chromosomal single- and double-strand break repair on aprataxin activity by slowing the rate of repair of 3'-termini in aprataxin-defective neural cells, thereby increasing the likelihood that the 5'-termini at such breaks become adenylated and/or block alternative repair mechanisms.  To do this, we generated a mouse model in which APTX is deleted together with tyrosyl DNA phosphodiesterase (TDP1), an enzyme that repairs 3'-termini at a subset of single-strand breaks (SSBs), including those with 3'-topoisomerase-1 (Top1) peptide.  Notably, the global rate of repair of oxidative and alkylation-induced SSBs was significantly slower in Tdp1 -/-/Aptx -/- double knockout quiescent mouse astrocytes compared with Tdp1 -/- or Aptx -/- single knockouts.  In contrast, camptothecin-induced Top1-SSBs accumulated to similar levels in Tdp1 -/- and Tdp1 -/-/Aptx -/- double knockout astrocytes.  Finally, we failed to identify a measurable defect in double-strand break repair in Tdp1 -/-, Aptx -/- or Tdp1 -/-/Aptx -/- astrocytes.  These data provide direct evidence for a requirement for aprataxin during chromosomal single-strand break repair in primary neural cells lacking Tdp1.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpNBIcmYZzPOLVg90H21EOLACvtfcHk0lgbjRdMvGrRIg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXmsVGju78%253D&md5=33ea9ce56b8626c83b1e0e40b6372e3f</span></div><a href="/servlet/linkout?suffix=cit29&amp;dbid=16384&amp;doi=10.1016%2Fj.dnarep.2009.02.002&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.dnarep.2009.02.002%26sid%3Dliteratum%253Aachs%26aulast%3DEl-Khamisy%26aufirst%3DS.%2BF.%26aulast%3DKatyal%26aufirst%3DS.%26aulast%3DPatel%26aufirst%3DP.%26aulast%3DJu%26aufirst%3DL.%26aulast%3DMcKinnon%26aufirst%3DP.%2BJ.%26aulast%3DCaldecott%26aufirst%3DK.%2BW.%26atitle%3DSynergistic%2520decrease%2520of%2520DNA%2520single-strand%2520break%2520repair%2520rates%2520in%2520mouse%2520neural%2520cells%2520lacking%2520both%2520Tdp1%2520and%2520aprataxin%26jtitle%3DDNA%2520Repair%26date%3D2009%26volume%3D8%26spage%3D760%26epage%3D766%26doi%3D10.1016%2Fj.dnarep.2009.02.002" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref30"><div class="reference"><strong class="refLabel"><a href="#ref30" class="rightTabRefNumLink">30</a></strong><div class="NLM_citation" id="rightTab-cit30"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Das, B. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Antony, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gupta, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dexheimer, T. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Redon, C. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Garfield, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shiloh, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pommier, Y.</span></span> <span> </span><span class="NLM_article-title">Optimal function of the DNA repair enzyme TDP1 requires its phosphorylation by ATM and/or DNA-PK</span>. <i>EMBO J.</i> <span class="NLM_year" style="font-weight: bold;">2009</span>,  <span class="NLM_volume"><i>28</i></span>,  <span class="NLM_fpage">3667</span>– <span class="NLM_lpage">3680</span>, <span class="refDoi"> DOI: 10.1038/emboj.2009.302</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref30/cit30&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00639&amp;key=10.1038%2Femboj.2009.302" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref30/cit30&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00639&amp;key=19851285" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref30/cit30&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00639&amp;key=1%3ACAS%3A528%3ADC%252BD1MXht1KqsLbJ" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=28&publication_year=2009&pages=3667-3680&author=B.+B.+Dasauthor=S.+Antonyauthor=S.+Guptaauthor=T.+S.+Dexheimerauthor=C.+E.+Redonauthor=S.+Garfieldauthor=Y.+Shilohauthor=Y.+Pommier&title=Optimal+function+of+the+DNA+repair+enzyme+TDP1+requires+its+phosphorylation+by+ATM+and%2For+DNA-PK&doi=10.1038%2Femboj.2009.302"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit30R"><div class="casContent"><span class="casTitleNuber">30</span><div class="casTitle"><span class="NLM_cas:atitle">Optimal function of the DNA repair enzyme TDP1 requires its phosphorylation by ATM and/or DNA-PK</span></div><div class="casAuthors">Das, Benu Brata; Antony, Smitha; Gupta, Shalu; Dexheimer, Thomas S.; Redon, Christophe E.; Garfield, Susan; Shiloh, Yosef; Pommier, Yves</div><div class="citationInfo"><span class="NLM_cas:title">EMBO Journal</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">28</span>
        (<span class="NLM_cas:issue">23</span>),
    <span class="NLM_cas:pages">3667-3680</span>CODEN:
                <span class="NLM_cas:coden">EMJODG</span>;
        ISSN:<span class="NLM_cas:issn">0261-4189</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">Human tyrosyl-DNA phosphodiesterase (TDP1) hydrolyzes the phosphodiester bond at a DNA 3'-end linked to a tyrosyl moiety.  This type of linkage is found at stalled topoisomerase I (Top1)-DNA covalent complexes, and TDP1 has been implicated in the repair of such complexes.  Here, we show that Top1-assocd. DNA double-stranded breaks (DSBs) induce the phosphorylation of TDP1 at S81.  This phosphorylation is mediated by the protein kinases: ataxia-telangiectasia-mutated (ATM) and DNA-dependent protein kinase (DNA-PK).  Phosphorylated TDP1 forms nuclear foci that co-localize with those of phosphorylated histone H2AX (γH2AX).  Both Top1-induced replication- and transcription-mediated DNA damages induce TDP1 phosphorylation.  Furthermore, we show that S81 phosphorylation stabilizes TDP1, induces the formation of XRCC1 (X-ray cross-complementing group 1)-TDP1 complexes and enhances the mobilization of TDP1 to DNA damage sites.  Finally, we provide evidence that TDP1-S81 phosphorylation promotes cell survival and DNA repair in response to CPT-induced DSBs.  Together; our findings provide a new mechanism for TDP1 post-translational regulation by ATM and DNA-PK.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrboUgcsxZlJ7Vg90H21EOLACvtfcHk0lh7fcO9_KTkYw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXht1KqsLbJ&md5=49fd7ac1bcc126871fe35011a028c030</span></div><a href="/servlet/linkout?suffix=cit30&amp;dbid=16384&amp;doi=10.1038%2Femboj.2009.302&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Femboj.2009.302%26sid%3Dliteratum%253Aachs%26aulast%3DDas%26aufirst%3DB.%2BB.%26aulast%3DAntony%26aufirst%3DS.%26aulast%3DGupta%26aufirst%3DS.%26aulast%3DDexheimer%26aufirst%3DT.%2BS.%26aulast%3DRedon%26aufirst%3DC.%2BE.%26aulast%3DGarfield%26aufirst%3DS.%26aulast%3DShiloh%26aufirst%3DY.%26aulast%3DPommier%26aufirst%3DY.%26atitle%3DOptimal%2520function%2520of%2520the%2520DNA%2520repair%2520enzyme%2520TDP1%2520requires%2520its%2520phosphorylation%2520by%2520ATM%2520and%252For%2520DNA-PK%26jtitle%3DEMBO%2520J.%26date%3D2009%26volume%3D28%26spage%3D3667%26epage%3D3680%26doi%3D10.1038%2Femboj.2009.302" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref31"><div class="reference"><strong class="refLabel"><a href="#ref31" class="rightTabRefNumLink">31</a></strong><div class="NLM_citation" id="rightTab-cit31"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Katyal, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">El-Khamisy, S. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Russell, H. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ju, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Caldecott, K. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">McKinnon, P. J.</span></span> <span> </span><span class="NLM_article-title">TDP1 facilitates chromosomal single-strand break repair in neurons and is neuroprotective in vivo</span>. <i>EMBO J.</i> <span class="NLM_year" style="font-weight: bold;">2007</span>,  <span class="NLM_volume"><i>26</i></span>,  <span class="NLM_fpage">4720</span>– <span class="NLM_lpage">4731</span>, <span class="refDoi"> DOI: 10.1038/sj.emboj.7601869</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref31/cit31&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00639&amp;key=10.1038%2Fsj.emboj.7601869" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref31/cit31&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00639&amp;key=17914460" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref31/cit31&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00639&amp;key=1%3ACAS%3A528%3ADC%252BD2sXht12gtbfF" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=26&publication_year=2007&pages=4720-4731&author=S.+Katyalauthor=S.+F.+El-Khamisyauthor=H.+R.+Russellauthor=Y.+Liauthor=L.+Juauthor=K.+W.+Caldecottauthor=P.+J.+McKinnon&title=TDP1+facilitates+chromosomal+single-strand+break+repair+in+neurons+and+is+neuroprotective+in+vivo&doi=10.1038%2Fsj.emboj.7601869"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit31R"><div class="casContent"><span class="casTitleNuber">31</span><div class="casTitle"><span class="NLM_cas:atitle">TDP1 facilitates chromosomal single-strand break repair in neurons and is neuroprotective in vivo</span></div><div class="casAuthors">Katyal, Sachin; El-Khamisy, Sherif F.; Russell, Helen R.; Li, Yang; Ju, Limei; Caldecott, Keith W.; McKinnon, Peter J.</div><div class="citationInfo"><span class="NLM_cas:title">EMBO Journal</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">26</span>
        (<span class="NLM_cas:issue">22</span>),
    <span class="NLM_cas:pages">4720-4731</span>CODEN:
                <span class="NLM_cas:coden">EMJODG</span>;
        ISSN:<span class="NLM_cas:issn">0261-4189</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">Defective Tyrosyl-DNA phosphodiesterase 1 (TDP1) can cause spinocerebellar ataxia with axonal neuropathy (SCAN1), a neurodegenerative syndrome assocd. with marked cerebellar atrophy and peripheral neuropathy.  Although SCAN1 lymphoblastoid cells show pronounced defects in the repair of chromosomal single-strand breaks (SSBs), it is unknown if this DNA repair activity is important for neurons or for preventing neurodegeneration.  Therefore, we generated Tdp1-/- mice to assess the role of Tdp1 in the nervous system.  Using both in vitro and in vivo assays, we found that cerebellar neurons or primary astrocytes derived from Tdp1-/- mice display an inability to rapidly repair DNA SSBs assocd. with Top1-DNA complexes or oxidative damage.  Moreover, loss of Tdp1 resulted in age-dependent and progressive cerebellar atrophy.  Tdp1-/- mice treated with topotecan, a drug that increases levels of Top1-DNA complexes, also demonstrated significant loss of intestinal and hematopoietic progenitor cells.  These data indicate that TDP1 is required for neural homeostasis, and reveal a widespread requisite for TDP1 function in response to acutely elevated levels of Top1-assocd. DNA strand breaks.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrCynHEqfbsSLVg90H21EOLACvtfcHk0lh7fcO9_KTkYw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2sXht12gtbfF&md5=4c0b2aa60255f2fa28ff3150f05b15f2</span></div><a href="/servlet/linkout?suffix=cit31&amp;dbid=16384&amp;doi=10.1038%2Fsj.emboj.7601869&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fsj.emboj.7601869%26sid%3Dliteratum%253Aachs%26aulast%3DKatyal%26aufirst%3DS.%26aulast%3DEl-Khamisy%26aufirst%3DS.%2BF.%26aulast%3DRussell%26aufirst%3DH.%2BR.%26aulast%3DLi%26aufirst%3DY.%26aulast%3DJu%26aufirst%3DL.%26aulast%3DCaldecott%26aufirst%3DK.%2BW.%26aulast%3DMcKinnon%26aufirst%3DP.%2BJ.%26atitle%3DTDP1%2520facilitates%2520chromosomal%2520single-strand%2520break%2520repair%2520in%2520neurons%2520and%2520is%2520neuroprotective%2520in%2520vivo%26jtitle%3DEMBO%2520J.%26date%3D2007%26volume%3D26%26spage%3D4720%26epage%3D4731%26doi%3D10.1038%2Fsj.emboj.7601869" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref32"><div class="reference"><strong class="refLabel"><a href="#ref32" class="rightTabRefNumLink">32</a></strong><div class="NLM_citation" id="rightTab-cit32"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Perego, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cossa, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tinelli, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Corna, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Carenini, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gatti, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">De Cesare, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ciusani, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zunino, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Luison, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Canevari, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zaffaroni, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Beretta, G. L.</span></span> <span> </span><span class="NLM_article-title">Role of tyrosyl-DNA phosphodiesterase 1 and inter-players in regulation of tumor cell sensitivity to topoisomerase I inhibition</span>. <i>Biochem. Pharmacol.</i> <span class="NLM_year" style="font-weight: bold;">2012</span>,  <span class="NLM_volume"><i>83</i></span>,  <span class="NLM_fpage">27</span>– <span class="NLM_lpage">36</span>, <span class="refDoi"> DOI: 10.1016/j.bcp.2011.09.021</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref32/cit32&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00639&amp;key=10.1016%2Fj.bcp.2011.09.021" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=83&publication_year=2012&pages=27-36&author=P.+Peregoauthor=G.+Cossaauthor=S.+Tinelliauthor=E.+Cornaauthor=N.+Careniniauthor=L.+Gattiauthor=M.+De+Cesareauthor=E.+Ciusaniauthor=F.+Zuninoauthor=E.+Luisonauthor=S.+Canevariauthor=N.+Zaffaroniauthor=G.+L.+Beretta&title=Role+of+tyrosyl-DNA+phosphodiesterase+1+and+inter-players+in+regulation+of+tumor+cell+sensitivity+to+topoisomerase+I+inhibition&doi=10.1016%2Fj.bcp.2011.09.021"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit32&amp;dbid=16384&amp;doi=10.1016%2Fj.bcp.2011.09.021&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bcp.2011.09.021%26sid%3Dliteratum%253Aachs%26aulast%3DPerego%26aufirst%3DP.%26aulast%3DCossa%26aufirst%3DG.%26aulast%3DTinelli%26aufirst%3DS.%26aulast%3DCorna%26aufirst%3DE.%26aulast%3DCarenini%26aufirst%3DN.%26aulast%3DGatti%26aufirst%3DL.%26aulast%3DDe%2BCesare%26aufirst%3DM.%26aulast%3DCiusani%26aufirst%3DE.%26aulast%3DZunino%26aufirst%3DF.%26aulast%3DLuison%26aufirst%3DE.%26aulast%3DCanevari%26aufirst%3DS.%26aulast%3DZaffaroni%26aufirst%3DN.%26aulast%3DBeretta%26aufirst%3DG.%2BL.%26atitle%3DRole%2520of%2520tyrosyl-DNA%2520phosphodiesterase%25201%2520and%2520inter-players%2520in%2520regulation%2520of%2520tumor%2520cell%2520sensitivity%2520to%2520topoisomerase%2520I%2520inhibition%26jtitle%3DBiochem.%2520Pharmacol.%26date%3D2012%26volume%3D83%26spage%3D27%26epage%3D36%26doi%3D10.1016%2Fj.bcp.2011.09.021" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref33"><div class="reference"><strong class="refLabel"><a href="#ref33" class="rightTabRefNumLink">33</a></strong><div class="NLM_citation" id="rightTab-cit33"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Alagoz, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wells, O. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">El-Khamisy, S. F.</span></span> <span> </span><span class="NLM_article-title">TDP1 deficiency sensitizes human cells to base damage via distinct topoisomerase I and PARP mechanisms with potential applications for cancer therapy</span>. <i>Nucleic Acids Res.</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>42</i></span>,  <span class="NLM_fpage">3089</span>– <span class="NLM_lpage">3103</span>, <span class="refDoi"> DOI: 10.1093/nar/gkt1260</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref33/cit33&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00639&amp;key=10.1093%2Fnar%2Fgkt1260" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=42&publication_year=2014&pages=3089-3103&author=M.+Alagozauthor=O.+S.+Wellsauthor=S.+F.+El-Khamisy&title=TDP1+deficiency+sensitizes+human+cells+to+base+damage+via+distinct+topoisomerase+I+and+PARP+mechanisms+with+potential+applications+for+cancer+therapy&doi=10.1093%2Fnar%2Fgkt1260"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit33&amp;dbid=16384&amp;doi=10.1093%2Fnar%2Fgkt1260&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1093%252Fnar%252Fgkt1260%26sid%3Dliteratum%253Aachs%26aulast%3DAlagoz%26aufirst%3DM.%26aulast%3DWells%26aufirst%3DO.%2BS.%26aulast%3DEl-Khamisy%26aufirst%3DS.%2BF.%26atitle%3DTDP1%2520deficiency%2520sensitizes%2520human%2520cells%2520to%2520base%2520damage%2520via%2520distinct%2520topoisomerase%2520I%2520and%2520PARP%2520mechanisms%2520with%2520potential%2520applications%2520for%2520cancer%2520therapy%26jtitle%3DNucleic%2520Acids%2520Res.%26date%3D2014%26volume%3D42%26spage%3D3089%26epage%3D3103%26doi%3D10.1093%2Fnar%2Fgkt1260" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref34"><div class="reference"><strong class="refLabel"><a href="#ref34" class="rightTabRefNumLink">34</a></strong><div class="NLM_citation" id="rightTab-cit34"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Zakharenko, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Luzina, O.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Koval, O.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nilov, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gushchina, I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dyrkheeva, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Svedas, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Salakhutdinov, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lavrik, O.</span></span> <span> </span><span class="NLM_article-title">Tyrosyl-DNA phosphodiesterase 1 inhibitors: usnic acid enamines enhance the cytotoxic effect of camptothecin</span>. <i>J. Nat. Prod.</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>79</i></span>,  <span class="NLM_fpage">2961</span>– <span class="NLM_lpage">2967</span>, <span class="refDoi"> DOI: 10.1021/acs.jnatprod.6b00979</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acs.jnatprod.6b00979" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref34/cit34&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00639&amp;key=1%3ACAS%3A528%3ADC%252BC28XhvVeltrbI" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=79&publication_year=2016&pages=2961-2967&author=A.+Zakharenkoauthor=O.+Luzinaauthor=O.+Kovalauthor=D.+Nilovauthor=I.+Gushchinaauthor=N.+Dyrkheevaauthor=V.+Svedasauthor=N.+Salakhutdinovauthor=O.+Lavrik&title=Tyrosyl-DNA+phosphodiesterase+1+inhibitors%3A+usnic+acid+enamines+enhance+the+cytotoxic+effect+of+camptothecin&doi=10.1021%2Facs.jnatprod.6b00979"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit34R"><div class="casContent"><span class="casTitleNuber">34</span><div class="casTitle"><span class="NLM_cas:atitle">Tyrosyl-DNA Phosphodiesterase 1 Inhibitors: Usnic Acid Enamines Enhance the Cytotoxic Effect of Camptothecin</span></div><div class="casAuthors">Zakharenko, Alexandra; Luzina, Olga; Koval, Olga; Nilov, Dmitry; Gushchina, Irina; Dyrkheeva, Nadezhda; Svedas, Vytas; Salakhutdinov, Nariman; Lavrik, Olga</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Natural Products</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">79</span>
        (<span class="NLM_cas:issue">11</span>),
    <span class="NLM_cas:pages">2961-2967</span>CODEN:
                <span class="NLM_cas:coden">JNPRDF</span>;
        ISSN:<span class="NLM_cas:issn">0163-3864</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society-American Society of Pharmacognosy</span>)
        </div><div class="casAbstract">Tyrosyl-DNA phosphodiesterase 1 (TDP1) is a repair enzyme for stalled DNA-topoisomerase 1 (Top1) cleavage complexes and other 3'-end DNA lesions.  TDP1 is a perspective target for anticancer therapy based on Top1-poison mediated DNA damage.  Several novel usnic acid derivs. with an enamine moiety have been synthesized and tested as inhibitors of TDP1.  The enamines of usnic acid showed IC50 values in the range of 0.16 to 2.0 μM.  These compds. revealed moderate cytotoxicity against human tumor MCF-7 cells.  These new compds. enhanced the cytotoxicity of the established Top1 poison camptothecin by an order of magnitude.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoRWIxdncprlbVg90H21EOLACvtfcHk0lhFhbAlW73sKA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28XhvVeltrbI&md5=e18a247aaea40561cb59972717771054</span></div><a href="/servlet/linkout?suffix=cit34&amp;dbid=16384&amp;doi=10.1021%2Facs.jnatprod.6b00979&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facs.jnatprod.6b00979%26sid%3Dliteratum%253Aachs%26aulast%3DZakharenko%26aufirst%3DA.%26aulast%3DLuzina%26aufirst%3DO.%26aulast%3DKoval%26aufirst%3DO.%26aulast%3DNilov%26aufirst%3DD.%26aulast%3DGushchina%26aufirst%3DI.%26aulast%3DDyrkheeva%26aufirst%3DN.%26aulast%3DSvedas%26aufirst%3DV.%26aulast%3DSalakhutdinov%26aufirst%3DN.%26aulast%3DLavrik%26aufirst%3DO.%26atitle%3DTyrosyl-DNA%2520phosphodiesterase%25201%2520inhibitors%253A%2520usnic%2520acid%2520enamines%2520enhance%2520the%2520cytotoxic%2520effect%2520of%2520camptothecin%26jtitle%3DJ.%2520Nat.%2520Prod.%26date%3D2016%26volume%3D79%26spage%3D2961%26epage%3D2967%26doi%3D10.1021%2Facs.jnatprod.6b00979" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref35"><div class="reference"><strong class="refLabel"><a href="#ref35" class="rightTabRefNumLink">35</a></strong><div class="NLM_citation" id="rightTab-cit35"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Khomenko, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zakharenko, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Odarchenko, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Arabshahi, H. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sannikova, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zakharova, O.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Korchagina, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Reynisson, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Volcho, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Salakhutdinov, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lavrik, O.</span></span> <span> </span><span class="NLM_article-title">New inhibitors of tyrosyl-DNA phosphodiesterase I (Tdp 1) combining 7-hydroxycoumarin and monoterpenoid moieties</span>. <i>Bioorg. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>24</i></span>,  <span class="NLM_fpage">5573</span>– <span class="NLM_lpage">5581</span>, <span class="refDoi"> DOI: 10.1016/j.bmc.2016.09.016</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref35/cit35&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00639&amp;key=10.1016%2Fj.bmc.2016.09.016" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=24&publication_year=2016&pages=5573-5581&author=T.+Khomenkoauthor=A.+Zakharenkoauthor=T.+Odarchenkoauthor=H.+J.+Arabshahiauthor=V.+Sannikovaauthor=O.+Zakharovaauthor=D.+Korchaginaauthor=J.+Reynissonauthor=K.+Volchoauthor=N.+Salakhutdinovauthor=O.+Lavrik&title=New+inhibitors+of+tyrosyl-DNA+phosphodiesterase+I+%28Tdp+1%29+combining+7-hydroxycoumarin+and+monoterpenoid+moieties&doi=10.1016%2Fj.bmc.2016.09.016"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit35&amp;dbid=16384&amp;doi=10.1016%2Fj.bmc.2016.09.016&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmc.2016.09.016%26sid%3Dliteratum%253Aachs%26aulast%3DKhomenko%26aufirst%3DT.%26aulast%3DZakharenko%26aufirst%3DA.%26aulast%3DOdarchenko%26aufirst%3DT.%26aulast%3DArabshahi%26aufirst%3DH.%2BJ.%26aulast%3DSannikova%26aufirst%3DV.%26aulast%3DZakharova%26aufirst%3DO.%26aulast%3DKorchagina%26aufirst%3DD.%26aulast%3DReynisson%26aufirst%3DJ.%26aulast%3DVolcho%26aufirst%3DK.%26aulast%3DSalakhutdinov%26aufirst%3DN.%26aulast%3DLavrik%26aufirst%3DO.%26atitle%3DNew%2520inhibitors%2520of%2520tyrosyl-DNA%2520phosphodiesterase%2520I%2520%2528Tdp%25201%2529%2520combining%25207-hydroxycoumarin%2520and%2520monoterpenoid%2520moieties%26jtitle%3DBioorg.%2520Med.%2520Chem.%26date%3D2016%26volume%3D24%26spage%3D5573%26epage%3D5581%26doi%3D10.1016%2Fj.bmc.2016.09.016" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref36"><div class="reference"><strong class="refLabel"><a href="#ref36" class="rightTabRefNumLink">36</a></strong><div class="NLM_citation" id="rightTab-cit36"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Ponomarev, K. Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Suslov, E. V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zakharenko, A. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zakharova, O. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rogachev, A. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Korchagina, D. V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zafar, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Reynisson, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nefedov, A. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Volcho, K. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Salakhutdinov, N. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lavrik, O. I.</span></span> <span> </span><span class="NLM_article-title">Aminoadamantanes containing monoterpene-derived fragments as potent tyrosyl-DNA phosphodiesterase 1 inhibitors</span>. <i>Bioorg. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>76</i></span>,  <span class="NLM_fpage">392</span>– <span class="NLM_lpage">399</span>, <span class="refDoi"> DOI: 10.1016/j.bioorg.2017.12.005</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref36/cit36&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00639&amp;key=10.1016%2Fj.bioorg.2017.12.005" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref36/cit36&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00639&amp;key=29248742" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref36/cit36&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00639&amp;key=1%3ACAS%3A528%3ADC%252BC2sXhvFykur%252FI" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=76&publication_year=2018&pages=392-399&author=K.+Y.+Ponomarevauthor=E.+V.+Suslovauthor=A.+L.+Zakharenkoauthor=O.+D.+Zakharovaauthor=A.+D.+Rogachevauthor=D.+V.+Korchaginaauthor=A.+Zafarauthor=J.+Reynissonauthor=A.+A.+Nefedovauthor=K.+P.+Volchoauthor=N.+F.+Salakhutdinovauthor=O.+I.+Lavrik&title=Aminoadamantanes+containing+monoterpene-derived+fragments+as+potent+tyrosyl-DNA+phosphodiesterase+1+inhibitors&doi=10.1016%2Fj.bioorg.2017.12.005"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit36R"><div class="casContent"><span class="casTitleNuber">36</span><div class="casTitle"><span class="NLM_cas:atitle">Aminoadamantanes containing monoterpene-derived fragments as potent tyrosyl-DNA phosphodiesterase 1 inhibitors</span></div><div class="casAuthors">Ponomarev, Konstantin Yu.; Suslov, Evgeniy V.; Zakharenko, Alexandra L.; Zakharova, Olga D.; Rogachev, Artem D.; Korchagina, Dina V.; Zafar, Ayesha; Reynisson, Johannes; Nefedov, Andrey A.; Volcho, Konstantin P.; Salakhutdinov, Nariman F.; Lavrik, Olga I.</div><div class="citationInfo"><span class="NLM_cas:title">Bioorganic Chemistry</span>
        (<span class="NLM_cas:date">2018</span>),
    <span class="NLM_cas:volume">76</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">392-399</span>CODEN:
                <span class="NLM_cas:coden">BOCMBM</span>;
        ISSN:<span class="NLM_cas:issn">0045-2068</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">The ability of a no. of nitrogen-contg. compds. that simultaneously carry the adamantane and monoterpene moieties to inhibit Tdp1, an important enzyme of the DNA repair system, is studied.  Inhibition of this enzyme has the potential to overcome chemotherapeutic resistance of some tumor types.  Compd. (+)-3c synthesized from 1-aminoadamantane and (+)-myrtenal, and compd. 4a produced from 2-aminoadamantane and citronellal were found to be most potent as they inhibited Tdp1 with IC50 values of 6 and 3.5 μM, resp.  These compds. proved to have low cytotoxicity in colon HCT-116 and lung A-549 human tumor cell lines (CC50 > 50 μM).  It was demonstrated that compd. 4a at 10 μM enhanced cytotoxicity of topotecan, a topoisomerase 1 poison in clin. use, against HCT-116 more than fivefold and to a lesser extent of 1.5 increase in potency for A-549.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGp7FoEXVhB937Vg90H21EOLACvtfcHk0lhFhbAlW73sKA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2sXhvFykur%252FI&md5=c89d8aef5748976cf221ab776804d03a</span></div><a href="/servlet/linkout?suffix=cit36&amp;dbid=16384&amp;doi=10.1016%2Fj.bioorg.2017.12.005&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bioorg.2017.12.005%26sid%3Dliteratum%253Aachs%26aulast%3DPonomarev%26aufirst%3DK.%2BY.%26aulast%3DSuslov%26aufirst%3DE.%2BV.%26aulast%3DZakharenko%26aufirst%3DA.%2BL.%26aulast%3DZakharova%26aufirst%3DO.%2BD.%26aulast%3DRogachev%26aufirst%3DA.%2BD.%26aulast%3DKorchagina%26aufirst%3DD.%2BV.%26aulast%3DZafar%26aufirst%3DA.%26aulast%3DReynisson%26aufirst%3DJ.%26aulast%3DNefedov%26aufirst%3DA.%2BA.%26aulast%3DVolcho%26aufirst%3DK.%2BP.%26aulast%3DSalakhutdinov%26aufirst%3DN.%2BF.%26aulast%3DLavrik%26aufirst%3DO.%2BI.%26atitle%3DAminoadamantanes%2520containing%2520monoterpene-derived%2520fragments%2520as%2520potent%2520tyrosyl-DNA%2520phosphodiesterase%25201%2520inhibitors%26jtitle%3DBioorg.%2520Chem.%26date%3D2018%26volume%3D76%26spage%3D392%26epage%3D399%26doi%3D10.1016%2Fj.bioorg.2017.12.005" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref37"><div class="reference"><strong class="refLabel"><a href="#ref37" class="rightTabRefNumLink">37</a></strong><div class="NLM_citation" id="rightTab-cit37"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Huang, S.-y. N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pommier, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Marchand, C.</span></span> <span> </span><span class="NLM_article-title">Tyrosyl-DNA phosphodiesterase 1 (Tdp1) inhibitors</span>. <i>Expert Opin. Ther. Pat.</i> <span class="NLM_year" style="font-weight: bold;">2011</span>,  <span class="NLM_volume"><i>21</i></span>,  <span class="NLM_fpage">1285</span>– <span class="NLM_lpage">1292</span>, <span class="refDoi"> DOI: 10.1517/13543776.2011.604314</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref37/cit37&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00639&amp;key=10.1517%2F13543776.2011.604314" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref37/cit37&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00639&amp;key=21843105" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref37/cit37&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00639&amp;key=1%3ACAS%3A528%3ADC%252BC3MXhtVWnurfK" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=21&publication_year=2011&pages=1285-1292&author=S.-y.+N.+Huangauthor=Y.+Pommierauthor=C.+Marchand&title=Tyrosyl-DNA+phosphodiesterase+1+%28Tdp1%29+inhibitors&doi=10.1517%2F13543776.2011.604314"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit37R"><div class="casContent"><span class="casTitleNuber">37</span><div class="casTitle"><span class="NLM_cas:atitle">Tyrosyl-DNA Phosphodiesterase 1 (Tdp1) inhibitors</span></div><div class="casAuthors">Huang, Shar-yin N.; Pommier, Yves; Marchand, Christophe</div><div class="citationInfo"><span class="NLM_cas:title">Expert Opinion on Therapeutic Patents</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">21</span>
        (<span class="NLM_cas:issue">9</span>),
    <span class="NLM_cas:pages">1285-1292</span>CODEN:
                <span class="NLM_cas:coden">EOTPEG</span>;
        ISSN:<span class="NLM_cas:issn">1354-3776</span>.
    
            (<span class="NLM_cas:orgname">Informa Healthcare</span>)
        </div><div class="casAbstract">A review.  Inhibitors of topoisomerase I (Top1) that result in stalled Top1 cleavage complexes (Top1cc) are commonly employed against cancer.  Combination chemotherapy with DNA repair inhibitors can potentially improve response to these widely used chemotherapeutics.  One line of inquiry focuses on inhibitors of tyrosyl-DNA phosphodiesterase 1 (Tdp1), a repair enzyme for Top1cc.  Tdp1 catalyzes the hydrolysis of DNA adducts covalently linked to the 3'-phosphate of DNA, including Top1-derived peptides and also 3'-phosphoglycolates.  Tdp1 inhibitors should synergize not only with Top1-targeting drugs (camptothecins, indenoisoquinolines), but also with bleomycin, topoisomerase II (Top2) inhibitors (etoposide, doxorubicin) and DNA alkylating agents.  Here, we summarize the structure-activity relationship obtained from the reported Tdp1 inhibitors.  Better understanding of Top1cc repair in vivo coupled with detailed structural studies on Tdp1-inhibitor interaction will be crucial in guiding the rational design of Tdp1 inhibitors.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoTQ1eWsSHiebVg90H21EOLACvtfcHk0liLg6WxrYm2dQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXhtVWnurfK&md5=159aa1443c8ad694fe6eead535a8c687</span></div><a href="/servlet/linkout?suffix=cit37&amp;dbid=16384&amp;doi=10.1517%2F13543776.2011.604314&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1517%252F13543776.2011.604314%26sid%3Dliteratum%253Aachs%26aulast%3DHuang%26aufirst%3DS.-y.%2BN.%26aulast%3DPommier%26aufirst%3DY.%26aulast%3DMarchand%26aufirst%3DC.%26atitle%3DTyrosyl-DNA%2520phosphodiesterase%25201%2520%2528Tdp1%2529%2520inhibitors%26jtitle%3DExpert%2520Opin.%2520Ther.%2520Pat.%26date%3D2011%26volume%3D21%26spage%3D1285%26epage%3D1292%26doi%3D10.1517%2F13543776.2011.604314" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref38"><div class="reference"><strong class="refLabel"><a href="#ref38" class="rightTabRefNumLink">38</a></strong><div class="NLM_citation" id="rightTab-cit38"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Comeaux, E. Q.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">van Waardenburg, R. C. A. M.</span></span> <span> </span><span class="NLM_article-title">Tyrosyl-DNA phosphodiesterase I resolves both naturally and chemically induced DNA adducts and its potential as a therapeutic target</span>. <i>Drug Metab. Rev.</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>46</i></span>,  <span class="NLM_fpage">494</span>– <span class="NLM_lpage">507</span>, <span class="refDoi"> DOI: 10.3109/03602532.2014.971957</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref38/cit38&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00639&amp;key=10.3109%2F03602532.2014.971957" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref38/cit38&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00639&amp;key=25327705" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref38/cit38&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00639&amp;key=1%3ACAS%3A528%3ADC%252BC2cXhvVGgsbzN" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=46&publication_year=2014&pages=494-507&author=E.+Q.+Comeauxauthor=R.+C.+A.+M.+van+Waardenburg&title=Tyrosyl-DNA+phosphodiesterase+I+resolves+both+naturally+and+chemically+induced+DNA+adducts+and+its+potential+as+a+therapeutic+target&doi=10.3109%2F03602532.2014.971957"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit38R"><div class="casContent"><span class="casTitleNuber">38</span><div class="casTitle"><span class="NLM_cas:atitle">Tyrosyl-DNA phosphodiesterase I resolves both naturally and chemically induced DNA adducts and its potential as a therapeutic target</span></div><div class="casAuthors">Comeaux, Evan Q.; van Waardenburg, Robert C. A. M.</div><div class="citationInfo"><span class="NLM_cas:title">Drug Metabolism Reviews</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">46</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">494-507</span>CODEN:
                <span class="NLM_cas:coden">DMTRAR</span>;
        ISSN:<span class="NLM_cas:issn">0360-2532</span>.
    
            (<span class="NLM_cas:orgname">Informa Healthcare</span>)
        </div><div class="casAbstract">DNA is subject to a wide range of insults, resulting from endogenous and exogenous sources that need to be metabolized/resolved to maintain genome integrity.  Tyrosyl-DNA phosphodiesterase I (Tdp1) is a eukaryotic DNA repair enzyme that catalyzes the removal of covalent 3'-DNA adducts.  As a phospholipase D superfamily member Tdp1 utilizes two catalytic histidines each within a His-Lys-Asn motif.  Tdp1 was discovered for its ability to hydrolyze the 3'-phospho-tyrosyl that in the cell covalently links DNA Topoisomerase I (Topo1) and DNA.  Tdp1's list of substrates has since grown and can be divided into two groups: protein-DNA adducts, such as camptothecin stabilized Topo1-DNA adducts, and modified nucleotides, including oxidized nucleotides and chain terminating nucleoside analogs.  Since many of Tdp1's substrates are generated by clin. relevant chemotherapeutics, Tdp1 became a therapeutic target for molecularly targeted small mols.  Tdp1's unique catalytic cycle allows for two different targeting strategies: (1) the intuitive inhibition of Tdp1 catalysis to prevent Tdp1-mediated repair of chemotherapeutically induced DNA adducts, thereby enhancing their toxicity and (2) stabilization of the Tdp1-DNA covalent reaction intermediate, prevents resoln. of Tdp1-DNA adduct and increases the half-life of this potentially toxic DNA adduct.  This concept is best illustrated by a catalytic Tdp1 mutant that forms the mol. basis of the autosomal recessive neurodegenerative disease spinocerebellar ataxia with axonal neuropathy, and results in an increased stability of its Tdp1-DNA reaction intermediate.  Here, we will discuss Tdp1 catalysis from a structure-function perspective, Tdp1 substrates and Tdp1 potential as a therapeutic target.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqQu-Tqidjb0rVg90H21EOLACvtfcHk0liLg6WxrYm2dQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXhvVGgsbzN&md5=b7d187702ad24661a7a670f974d64ec3</span></div><a href="/servlet/linkout?suffix=cit38&amp;dbid=16384&amp;doi=10.3109%2F03602532.2014.971957&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.3109%252F03602532.2014.971957%26sid%3Dliteratum%253Aachs%26aulast%3DComeaux%26aufirst%3DE.%2BQ.%26aulast%3Dvan%2BWaardenburg%26aufirst%3DR.%2BC.%2BA.%2BM.%26atitle%3DTyrosyl-DNA%2520phosphodiesterase%2520I%2520resolves%2520both%2520naturally%2520and%2520chemically%2520induced%2520DNA%2520adducts%2520and%2520its%2520potential%2520as%2520a%2520therapeutic%2520target%26jtitle%3DDrug%2520Metab.%2520Rev.%26date%3D2014%26volume%3D46%26spage%3D494%26epage%3D507%26doi%3D10.3109%2F03602532.2014.971957" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref39"><div class="reference"><strong class="refLabel"><a href="#ref39" class="rightTabRefNumLink">39</a></strong><div class="NLM_citation" id="rightTab-cit39"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Laev, S. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Salakhutdinov, N. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lavrik, O. I.</span></span> <span> </span><span class="NLM_article-title">Tyrosyl-DNA phosphodiesterase inhibitors: Progress and potential</span>. <i>Bioorg. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>24</i></span>,  <span class="NLM_fpage">5017</span>– <span class="NLM_lpage">5027</span>, <span class="refDoi"> DOI: 10.1016/j.bmc.2016.09.045</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref39/cit39&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00639&amp;key=10.1016%2Fj.bmc.2016.09.045" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref39/cit39&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00639&amp;key=27687971" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref39/cit39&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00639&amp;key=1%3ACAS%3A528%3ADC%252BC28XhsFOku7fM" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=24&publication_year=2016&pages=5017-5027&author=S.+S.+Laevauthor=N.+F.+Salakhutdinovauthor=O.+I.+Lavrik&title=Tyrosyl-DNA+phosphodiesterase+inhibitors%3A+Progress+and+potential&doi=10.1016%2Fj.bmc.2016.09.045"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit39R"><div class="casContent"><span class="casTitleNuber">39</span><div class="casTitle"><span class="NLM_cas:atitle">Tyrosyl-DNA phosphodiesterase inhibitors: Progress and potential</span></div><div class="casAuthors">Laev, Sergey S.; Salakhutdinov, Nariman F.; Lavrik, Olga I.</div><div class="citationInfo"><span class="NLM_cas:title">Bioorganic & Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">24</span>
        (<span class="NLM_cas:issue">21</span>),
    <span class="NLM_cas:pages">5017-5027</span>CODEN:
                <span class="NLM_cas:coden">BMECEP</span>;
        ISSN:<span class="NLM_cas:issn">0968-0896</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">A review.  DNA topoisomerases are essential during transcription and replication.  The therapeutic mechanism of action of topoisomerase inhibitors is enzyme poisoning rather than catalytic inhibition.  Tyrosyl-DNA phosphodiesterases 1 or 2 were found as DNA repair enzymes hydrolyzing the covalent bond between the tyrosyl residue of topoisomerases I or II and the 3'- or 5'-phosphate groups in DNA, resp.  Tyrosyl-DNA phosphodiesterase 1 is a key enzyme in DNA repair machinery and a promising target for antitumor and neurodegenerative therapy.  Inhibitors of tyrosyl-DNA phosphodiesterase 1 could act synergistically with topoisomerase I inhibitors and thereby potentiate the effects of topoisomerase I poisons.  Tyrosyl-DNA phosphodiesterase 2 is an enzyme that specifically repairs DNA damages induced by topoisomerase II poisons and causes resistance to these drugs.  Selective inhibition of tyrosyl-DNA phosphodiesterase 2 may be a novel approach to overcome intrinsic or acquired resistance to topoisomerase II-targeted drug therapy.  Thus, agents that inhibit tyrosyl-DNA phosphodiesterases 1 and 2 have many applications in biochem. and physiol. research and they have the potential to become anticancer and antiviral drugs.  The structures, mechanism of action and therapeutic rationale of tyrosyl-DNA phosphodiesterase inhibitors and their development for combinations with topoisomerase inhibitors and DNA damaging agents are discussed.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGp5aNMaBXRtn7Vg90H21EOLACvtfcHk0liLg6WxrYm2dQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28XhsFOku7fM&md5=ce014f1069a979cc5d148695751ac31c</span></div><a href="/servlet/linkout?suffix=cit39&amp;dbid=16384&amp;doi=10.1016%2Fj.bmc.2016.09.045&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmc.2016.09.045%26sid%3Dliteratum%253Aachs%26aulast%3DLaev%26aufirst%3DS.%2BS.%26aulast%3DSalakhutdinov%26aufirst%3DN.%2BF.%26aulast%3DLavrik%26aufirst%3DO.%2BI.%26atitle%3DTyrosyl-DNA%2520phosphodiesterase%2520inhibitors%253A%2520Progress%2520and%2520potential%26jtitle%3DBioorg.%2520Med.%2520Chem.%26date%3D2016%26volume%3D24%26spage%3D5017%26epage%3D5027%26doi%3D10.1016%2Fj.bmc.2016.09.045" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref40"><div class="reference"><strong class="refLabel"><a href="#ref40" class="rightTabRefNumLink">40</a></strong><div class="NLM_citation" id="rightTab-cit40"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Lian, Q.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Xu, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yan, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Huang, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ding, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sun, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bi, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ding, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sun, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Geng, M.</span></span> <span> </span><span class="NLM_article-title">Chemotherapy-induced intestinal inflammatory responses are mediated by exosome secretion of double-strand DNA via AIM2 inflammasome activation</span>. <i>Cell Res.</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>27</i></span>,  <span class="NLM_fpage">784</span>– <span class="NLM_lpage">800</span>, <span class="refDoi"> DOI: 10.1038/cr.2017.54</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref40/cit40&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00639&amp;key=10.1038%2Fcr.2017.54" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref40/cit40&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00639&amp;key=28409562" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref40/cit40&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00639&amp;key=1%3ACAS%3A528%3ADC%252BC2sXmtVCqtrc%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=27&publication_year=2017&pages=784-800&author=Q.+Lianauthor=J.+Xuauthor=S.+Yanauthor=M.+Huangauthor=H.+Dingauthor=X.+Sunauthor=A.+Biauthor=J.+Dingauthor=B.+Sunauthor=M.+Geng&title=Chemotherapy-induced+intestinal+inflammatory+responses+are+mediated+by+exosome+secretion+of+double-strand+DNA+via+AIM2+inflammasome+activation&doi=10.1038%2Fcr.2017.54"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit40R"><div class="casContent"><span class="casTitleNuber">40</span><div class="casTitle"><span class="NLM_cas:atitle">Chemotherapy-induced intestinal inflammatory responses are mediated by exosome secretion of double-strand DNA via AIM2 inflammasome activation</span></div><div class="casAuthors">Lian, Qiaoshi; Xu, Jun; Yan, Shanshan; Huang, Min; Ding, Honghua; Sun, Xiaoyu; Bi, Aiwei; Ding, Jian; Sun, Bing; Geng, Meiyu</div><div class="citationInfo"><span class="NLM_cas:title">Cell Research</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">27</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">784-800</span>CODEN:
                <span class="NLM_cas:coden">CREEB6</span>;
        ISSN:<span class="NLM_cas:issn">1001-0602</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">Chemotherapies are known often to induce severe gastrointestinal tract toxicity but the underlying mechanism remains unclear.  This study considers the widely applied cytotoxic agent irinotecan (CPT-11) as a representative agent and demonstrates that treatment induces massive release of double-strand DNA from the intestine that accounts for the dose-limiting intestinal toxicity of the compd.  Specifically, "self-DNA" released through exosome secretion enters the cytosol of innate immune cells and activates the AIM2 (absent in melanoma 2) inflammasome.  This leads to mature IL-1β and IL-18 secretion and induces intestinal mucositis and late-onset diarrhoea.  Interestingly, abrogation of AIM2 signalling, either in AIM2-deficient mice or by a pharmacol. inhibitor such as thalidomide, significantly reduces the incidence of drug-induced diarrhoea without affecting the anticancer efficacy of CPT-11.  These findings provide mechanistic insights into how chemotherapy triggers innate immune responses causing intestinal toxicity, and reveal new chemotherapy regimens that maintain anti-tumor effects but circumvent the assocd. adverse inflammatory response.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpKNUp5ZVGDErVg90H21EOLACvtfcHk0liLg6WxrYm2dQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2sXmtVCqtrc%253D&md5=8577ec415ca7fb0a111163b342b3860f</span></div><a href="/servlet/linkout?suffix=cit40&amp;dbid=16384&amp;doi=10.1038%2Fcr.2017.54&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fcr.2017.54%26sid%3Dliteratum%253Aachs%26aulast%3DLian%26aufirst%3DQ.%26aulast%3DXu%26aufirst%3DJ.%26aulast%3DYan%26aufirst%3DS.%26aulast%3DHuang%26aufirst%3DM.%26aulast%3DDing%26aufirst%3DH.%26aulast%3DSun%26aufirst%3DX.%26aulast%3DBi%26aufirst%3DA.%26aulast%3DDing%26aufirst%3DJ.%26aulast%3DSun%26aufirst%3DB.%26aulast%3DGeng%26aufirst%3DM.%26atitle%3DChemotherapy-induced%2520intestinal%2520inflammatory%2520responses%2520are%2520mediated%2520by%2520exosome%2520secretion%2520of%2520double-strand%2520DNA%2520via%2520AIM2%2520inflammasome%2520activation%26jtitle%3DCell%2520Res.%26date%3D2017%26volume%3D27%26spage%3D784%26epage%3D800%26doi%3D10.1038%2Fcr.2017.54" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref41"><div class="reference"><strong class="refLabel"><a href="#ref41" class="rightTabRefNumLink">41</a></strong><div class="NLM_citation" id="rightTab-cit41"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Li, T.-K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Houghton, P. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Desai, S. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Daroui, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liu, A. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hars, E. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ruchelman, A. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">LaVoie, E. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liu, L. F.</span></span> <span> </span><span class="NLM_article-title">Characterization of ARC-111 as a novel topoisomerase I-targeting anticancer drug</span>. <i>Cancer Res.</i> <span class="NLM_year" style="font-weight: bold;">2003</span>,  <span class="NLM_volume"><i>63</i></span>,  <span class="NLM_fpage">8400</span>– <span class="NLM_lpage">8407</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref41/cit41&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00639&amp;key=14679002" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref41/cit41&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00639&amp;key=1%3ACAS%3A528%3ADC%252BD3sXpvVagtb0%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=63&publication_year=2003&pages=8400-8407&author=T.-K.+Liauthor=P.+J.+Houghtonauthor=S.+D.+Desaiauthor=P.+Darouiauthor=A.+A.+Liuauthor=E.+S.+Harsauthor=A.+L.+Ruchelmanauthor=E.+J.+LaVoieauthor=L.+F.+Liu&title=Characterization+of+ARC-111+as+a+novel+topoisomerase+I-targeting+anticancer+drug"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit41R"><div class="casContent"><span class="casTitleNuber">41</span><div class="casTitle"><span class="NLM_cas:atitle">Characterization of ARC-111 as a Novel Topoisomerase I-Targeting Anticancer Drug</span></div><div class="casAuthors">Li, Tsai-Kun; Houghton, Peter J.; Desai, Shyamal D.; Daroui, Parima; Liu, Angela A.; Hars, Eszter S.; Ruchelman, Alexander L.; LaVoie, Edmond J.; Liu, Leroy F.</div><div class="citationInfo"><span class="NLM_cas:title">Cancer Research</span>
        (<span class="NLM_cas:date">2003</span>),
    <span class="NLM_cas:volume">63</span>
        (<span class="NLM_cas:issue">23</span>),
    <span class="NLM_cas:pages">8400-8407</span>CODEN:
                <span class="NLM_cas:coden">CNREA8</span>;
        ISSN:<span class="NLM_cas:issn">0008-5472</span>.
    
            (<span class="NLM_cas:orgname">American Association for Cancer Research</span>)
        </div><div class="casAbstract">8,9-Dimethoxy-5-(2-N,N-dimethylaminoethyl)-2,3-methylenedioxy-5H-dibenzo[c,h][1,6] naphthyridin-6-one (ARC-111, topovale) is a new synthetic antitumor agent.  In the current study, we show that ARC-111 is highly potent in scid mice carrying human tumor xenografts.  ARC-111 was shown to be as active as camptothecin (CPT)-11 in the HCT-8 colon tumor model, and compared favorably with CPT-11 and topotecan in the SKNEP anaplastic Wilms' tumor model.  In tissue culture models, ARC-111 exhibited low nM cytotoxicity against a panel of cancer cells.  ARC-111 cytotoxicity as well as ARC-111-induced apoptosis was reduced >100-fold in CPT-resistant topoisomerase I (TOP1)-deficient P388/CPT45 cells as compared with P388 cells.  Similarly, ARC-111 cytotoxicity was greatly reduced in CPT-resistant CPT-K5 and U937/CR cells, which express CPT-resistant mutant TOP1, suggesting that the cytotoxic target of ARC-111 is TOP1.  Indeed, ARC-111, like CPT, was shown to induce reversible TOP1 cleavage complexes in tumor cells as evidenced by specific redn. of the TOP1 immunoreactive band in a band depletion assay, as well as elevation of small ubiquitin modifier-TOP1 conjugate levels and activation of 26S proteasome-mediated degrdn. of TOP1.  Unlike CPT, ARC-111 is not a substrate for the ATP-binding cassette transporter breast cancer resistance protein.  In addn., ARC-111 cytotoxicity was not significantly reduced in the presence of human serum albumin.  These results suggest that ARC-111 is a promising new TOP1-targeting antitumor drug with a different drug resistance profile than CPT.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGopJxPJna3TObVg90H21EOLACvtfcHk0lgDruOhGpZIdQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3sXpvVagtb0%253D&md5=9d7823f2cf3c6910c85d1012109427e0</span></div><a href="/servlet/linkout?suffix=cit41&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DLi%26aufirst%3DT.-K.%26aulast%3DHoughton%26aufirst%3DP.%2BJ.%26aulast%3DDesai%26aufirst%3DS.%2BD.%26aulast%3DDaroui%26aufirst%3DP.%26aulast%3DLiu%26aufirst%3DA.%2BA.%26aulast%3DHars%26aufirst%3DE.%2BS.%26aulast%3DRuchelman%26aufirst%3DA.%2BL.%26aulast%3DLaVoie%26aufirst%3DE.%2BJ.%26aulast%3DLiu%26aufirst%3DL.%2BF.%26atitle%3DCharacterization%2520of%2520ARC-111%2520as%2520a%2520novel%2520topoisomerase%2520I-targeting%2520anticancer%2520drug%26jtitle%3DCancer%2520Res.%26date%3D2003%26volume%3D63%26spage%3D8400%26epage%3D8407" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref42"><div class="reference"><strong class="refLabel"><a href="#ref42" class="rightTabRefNumLink">42</a></strong><div class="NLM_citation" id="rightTab-cit42"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Teicher, B. A.</span></span> <span> </span><span class="NLM_article-title">Next generation topoisomerase I inhibitors: rationale and biomarker strategies</span>. <i>Biochem. Pharmacol.</i> <span class="NLM_year" style="font-weight: bold;">2008</span>,  <span class="NLM_volume"><i>75</i></span>,  <span class="NLM_fpage">1262</span>– <span class="NLM_lpage">1271</span>, <span class="refDoi"> DOI: 10.1016/j.bcp.2007.10.016</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref42/cit42&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00639&amp;key=10.1016%2Fj.bcp.2007.10.016" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=75&publication_year=2008&pages=1262-1271&author=B.+A.+Teicher&title=Next+generation+topoisomerase+I+inhibitors%3A+rationale+and+biomarker+strategies&doi=10.1016%2Fj.bcp.2007.10.016"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit42&amp;dbid=16384&amp;doi=10.1016%2Fj.bcp.2007.10.016&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bcp.2007.10.016%26sid%3Dliteratum%253Aachs%26aulast%3DTeicher%26aufirst%3DB.%2BA.%26atitle%3DNext%2520generation%2520topoisomerase%2520I%2520inhibitors%253A%2520rationale%2520and%2520biomarker%2520strategies%26jtitle%3DBiochem.%2520Pharmacol.%26date%3D2008%26volume%3D75%26spage%3D1262%26epage%3D1271%26doi%3D10.1016%2Fj.bcp.2007.10.016" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref43"><div class="reference"><strong class="refLabel"><a href="#ref43" class="rightTabRefNumLink">43</a></strong><div class="NLM_citation" id="rightTab-cit43"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Burton, J. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mazcko, C. N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">LeBlanc, A. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Covey, J. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ji, J. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kinders, R. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Parchment, R. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Khanna, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Paoloni, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lana, S. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Weishaar, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">London, C. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kisseberth, W. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Krick, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Vail, D. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Childress, M. O.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bryan, J. N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Barber, L. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ehrhart, E. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kent, M. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fan, T. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kow, K. Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Northup, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wilson-Robles, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tomaszewski, J. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Holleran, J. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Muzzio, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Eiseman, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Beumer, J. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Doroshow, J. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pommier, Y.</span></span> <span> </span><span class="NLM_article-title">NCI comparative oncology program testing of non-camptothecin indenoisoquinoline topoisomerase I inhibitors in naturally occurring canine lymphoma</span>. <i>Clin. Cancer Res.</i> <span class="NLM_year" style="font-weight: bold;">2018</span>, <span class="refDoi"> DOI: 10.1158/1078-0432.CCR-18-1498</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref43/cit43&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00639&amp;key=10.1158%2F1078-0432.CCR-18-1498" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref43/cit43&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00639&amp;key=30061364" title="">PubMed</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2018&author=J.+H.+Burtonauthor=C.+N.+Mazckoauthor=A.+K.+LeBlancauthor=J.+M.+Coveyauthor=J.+J.+Jiauthor=R.+J.+Kindersauthor=R.+E.+Parchmentauthor=C.+Khannaauthor=M.+Paoloniauthor=S.+E.+Lanaauthor=K.+Weishaarauthor=C.+A.+Londonauthor=W.+C.+Kisseberthauthor=E.+Krickauthor=D.+M.+Vailauthor=M.+O.+Childressauthor=J.+N.+Bryanauthor=L.+G.+Barberauthor=E.+J.+Ehrhartauthor=M.+S.+Kentauthor=T.+M.+Fanauthor=K.+Y.+Kowauthor=N.+Northupauthor=H.+Wilson-Roblesauthor=J.+E.+Tomaszewskiauthor=J.+L.+Holleranauthor=M.+Muzzioauthor=J.+Eisemanauthor=J.+H.+Beumerauthor=J.+H.+Doroshowauthor=Y.+Pommier&title=NCI+comparative+oncology+program+testing+of+non-camptothecin+indenoisoquinoline+topoisomerase+I+inhibitors+in+naturally+occurring+canine+lymphoma&doi=10.1158%2F1078-0432.CCR-18-1498"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit43&amp;dbid=16384&amp;doi=10.1158%2F1078-0432.CCR-18-1498&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1158%252F1078-0432.CCR-18-1498%26sid%3Dliteratum%253Aachs%26aulast%3DBurton%26aufirst%3DJ.%2BH.%26aulast%3DMazcko%26aufirst%3DC.%2BN.%26aulast%3DLeBlanc%26aufirst%3DA.%2BK.%26aulast%3DCovey%26aufirst%3DJ.%2BM.%26aulast%3DJi%26aufirst%3DJ.%2BJ.%26aulast%3DKinders%26aufirst%3DR.%2BJ.%26aulast%3DParchment%26aufirst%3DR.%2BE.%26aulast%3DKhanna%26aufirst%3DC.%26aulast%3DPaoloni%26aufirst%3DM.%26aulast%3DLana%26aufirst%3DS.%2BE.%26aulast%3DWeishaar%26aufirst%3DK.%26aulast%3DLondon%26aufirst%3DC.%2BA.%26aulast%3DKisseberth%26aufirst%3DW.%2BC.%26aulast%3DKrick%26aufirst%3DE.%26aulast%3DVail%26aufirst%3DD.%2BM.%26aulast%3DChildress%26aufirst%3DM.%2BO.%26aulast%3DBryan%26aufirst%3DJ.%2BN.%26aulast%3DBarber%26aufirst%3DL.%2BG.%26aulast%3DEhrhart%26aufirst%3DE.%2BJ.%26aulast%3DKent%26aufirst%3DM.%2BS.%26aulast%3DFan%26aufirst%3DT.%2BM.%26aulast%3DKow%26aufirst%3DK.%2BY.%26aulast%3DNorthup%26aufirst%3DN.%26aulast%3DWilson-Robles%26aufirst%3DH.%26aulast%3DTomaszewski%26aufirst%3DJ.%2BE.%26aulast%3DHolleran%26aufirst%3DJ.%2BL.%26aulast%3DMuzzio%26aufirst%3DM.%26aulast%3DEiseman%26aufirst%3DJ.%26aulast%3DBeumer%26aufirst%3DJ.%2BH.%26aulast%3DDoroshow%26aufirst%3DJ.%2BH.%26aulast%3DPommier%26aufirst%3DY.%26atitle%3DNCI%2520comparative%2520oncology%2520program%2520testing%2520of%2520non-camptothecin%2520indenoisoquinoline%2520topoisomerase%2520I%2520inhibitors%2520in%2520naturally%2520occurring%2520canine%2520lymphoma%26jtitle%3DClin.%2520Cancer%2520Res.%26date%3D2018%26doi%3D10.1158%2F1078-0432.CCR-18-1498" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref44"><div class="reference"><strong class="refLabel"><a href="#ref44" class="rightTabRefNumLink">44</a></strong><div class="NLM_citation" id="rightTab-cit44"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Hu, Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, H. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">An, L. K.</span></span> <span> </span><span class="NLM_article-title">Tyrosyl-DNA phosphodiesterases: potential targets for cancer treatment</span>. <i>Acta Pharm. Sin.</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>51</i></span>,  <span class="NLM_fpage">215</span>– <span class="NLM_lpage">225</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref44/cit44&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00639&amp;key=1%3ACAS%3A280%3ADC%252BC1MbislCmuw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=51&publication_year=2016&pages=215-225&author=Z.+Huauthor=H.+W.+Wangauthor=L.+K.+An&title=Tyrosyl-DNA+phosphodiesterases%3A+potential+targets+for+cancer+treatment"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit44R"><div class="casContent"><span class="casTitleNuber">44</span><div class="casTitle"><span class="NLM_cas:atitle">Tyrosyl-DNA phosphodiesterases: potential targets for cancer treatment</span></div><div class="casAuthors">Hu Zhu; Wang Hao-wen; An Lin-kun</div><div class="citationInfo"><span class="NLM_cas:title">Yao xue xue bao = Acta pharmaceutica Sinica</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">51</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">215-25</span>
        ISSN:<span class="NLM_cas:issn">0513-4870</span>.
    </div><div class="casAbstract">DNA topoisomerases-mediated DNA damages are generated from exogenous and endogenous effects, which need to be metabolized or repaired to maintain genome stability involving in many of repair enzymes.  Tyrosyl-DNA phosphodiesterase 1(TDP1) and tyrosyl-DNA phosphodiesterase 2(TDP2) are two DNA repair enzymes discovered recently.  TDP1 and TDP2 have the ability to hydrolyze the tyrosyl-phosphodiester bond of the phenol of tyrosine with 3'- and 5'-DNA end, respectively, which are contained in the metabolites of the damaged DNA mediated by topoisomerase 1 and topoisomerase 2, respectively.  The abnormal activation and expression of TDP1 or TDP2 is the important reason for cancer development.  Therefore, TDP1 and TDP2 have been regarded as potential targets in cancer therapy.  In this review, we discuss the rationales of their potential as targets and development of their inhibitors together with topoisomerase poisons or DNA damaging agents.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcQZlfYPqtGKR4kFb3mqPUYDfW6udTcc2ebdYiwR-nWH-rntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BC1MbislCmuw%253D%253D&md5=99618fbd18fcbd6bcecd47826a4f2b97</span></div><a href="/servlet/linkout?suffix=cit44&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DHu%26aufirst%3DZ.%26aulast%3DWang%26aufirst%3DH.%2BW.%26aulast%3DAn%26aufirst%3DL.%2BK.%26atitle%3DTyrosyl-DNA%2520phosphodiesterases%253A%2520potential%2520targets%2520for%2520cancer%2520treatment%26jtitle%3DActa%2520Pharm.%2520Sin.%26date%3D2016%26volume%3D51%26spage%3D215%26epage%3D225" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref45"><div class="reference"><strong class="refLabel"><a href="#ref45" class="rightTabRefNumLink">45</a></strong><div class="NLM_citation" id="rightTab-cit45"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Davies, D. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Interthal, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Champoux, J. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hol, W. G. J.</span></span> <span> </span><span class="NLM_article-title">Insights into substrate binding and catalytic mechanism of human tyrosyl-DNA phosphodiesterase (Tdp1) from vanadate and tungstate-inhibited structures</span>. <i>J. Mol. Biol.</i> <span class="NLM_year" style="font-weight: bold;">2002</span>,  <span class="NLM_volume"><i>324</i></span>,  <span class="NLM_fpage">917</span>– <span class="NLM_lpage">932</span>, <span class="refDoi"> DOI: 10.1016/S0022-2836(02)01154-3</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref45/cit45&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00639&amp;key=10.1016%2FS0022-2836%2802%2901154-3" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref45/cit45&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00639&amp;key=12470949" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref45/cit45&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00639&amp;key=1%3ACAS%3A528%3ADC%252BD38XpsF2kurY%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=324&publication_year=2002&pages=917-932&author=D.+R.+Daviesauthor=H.+Interthalauthor=J.+J.+Champouxauthor=W.+G.+J.+Hol&title=Insights+into+substrate+binding+and+catalytic+mechanism+of+human+tyrosyl-DNA+phosphodiesterase+%28Tdp1%29+from+vanadate+and+tungstate-inhibited+structures&doi=10.1016%2FS0022-2836%2802%2901154-3"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit45R"><div class="casContent"><span class="casTitleNuber">45</span><div class="casTitle"><span class="NLM_cas:atitle">Insights into Substrate Binding and Catalytic Mechanism of Human Tyrosyl-DNA Phosphodiesterase (Tdp1) from Vanadate and Tungstate-inhibited Structures</span></div><div class="casAuthors">Davies, Douglas R.; Interthal, Heidrun; Champoux, James J.; Hol, Wim G. J.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Molecular Biology</span>
        (<span class="NLM_cas:date">2002</span>),
    <span class="NLM_cas:volume">324</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">917-932</span>CODEN:
                <span class="NLM_cas:coden">JMOBAK</span>;
        ISSN:<span class="NLM_cas:issn">0022-2836</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Science Ltd.</span>)
        </div><div class="casAbstract">Tyrosyl-DNA phosphodiesterase (Tdp1) is a DNA repair enzyme that catalyzes the hydrolysis of a phosphodiester bond between a tyrosine residue and a DNA 3'-phosphate.  The only known example of such a linkage in eukaryotic cells occurs normally as a transient link between a type IB topoisomerase and DNA.  Thus human Tdp1 is thought to be responsible for repairing lesions that occur when topoisomerase I becomes stalled on the DNA in the cell.  Tdp1 has also been shown to remove glycolate from single-stranded DNA contg. a 3'-phosphoglycolate, suggesting a role for Tdp1 in repair of free-radical mediated DNA double-strand breaks.  We report the three-dimensional structures of human Tdp1 bound to the phosphate transition state analogs vanadate and tungstate.  Each structure shows the inhibitor covalently bound to His263, confirming that this residue is the nucleophile in the first step of the catalytic reaction.  Vanadate in the Tdp1-vanadate structure has a trigonal bipyramidal geometry that mimics the transition state for hydrolysis of a phosphodiester bond, while Tdp1-tungstate displays unusual octahedral coordination.  The presence of low-occupancy tungstate mols. along the narrow groove of the substrate binding cleft is suggestive evidence that this groove binds ssDNA.  In both cases, glycerol from the cryoprotectant soln. became liganded to the vanadate or tungstate inhibitor mols. in a bidentate 1,2-diol fashion.  These structural models allow predictions to be made regarding the specific binding mode of the substrate and the mechanism of catalysis.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqK8h8pfQyO4LVg90H21EOLACvtfcHk0lhoYZf3VPPBCQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD38XpsF2kurY%253D&md5=6dedb178fa7dc3ec57ed3fd0bd5d7bb1</span></div><a href="/servlet/linkout?suffix=cit45&amp;dbid=16384&amp;doi=10.1016%2FS0022-2836%2802%2901154-3&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS0022-2836%252802%252901154-3%26sid%3Dliteratum%253Aachs%26aulast%3DDavies%26aufirst%3DD.%2BR.%26aulast%3DInterthal%26aufirst%3DH.%26aulast%3DChampoux%26aufirst%3DJ.%2BJ.%26aulast%3DHol%26aufirst%3DW.%2BG.%2BJ.%26atitle%3DInsights%2520into%2520substrate%2520binding%2520and%2520catalytic%2520mechanism%2520of%2520human%2520tyrosyl-DNA%2520phosphodiesterase%2520%2528Tdp1%2529%2520from%2520vanadate%2520and%2520tungstate-inhibited%2520structures%26jtitle%3DJ.%2520Mol.%2520Biol.%26date%3D2002%26volume%3D324%26spage%3D917%26epage%3D932%26doi%3D10.1016%2FS0022-2836%2802%2901154-3" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref46"><div class="reference"><strong class="refLabel"><a href="#ref46" class="rightTabRefNumLink">46</a></strong><div class="NLM_citation" id="rightTab-cit46"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Davies, D. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Interthal, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Champoux, J. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hol, W. G. J.</span></span> <span> </span><span class="NLM_article-title">Crystal structure of a transition state mimic for Tdp1 assembled from vanadate, DNA, and a topoisomerase I-derived peptide</span>. <i>Chem. Biol.</i> <span class="NLM_year" style="font-weight: bold;">2003</span>,  <span class="NLM_volume"><i>10</i></span>,  <span class="NLM_fpage">139</span>– <span class="NLM_lpage">147</span>, <span class="refDoi"> DOI: 10.1016/S1074-5521(03)00021-8</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref46/cit46&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00639&amp;key=10.1016%2FS1074-5521%2803%2900021-8" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref46/cit46&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00639&amp;key=12618186" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref46/cit46&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00639&amp;key=1%3ACAS%3A528%3ADC%252BD3sXhs1Crsrs%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=10&publication_year=2003&pages=139-147&author=D.+R.+Daviesauthor=H.+Interthalauthor=J.+J.+Champouxauthor=W.+G.+J.+Hol&title=Crystal+structure+of+a+transition+state+mimic+for+Tdp1+assembled+from+vanadate%2C+DNA%2C+and+a+topoisomerase+I-derived+peptide&doi=10.1016%2FS1074-5521%2803%2900021-8"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit46R"><div class="casContent"><span class="casTitleNuber">46</span><div class="casTitle"><span class="NLM_cas:atitle">Crystal structure of a transition state mimic for Tdp1 assembled from vanadate, DNA, and a topoisomerase I-derived peptide</span></div><div class="casAuthors">Davies, Douglas R.; Interthal, Heidrun; Champoux, James J.; Hol, Wim G. J.</div><div class="citationInfo"><span class="NLM_cas:title">Chemistry & Biology</span>
        (<span class="NLM_cas:date">2003</span>),
    <span class="NLM_cas:volume">10</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">139-147</span>CODEN:
                <span class="NLM_cas:coden">CBOLE2</span>;
        ISSN:<span class="NLM_cas:issn">1074-5521</span>.
    
            (<span class="NLM_cas:orgname">Cell Press</span>)
        </div><div class="casAbstract">Tyrosyl-DNA phosphodiesterase (Tdp1) is a member of the phospholipase D superfamily and acts as a DNA repair enzyme that removes stalled topoisomerase I- DNA complexes by hydrolyzing the bond between a tyrosine side chain and a DNA 3' phosphate.  Despite the complexity of the substrate of this phosphodiesterase, vanadate succeeded in linking human Tdp1, a tyrosine-contg. peptide, and a single-stranded DNA oligonucleotide into a quaternary complex that mimics the transition state for the first step of the catalytic reaction.  The conformation of the bound substrate mimic gives compelling evidence that the topoisomerase I-DNA complex must undergo extensive modification prior to cleavage by Tdp1.  The structure also illustrates that the use of vanadate as the central moiety in high-order complexes has the potential to be a general method for capturing protein-substrate interactions for phosphoryl transfer enzymes, even when the substrates are large, complicated, and unusual.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqrNJv97ppHfbVg90H21EOLACvtfcHk0lhoYZf3VPPBCQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3sXhs1Crsrs%253D&md5=9ce9e926b648eca1bd6a5335eaa30cb7</span></div><a href="/servlet/linkout?suffix=cit46&amp;dbid=16384&amp;doi=10.1016%2FS1074-5521%2803%2900021-8&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS1074-5521%252803%252900021-8%26sid%3Dliteratum%253Aachs%26aulast%3DDavies%26aufirst%3DD.%2BR.%26aulast%3DInterthal%26aufirst%3DH.%26aulast%3DChampoux%26aufirst%3DJ.%2BJ.%26aulast%3DHol%26aufirst%3DW.%2BG.%2BJ.%26atitle%3DCrystal%2520structure%2520of%2520a%2520transition%2520state%2520mimic%2520for%2520Tdp1%2520assembled%2520from%2520vanadate%252C%2520DNA%252C%2520and%2520a%2520topoisomerase%2520I-derived%2520peptide%26jtitle%3DChem.%2520Biol.%26date%3D2003%26volume%3D10%26spage%3D139%26epage%3D147%26doi%3D10.1016%2FS1074-5521%2803%2900021-8" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref47"><div class="reference"><strong class="refLabel"><a href="#ref47" class="rightTabRefNumLink">47</a></strong><div class="NLM_citation" id="rightTab-cit47"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Liao, Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Thibaut, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jobson, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pommier, Y.</span></span> <span> </span><span class="NLM_article-title">Inhibition of human tyrosyl-DNA phosphodiesterase by aminoglycoside antibiotics and ribosome inhibitors</span>. <i>Mol. Pharmacol.</i> <span class="NLM_year" style="font-weight: bold;">2006</span>,  <span class="NLM_volume"><i>70</i></span>,  <span class="NLM_fpage">366</span>– <span class="NLM_lpage">372</span>, <span class="refDoi"> DOI: 10.1124/mol.105.021865</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref47/cit47&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00639&amp;key=10.1124%2Fmol.105.021865" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=70&publication_year=2006&pages=366-372&author=Z.+Liaoauthor=L.+Thibautauthor=A.+Jobsonauthor=Y.+Pommier&title=Inhibition+of+human+tyrosyl-DNA+phosphodiesterase+by+aminoglycoside+antibiotics+and+ribosome+inhibitors&doi=10.1124%2Fmol.105.021865"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit47&amp;dbid=16384&amp;doi=10.1124%2Fmol.105.021865&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1124%252Fmol.105.021865%26sid%3Dliteratum%253Aachs%26aulast%3DLiao%26aufirst%3DZ.%26aulast%3DThibaut%26aufirst%3DL.%26aulast%3DJobson%26aufirst%3DA.%26aulast%3DPommier%26aufirst%3DY.%26atitle%3DInhibition%2520of%2520human%2520tyrosyl-DNA%2520phosphodiesterase%2520by%2520aminoglycoside%2520antibiotics%2520and%2520ribosome%2520inhibitors%26jtitle%3DMol.%2520Pharmacol.%26date%3D2006%26volume%3D70%26spage%3D366%26epage%3D372%26doi%3D10.1124%2Fmol.105.021865" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref48"><div class="reference"><strong class="refLabel"><a href="#ref48" class="rightTabRefNumLink">48</a></strong><div class="NLM_citation" id="rightTab-cit48"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Marchand, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lea, W. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jadhav, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dexheimer, T. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Austin, C. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Inglese, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pommier, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Simeonov, A.</span></span> <span> </span><span class="NLM_article-title">Identification of phosphotyrosine mimetic inhibitors of human tyrosyl-DNA phosphodiesterase I by a novel AlphaScreen high-throughput assay</span>. <i>Mol. Cancer Ther.</i> <span class="NLM_year" style="font-weight: bold;">2009</span>,  <span class="NLM_volume"><i>8</i></span>,  <span class="NLM_fpage">240</span>– <span class="NLM_lpage">248</span>, <span class="refDoi"> DOI: 10.1158/1535-7163.MCT-08-0878</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref48/cit48&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00639&amp;key=10.1158%2F1535-7163.MCT-08-0878" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref48/cit48&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00639&amp;key=19139134" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref48/cit48&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00639&amp;key=1%3ACAS%3A528%3ADC%252BD1MXjvFSltw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=8&publication_year=2009&pages=240-248&author=C.+Marchandauthor=W.+A.+Leaauthor=A.+Jadhavauthor=T.+S.+Dexheimerauthor=C.+P.+Austinauthor=J.+Ingleseauthor=Y.+Pommierauthor=A.+Simeonov&title=Identification+of+phosphotyrosine+mimetic+inhibitors+of+human+tyrosyl-DNA+phosphodiesterase+I+by+a+novel+AlphaScreen+high-throughput+assay&doi=10.1158%2F1535-7163.MCT-08-0878"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit48R"><div class="casContent"><span class="casTitleNuber">48</span><div class="casTitle"><span class="NLM_cas:atitle">Identification of phosphotyrosine mimetic inhibitors of human tyrosyl-DNA phosphodiesterase I by a novel AlphaScreen high-throughput assay</span></div><div class="casAuthors">Marchand, Christophe; Lea, Wendy A.; Jadhav, Ajit; Dexheimer, Thomas S.; Austin, Christopher P.; Inglese, James; Pommier, Yves; Simeonov, Anton</div><div class="citationInfo"><span class="NLM_cas:title">Molecular Cancer Therapeutics</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">8</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">240-248</span>CODEN:
                <span class="NLM_cas:coden">MCTOCF</span>;
        ISSN:<span class="NLM_cas:issn">1535-7163</span>.
    
            (<span class="NLM_cas:orgname">American Association for Cancer Research</span>)
        </div><div class="casAbstract">Tyrosyl-DNA phosphodiesterase I (Tdp1) resolves topoisomerase I (Top1)-DNA adducts accumulated from natural DNA damage as well as from the action of certain anticancer drugs.  Tdp1 catalyzes the hydrolysis of the phosphodiester bond between the catalytic tyrosine residue of topoisomerase I and the DNA 3'-phosphate.  Only a limited no. of weak inhibitors have been reported for Tdp1, and there is an unmet need to identify novel chemotypes through screening of chem. libraries.  Herein, we present an easily configured, highly miniaturized, and robust Tdp1 assay using the AlphaScreen technol.  Uninhibited enzyme reaction is assocd. with low signal, whereas inhibition leads to a gain of signal, making the present assay format esp. attractive for automated large-collection high-throughput screening.  We report the identification and initial characterization of four previously unreported inhibitors of Tdp1.  Among them, suramin, NF449, and methyl-3,4-dephostatin are phosphotyrosine mimetics that may act as Tdp1 substrate decoys.  We also report a novel biochem. assay using the SCAN1 Tdp1 mutant to study the mechanism of action of methyl-3,4-dephostatin.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqw2O21mqWopLVg90H21EOLACvtfcHk0limNN5NxoM38Q"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXjvFSltw%253D%253D&md5=05a32d97be998b397a5dc3586b81bef4</span></div><a href="/servlet/linkout?suffix=cit48&amp;dbid=16384&amp;doi=10.1158%2F1535-7163.MCT-08-0878&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1158%252F1535-7163.MCT-08-0878%26sid%3Dliteratum%253Aachs%26aulast%3DMarchand%26aufirst%3DC.%26aulast%3DLea%26aufirst%3DW.%2BA.%26aulast%3DJadhav%26aufirst%3DA.%26aulast%3DDexheimer%26aufirst%3DT.%2BS.%26aulast%3DAustin%26aufirst%3DC.%2BP.%26aulast%3DInglese%26aufirst%3DJ.%26aulast%3DPommier%26aufirst%3DY.%26aulast%3DSimeonov%26aufirst%3DA.%26atitle%3DIdentification%2520of%2520phosphotyrosine%2520mimetic%2520inhibitors%2520of%2520human%2520tyrosyl-DNA%2520phosphodiesterase%2520I%2520by%2520a%2520novel%2520AlphaScreen%2520high-throughput%2520assay%26jtitle%3DMol.%2520Cancer%2520Ther.%26date%3D2009%26volume%3D8%26spage%3D240%26epage%3D248%26doi%3D10.1158%2F1535-7163.MCT-08-0878" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref49"><div class="reference"><strong class="refLabel"><a href="#ref49" class="rightTabRefNumLink">49</a></strong><div class="NLM_citation" id="rightTab-cit49"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Sirivolu, V. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Vernekar, S. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Marchand, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Naumova, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chergui, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Renaud, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Stephen, A. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chen, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sham, Y. Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pommier, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, Z.</span></span> <span> </span><span class="NLM_article-title">5-Arylidenethioxothiazolidinones as inhibitors of tyrosyl-DNA phosphodiesterase I</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2012</span>,  <span class="NLM_volume"><i>55</i></span>,  <span class="NLM_fpage">8671</span>– <span class="NLM_lpage">8684</span>, <span class="refDoi"> DOI: 10.1021/jm3008773</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm3008773" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=55&publication_year=2012&pages=8671-8684&author=V.+R.+Sirivoluauthor=S.+K.+Vernekarauthor=C.+Marchandauthor=A.+Naumovaauthor=A.+Cherguiauthor=A.+Renaudauthor=A.+G.+Stephenauthor=F.+Chenauthor=Y.+Y.+Shamauthor=Y.+Pommierauthor=Z.+Wang&title=5-Arylidenethioxothiazolidinones+as+inhibitors+of+tyrosyl-DNA+phosphodiesterase+I&doi=10.1021%2Fjm3008773"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit49&amp;dbid=16384&amp;doi=10.1021%2Fjm3008773&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm3008773%26sid%3Dliteratum%253Aachs%26aulast%3DSirivolu%26aufirst%3DV.%2BR.%26aulast%3DVernekar%26aufirst%3DS.%2BK.%26aulast%3DMarchand%26aufirst%3DC.%26aulast%3DNaumova%26aufirst%3DA.%26aulast%3DChergui%26aufirst%3DA.%26aulast%3DRenaud%26aufirst%3DA.%26aulast%3DStephen%26aufirst%3DA.%2BG.%26aulast%3DChen%26aufirst%3DF.%26aulast%3DSham%26aufirst%3DY.%2BY.%26aulast%3DPommier%26aufirst%3DY.%26aulast%3DWang%26aufirst%3DZ.%26atitle%3D5-Arylidenethioxothiazolidinones%2520as%2520inhibitors%2520of%2520tyrosyl-DNA%2520phosphodiesterase%2520I%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2012%26volume%3D55%26spage%3D8671%26epage%3D8684%26doi%3D10.1021%2Fjm3008773" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref50"><div class="reference"><strong class="refLabel"><a href="#ref50" class="rightTabRefNumLink">50</a></strong><div class="NLM_citation" id="rightTab-cit50"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Dean, R. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fam, H. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">An, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Choi, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shimizu, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jones, S. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Boerkoel, C. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Interthal, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pfeifer, T. A.</span></span> <span> </span><span class="NLM_article-title">Identification of a putative Tdp1 inhibitor (CD00509) by in vitro and cell-based assays</span>. <i>J. Biomol. Screening</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>19</i></span>,  <span class="NLM_fpage">1372</span>– <span class="NLM_lpage">1382</span>, <span class="refDoi"> DOI: 10.1177/1087057114546551</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref50/cit50&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00639&amp;key=10.1177%2F1087057114546551" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref50/cit50&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00639&amp;key=25117203" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref50/cit50&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00639&amp;key=1%3ACAS%3A528%3ADC%252BC2cXitFGgs7nJ" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=19&publication_year=2014&pages=1372-1382&author=R.+A.+Deanauthor=H.+K.+Famauthor=J.+Anauthor=K.+Choiauthor=Y.+Shimizuauthor=S.+J.+Jonesauthor=C.+F.+Boerkoelauthor=H.+Interthalauthor=T.+A.+Pfeifer&title=Identification+of+a+putative+Tdp1+inhibitor+%28CD00509%29+by+in+vitro+and+cell-based+assays&doi=10.1177%2F1087057114546551"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit50R"><div class="casContent"><span class="casTitleNuber">50</span><div class="casTitle"><span class="NLM_cas:atitle">Identification of a putative Tdp1 inhibitor (CD00509) by in vitro and cell-based assays</span></div><div class="casAuthors">Dean, Richard A.; Fam, Hok Khim; An, Jianghong; Choi, Kunho; Shimizu, Yoko; Jones, Steven J. M.; Boerkoel, Cornelius F.; Interthal, Heidrun; Pfeifer, Tom A.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Biomolecular Screening</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">19</span>
        (<span class="NLM_cas:issue">10</span>),
    <span class="NLM_cas:pages">1372-1382</span>CODEN:
                <span class="NLM_cas:coden">JBISF3</span>;
        ISSN:<span class="NLM_cas:issn">1087-0571</span>.
    
            (<span class="NLM_cas:orgname">Sage Publications</span>)
        </div><div class="casAbstract">Mutations of DNA repair pathways contribute to tumorigenesis and provide a therapeutic target for synthetic lethal interactions in tumor cells.  Given that tyrosyl-DNA phosphodiesterase 1 (Tdp1) repairs stalled topoisomerase-I DNA complexes, we hypothesized that inhibition of Tdp1 has synthetic lethal effects in some cancers.  To test this, we screened tumor arrays for Tdp1 expression and obsd. that Tdp1 is expressed in many tumors, including more than 90% of human breast tumors.  Subsequent chem. screening identified putative Tdp1 inhibitors.  Treatment of control human mammary epithelial cells and the breast cancer cell line MCF-7 with compd. CD00509 preferentially sensitized MCF- 7 cells to camptothecin and decreased cell proliferation 25% more than camptothecin treatment alone.  This suggests that CD00509 specifically targeted Tdp1 in vitro, and CD00509 increased the sensitivity of wild-type murine embryonic fibroblasts (MEFs) to camptothecin to a degree comparable to that of Tdp1-/- MEFs.  In addn., consistent with poly ADPribose polymerase-1 (PARP-1) collaborating with Tdp1 in DNA repair, combined Tdp1 and PARP-1 inhibition was more detrimental to MCF-7 cells than either treatment alone, whereas the combination was not additively harmful to control mammary cells.  We conclude that targeting Tdp1 in anticancer therapy preferentially enhances the sensitivity of some breast cancer cells to camptothecin and may be an effective adjuvant for breast cancer therapy.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGp9JJs__w2bnLVg90H21EOLACvtfcHk0limNN5NxoM38Q"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXitFGgs7nJ&md5=01019816a3bf5e716e007ad40157a711</span></div><a href="/servlet/linkout?suffix=cit50&amp;dbid=16384&amp;doi=10.1177%2F1087057114546551&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1177%252F1087057114546551%26sid%3Dliteratum%253Aachs%26aulast%3DDean%26aufirst%3DR.%2BA.%26aulast%3DFam%26aufirst%3DH.%2BK.%26aulast%3DAn%26aufirst%3DJ.%26aulast%3DChoi%26aufirst%3DK.%26aulast%3DShimizu%26aufirst%3DY.%26aulast%3DJones%26aufirst%3DS.%2BJ.%26aulast%3DBoerkoel%26aufirst%3DC.%2BF.%26aulast%3DInterthal%26aufirst%3DH.%26aulast%3DPfeifer%26aufirst%3DT.%2BA.%26atitle%3DIdentification%2520of%2520a%2520putative%2520Tdp1%2520inhibitor%2520%2528CD00509%2529%2520by%2520in%2520vitro%2520and%2520cell-based%2520assays%26jtitle%3DJ.%2520Biomol.%2520Screening%26date%3D2014%26volume%3D19%26spage%3D1372%26epage%3D1382%26doi%3D10.1177%2F1087057114546551" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref51"><div class="reference"><strong class="refLabel"><a href="#ref51" class="rightTabRefNumLink">51</a></strong><div class="NLM_citation" id="rightTab-cit51"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Zakharenko, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Khomenko, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhukova, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Koval, O.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zakharova, O.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Anarbaev, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lebedeva, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Korchagina, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Komarova, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Vasiliev, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Reynisson, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Volcho, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Salakhutdinov, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lavrik, O.</span></span> <span> </span><span class="NLM_article-title">Synthesis and biological evaluation of novel tyrosyl-DNA phosphodiesterase 1 inhibitors with a benzopentathiepine moiety</span>. <i>Bioorg. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>23</i></span>,  <span class="NLM_fpage">2044</span>– <span class="NLM_lpage">2052</span>, <span class="refDoi"> DOI: 10.1016/j.bmc.2015.03.020</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref51/cit51&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00639&amp;key=10.1016%2Fj.bmc.2015.03.020" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=23&publication_year=2015&pages=2044-2052&author=A.+Zakharenkoauthor=T.+Khomenkoauthor=S.+Zhukovaauthor=O.+Kovalauthor=O.+Zakharovaauthor=R.+Anarbaevauthor=N.+Lebedevaauthor=D.+Korchaginaauthor=N.+Komarovaauthor=V.+Vasilievauthor=J.+Reynissonauthor=K.+Volchoauthor=N.+Salakhutdinovauthor=O.+Lavrik&title=Synthesis+and+biological+evaluation+of+novel+tyrosyl-DNA+phosphodiesterase+1+inhibitors+with+a+benzopentathiepine+moiety&doi=10.1016%2Fj.bmc.2015.03.020"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit51&amp;dbid=16384&amp;doi=10.1016%2Fj.bmc.2015.03.020&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmc.2015.03.020%26sid%3Dliteratum%253Aachs%26aulast%3DZakharenko%26aufirst%3DA.%26aulast%3DKhomenko%26aufirst%3DT.%26aulast%3DZhukova%26aufirst%3DS.%26aulast%3DKoval%26aufirst%3DO.%26aulast%3DZakharova%26aufirst%3DO.%26aulast%3DAnarbaev%26aufirst%3DR.%26aulast%3DLebedeva%26aufirst%3DN.%26aulast%3DKorchagina%26aufirst%3DD.%26aulast%3DKomarova%26aufirst%3DN.%26aulast%3DVasiliev%26aufirst%3DV.%26aulast%3DReynisson%26aufirst%3DJ.%26aulast%3DVolcho%26aufirst%3DK.%26aulast%3DSalakhutdinov%26aufirst%3DN.%26aulast%3DLavrik%26aufirst%3DO.%26atitle%3DSynthesis%2520and%2520biological%2520evaluation%2520of%2520novel%2520tyrosyl-DNA%2520phosphodiesterase%25201%2520inhibitors%2520with%2520a%2520benzopentathiepine%2520moiety%26jtitle%3DBioorg.%2520Med.%2520Chem.%26date%3D2015%26volume%3D23%26spage%3D2044%26epage%3D2052%26doi%3D10.1016%2Fj.bmc.2015.03.020" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref52"><div class="reference"><strong class="refLabel"><a href="#ref52" class="rightTabRefNumLink">52</a></strong><div class="NLM_citation" id="rightTab-cit52"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Nguyen, T. X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Morrell, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Conda-Sheridan, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Marchand, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Agama, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bermingam, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Stephen, A. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chergui, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Naumova, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fisher, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">O’Keefe, B. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pommier, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cushman, M.</span></span> <span> </span><span class="NLM_article-title">Synthesis and biological evaluation of the first dual tyrosyl-DNA phosphodiesterase I (Tdp1)-topoisomerase I (Top1) inhibitors</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2012</span>,  <span class="NLM_volume"><i>55</i></span>,  <span class="NLM_fpage">4457</span>– <span class="NLM_lpage">4478</span>, <span class="refDoi"> DOI: 10.1021/jm300335n</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm300335n" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref52/cit52&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00639&amp;key=1%3ACAS%3A528%3ADC%252BC38XmtFartrY%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=55&publication_year=2012&pages=4457-4478&author=T.+X.+Nguyenauthor=A.+Morrellauthor=M.+Conda-Sheridanauthor=C.+Marchandauthor=K.+Agamaauthor=A.+Bermingamauthor=A.+G.+Stephenauthor=A.+Cherguiauthor=A.+Naumovaauthor=R.+Fisherauthor=B.+R.+O%E2%80%99Keefeauthor=Y.+Pommierauthor=M.+Cushman&title=Synthesis+and+biological+evaluation+of+the+first+dual+tyrosyl-DNA+phosphodiesterase+I+%28Tdp1%29-topoisomerase+I+%28Top1%29+inhibitors&doi=10.1021%2Fjm300335n"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit52R"><div class="casContent"><span class="casTitleNuber">52</span><div class="casTitle"><span class="NLM_cas:atitle">Synthesis and Biological Evaluation of the First Dual Tyrosyl-DNA Phosphodiesterase I (Tdp1)-Topoisomerase I (Top1) Inhibitors</span></div><div class="casAuthors">Nguyen, Trung Xuan; Morrell, Andrew; Conda-Sheridan, Martin; Marchand, Christophe; Agama, Keli; Berminham, Alun; Stephen, Andrew G.; Chergui, Adel; Naumova, Alena; Fisher, Robert; O'Keefe, Barry R.; Pommier, Yves; Cushman, Mark</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">55</span>
        (<span class="NLM_cas:issue">9</span>),
    <span class="NLM_cas:pages">4457-4478</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Substances with dual tyrosyl-DNA phosphodiesterase I-topoisomerase I inhibitory activity in one low mol. wt. compd. would constitute a unique class of anticancer agents that could potentially have significant advantages over drugs that work against the individual enzymes.  The present study demonstrates the successful synthesis and evaluation of the first dual Top1-Tdp1 inhibitors, which are based on the indenoisoquinoline chemotype.  One bis(indenoisoquinoline) (I.2TFA) had significant activity against human Tdp1 (IC50 = 1.52 ± 0.05 μM), and it was also equipotent to camptothecin as a Top1 inhibitor.  Significant insights into enzyme-drug interactions were gained via structure-activity relationship studies of the series.  The present results also document the failure of the previously reported sulfonyl ester pharmacophore to confer Tdp1 inhibition in this indenoisoquinoline class of inhibitors even though it was demonstrated to work well for the steroid NSC 88915 (7).  The current study will facilitate future efforts to optimize dual Top1-Tdp1 inhibitors.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpHBLLYpVMf5rVg90H21EOLACvtfcHk0lgBzd29UTgeBQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38XmtFartrY%253D&md5=c6f74f01e36da72fe9d5e0c435b9e3dd</span></div><a href="/servlet/linkout?suffix=cit52&amp;dbid=16384&amp;doi=10.1021%2Fjm300335n&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm300335n%26sid%3Dliteratum%253Aachs%26aulast%3DNguyen%26aufirst%3DT.%2BX.%26aulast%3DMorrell%26aufirst%3DA.%26aulast%3DConda-Sheridan%26aufirst%3DM.%26aulast%3DMarchand%26aufirst%3DC.%26aulast%3DAgama%26aufirst%3DK.%26aulast%3DBermingam%26aufirst%3DA.%26aulast%3DStephen%26aufirst%3DA.%2BG.%26aulast%3DChergui%26aufirst%3DA.%26aulast%3DNaumova%26aufirst%3DA.%26aulast%3DFisher%26aufirst%3DR.%26aulast%3DO%25E2%2580%2599Keefe%26aufirst%3DB.%2BR.%26aulast%3DPommier%26aufirst%3DY.%26aulast%3DCushman%26aufirst%3DM.%26atitle%3DSynthesis%2520and%2520biological%2520evaluation%2520of%2520the%2520first%2520dual%2520tyrosyl-DNA%2520phosphodiesterase%2520I%2520%2528Tdp1%2529-topoisomerase%2520I%2520%2528Top1%2529%2520inhibitors%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2012%26volume%3D55%26spage%3D4457%26epage%3D4478%26doi%3D10.1021%2Fjm300335n" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref53"><div class="reference"><strong class="refLabel"><a href="#ref53" class="rightTabRefNumLink">53</a></strong><div class="NLM_citation" id="rightTab-cit53"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Conda-Sheridan, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Reddy, P. V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Morrell, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cobb, B. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Marchand, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Agama, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chergui, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Renaud, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Stephen, A. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bindu, L. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pommier, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cushman, M.</span></span> <span> </span><span class="NLM_article-title">Synthesis and biological evaluation of indenoisoquinolines that inhibit both tyrosyl-DNA phosphodiesterase I (Tdp1) and topoisomerase I (Top1)</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2013</span>,  <span class="NLM_volume"><i>56</i></span>,  <span class="NLM_fpage">182</span>– <span class="NLM_lpage">200</span>, <span class="refDoi"> DOI: 10.1021/jm3014458</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm3014458" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref53/cit53&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00639&amp;key=1%3ACAS%3A528%3ADC%252BC38XhvVyitbvN" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=56&publication_year=2013&pages=182-200&author=M.+Conda-Sheridanauthor=P.+V.+Reddyauthor=A.+Morrellauthor=B.+T.+Cobbauthor=C.+Marchandauthor=K.+Agamaauthor=A.+Cherguiauthor=A.+Renaudauthor=A.+G.+Stephenauthor=L.+K.+Binduauthor=Y.+Pommierauthor=M.+Cushman&title=Synthesis+and+biological+evaluation+of+indenoisoquinolines+that+inhibit+both+tyrosyl-DNA+phosphodiesterase+I+%28Tdp1%29+and+topoisomerase+I+%28Top1%29&doi=10.1021%2Fjm3014458"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit53R"><div class="casContent"><span class="casTitleNuber">53</span><div class="casTitle"><span class="NLM_cas:atitle">Synthesis and biological evaluation of indenoisoquinolines that inhibit both Tyrosyl-DNA phosphodiesterase I (Tdp1) and Topoisomerase I (Top1)</span></div><div class="casAuthors">Conda-Sheridan, Martin; Reddy, P. V. Narasimha; Morrell, Andrew; Cobb, Brooklyn T.; Marchand, Christophe; Agama, Keli; Chergui, Adel; Renaud, Amelie; Stephen, Andrew G.; Bindu, Lakshman K.; Pommier, Yves; Cushman, Mark</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">56</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">182-200</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Tyrosyl-DNA phosphodiesterase I (Tdp1) plays a key role in the repair of damaged DNA resulting from the topoisomerase I (Top1) inhibitor camptothecin and a variety of other DNA-damaging anticancer agents.  This report documents the design, synthesis, and evaluation of new indenoisoquinolines e. g., I that are dual inhibitors of both Tdp1 and Top1.  Enzyme inhibitory data and cytotoxicity data from human cancer cell cultures were used to establish structure-activity relationships.  The potencies of the indenoisoquinolines against Tdp1 ranged from 5 μM to 111 μM, which places the more active compds. among the most potent known inhibitors of this target.  The cytotoxicity mean graph midpoints ranged from 0.02 to 2.34 μM.  Dual Tdp1-Top1 inhibitors are of interest because the Top1 and Tdp1 inhibitory activities could theor. work synergistically to create more effective anticancer agents.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr4X-QxF_UW9LVg90H21EOLACvtfcHk0lgBzd29UTgeBQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38XhvVyitbvN&md5=5441a5d126a969b1ba435c3e00f03fc1</span></div><a href="/servlet/linkout?suffix=cit53&amp;dbid=16384&amp;doi=10.1021%2Fjm3014458&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm3014458%26sid%3Dliteratum%253Aachs%26aulast%3DConda-Sheridan%26aufirst%3DM.%26aulast%3DReddy%26aufirst%3DP.%2BV.%26aulast%3DMorrell%26aufirst%3DA.%26aulast%3DCobb%26aufirst%3DB.%2BT.%26aulast%3DMarchand%26aufirst%3DC.%26aulast%3DAgama%26aufirst%3DK.%26aulast%3DChergui%26aufirst%3DA.%26aulast%3DRenaud%26aufirst%3DA.%26aulast%3DStephen%26aufirst%3DA.%2BG.%26aulast%3DBindu%26aufirst%3DL.%2BK.%26aulast%3DPommier%26aufirst%3DY.%26aulast%3DCushman%26aufirst%3DM.%26atitle%3DSynthesis%2520and%2520biological%2520evaluation%2520of%2520indenoisoquinolines%2520that%2520inhibit%2520both%2520tyrosyl-DNA%2520phosphodiesterase%2520I%2520%2528Tdp1%2529%2520and%2520topoisomerase%2520I%2520%2528Top1%2529%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2013%26volume%3D56%26spage%3D182%26epage%3D200%26doi%3D10.1021%2Fjm3014458" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref54"><div class="reference"><strong class="refLabel"><a href="#ref54" class="rightTabRefNumLink">54</a></strong><div class="NLM_citation" id="rightTab-cit54"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Lv, P. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Agama, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Marchand, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pommier, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cushman, M.</span></span> <span> </span><span class="NLM_article-title">Design, synthesis, and biological evaluation of O-2-modified indenoisoquinolines as dual topoisomerase I-tyrosyl-DNA phosphodiesterase I inhibitors</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>57</i></span>,  <span class="NLM_fpage">4324</span>– <span class="NLM_lpage">4336</span>, <span class="refDoi"> DOI: 10.1021/jm500294a</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm500294a" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=57&publication_year=2014&pages=4324-4336&author=P.+C.+Lvauthor=K.+Agamaauthor=C.+Marchandauthor=Y.+Pommierauthor=M.+Cushman&title=Design%2C+synthesis%2C+and+biological+evaluation+of+O-2-modified+indenoisoquinolines+as+dual+topoisomerase+I-tyrosyl-DNA+phosphodiesterase+I+inhibitors&doi=10.1021%2Fjm500294a"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit54&amp;dbid=16384&amp;doi=10.1021%2Fjm500294a&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm500294a%26sid%3Dliteratum%253Aachs%26aulast%3DLv%26aufirst%3DP.%2BC.%26aulast%3DAgama%26aufirst%3DK.%26aulast%3DMarchand%26aufirst%3DC.%26aulast%3DPommier%26aufirst%3DY.%26aulast%3DCushman%26aufirst%3DM.%26atitle%3DDesign%252C%2520synthesis%252C%2520and%2520biological%2520evaluation%2520of%2520O-2-modified%2520indenoisoquinolines%2520as%2520dual%2520topoisomerase%2520I-tyrosyl-DNA%2520phosphodiesterase%2520I%2520inhibitors%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2014%26volume%3D57%26spage%3D4324%26epage%3D4336%26doi%3D10.1021%2Fjm500294a" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref55"><div class="reference"><strong class="refLabel"><a href="#ref55" class="rightTabRefNumLink">55</a></strong><div class="NLM_citation" id="rightTab-cit55"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Nguyen, T. X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Abdelmalak, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Marchand, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Agama, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pommier, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cushman, M.</span></span> <span> </span><span class="NLM_article-title">Synthesis and biological evaluation of nitrated 7-, 8-, 9-, and 10-hydroxyindenoisoquinolines as potential dual topoisomerase I (Top1)-tyrosyl-DNA phosphodiesterase I (TDP1) inhibitors</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>58</i></span>,  <span class="NLM_fpage">3188</span>– <span class="NLM_lpage">3208</span>, <span class="refDoi"> DOI: 10.1021/acs.jmedchem.5b00136</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acs.jmedchem.5b00136" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=58&publication_year=2015&pages=3188-3208&author=T.+X.+Nguyenauthor=M.+Abdelmalakauthor=C.+Marchandauthor=K.+Agamaauthor=Y.+Pommierauthor=M.+Cushman&title=Synthesis+and+biological+evaluation+of+nitrated+7-%2C+8-%2C+9-%2C+and+10-hydroxyindenoisoquinolines+as+potential+dual+topoisomerase+I+%28Top1%29-tyrosyl-DNA+phosphodiesterase+I+%28TDP1%29+inhibitors&doi=10.1021%2Facs.jmedchem.5b00136"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit55&amp;dbid=16384&amp;doi=10.1021%2Facs.jmedchem.5b00136&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facs.jmedchem.5b00136%26sid%3Dliteratum%253Aachs%26aulast%3DNguyen%26aufirst%3DT.%2BX.%26aulast%3DAbdelmalak%26aufirst%3DM.%26aulast%3DMarchand%26aufirst%3DC.%26aulast%3DAgama%26aufirst%3DK.%26aulast%3DPommier%26aufirst%3DY.%26aulast%3DCushman%26aufirst%3DM.%26atitle%3DSynthesis%2520and%2520biological%2520evaluation%2520of%2520nitrated%25207-%252C%25208-%252C%25209-%252C%2520and%252010-hydroxyindenoisoquinolines%2520as%2520potential%2520dual%2520topoisomerase%2520I%2520%2528Top1%2529-tyrosyl-DNA%2520phosphodiesterase%2520I%2520%2528TDP1%2529%2520inhibitors%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2015%26volume%3D58%26spage%3D3188%26epage%3D3208%26doi%3D10.1021%2Facs.jmedchem.5b00136" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref56"><div class="reference"><strong class="refLabel"><a href="#ref56" class="rightTabRefNumLink">56</a></strong><div class="NLM_citation" id="rightTab-cit56"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Wang, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Elsayed, M. S. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Plescia, C. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ravji, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Redon, C. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kiselev, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Marchand, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zeleznik, O.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Agama, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pommier, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cushman, M.</span></span> <span> </span><span class="NLM_article-title">Synthesis and biological evaluation of the first triple inhibitors of human topoisomerase 1, tyrosyl-DNA phosphodiesterase 1 (Tdp1), and tyrosyl-DNA phosphodiesterase 2 (Tdp2)</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>60</i></span>,  <span class="NLM_fpage">3275</span>– <span class="NLM_lpage">3288</span>, <span class="refDoi"> DOI: 10.1021/acs.jmedchem.6b01565</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acs.jmedchem.6b01565" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref56/cit56&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00639&amp;key=1%3ACAS%3A528%3ADC%252BC2sXmtV2ksLg%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=60&publication_year=2017&pages=3275-3288&author=P.+Wangauthor=M.+S.+A.+Elsayedauthor=C.+B.+Plesciaauthor=A.+Ravjiauthor=C.+E.+Redonauthor=E.+Kiselevauthor=C.+Marchandauthor=O.+Zeleznikauthor=K.+Agamaauthor=Y.+Pommierauthor=M.+Cushman&title=Synthesis+and+biological+evaluation+of+the+first+triple+inhibitors+of+human+topoisomerase+1%2C+tyrosyl-DNA+phosphodiesterase+1+%28Tdp1%29%2C+and+tyrosyl-DNA+phosphodiesterase+2+%28Tdp2%29&doi=10.1021%2Facs.jmedchem.6b01565"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit56R"><div class="casContent"><span class="casTitleNuber">56</span><div class="casTitle"><span class="NLM_cas:atitle">Synthesis and Biological Evaluation of the First Triple Inhibitors of Human Topoisomerase 1, Tyrosyl-DNA Phosphodiesterase 1 (Tdp1), and Tyrosyl-DNA Phosphodiesterase 2 (Tdp2)</span></div><div class="casAuthors">Wang, Ping; Elsayed, Mohamed S. A.; Plescia, Caroline B.; Ravji, Azhar; Redon, Christophe E.; Kiselev, Evgeny; Marchand, Christophe; Zeleznik, Olga; Agama, Keli; Pommier, Yves; Cushman, Mark</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">60</span>
        (<span class="NLM_cas:issue">8</span>),
    <span class="NLM_cas:pages">3275-3288</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Tdp1 and Tdp2 are two tyrosyl-DNA phosphodiesterases that can repair damaged DNA resulting from topoisomerase inhibitors and a variety of other DNA-damaging agents.  Both Tdp1 and Tdp2 inhibition could hypothetically potentiate the cytotoxicities of topoisomerase inhibitors.  This study reports the successful structure-based design and synthesis of new 7-azaindenoisoquinolines I that act as triple inhibitors of Top1, Tdp1, and Tdp2.  Enzyme inhibitory data and cytotoxicity data from human cancer cell cultures establish that modification of the lactam side chain of the 7-azaindenoisoquinolines can modulate their inhibitory potencies and selectivities vs. Top1, Tdp1, and Tdp2.  Mol. modeling of selected target compds. bound to Top1, Tdp1, and Tdp2 was used to design the inhibitors and facilitate the structure-activity relation anal.  The monitoring of DNA damage by γ-H2AX foci formation in human PBMCs (lymphocytes) and acute lymphoblastic leukemia CCRF-CEM cells documented significantly more DNA damage in the cancer cells vs. normal cells.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrqwZT0U9BVo7Vg90H21EOLACvtfcHk0ljGqpETPlowpw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2sXmtV2ksLg%253D&md5=f7007ee2a9fc0423efdbf791f4550f57</span></div><a href="/servlet/linkout?suffix=cit56&amp;dbid=16384&amp;doi=10.1021%2Facs.jmedchem.6b01565&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facs.jmedchem.6b01565%26sid%3Dliteratum%253Aachs%26aulast%3DWang%26aufirst%3DP.%26aulast%3DElsayed%26aufirst%3DM.%2BS.%2BA.%26aulast%3DPlescia%26aufirst%3DC.%2BB.%26aulast%3DRavji%26aufirst%3DA.%26aulast%3DRedon%26aufirst%3DC.%2BE.%26aulast%3DKiselev%26aufirst%3DE.%26aulast%3DMarchand%26aufirst%3DC.%26aulast%3DZeleznik%26aufirst%3DO.%26aulast%3DAgama%26aufirst%3DK.%26aulast%3DPommier%26aufirst%3DY.%26aulast%3DCushman%26aufirst%3DM.%26atitle%3DSynthesis%2520and%2520biological%2520evaluation%2520of%2520the%2520first%2520triple%2520inhibitors%2520of%2520human%2520topoisomerase%25201%252C%2520tyrosyl-DNA%2520phosphodiesterase%25201%2520%2528Tdp1%2529%252C%2520and%2520tyrosyl-DNA%2520phosphodiesterase%25202%2520%2528Tdp2%2529%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2017%26volume%3D60%26spage%3D3275%26epage%3D3288%26doi%3D10.1021%2Facs.jmedchem.6b01565" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref57"><div class="reference"><strong class="refLabel"><a href="#ref57" class="rightTabRefNumLink">57</a></strong><div class="NLM_citation" id="rightTab-cit57"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Rodrigues, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Reker, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schneider, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schneider, G.</span></span> <span> </span><span class="NLM_article-title">Counting on natural products for drug design</span>. <i>Nat. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>8</i></span>,  <span class="NLM_fpage">531</span>– <span class="NLM_lpage">541</span>, <span class="refDoi"> DOI: 10.1038/nchem.2479</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref57/cit57&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00639&amp;key=10.1038%2Fnchem.2479" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref57/cit57&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00639&amp;key=27219696" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref57/cit57&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00639&amp;key=1%3ACAS%3A528%3ADC%252BC28XmslSrsbk%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=8&publication_year=2016&pages=531-541&author=T.+Rodriguesauthor=D.+Rekerauthor=P.+Schneiderauthor=G.+Schneider&title=Counting+on+natural+products+for+drug+design&doi=10.1038%2Fnchem.2479"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit57R"><div class="casContent"><span class="casTitleNuber">57</span><div class="casTitle"><span class="NLM_cas:atitle">Counting on natural products for drug design</span></div><div class="casAuthors">Rodrigues, Tiago; Reker, Daniel; Schneider, Petra; Schneider, Gisbert</div><div class="citationInfo"><span class="NLM_cas:title">Nature Chemistry</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">8</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">531-541</span>CODEN:
                <span class="NLM_cas:coden">NCAHBB</span>;
        ISSN:<span class="NLM_cas:issn">1755-4330</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">A review.  Natural products and their mol. frameworks have a long tradition as valuable starting points for medicinal chem. and drug discovery.  Recently, there has been a revitalization of interest in the inclusion of these chemotypes in compd. collections for screening and achieving selective target modulation.  Here the authors discuss natural-product-inspired drug discovery with a focus on recent advances in the design of synthetically tractable small mols. that mimic nature's chem.  The authors highlight the potential of innovative computational tools in processing structurally complex natural products to predict their macromol. targets and attempt to forecast the role that natural-product-derived fragments and fragment-like natural products will play in next-generation drug discovery.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrNR16z66-NgLVg90H21EOLACvtfcHk0ljGqpETPlowpw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28XmslSrsbk%253D&md5=3f6391192d648de2a54524afafd6203a</span></div><a href="/servlet/linkout?suffix=cit57&amp;dbid=16384&amp;doi=10.1038%2Fnchem.2479&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnchem.2479%26sid%3Dliteratum%253Aachs%26aulast%3DRodrigues%26aufirst%3DT.%26aulast%3DReker%26aufirst%3DD.%26aulast%3DSchneider%26aufirst%3DP.%26aulast%3DSchneider%26aufirst%3DG.%26atitle%3DCounting%2520on%2520natural%2520products%2520for%2520drug%2520design%26jtitle%3DNat.%2520Chem.%26date%3D2016%26volume%3D8%26spage%3D531%26epage%3D541%26doi%3D10.1038%2Fnchem.2479" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref58"><div class="reference"><strong class="refLabel"><a href="#ref58" class="rightTabRefNumLink">58</a></strong><div class="NLM_citation" id="rightTab-cit58"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Xiao, Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Morris-Natschke, S. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lee, K. H.</span></span> <span> </span><span class="NLM_article-title">Strategies for the optimization of natural leads to anticancer drugs or drug candidates</span>. <i>Med. Res. Rev.</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>36</i></span>,  <span class="NLM_fpage">32</span>– <span class="NLM_lpage">91</span>, <span class="refDoi"> DOI: 10.1002/med.21377</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref58/cit58&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00639&amp;key=10.1002%2Fmed.21377" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref58/cit58&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00639&amp;key=26359649" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref58/cit58&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00639&amp;key=1%3ACAS%3A528%3ADC%252BC2MXitVagsb%252FJ" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=36&publication_year=2016&pages=32-91&author=Z.+Xiaoauthor=S.+L.+Morris-Natschkeauthor=K.+H.+Lee&title=Strategies+for+the+optimization+of+natural+leads+to+anticancer+drugs+or+drug+candidates&doi=10.1002%2Fmed.21377"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit58R"><div class="casContent"><span class="casTitleNuber">58</span><div class="casTitle"><span class="NLM_cas:atitle">Strategies for the Optimization of Natural Leads to Anticancer Drugs or Drug Candidates</span></div><div class="casAuthors">Xiao, Zhiyan; Morris-Natschke, Susan L.; Lee, Kuo-Hsiung</div><div class="citationInfo"><span class="NLM_cas:title">Medicinal Research Reviews</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">36</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">32-91</span>CODEN:
                <span class="NLM_cas:coden">MRREDD</span>;
        ISSN:<span class="NLM_cas:issn">0198-6325</span>.
    
            (<span class="NLM_cas:orgname">John Wiley & Sons, Inc.</span>)
        </div><div class="casAbstract">A review.  Natural products have made significant contribution to cancer chemotherapy over the past decades and remain an indispensable source of mol. and mechanistic diversity for anticancer drug discovery.  More often than not, natural products may serve as leads for further drug development rather than as effective anticancer drugs by themselves.  Generally, optimization of natural leads into anticancer drugs or drug candidates should not only address drug efficacy, but also improve absorption, distribution, metab., excretion, and toxicity (ADMET) profiles and chem. accessibility assocd. with the natural leads.  Optimization strategies involve direct chem. manipulation of functional groups, structure-activity relationship directed optimization and pharmacophore-oriented mol. design based on the natural templates.  Both fundamental medicinal chem. principles (e.g., bioisosterism) and state-of-the-art computer-aided drug design techniques (e.g., structure-based design) can be applied to facilitate optimization efforts.  In this review, the strategies to optimize natural leads to anticancer drugs or drug candidates are illustrated with examples and described according to their purposes.  Furthermore, successful case studies on lead optimization of bioactive compds. performed in the Natural Products Research Labs. at UNC are highlighted.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGo6SGKXSp6ip7Vg90H21EOLACvtfcHk0lhBExFkPApKYQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXitVagsb%252FJ&md5=dc8c68d23f1f8e9ff6e98847a69558c4</span></div><a href="/servlet/linkout?suffix=cit58&amp;dbid=16384&amp;doi=10.1002%2Fmed.21377&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fmed.21377%26sid%3Dliteratum%253Aachs%26aulast%3DXiao%26aufirst%3DZ.%26aulast%3DMorris-Natschke%26aufirst%3DS.%2BL.%26aulast%3DLee%26aufirst%3DK.%2BH.%26atitle%3DStrategies%2520for%2520the%2520optimization%2520of%2520natural%2520leads%2520to%2520anticancer%2520drugs%2520or%2520drug%2520candidates%26jtitle%3DMed.%2520Res.%2520Rev.%26date%3D2016%26volume%3D36%26spage%3D32%26epage%3D91%26doi%3D10.1002%2Fmed.21377" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref59"><div class="reference"><strong class="refLabel"><a href="#ref59" class="rightTabRefNumLink">59</a></strong><div class="NLM_citation" id="rightTab-cit59"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Qin, X. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yu, Q.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yan, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Khan, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Feng, M. Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, P. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hao, X. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">An, L. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liu, H. Y.</span></span> <span> </span><span class="NLM_article-title">Meroterpenoids with antitumor activities from guava (Psidium guajava)</span>. <i>J. Agric. Food Chem.</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>65</i></span>,  <span class="NLM_fpage">4993</span>– <span class="NLM_lpage">4999</span>, <span class="refDoi"> DOI: 10.1021/acs.jafc.7b01762</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acs.jafc.7b01762" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref59/cit59&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00639&amp;key=1%3ACAS%3A528%3ADC%252BC2sXptFeltbo%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=65&publication_year=2017&pages=4993-4999&author=X.+J.+Qinauthor=Q.+Yuauthor=H.+Yanauthor=A.+Khanauthor=M.+Y.+Fengauthor=P.+P.+Liauthor=X.+J.+Haoauthor=L.+K.+Anauthor=H.+Y.+Liu&title=Meroterpenoids+with+antitumor+activities+from+guava+%28Psidium+guajava%29&doi=10.1021%2Facs.jafc.7b01762"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit59R"><div class="casContent"><span class="casTitleNuber">59</span><div class="casTitle"><span class="NLM_cas:atitle">Meroterpenoids with Antitumor Activities from Guava (Psidium guajava)</span></div><div class="casAuthors">Qin, Xu-Jie; Yu, Qian; Yan, Huan; Khan, Afsar; Feng, Mi-Yan; Li, Pan-Pan; Hao, Xiao-Jiang; An, Lin-Kun; Liu, Hai-Yang</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Agricultural and Food Chemistry</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">65</span>
        (<span class="NLM_cas:issue">24</span>),
    <span class="NLM_cas:pages">4993-4999</span>CODEN:
                <span class="NLM_cas:coden">JAFCAU</span>;
        ISSN:<span class="NLM_cas:issn">0021-8561</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Psidium guajava L., a species native to South America, has been widely cultivated in the tropical and subtropical areas of China for its popular fruits.  The preliminary anal. by liq. chromatog.-UV (LC-UV) indicated the presence of meroterpenoids in the fruits of P. guajava (guava).  Subsequent fractionation of the petroleum ether ext. resulted in the identification of two new meroterpenoids, psiguajavadials A (I) and B (II), together with 14 previously described meroterpenoids.  Their structures were fully elucidated by comprehensive spectroscopic techniques and theor. calcns.  All of the meroterpenoids showed cytotoxicities against five human cancer cell lines, with guajadial B (12) being the most effective having an IC50 value of 150 nM toward A549 cells.  Furthermore, biochem. topoisomerase I (Top1) assay revealed that psiguajavadial A, psiguajavadial B, guajadial B, guajadial C, and guajadial F acted as Top1 catalytic inhibitors and delayed Top1 poison-mediated DNA damage.  The flow cytometric anal. indicated that the new meroterpenoids psiguajavadials A and B could induce apoptosis of HCT116 cells.  These data suggest that meroterpenoids from guava fruit could be used for the development of antitumor agents.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqUPHFiIaUiGbVg90H21EOLACvtfcHk0lhBExFkPApKYQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2sXptFeltbo%253D&md5=27cebbe906a3a057a83dfe1e54bfcc89</span></div><a href="/servlet/linkout?suffix=cit59&amp;dbid=16384&amp;doi=10.1021%2Facs.jafc.7b01762&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facs.jafc.7b01762%26sid%3Dliteratum%253Aachs%26aulast%3DQin%26aufirst%3DX.%2BJ.%26aulast%3DYu%26aufirst%3DQ.%26aulast%3DYan%26aufirst%3DH.%26aulast%3DKhan%26aufirst%3DA.%26aulast%3DFeng%26aufirst%3DM.%2BY.%26aulast%3DLi%26aufirst%3DP.%2BP.%26aulast%3DHao%26aufirst%3DX.%2BJ.%26aulast%3DAn%26aufirst%3DL.%2BK.%26aulast%3DLiu%26aufirst%3DH.%2BY.%26atitle%3DMeroterpenoids%2520with%2520antitumor%2520activities%2520from%2520guava%2520%2528Psidium%2520guajava%2529%26jtitle%3DJ.%2520Agric.%2520Food%2520Chem.%26date%3D2017%26volume%3D65%26spage%3D4993%26epage%3D4999%26doi%3D10.1021%2Facs.jafc.7b01762" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref60"><div class="reference"><strong class="refLabel"><a href="#ref60" class="rightTabRefNumLink">60</a></strong><div class="NLM_citation" id="rightTab-cit60"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Wu, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wu, X. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Agama, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pommier, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Du, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gu, L. Q.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Huang, Z. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">An, L. K.</span></span> <span> </span><span class="NLM_article-title">A novel DNA topoisomerase I inhibitor with different mechanism from camptothecin induces G2/M phase cell cycle arrest to K562 cells</span>. <i>Biochemistry</i> <span class="NLM_year" style="font-weight: bold;">2010</span>,  <span class="NLM_volume"><i>49</i></span>,  <span class="NLM_fpage">10131</span>– <span class="NLM_lpage">10136</span>, <span class="refDoi"> DOI: 10.1021/bi1009419</span> </span><div class="citationLinks">[<a href="/doi/10.1021/bi1009419" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=49&publication_year=2010&pages=10131-10136&author=N.+Wuauthor=X.+W.+Wuauthor=K.+Agamaauthor=Y.+Pommierauthor=J.+Duauthor=D.+Liauthor=L.+Q.+Guauthor=Z.+S.+Huangauthor=L.+K.+An&title=A+novel+DNA+topoisomerase+I+inhibitor+with+different+mechanism+from+camptothecin+induces+G2%2FM+phase+cell+cycle+arrest+to+K562+cells&doi=10.1021%2Fbi1009419"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit60&amp;dbid=16384&amp;doi=10.1021%2Fbi1009419&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fbi1009419%26sid%3Dliteratum%253Aachs%26aulast%3DWu%26aufirst%3DN.%26aulast%3DWu%26aufirst%3DX.%2BW.%26aulast%3DAgama%26aufirst%3DK.%26aulast%3DPommier%26aufirst%3DY.%26aulast%3DDu%26aufirst%3DJ.%26aulast%3DLi%26aufirst%3DD.%26aulast%3DGu%26aufirst%3DL.%2BQ.%26aulast%3DHuang%26aufirst%3DZ.%2BS.%26aulast%3DAn%26aufirst%3DL.%2BK.%26atitle%3DA%2520novel%2520DNA%2520topoisomerase%2520I%2520inhibitor%2520with%2520different%2520mechanism%2520from%2520camptothecin%2520induces%2520G2%252FM%2520phase%2520cell%2520cycle%2520arrest%2520to%2520K562%2520cells%26jtitle%3DBiochemistry%26date%3D2010%26volume%3D49%26spage%3D10131%26epage%3D10136%26doi%3D10.1021%2Fbi1009419" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref61"><div class="reference"><strong class="refLabel"><a href="#ref61" class="rightTabRefNumLink">61</a></strong><div class="NLM_citation" id="rightTab-cit61"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Wang, L. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Johnson, R. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hecht, S. M.</span></span> <span> </span><span class="NLM_article-title">Inhibition of topoisomerase I function by nitidine and fagaronine</span>. <i>Chem. Res. Toxicol.</i> <span class="NLM_year" style="font-weight: bold;">1993</span>,  <span class="NLM_volume"><i>6</i></span>,  <span class="NLM_fpage">813</span>– <span class="NLM_lpage">818</span>, <span class="refDoi"> DOI: 10.1021/tx00036a010</span> </span><div class="citationLinks">[<a href="/doi/10.1021/tx00036a010" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=6&publication_year=1993&pages=813-818&author=L.+K.+Wangauthor=R.+K.+Johnsonauthor=S.+M.+Hecht&title=Inhibition+of+topoisomerase+I+function+by+nitidine+and+fagaronine&doi=10.1021%2Ftx00036a010"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit61&amp;dbid=16384&amp;doi=10.1021%2Ftx00036a010&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Ftx00036a010%26sid%3Dliteratum%253Aachs%26aulast%3DWang%26aufirst%3DL.%2BK.%26aulast%3DJohnson%26aufirst%3DR.%2BK.%26aulast%3DHecht%26aufirst%3DS.%2BM.%26atitle%3DInhibition%2520of%2520topoisomerase%2520I%2520function%2520by%2520nitidine%2520and%2520fagaronine%26jtitle%3DChem.%2520Res.%2520Toxicol.%26date%3D1993%26volume%3D6%26spage%3D813%26epage%3D818%26doi%3D10.1021%2Ftx00036a010" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref62"><div class="reference"><strong class="refLabel"><a href="#ref62" class="rightTabRefNumLink">62</a></strong><div class="NLM_citation" id="rightTab-cit62"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Holden, J. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wall, M. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wani, M. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Manikumar, G.</span></span> <span> </span><span class="NLM_article-title">Human DNA topoisomerase I: quantitative analysis of the effects of camptothecin analogs and the benzophenanthridine alkaloids nitidine and 6-ethoxydihydronitidine on DNA topoisomerase I-induced DNA strand breakage</span>. <i>Arch. Biochem. Biophys.</i> <span class="NLM_year" style="font-weight: bold;">1999</span>,  <span class="NLM_volume"><i>370</i></span>,  <span class="NLM_fpage">66</span>– <span class="NLM_lpage">76</span>, <span class="refDoi"> DOI: 10.1006/abbi.1999.1355</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref62/cit62&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00639&amp;key=10.1006%2Fabbi.1999.1355" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=370&publication_year=1999&pages=66-76&author=J.+A.+Holdenauthor=M.+E.+Wallauthor=M.+C.+Waniauthor=G.+Manikumar&title=Human+DNA+topoisomerase+I%3A+quantitative+analysis+of+the+effects+of+camptothecin+analogs+and+the+benzophenanthridine+alkaloids+nitidine+and+6-ethoxydihydronitidine+on+DNA+topoisomerase+I-induced+DNA+strand+breakage&doi=10.1006%2Fabbi.1999.1355"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit62&amp;dbid=16384&amp;doi=10.1006%2Fabbi.1999.1355&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1006%252Fabbi.1999.1355%26sid%3Dliteratum%253Aachs%26aulast%3DHolden%26aufirst%3DJ.%2BA.%26aulast%3DWall%26aufirst%3DM.%2BE.%26aulast%3DWani%26aufirst%3DM.%2BC.%26aulast%3DManikumar%26aufirst%3DG.%26atitle%3DHuman%2520DNA%2520topoisomerase%2520I%253A%2520quantitative%2520analysis%2520of%2520the%2520effects%2520of%2520camptothecin%2520analogs%2520and%2520the%2520benzophenanthridine%2520alkaloids%2520nitidine%2520and%25206-ethoxydihydronitidine%2520on%2520DNA%2520topoisomerase%2520I-induced%2520DNA%2520strand%2520breakage%26jtitle%3DArch.%2520Biochem.%2520Biophys.%26date%3D1999%26volume%3D370%26spage%3D66%26epage%3D76%26doi%3D10.1006%2Fabbi.1999.1355" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref63"><div class="reference"><strong class="refLabel"><a href="#ref63" class="rightTabRefNumLink">63</a></strong><div class="NLM_citation" id="rightTab-cit63"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Bai, L. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhao, Z. Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cai, Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jiang, Z. H.</span></span> <span> </span><span class="NLM_article-title">DNA-binding affinities and sequence selectivity of quaternary benzophenanthridine alkaloids sanguinarine, chelerythrine, and nitidine</span>. <i>Bioorg. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2006</span>,  <span class="NLM_volume"><i>14</i></span>,  <span class="NLM_fpage">5439</span>– <span class="NLM_lpage">5445</span>, <span class="refDoi"> DOI: 10.1016/j.bmc.2006.05.012</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref63/cit63&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00639&amp;key=10.1016%2Fj.bmc.2006.05.012" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=14&publication_year=2006&pages=5439-5445&author=L.+P.+Baiauthor=Z.+Z.+Zhaoauthor=Z.+Caiauthor=Z.+H.+Jiang&title=DNA-binding+affinities+and+sequence+selectivity+of+quaternary+benzophenanthridine+alkaloids+sanguinarine%2C+chelerythrine%2C+and+nitidine&doi=10.1016%2Fj.bmc.2006.05.012"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit63&amp;dbid=16384&amp;doi=10.1016%2Fj.bmc.2006.05.012&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmc.2006.05.012%26sid%3Dliteratum%253Aachs%26aulast%3DBai%26aufirst%3DL.%2BP.%26aulast%3DZhao%26aufirst%3DZ.%2BZ.%26aulast%3DCai%26aufirst%3DZ.%26aulast%3DJiang%26aufirst%3DZ.%2BH.%26atitle%3DDNA-binding%2520affinities%2520and%2520sequence%2520selectivity%2520of%2520quaternary%2520benzophenanthridine%2520alkaloids%2520sanguinarine%252C%2520chelerythrine%252C%2520and%2520nitidine%26jtitle%3DBioorg.%2520Med.%2520Chem.%26date%3D2006%26volume%3D14%26spage%3D5439%26epage%3D5445%26doi%3D10.1016%2Fj.bmc.2006.05.012" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref64"><div class="reference"><strong class="refLabel"><a href="#ref64" class="rightTabRefNumLink">64</a></strong><div class="NLM_citation" id="rightTab-cit64"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Kumar, C. V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Turner, R. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Asuncion, E. H.</span></span> <span> </span><span class="NLM_article-title">Groove binding of a styrylcyanine dye to the DNA double helix: the salt effect</span>. <i>J. Photochem. Photobiol., A</i> <span class="NLM_year" style="font-weight: bold;">1993</span>,  <span class="NLM_volume"><i>74</i></span>,  <span class="NLM_fpage">231</span>– <span class="NLM_lpage">238</span>, <span class="refDoi"> DOI: 10.1016/1010-6030(93)80121-O</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref64/cit64&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00639&amp;key=10.1016%2F1010-6030%2893%2980121-O" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref64/cit64&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00639&amp;key=1%3ACAS%3A528%3ADyaK3sXms1Gktr0%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=74&publication_year=1993&pages=231-238&author=C.+V.+Kumarauthor=R.+S.+Turnerauthor=E.+H.+Asuncion&title=Groove+binding+of+a+styrylcyanine+dye+to+the+DNA+double+helix%3A+the+salt+effect&doi=10.1016%2F1010-6030%2893%2980121-O"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit64R"><div class="casContent"><span class="casTitleNuber">64</span><div class="casTitle"><span class="NLM_cas:atitle">Groove binding of a styrylcyanine dye to the DNA double helix: the salt effect</span></div><div class="casAuthors">Kumar, C. V.; Turner, R. S.; Asuncion, E. H.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Photochemistry and Photobiology, A:  Chemistry</span>
        (<span class="NLM_cas:date">1993</span>),
    <span class="NLM_cas:volume">74</span>
        (<span class="NLM_cas:issue">2-3</span>),
    <span class="NLM_cas:pages">231-8</span>CODEN:
                <span class="NLM_cas:coden">JPPCEJ</span>;
        ISSN:<span class="NLM_cas:issn">1010-6030</span>.
    </div><div class="casAbstract">The cationic styryl dye DSMI binds to the double helical DNA with a high affinity.  A red shift of the absorption spectrum and hypochromism accompany the binding of DSMI to calf thymus DNA.  The fluorescence yields increase dramatically when DSMI binds to DNA, with no shifts in the emission max.  These spectral changes are in contrast to the behavior obsd. with many fluorescent intercalators.  Groove binding rather than intercalation of the dye was suggested to be the cause of these spectral changes, based on a variety of exptl. results.  Consistent with groove binding, the fluorescence enhancements were greater with poly(dA-dT) when compared with poly(dG-dC).  The addn. of salt or a strong electrolyte to the soln. releases the DNA-bound dye cations from the groove and causes a decrease in the fluorescence yield.  Therefore, when the dye binds to DNA, the fluorescence quenching with anionic quenchers was enhanced dramatically, in contrast to the expected protection of the probe fluorescence by the DNA helix.  Binding of DSMI to DNA inhibits the non-radiative deactivation of the excited state, perhaps owing to the restriction imposed by the narrow minor groove of the DNA.  The steric constraints imposed on the dye owing to the binding in the groove result in enhanced fluorescence yields and longer fluorescence lifetimes.  Since the lifetimes of the DNA-bound dye were still in the nanosecond range, it is very likely that groove binding of the dye permits twisting in the excited state, which may be important in the excited state dynamics of this class of dyes.  The large fluorescence enhancements obsd. when DSMI binds to the helix and the poor fluorescence yield of the dye in the absence of DNA suggests that DSMI should be quite useful in the staining of DNA gels and for the detection of very low concns. of DNA.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGp0G9PUHMDD4bVg90H21EOLACvtfcHk0lgItqME-PokXg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK3sXms1Gktr0%253D&md5=4c39dfcf313b5d98f127239385a6c711</span></div><a href="/servlet/linkout?suffix=cit64&amp;dbid=16384&amp;doi=10.1016%2F1010-6030%2893%2980121-O&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252F1010-6030%252893%252980121-O%26sid%3Dliteratum%253Aachs%26aulast%3DKumar%26aufirst%3DC.%2BV.%26aulast%3DTurner%26aufirst%3DR.%2BS.%26aulast%3DAsuncion%26aufirst%3DE.%2BH.%26atitle%3DGroove%2520binding%2520of%2520a%2520styrylcyanine%2520dye%2520to%2520the%2520DNA%2520double%2520helix%253A%2520the%2520salt%2520effect%26jtitle%3DJ.%2520Photochem.%2520Photobiol.%252C%2520A%26date%3D1993%26volume%3D74%26spage%3D231%26epage%3D238%26doi%3D10.1016%2F1010-6030%2893%2980121-O" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref65"><div class="reference"><strong class="refLabel"><a href="#ref65" class="rightTabRefNumLink">65</a></strong><div class="NLM_citation" id="rightTab-cit65"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Tan, J.-H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ou, T.-M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hou, J.-Q.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lu, Y.-J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Huang, S.-L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Luo, H.-B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wu, J.-Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Huang, Z.-S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wong, K.-Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gu, L.-Q.</span></span> <span> </span><span class="NLM_article-title">Isaindigotone derivatives: a new class of highly selective ligands for telomeric G-quadruplex DNA</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2009</span>,  <span class="NLM_volume"><i>52</i></span>,  <span class="NLM_fpage">2825</span>– <span class="NLM_lpage">2835</span>, <span class="refDoi"> DOI: 10.1021/jm801600m</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm801600m" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref65/cit65&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00639&amp;key=1%3ACAS%3A528%3ADC%252BD1MXktF2gtb4%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=52&publication_year=2009&pages=2825-2835&author=J.-H.+Tanauthor=T.-M.+Ouauthor=J.-Q.+Houauthor=Y.-J.+Luauthor=S.-L.+Huangauthor=H.-B.+Luoauthor=J.-Y.+Wuauthor=Z.-S.+Huangauthor=K.-Y.+Wongauthor=L.-Q.+Gu&title=Isaindigotone+derivatives%3A+a+new+class+of+highly+selective+ligands+for+telomeric+G-quadruplex+DNA&doi=10.1021%2Fjm801600m"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit65R"><div class="casContent"><span class="casTitleNuber">65</span><div class="casTitle"><span class="NLM_cas:atitle">Isaindigotone Derivatives: A New Class of Highly Selective Ligands for Telomeric G-Quadruplex DNA</span></div><div class="casAuthors">Tan, Jia-Heng; Ou, Tian-Miao; Hou, Jin-Qiang; Lu, Yu-Jing; Huang, Shi-Liang; Luo, Hai-Bin; Wu, Jian-Yong; Huang, Zhi-Shu; Wong, Kwok-Yin; Gu, Lian-Quan</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">52</span>
        (<span class="NLM_cas:issue">9</span>),
    <span class="NLM_cas:pages">2825-2835</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Four isaindigotone derivs. designed as telomeric G-quadruplex ligands have been synthesized and characterized.  The unfused arom. rings in these compds. allow a flexible and adaptive conformation in G-quadruplex recognition.  The interaction of human telomeric G-quadruplex DNA with these designed ligands was explored by means of FRET melting, fluorescence titrn., CD spectroscopy, continuous variation, and mol. modeling studies.  Our results showed that the adaptive scaffold might not only allow the ligands to well occupy the G-quartet but also perfectly bind to the grooves of the G-quadruplex.  The synergetic effect of the multiple binding modes might be responsible for the improved binding ability and high selectivity of these ligands toward G-quadruplex over duplex DNA.  Long-term exposure of HL60 and CA46 cancer cells to compd. I showed a remarkable decrease in population growth, cellular senescence phenotype, and shortening of the telomere length, which is consistent with the behavior of an effective telomeric G-quadruplex ligand and telomerase inhibitor.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqOsJ3zOmz9PLVg90H21EOLACvtfcHk0liXWZUMm-PYGg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXktF2gtb4%253D&md5=bd333ba813b3afc4d9ea89ca0925ed3d</span></div><a href="/servlet/linkout?suffix=cit65&amp;dbid=16384&amp;doi=10.1021%2Fjm801600m&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm801600m%26sid%3Dliteratum%253Aachs%26aulast%3DTan%26aufirst%3DJ.-H.%26aulast%3DOu%26aufirst%3DT.-M.%26aulast%3DHou%26aufirst%3DJ.-Q.%26aulast%3DLu%26aufirst%3DY.-J.%26aulast%3DHuang%26aufirst%3DS.-L.%26aulast%3DLuo%26aufirst%3DH.-B.%26aulast%3DWu%26aufirst%3DJ.-Y.%26aulast%3DHuang%26aufirst%3DZ.-S.%26aulast%3DWong%26aufirst%3DK.-Y.%26aulast%3DGu%26aufirst%3DL.-Q.%26atitle%3DIsaindigotone%2520derivatives%253A%2520a%2520new%2520class%2520of%2520highly%2520selective%2520ligands%2520for%2520telomeric%2520G-quadruplex%2520DNA%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2009%26volume%3D52%26spage%3D2825%26epage%3D2835%26doi%3D10.1021%2Fjm801600m" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref66"><div class="reference"><strong class="refLabel"><a href="#ref66" class="rightTabRefNumLink">66</a></strong><div class="NLM_citation" id="rightTab-cit66"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Korivi, R. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cheng, C. H.</span></span> <span> </span><span class="NLM_article-title">Protecting-group-free total synthesis of isoquinoline alkaloids by nickel-catalyzed annulation of o-halobenzaldimine with an alkyne as the key step</span>. <i>Chem. - Eur. J.</i> <span class="NLM_year" style="font-weight: bold;">2010</span>,  <span class="NLM_volume"><i>16</i></span>,  <span class="NLM_fpage">282</span>– <span class="NLM_lpage">287</span>, <span class="refDoi"> DOI: 10.1002/chem.200902275</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref66/cit66&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00639&amp;key=10.1002%2Fchem.200902275" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref66/cit66&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00639&amp;key=19904781" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref66/cit66&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00639&amp;key=1%3ACAS%3A528%3ADC%252BD1MXhs1WksLvL" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=16&publication_year=2010&pages=282-287&author=R.+P.+Koriviauthor=C.+H.+Cheng&title=Protecting-group-free+total+synthesis+of+isoquinoline+alkaloids+by+nickel-catalyzed+annulation+of+o-halobenzaldimine+with+an+alkyne+as+the+key+step&doi=10.1002%2Fchem.200902275"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit66R"><div class="casContent"><span class="casTitleNuber">66</span><div class="casTitle"><span class="NLM_cas:atitle">Protecting-Group-Free Total Synthesis of Isoquinoline Alkaloids by Nickel-Catalyzed Annulation of o-Halobenzaldimine with an Alkyne as the Key Step</span></div><div class="casAuthors">Korivi, Rajendra Prasad; Cheng, Chien-Hong</div><div class="citationInfo"><span class="NLM_cas:title">Chemistry - A European Journal</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">16</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">282-287, S282/1-S282/30</span>CODEN:
                <span class="NLM_cas:coden">CEUJED</span>;
        ISSN:<span class="NLM_cas:issn">0947-6539</span>.
    
            (<span class="NLM_cas:orgname">Wiley-VCH Verlag GmbH & Co. KGaA</span>)
        </div><div class="casAbstract">An efficient short total synthesis of benzo[c]phenanthridine alkaloids including oxyavicine (I), oxynitidine (II), and oxysanguinarine (III) is described.  Thus, N-methyl-o-bromobenzaldimines undergo regioselective cyclization with 4-(benzo[d][1,3]dioxol-5-yl)but-3-yn-1-ol in the presence of [Ni(cod)2] (cod=1,5-cyclooctadiene).  In situ oxidn. of the resultant isoquinolinium salts gives isoquinolinone derivs. with benzo[d][1,3]dioxol-5-yl substitution at the C3 atom and a (CH2)2OH group at the C4 atom.  Later, oxidn. of the alc. group in the isoquinolinone derivs. to the aldehyde moiety followed by acid-catalyzed cyclization and dehydration completes the total syntheses to give I, II and III in 67, 65, and 60% yields, resp.  The synthesis requires four steps from o-bromobenzaldehyde derivs.  Transformations of these alkaloids to the other alkaloids in this family are also discussed herein.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoTyBinXqeEKrVg90H21EOLACvtfcHk0liXWZUMm-PYGg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXhs1WksLvL&md5=54c0314b0b23dd14a814a26264ee0183</span></div><a href="/servlet/linkout?suffix=cit66&amp;dbid=16384&amp;doi=10.1002%2Fchem.200902275&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fchem.200902275%26sid%3Dliteratum%253Aachs%26aulast%3DKorivi%26aufirst%3DR.%2BP.%26aulast%3DCheng%26aufirst%3DC.%2BH.%26atitle%3DProtecting-group-free%2520total%2520synthesis%2520of%2520isoquinoline%2520alkaloids%2520by%2520nickel-catalyzed%2520annulation%2520of%2520o-halobenzaldimine%2520with%2520an%2520alkyne%2520as%2520the%2520key%2520step%26jtitle%3DChem.%2520-%2520Eur.%2520J.%26date%3D2010%26volume%3D16%26spage%3D282%26epage%3D287%26doi%3D10.1002%2Fchem.200902275" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref67"><div class="reference"><strong class="refLabel"><a href="#ref67" class="rightTabRefNumLink">67</a></strong><div class="NLM_citation" id="rightTab-cit67"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Liu, C. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Korivi, R. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cheng, C. H.</span></span> <span> </span><span class="NLM_article-title">Cobalt-catalyzed regioselective synthesis of indenamine from o-iodobenzaldimine and alkyne: intriguing difference to the nickel-catalyzed reaction</span>. <i>Chem. - Eur. J.</i> <span class="NLM_year" style="font-weight: bold;">2008</span>,  <span class="NLM_volume"><i>14</i></span>,  <span class="NLM_fpage">9503</span>– <span class="NLM_lpage">9506</span>, <span class="refDoi"> DOI: 10.1002/chem.200801457</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref67/cit67&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00639&amp;key=10.1002%2Fchem.200801457" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref67/cit67&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00639&amp;key=18810733" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref67/cit67&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00639&amp;key=1%3ACAS%3A528%3ADC%252BD1cXhsVSntb%252FF" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=14&publication_year=2008&pages=9503-9506&author=C.+C.+Liuauthor=R.+P.+Koriviauthor=C.+H.+Cheng&title=Cobalt-catalyzed+regioselective+synthesis+of+indenamine+from+o-iodobenzaldimine+and+alkyne%3A+intriguing+difference+to+the+nickel-catalyzed+reaction&doi=10.1002%2Fchem.200801457"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit67R"><div class="casContent"><span class="casTitleNuber">67</span><div class="casTitle"><span class="NLM_cas:atitle">Cobalt-catalyzed regioselective synthesis of indenamine from o-iodobenzaldimine and alkyne: intriguing difference to the nickel-catalyzed reaction</span></div><div class="casAuthors">Liu, Chuan-Che; Korivi, Rajendra Prasad; Cheng, Chien-Hong</div><div class="citationInfo"><span class="NLM_cas:title">Chemistry - A European Journal</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">14</span>
        (<span class="NLM_cas:issue">31</span>),
    <span class="NLM_cas:pages">9503-9506</span>CODEN:
                <span class="NLM_cas:coden">CEUJED</span>;
        ISSN:<span class="NLM_cas:issn">0947-6539</span>.
    
            (<span class="NLM_cas:orgname">Wiley-VCH Verlag GmbH & Co. KGaA</span>)
        </div><div class="casAbstract">In contrast to nickel- and palladium-catalyzed reactions, the cobalt-catalyzed reaction from from o-iodobenzaldimine and alkyne gave indenamine derivs. instead of isoquinoline derivs.  The difference of the regiochem. and product formation with respect to the nickel-catalyzed reaction was explained.  The indenamines are readily converted to the corresponding indenimines in the presence of tetrabutylammonium fluoride and can then be hydrolyzed to indenones.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGp1GKZvQYnLrLVg90H21EOLACvtfcHk0lhU7yU3VLhurA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXhsVSntb%252FF&md5=f9148261c9fd7c71f3e9dac54f969b72</span></div><a href="/servlet/linkout?suffix=cit67&amp;dbid=16384&amp;doi=10.1002%2Fchem.200801457&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fchem.200801457%26sid%3Dliteratum%253Aachs%26aulast%3DLiu%26aufirst%3DC.%2BC.%26aulast%3DKorivi%26aufirst%3DR.%2BP.%26aulast%3DCheng%26aufirst%3DC.%2BH.%26atitle%3DCobalt-catalyzed%2520regioselective%2520synthesis%2520of%2520indenamine%2520from%2520o-iodobenzaldimine%2520and%2520alkyne%253A%2520intriguing%2520difference%2520to%2520the%2520nickel-catalyzed%2520reaction%26jtitle%3DChem.%2520-%2520Eur.%2520J.%26date%3D2008%26volume%3D14%26spage%3D9503%26epage%3D9506%26doi%3D10.1002%2Fchem.200801457" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref68"><div class="reference"><strong class="refLabel"><a href="#ref68" class="rightTabRefNumLink">68</a></strong><div class="NLM_citation" id="rightTab-cit68"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Omura, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sharma, A. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Swern, D.</span></span> <span> </span><span class="NLM_article-title">Dimethyl sulfoxide-trifltioroacetic anhydride: a new reagent for oxidation of alcohols to carbonyls</span>. <i>J. Org. Chem.</i> <span class="NLM_year" style="font-weight: bold;">1976</span>,  <span class="NLM_volume"><i>41</i></span>,  <span class="NLM_fpage">957</span>– <span class="NLM_lpage">962</span>, <span class="refDoi"> DOI: 10.1021/jo00868a012</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jo00868a012" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=41&publication_year=1976&pages=957-962&author=K.+Omuraauthor=A.+K.+Sharmaauthor=D.+Swern&title=Dimethyl+sulfoxide-trifltioroacetic+anhydride%3A+a+new+reagent+for+oxidation+of+alcohols+to+carbonyls&doi=10.1021%2Fjo00868a012"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit68&amp;dbid=16384&amp;doi=10.1021%2Fjo00868a012&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjo00868a012%26sid%3Dliteratum%253Aachs%26aulast%3DOmura%26aufirst%3DK.%26aulast%3DSharma%26aufirst%3DA.%2BK.%26aulast%3DSwern%26aufirst%3DD.%26atitle%3DDimethyl%2520sulfoxide-trifltioroacetic%2520anhydride%253A%2520a%2520new%2520reagent%2520for%2520oxidation%2520of%2520alcohols%2520to%2520carbonyls%26jtitle%3DJ.%2520Org.%2520Chem.%26date%3D1976%26volume%3D41%26spage%3D957%26epage%3D962%26doi%3D10.1021%2Fjo00868a012" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref69"><div class="reference"><strong class="refLabel"><a href="#ref69" class="rightTabRefNumLink">69</a></strong><div class="NLM_citation" id="rightTab-cit69"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Kiselev, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">DeGuire, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Morrell, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Agama, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dexheimer, T. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pommier, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cushman, M.</span></span> <span> </span><span class="NLM_article-title">7-azaindenoisoquinolines as topoisomerase I inhibitors and potential anticancer agents</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2011</span>,  <span class="NLM_volume"><i>54</i></span>,  <span class="NLM_fpage">6106</span>– <span class="NLM_lpage">6116</span>, <span class="refDoi"> DOI: 10.1021/jm200719v</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm200719v" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref69/cit69&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00639&amp;key=1%3ACAS%3A528%3ADC%252BC3MXpvFSnsbg%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=54&publication_year=2011&pages=6106-6116&author=E.+Kiselevauthor=S.+DeGuireauthor=A.+Morrellauthor=K.+Agamaauthor=T.+S.+Dexheimerauthor=Y.+Pommierauthor=M.+Cushman&title=7-azaindenoisoquinolines+as+topoisomerase+I+inhibitors+and+potential+anticancer+agents&doi=10.1021%2Fjm200719v"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit69R"><div class="casContent"><span class="casTitleNuber">69</span><div class="casTitle"><span class="NLM_cas:atitle">7-Azaindenoisoquinolines as Topoisomerase I Inhibitors and Potential Anticancer Agents</span></div><div class="casAuthors">Kiselev, Evgeny; DeGuire, Sean; Morrell, Andrew; Agama, Keli; Dexheimer, Thomas S.; Pommier, Yves; Cushman, Mark</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">54</span>
        (<span class="NLM_cas:issue">17</span>),
    <span class="NLM_cas:pages">6106-6116</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">A series of 7-azaindenoisoquinoline topoisomerase I (Top1) inhibitors have been prepd. to investigate the effect of increased electron affinity of the arom. system on the ability to stabilize the Top1-DNA cleavage complex.  Ab initio calcns. suggest that introduction of nitrogen into the arom. system of the indenoisoquinolines would facilitate charge transfer complex formation with DNA, thus improving the π-π stacking interactions.  The present study shows that 7-azaindenoisoquinolines, e.g. I (R = Me2N, 1-imidazolyl, HOCH2CH2NH), demonstrate improved water soly. without any decrease in Top1 inhibitory activity or cytotoxicity.  Anal. of the biol. results reveals that smaller lactam ring substituents enable intercalation into both free DNA and Top1-DNA cleavage complex, whereas larger substituents only allow binding to the cleavage complex but not free DNA.  Free DNA binding suppresses Top1-catalyzed DNA cleavage at high drug concns., whereas DNA cleavage and inhibition of religation occurs at low drug concn.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqEwcEqjS2N5LVg90H21EOLACvtfcHk0lhU7yU3VLhurA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXpvFSnsbg%253D&md5=23d9925cfecda6c6d636de85e348832f</span></div><a href="/servlet/linkout?suffix=cit69&amp;dbid=16384&amp;doi=10.1021%2Fjm200719v&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm200719v%26sid%3Dliteratum%253Aachs%26aulast%3DKiselev%26aufirst%3DE.%26aulast%3DDeGuire%26aufirst%3DS.%26aulast%3DMorrell%26aufirst%3DA.%26aulast%3DAgama%26aufirst%3DK.%26aulast%3DDexheimer%26aufirst%3DT.%2BS.%26aulast%3DPommier%26aufirst%3DY.%26aulast%3DCushman%26aufirst%3DM.%26atitle%3D7-azaindenoisoquinolines%2520as%2520topoisomerase%2520I%2520inhibitors%2520and%2520potential%2520anticancer%2520agents%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2011%26volume%3D54%26spage%3D6106%26epage%3D6116%26doi%3D10.1021%2Fjm200719v" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref70"><div class="reference"><strong class="refLabel"><a href="#ref70" class="rightTabRefNumLink">70</a></strong><div class="NLM_citation" id="rightTab-cit70"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Kiselev, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sooryakumar, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Agama, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cushman, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pommier, Y.</span></span> <span> </span><span class="NLM_article-title">Optimization of the lactam side chain of 7-azaindenoisoquinoline topoisomerase I inhibitors and mechanism of action studies in cancer cells</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>57</i></span>,  <span class="NLM_fpage">1289</span>– <span class="NLM_lpage">1298</span>, <span class="refDoi"> DOI: 10.1021/jm401471v</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm401471v" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref70/cit70&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00639&amp;key=1%3ACAS%3A528%3ADC%252BC2cXitVartr8%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=57&publication_year=2014&pages=1289-1298&author=E.+Kiselevauthor=D.+Sooryakumarauthor=K.+Agamaauthor=M.+Cushmanauthor=Y.+Pommier&title=Optimization+of+the+lactam+side+chain+of+7-azaindenoisoquinoline+topoisomerase+I+inhibitors+and+mechanism+of+action+studies+in+cancer+cells&doi=10.1021%2Fjm401471v"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit70R"><div class="casContent"><span class="casTitleNuber">70</span><div class="casTitle"><span class="NLM_cas:atitle">Optimization of the Lactam Side Chain of 7-Azaindenoisoquinoline Topoisomerase I Inhibitors and Mechanism of Action Studies in Cancer Cells</span></div><div class="casAuthors">Kiselev, Evgeny; Sooryakumar, Dhriti; Agama, Keli; Cushman, Mark; Pommier, Yves</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">57</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">1289-1298</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Optimization of the lactam ω-aminoalkyl substituents in a series of 7-azaindenoisoquinolines resulted in new anticancer agents with improved Top1 inhibitory potencies and cancer cell cytotoxicities.  The new compds. 14-17 and 19 exhibited mean graph midpoint cytotoxicity (GI50) values of 21-71 nM in the NCI panel of 60 human cancer cell cultures.  Ternary 7-azaindenoisoquinoline-DNA-Top1 cleavage complexes that persist for up to 6 h were detected in HCT116 colon cancer cells.  Ternary complexes contg. 7-azaindenoisoquinolines were significantly more stable than those in which camptothecin was incorporated.  DNA content distribution histograms showed S-phase block 3 h after drug removal.  Drug-induced DNA damage in HCT116 cells was revealed by induction of the histone γ-H2AX marker.  The 7-azaindenoisoquinolines were able to partially overcome resistance in several drug-resistant cell lines, and they were not substrates for the ABCB1 drug efflux transporter.  Mol. modeling studies indicate that the 7-azaindenoisoquinolines intercalate at the DNA cleavage site in DNA-Top1 covalent complexes with the lactam side chain projecting into the major groove.  Overall, the results indicate that the 7-azaindenoisoquinolines are promising anticancer agents that merit further development.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrxOWg6LqPWqrVg90H21EOLACvtfcHk0lik3I6lYp5uEA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXitVartr8%253D&md5=114c720750253fdaf4c80cd5ff1d743e</span></div><a href="/servlet/linkout?suffix=cit70&amp;dbid=16384&amp;doi=10.1021%2Fjm401471v&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm401471v%26sid%3Dliteratum%253Aachs%26aulast%3DKiselev%26aufirst%3DE.%26aulast%3DSooryakumar%26aufirst%3DD.%26aulast%3DAgama%26aufirst%3DK.%26aulast%3DCushman%26aufirst%3DM.%26aulast%3DPommier%26aufirst%3DY.%26atitle%3DOptimization%2520of%2520the%2520lactam%2520side%2520chain%2520of%25207-azaindenoisoquinoline%2520topoisomerase%2520I%2520inhibitors%2520and%2520mechanism%2520of%2520action%2520studies%2520in%2520cancer%2520cells%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2014%26volume%3D57%26spage%3D1289%26epage%3D1298%26doi%3D10.1021%2Fjm401471v" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref71"><div class="reference"><strong class="refLabel"><a href="#ref71" class="rightTabRefNumLink">71</a></strong><div class="NLM_citation" id="rightTab-cit71"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Elsayed, M. S. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Su, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sethi, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Agama, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ravji, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Redon, C. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kiselev, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Horzmann, K. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Freeman, J. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pommier, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cushman, M.</span></span> <span> </span><span class="NLM_article-title">Design and synthesis of chlorinated and fluorinated 7-azaindenoisoquinolines as potent cytotoxic anticancer agents that inhibit topoisomerase I</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>60</i></span>,  <span class="NLM_fpage">5364</span>– <span class="NLM_lpage">5376</span>, <span class="refDoi"> DOI: 10.1021/acs.jmedchem.6b01870</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acs.jmedchem.6b01870" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref71/cit71&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00639&amp;key=1%3ACAS%3A528%3ADC%252BC2sXhtVKnur7O" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=60&publication_year=2017&pages=5364-5376&author=M.+S.+A.+Elsayedauthor=Y.+Suauthor=P.+Wangauthor=T.+Sethiauthor=K.+Agamaauthor=A.+Ravjiauthor=C.+E.+Redonauthor=E.+Kiselevauthor=K.+A.+Horzmannauthor=J.+L.+Freemanauthor=Y.+Pommierauthor=M.+Cushman&title=Design+and+synthesis+of+chlorinated+and+fluorinated+7-azaindenoisoquinolines+as+potent+cytotoxic+anticancer+agents+that+inhibit+topoisomerase+I&doi=10.1021%2Facs.jmedchem.6b01870"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit71R"><div class="casContent"><span class="casTitleNuber">71</span><div class="casTitle"><span class="NLM_cas:atitle">Design and Synthesis of Chlorinated and Fluorinated 7-Azaindenoisoquinolines as Potent Cytotoxic Anticancer Agents That Inhibit Topoisomerase I</span></div><div class="casAuthors">Elsayed, Mohamed S. A.; Su, Yafan; Wang, Ping; Sethi, Taresh; Agama, Keli; Ravji, Azhar; Redon, Christophe E.; Kiselev, Evgeny; Horzmann, Katharine A.; Freeman, Jennifer L.; Pommier, Yves; Cushman, Mark</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">60</span>
        (<span class="NLM_cas:issue">13</span>),
    <span class="NLM_cas:pages">5364-5376</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">The 7-azaindenoisoquinolines are cytotoxic topoisomerase I (Top1) inhibitors.  Previously reported representatives bear a 3-nitro group.  The present report documents the replacement of the potentially genotoxic 3-nitro group by 3-chloro and 3-fluoro substituents, resulting in compds. with high Top1 inhibitory activities and potent cytotoxicities in human cancer cell cultures and reduced lethality in an animal model.  Some of the new Top1 inhibitors also possess moderate inhibitory activities against tyrosyl-DNA phosphodiesterase 1 (TDP1) and tyrosyl-DNA phosphodiesterase 2 (TDP2), two enzymes that are involved in DNA damage repair resulting from Top1 inhibitors, and they produce significantly more DNA damage in cancer cells than in normal cells.  Eighteen of the new compds. had cytotoxicity mean-graph midpoint (MGM) GI50 values in the submicromolar (0.033-0.630 μM) range.  Compds. I and II are the most potent in human cancer cell cultures with MGM GI50 values of 0.063 and 0.033 μM, respectively.  Possible binding modes to Top1 and TDP1were investigated by mol. modeling.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqRgy6fIbq0FLVg90H21EOLACvtfcHk0ljVysjzLrMk3Q"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2sXhtVKnur7O&md5=3b22f12a9b5483e5a28a3a6775ac4210</span></div><a href="/servlet/linkout?suffix=cit71&amp;dbid=16384&amp;doi=10.1021%2Facs.jmedchem.6b01870&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facs.jmedchem.6b01870%26sid%3Dliteratum%253Aachs%26aulast%3DElsayed%26aufirst%3DM.%2BS.%2BA.%26aulast%3DSu%26aufirst%3DY.%26aulast%3DWang%26aufirst%3DP.%26aulast%3DSethi%26aufirst%3DT.%26aulast%3DAgama%26aufirst%3DK.%26aulast%3DRavji%26aufirst%3DA.%26aulast%3DRedon%26aufirst%3DC.%2BE.%26aulast%3DKiselev%26aufirst%3DE.%26aulast%3DHorzmann%26aufirst%3DK.%2BA.%26aulast%3DFreeman%26aufirst%3DJ.%2BL.%26aulast%3DPommier%26aufirst%3DY.%26aulast%3DCushman%26aufirst%3DM.%26atitle%3DDesign%2520and%2520synthesis%2520of%2520chlorinated%2520and%2520fluorinated%25207-azaindenoisoquinolines%2520as%2520potent%2520cytotoxic%2520anticancer%2520agents%2520that%2520inhibit%2520topoisomerase%2520I%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2017%26volume%3D60%26spage%3D5364%26epage%3D5376%26doi%3D10.1021%2Facs.jmedchem.6b01870" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref72"><div class="reference"><strong class="refLabel"><a href="#ref72" class="rightTabRefNumLink">72</a></strong><div class="NLM_citation" id="rightTab-cit72"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Janin, Y. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bisagni, E.</span></span> <span> </span><span class="NLM_article-title">A formal new access to the benzo[c]phenanthridine alkaloids, synthesis of nitidine and O-methyl fagaronine analogues</span>. <i>Tetrahedron</i> <span class="NLM_year" style="font-weight: bold;">1993</span>,  <span class="NLM_volume"><i>49</i></span>,  <span class="NLM_fpage">10305</span>– <span class="NLM_lpage">10316</span>, <span class="refDoi"> DOI: 10.1016/S0040-4020(01)80559-7</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref72/cit72&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00639&amp;key=10.1016%2FS0040-4020%2801%2980559-7" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=49&publication_year=1993&pages=10305-10316&author=Y.+L.+Janinauthor=E.+Bisagni&title=A+formal+new+access+to+the+benzo%5Bc%5Dphenanthridine+alkaloids%2C+synthesis+of+nitidine+and+O-methyl+fagaronine+analogues&doi=10.1016%2FS0040-4020%2801%2980559-7"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit72&amp;dbid=16384&amp;doi=10.1016%2FS0040-4020%2801%2980559-7&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS0040-4020%252801%252980559-7%26sid%3Dliteratum%253Aachs%26aulast%3DJanin%26aufirst%3DY.%2BL.%26aulast%3DBisagni%26aufirst%3DE.%26atitle%3DA%2520formal%2520new%2520access%2520to%2520the%2520benzo%255Bc%255Dphenanthridine%2520alkaloids%252C%2520synthesis%2520of%2520nitidine%2520and%2520O-methyl%2520fagaronine%2520analogues%26jtitle%3DTetrahedron%26date%3D1993%26volume%3D49%26spage%3D10305%26epage%3D10316%26doi%3D10.1016%2FS0040-4020%2801%2980559-7" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref73"><div class="reference"><strong class="refLabel"><a href="#ref73" class="rightTabRefNumLink">73</a></strong><div class="NLM_citation" id="rightTab-cit73"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Dexheimer, T. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pommier, Y.</span></span> <span> </span><span class="NLM_article-title">DNA cleavage assay for the identification of topoisomerase I inhibitors</span>. <i>Nat. Protoc.</i> <span class="NLM_year" style="font-weight: bold;">2008</span>,  <span class="NLM_volume"><i>3</i></span>,  <span class="NLM_fpage">1736</span>– <span class="NLM_lpage">1750</span>, <span class="refDoi"> DOI: 10.1038/nprot.2008.174</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref73/cit73&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00639&amp;key=10.1038%2Fnprot.2008.174" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref73/cit73&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00639&amp;key=18927559" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref73/cit73&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00639&amp;key=1%3ACAS%3A528%3ADC%252BD1cXht1GgtLbO" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=3&publication_year=2008&pages=1736-1750&author=T.+S.+Dexheimerauthor=Y.+Pommier&title=DNA+cleavage+assay+for+the+identification+of+topoisomerase+I+inhibitors&doi=10.1038%2Fnprot.2008.174"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit73R"><div class="casContent"><span class="casTitleNuber">73</span><div class="casTitle"><span class="NLM_cas:atitle">DNA cleavage assay for the identification of topoisomerase I inhibitors</span></div><div class="casAuthors">Dexheimer, Thomas S.; Pommier, Yves</div><div class="citationInfo"><span class="NLM_cas:title">Nature Protocols</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">3</span>
        (<span class="NLM_cas:issue">11</span>),
    <span class="NLM_cas:pages">1736-1750</span>CODEN:
                <span class="NLM_cas:coden">NPARDW</span>;
        ISSN:<span class="NLM_cas:issn">1750-2799</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">A review.  The inhibition of DNA topoisomerase I (Top1) has proven to be a successful approach in the design of anticancer agents.  However, despite the clin. successes of the camptothecin derivs., a significant need for less toxic and more chem. stable Top1 inhibitors still persists.  Here, we describe one of the most frequently used protocols to identify novel Top1 inhibitors.  These methods use uniquely 3'-radiolabeled DNA substrates and denaturing polyacrylamide gel electrophoresis to provide evidence for the Top1-mediated DNA cleaving activity of potential Top1 inhibitors.  These assays allow comparison of the effectiveness of different drugs in stabilizing the Top1-DNA intermediate or cleavage (cleavable) complex.  A variation on these assays is also presented, which provides a suitable system for detg. whether the inhibitor blocks the forward cleavage or religation reactions by measuring the reversibility of the drug-induced Top1-DNA cleavage complexes.  This entire protocol can be completed in ∼2 d.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoVKYmp2bCwu7Vg90H21EOLACvtfcHk0ljVysjzLrMk3Q"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXht1GgtLbO&md5=ad5aa65100610b358be19276bada5fbd</span></div><a href="/servlet/linkout?suffix=cit73&amp;dbid=16384&amp;doi=10.1038%2Fnprot.2008.174&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnprot.2008.174%26sid%3Dliteratum%253Aachs%26aulast%3DDexheimer%26aufirst%3DT.%2BS.%26aulast%3DPommier%26aufirst%3DY.%26atitle%3DDNA%2520cleavage%2520assay%2520for%2520the%2520identification%2520of%2520topoisomerase%2520I%2520inhibitors%26jtitle%3DNat.%2520Protoc.%26date%3D2008%26volume%3D3%26spage%3D1736%26epage%3D1750%26doi%3D10.1038%2Fnprot.2008.174" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref74"><div class="reference"><strong class="refLabel"><a href="#ref74" class="rightTabRefNumLink">74</a></strong><div class="NLM_citation" id="rightTab-cit74"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Sooryakumar, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dexheimer, T. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Teicher, B. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pommier, Y.</span></span> <span> </span><span class="NLM_article-title">Molecular and cellular pharmacology of the novel noncamptothecin topoisomerase I inhibitor Genz-644282</span>. <i>Mol. Cancer Ther.</i> <span class="NLM_year" style="font-weight: bold;">2011</span>,  <span class="NLM_volume"><i>10</i></span>,  <span class="NLM_fpage">1490</span>– <span class="NLM_lpage">1499</span>, <span class="refDoi"> DOI: 10.1158/1535-7163.MCT-10-1043</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref74/cit74&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00639&amp;key=10.1158%2F1535-7163.MCT-10-1043" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref74/cit74&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00639&amp;key=21636699" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref74/cit74&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00639&amp;key=1%3ACAS%3A528%3ADC%252BC3MXhtFSqtLbE" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=10&publication_year=2011&pages=1490-1499&author=D.+Sooryakumarauthor=T.+S.+Dexheimerauthor=B.+A.+Teicherauthor=Y.+Pommier&title=Molecular+and+cellular+pharmacology+of+the+novel+noncamptothecin+topoisomerase+I+inhibitor+Genz-644282&doi=10.1158%2F1535-7163.MCT-10-1043"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit74R"><div class="casContent"><span class="casTitleNuber">74</span><div class="casTitle"><span class="NLM_cas:atitle">Molecular and cellular pharmacology of the novel noncamptothecin topoisomerase I inhibitor Genz-644282</span></div><div class="casAuthors">Sooryakumar, Dhriti; Dexheimer, Thomas S.; Teicher, Beverly A.; Pommier, Yves</div><div class="citationInfo"><span class="NLM_cas:title">Molecular Cancer Therapeutics</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">10</span>
        (<span class="NLM_cas:issue">8</span>),
    <span class="NLM_cas:pages">1490-1499</span>CODEN:
                <span class="NLM_cas:coden">MCTOCF</span>;
        ISSN:<span class="NLM_cas:issn">1535-7163</span>.
    
            (<span class="NLM_cas:orgname">American Association for Cancer Research</span>)
        </div><div class="casAbstract">Camptothecin derivs. are powerful anticancer drugs because of their ability to trap topoisomerase I (Top1)-DNA cleavage complexes.  However, they exhibit clin. limitations due to the instability of their α-hydroxylactone six-membered E-ring structure.  In addn., they exhibit bone marrow and intestinal toxicity, esp. in adults, and are drug efflux substrates.  Here, we report a novel Top1 inhibitor, Genz-644282.  We show that Genz-644282 and its metabolites induce Top1 cleavage at similar, as well as unique genomic positions, compared with camptothecin.  The compd. also induces protein-linked DNA breaks and Top1-DNA cleavage complexes that persist longer after compd. removal than camptothecin.  Concn.-dependent and persistent γH2AX formation was readily obsd. in cells treated with Genz-644282, and was present in greater than 50% of the cell population following 24 h compd. exposure.  The compd. shows partial cross-resistance in cell lines resistant to camptothecin.  These cell lines include the human prostate DU145RC0.1 and the leukemic CEM/C2 cells.  Limited cross-resistance to Genz-644282 was also found in the Top1 knockdown colon cancer (HCT116) and breast cancer (MCF7) cell lines and in human adenocarcinoma cells (KB31/KBV1) that overexpress (P-glycoprotein, ABCB1), a member of the ATP-binding cassette family of cell surface transport proteins known to confer MDR.  Together, our results provide the first mol. and cellular characterization of Genz-644282 and its clin. relevant metabolites.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr-rOnt_rP4X7Vg90H21EOLACvtfcHk0lhNJ_GL71huVg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXhtFSqtLbE&md5=8f095f9c31d5f7fd987abc67777d4333</span></div><a href="/servlet/linkout?suffix=cit74&amp;dbid=16384&amp;doi=10.1158%2F1535-7163.MCT-10-1043&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1158%252F1535-7163.MCT-10-1043%26sid%3Dliteratum%253Aachs%26aulast%3DSooryakumar%26aufirst%3DD.%26aulast%3DDexheimer%26aufirst%3DT.%2BS.%26aulast%3DTeicher%26aufirst%3DB.%2BA.%26aulast%3DPommier%26aufirst%3DY.%26atitle%3DMolecular%2520and%2520cellular%2520pharmacology%2520of%2520the%2520novel%2520noncamptothecin%2520topoisomerase%2520I%2520inhibitor%2520Genz-644282%26jtitle%3DMol.%2520Cancer%2520Ther.%26date%3D2011%26volume%3D10%26spage%3D1490%26epage%3D1499%26doi%3D10.1158%2F1535-7163.MCT-10-1043" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref75"><div class="reference"><strong class="refLabel"><a href="#ref75" class="rightTabRefNumLink">75</a></strong><div class="NLM_citation" id="rightTab-cit75"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Staker, B. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hjerrild, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Feese, M. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Behnke, C. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Burgin, A. B.,  Jr.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Stewart, L.</span></span> <span> </span><span class="NLM_article-title">The mechanism of topoisomerase I poisoning by a camptothecin analog</span>. <i>Proc. Natl. Acad. Sci. U. S. A.</i> <span class="NLM_year" style="font-weight: bold;">2002</span>,  <span class="NLM_volume"><i>99</i></span>,  <span class="NLM_fpage">15387</span>– <span class="NLM_lpage">15392</span>, <span class="refDoi"> DOI: 10.1073/pnas.242259599</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref75/cit75&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00639&amp;key=10.1073%2Fpnas.242259599" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref75/cit75&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00639&amp;key=12426403" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref75/cit75&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00639&amp;key=1%3ACAS%3A528%3ADC%252BD3sXjvVGh" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=99&publication_year=2002&pages=15387-15392&author=B.+L.+Stakerauthor=K.+Hjerrildauthor=M.+D.+Feeseauthor=C.+A.+Behnkeauthor=A.+B.+Burginauthor=L.+Stewart&title=The+mechanism+of+topoisomerase+I+poisoning+by+a+camptothecin+analog&doi=10.1073%2Fpnas.242259599"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit75R"><div class="casContent"><span class="casTitleNuber">75</span><div class="casTitle"><span class="NLM_cas:atitle">The mechanism of topoisomerase I poisoning by a camptothecin analog</span></div><div class="casAuthors">Staker, Bart L.; Hjerrild, Kathryn; Feese, Michael D.; Behnke, Craig A.; Burgin, Alex B., Jr.; Stewart, Lance</div><div class="citationInfo"><span class="NLM_cas:title">Proceedings of the National Academy of Sciences of the United States of America</span>
        (<span class="NLM_cas:date">2002</span>),
    <span class="NLM_cas:volume">99</span>
        (<span class="NLM_cas:issue">24</span>),
    <span class="NLM_cas:pages">15387-15392</span>CODEN:
                <span class="NLM_cas:coden">PNASA6</span>;
        ISSN:<span class="NLM_cas:issn">0027-8424</span>.
    
            (<span class="NLM_cas:orgname">National Academy of Sciences</span>)
        </div><div class="casAbstract">We report the x-ray crystal structure of human topoisomerase I covalently joined to double-stranded DNA and bound to the clin. approved anticancer agent topotecan.  Topotecan mimics a DNA base pair and binds at the site of DNA cleavage by intercalating between the upstream (-1) and downstream (+1) base pairs.  Intercalation displaces the downstream DNA, thus preventing re-ligation of the cleaved strand.  By specifically binding to the enzyme-substrate complex, topotecan acts as an uncompetitive inhibitor.  The structure can explain several of the known structure-activity relationships of the camptothecin family of anticancer drugs and suggests that there are at least two classes of mutations that can produce a drug-resistant enzyme.  The first class includes changes to residues that contribute to direct interactions with the drug, whereas a second class would alter interactions with the DNA and thereby destabilize the drug-binding site.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr6ZhyvRMWZBLVg90H21EOLACvtfcHk0lhNJ_GL71huVg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3sXjvVGh&md5=fe1f9e01f0277f8d46e8726ba7866bdb</span></div><a href="/servlet/linkout?suffix=cit75&amp;dbid=16384&amp;doi=10.1073%2Fpnas.242259599&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1073%252Fpnas.242259599%26sid%3Dliteratum%253Aachs%26aulast%3DStaker%26aufirst%3DB.%2BL.%26aulast%3DHjerrild%26aufirst%3DK.%26aulast%3DFeese%26aufirst%3DM.%2BD.%26aulast%3DBehnke%26aufirst%3DC.%2BA.%26aulast%3DBurgin%26aufirst%3DA.%2BB.%26aulast%3DStewart%26aufirst%3DL.%26atitle%3DThe%2520mechanism%2520of%2520topoisomerase%2520I%2520poisoning%2520by%2520a%2520camptothecin%2520analog%26jtitle%3DProc.%2520Natl.%2520Acad.%2520Sci.%2520U.%2520S.%2520A.%26date%3D2002%26volume%3D99%26spage%3D15387%26epage%3D15392%26doi%3D10.1073%2Fpnas.242259599" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref76"><div class="reference"><strong class="refLabel"><a href="#ref76" class="rightTabRefNumLink">76</a></strong><div class="NLM_citation" id="rightTab-cit76"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Dexheimer, T. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gediya, L. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Stephen, A. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Weidlich, I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Antony, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Marchand, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Interthal, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nicklaus, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fisher, R. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Njar, V. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pommier, Y.</span></span> <span> </span><span class="NLM_article-title">4-Pregnen-21-ol-3,20-dione-21-(4-bromobenzenesulfonate) (NSC 88915) and related novel steroid derivatives as tyrosyl-DNA phosphodiesterase (Tdp1) inhibitors</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2009</span>,  <span class="NLM_volume"><i>52</i></span>,  <span class="NLM_fpage">7122</span>– <span class="NLM_lpage">7131</span>, <span class="refDoi"> DOI: 10.1021/jm901061s</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm901061s" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=52&publication_year=2009&pages=7122-7131&author=T.+S.+Dexheimerauthor=L.+K.+Gediyaauthor=A.+G.+Stephenauthor=I.+Weidlichauthor=S.+Antonyauthor=C.+Marchandauthor=H.+Interthalauthor=M.+Nicklausauthor=R.+J.+Fisherauthor=V.+C.+Njarauthor=Y.+Pommier&title=4-Pregnen-21-ol-3%2C20-dione-21-%284-bromobenzenesulfonate%29+%28NSC+88915%29+and+related+novel+steroid+derivatives+as+tyrosyl-DNA+phosphodiesterase+%28Tdp1%29+inhibitors&doi=10.1021%2Fjm901061s"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit76&amp;dbid=16384&amp;doi=10.1021%2Fjm901061s&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm901061s%26sid%3Dliteratum%253Aachs%26aulast%3DDexheimer%26aufirst%3DT.%2BS.%26aulast%3DGediya%26aufirst%3DL.%2BK.%26aulast%3DStephen%26aufirst%3DA.%2BG.%26aulast%3DWeidlich%26aufirst%3DI.%26aulast%3DAntony%26aufirst%3DS.%26aulast%3DMarchand%26aufirst%3DC.%26aulast%3DInterthal%26aufirst%3DH.%26aulast%3DNicklaus%26aufirst%3DM.%26aulast%3DFisher%26aufirst%3DR.%2BJ.%26aulast%3DNjar%26aufirst%3DV.%2BC.%26aulast%3DPommier%26aufirst%3DY.%26atitle%3D4-Pregnen-21-ol-3%252C20-dione-21-%25284-bromobenzenesulfonate%2529%2520%2528NSC%252088915%2529%2520and%2520related%2520novel%2520steroid%2520derivatives%2520as%2520tyrosyl-DNA%2520phosphodiesterase%2520%2528Tdp1%2529%2520inhibitors%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2009%26volume%3D52%26spage%3D7122%26epage%3D7131%26doi%3D10.1021%2Fjm901061s" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref77"><div class="reference"><strong class="refLabel"><a href="#ref77" class="rightTabRefNumLink">77</a></strong><div class="NLM_citation" id="rightTab-cit77"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Davies, D. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Interthal, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Champoux, J. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hol, W. G. J.</span></span> <span> </span><span class="NLM_article-title">Explorations of peptide and oligonucleotide binding sites of Tdp1 using vanadate complexes</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2004</span>,  <span class="NLM_volume"><i>47</i></span>,  <span class="NLM_fpage">829</span>– <span class="NLM_lpage">837</span>, <span class="refDoi"> DOI: 10.1021/jm030487x</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm030487x" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=47&publication_year=2004&pages=829-837&author=D.+R.+Daviesauthor=H.+Interthalauthor=J.+J.+Champouxauthor=W.+G.+J.+Hol&title=Explorations+of+peptide+and+oligonucleotide+binding+sites+of+Tdp1+using+vanadate+complexes&doi=10.1021%2Fjm030487x"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit77&amp;dbid=16384&amp;doi=10.1021%2Fjm030487x&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm030487x%26sid%3Dliteratum%253Aachs%26aulast%3DDavies%26aufirst%3DD.%2BR.%26aulast%3DInterthal%26aufirst%3DH.%26aulast%3DChampoux%26aufirst%3DJ.%2BJ.%26aulast%3DHol%26aufirst%3DW.%2BG.%2BJ.%26atitle%3DExplorations%2520of%2520peptide%2520and%2520oligonucleotide%2520binding%2520sites%2520of%2520Tdp1%2520using%2520vanadate%2520complexes%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2004%26volume%3D47%26spage%3D829%26epage%3D837%26doi%3D10.1021%2Fjm030487x" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref78"><div class="reference"><strong class="refLabel"><a href="#ref78" class="rightTabRefNumLink">78</a></strong><div class="NLM_citation" id="rightTab-cit78"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Pommier, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Covey, J. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kerrigan, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Markovits, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pham, R.</span></span> <span> </span><span class="NLM_article-title">DNA unwinding and inhibition of mouse leukemia L1210 DNA topoisomerase I by intercalators</span>. <i>Nucleic Acids Res.</i> <span class="NLM_year" style="font-weight: bold;">1987</span>,  <span class="NLM_volume"><i>15</i></span>,  <span class="NLM_fpage">6713</span>– <span class="NLM_lpage">6731</span>, <span class="refDoi"> DOI: 10.1093/nar/15.16.6713</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref78/cit78&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00639&amp;key=10.1093%2Fnar%2F15.16.6713" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=15&publication_year=1987&pages=6713-6731&author=Y.+Pommierauthor=J.+M.+Coveyauthor=D.+Kerriganauthor=J.+Markovitsauthor=R.+Pham&title=DNA+unwinding+and+inhibition+of+mouse+leukemia+L1210+DNA+topoisomerase+I+by+intercalators&doi=10.1093%2Fnar%2F15.16.6713"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit78&amp;dbid=16384&amp;doi=10.1093%2Fnar%2F15.16.6713&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1093%252Fnar%252F15.16.6713%26sid%3Dliteratum%253Aachs%26aulast%3DPommier%26aufirst%3DY.%26aulast%3DCovey%26aufirst%3DJ.%2BM.%26aulast%3DKerrigan%26aufirst%3DD.%26aulast%3DMarkovits%26aufirst%3DJ.%26aulast%3DPham%26aufirst%3DR.%26atitle%3DDNA%2520unwinding%2520and%2520inhibition%2520of%2520mouse%2520leukemia%2520L1210%2520DNA%2520topoisomerase%2520I%2520by%2520intercalators%26jtitle%3DNucleic%2520Acids%2520Res.%26date%3D1987%26volume%3D15%26spage%3D6713%26epage%3D6731%26doi%3D10.1093%2Fnar%2F15.16.6713" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref79"><div class="reference"><strong class="refLabel"><a href="#ref79" class="rightTabRefNumLink">79</a></strong><div class="NLM_citation" id="rightTab-cit79"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Pommier, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Covey, J. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kerrigan, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Markovits, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pham, R.</span></span> <span> </span><span class="NLM_article-title">DNA unwinding and inhibition of mouse leukemia L1210 DNA topoisomerase I by intercalators</span>. <i>Nucleic Acids Res.</i> <span class="NLM_year" style="font-weight: bold;">1987</span>,  <span class="NLM_volume"><i>15</i></span>,  <span class="NLM_fpage">6713</span>– <span class="NLM_lpage">6731</span>, <span class="refDoi"> DOI: 10.1093/nar/15.16.6713</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref79/cit79&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00639&amp;key=10.1093%2Fnar%2F15.16.6713" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=15&publication_year=1987&pages=6713-6731&author=Y.+Pommierauthor=J.+M.+Coveyauthor=D.+Kerriganauthor=J.+Markovitsauthor=R.+Pham&title=DNA+unwinding+and+inhibition+of+mouse+leukemia+L1210+DNA+topoisomerase+I+by+intercalators&doi=10.1093%2Fnar%2F15.16.6713"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit79&amp;dbid=16384&amp;doi=10.1093%2Fnar%2F15.16.6713&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1093%252Fnar%252F15.16.6713%26sid%3Dliteratum%253Aachs%26aulast%3DPommier%26aufirst%3DY.%26aulast%3DCovey%26aufirst%3DJ.%2BM.%26aulast%3DKerrigan%26aufirst%3DD.%26aulast%3DMarkovits%26aufirst%3DJ.%26aulast%3DPham%26aufirst%3DR.%26atitle%3DDNA%2520unwinding%2520and%2520inhibition%2520of%2520mouse%2520leukemia%2520L1210%2520DNA%2520topoisomerase%2520I%2520by%2520intercalators%26jtitle%3DNucleic%2520Acids%2520Res.%26date%3D1987%26volume%3D15%26spage%3D6713%26epage%3D6731%26doi%3D10.1093%2Fnar%2F15.16.6713" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref80"><div class="reference"><strong class="refLabel"><a href="#ref80" class="rightTabRefNumLink">80</a></strong><div class="NLM_citation" id="rightTab-cit80"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Shoemaker, R. H.</span></span> <span> </span><span class="NLM_article-title">The NCI60 human tumour cell line anticancer drug screen</span>. <i>Nat. Rev. Cancer</i> <span class="NLM_year" style="font-weight: bold;">2006</span>,  <span class="NLM_volume"><i>6</i></span>,  <span class="NLM_fpage">813</span>– <span class="NLM_lpage">823</span>, <span class="refDoi"> DOI: 10.1038/nrc1951</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref80/cit80&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00639&amp;key=10.1038%2Fnrc1951" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref80/cit80&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00639&amp;key=16990858" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref80/cit80&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00639&amp;key=1%3ACAS%3A528%3ADC%252BD28XpvVCmu7c%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=6&publication_year=2006&pages=813-823&author=R.+H.+Shoemaker&title=The+NCI60+human+tumour+cell+line+anticancer+drug+screen&doi=10.1038%2Fnrc1951"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit80R"><div class="casContent"><span class="casTitleNuber">80</span><div class="casTitle"><span class="NLM_cas:atitle">The NCI60 human tumour cell line anticancer drug screen</span></div><div class="casAuthors">Shoemaker, Robert H.</div><div class="citationInfo"><span class="NLM_cas:title">Nature Reviews Cancer</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">6</span>
        (<span class="NLM_cas:issue">10</span>),
    <span class="NLM_cas:pages">813-823</span>CODEN:
                <span class="NLM_cas:coden">NRCAC4</span>;
        ISSN:<span class="NLM_cas:issn">1474-175X</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">A review.  The US National Cancer Institute (NCI) 60 human tumor cell line anticancer drug screen (NCI60) was developed in the late 1980s as an in vitro drug-discovery tool intended to supplant the use of transplantable animal tumors in anticancer drug screening.  This screening model was rapidly recognized as a rich source of information about the mechanisms of growth inhibition and tumor-cell kill.  Recently, its role has changed to that of a service screen supporting the cancer research community.  The author reviews the development, use and productivity of the screen, highlighting several outcomes that have contributed to advances in cancer chemotherapy.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr0ysyTSc1-p7Vg90H21EOLACvtfcHk0lhJOoavllFXYg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28XpvVCmu7c%253D&md5=c6c1a074b9dc7e138f45734499769284</span></div><a href="/servlet/linkout?suffix=cit80&amp;dbid=16384&amp;doi=10.1038%2Fnrc1951&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnrc1951%26sid%3Dliteratum%253Aachs%26aulast%3DShoemaker%26aufirst%3DR.%2BH.%26atitle%3DThe%2520NCI60%2520human%2520tumour%2520cell%2520line%2520anticancer%2520drug%2520screen%26jtitle%3DNat.%2520Rev.%2520Cancer%26date%3D2006%26volume%3D6%26spage%3D813%26epage%3D823%26doi%3D10.1038%2Fnrc1951" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref81"><div class="reference"><strong class="refLabel"><a href="#ref81" class="rightTabRefNumLink">81</a></strong><div class="NLM_citation" id="rightTab-cit81"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Holbeck, S. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Collins, J. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Doroshow, J. H.</span></span> <span> </span><span class="NLM_article-title">Analysis of Food and Drug Administration-approved anticancer agents in the NCI60 panel of human tumor cell lines</span>. <i>Mol. Cancer Ther.</i> <span class="NLM_year" style="font-weight: bold;">2010</span>,  <span class="NLM_volume"><i>9</i></span>,  <span class="NLM_fpage">1451</span>– <span class="NLM_lpage">1460</span>, <span class="refDoi"> DOI: 10.1158/1535-7163.MCT-10-0106</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref81/cit81&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00639&amp;key=10.1158%2F1535-7163.MCT-10-0106" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref81/cit81&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00639&amp;key=20442306" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref81/cit81&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00639&amp;key=1%3ACAS%3A528%3ADC%252BC3cXlslektbY%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=9&publication_year=2010&pages=1451-1460&author=S.+L.+Holbeckauthor=J.+M.+Collinsauthor=J.+H.+Doroshow&title=Analysis+of+Food+and+Drug+Administration-approved+anticancer+agents+in+the+NCI60+panel+of+human+tumor+cell+lines&doi=10.1158%2F1535-7163.MCT-10-0106"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit81R"><div class="casContent"><span class="casTitleNuber">81</span><div class="casTitle"><span class="NLM_cas:atitle">Analysis of Food and Drug Administration-Approved Anticancer Agents in the NCI60 Panel of Human Tumor Cell Lines</span></div><div class="casAuthors">Holbeck, Susan L.; Collins, Jerry M.; Doroshow, James H.</div><div class="citationInfo"><span class="NLM_cas:title">Molecular Cancer Therapeutics</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">9</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">1451-1460</span>CODEN:
                <span class="NLM_cas:coden">MCTOCF</span>;
        ISSN:<span class="NLM_cas:issn">1535-7163</span>.
    
            (<span class="NLM_cas:orgname">American Association for Cancer Research</span>)
        </div><div class="casAbstract">Since the early 1990s the Developmental Therapeutics Program of the National Cancer Institute (NCI) has utilized a panel of 60 human tumor cell lines (NCI60) representing 9 tissue types to screen for potential new anticancer agents.  To date, about 100,000 compds. and 50,000 natural product exts. have been screened.  Early in this program it was discovered that the pattern of growth inhibition in these cell lines was similar for compds. of similar mechanism.  The development of the COMPARE algorithm provided a means by which investigators, starting with a compd. of interest, could identify other compds. whose pattern of growth inhibition was similar.  With extensive mol. characterization of these cell lines, COMPARE and other user-defined algorithms have been used to link patterns of mol. expression and drug sensitivity.  We describe here the results of screening current Food and Drug Administration (FDA)-approved anticancer agents in the NCI60 screen, with an emphasis on those agents that target signal transduction.  We analyzed results from agents with mechanisms of action presumed to be similar; we also carried out a hierarchical clustering of all of these agents.  The addn. of data from recently approved anticancer agents will increase the utility of the NCI60 databases to the cancer research community.  These data are freely accessible to the public on the DTP website (http://dtp.cancer.gov/).  The FDA-approved anticancer agents are themselves available from the NCI as a plated set of compds. for research use.  Mol Cancer Ther; 9(5); 1451-60.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqStY8k37YNdLVg90H21EOLACvtfcHk0livJk6ZmHdhKg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXlslektbY%253D&md5=cd87602a9fb3e4b1eb196abb4bb91f1a</span></div><a href="/servlet/linkout?suffix=cit81&amp;dbid=16384&amp;doi=10.1158%2F1535-7163.MCT-10-0106&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1158%252F1535-7163.MCT-10-0106%26sid%3Dliteratum%253Aachs%26aulast%3DHolbeck%26aufirst%3DS.%2BL.%26aulast%3DCollins%26aufirst%3DJ.%2BM.%26aulast%3DDoroshow%26aufirst%3DJ.%2BH.%26atitle%3DAnalysis%2520of%2520Food%2520and%2520Drug%2520Administration-approved%2520anticancer%2520agents%2520in%2520the%2520NCI60%2520panel%2520of%2520human%2520tumor%2520cell%2520lines%26jtitle%3DMol.%2520Cancer%2520Ther.%26date%3D2010%26volume%3D9%26spage%3D1451%26epage%3D1460%26doi%3D10.1158%2F1535-7163.MCT-10-0106" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref82"><div class="reference"><strong class="refLabel"><a href="#ref82" class="rightTabRefNumLink">82</a></strong><div class="NLM_citation" id="rightTab-cit82"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Reinhold, W. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sunshine, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Varma, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Doroshow, J. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pommier, Y.</span></span> <span> </span><span class="NLM_article-title">Using cellMiner 1.6 for systems pharmacology and genomic analysis of the NCI-60</span>. <i>Clin. Cancer Res.</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>21</i></span>,  <span class="NLM_fpage">3841</span>– <span class="NLM_lpage">3852</span>, <span class="refDoi"> DOI: 10.1158/1078-0432.CCR-15-0335</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref82/cit82&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00639&amp;key=10.1158%2F1078-0432.CCR-15-0335" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref82/cit82&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00639&amp;key=26048278" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref82/cit82&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00639&amp;key=1%3ACAS%3A528%3ADC%252BC2MXhsVCrsLfM" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=21&publication_year=2015&pages=3841-3852&author=W.+C.+Reinholdauthor=M.+Sunshineauthor=S.+Varmaauthor=J.+H.+Doroshowauthor=Y.+Pommier&title=Using+cellMiner+1.6+for+systems+pharmacology+and+genomic+analysis+of+the+NCI-60&doi=10.1158%2F1078-0432.CCR-15-0335"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit82R"><div class="casContent"><span class="casTitleNuber">82</span><div class="casTitle"><span class="NLM_cas:atitle">Using CellMiner 1.6 for Systems Pharmacology and Genomic Analysis of the NCI-60</span></div><div class="casAuthors">Reinhold, William C.; Sunshine, Margot; Varma, Sudhir; Doroshow, James H.; Pommier, Yves</div><div class="citationInfo"><span class="NLM_cas:title">Clinical Cancer Research</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">21</span>
        (<span class="NLM_cas:issue">17</span>),
    <span class="NLM_cas:pages">3841-3852</span>CODEN:
                <span class="NLM_cas:coden">CCREF4</span>;
        ISSN:<span class="NLM_cas:issn">1078-0432</span>.
    
            (<span class="NLM_cas:orgname">American Association for Cancer Research</span>)
        </div><div class="casAbstract">The NCI-60 cancer cell line panel provides a premier model for data integration, and systems pharmacol. being the largest publicly available database of anticancer drug activity, genomic, mol., and phenotypic data.  It comprises gene expression (25,722 transcripts), microRNAs (360 miRNAs), whole-genome DNA copy no. (23,413 genes), whole-exome sequencing (variants for 16,568 genes), protein levels (94 genes), and cytotoxic activity (20,861 compds.).  Included are 158 FDA-approved drugs and 79 that are in clin. trials.  To improve data accessibility to bioinformaticists and non-bioinformaticists alike, we have developed the CellMiner web-based tools.  Here, we describe the newest CellMiner version, including integration of novel databases and tools assocd. with whole-exome sequencing and protein expression, and review the tools.  Included are (i) "Cell line signature" for DNA, RNA, protein, and drugs; (ii) "Cross correlations" for up to 150 input genes, microRNAs, and compds. in a single query; (iii) "Pattern comparison" to identify connections among drugs, gene expression, genomic variants, microRNA, and protein expressions; (iv) "Genetic variation vs. drug visualization" to identify potential new drug:gene DNA variant relationships; and (v) "Genetic variant summation" designed to provide a synopsis of mutational burden on any pathway or gene group for up to 150 genes.  Together, these tools allow users to flexibly query the NCI-60 data for potential relationships between genomic, mol., and pharmacol. parameters in a manner specific to the user's area of expertise.  Examples for both gain- (RAS) and loss-of-function (PTEN) alterations are provided.  Clin Cancer Res; 21(17); 3841-52. ©2015 AACR.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGo_ibthuFKkfbVg90H21EOLACvtfcHk0livJk6ZmHdhKg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXhsVCrsLfM&md5=3072d4c59c550ed785f66a6fb25cde15</span></div><a href="/servlet/linkout?suffix=cit82&amp;dbid=16384&amp;doi=10.1158%2F1078-0432.CCR-15-0335&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1158%252F1078-0432.CCR-15-0335%26sid%3Dliteratum%253Aachs%26aulast%3DReinhold%26aufirst%3DW.%2BC.%26aulast%3DSunshine%26aufirst%3DM.%26aulast%3DVarma%26aufirst%3DS.%26aulast%3DDoroshow%26aufirst%3DJ.%2BH.%26aulast%3DPommier%26aufirst%3DY.%26atitle%3DUsing%2520cellMiner%25201.6%2520for%2520systems%2520pharmacology%2520and%2520genomic%2520analysis%2520of%2520the%2520NCI-60%26jtitle%3DClin.%2520Cancer%2520Res.%26date%3D2015%26volume%3D21%26spage%3D3841%26epage%3D3852%26doi%3D10.1158%2F1078-0432.CCR-15-0335" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref83"><div class="reference"><strong class="refLabel"><a href="#ref83" class="rightTabRefNumLink">83</a></strong><div class="NLM_citation" id="rightTab-cit83"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Miao, Z. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Player, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shankavaram, U.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, Y. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zimonjic, D. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lorenzi, P. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liao, Z. Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liu, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shimura, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, H. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Meng, L. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, Y. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kawasaki, E. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Popescu, N. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Aladjem, M. I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Goldstein, D. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Weinstein, J. N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pommier, Y.</span></span> <span> </span><span class="NLM_article-title">Nonclassic functions of human topoisomerase I: genome-wide and pharmacologic analyses</span>. <i>Cancer Res.</i> <span class="NLM_year" style="font-weight: bold;">2007</span>,  <span class="NLM_volume"><i>67</i></span>,  <span class="NLM_fpage">8752</span>– <span class="NLM_lpage">8761</span>, <span class="refDoi"> DOI: 10.1158/0008-5472.CAN-06-4554</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref83/cit83&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00639&amp;key=10.1158%2F0008-5472.CAN-06-4554" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=67&publication_year=2007&pages=8752-8761&author=Z.+H.+Miaoauthor=A.+Playerauthor=U.+Shankavaramauthor=Y.+H.+Wangauthor=D.+B.+Zimonjicauthor=P.+L.+Lorenziauthor=Z.+Y.+Liaoauthor=H.+Liuauthor=T.+Shimuraauthor=H.+L.+Zhangauthor=L.+H.+Mengauthor=Y.+W.+Zhangauthor=E.+S.+Kawasakiauthor=N.+C.+Popescuauthor=M.+I.+Aladjemauthor=D.+J.+Goldsteinauthor=J.+N.+Weinsteinauthor=Y.+Pommier&title=Nonclassic+functions+of+human+topoisomerase+I%3A+genome-wide+and+pharmacologic+analyses&doi=10.1158%2F0008-5472.CAN-06-4554"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit83&amp;dbid=16384&amp;doi=10.1158%2F0008-5472.CAN-06-4554&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1158%252F0008-5472.CAN-06-4554%26sid%3Dliteratum%253Aachs%26aulast%3DMiao%26aufirst%3DZ.%2BH.%26aulast%3DPlayer%26aufirst%3DA.%26aulast%3DShankavaram%26aufirst%3DU.%26aulast%3DWang%26aufirst%3DY.%2BH.%26aulast%3DZimonjic%26aufirst%3DD.%2BB.%26aulast%3DLorenzi%26aufirst%3DP.%2BL.%26aulast%3DLiao%26aufirst%3DZ.%2BY.%26aulast%3DLiu%26aufirst%3DH.%26aulast%3DShimura%26aufirst%3DT.%26aulast%3DZhang%26aufirst%3DH.%2BL.%26aulast%3DMeng%26aufirst%3DL.%2BH.%26aulast%3DZhang%26aufirst%3DY.%2BW.%26aulast%3DKawasaki%26aufirst%3DE.%2BS.%26aulast%3DPopescu%26aufirst%3DN.%2BC.%26aulast%3DAladjem%26aufirst%3DM.%2BI.%26aulast%3DGoldstein%26aufirst%3DD.%2BJ.%26aulast%3DWeinstein%26aufirst%3DJ.%2BN.%26aulast%3DPommier%26aufirst%3DY.%26atitle%3DNonclassic%2520functions%2520of%2520human%2520topoisomerase%2520I%253A%2520genome-wide%2520and%2520pharmacologic%2520analyses%26jtitle%3DCancer%2520Res.%26date%3D2007%26volume%3D67%26spage%3D8752%26epage%3D8761%26doi%3D10.1158%2F0008-5472.CAN-06-4554" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref84"><div class="reference"><strong class="refLabel"><a href="#ref84" class="rightTabRefNumLink">84</a></strong><div class="NLM_citation" id="rightTab-cit84"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Hsiang, Y. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hertzberg, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hecht, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liu, L.</span></span> <span> </span><span class="NLM_article-title">Camptothecin induces protein-linked DNA breaks via mammalian DNA topoisomerase I</span>. <i>J. Biol. Chem.</i> <span class="NLM_year" style="font-weight: bold;">1985</span>,  <span class="NLM_volume"><i>260</i></span>,  <span class="NLM_fpage">14873</span>– <span class="NLM_lpage">14878</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref84/cit84&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00639&amp;key=2997227" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref84/cit84&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00639&amp;key=1%3ACAS%3A528%3ADyaL2MXlsFemt7c%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=260&publication_year=1985&pages=14873-14878&author=Y.+H.+Hsiangauthor=R.+Hertzbergauthor=S.+Hechtauthor=L.+Liu&title=Camptothecin+induces+protein-linked+DNA+breaks+via+mammalian+DNA+topoisomerase+I"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit84R"><div class="casContent"><span class="casTitleNuber">84</span><div class="casTitle"><span class="NLM_cas:atitle">Camptothecin induces protein-linked DNA breaks via mammalian DNA topoisomerase I</span></div><div class="casAuthors">Hsiang, Yaw Huei; Hertzberg, Robert; Hecht, Sidney; Liu, Leroy F.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Biological Chemistry</span>
        (<span class="NLM_cas:date">1985</span>),
    <span class="NLM_cas:volume">260</span>
        (<span class="NLM_cas:issue">27</span>),
    <span class="NLM_cas:pages">14873-8</span>CODEN:
                <span class="NLM_cas:coden">JBCHA3</span>;
        ISSN:<span class="NLM_cas:issn">0021-9258</span>.
    </div><div class="casAbstract">Camptothecin (I)  [7689-03-4], a cytotoxic drug, is a strong inhibitor of nucleic acid synthesis in mammalian cells and a potent inducer of strand breaks in chromosomal DNA.  Neither equil. dialysis nor unwinding measurement indicated any interaction between camptothecin and purified DNA.  However, I induces extensive single-strand DNA breaks in systems contg. purified mammalian DNA topoisomerase  [80449-01-0] I.  DNA breakage in vitro is immediate and reversible.  Analyses of camptothecin-induced DNA breaks show that topoisomerase I is covalently linked to the 3' end of the broken DNA.  In addn., I inhibits the catalytic activity of mammalian DNA topoisomerase I.  Apparently, I blocks the rejoining step of the breakage-reunion reaction of mammalian DNA topoisomerase I; this blockade results in the accumulation of a cleavable complex which resembles the transient intermediate proposed for eukaryotic DNA topoisomerase I.  The inhibition of nucleic acid synthesis and the induction of DNA strand breaks obsd. in vivo may be related to the formation of this drug-induced cleavable complex.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGp4OWZ16tDJsbVg90H21EOLACvtfcHk0lhvlWaTNEj5zw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaL2MXlsFemt7c%253D&md5=d5811c51314199e69d2fad324720b1aa</span></div><a href="/servlet/linkout?suffix=cit84&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DHsiang%26aufirst%3DY.%2BH.%26aulast%3DHertzberg%26aufirst%3DR.%26aulast%3DHecht%26aufirst%3DS.%26aulast%3DLiu%26aufirst%3DL.%26atitle%3DCamptothecin%2520induces%2520protein-linked%2520DNA%2520breaks%2520via%2520mammalian%2520DNA%2520topoisomerase%2520I%26jtitle%3DJ.%2520Biol.%2520Chem.%26date%3D1985%26volume%3D260%26spage%3D14873%26epage%3D14878" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref85"><div class="reference"><strong class="refLabel"><a href="#ref85" class="rightTabRefNumLink">85</a></strong><div class="NLM_citation" id="rightTab-cit85"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Urasaki, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Laco, G. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pourquier, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Takebayashi, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kohlhagen, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gioffre, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chatterjee, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pantazis, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pommier, Y.</span></span> <span> </span><span class="NLM_article-title">Characterization of a novel topoisomerase I mutation from a camptothecin resistant human prostate cancer cell line</span>. <i>Cancer Res.</i> <span class="NLM_year" style="font-weight: bold;">2001</span>,  <span class="NLM_volume"><i>61</i></span>,  <span class="NLM_fpage">1964</span>– <span class="NLM_lpage">1969</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=61&publication_year=2001&pages=1964-1969&author=Y.+Urasakiauthor=G.+S.+Lacoauthor=P.+Pourquierauthor=Y.+Takebayashiauthor=G.+Kohlhagenauthor=C.+Gioffreauthor=H.+Zhangauthor=D.+Chatterjeeauthor=P.+Pantazisauthor=Y.+Pommier&title=Characterization+of+a+novel+topoisomerase+I+mutation+from+a+camptothecin+resistant+human+prostate+cancer+cell+line"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit85&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DUrasaki%26aufirst%3DY.%26aulast%3DLaco%26aufirst%3DG.%2BS.%26aulast%3DPourquier%26aufirst%3DP.%26aulast%3DTakebayashi%26aufirst%3DY.%26aulast%3DKohlhagen%26aufirst%3DG.%26aulast%3DGioffre%26aufirst%3DC.%26aulast%3DZhang%26aufirst%3DH.%26aulast%3DChatterjee%26aufirst%3DD.%26aulast%3DPantazis%26aufirst%3DP.%26aulast%3DPommier%26aufirst%3DY.%26atitle%3DCharacterization%2520of%2520a%2520novel%2520topoisomerase%2520I%2520mutation%2520from%2520a%2520camptothecin%2520resistant%2520human%2520prostate%2520cancer%2520cell%2520line%26jtitle%3DCancer%2520Res.%26date%3D2001%26volume%3D61%26spage%3D1964%26epage%3D1969" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref86"><div class="reference"><strong class="refLabel"><a href="#ref86" class="rightTabRefNumLink">86</a></strong><div class="NLM_citation" id="rightTab-cit86"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Staker, B. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Feese, M. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cushman, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pommier, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zembower, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Stewart, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Burgin, A. B.</span></span> <span> </span><span class="NLM_article-title">Structures of three classes of anticancer agents bound to the human topoisomerase I-DNA covalent complex</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2005</span>,  <span class="NLM_volume"><i>48</i></span>,  <span class="NLM_fpage">2336</span>– <span class="NLM_lpage">2345</span>, <span class="refDoi"> DOI: 10.1021/jm049146p</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm049146p" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref86/cit86&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00639&amp;key=1%3ACAS%3A528%3ADC%252BD2MXhslajtro%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=48&publication_year=2005&pages=2336-2345&author=B.+L.+Stakerauthor=M.+D.+Feeseauthor=M.+Cushmanauthor=Y.+Pommierauthor=D.+Zembowerauthor=L.+Stewartauthor=A.+B.+Burgin&title=Structures+of+three+classes+of+anticancer+agents+bound+to+the+human+topoisomerase+I-DNA+covalent+complex&doi=10.1021%2Fjm049146p"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit86R"><div class="casContent"><span class="casTitleNuber">86</span><div class="casTitle"><span class="NLM_cas:atitle">Structures of Three Classes of Anticancer Agents Bound to the Human Topoisomerase I-DNA Covalent Complex</span></div><div class="casAuthors">Staker, Bart L.; Feese, Michael D.; Cushman, Mark; Pommier, Yves; Zembower, David; Stewart, Lance; Burgin, Alex B.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2005</span>),
    <span class="NLM_cas:volume">48</span>
        (<span class="NLM_cas:issue">7</span>),
    <span class="NLM_cas:pages">2336-2345</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Human topoisomerase I (top1) is the mol. target of a diverse set of anticancer compds., including the camptothecins, indolocarbazoles, and indenoisoquinolines.  These compds. bind to a transient top1-DNA covalent complex and inhibit the resealing of a single-strand nick that the enzyme creates to relieve superhelical tension in duplex DNA.  The authors report the x-ray crystal structures of the human top1-DNA complex bound with camptothecin and representative members of the indenoisoquinoline and indolocarbazole classes of top1 poisons.  The planar nature of all three structurally diverse classes allows them to intercalate between DNA base pairs at the site of single-strand cleavage.  All three classes of compds. have a free electron pair near Arg364, a residue that if mutated confers resistance to all three classes of drugs.  The common intercalative binding mode is augmented by unexpected chemotype-specific contacts with amino acid residues Asn352 and Glu356, which adopt alternative side-chain conformations to accommodate the bound compds.  These new x-ray structures explain how very different mols. can stabilize top1-DNA covalent complexes and will aid the rational design of completely novel structural classes of anticancer drugs.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpvtOcEkHplxLVg90H21EOLACvtfcHk0lhvlWaTNEj5zw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2MXhslajtro%253D&md5=ed236ed57668e8491966b836ceaacac4</span></div><a href="/servlet/linkout?suffix=cit86&amp;dbid=16384&amp;doi=10.1021%2Fjm049146p&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm049146p%26sid%3Dliteratum%253Aachs%26aulast%3DStaker%26aufirst%3DB.%2BL.%26aulast%3DFeese%26aufirst%3DM.%2BD.%26aulast%3DCushman%26aufirst%3DM.%26aulast%3DPommier%26aufirst%3DY.%26aulast%3DZembower%26aufirst%3DD.%26aulast%3DStewart%26aufirst%3DL.%26aulast%3DBurgin%26aufirst%3DA.%2BB.%26atitle%3DStructures%2520of%2520three%2520classes%2520of%2520anticancer%2520agents%2520bound%2520to%2520the%2520human%2520topoisomerase%2520I-DNA%2520covalent%2520complex%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2005%26volume%3D48%26spage%3D2336%26epage%3D2345%26doi%3D10.1021%2Fjm049146p" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref87"><div class="reference"><strong class="refLabel"><a href="#ref87" class="rightTabRefNumLink">87</a></strong><div class="NLM_citation" id="rightTab-cit87"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Wu, C. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hsieh, C. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wu, Y. S.</span></span> <span> </span><span class="NLM_article-title">The emergence of drug transporter-mediated multidrug resistance to cancer chemotherapy</span>. <i>Mol. Pharmaceutics</i> <span class="NLM_year" style="font-weight: bold;">2011</span>,  <span class="NLM_volume"><i>8</i></span>,  <span class="NLM_fpage">1996</span>– <span class="NLM_lpage">2011</span>, <span class="refDoi"> DOI: 10.1021/mp200261n</span> </span><div class="citationLinks">[<a href="/doi/10.1021/mp200261n" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref87/cit87&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00639&amp;key=1%3ACAS%3A528%3ADC%252BC3MXptlert74%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=8&publication_year=2011&pages=1996-2011&author=C.+P.+Wuauthor=C.+H.+Hsiehauthor=Y.+S.+Wu&title=The+emergence+of+drug+transporter-mediated+multidrug+resistance+to+cancer+chemotherapy&doi=10.1021%2Fmp200261n"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit87R"><div class="casContent"><span class="casTitleNuber">87</span><div class="casTitle"><span class="NLM_cas:atitle">The Emergence of Drug Transporter-Mediated Multidrug Resistance to Cancer Chemotherapy</span></div><div class="casAuthors">Wu, Chung-Pu; Hsieh, Chia-Hung; Wu, Yu-Shan</div><div class="citationInfo"><span class="NLM_cas:title">Molecular Pharmaceutics</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">8</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">1996-2011</span>CODEN:
                <span class="NLM_cas:coden">MPOHBP</span>;
        ISSN:<span class="NLM_cas:issn">1543-8384</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">A review.  Chemotherapy is currently one of the most effective ways to treat metastatic cancers.  However, of the various mechanisms that are involved in conferring resistance, upregulation of drug efflux ATP-binding cassette (ABC) transporters, such as P-glycoprotein (ABCB1), multidrug resistance protein 1 (ABCC1) and ABCG2, has become a major obstacle to cancer chemotherapy and seriously affects the clin. outcome.  To date, at least 15 ABC drug transporters have been identified and characterized to transport and confer resistance to practically the entire spectrum of cancer drugs, causing multidrug resistance (MDR) in cancers.  Unfortunately, despite decades of research, there is still no real soln. to MDR.  This review highlights some of the major findings, the roles and problems assocd. with MDR-linked ABC drug transporters in metastatic cancers and solid tumors, and the current strategies to improve the clin. outcome in cancer chemotherapy.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpRXYw8gOc5m7Vg90H21EOLACvtfcHk0lizRFxumSt1qg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXptlert74%253D&md5=f28ff271be9eceb7cebbfe1cd3676c20</span></div><a href="/servlet/linkout?suffix=cit87&amp;dbid=16384&amp;doi=10.1021%2Fmp200261n&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fmp200261n%26sid%3Dliteratum%253Aachs%26aulast%3DWu%26aufirst%3DC.%2BP.%26aulast%3DHsieh%26aufirst%3DC.%2BH.%26aulast%3DWu%26aufirst%3DY.%2BS.%26atitle%3DThe%2520emergence%2520of%2520drug%2520transporter-mediated%2520multidrug%2520resistance%2520to%2520cancer%2520chemotherapy%26jtitle%3DMol.%2520Pharmaceutics%26date%3D2011%26volume%3D8%26spage%3D1996%26epage%3D2011%26doi%3D10.1021%2Fmp200261n" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref88"><div class="reference"><strong class="refLabel"><a href="#ref88" class="rightTabRefNumLink">88</a></strong><div class="NLM_citation" id="rightTab-cit88"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Zhu, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lou, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tang, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bu, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yin, S.</span></span> <span> </span><span class="NLM_article-title">Jatrophane Diterpenoids as Modulators of P-Glycoprotein-Dependent Multidrug Resistance (MDR): Advances of Structure-Activity Relationships and Discovery of Promising MDR Reversal Agents</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>59</i></span>,  <span class="NLM_fpage">6353</span>– <span class="NLM_lpage">6369</span>, <span class="refDoi"> DOI: 10.1021/acs.jmedchem.6b00605</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acs.jmedchem.6b00605" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref88/cit88&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00639&amp;key=1%3ACAS%3A528%3ADC%252BC28XhtVSrtb%252FI" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=59&publication_year=2016&pages=6353-6369&author=J.+Zhuauthor=R.+Wangauthor=L.+Louauthor=W.+Liauthor=G.+Tangauthor=X.+Buauthor=S.+Yin&title=Jatrophane+Diterpenoids+as+Modulators+of+P-Glycoprotein-Dependent+Multidrug+Resistance+%28MDR%29%3A+Advances+of+Structure-Activity+Relationships+and+Discovery+of+Promising+MDR+Reversal+Agents&doi=10.1021%2Facs.jmedchem.6b00605"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit88R"><div class="casContent"><span class="casTitleNuber">88</span><div class="casTitle"><span class="NLM_cas:atitle">Jatrophane Diterpenoids as Modulators of P-Glycoprotein-Dependent Multidrug Resistance (MDR): Advances of Structure-Activity Relationships and Discovery of Promising MDR Reversal Agents</span></div><div class="casAuthors">Zhu, Jianyong; Wang, Ruimin; Lou, Lanlan; Li, Wei; Tang, Guihua; Bu, Xianzhang; Yin, Sheng</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">59</span>
        (<span class="NLM_cas:issue">13</span>),
    <span class="NLM_cas:pages">6353-6369</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">The phytochem. study of Pedilanthus tithymaloides led to the isolation of 13 jatrophane diterpenoids (1-13), of which eight (1-8) are new.  Subsequent structural modification of the major components by esterification, hydrolysis, hydrogenation, or epoxidn. yielded 22 new derivs. (14-35).  Thus, a jatrophane library contg. two series of compds. was established to screen for P-glycoprotein (Pgp)-dependent MDR modulators.  The activity was evaluated through a combination of Rho123 efflux and chemoreversal assays on adriamycin resistant human hepatocellular carcinoma cell line HepG2 (HepG2/ADR) and adriamycin resistant human breast adenocarcinoma cell line MCF-7 (MCF-7/ADR).  Compds. 19, 25, and 26 were identified as potent MDR modulators with greater chemoreversal ability and less cytotoxicity than the third-generation drug tariquidar.  The structure-activity relationship (SAR) was discussed, which showed that modifications beyond just increasing the lipophilicity of this class of Pgp inhibitors are beneficial to the activity.  Compd. 26, which exhibited a remarkable metabolic stability in vitro and a favorable antitumor effect in vivo, would serve as a promising lead for the development of new MDR reversal agents.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGobYTCdHUEwx7Vg90H21EOLACvtfcHk0lizRFxumSt1qg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28XhtVSrtb%252FI&md5=3980b1349ffea40674e82fff3fba2f5d</span></div><a href="/servlet/linkout?suffix=cit88&amp;dbid=16384&amp;doi=10.1021%2Facs.jmedchem.6b00605&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facs.jmedchem.6b00605%26sid%3Dliteratum%253Aachs%26aulast%3DZhu%26aufirst%3DJ.%26aulast%3DWang%26aufirst%3DR.%26aulast%3DLou%26aufirst%3DL.%26aulast%3DLi%26aufirst%3DW.%26aulast%3DTang%26aufirst%3DG.%26aulast%3DBu%26aufirst%3DX.%26aulast%3DYin%26aufirst%3DS.%26atitle%3DJatrophane%2520Diterpenoids%2520as%2520Modulators%2520of%2520P-Glycoprotein-Dependent%2520Multidrug%2520Resistance%2520%2528MDR%2529%253A%2520Advances%2520of%2520Structure-Activity%2520Relationships%2520and%2520Discovery%2520of%2520Promising%2520MDR%2520Reversal%2520Agents%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2016%26volume%3D59%26spage%3D6353%26epage%3D6369%26doi%3D10.1021%2Facs.jmedchem.6b00605" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref89"><div class="reference"><strong class="refLabel"><a href="#ref89" class="rightTabRefNumLink">89</a></strong><div class="NLM_citation" id="rightTab-cit89"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Carmichael, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">DeGraff, W. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gazdar, A. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Minna, J. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mitchell, J. B.</span></span> <span> </span><span class="NLM_article-title">Evaluation of a tetrazolium-based semiautomated colorimetrie assay: assessment of chemosensitivity testing</span>. <i>Cancer Res.</i> <span class="NLM_year" style="font-weight: bold;">1987</span>,  <span class="NLM_volume"><i>47</i></span>,  <span class="NLM_fpage">936</span>– <span class="NLM_lpage">942</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=47&publication_year=1987&pages=936-942&author=J.+Carmichaelauthor=W.+G.+DeGraffauthor=A.+F.+Gazdarauthor=J.+D.+Minnaauthor=J.+B.+Mitchell&title=Evaluation+of+a+tetrazolium-based+semiautomated+colorimetrie+assay%3A+assessment+of+chemosensitivity+testing"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit89&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DCarmichael%26aufirst%3DJ.%26aulast%3DDeGraff%26aufirst%3DW.%2BG.%26aulast%3DGazdar%26aufirst%3DA.%2BF.%26aulast%3DMinna%26aufirst%3DJ.%2BD.%26aulast%3DMitchell%26aufirst%3DJ.%2BB.%26atitle%3DEvaluation%2520of%2520a%2520tetrazolium-based%2520semiautomated%2520colorimetrie%2520assay%253A%2520assessment%2520of%2520chemosensitivity%2520testing%26jtitle%3DCancer%2520Res.%26date%3D1987%26volume%3D47%26spage%3D936%26epage%3D942" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref90"><div class="reference"><strong class="refLabel"><a href="#ref90" class="rightTabRefNumLink">90</a></strong><div class="NLM_citation" id="rightTab-cit90"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Yalowich, J. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wu, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kanagasabai, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hornbaker, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hasinoff, B. B.</span></span> <span> </span><span class="NLM_article-title">The anticancer thiosemicarbazones Dp44mT and triapine lack inhibitory effects as catalytic inhibitors or poisons of DNA topoisomerase IIalpha</span>. <i>Biochem. Pharmacol.</i> <span class="NLM_year" style="font-weight: bold;">2012</span>,  <span class="NLM_volume"><i>84</i></span>,  <span class="NLM_fpage">52</span>– <span class="NLM_lpage">58</span>, <span class="refDoi"> DOI: 10.1016/j.bcp.2012.03.021</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref90/cit90&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00639&amp;key=10.1016%2Fj.bcp.2012.03.021" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=84&publication_year=2012&pages=52-58&author=J.+C.+Yalowichauthor=X.+Wuauthor=R.+Zhangauthor=R.+Kanagasabaiauthor=M.+Hornbakerauthor=B.+B.+Hasinoff&title=The+anticancer+thiosemicarbazones+Dp44mT+and+triapine+lack+inhibitory+effects+as+catalytic+inhibitors+or+poisons+of+DNA+topoisomerase+IIalpha&doi=10.1016%2Fj.bcp.2012.03.021"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit90&amp;dbid=16384&amp;doi=10.1016%2Fj.bcp.2012.03.021&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bcp.2012.03.021%26sid%3Dliteratum%253Aachs%26aulast%3DYalowich%26aufirst%3DJ.%2BC.%26aulast%3DWu%26aufirst%3DX.%26aulast%3DZhang%26aufirst%3DR.%26aulast%3DKanagasabai%26aufirst%3DR.%26aulast%3DHornbaker%26aufirst%3DM.%26aulast%3DHasinoff%26aufirst%3DB.%2BB.%26atitle%3DThe%2520anticancer%2520thiosemicarbazones%2520Dp44mT%2520and%2520triapine%2520lack%2520inhibitory%2520effects%2520as%2520catalytic%2520inhibitors%2520or%2520poisons%2520of%2520DNA%2520topoisomerase%2520IIalpha%26jtitle%3DBiochem.%2520Pharmacol.%26date%3D2012%26volume%3D84%26spage%3D52%26epage%3D58%26doi%3D10.1016%2Fj.bcp.2012.03.021" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li></ol></li><li id="pane-m3" aria-labelledby="pane-m3" class="tab__pane tab__pane-suppInfo empty"><div class="accessionCode mb-5"><div class="toolbar-section accession-codes"><ul><li><a href="http://www.rcsb.org/pdb/search/structidSearch.do?structureId=1K4T" onclick="trackOutboundLink('http://www.rcsb.org/pdb/search/structidSearch.do?structureId=1K4T','PDB','1K4T'); return false;">PDB: 1K4T</a></li><li><a href="http://www.rcsb.org/pdb/search/structidSearch.do?structureId=1RFF" onclick="trackOutboundLink('http://www.rcsb.org/pdb/search/structidSearch.do?structureId=1RFF','PDB','1RFF'); return false;">PDB: 1RFF</a></li></ul></div></div><h2 class="supp-info-label">Supporting Information</h2><div class="article_supporting-info" id="rightTab-notes4"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="rightTab-rightTab-_i109"><a class="ext-link" href="/doi/suppl/10.1021/acs.jmedchem.8b00639">Supporting Information</a></h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a class="" href="#"><span>Jump To</span><i class="icon-angle-down"></i></a><div class="dropBlock__holder" data-db-target-of="sectionsDB_65480"></div></div></div></div></div><hr /></hr><p class="last">The Supporting Information is available free of charge on the <a class="ext-link" href="/">ACS Publications website</a> at DOI: <a class="ext-link" href="/doi/abs/10.1021/acs.jmedchem.8b00639">10.1021/acs.jmedchem.8b00639</a>.<ul id="rightTab-silist" class="NLM_list-list_type-label"><li><p class="inline">TOP1-mediated cleavage assay gel of compound <b>6</b> (<a class="ext-link" href="/doi/suppl/10.1021/acs.jmedchem.8b00639/suppl_file/jm8b00639_si_001.pdf">PDF</a>)</p></li><li><p class="inline">X-ray crystallography file of compound <b>20b</b> (<a class="ext-link" href="/doi/suppl/10.1021/acs.jmedchem.8b00639/suppl_file/jm8b00639_si_002.cif">CIF</a>)</p></li><li><p class="inline">Docking results of <b>19a</b> with TOP1cc (<a class="ext-link" href="/doi/suppl/10.1021/acs.jmedchem.8b00639/suppl_file/jm8b00639_si_003.pdb">PDB</a>)</p></li><li><p class="inline">Docking results of <b>41a</b> with TDP1 (<a class="ext-link" href="/doi/suppl/10.1021/acs.jmedchem.8b00639/suppl_file/jm8b00639_si_004.pdb">PDB</a>)</p></li><li><p class="inline">Molecular formula strings (<a class="ext-link" href="/doi/suppl/10.1021/acs.jmedchem.8b00639/suppl_file/jm8b00639_si_005.csv">CSV</a>)</p></li></ul></p><div class="supInfoBoxOnFTP "><div class="sup-info-attachments"><ul><li><a class="suppl-anchor" href="/doi/suppl/10.1021/acs.jmedchem.8b00639/suppl_file/jm8b00639_si_001.pdf">jm8b00639_si_001.pdf (486.42 kb)</a></li><li><a class="suppl-anchor" href="/doi/suppl/10.1021/acs.jmedchem.8b00639/suppl_file/jm8b00639_si_002.cif">jm8b00639_si_002.cif (389.8 kb)</a></li><li><a class="suppl-anchor" href="/doi/suppl/10.1021/acs.jmedchem.8b00639/suppl_file/jm8b00639_si_003.pdb">jm8b00639_si_003.pdb (913.44 kb)</a></li><li><a class="suppl-anchor" href="/doi/suppl/10.1021/acs.jmedchem.8b00639/suppl_file/jm8b00639_si_004.pdb">jm8b00639_si_004.pdb (561.94 kb)</a></li><li><a class="suppl-anchor" href="/doi/suppl/10.1021/acs.jmedchem.8b00639/suppl_file/jm8b00639_si_005.csv">jm8b00639_si_005.csv (7.63 kb)</a></li></ul></div></div><div id="rightTab-figshare-widget"></div><br /></br><div class="TermsAndConditionsDropzoneRight" data-pb-dropzone="TermsAndConditionsDropzoneRight"><div data-widget-def="UX3HTMLWidget" data-widget-id="b84e6b6c-b4d0-4427-b286-3cf14d52d013" class="mb-4">
        



        
        <h2 style="font-size: 1rem;margin-bottom: 10px;">Terms & Conditions</h2>
<p>Most electronic Supporting Information files are available without a subscription to ACS Web Editions. Such files may be downloaded by article for research use (if there is a public use license linked to the relevant article, that license may permit other uses). Permission may be obtained from ACS for other uses through requests via the RightsLink permission system:
<a href="/page/copyright/permissions.html" title="RightsLink">http://pubs.acs.org/page/copyright/permissions.html</a>.</p>

        </div></div></div></li></ul><div class="recommendedDropzone7" data-pb-dropzone="recommendedDropzone7"><div data-ajaxurl="/pb/widgets/ux3/ux3-showRecommend?widgetId=b272b1fe-ab4e-454f-940c-a3deaf223d23&amp;doi=10.1021%2Facs.jmedchem.8b00639&amp;pbContext=%3BrequestedJournal%3Ajournal%3Ajmcmar%3Bissue%3Aissue%3A10.1021%2Fjmcmar.2018.61.issue-22%3Bjournal%3Ajournal%3Ajmcmar%3Bpage%3Astring%3AArticle%2FChapter+View%3Bctype%3Astring%3AJournal+Content%3Bwgroup%3Astring%3AACHS+website+Group%3Bwebsite%3Awebsite%3Aacspubs%3Barticle%3Aarticle%3A10.1021%2Facs.jmedchem.8b00639%3BpageGroup%3Astring%3APublication+Pages%3BsubPage%3Astring%3AFull+Text" class="show-recommended-placeholder"></div>




        
        <script>
$(document).ready(function() {
  setTimeout(function() {
    var myLink = $(".show-recommended").find("a").not("[href='http://acsmediakit.org']").not("[href='javascript:void(0);']");
    myLink.attr("href", function(i, href) {
        return href + '?ref=recommended';
    });
  }, 5000);
});
</script></div></div></div></div></div></div></div><div class="col-xs-12.clearfix"><div class="article_qv-xs-container"><div class="article_qv-xs"><ul><li><a href="#" title="In This Article"><span>In This Article</span></a></li><li><a href="#" title="Figures" data-slide-target=".tab__pane-figures" class="w-slide__btn slide-active"><i class="icon-image"></i><span>Figures</span></a></li><li><a href="#" title="References" data-slide-target=".tab__pane-references" class="w-slide__btn slide-active"><i class="icon-link"></i><span>References</span></a></li><li><a href="#" title="Supporting Information" data-slide-target=".tab__pane-suppInfo" class="w-slide__btn slide-active"><i class="icon-supporting-info"></i><span>Supporting Information</span></a></li><li><a href="#" title="Recommended Articles" data-slide-target=".recommendedDropzone7" class="show-recommended-qv w-slide__btn slide-active" target="_self"><i class="icon-newspaper-o"></i><span>Recommended Articles</span></a></li></ul><a title="PDF" href="/doi/pdf/10.1021/acs.jmedchem.8b00639" class="button_primary"><i class="icon-file-pdf-o"></i>PDF  <span class="filesize">[
                6MB]
            </span></a></div></div></div></div></div></div></article></main>




        
        <footer class="footer">



        
        <div class="footer_first-row" id="partners">
	<div class="container">
		<div class="row">
			<div class="col-xs-12">
				<div class="footer_first-row_title">
					<h2>
						Partners
					</h2>
				</div>
				<div class="footer_first-row_logos">
					<div>
						<a href="http://www.atypon.com/">
							<img src="/pb-assets/images/footer_logos/logo-atypon-1525376610217.png" alt="Atypon">
						</a>
					</div>
					<div>
						<a href="http://www.chorusaccess.org/">
							<img src="/pb-assets/images/footer_logos/logo-chorus-1525375622947.png" alt="Chorus">
						</a>
					</div>
					<div>
						<a href="http://publicationethics.org/">
							<img src="/pb-assets/images/footer_logos/logo-cope-1525375622977.png" alt="Cope publication ethics">
						</a>
					</div>
					<div>
						<a href="http://www.projectcounter.org/">
							<img src="/pb-assets/images/footer_logos/logo-counter-1523044519173.jpg" alt="Project Counter">
						</a>
					</div>
					<div>
						<a href="http://www.crossref.org/">
							<img src="/pb-assets/images/footer_logos/logo-crossref-1525377362093.png" alt="Crossref">
						</a>
					</div>
					<div>
						<a href="http://www.crossref.org/crosscheck/index.html">
							<img src="/pb-assets/images/footer_logos/logo-crosscheck-1525375623000.png" alt="Crossref similarity check">
						</a>
					</div>
					<div>
						<a href="http://www.orcid.org/">
							<img src="/pb-assets/images/footer_logos/logo-orcid-1525375623187.png" alt="Orcid Connecting Research and Researchers">
						</a>
					</div>
					<div>
						<a href="http://www.portico.org/">
							<img src="/pb-assets/images/footer_logos/logo-portico-1525375623203.png" alt="Portico digital preservation service">
						</a>
					</div>
				</div>
			</div>
		</div>
	</div>
</div>





        
        <div class="footer_second-row col-xs-12 gutterless ">









        <div data-widget-def="ux3-layout-widget" data-widget-id="f963f9aa-5ade-4a09-8515-e6cd8e6364cf" class="row container">
        



        
        <div class="col-xs-12">



        
        <div class="footer_second-row_left col-md-2 gutterless ">



        
        <a href="/"><img src="/pb-assets/images/pubslogo-small-1444685090580.png" alt="ACS Publications"></a>
<div class="footer_menu">
	<ul>
		<li class="footer_menu_address">
			<span>
				1155 Sixteenth Street N.W.
			</span>
		</li>
		<li class="footer_menu_address">
			<span>
				Washington, DC 20036
			</span>
		</li>

		<li class="footer_menu_copyright">
			<a href="http://www.acs.org/content/acs/en/copyright.html">
				Copyright © 2021<br>
				American Chemical Society
			</a>
		</li>
	</ul>
</div>
</div><div class="footer_second-row_middle col-md-2 gutterless "></div><div class="footer_second-row_right col-md-8 gutterless ">



        
        <div class="footer_second-row_about col-xs-4">



        
        <h2>About</h2>
<ul>
    <li><a href="/page/about-us.html">About ACS Publications</a></li>
    <li><a href="http://acsopenscience.org">ACS & Open Access</a></li>
    <li><a href="https://www.acs.org/content/acs/en/membership/member-benefits/publications-discounts.html">ACS Membership</a></li>
</ul>
</div><div class="footer_second-row_resources col-xs-5">



        
        <h2>Resources and Information</h2>
<ul>
	<li><a href="/action/showPublications?pubType=journal">Journals A-Z</a></li>
	<li><a href="/action/showPublications?pubType=book">Books and Reference</a></li>
    <li><a href="http://acsmediakit.org/digital/acs-pubs/?utm_source=Footer&amp;utm_medium=Pubs&amp;utm_campaign=CEN">Advertising Media Kit</a></li>
    <li><a href="https://solutions.acs.org">Institutional Sales</a></li>
    <li><a href="https://publish.acs.org/publish/">ACS Publishing Center</a></li>
    <li><a href="http://www.acs.org/content/acs/en/privacy.html">Privacy Policy</a></li>
    <li><a href="https://www.acs.org/content/acs/en/terms.html">Terms of Use</a></li>
</ul>
</div><div class="footer_second-row_support col-xs-3">



        
        <h2>Support & Contact</h2>
<ul>
    <li><a href="https://acs.service-now.com/acs">Help</a></li>
    <li><a href="#" onclick="SnapEngage.startLink();return false;" class="help help-chat">Live Chat</a></li>
    <li><a href="https://acs.service-now.com/acs">FAQ</a></li>
</ul>
</div>
</div>




        
        <div class="footer_social_section col-xs-12">



        
        <div class="footer_social_header">
	<h2>Connect with ACS Publications</h2>
</div>
<div class="footer_social">
	<ul>
		<li>
			<a href="https://preferences.acspubs.org/journals" class="icon-envelope-o" aria-label="email">
			</a>
		</li>
		<li>
			<a href="https://www.facebook.com/ACSPublications/" class="icon-facebook" aria-label="facebook" target="_blank" rel="noreferrer">
			</a>
		</li>
		<li>
			<a href="https://twitter.com/ACSPublications" class="icon-twitter" aria-label="twitter" target="_blank" rel="noreferrer">
			</a>
		</li>
		<li>
			<a href="https://www.youtube.com/user/AmerChemSoc" class="icon-youtube-play" aria-label="youtube" target="_blank" rel="noreferrer">
			</a>
		</li>
		<li>
			<a href="/page/follow.html?widget=follow-pane-rss" class="icon-rss" aria-label="rss feed">
			</a>
		</li>
	</ul>
</div>

</div>
</div>

        </div>
    
</div>
</footer>




        
        <script>
(function(){
	
	/*Event Tracking for RIS menu dropdown - Article pages*/

	$('.cit-download-dropdown_button').on('click',function(e)
	{	
		e.preventDefault();
	    ga('send', 'event', 'Citation', 'Export', 'Main');
	});


	$('.cit-download-dropdown_content ul li').on('click',function(e)
	{	
	//	e.preventDefault();
	    var idx = $(this).index();
	    
	    var label = '';
	    if (idx === 0 ) {
	    	label = 'Citation';
	    } else if (idx === 1 ) {
	    	label = 'Abstract';
	    } else if (idx === 2 ) {
	    	label = 'Reference';
	    } else if (idx === 3 ) {
	    	label = 'More Options';
	    }
	   ga('send', 'event', 'Citation', 'Export', label);
	});

	$('.header_contnav-next a').on('click', function(e){
        e.preventDefault();
        ga('send', 'event', 'Article', 'Top', 'Right Arrow');
	}); 

 	$('.header_contnav-pre a').on('click', function(e){
	    e.preventDefault();
	     ga('send', 'event', 'Article', 'Top', 'Left Arrow');
	}); 

	$('.share_button').on('click', function(e){
		e.preventDefault();
		ga('send', 'event', 'Article', 'Top', 'Share');
	});

	$("#pane-m1con").on('click', function(e) {
		e.preventDefault();
		ga('send', 'event', 'Article', 'Sidebar', 'Figures');
	});

	$("#pane-m2con").on('click', function(e) {
		e.preventDefault();
		ga('send', 'event', 'Article', 'Sidebar', 'References');
	});

	$("#pane-m3con").on('click', function(e) {
		e.preventDefault();
		ga('send', 'event', 'Article', 'Sidebar', 'Supporting Info');
	});

	$('.tab__close').on('click', function(){
		ga('send', 'event', 'Article', 'Sidebar', 'Close');
	}); 



})();

</script>






        
        <div aria-live="polite" aria-atomic="true" class="achs-mendeley"><input type="hidden" name="tokenEndpoint" value="https://sso.acs.org/mendeley/token" class="tokenEndpoint"/></input><input type="hidden" name="appID" value="literatum" class="appID"/></input><input type="hidden" name="reopen-mendeley-modal-after-reload" class="reopen-mendeley-modal-after-reload"/></input><input type="hidden" name="statusEndpoint" value="https://sso.acs.org/idp/status" class="statusEndpoint"/></input><input type="hidden" name="clientID" value="atypon-lives" class="clientID"/></input><div class="achs-mendeley_table"><div class="achs-mendeley_row"><div class="achs-mendeley_cell loop-trap"><div class="achs-mendeley_container"><a title="Close" aria-label="close" tabindex="0" class="achs-mendeley_close"><i aria-hidden="true" class="icon-close"></i></a><div class="achs-mendeley_dropzone1"><div class="achs-mendeley_dropzone1_state1">



        
        <p style="font-weight: bold;">Pair your accounts.</p>
<p>Export articles to Mendeley</p>
<p>Get article recommendations from ACS based on references in your Mendeley library.</p>
</div><div class="achs-mendeley_dropzone1_state2">



        
        <p style="font-weight: bold;">Pair your accounts.</p>
<p>Export articles to Mendeley</p>
<p>Get article recommendations from ACS based on references in your Mendeley library.</p>
</div><div class="achs-mendeley_dropzone1_state3">



        
        <p style="font-weight: bold;">You’ve supercharged your research process with ACS and Mendeley!</p>
</div></div><div class="achs-mendeley_continue-header"><button class="achs-mendeley_continue-btn"><span class="achs-mendeley_buttonText">Continue</span></button></div><div class="achs-mendeley_steps"><div class="achs-mendeley_steps_row"><div class="achs-mendeley_steps_cell achs-mendeley_acsLogin"><h6>STEP 1:</h6><button class="button_primary achs-mendeley_acsLogin_button"><span class="achs-mendeley_buttonText">Login with ACS ID</span><span class="achs-mendeley_success_buttonText">Logged in Success</span></button><span class="achs-mendeley_acsLogin_label">Click to create an ACS ID</span><i class="icon-if-arrow-right"></i></div><div class="achs-mendeley_steps_cell achs-mendeley_login"><h6>STEP 2:</h6><button class="button_primary achs-mendeley_login_button"><i class="icon-mendeley"></i><span class="achs-mendeley_buttonText">Login with Mendeley</span><span class="achs-mendeley_success_buttonText">Logged in Success</span></button><a href="https://id.elsevier.com/as/authorization.oauth2?state=c33c27125763433d4d32a15accaacc18&amp;prompt=login&amp;scope=openid%20email%20profile%20els_auth_info&amp;authType=SINGLE_SIGN_IN&amp;response_type=code&amp;platSite=MDY%2Fmendeley&amp;redirect_uri=https%3A%2F%2Fwww.mendeley.com%2Fcallback%2F&amp;client_id=MENDELEY" title="Create a Mendeley account">Create a Mendeley account</a></div></div></div><div class="achs-mendeley_dropzone2"><div class="achs-mendeley_dropzone2_state1">



        
        <p style="font-weight: bold;font-style:italic;">Please note: If you switch to a different device, you may be asked to login again with only your ACS ID.
</p>
</div><div class="achs-mendeley_dropzone2_state2">



        
        <p style="font-weight: bold;font-style:italic;">Please note: If you switch to a different device, you may be asked to login again with only your ACS ID.
</p>
</div><div class="achs-mendeley_dropzone2_state3">



        
        <p style="font-weight: bold;font-style:italic;">Please note: If you switch to a different device, you may be asked to login again with only your ACS ID.
</p>
</div></div></div></div></div></div></div><div class="achs-mendeley_alert"><div class="achs-mendeley_alert_table"><div class="achs-mendeley_alert_row"><div class="achs-mendeley_alert_cell"><div class="achs-mendeley_alert_container"><a title="Close" aria-label="close" class="achs-mendeley_alert_close"><i aria-hidden="true" class="icon-close"></i></a><div role="alert" aria-live="polite" aria-atomic="true" class="achs-mendeley_alert_dropzone">



        
        <p>Please login with your ACS ID before connecting to your Mendeley account.</p><button class="button_tertiary achs-mendeley_acsLogin_button mendeley-acs-custom-login-btn" onclick="loginToAcsSso(event); return false;">Login with ACS ID</button>

<script>
 function loginToAcsSso(event){
 event.preventDefault();
 $('.achs-mendeley_acsLogin .achs-mendeley_acsLogin_button').trigger('click');
 }
</script>
</div><div class="achs-mendeley_alert_error-msg"></div></div></div></div></div><div class="pairing-expired-dialog-container"><div class="pairing-expired-dialog"><div class="pairing-expired-dialog_top-btns"><span class="pairing-expired-dialog_heading">MENDELEY PAIRING EXPIRED</span><button onClick="UX.achsMendeley.reconnectOnClickHandler();" class="pairing-expired-dialog_reconnect">Reconnect</button></div><div class="pairing-expired-dialog_content"><span>Your Mendeley pairing has expired. Please reconnect</span></div></div></div></div>




        
        <style type="text/css">
#gdpr-message-modal {
    display: none;
    /* Hidden by default */
    position: fixed;
    /* Stay in place */
    z-index: 2;
    /* Sit on top */
    /*padding-top: 100px;*/
    /* Location of the box */
    left: 0;
    bottom: 0;
    width: 100%;
    /* Full width */
    /*height: 100%;*/
    /* Full height */
    overflow: auto;
    /* Enable scroll if needed */
    /*background-color: rgb(0,0,0);*/
    /* Fallback color */
    /*background-color: rgba(0,0,0,0.4);*/
    /* Black w/ opacity */
}
#gdpr-message-content {
    font-family: Arial;
    background-color: #005083;
    color: #fff;
    margin: auto;
    padding: 5px 0 10px 0;
    /*border: 1px solid #888;*/
    box-shadow: 0 -1px 3px #666;
    width: 100%;
    display: block;
    bottom: 0;
}
#gdpr-message-container {
    /*width: 1130px;*/
    margin: 0 auto;
}
.gdpr-innerwrap {
    display: block;
    /*width: 1100px;*/
    margin: 0 auto;
    text-align: center;
}
#gdpr-message-content h1 {
    color: #0629b5;
    font-size: 26px;
    margin: 0.5em 0 0 0;
    border-bottom: solid 2px #4c7fb9;
    display: inline;
    padding-bottom: 10px;
}
#gdpr-message-content h4 {
    display: inline-block;
    margin-left: 0;
    margin-right: 14px;
    margin-top: 13px;
    /*width: 980px;*/
    font-size: 14px;
    font-weight: normal;
}
#gdpr-message-content p {
    font-size: 14px;
    margin: 2em 2em 0.5em 0em;
    text-align: left;
    font-weight: bold;
}
#gdpr-message-content a,
#gdpr-message-content a:hover {
    color: #9bcfff;
}
.gdpr-listwrap {
    display: block;
    margin-bottom: 10px;
    min-height: 100px;
    min-width: 200px;
}
#gdpr-message-content ul {
    margin-top: 20px;
    font-size: 13px;
}
#gdpr-ul1 {
    display: inline-block;
    float: left;
}
#gdpr-ul2 {
    display: inline-block;
    margin-left: 10px;
}
#gdpr-message-content ul li {
    margin-top: 4px;
}
a#gdpr-con-btn,
a#gdpr-con-btn:hover {
    width: 110px;
    height: 35px;
    background: #fec82a;
    background-image: none;
    background-image: -webkit-gradient(linear, 50% 0%, 50% 100%, color-stop(0%, #fec82a), color-stop(100%, #daa301));
    background-image: -webkit-linear-gradient(top, #fec82a, #daa301);
    background-image: -moz-linear-gradient(top, #fec82a, #daa301);
    background-image: -o-linear-gradient(top, #fec82a, #daa301);
    background-image: linear-gradient(top, #fec82a, #daa301);
    border-radius: 4px;
    color: #004a7b;
    display: inline-block;
    text-decoration: none;
    line-height: 35px;
    text-align: center;
    margin-top: 5px;
    /*margin-right: 14px;*/
    /*float: right;*/
    font-weight: bold;
}
#gdpr-message-btn {
    width: 60px;
    height: 38px;
    background: #4b8fc2;
    border-radius: 4px;
    color: white;
    display: inline-block;
    margin-top: -4px;
    font-size: 12px;
}
a#closebtn {
    float: right;
    color: #d4e5ef;
}
#gdpr-input {
    width: 200px;
    height: 30px;
    border-radius: 3px;
    border-width: 1px;
    box-shadow: none;
    margin-right: 10px;
    font-size: 14px;
    outline: none;
    padding-left: 2px;
    display: inline-block;
    float: left;
}
#gdpr-message-content p.gdpr_err {
    font-size: 15px;
    margin-top: 10px;
}
#gdpr-message-modal.mobile, #gdpr-message-modal.mobile .gdpr-message-content {
    height: 160px;
}
@media only screen and (min-width: 1026px) and (max-width: 1368px) {
	#gdpr-message-content h4 {
		width: 80%;
		text-align: left;
	}
}
</style>

<div id="gdpr-message-modal">
    <div id="gdpr-message-content">
        
	        <div class="gdpr-innerwrap container">
	            <h4>This website uses cookies to improve your user experience. By continuing to use the site, you are accepting our use of cookies. <a href="http://www.acs.org/content/acs/en/privacy.html">Read the ACS privacy policy</a>.</h4>
	            <a href="#" id="gdpr-con-btn">CONTINUE</a>
	        </div>
        
    </div>
</div>

<script type="text/javascript">
"use strict"
//Script checks gdpr cookie and submits form
	/* 
	Create an in-page pop-up message, only for the InfoCentral homepage, that will gather email registrants for the library marketing list.
	 
	Needs the end point
	*/

var infoCentralCapture = (function() {

    //Detect mobile device
    window.mobilecheck = function() {
        var check = false;
        (function(a){if(/(android|bb\d+|meego).+mobile|avantgo|bada\/|blackberry|blazer|compal|elaine|fennec|hiptop|iemobile|ip(hone|od)|iris|kindle|lge |maemo|midp|mmp|mobile.+firefox|netfront|opera m(ob|in)i|palm( os)?|phone|p(ixi|re)\/|plucker|pocket|psp|series(4|6)0|symbian|treo|up\.(browser|link)|vodafone|wap|windows ce|xda|xiino/i.test(a)||/1207|6310|6590|3gso|4thp|50[1-6]i|770s|802s|a wa|abac|ac(er|oo|s\-)|ai(ko|rn)|al(av|ca|co)|amoi|an(ex|ny|yw)|aptu|ar(ch|go)|as(te|us)|attw|au(di|\-m|r |s )|avan|be(ck|ll|nq)|bi(lb|rd)|bl(ac|az)|br(e|v)w|bumb|bw\-(n|u)|c55\/|capi|ccwa|cdm\-|cell|chtm|cldc|cmd\-|co(mp|nd)|craw|da(it|ll|ng)|dbte|dc\-s|devi|dica|dmob|do(c|p)o|ds(12|\-d)|el(49|ai)|em(l2|ul)|er(ic|k0)|esl8|ez([4-7]0|os|wa|ze)|fetc|fly(\-|_)|g1 u|g560|gene|gf\-5|g\-mo|go(\.w|od)|gr(ad|un)|haie|hcit|hd\-(m|p|t)|hei\-|hi(pt|ta)|hp( i|ip)|hs\-c|ht(c(\-| |_|a|g|p|s|t)|tp)|hu(aw|tc)|i\-(20|go|ma)|i230|iac( |\-|\/)|ibro|idea|ig01|ikom|im1k|inno|ipaq|iris|ja(t|v)a|jbro|jemu|jigs|kddi|keji|kgt( |\/)|klon|kpt |kwc\-|kyo(c|k)|le(no|xi)|lg( g|\/(k|l|u)|50|54|\-[a-w])|libw|lynx|m1\-w|m3ga|m50\/|ma(te|ui|xo)|mc(01|21|ca)|m\-cr|me(rc|ri)|mi(o8|oa|ts)|mmef|mo(01|02|bi|de|do|t(\-| |o|v)|zz)|mt(50|p1|v )|mwbp|mywa|n10[0-2]|n20[2-3]|n30(0|2)|n50(0|2|5)|n7(0(0|1)|10)|ne((c|m)\-|on|tf|wf|wg|wt)|nok(6|i)|nzph|o2im|op(ti|wv)|oran|owg1|p800|pan(a|d|t)|pdxg|pg(13|\-([1-8]|c))|phil|pire|pl(ay|uc)|pn\-2|po(ck|rt|se)|prox|psio|pt\-g|qa\-a|qc(07|12|21|32|60|\-[2-7]|i\-)|qtek|r380|r600|raks|rim9|ro(ve|zo)|s55\/|sa(ge|ma|mm|ms|ny|va)|sc(01|h\-|oo|p\-)|sdk\/|se(c(\-|0|1)|47|mc|nd|ri)|sgh\-|shar|sie(\-|m)|sk\-0|sl(45|id)|sm(al|ar|b3|it|t5)|so(ft|ny)|sp(01|h\-|v\-|v )|sy(01|mb)|t2(18|50)|t6(00|10|18)|ta(gt|lk)|tcl\-|tdg\-|tel(i|m)|tim\-|t\-mo|to(pl|sh)|ts(70|m\-|m3|m5)|tx\-9|up(\.b|g1|si)|utst|v400|v750|veri|vi(rg|te)|vk(40|5[0-3]|\-v)|vm40|voda|vulc|vx(52|53|60|61|70|80|81|83|85|98)|w3c(\-| )|webc|whit|wi(g |nc|nw)|wmlb|wonu|x700|yas\-|your|zeto|zte\-/i.test(a.substr(0,4))) check = true;})(navigator.userAgent||navigator.vendor||window.opera);
              return check;
        };

    var _isMobile = window.mobilecheck();
    if (_isMobile) {
        $('#gdpr-message-modal').addClass('mobile');
    }

    var emailValid = "",
        time = 3000,
        btnStatus = true,
        errorStatus = false,
        errormessage = "<p class='gdpr_err'><b>Please Enter a valid email address<b><p>";

    function init() {
        setTimeout(function() {
            var cookieExist = getCookie("gdpr");
            if (cookieExist) {
                //console.log("gdpr cookie exist");
                return false;
            } else {
                //console.log("gdpr cookie does not exist")
                gdprMessage();
            }
            //Events
            $('#closebtn').on("click", hideForm);

            //Handle submit
            $('#gdpr-message-btn').on("click", function(event) {
                handleClick();
            });

            // //Hide if clicked outside div - TO DO stop handling click after submit
            // $(document).click(function(event) {
            // 	event.stopPropagation();
            //   console.log(event.target);
            //   if (!$(event.target).closest("#gdpr-message-content").length) {
            //     $("body").find("#gdpr-message-modal").hide();
            //     $(this).off();
            //   }
            // });
            $('#gdpr-con-btn').click(function() {
                setCookie("gdpr", "true");
                hideForm();
            });
        }, time);
    }

    //Show the message
    function gdprMessage() {
        //console.log("Show GDPR Message");
        var tMessage, emailInput, messageButton, ewrap;

        $('#gdpr-message-modal').show();
    }

    function handleClick() {
        //console.log($("#gdpr-input").val());
        emailValid = validateEmail($("#gdpr-input").val());
        if (emailValid) {
            //Submit the form
            //Hide form
            if ($('.gdpr_err')) {
                $('.gdpr_err').hide();
            }

            $("#gdpr-message-content")
                //If successful then...
            setCookie("gdpr", "true");
            //console.log("emailValid " + emailValid + " submiting form");
        } else {
            //Show error message
            gdprErrorMessage();
            //console.log("emailValid " + emailValid);
        }
    }

    function gdprErrorMessage() {
        if (errorStatus) {
            return false;
        } else {
            errorStatus = true;
            $("#gdpr-message-content").append(errormessage);
        }
    }

    function validateEmail(email) {
        var re = /^(([^<>()\[\]\\.,;:\s@"]+(\.[^<>()\[\]\\.,;:\s@"]+)*)|(".+"))@((\[[0-9]{1,3}\.[0-9]{1,3}\.[0-9]{1,3}\.[0-9]{1,3}\])|(([a-zA-Z\-0-9]+\.)+[a-zA-Z]{2,}))$/;
        return re.test(String(email).toLowerCase());
    }

    function setCookie(name, value) {
        var expires = "";
        expires = "; expires=Fri, 31 Dec 9999 23:59:59 GMT";
        document.cookie = name + "=" + (value || "") + expires + "; path=/";
    }

    function getCookie(name) {
        var match = document.cookie.match(new RegExp(name + '=([^;]+)'));
        if (match) return match[1];
    }

    function hideForm() { //And set cookie
        $('#gdpr-message-modal').hide();
        setCookie("gdpr", "false");
        ga('send', 'event', 'Pubs GDPR', 'GDPR Modal', 'GDPR Dismissal');
    }

    return {
        init: init
    }
})();

$(document).ready(infoCentralCapture.init);
</script>





        
        <script>
    //Top nav tracking

    (function(){
        $('.header_my-activity a:first').on('click', function(e){
            e.preventDefault();
            //console.log('Button , Activity')
            ga('send', 'event', 'Top Nav', 'Button', 'Activity');
        })


        $('.pubModal_button').on('click', function(e){
            e.preventDefault();
            //console.log('Button , Publications')
            ga('send', 'event', 'Top Nav', 'Button', 'Publications');
        }) 

        $('.header_burger-menu_button').on('click', function(e){
            e.preventDefault();
            //console.log('Button , Hamburger');
            ga('send', 'event', 'Top Nav', 'Button', 'Hamburger');
        }) 

        // $('.header_burger-menu_content ul li').on('click', function(e){
        //     // e.preventDefault();
        //     var idx = $(this).index();
        //     console.log('Menu item' + idx)
        // })
    })();
    
    
</script>




        
        
<script type="text/javascript">
    adroll_adv_id = "3LBZJ4KXKBF2PJ46QCMT3X";
    adroll_pix_id = "6EITYRDI4FFGJPSZQ62UJJ";

    (function () {
        var _onload = function(){
            if (document.readyState && !/loaded|complete/.test(document.readyState)){setTimeout(_onload, 10);return}
            if (!window.__adroll_loaded){__adroll_loaded=true;setTimeout(_onload, 50);return}
            var scr = document.createElement("script");
            var host = (("https:" == document.location.protocol) ? "https://s.adroll.com" : "http://a.adroll.com");
            scr.setAttribute('async', 'true');
            scr.type = "text/javascript";
            scr.src = host + "/j/roundtrip.js";
            ((document.getElementsByTagName('head') || [null])[0] ||
                document.getElementsByTagName('script')[0].parentNode).appendChild(scr);
        };
        if (window.addEventListener) {window.addEventListener('load', _onload, false);}
        else {window.attachEvent('onload', _onload)}
    }());
</script>










        
        <div class="activity-container hidden-lg hidden-md"><div class="recentlyViewed" style="right: -100%;"><div class="activity_title_container"><span class="activity_title">Recently Viewed</span><a href="javascript:void(0)" class="activity_back"><i class="icon-angle-left"></i></a></div></div></div>




        
        <script>
$(document).ready(function(){
    var cookie = "";
    var uri = "/doi/full/10.1021/html_original_uri?id=123";
    console.log("ACSPubs2 start");
    $.getJSON('https://extreme-ip-lookup.com/json/', function(data, status) {
            if ( status == 'success' ) {
                $.each(data, function(i, field){
                    cookie=cookie.concat(i+' = '+field+" - ");
                });
                
            } else {
                    cookie=status;
            }

            cookie1 = cookie;
            cookie = cookie1 + "; path=/; domain=.acs.org";
            //document.cookie = "ACSPubs2= "+ btoa(cookie) ;
            $.cookie("ACSPubs2", btoa(cookie), {path: '/'}); // Session cookie valid across the entire site.
            //TODO send cookie val to the controller for logging
            console.log("ACSPubs2 success");
    })
    .fail(function(xx, status, err){
        cookie="error: 127.0.0.1";
        //document.cookie = "ACSPubs2= "+ btoa(cookie) ;
        $.cookie("ACSPubs2", btoa(cookie), {path: '/'}); // Session cookie valid across the entire site.
        console.log("ACSPubs2 failed");
        //TODO send cookie val to the controller for logging
    });
});    
</script>





        
        



        
    

        </div>
    </div>





	

    <script>if (typeof define !== 'undefined')
    if (define.amd)
        define.amd = false</script><script src="/products/achs/releasedAssets/js/build.lazyload.bundle-191cb5c7d88ed9894acd.js"></script><script src="/products/achs/releasedAssets/js/main.bundle-524acd43b3dccf6df3df.js"></script>

<script type="text/javascript" src="/wro/kfa7~product.js"></script>































    












<script defer src="https://static.cloudflareinsights.com/beacon.min.js" data-cf-beacon='{"rayId":"679ac3366ff23d1e","token":"d4e766cffbf14806ad37e095398b9c5f","version":"2021.7.0","si":10}'></script>
</body>
</html>
